data_1iu2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iu2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.42 ' CG ' HD12 ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.12 161.93 18.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -115.92 144.63 43.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.48 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.84 111.69 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.773 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.5 115.63 20.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.557 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -126.05 127.11 45.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -85.5 100.66 12.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.054 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.35 89.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.188 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.321 -0.287 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.496 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.557 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.81 -0.071 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 131.55 22.35 0.96 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 119.725 -1.226 . . . . 0.0 114.97 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.752 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.6 p90 -161.59 135.35 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.063 0.932 . . . . 0.0 111.224 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.434 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.55 135.47 34.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.16 147.7 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.541 0.686 . . . . 0.0 111.568 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.51 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -126.64 119.72 27.73 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.43 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 143.66 159.3 7.93 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.551 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 145.09 173.64 16.56 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.384 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 24.3 p -63.67 -14.44 52.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.79 -25.79 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -124.25 86.77 54.29 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.486 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 64.13 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.306 2.004 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.778 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.0 t60 -49.05 -27.16 3.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.527 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.653 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.45 -152.29 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.693 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.79 52.65 4.62 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.941 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 76.54 43.36 0.14 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 158.78 74.15 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.929 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 0.33 9.49 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.507 2.138 . . . . 0.0 112.569 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.1 114.92 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -89.23 119.62 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.984 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.778 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.41 147.65 36.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.34 155.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.655 -177.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.0 -32.86 4.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.753 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.33 142.11 2.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 111.424 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.51 133.35 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 122.69 76.2 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.4 Cg_endo -64.63 132.18 32.12 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.23 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.96 5.31 56.47 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.412 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.07 179.17 21.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.804 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.426 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . . . -55.66 -39.08 70.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 111.121 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . . . -66.4 -57.4 7.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.466 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.8 -28.82 67.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.382 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -72.25 -34.61 68.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.069 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.72 -57.97 3.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.16 41.23 9.53 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.474 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.4 mmp_? -113.14 -4.72 13.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.773 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.0 tp -121.44 153.66 37.58 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.019 0.438 . . . . 0.0 110.822 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.12 135.28 48.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.689 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.14 157.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 111.758 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.47 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 t30 75.41 0.99 3.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.17 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -68.55 125.18 25.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -86.55 102.23 13.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.625 . . . . 0.0 111.602 -178.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ILE . 16.4 mt -49.8 124.94 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.866 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.42 HD12 ' CG ' ' A' ' 3' ' ' TYR . 3.6 mt -109.76 -34.14 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.972 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.8 m-85 -150.27 161.22 42.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 ' CG1' ' CB ' ' A' ' 76' ' ' ALA . 6.9 p -148.7 103.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.626 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.4 ' CB ' HG22 ' A' ' 84' ' ' VAL . 6.8 t-20 70.42 -66.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.289 0.566 . . . . 0.0 109.907 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.39 29.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 1.4 t -121.01 142.0 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.492 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.0 p-10 -101.07 111.45 23.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.859 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 21.3 m -89.68 24.1 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -67.85 -22.13 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 110.734 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -145.97 44.62 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 19.0 m -117.87 148.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.403 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -67.52 151.99 46.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.54 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 9.8 t-160 -49.55 -34.1 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.533 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 20.0 m -71.76 -33.66 68.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.495 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.49 -39.72 81.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -64.32 -46.88 81.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.616 0.722 . . . . 0.0 109.226 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.7 t -59.97 -50.63 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.333 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 2.2 pt-20 -57.75 -35.12 70.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.637 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.425 ' CB ' ' CG1' ' A' ' 60' ' ' VAL . . . -55.33 -51.92 65.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.269 0.557 . . . . 0.0 110.228 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD13 ' CE1' ' A' ' 17' ' ' PHE . 6.2 mt -56.42 -36.64 69.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.533 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.32 -25.67 51.42 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.478 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.3 mt-10 -96.6 -6.96 35.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.294 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -57.62 -17.74 16.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.147 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.54 -100.74 2.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.9 m -130.45 -91.31 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 5.4 tp -87.03 86.27 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.254 0.55 . . . . 0.0 109.559 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.62 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 11.6 p -101.29 138.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.5 mtt180 -88.68 103.2 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.041 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.406 HD11 ' CD2' ' A' ' 15' ' ' LEU . 12.3 mt -92.6 138.04 31.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.722 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 133.53 46.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.404 ' CB ' ' HB3' ' A' ' 55' ' ' ASP . 3.7 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.144 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.469 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.762 0.315 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -139.83 160.2 40.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.2 mt-10 -117.08 144.9 44.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.835 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.82 111.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.886 0.374 . . . . 0.0 111.73 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.42 115.6 20.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.542 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 5.0 tp -126.09 127.08 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.25 100.4 11.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.126 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.78 88.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.067 179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.628 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.7 tp . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.65 21.01 1.05 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.716 -1.23 . . . . 0.0 114.754 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.754 ' HB3' HG21 ' A' ' 39' ' ' ILE . 6.5 p90 -161.62 135.6 6.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.999 0.9 . . . . 0.0 111.12 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.47 138.55 32.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.455 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.14 146.5 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.691 0.757 . . . . 0.0 112.228 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -138.43 134.59 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.198 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.3 -5.32 1.4 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.573 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.57 -175.36 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.113 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 68' ' ' VAL . 16.1 p -71.43 -19.23 62.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.62 -24.91 15.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.591 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 2.2 t30 -124.41 87.91 53.66 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.099 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.96 63.07 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.463 2.109 . . . . 0.0 112.631 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.73 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 50.3 t60 -50.59 -25.74 4.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.165 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.69 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.73 -151.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.513 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -82.56 49.75 4.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.843 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 76.88 45.38 0.09 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.03 153.75 78.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.39 -0.17 9.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.468 2.112 . . . . 0.0 112.657 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.87 115.24 1.9 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.943 0.402 . . . . 0.0 110.495 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.08 119.8 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.092 -179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.73 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.05 147.41 36.78 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.348 0.594 . . . . 0.0 110.461 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.14 155.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.059 -176.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.05 -31.83 4.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.986 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.41 134.24 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.042 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.754 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.52 132.93 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.26 123.84 74.65 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 36.9 Cg_endo -65.18 132.68 32.56 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 112.289 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.2 5.5 57.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.48 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.84 178.56 20.93 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.928 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.65 -37.72 68.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.757 0.313 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . . . -67.78 -57.51 6.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.417 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.53 -28.87 68.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -72.13 -34.52 68.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.063 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.5 -58.07 2.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.6 41.02 9.25 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.481 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.485 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mtm180 -113.8 6.24 16.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.6 tp -132.8 154.6 50.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.071 0.462 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.594 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -130.86 136.1 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -51.74 157.78 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.315 0.578 . . . . 0.0 111.663 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.6 -2.01 2.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.352 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.4 m-20 -67.82 126.34 29.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.65 104.14 15.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.489 0.661 . . . . 0.0 111.259 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 34' ' ' ILE . 67.8 mt -52.71 133.84 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.96 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.469 ' CD1' ' CD2' ' A' ' 3' ' ' TYR . 14.2 mt -116.62 -28.56 6.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.661 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.3 m-85 -156.29 149.54 24.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.44 105.94 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.168 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 t30 55.04 38.68 30.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 110.108 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 78.86 33.43 0.25 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.475 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 92.7 t -120.99 107.82 21.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.596 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.5 t0 -74.01 111.6 9.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.744 0.307 . . . . 0.0 110.564 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 35.0 m -96.56 29.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -59.86 -22.71 62.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -150.8 76.27 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 111.106 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.418 ' N ' HG23 ' A' ' 23' ' ' THR . 35.4 m -149.81 145.75 17.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.19 155.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.212 0.529 . . . . 0.0 111.154 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.514 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.6 p-80 -50.89 -33.7 25.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.886 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.5 t -72.14 -33.96 68.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.32 -40.8 90.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.196 0.522 . . . . 0.0 109.874 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -65.48 -46.85 78.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.668 0.747 . . . . 0.0 109.168 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 86.2 t -56.9 -50.27 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.255 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.92 -29.24 59.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.917 178.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -62.32 -51.9 65.81 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 109.81 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -55.03 -37.52 66.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.558 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -27.41 52.13 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.244 179.225 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.28 14.72 25.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.313 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.592 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -86.77 16.42 4.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.517 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.27 -92.0 0.56 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.276 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.6 m -142.19 -90.25 0.14 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.3 tp -84.67 90.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.283 0.563 . . . . 0.0 109.723 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 10.8 p -105.82 138.11 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.4 ttt180 -88.29 102.87 15.27 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 14.4 mt -91.45 138.49 31.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.239 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.65 134.51 44.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 6.2 m . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.43 ' CD2' HD12 ' A' ' 58' ' ' LEU . 4.0 m-85 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.732 0.301 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -118.84 153.01 35.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.15 144.91 31.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.481 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.492 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -137.19 110.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.443 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.73 117.61 20.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.55 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 5.0 tp -127.6 127.0 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.4 pt-20 -83.96 100.45 11.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.296 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -51.4 88.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.322 -0.23 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.586 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.55 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.5 tp . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.283 0.087 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 131.81 21.28 1.01 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.707 -1.235 . . . . 0.0 114.614 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.767 ' HB3' HG22 ' A' ' 39' ' ' ILE . 5.3 p90 -161.31 134.7 6.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.874 0.837 . . . . 0.0 110.981 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.32 135.43 34.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.566 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.88 146.07 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.593 0.711 . . . . 0.0 111.385 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.512 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -125.34 122.69 37.55 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.457 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 140.01 157.77 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.787 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.71 176.09 22.55 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 68' ' ' VAL . 17.4 p -66.54 -18.37 65.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -107.06 -27.26 10.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.69 0.281 . . . . 0.0 111.635 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.42 87.38 54.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.494 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.27 64.53 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.405 2.07 . . . . 0.0 112.545 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.746 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.8 t60 -46.23 -29.76 1.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.545 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.596 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -83.13 -155.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.412 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.31 -52.63 51.5 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.698 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 4.1 p-10 -179.34 42.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.615 0.245 . . . . 0.0 111.322 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.47 174.08 5.13 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.992 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 88.6 Cg_endo -81.4 10.78 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.658 2.239 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 112.1 1.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.079 0.466 . . . . 0.0 111.316 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -90.11 119.87 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.9 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.746 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.63 149.75 39.35 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.38 0.61 . . . . 0.0 110.897 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.41 155.72 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.436 -177.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.512 HG22 ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.72 -32.25 4.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.609 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 141.23 2.0 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.91 0.386 . . . . 0.0 111.337 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.767 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -103.38 132.98 48.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.0 124.59 74.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.2 Cg_endo -65.63 132.58 31.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.769 2.312 . . . . 0.0 112.1 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.51 5.15 56.98 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.473 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.86 176.1 19.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.797 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.43 -37.11 62.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 111.295 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -68.11 -57.41 6.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.527 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.31 -29.07 67.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.345 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -72.06 -36.08 69.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 109.979 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.35 -57.9 3.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.91 41.5 9.57 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.466 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.492 ' CB ' HG12 ' A' ' 6' ' ' ILE . 74.7 mtp180 -113.2 8.23 18.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.848 0.356 . . . . 0.0 110.644 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.8 tp -133.48 155.48 49.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.599 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.77 134.89 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.619 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -49.08 157.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.627 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.03 -2.31 2.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.203 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -64.86 124.05 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.58 100.06 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.567 0.698 . . . . 0.0 111.867 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' ILE . 35.2 mt -47.82 126.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.616 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.582 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -122.08 -5.72 8.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.585 179.161 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -171.61 143.9 1.8 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.977 0.418 . . . . 0.0 110.728 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.97 109.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.3 t30 52.85 38.59 27.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.161 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 78.73 32.29 0.3 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.92 103.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.6 p-10 -66.68 113.43 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.532 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 25.8 m -92.51 18.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.497 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -65.47 -21.29 66.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.981 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.56 45.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.425 ' N ' HG22 ' A' ' 23' ' ' THR . 17.2 m -127.35 142.74 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.059 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 153.47 31.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.011 0.434 . . . . 0.0 110.62 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 8.0 t-160 -49.33 -33.88 14.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.591 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -70.33 -33.7 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.834 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.639 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -71.42 -46.9 58.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.614 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 78.6 t -60.08 -50.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.334 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 9.2 pt-20 -57.9 -30.22 65.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.629 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -59.68 -51.12 71.15 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.329 0.585 . . . . 0.0 109.861 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.488 HD13 ' CE1' ' A' ' 17' ' ' PHE . 1.3 mt -57.46 -37.55 73.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.891 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.28 -27.51 53.13 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.603 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 5.8 pt-20 -101.06 18.03 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.309 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.596 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -86.15 16.33 4.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.408 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.33 -92.4 0.66 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.27 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -142.84 -90.05 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.3 tp -84.74 87.24 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.286 0.565 . . . . 0.0 109.745 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.596 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 10.8 p -102.29 137.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.4 mtt-85 -88.36 102.69 15.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.477 ' HB2' HG23 ' A' ' 6' ' ' ILE . 19.1 mt -91.61 132.53 36.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.582 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.46 115.11 29.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.075 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.436 ' CA ' HD22 ' A' ' 58' ' ' LEU . 1.7 m . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.661 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.426 ' CG ' HD23 ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.847 0.356 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 25.1 mt-10 -111.68 166.04 11.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 13.1 pt-20 -126.76 144.81 50.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.491 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -138.32 109.47 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.955 0.407 . . . . 0.0 112.016 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.89 121.55 25.0 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.617 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.3 tp -130.54 128.48 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 mt-10 -83.65 100.68 11.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.49 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 11.8 mtp180 -44.76 92.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.984 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.405 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.896 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.617 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 4.5 mt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.617 0.246 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 136.63 42.1 0.11 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.877 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.742 ' HB3' HG22 ' A' ' 39' ' ' ILE . 9.2 p90 -163.39 133.09 4.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.121 0.461 . . . . 0.0 110.895 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.441 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.32 136.64 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.548 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.73 148.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.669 0.747 . . . . 0.0 111.972 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -141.94 134.38 28.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.267 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 141.56 3.61 1.14 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.684 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.548 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.89 -175.75 1.49 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 40.8 p -66.39 -26.9 67.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.5 -19.21 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.42 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.34 87.53 53.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.415 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.93 60.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.292 1.995 . . . . 0.0 112.562 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.728 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.3 t60 -48.16 -27.77 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.088 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.657 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.39 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.276 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.13 -50.22 68.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.679 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.8 40.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.87 168.18 15.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.0 5.34 5.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.546 2.164 . . . . 0.0 112.81 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -54.92 113.16 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.391 . . . . 0.0 110.757 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.19 119.49 33.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.845 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.728 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.82 145.93 35.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.328 0.585 . . . . 0.0 110.436 178.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.136 -176.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.82 -31.65 4.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.146 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.549 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -171.55 136.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.748 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.742 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -100.46 131.91 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.445 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 116.19 63.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.5 Cg_exo -58.98 136.49 73.78 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.785 2.324 . . . . 0.0 112.288 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.2 15.87 42.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.604 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.19 178.27 16.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.182 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.452 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . . . -52.23 -36.18 51.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 111.397 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . . . -70.28 -56.75 5.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.36 -30.47 66.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.4 pp0? -72.12 -29.93 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.265 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.65 -57.94 3.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.529 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 40.64 9.47 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.624 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -117.83 -3.71 11.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.3 tp -123.3 153.11 40.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.956 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.38 135.88 47.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.17 157.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.337 0.589 . . . . 0.0 111.424 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.47 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.4 -3.02 2.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -64.86 125.3 24.39 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 14.2 p -86.72 100.24 12.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.5 0.667 . . . . 0.0 111.74 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.495 HD11 HG21 ' A' ' 19' ' ' ILE . 11.2 mt -52.99 127.41 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.698 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -120.0 -10.98 9.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.579 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -167.02 143.29 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.06 0.457 . . . . 0.0 110.71 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.47 112.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.233 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.87 37.0 16.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 0.0 110.164 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 79.55 34.0 0.19 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.552 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 88.9 t -120.97 107.84 21.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.479 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -71.59 110.33 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.606 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.406 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 34.7 m -95.97 40.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -24.96 59.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -143.87 61.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 26.9 m -135.62 146.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.023 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.443 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.66 155.62 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.055 0.455 . . . . 0.0 111.267 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.548 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.2 p-80 -48.23 -35.14 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.17 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -72.35 -33.85 67.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.153 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.649 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -42.87 88.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.813 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -63.06 -46.82 85.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.619 0.723 . . . . 0.0 109.169 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.602 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 91.7 t -56.85 -50.29 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.194 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.649 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.21 -30.05 61.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.902 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.64 -50.14 74.7 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.327 0.584 . . . . 0.0 109.735 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.422 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -58.85 -36.53 74.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.825 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.5 -25.25 50.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.452 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -103.09 17.87 23.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 111.213 -178.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.622 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -87.82 16.31 5.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.83 -109.85 2.95 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -120.68 -89.38 0.6 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -88.2 95.42 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 109.842 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.622 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -108.07 135.2 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.7 ptm180 -87.52 102.87 15.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.415 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HB2' HG21 ' A' ' 6' ' ' ILE . 19.4 mt -89.78 132.94 34.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.563 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.77 120.01 39.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.5 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 -179.707 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.418 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 40.1 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.729 0.299 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -117.17 159.47 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.93 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 pt-20 -120.23 144.67 47.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.462 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -136.85 109.56 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.988 0.423 . . . . 0.0 111.768 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.18 112.2 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 tp -122.91 127.19 48.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.4 pt-20 -83.92 100.29 10.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.287 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -47.83 88.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.254 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.323 -0.178 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.6 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.9 tp . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 110.659 -0.126 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 127.67 26.16 1.07 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 114.77 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.762 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.9 p90 -163.71 132.11 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.016 0.908 . . . . 0.0 111.266 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.7 139.62 30.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.707 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -121.37 146.57 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -138.46 135.43 35.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.353 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.91 -3.41 1.52 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.655 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.519 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.33 -174.78 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.06 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.4 p -71.52 -21.27 61.93 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -22.29 16.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 111.48 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 1.5 t-20 -124.27 87.66 53.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.166 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.72 62.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.368 2.045 . . . . 0.0 112.71 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.739 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 46.6 t60 -50.98 -26.16 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.031 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.686 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.25 -151.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.477 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -82.89 49.01 4.14 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.858 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.23 45.88 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.475 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 154.14 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.98 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.71 0.26 9.39 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.497 2.131 . . . . 0.0 112.692 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.71 115.65 2.27 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.917 0.389 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.482 HD12 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.21 119.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.075 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.739 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.24 147.05 35.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.358 0.599 . . . . 0.0 110.492 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.12 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.339 -176.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.14 -31.77 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.52 134.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.051 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.83 132.51 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 125.37 72.83 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.6 Cg_endo -65.94 132.26 29.72 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.738 2.292 . . . . 0.0 112.226 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.01 56.66 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.486 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.68 177.07 20.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.944 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.95 -37.46 63.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.763 0.315 . . . . 0.0 111.173 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -68.7 -57.6 5.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.54 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.18 -34.74 68.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.226 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.81 -58.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.4 40.88 9.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.726 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.462 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mmt180 -111.13 -5.98 14.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.846 0.355 . . . . 0.0 110.759 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.603 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.4 tp -119.13 156.15 30.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.751 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.39 134.91 45.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.818 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.558 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -51.51 157.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 121.243 0.544 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.1 OUTLIER 75.29 -1.54 3.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.36 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 m-20 -69.76 129.35 39.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.76 104.03 15.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.646 0.736 . . . . 0.0 111.491 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 34' ' ' ILE . 72.5 mt -50.71 138.65 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 2.1 mm? -116.67 -44.15 2.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.372 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -143.62 172.71 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.783 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 62' ' ' GLU . 44.9 t -149.88 97.11 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.821 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.491 ' HB2' HG22 ' A' ' 84' ' ' VAL . 1.5 t-20 67.82 -67.56 0.18 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.138 0.494 . . . . 0.0 109.775 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mt-10 -156.41 32.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.479 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -118.58 142.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.559 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 16.1 p-10 -111.09 108.93 18.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.173 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.6 m -92.82 40.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 111.66 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.51 70.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.78 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -152.87 70.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.95 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 27.6 m -135.87 146.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.7 152.58 26.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 0.0 110.826 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.519 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.6 p-80 -48.55 -33.86 10.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.01 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.19 -33.82 70.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.542 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.4 -42.14 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -64.48 -46.89 81.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.582 0.706 . . . . 0.0 109.123 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 83.9 t -56.57 -50.39 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.205 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.86 -30.11 60.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.053 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.3 -50.42 73.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 109.909 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -58.53 -36.05 73.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.861 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.5 -29.21 52.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.494 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -99.64 18.46 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -178.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.604 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -87.22 16.17 5.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.273 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.66 -94.11 0.66 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.18 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.0 p -140.49 -90.65 0.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.0 tp -83.84 89.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.185 0.517 . . . . 0.0 109.718 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.604 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 11.5 p -105.17 137.01 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.96 103.0 15.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 15.5 mt -91.24 142.68 27.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.174 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.76 139.58 37.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.692 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.3 m . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.788 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.423 ' CG ' HD12 ' A' ' 58' ' ' LEU . 2.4 m-30 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.836 0.351 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.9 153.86 39.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 85' ' ' ARG . 1.8 tt0 -108.01 138.36 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.645 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.422 ' CD1' ' CD1' ' A' ' 51' ' ' LEU . 1.1 mt -132.69 109.17 14.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.05 112.16 15.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 tp -121.91 126.84 49.58 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -87.81 99.54 12.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.021 178.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -57.79 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.573 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.889 -179.231 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 8' ' ' LEU . 6.4 tp . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 72.64 30.24 64.39 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.751 ' HB3' HG21 ' A' ' 39' ' ' ILE . 10.0 p90 -164.64 135.38 4.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.354 1.077 . . . . 0.0 111.745 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.463 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -100.91 137.63 39.03 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.659 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -116.74 150.84 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.723 0.773 . . . . 0.0 112.293 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -145.79 134.58 22.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.31 2.92 0.92 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.633 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.561 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.67 -173.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.005 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 33.2 p -70.57 -26.01 63.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -94.24 -24.05 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 4.0 m-20 -124.47 87.98 53.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 63.89 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.316 2.011 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.744 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 40.9 t60 -47.26 -28.32 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.315 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.675 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.06 -155.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.385 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -56.25 -50.91 59.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.691 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.89 39.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.18 166.08 23.78 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.838 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.76 7.28 4.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.52 2.147 . . . . 0.0 112.727 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -57.01 114.25 2.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.85 0.357 . . . . 0.0 110.779 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.522 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.39 118.07 29.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.795 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.744 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.48 147.21 37.49 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.187 0.518 . . . . 0.0 110.732 178.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.92 155.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.902 -176.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.49 -29.93 4.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.223 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.38 125.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.291 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.49 127.43 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 125.37 72.49 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.9 138.39 78.67 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.716 2.278 . . . . 0.0 112.206 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 14.1 64.4 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.377 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . -107.05 -159.16 21.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.886 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -75.97 -38.72 57.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.832 0.316 . . . . 0.0 110.987 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -74.41 -54.19 8.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.893 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -33.72 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.162 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 13.5 mm-40 -72.45 -32.39 66.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.41 -57.98 3.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.63 38.34 8.91 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -120.29 1.92 10.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 29.5 tp -128.07 162.98 25.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.163 0.506 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.608 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.45 137.35 26.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.708 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.99 157.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.328 0.585 . . . . 0.0 111.629 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t-20 75.73 -0.52 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.328 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -69.34 126.75 30.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.66 101.99 13.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.585 0.707 . . . . 0.0 111.492 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' ILE . 68.0 mt -48.81 137.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.581 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 5.2 mt -119.01 -32.9 4.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -150.13 160.13 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.577 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 t -152.42 110.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 t30 47.92 50.19 16.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 73.29 31.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 77.8 t -120.85 141.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.0 p-10 -109.47 109.57 20.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.664 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 32.5 m -94.01 43.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.247 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -30.17 68.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -149.87 67.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.768 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.5 m -135.02 148.1 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.433 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.04 154.35 39.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.561 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 7.4 p-80 -49.17 -34.15 13.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.098 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -69.57 -33.93 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.37 -42.58 83.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 109.793 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -64.09 -46.62 83.42 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 88.0 t -56.61 -50.4 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.21 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.29 -29.85 59.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.949 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.96 -50.77 70.81 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.2 mt -57.01 -37.16 71.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.484 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.64 -23.62 49.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.957 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 5.0 pt-20 -93.6 3.21 55.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.032 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.689 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -90.28 16.3 8.92 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.46 -121.86 27.96 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.748 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -104.19 -87.12 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.2 tp -82.59 107.82 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.689 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 7.1 p -127.05 137.72 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.424 ' N ' HG21 ' A' ' 84' ' ' VAL . 13.2 mtp180 -83.49 103.07 12.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.373 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -94.92 142.12 27.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.017 0.436 . . . . 0.0 111.363 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.66 131.43 49.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.304 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.626 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.494 ' CG ' HD21 ' A' ' 58' ' ' LEU . 5.8 m-30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.822 0.344 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.19 141.93 51.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 17.0 pt-20 -99.46 144.66 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.483 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -136.43 109.42 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.372 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.81 118.39 20.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.563 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 5.0 tp -128.51 127.18 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.1 pt-20 -84.06 100.63 11.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.195 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -51.63 89.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.111 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.339 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.613 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.563 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.9 tp . . . . . 0 CA--C 1.527 0.068 0 N-CA-C 110.637 -0.135 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 133.93 20.27 0.86 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.928 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.733 ' HB3' HG22 ' A' ' 39' ' ' ILE . 7.0 p90 -161.18 135.91 7.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.055 0.927 . . . . 0.0 111.381 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.44 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 135.82 34.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -115.27 148.03 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -130.46 124.85 32.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.71 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 25' ' ' ASN . . . 158.3 -120.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.874 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 63.83 168.29 1.27 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.12 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.401 ' N ' ' HA ' ' A' ' 69' ' ' THR . 25.1 p -70.18 -1.98 11.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.411 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 35.4 t70 -117.08 -22.52 8.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' HIS . 4.3 m-80 -124.72 85.89 56.41 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.61 65.74 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.008 1.805 . . . . 0.0 112.477 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.738 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 48.7 t60 -55.09 -23.62 21.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.173 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.678 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -94.75 -150.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.377 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -82.26 51.65 4.52 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.692 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 t0 76.25 43.53 0.15 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 110.414 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.53 156.77 79.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.9 0.03 10.22 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.507 2.138 . . . . 0.0 112.599 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -55.2 120.09 6.5 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.108 0.48 . . . . 0.0 111.313 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.62 118.68 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.738 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.98 146.84 36.07 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.316 0.579 . . . . 0.0 110.463 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.23 155.78 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.042 -176.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.35 -33.51 4.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.772 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.82 142.04 2.37 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.483 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -103.92 133.58 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 115.0 57.79 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.6 Cg_exo -56.07 136.87 77.22 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.89 2.393 . . . . 0.0 112.405 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.91 2.57 66.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.1 176.39 22.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.111 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -52.47 -38.41 59.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . . . -68.18 -57.41 6.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.659 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.59 -35.35 80.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.081 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.1 pp0? -71.96 -30.07 64.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 0.0 110.471 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.89 -58.07 3.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.598 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 41.39 9.81 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.593 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.483 ' CB ' HG12 ' A' ' 6' ' ' ILE . 5.5 mtm180 -117.09 -1.19 11.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -126.56 153.53 45.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.85 135.26 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.688 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.5 157.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.339 0.59 . . . . 0.0 111.619 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 75.79 -0.27 3.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.26 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -67.45 124.4 23.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.59 100.33 12.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 111.549 -178.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 34' ' ' ILE . 12.1 mt -49.89 132.65 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.674 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.494 HD21 ' CG ' ' A' ' 3' ' ' TYR . 1.8 pp -130.04 -0.01 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.114 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 179.16 134.64 0.09 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.409 ' HA ' HD21 ' A' ' 86' ' ' LEU . 40.7 t -120.02 97.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.692 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 t30 71.32 -61.82 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -164.3 31.24 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.084 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.3 t -120.99 110.43 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' N ' ' CE1' ' A' ' 59' ' ' PHE . 6.7 t0 -72.47 112.37 8.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.79 0.328 . . . . 0.0 110.593 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 m -94.92 27.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.5 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -67.81 -25.54 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.44 51.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.19 148.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.006 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -68.42 154.53 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 9.2 t-160 -48.29 -34.86 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.044 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 4.0 m -68.6 -33.76 74.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.244 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.642 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.6 -33.09 68.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.21 0.529 . . . . 0.0 109.598 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB3' HD13 ' A' ' 34' ' ' ILE . . . -71.59 -46.76 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.616 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 67.9 t -60.58 -50.86 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.303 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -57.14 -29.32 63.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.69 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.404 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -61.16 -52.19 65.87 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.905 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 19' ' ' ILE . 3.0 mt -56.6 -37.27 70.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.909 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.6 -28.33 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -97.37 15.93 21.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.295 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.614 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -88.11 16.28 6.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.39 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.54 -96.05 0.55 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.422 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -136.09 -90.2 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.0 tp -84.5 93.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 109.879 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 9.1 p -109.81 136.39 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.2 ptt180 -87.01 103.05 14.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.273 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 15' ' ' LEU . 15.1 mt -91.78 134.51 34.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.119 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.491 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.56 125.35 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.728 -179.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 3.1 m-85 . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.66 0.267 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 4.3 pt-20 -129.0 164.62 22.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.978 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -121.45 144.77 48.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.94 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.493 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.59 112.12 13.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.638 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.12 115.36 20.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.555 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 4.6 tp -125.44 128.76 48.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -89.48 100.84 13.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.698 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -45.6 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.342 0.591 . . . . 0.0 109.801 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.363 0 CA-C-N 114.835 -1.075 . . . . 0.0 114.168 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.1 tp . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.397 0.141 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 134.93 19.61 0.79 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.674 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.759 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -161.04 135.08 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.006 0.903 . . . . 0.0 111.19 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.37 138.86 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.466 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.65 147.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 112.037 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -139.98 134.98 32.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.283 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.4 1.23 0.92 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.409 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.34 -173.79 0.92 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.885 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 28.7 p -66.83 -32.6 73.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -90.43 -20.7 22.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 20.7 t-20 -124.28 87.29 53.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.617 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.91 61.49 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.277 1.985 . . . . 0.0 112.387 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 49.2 t60 -47.9 -27.75 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.202 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.66 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.43 -153.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -57.2 -50.17 66.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.681 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.48 40.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.724 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 168.5 14.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.87 6.5 4.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.814 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 113.34 1.36 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.513 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.31 119.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.72 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.23 147.46 36.53 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.265 0.555 . . . . 0.0 110.456 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.02 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.121 -176.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.65 -34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.661 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.15 143.14 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.044 0.449 . . . . 0.0 111.737 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.759 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.46 132.79 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.458 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.2 124.54 73.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.0 Cg_endo -65.39 133.14 33.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 112.209 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.53 5.96 57.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.384 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.66 175.06 18.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.868 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HB1' ' HG ' ' A' ' 8' ' ' LEU . . . -52.8 -36.15 57.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.721 0.296 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -68.89 -57.46 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.466 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.6 -29.04 67.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.401 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.02 -34.99 69.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.101 0.477 . . . . 0.0 110.005 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -84.75 -58.05 2.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.602 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 41.78 9.46 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.464 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.493 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.4 mmt85 -112.88 9.01 18.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.704 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.6 tp -134.34 155.1 50.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.635 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -132.09 133.52 44.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.881 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -49.4 157.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.79 -1.11 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.368 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.83 126.46 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.61 103.88 15.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.525 0.678 . . . . 0.0 111.361 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ILE . 64.2 mt -50.83 152.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.863 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -136.58 -39.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.474 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -142.58 159.52 42.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.402 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 35.9 t -152.5 113.78 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 49.84 44.87 25.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.773 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 72.86 32.62 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.595 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 68.6 t -120.37 142.19 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.7 p-10 -108.8 111.05 22.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.54 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 30.3 m -79.21 57.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.967 0.413 . . . . 0.0 110.948 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.62 103.02 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.85 53.81 1.41 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.442 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 16.7 m -119.85 142.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.444 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -62.99 154.21 31.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.075 0.465 . . . . 0.0 111.226 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.52 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.8 p-80 -48.09 -34.16 9.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -70.69 -33.98 71.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.94 -45.06 83.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 0.0 109.764 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -62.21 -46.92 86.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.299 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 84.9 t -56.55 -50.35 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.319 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.585 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.06 -29.35 57.31 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.971 178.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.479 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.78 -52.07 65.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.397 0.618 . . . . 0.0 109.759 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.461 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.1 mt -56.61 -36.16 69.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.872 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.36 -30.53 53.84 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.674 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -98.29 19.82 13.63 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.406 -178.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.617 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -88.99 16.26 7.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.37 -101.4 1.15 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.237 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.1 t -130.28 -89.29 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 2.1 tp -88.41 91.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 109.919 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 8.9 p -105.11 137.18 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.72 102.63 14.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.485 ' HB2' HG21 ' A' ' 6' ' ' ILE . 15.9 mt -89.48 139.62 30.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.75 132.86 47.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.718 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.387 179.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 1.4 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.795 0.331 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -102.04 170.78 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.13 144.95 51.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.97 109.65 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.992 0.425 . . . . 0.0 111.966 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.27 119.53 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.1 tp -132.03 127.15 35.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.3 pm0 -83.94 100.38 10.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.823 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HA ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.77 89.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.519 0.326 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.788 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 21.3 mt . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.98 0.419 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.85 32.82 0.54 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.436 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.768 ' HB3' HG22 ' A' ' 39' ' ' ILE . 10.8 p90 -158.86 135.97 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.068 0.434 . . . . 0.0 111.026 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.44 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.76 137.93 34.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.38 146.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.762 0.792 . . . . 0.0 112.377 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -139.77 133.59 30.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.096 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.463 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.36 -0.43 1.09 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.731 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.65 -173.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.919 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 37.2 p -69.09 -30.65 69.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.21 -20.86 21.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.35 87.23 54.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.425 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.63 61.79 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.349 2.033 . . . . 0.0 112.635 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 46.2 t60 -48.89 -27.55 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.671 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -91.23 -152.27 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.195 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.449 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -83.89 49.4 4.22 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.591 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.29 48.21 0.06 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 110.223 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.88 150.45 71.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.18 -5.23 15.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.674 2.249 . . . . 0.0 112.669 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.1 113.96 1.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.041 0.448 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -83.69 118.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.512 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.66 147.36 39.17 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.357 0.599 . . . . 0.0 110.69 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.05 155.71 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.017 -176.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.45 -29.6 4.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.252 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.76 130.57 0.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.176 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.768 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.61 129.75 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.27 116.87 67.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.7 134.47 60.89 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.67 2.247 . . . . 0.0 112.287 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.73 31.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.551 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.84 177.61 17.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -52.32 -34.77 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.425 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -70.77 -56.65 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.97 -31.1 65.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -72.0 -30.12 64.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.375 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.0 -57.96 3.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.97 9.57 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.615 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.492 ' CB ' HG12 ' A' ' 6' ' ' ILE . 44.1 mtt-85 -118.14 5.81 12.01 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.95 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -134.59 153.39 51.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.189 0.519 . . . . 0.0 111.026 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.58 137.35 49.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -52.19 157.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.344 0.592 . . . . 0.0 111.563 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.08 0.01 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.35 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.48 127.42 32.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 103.8 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.539 0.685 . . . . 0.0 111.339 -178.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ILE . 69.6 mt -51.0 139.95 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.633 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.41 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.85 -37.08 3.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.5 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -148.68 165.41 31.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.76 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 62' ' ' GLU . 39.4 t -142.07 97.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.73 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.417 ' HB2' HG22 ' A' ' 84' ' ' VAL . 3.7 t-20 68.53 -67.07 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.076 0.465 . . . . 0.0 109.771 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.4 mt-10 -157.37 33.36 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.582 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.4 t -120.59 142.36 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -107.19 108.38 19.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.393 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 21.1 m -92.23 45.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.347 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -25.47 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -149.58 58.07 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.996 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 27.2 m -128.27 149.05 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.434 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.44 153.79 42.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 111.018 -179.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.557 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 2.2 t-160 -49.86 -34.14 19.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -69.62 -33.87 73.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.749 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.32 -42.68 79.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.498 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -62.79 -46.89 85.89 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.3 t -57.49 -50.41 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.259 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.663 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -30.03 61.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.889 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.476 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.76 -50.21 74.38 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.341 0.591 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -59.53 -35.82 74.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.961 179.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.44 -25.79 50.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.348 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -102.58 16.78 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.36 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.585 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -85.9 16.27 4.26 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 -92.49 0.69 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.061 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 22.5 t -143.06 -89.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 8.8 tp -84.47 88.23 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.217 0.532 . . . . 0.0 109.811 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 12.4 p -103.93 139.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.0 mtt-85 -88.15 102.82 15.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.434 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 12.9 mt -91.8 138.61 31.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.259 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.6 m-85 -101.66 138.66 38.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.586 179.995 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.431 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 22.5 m-85 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 142.36 18.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -106.24 144.63 32.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -137.03 109.41 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.46 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.39 121.22 24.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.633 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -132.05 127.38 36.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 pt-20 -85.57 101.07 12.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.853 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.453 ' NE ' ' HA ' ' A' ' 78' ' ' LYS . 11.2 mtp180 -47.79 94.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.384 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.317 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.633 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.17 44.14 0.07 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.978 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.738 ' HB3' HG21 ' A' ' 39' ' ' ILE . 12.5 p90 -164.55 134.16 3.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.149 0.474 . . . . 0.0 110.875 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.443 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.75 136.52 33.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.525 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.26 146.81 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.753 0.787 . . . . 0.0 112.247 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -140.0 132.86 29.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.13 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.424 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.5 3.61 0.71 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.707 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.75 -171.11 0.67 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.8 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 39.1 p -70.42 -29.14 65.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.97 -21.0 20.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.9 OUTLIER -124.38 87.32 54.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.524 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 62.2 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.266 1.977 . . . . 0.0 112.459 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.706 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.5 t60 -47.46 -28.12 2.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.327 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.49 -154.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.3 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.68 -50.09 70.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.604 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.37 40.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.48 165.84 25.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 3.5 Cg_exo -74.98 1.21 7.98 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.967 2.445 . . . . 0.0 112.815 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.46 112.3 0.79 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.034 0.445 . . . . 0.0 111.16 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.513 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.05 118.54 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.47 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.706 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.99 147.2 38.33 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.352 0.596 . . . . 0.0 110.841 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.11 155.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.911 -176.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.83 -29.02 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.189 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.4 131.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.998 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.738 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.59 132.29 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.32 114.23 53.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.8 Cg_exo -57.83 137.43 81.0 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.709 2.273 . . . . 0.0 112.326 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.77 54.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.568 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 179.5 16.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.113 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -54.69 -36.44 64.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.188 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -68.05 -57.68 5.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 0.0 111.87 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.75 -28.29 65.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.53 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.64 -30.21 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.362 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.91 -57.87 3.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.14 37.74 10.91 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.574 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.434 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.6 mtt85 -112.44 -13.36 13.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.2 tp -114.69 154.82 27.76 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 111.408 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -133.11 135.71 45.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.691 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.84 157.41 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.195 0.521 . . . . 0.0 111.747 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.86 0.28 3.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.329 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.95 126.26 29.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.3 t -86.58 100.25 12.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.715 0.769 . . . . 0.0 111.316 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 34' ' ' ILE . 69.9 mt -46.83 135.21 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.708 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.45 -42.29 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.052 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.2 m-85 -142.36 169.99 16.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.73 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 t -150.04 99.12 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.218 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 t30 67.04 -67.61 0.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.167 0.508 . . . . 0.0 109.874 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.42 32.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.668 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.7 t -119.46 142.25 35.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.564 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.7 t0 -112.08 87.55 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 65' ' ' VAL . 24.9 m -70.22 63.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -29.9 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.691 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -149.03 58.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.493 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.8 m -123.91 146.67 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.246 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -65.81 154.94 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.533 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.5 p-80 -48.21 -34.65 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.1 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 p -71.58 -33.75 69.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.169 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.623 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.93 -45.49 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -60.86 -46.85 88.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.587 0.708 . . . . 0.0 109.162 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.649 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 86.8 t -57.12 -49.25 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.403 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.97 -30.15 63.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.957 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.77 -49.71 76.4 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.333 0.587 . . . . 0.0 109.679 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.425 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -59.94 -34.65 73.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.859 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.9 mmmt -77.36 -28.1 52.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.426 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.86 18.49 19.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 -178.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.48 16.29 6.71 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.39 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -111.03 3.42 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.155 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -119.68 -90.26 0.58 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.0 tp -87.28 93.68 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.976 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.637 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -105.81 138.59 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 49.1 mtp180 -88.67 102.96 15.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 13.0 mt -90.56 141.61 28.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.213 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 136.03 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.683 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.625 0.25 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 1.6 mp0 -115.42 153.01 31.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -107.84 144.82 34.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.456 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.461 HD13 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.77 109.63 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 111.704 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -80.0 122.3 26.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.3 tp -131.54 126.85 35.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 12.8 mt-10 -80.31 99.99 8.17 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.279 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.28 88.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.085 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.441 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.545 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.8 tp . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.41 0.148 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 132.42 20.64 0.99 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.765 -1.207 . . . . 0.0 114.486 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.796 ' HB3' HG22 ' A' ' 39' ' ' ILE . 6.0 p90 -159.28 135.52 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.608 0.704 . . . . 0.0 110.847 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.425 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -95.27 135.2 37.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -113.89 146.6 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.543 0.687 . . . . 0.0 111.552 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 37' ' ' THR . . . -126.59 120.7 30.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.628 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 141.92 159.24 7.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.783 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.64 175.56 22.02 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 26.6 p -65.87 -12.19 52.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -114.96 -26.35 7.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.53 87.37 54.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.466 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.94 66.06 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.365 2.043 . . . . 0.0 112.329 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.75 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 31.7 t60 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.656 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.648 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -85.96 -155.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.438 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.01 -50.1 69.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.746 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.03 76.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 110.701 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' CB ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -166.63 176.69 1.71 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 31' ' ' ASP . 94.1 Cg_endo -85.36 26.77 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.729 2.286 . . . . 0.0 112.543 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 m -77.21 112.29 13.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.59 118.85 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.009 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.75 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.34 148.15 37.47 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.259 0.552 . . . . 0.0 110.789 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.31 155.87 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.81 -177.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.502 HG21 ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.31 -30.65 4.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.098 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.46 132.59 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.896 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.26 131.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.417 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 115.69 61.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.5 Cg_exo -57.72 134.79 65.23 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.731 2.288 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 8.12 56.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.43 179.75 18.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.903 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.08 -38.8 68.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 111.064 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -65.44 -57.46 8.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.25 -28.93 66.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.27 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.76 -57.94 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.632 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.06 9.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.602 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.1 mtt-85 -115.25 -6.18 12.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.4 tp -121.23 154.06 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.162 0.506 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.586 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.46 135.45 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.552 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.21 157.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 0.0 111.538 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.466 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER 77.06 -2.27 2.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -64.94 124.63 22.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.49 100.22 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.472 0.653 . . . . 0.0 111.615 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 34' ' ' ILE . 38.0 mt -48.51 125.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.565 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.585 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -117.42 -16.46 10.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.739 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -164.64 142.59 6.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.114 0.483 . . . . 0.0 110.94 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.4 ' CG1' ' CD2' ' A' ' 86' ' ' LEU . 38.6 t -136.98 112.18 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.393 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 50.69 39.29 21.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.918 0.389 . . . . 0.0 110.276 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.67 33.83 0.36 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.564 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.7 t -120.9 103.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.307 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 10.3 t0 -65.99 108.05 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 25.3 m -87.39 8.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.638 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.64 -21.32 53.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.634 0.254 . . . . 0.0 111.051 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -139.21 42.04 2.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.185 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 8.3 m -124.42 144.71 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.412 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.48 153.92 41.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.93 0.395 . . . . 0.0 110.613 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.46 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 13.3 t-160 -48.76 -34.43 12.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 2.7 m -70.06 -33.68 72.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.608 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.04 -33.2 71.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -70.64 -46.79 62.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.612 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.8 t -59.57 -50.76 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.352 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 3.5 pt-20 -57.69 -31.82 66.75 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.605 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -58.11 -49.75 75.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.328 0.585 . . . . 0.0 110.022 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.47 HD12 ' CE1' ' A' ' 17' ' ' PHE . 1.3 mt -59.8 -37.33 78.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.983 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.31 -25.74 51.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.699 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 6.4 pt-20 -103.26 17.75 23.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.191 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.602 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -85.73 16.15 4.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.16 -93.77 0.6 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.321 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 28.1 t -141.06 -90.63 0.15 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.2 86.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.3 0.571 . . . . 0.0 109.706 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 9.7 p -100.27 137.57 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.114 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 6.0 ttt180 -89.4 102.65 15.32 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.43 HD12 HD23 ' A' ' 77' ' ' LEU . 19.0 mt -91.46 133.65 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.585 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.99 114.77 29.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.826 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.413 ' CA ' HD22 ' A' ' 58' ' ' LEU . 3.7 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.779 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.412 ' CG ' HD13 ' A' ' 58' ' ' LEU . 6.4 m-30 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.825 0.345 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -143.86 149.79 37.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.6 mt-10 -104.51 144.62 31.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.489 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.91 109.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.382 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.72 114.95 19.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 tp -125.78 127.27 45.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.4 pt-20 -84.24 100.49 11.24 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.38 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.09 89.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.257 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.736 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 5.1 tp . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 128.82 25.91 0.97 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.765 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.737 ' HB3' HG21 ' A' ' 39' ' ' ILE . 5.7 p90 -164.27 132.27 3.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.862 0.831 . . . . 0.0 111.363 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.39 137.13 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.331 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -116.22 161.76 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.767 0.794 . . . . 0.0 112.092 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -155.51 131.91 10.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.777 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.504 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 15.01 0.26 Allowed Glycine 0 C--O 1.229 -0.16 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.468 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -73.04 -174.14 26.45 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.2 p -66.93 -32.71 74.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -85.09 -33.35 22.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.514 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.65 77.21 64.14 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 28' ' ' ILE . 3.6 Cg_endo -46.02 -24.25 2.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.736 2.29 . . . . 0.0 112.679 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.692 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.4 t60 58.94 -59.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.251 0.548 . . . . 0.0 111.497 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.627 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -66.28 -158.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.659 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.45 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -60.99 -49.45 78.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.484 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 179.39 75.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.56 156.99 14.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.2 5.73 4.38 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.857 2.371 . . . . 0.0 112.937 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -60.51 111.76 1.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.804 0.335 . . . . 0.0 110.707 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -79.76 121.45 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.263 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.692 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.2 OUTLIER -142.23 147.2 36.13 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.419 0.628 . . . . 0.0 110.446 178.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.51 155.35 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.142 -0.935 . . . . 0.0 113.139 -176.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.98 -32.94 4.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.803 -179.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.563 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.13 143.67 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.616 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.737 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.27 132.27 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.44 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 116.78 66.43 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.8 Cg_exo -56.62 136.87 78.46 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.594 2.196 . . . . 0.0 112.305 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.61 1.98 67.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.689 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.55 174.83 24.06 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.864 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.418 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -52.84 -35.32 57.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.868 0.334 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -70.55 -57.44 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.485 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.0 -28.92 68.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.397 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -72.05 -35.36 69.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.049 0.452 . . . . 0.0 109.968 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.58 -57.77 3.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.523 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 40.88 9.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.599 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.489 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.49 9.55 19.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.794 0.33 . . . . 0.0 110.689 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.7 tp -136.3 153.8 51.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.549 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -131.2 134.37 46.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -48.98 157.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 111.83 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.5 t-20 76.56 -0.26 3.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.387 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.02 125.93 28.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.46 102.61 14.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.614 0.721 . . . . 0.0 111.199 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' ILE . 61.6 mt -50.91 134.74 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.776 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.412 HD13 ' CG ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -117.47 -30.54 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -152.47 163.69 39.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 62' ' ' GLU . 19.3 t -144.05 97.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.029 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.415 ' HB2' HG22 ' A' ' 84' ' ' VAL . 4.7 t30 68.13 -67.36 0.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 6.2 pt-20 -156.54 32.41 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.691 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 59.0 t -119.78 142.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.496 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 p-10 -110.0 99.51 8.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.437 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 30.8 m -83.54 56.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.906 0.384 . . . . 0.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -29.09 26.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -147.36 56.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 31.7 m -126.22 144.39 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.14 151.77 34.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.556 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.4 t-160 -47.95 -33.98 8.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.717 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -33.99 75.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.977 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.671 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.18 -42.16 80.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -63.04 -46.65 86.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.631 0.729 . . . . 0.0 109.124 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.6 t -57.62 -50.56 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.193 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.34 -29.57 61.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.89 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.04 -50.66 72.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.318 0.58 . . . . 0.0 109.862 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.1 mt -58.11 -37.14 73.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.836 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.51 -28.31 52.06 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.15 18.11 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 -178.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -87.04 16.38 5.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.246 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 -97.08 0.8 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.275 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.483 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.4 m -136.9 -90.44 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 8.7 tp -84.86 89.97 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.23 0.538 . . . . 0.0 109.737 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 11.4 p -104.84 138.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.9 ttm-85 -87.95 103.12 15.39 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 14.6 mt -92.37 138.6 31.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.241 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.69 132.44 47.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.3 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.883 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.422 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 4.0 m-30 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.819 0.343 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -154.98 159.64 40.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -109.57 144.68 37.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.448 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.69 109.6 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 111.599 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.444 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.38 121.03 23.22 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -132.3 127.25 35.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.5 mt-10 -83.29 100.2 10.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.841 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -46.57 89.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.338 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.321 -0.301 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.747 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 20.1 mt . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.87 0.367 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.89 34.72 0.47 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.446 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.76 ' HB3' HG21 ' A' ' 39' ' ' ILE . 10.1 p90 -160.1 136.56 8.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.133 0.466 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.5 137.05 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.294 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.26 148.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.729 0.776 . . . . 0.0 112.355 -179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.75 133.8 27.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.065 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.41 4.77 0.88 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.725 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.537 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -61.49 -169.72 0.72 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.902 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 43.4 p -70.95 -29.89 66.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -93.54 -19.85 20.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.42 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 3.8 t-20 -124.46 87.43 54.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.91 61.24 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.32 2.013 . . . . 0.0 112.46 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.714 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.8 t60 -47.19 -28.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -88.79 -154.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.208 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -59.45 -49.9 73.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.51 40.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 0.0 110.799 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.85 165.59 27.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.22 1.6 7.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.956 2.437 . . . . 0.0 112.754 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 t -52.62 112.07 0.76 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.978 0.418 . . . . 0.0 111.185 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.507 HD12 ' HB1' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.88 118.52 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.524 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.714 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.31 147.2 37.76 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.422 0.629 . . . . 0.0 110.622 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.94 155.72 7.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.064 -176.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.06 -30.4 4.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.165 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.25 130.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.995 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.76 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.19 130.86 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 126.06 70.67 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.4 Cg_endo -67.71 132.11 26.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.71 2.273 . . . . 0.0 112.34 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.39 26.89 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.333 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.24 177.54 16.9 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.022 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.49 -34.39 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.747 0.308 . . . . 0.0 111.487 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 39' ' ' ILE . . . -70.62 -57.45 4.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.832 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.48 -28.82 64.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.603 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.74 -32.83 68.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 110.337 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.14 -57.89 3.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.685 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.57 9.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.717 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.448 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.7 mtm180 -113.93 -7.62 13.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.739 0.304 . . . . 0.0 110.821 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.5 tp -121.2 154.02 36.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.079 0.466 . . . . 0.0 111.209 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.564 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -130.95 135.88 48.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.604 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -49.03 157.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.244 0.545 . . . . 0.0 111.454 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.9 t30 76.87 -2.02 2.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.111 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -65.47 124.54 22.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.1 p -86.5 100.76 12.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.52 0.676 . . . . 0.0 111.233 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' ILE . 65.8 mt -49.99 130.37 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.875 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.7 mt -112.91 -34.04 5.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.113 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.7 m-85 -151.09 159.41 44.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.438 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 76' ' ' ALA . 7.7 p -146.69 105.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.409 ' CB ' HG21 ' A' ' 84' ' ' VAL . 18.7 t30 68.62 -67.18 0.21 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.137 0.494 . . . . 0.0 109.992 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -162.46 29.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.047 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 1.4 t -121.01 142.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.279 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 18.0 t0 -106.36 90.75 3.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 30.3 m -70.54 63.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.429 . . . . 0.0 111.567 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -26.64 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -147.6 55.27 1.07 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 29.4 m -124.69 146.97 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.61 154.44 40.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.226 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.8 p-80 -48.12 -34.61 10.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.2 p -71.95 -33.75 68.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.197 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.668 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -45.39 80.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -60.61 -46.58 89.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.582 0.706 . . . . 0.0 109.203 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.639 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 93.7 t -57.5 -50.47 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.245 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.668 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.86 -30.36 63.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.091 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.07 -49.79 75.9 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.28 0.562 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.451 HD13 ' CE1' ' A' ' 17' ' ' PHE . 4.0 mt -59.25 -35.54 73.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.739 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -77.31 -23.26 51.06 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.12 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -105.34 16.96 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.042 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.599 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -85.54 16.21 4.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.147 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -97.16 0.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.171 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 25.8 t -138.07 -89.09 0.24 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -85.98 87.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.264 0.554 . . . . 0.0 109.626 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.599 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 12.4 p -101.94 140.18 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -87.97 103.18 15.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.458 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 11.8 mt -91.76 139.01 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.64 131.98 47.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.244 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.855 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.458 ' CG ' ' CD2' ' A' ' 58' ' ' LEU . 3.7 m-30 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.703 0.287 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.1 144.57 38.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.085 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 43.9 mt-10 -102.33 144.69 30.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -138.19 109.39 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 111.563 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.33 121.53 23.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.605 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -132.27 128.2 37.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 pt-20 -86.96 100.9 12.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 6.6 mtp180 -43.72 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.935 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.433 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.042 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.727 0.299 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 135.67 39.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.484 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.749 ' HB3' HG21 ' A' ' 39' ' ' ILE . 7.5 p90 -161.79 137.31 7.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.986 0.393 . . . . 0.0 110.708 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.8 134.33 40.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.624 -179.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -113.51 146.92 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.588 0.709 . . . . 0.0 111.684 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -127.37 121.57 31.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.464 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 140.69 159.62 8.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.007 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 148.86 175.59 21.47 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.359 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 25.0 p -66.71 -11.69 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -114.62 -26.59 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 111.684 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.44 87.2 54.41 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.57 66.21 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.301 2.001 . . . . 0.0 112.579 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.753 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.8 t60 -48.43 -27.81 2.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.376 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.643 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -87.13 -155.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.437 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -52.83 -51.7 43.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.964 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.958 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.52 175.73 3.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.99 35.41 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.671 2.247 . . . . 0.0 112.445 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -84.84 114.77 22.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 110.903 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.69 118.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.066 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.753 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.15 148.03 37.61 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.344 0.593 . . . . 0.0 110.719 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.39 155.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.516 -177.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.492 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.13 -29.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.163 -178.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.34 130.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.785 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.62 132.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.438 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.33 125.56 71.71 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.1 Cg_endo -68.05 132.55 26.52 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 112.365 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.33 19.26 21.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.346 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.86 179.12 16.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.349 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -54.39 -33.31 59.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.653 0.263 . . . . 0.0 111.479 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -73.36 -56.0 5.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.45 -29.08 63.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.4 pt20 -72.19 -31.85 66.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.274 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.88 -57.94 3.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.4 11.9 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.592 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.407 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.67 -15.76 13.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.766 0.283 . . . . 0.0 110.863 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.5 tp -113.9 153.37 29.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.21 0.529 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.546 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.99 136.28 48.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.574 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.2 t -49.08 157.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.363 0.601 . . . . 0.0 111.543 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER 76.82 -1.04 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.302 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -66.51 124.52 23.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -86.54 100.48 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.55 0.691 . . . . 0.0 111.432 -178.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 34' ' ' ILE . 27.4 mt -48.3 135.61 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.596 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' CD2' ' CG ' ' A' ' 3' ' ' TYR . 3.0 pp -139.92 12.79 2.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 170.82 134.74 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.317 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -123.91 95.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.299 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 73.26 -60.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 27.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.475 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 40.8 t -121.27 109.11 24.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.993 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -70.48 120.81 16.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.512 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.401 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 22.1 m -93.99 20.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -22.63 66.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.116 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.26 44.18 1.89 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.059 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 16.7 m -124.41 145.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.036 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.407 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER -66.07 153.65 41.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.558 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.447 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 14.9 t-160 -49.14 -34.2 13.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.744 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -70.86 -33.76 70.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.7 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.648 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.05 -31.67 69.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.471 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -71.56 -46.96 57.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.631 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 81.8 t -60.48 -50.54 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.283 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -58.33 -34.89 71.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.39 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.22 -49.34 72.22 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.426 0.631 . . . . 0.0 110.09 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD11 ' CE1' ' A' ' 17' ' ' PHE . 1.8 mt -59.65 -36.01 75.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.591 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.36 -21.95 52.51 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mt-10 -102.05 -6.33 23.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.684 0.278 . . . . 0.0 111.383 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -59.71 -17.74 37.04 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.251 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.0 -117.04 5.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.921 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 m -110.68 -89.29 0.5 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -90.92 90.91 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.296 0.569 . . . . 0.0 109.732 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.626 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -103.89 138.29 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.05 102.89 15.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.457 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 14.1 mt -89.78 134.7 34.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.423 ' CD2' ' HG3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -101.91 116.52 32.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.271 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.644 0.259 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -113.2 163.87 14.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 111.065 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 68.8 mt-10 -114.16 144.6 42.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.78 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.444 ' O ' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -132.39 109.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.501 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.455 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.26 120.67 23.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.595 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -132.29 127.22 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.6 pt-20 -85.9 100.84 12.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.192 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 9.7 mtp180 -42.77 91.85 0.0 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.35 0.595 . . . . 0.0 110.835 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.56 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.117 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 11.9 mt . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.781 0.324 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . 131.97 38.25 0.26 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.594 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HB3' HG21 ' A' ' 39' ' ' ILE . 8.1 p90 -160.44 135.36 7.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.006 0.403 . . . . 0.0 110.729 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.41 136.84 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.525 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.21 148.84 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.743 0.783 . . . . 0.0 112.337 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -143.25 133.22 24.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.12 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.89 -2.95 1.24 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.184 -1.007 . . . . 0.0 113.879 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.04 -173.16 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.951 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 68' ' ' VAL . 19.9 p -73.09 -20.9 60.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -96.35 -24.61 16.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.585 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.36 87.52 53.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.211 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.73 63.17 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.384 2.056 . . . . 0.0 112.652 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.4 t60 -49.78 -26.58 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.15 -154.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.323 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.91 -50.04 71.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.615 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.72 40.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.09 169.19 12.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.35 3.5 7.42 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.566 2.178 . . . . 0.0 112.74 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -53.61 111.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.883 0.373 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -83.55 119.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.838 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.715 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.23 147.22 36.15 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 121.361 0.601 . . . . 0.0 110.779 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.96 155.6 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.803 -177.011 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.452 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.6 -29.53 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.286 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.99 130.19 0.49 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.001 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.769 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.5 131.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.448 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 124.33 74.25 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.0 Cg_endo -66.2 132.58 30.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.348 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.81 17.46 25.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.437 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 177.39 17.27 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.042 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.68 -32.76 52.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 111.444 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.458 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -71.55 -57.3 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.799 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.15 -29.02 63.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.477 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -71.95 -33.32 68.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.148 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -79.37 -58.05 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.38 39.97 10.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.592 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 6' ' ' ILE . 19.2 mmt180 -115.88 -4.75 12.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 110.814 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.1 tp -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.577 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 134.55 42.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.487 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.09 157.5 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.319 0.58 . . . . 0.0 111.681 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.5 OUTLIER 77.01 -1.61 2.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.174 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.17 125.55 26.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.26 12.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.753 0.787 . . . . 0.0 111.435 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ILE . 65.8 mt -47.35 138.35 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.887 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.31 -44.42 2.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.1 m-85 -142.52 167.14 22.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.771 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 62' ' ' GLU . 23.4 t -142.22 97.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.788 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.439 ' HB2' HG23 ' A' ' 84' ' ' VAL . 3.8 t-20 67.57 -67.99 0.17 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.093 0.473 . . . . 0.0 109.775 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.2 tt0 -155.71 33.71 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.481 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.1 t -120.73 142.49 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.636 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.7 p-10 -106.95 111.23 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.29 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 18.2 m -95.32 31.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.801 0.334 . . . . 0.0 111.54 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -29.16 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.766 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.85 65.91 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 27.2 m -136.19 147.12 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.274 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.54 153.01 33.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.544 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 2.0 t-160 -50.51 -33.75 22.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -34.02 73.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.756 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.29 -39.96 81.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -65.11 -46.99 78.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.644 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 84.6 t -57.02 -50.34 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.253 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.38 -30.69 63.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.026 178.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.475 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.44 -49.78 76.2 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.405 0.622 . . . . 0.0 109.908 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -60.27 -34.76 74.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.48 -26.77 51.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.361 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.84 15.54 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.383 -178.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.22 16.28 6.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.172 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.98 -114.01 5.57 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.989 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.4 m -114.99 -89.36 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.1 tp -86.77 97.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.993 0.425 . . . . 0.0 110.222 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.637 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -111.37 138.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 mtt85 -88.16 103.24 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 12.8 mt -91.12 142.97 27.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.74 136.07 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.768 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.86 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.415 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 20.6 m-85 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.778 0.323 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -144.42 147.46 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.968 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.63 144.74 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.23 109.26 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.033 0.444 . . . . 0.0 111.439 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.25 122.96 25.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.588 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tp -134.23 127.05 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -82.4 100.43 10.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -50.33 92.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.514 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.286 -179.173 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.588 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 8.4 mt . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 120.733 0.302 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 138.2 39.12 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.632 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.765 ' HB3' HG21 ' A' ' 39' ' ' ILE . 7.8 p90 -160.17 134.29 7.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.093 0.446 . . . . 0.0 110.764 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.68 133.43 37.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.714 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -111.67 162.98 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.711 0.767 . . . . 0.0 111.632 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 27' ' ' HIS . . . -160.36 132.61 6.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.357 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 -2.8 1.47 Allowed Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.464 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.74 -175.57 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.138 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 32.2 p -67.97 -29.1 68.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.78 -20.49 20.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -124.17 87.02 53.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.71 61.74 0.86 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.354 2.036 . . . . 0.0 112.645 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 28.8 t60 -47.57 -29.09 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.033 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.607 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.74 -155.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.194 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.88 -49.52 47.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.46 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -178.17 49.01 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.897 0.379 . . . . 0.0 111.231 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.08 159.16 70.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.1 3.41 7.45 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.647 2.232 . . . . 0.0 112.691 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.43 119.43 5.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.976 0.417 . . . . 0.0 110.931 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -84.71 119.19 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.567 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.72 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.24 144.71 33.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.48 0.657 . . . . 0.0 110.783 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.714 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.74 155.94 7.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.311 -176.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.12 -29.82 4.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.343 -178.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.552 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.97 131.57 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.931 -179.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.765 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.37 115.3 59.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.5 Cg_exo -58.11 136.48 75.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.697 2.265 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 19.96 27.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.48 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.48 179.54 16.83 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.175 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -52.65 -36.55 57.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.859 0.361 . . . . 0.0 111.531 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -68.86 -57.41 5.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.2 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.55 -28.39 62.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.781 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -29.91 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.257 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.49 -57.86 3.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.88 37.19 11.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.602 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.417 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtt180 -112.33 -14.43 13.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.713 0.292 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 7.1 tp -113.75 156.82 23.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.267 0.556 . . . . 0.0 111.374 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -135.09 134.66 40.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.413 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.552 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 52.9 t -49.04 157.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.248 0.547 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.4 OUTLIER 75.15 2.51 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.091 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.62 127.07 31.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.48 102.5 14.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 111.306 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.3 mt -49.7 131.2 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.814 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 3.4 mm? -109.63 -43.17 4.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.106 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -143.16 164.94 28.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.813 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.61 98.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.991 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 68.09 -66.89 0.21 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.126 0.488 . . . . 0.0 109.992 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -157.65 33.24 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.687 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.7 t -120.73 142.4 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.582 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.1 t0 -109.04 95.29 5.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.337 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.4 m -80.28 58.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 0.0 111.48 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -85.22 -31.52 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.757 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.68 52.69 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.4 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 27.3 m -121.16 148.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.436 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.06 153.4 43.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.547 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.4 t-160 -49.44 -34.1 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.792 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.9 m -68.71 -34.09 75.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.785 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.35 -42.05 79.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -63.4 -46.91 84.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.661 0.743 . . . . 0.0 109.076 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.602 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 84.5 t -57.31 -50.39 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.231 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.82 -29.89 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.864 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.482 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.14 -50.22 74.09 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.305 0.574 . . . . 0.0 109.847 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -58.78 -36.31 74.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.955 179.115 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.61 -25.16 49.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.452 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.53 16.38 26.53 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.32 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.616 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -87.38 16.3 5.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.241 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.35 -98.32 0.82 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.063 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 8.5 p -136.4 -90.38 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.5 tp -83.37 88.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 109.875 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.616 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 9.2 p -104.14 139.6 24.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.87 103.06 15.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 6' ' ' ILE . 12.2 mt -90.96 141.17 29.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.442 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.85 138.48 38.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.849 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.403 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 78.1 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.791 0.329 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -138.32 167.24 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HG3' ' CD1' ' A' ' 87' ' ' TYR . 5.6 tt0 -121.18 144.64 48.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.13 109.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.866 0.365 . . . . 0.0 111.739 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -82.02 112.19 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.9 tp -121.68 127.31 50.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.9 pt-20 -83.83 100.54 11.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.07 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.72 89.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.078 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.238 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.556 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.5 tp . . . . . 0 N--CA 1.457 -0.09 0 N-CA-C 110.731 -0.1 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.28 22.05 1.01 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 119.745 -1.216 . . . . 0.0 114.809 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.75 ' HB3' HG22 ' A' ' 39' ' ' ILE . 10.5 p90 -161.4 136.51 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.035 0.918 . . . . 0.0 111.143 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.42 135.22 38.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.656 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.719 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -115.44 146.93 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.628 0.728 . . . . 0.0 111.367 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -128.83 124.07 34.41 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.706 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 25' ' ' ASN . . . 159.85 -121.81 1.07 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.074 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 69.54 172.22 9.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.361 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 68' ' ' VAL . 4.3 p -77.85 -5.55 51.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.17 -23.14 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.516 ' O ' ' O ' ' A' ' 21' ' ' GLY . 2.6 t-20 -124.91 85.96 56.95 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.488 0.185 . . . . 0.0 110.57 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.153 1.902 . . . . 0.0 112.425 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.733 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.1 t60 -53.8 -24.36 15.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.053 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.649 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.79 -153.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.337 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.436 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -65.35 -47.62 77.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.757 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.19 79.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 110.676 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -172.75 164.01 3.69 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.67 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.7 50.94 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.503 2.135 . . . . 0.0 112.174 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -99.28 116.65 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -89.99 112.49 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.459 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.733 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -137.31 146.76 45.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.125 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.719 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.05 155.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.169 -176.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.481 HG22 ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.52 -30.36 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.04 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.12 131.04 0.48 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.031 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.75 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.88 132.8 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 115.26 59.32 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.3 Cg_exo -57.19 134.45 64.19 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.824 2.349 . . . . 0.0 112.201 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.25 4.02 59.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.642 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.55 179.39 22.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.801 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -55.66 -37.61 68.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -67.35 -57.45 6.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.56 -28.84 68.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.296 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.35 68.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 110.001 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -82.86 -58.02 3.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 40.88 9.22 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.539 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.485 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER -115.6 6.98 14.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.94 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.7 tp -135.24 154.76 51.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.993 0.425 . . . . 0.0 110.843 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.09 137.07 47.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.7 t -51.6 159.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.138 0.494 . . . . 0.0 111.716 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.485 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 m120 71.95 3.68 4.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.32 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.7 m-20 -74.63 128.37 35.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.85 105.25 16.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.564 0.697 . . . . 0.0 111.388 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' ILE . 68.5 mt -51.09 141.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.602 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -121.61 -44.31 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.496 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -143.18 148.61 36.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.335 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 54.5 t -139.54 112.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.026 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 50.81 35.8 13.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.129 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 80.23 33.94 0.16 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.501 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 78.1 t -120.93 108.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 t0 -71.26 117.18 12.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.713 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.8 m -101.89 23.45 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.301 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -62.84 -25.52 68.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -146.07 57.4 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.181 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.454 ' N ' HG22 ' A' ' 23' ' ' THR . 31.8 m -132.79 141.83 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.231 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.68 152.35 26.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.84 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 20.1 t-160 -47.99 -34.02 8.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.883 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -34.24 77.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.66 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.27 -40.62 77.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -64.0 -46.93 82.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.9 t -56.09 -50.86 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.391 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.76 -29.29 62.45 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.153 178.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.11 -56.72 18.18 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.359 0.6 . . . . 0.0 110.044 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 2.0 mp -53.86 -36.4 62.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.34 -27.29 52.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.659 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.417 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.26 15.67 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.0 111.47 -178.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -86.81 16.32 4.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.316 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.03 -89.33 0.13 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.384 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.501 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -143.44 -88.87 0.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 4.2 tp -84.4 91.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 9.4 p -107.06 135.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.1 ptt180 -86.81 102.96 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.48 ' HB2' HG23 ' A' ' 6' ' ' ILE . 12.8 mt -91.63 143.56 26.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.083 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.412 ' CD1' ' HG3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -101.68 139.71 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.523 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.9 m . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.805 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 36.1 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.769 0.318 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 133.31 21.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -97.17 144.61 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.474 HG23 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.0 109.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.863 0.364 . . . . 0.0 111.833 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -79.83 114.55 18.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 tp -120.78 127.05 51.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.819 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.8 pt-20 -80.59 99.92 8.36 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.44 88.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.901 178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.225 -179.012 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.5 tp . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.306 0.098 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.6 25.19 1.3 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.849 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.751 ' HB3' HG22 ' A' ' 39' ' ' ILE . 4.5 p90 -161.82 134.75 6.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.854 0.827 . . . . 0.0 111.256 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.444 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.67 134.16 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -110.96 168.26 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.686 0.755 . . . . 0.0 111.677 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -165.43 132.2 2.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.319 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.4 0.54 1.16 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.545 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.551 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.015 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 68' ' ' VAL . 16.6 p -74.42 -22.45 59.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -97.18 -23.76 16.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.693 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.32 87.7 53.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.365 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.84 63.16 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.339 2.026 . . . . 0.0 112.742 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.718 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.0 t60 -47.53 -28.47 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.638 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.85 -155.1 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.239 179.46 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.47 -47.49 56.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.597 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t0 177.23 76.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.818 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.37 165.26 7.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.861 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.12 6.68 5.42 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.657 2.238 . . . . 0.0 112.79 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.39 112.17 1.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -82.52 119.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.585 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.718 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.44 146.0 34.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.522 0.677 . . . . 0.0 110.668 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.79 155.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.415 -176.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.21 -30.46 4.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.347 -178.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.45 132.21 0.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.051 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.751 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.88 132.0 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.3 118.12 70.41 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.8 Cg_exo -58.01 135.29 67.72 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.363 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.1 3.02 62.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.845 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.77 178.49 23.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.057 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -55.58 -34.62 64.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.011 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HA ' HD23 ' A' ' 8' ' ' LEU . . . -71.82 -56.92 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.679 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.19 -30.28 70.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.94 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -72.06 -33.45 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -57.93 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.71 9.16 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.614 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.455 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.2 mtp85 -113.27 8.12 17.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.804 0.335 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.565 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -136.65 154.73 50.56 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.053 0.454 . . . . 0.0 110.816 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.565 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 tpm_? -131.76 136.3 47.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.56 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -51.58 157.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 111.564 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.2 t30 74.07 3.15 4.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.177 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -73.73 127.0 31.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.42 100.97 12.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.659 0.743 . . . . 0.0 111.296 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' ILE . 62.5 mt -46.24 149.51 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.813 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.439 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -127.62 -45.71 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.387 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -143.03 157.78 44.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.081 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 62' ' ' GLU . 41.7 t -132.55 95.73 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.873 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.42 ' HB2' HG23 ' A' ' 84' ' ' VAL . 2.9 t-20 68.85 -66.93 0.23 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.166 0.508 . . . . 0.0 109.896 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -155.59 32.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.654 179.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 86.4 t -120.7 142.2 37.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.512 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 24.5 t0 -107.86 112.15 24.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.424 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 23.8 m -94.18 36.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 111.513 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -65.07 -31.54 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.721 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.28 68.09 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.423 ' N ' HG21 ' A' ' 23' ' ' THR . 27.0 m -137.62 145.05 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.281 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.2 150.56 34.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.757 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.551 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.7 t-160 -48.1 -33.78 8.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.75 -34.1 76.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.027 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.67 -39.91 80.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -65.82 -46.92 76.81 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.646 0.736 . . . . 0.0 109.081 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 97.2 t -57.2 -50.55 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.206 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.57 -30.48 60.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.953 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.482 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.63 -50.57 72.97 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.41 0.624 . . . . 0.0 110.018 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.1 mt -58.55 -37.17 75.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.045 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -26.41 50.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.505 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.43 18.89 20.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 0.0 111.306 -178.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.584 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -87.77 16.25 6.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.531 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.31 -86.69 0.41 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.635 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' LEU . 38.1 m -147.67 -90.87 0.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.4 tp -84.17 90.68 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.452 0.644 . . . . 0.0 109.743 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 7.8 p -105.92 135.06 45.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.294 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.6 ttt180 -85.21 102.89 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 15.3 mt -92.05 140.9 29.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.969 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.55 141.18 34.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.713 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.1 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.581 179.947 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 4.6 m-30 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.828 0.347 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -151.18 146.15 25.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.8 pt-20 -100.74 144.57 29.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.45 110.0 9.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.895 0.379 . . . . 0.0 111.521 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.43 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -76.92 121.48 23.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.603 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.4 tp -134.22 127.1 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.1 pt-20 -85.89 100.88 12.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.344 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.441 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 8.0 mtp-105 -44.94 92.37 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.22 0.533 . . . . 0.0 110.897 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.315 -0.608 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.13 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.603 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 11.3 mt . . . . . 0 N--CA 1.455 -0.221 0 CA-C-O 120.84 0.353 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.77 39.17 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.086 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.767 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.9 p90 -162.51 132.38 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.345 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -92.48 137.29 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.134 0.492 . . . . 0.0 111.724 -179.046 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -120.3 142.11 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.661 0.744 . . . . 0.0 111.95 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -106.06 117.2 33.41 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 34' ' ' ILE . . . -71.21 -158.72 3.09 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.44 -44.09 0.12 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.734 -0.746 . . . . 0.0 114.571 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.754 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -69.02 -58.9 3.47 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.67 -34.2 30.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.09 0.471 . . . . 0.0 110.52 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' HIS . 11.1 t-20 -124.44 87.7 53.92 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.248 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.75 64.98 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.288 1.992 . . . . 0.0 112.538 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.76 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.3 t60 -57.53 -21.82 40.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.724 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.692 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -96.61 -150.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -85.19 44.22 3.35 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.885 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 76.18 30.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.961 0.41 . . . . 0.0 110.738 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.47 146.92 38.56 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.9 55.27 3.84 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.52 2.146 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -121.01 108.88 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.581 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 2.7 mp -79.49 131.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.76 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -142.89 152.82 42.5 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.213 0.53 . . . . 0.0 110.27 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -69.41 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.553 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.432 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -123.08 -26.12 4.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.978 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -176.53 131.73 0.21 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.868 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.767 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.49 130.37 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.446 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.36 114.16 53.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.1 Cg_exo -56.22 139.96 86.8 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.599 2.199 . . . . 0.0 112.205 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.2 15.24 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.522 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.55 174.69 16.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.986 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -30.64 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.251 . . . . 0.0 111.129 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -72.94 -57.52 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 111.823 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.66 -28.58 63.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.535 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -72.02 -30.84 65.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 110.382 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.53 -57.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.16 37.0 10.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.711 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 4.57 11.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.821 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 16.3 tp -132.73 159.81 38.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.218 0.532 . . . . 0.0 111.173 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -139.44 152.77 47.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 77.8 t -65.75 158.9 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.054 0.454 . . . . 0.0 111.271 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 55.3 m-80 77.27 -6.35 2.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.714 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -64.44 125.86 25.99 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.87 104.39 16.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.611 0.719 . . . . 0.0 111.773 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.498 ' CD1' HG21 ' A' ' 34' ' ' ILE . 46.1 mt -48.2 138.89 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.794 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 3' ' ' TYR . 1.1 mt -126.4 -37.75 2.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.471 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -147.17 156.67 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.405 ' CG1' ' CD2' ' A' ' 86' ' ' LEU . 47.8 t -141.21 102.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.232 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.95 -68.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.098 0.475 . . . . 0.0 110.247 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.86 31.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.929 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.8 t -120.79 142.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.281 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.8 p-10 -101.65 108.18 19.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 ' CG2' ' CG2' ' A' ' 57' ' ' ILE . 26.7 m -97.26 30.72 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.311 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.53 -37.45 75.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 110.725 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.25 56.32 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.505 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 23' ' ' THR . 33.6 m -114.59 141.03 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.159 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.754 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 1.8 p -51.06 150.16 3.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.223 0.535 . . . . 0.0 112.0 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.563 ' HA ' ' HA3' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -47.09 -32.99 4.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.527 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 3.6 m -73.81 -33.31 64.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.387 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.79 -32.12 70.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.042 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.55 -46.89 58.2 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.636 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 94.0 t -60.29 -50.66 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.733 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.7 pt-20 -58.31 -31.48 67.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.497 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -58.39 -49.26 77.9 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.308 0.575 . . . . 0.0 109.795 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 1.5 mt -61.25 -34.67 75.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.186 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.14 -29.06 54.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.512 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.7 pt-20 -98.79 15.39 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.525 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.652 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.57 16.3 6.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.35 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.21 -114.76 6.57 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.078 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.424 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.9 OUTLIER -113.59 -88.87 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.1 tp -86.72 100.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.122 0.487 . . . . 0.0 110.113 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.652 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -114.96 139.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.3 103.02 15.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.483 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 15.2 mt -91.84 137.22 32.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.511 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.87 131.56 48.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 2.5 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.134 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 3.0 m-30 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.751 0.31 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -115.16 165.02 13.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 111.251 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -120.0 145.01 47.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.836 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.511 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -134.15 110.98 14.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 111.931 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.435 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.35 117.15 20.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.1 tp -128.28 126.83 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.0 pt-20 -85.24 100.45 11.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.537 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.0 88.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.15 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.703 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.55 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.2 tp . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.361 0.124 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.77 21.95 0.97 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.65 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.743 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.8 p90 -161.42 137.46 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.736 0.768 . . . . 0.0 111.055 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.44 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.04 133.21 40.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.38 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -110.03 165.06 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.657 0.741 . . . . 0.0 111.76 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -162.64 132.11 4.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.262 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.84 0.66 0.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.42 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.15 -170.7 0.34 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.859 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.462 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 23.9 p -69.81 -32.62 71.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.79 -19.72 23.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.14 86.79 53.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.633 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.59 60.2 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.292 1.995 . . . . 0.0 112.547 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.675 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.8 t60 -47.8 -28.71 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.145 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.23 -153.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.14 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.438 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -66.29 -47.83 68.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.413 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.32 46.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.349 . . . . 0.0 110.835 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.97 161.74 61.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.03 -2.78 12.54 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.864 2.376 . . . . 0.0 112.689 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -49.16 113.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.929 0.395 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -85.7 119.19 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.46 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.675 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.46 146.45 34.8 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.526 0.679 . . . . 0.0 110.794 178.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.92 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.954 -176.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.443 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.19 -28.68 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.337 -178.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.56 129.64 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.071 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.743 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.49 133.05 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.33 129.95 55.93 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 56.0 Cg_endo -70.0 130.24 18.71 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.784 2.323 . . . . 0.0 112.304 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 2.65 55.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.64 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.49 179.23 24.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.078 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . . . -56.79 -35.48 68.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 111.065 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -71.9 -56.75 5.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.82 -31.89 72.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.93 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.1 pt20 -72.11 -33.73 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 110.159 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.43 -57.91 3.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.01 41.27 9.65 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.627 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.494 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -113.31 7.02 17.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.947 0.403 . . . . 0.0 110.795 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.3 tp -135.97 154.16 51.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.564 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.37 135.54 48.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -49.7 157.95 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.556 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.4 t30 75.05 2.18 3.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -70.45 123.37 21.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.53 100.42 12.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.889 0.852 . . . . 0.0 111.54 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' ILE . 20.0 mt -49.18 142.79 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.392 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.439 HD21 ' CZ ' ' A' ' 3' ' ' TYR . 1.4 mt -124.54 -37.84 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.069 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 m-85 -143.8 164.3 30.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -151.54 103.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.264 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.26 42.46 31.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.86 32.68 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.599 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 88.9 t -120.92 112.75 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.417 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 t0 -80.8 110.43 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 33.4 m -83.09 55.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.8 105.67 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.12 48.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 11.8 m -116.1 142.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.977 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.462 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -61.29 152.01 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.505 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.2 t-160 -49.6 -33.76 16.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.211 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.761 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.596 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.64 -43.22 80.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -63.89 -46.88 82.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.569 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 94.0 t -57.48 -48.45 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.285 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.596 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.88 -31.74 63.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.764 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.511 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -59.8 -53.11 61.83 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.211 0.529 . . . . 0.0 109.797 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.2 mt -52.49 -37.44 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.262 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.57 -27.8 51.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.082 178.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.2 mm-40 -84.08 -19.97 33.41 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 110.602 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -53.03 -18.81 2.24 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.628 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.78 -92.75 1.83 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.8 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -129.99 -92.34 0.44 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.8 tp -86.59 100.97 10.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.178 0.513 . . . . 0.0 110.442 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 80' ' ' ALA . 7.4 p -116.06 138.77 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 102.87 14.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.511 ' HB2' HG22 ' A' ' 6' ' ' ILE . 12.2 mt -93.37 135.59 34.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.57 135.46 43.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.743 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.808 -179.979 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.433 ' CG ' HD13 ' A' ' 58' ' ' LEU . 11.2 m-30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.746 0.308 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.9 mm-40 -145.13 168.29 20.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 0.0 111.287 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -118.05 144.79 45.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.5 HG21 HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -133.88 110.53 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 111.653 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.426 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.48 120.5 22.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.614 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.2 tp -132.58 127.45 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.0 pt-20 -86.56 100.88 12.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.588 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 2.6 mtp-105 -42.76 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.994 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.418 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.061 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.614 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.799 0.333 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . 135.34 39.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.598 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.755 ' HB3' HG22 ' A' ' 39' ' ' ILE . 7.4 p90 -161.69 133.85 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.483 . . . . 0.0 111.161 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.08 134.62 34.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.287 -179.489 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -112.93 162.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.675 0.75 . . . . 0.0 111.731 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -158.76 131.76 7.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.046 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.51 -1.3 0.98 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.504 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.14 -168.93 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.94 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.2 p -77.09 -23.49 51.86 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -94.87 -25.32 16.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.329 . . . . 0.0 111.557 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 27' ' ' HIS . 23.6 m-80 -124.65 82.82 59.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.6 64.24 0.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.912 2.408 . . . . 0.0 112.66 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.746 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.4 t60 -50.68 -24.27 3.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.374 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.713 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.12 -154.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.762 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -80.1 52.48 4.27 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.733 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 74.76 30.53 0.99 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.08 147.76 40.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.073 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.76 -2.71 11.33 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.812 2.342 . . . . 0.0 112.88 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -53.99 116.55 2.62 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.035 0.445 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.518 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.84 120.19 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.375 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.746 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.52 144.93 33.17 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.456 0.646 . . . . 0.0 110.642 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.78 155.68 7.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.307 -176.529 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.486 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.67 -33.79 4.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.846 -178.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.52 142.49 2.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.517 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.19 132.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.321 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.96 125.17 73.54 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 46.2 Cg_endo -68.15 131.94 24.86 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.784 2.322 . . . . 0.0 112.413 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.04 27.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.27 178.96 16.37 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.203 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . . . -52.35 -38.86 59.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.732 0.301 . . . . 0.0 111.461 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HB1' ' CG2' ' A' ' 39' ' ' ILE . . . -67.98 -57.11 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.43 -30.32 65.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -72.08 -30.59 65.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.948 0.404 . . . . 0.0 110.354 179.67 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 -58.03 3.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.514 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.92 9.62 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.527 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.49 ' CB ' HG12 ' A' ' 6' ' ' ILE . 23.8 mtm180 -115.75 -3.99 12.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.808 0.304 . . . . 0.0 110.944 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.1 tp -122.57 153.94 38.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.883 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.562 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -131.8 135.86 47.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.865 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.41 158.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.307 0.575 . . . . 0.0 111.725 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.27 1.87 3.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.028 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -70.06 124.85 25.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.41 101.06 12.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.16 -178.694 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ILE . 55.8 mt -49.44 129.68 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.703 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.433 HD13 ' CG ' ' A' ' 3' ' ' TYR . 7.9 mt -110.75 -31.7 7.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -151.05 166.42 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 t -148.91 100.45 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.219 179.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.411 ' CB ' HG23 ' A' ' 84' ' ' VAL . 14.0 t30 67.58 -67.31 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 110.065 -178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -157.92 32.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.711 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 49.5 t -119.57 142.21 36.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.529 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 30.1 t0 -111.65 84.96 2.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.362 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 32.6 m -69.39 64.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.55 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -87.03 -28.09 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -151.31 59.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.5 m -127.78 145.38 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.261 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 150.66 27.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.526 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 2.4 t-160 -48.29 -33.42 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -68.22 -34.04 75.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.072 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.11 -40.87 82.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -64.26 -46.84 81.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.021 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 89.0 t -57.74 -50.31 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.308 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -56.16 -34.31 66.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.647 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.458 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -56.58 -51.38 68.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.241 0.543 . . . . 0.0 110.109 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 19' ' ' ILE . 2.9 mt -56.22 -36.43 68.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.416 179.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.2 mmmt -77.47 -24.62 50.18 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.33 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -95.81 -10.11 29.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 111.327 -178.858 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -57.81 -17.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.387 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.98 -109.76 3.74 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.8 m -118.84 -90.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.9 tp -89.21 89.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.257 0.551 . . . . 0.0 109.735 178.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.611 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -103.54 140.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -87.73 102.98 15.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.083 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.431 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 13.2 mt -91.89 137.67 32.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.109 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.68 134.39 44.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.091 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.154 -179.441 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.451 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.3 m-30 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.771 0.319 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -132.65 160.61 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -107.37 144.67 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -135.04 109.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.91 0.386 . . . . 0.0 111.507 179.796 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.22 119.08 20.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.5 tp -130.81 127.33 38.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -86.68 99.41 11.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.647 179.443 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -54.49 92.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.868 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--O 1.229 -0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 114.597 -177.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 6.1 tp . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.706 0.289 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 81.7 25.0 54.76 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.77 ' HB3' HG22 ' A' ' 39' ' ' ILE . 8.0 p90 -161.75 132.23 4.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.424 1.112 . . . . 0.0 111.857 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.53 138.75 32.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.83 -179.302 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.52 147.12 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.608 0.718 . . . . 0.0 111.939 179.756 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 134.4 31.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.183 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.463 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.9 -3.12 1.49 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.631 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.568 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.78 -176.19 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.045 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 43.1 p -66.81 -30.33 70.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -93.56 -18.33 22.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 87.0 54.06 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.08 61.13 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.329 2.019 . . . . 0.0 112.606 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 30.7 t60 -48.34 -28.32 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.04 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.611 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -85.47 -154.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.218 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.44 -49.82 48.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.439 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -178.44 47.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.383 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.66 160.89 64.8 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.142 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.51 2.46 8.09 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 112.749 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -53.49 117.31 3.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.004 0.43 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.512 HD12 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.69 118.51 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.71 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.715 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.25 147.51 40.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.362 0.601 . . . . 0.0 110.599 178.453 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.06 155.5 7.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.8 -176.796 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.07 -33.71 3.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.528 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 142.29 2.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.063 0.458 . . . . 0.0 111.679 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.77 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.23 128.62 60.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.625 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 127.54 66.41 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 19.4 Cg_endo -60.2 137.99 78.61 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.759 2.306 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.65 -0.46 82.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.454 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.71 -179.99 38.82 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.084 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -55.26 -40.5 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.518 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . -73.05 -54.99 7.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.468 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -63.94 -28.96 70.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.283 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -72.35 -36.54 68.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.005 0.431 . . . . 0.0 110.069 179.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -57.93 2.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.07 39.27 8.06 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.751 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.472 ' CB ' HG12 ' A' ' 6' ' ' ILE . 69.6 mtt-85 -112.98 8.5 18.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.906 0.353 . . . . 0.0 110.711 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.2 tp -133.02 153.72 51.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.543 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.1 137.75 49.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.836 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -51.65 157.88 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 111.732 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.475 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.5 t-20 76.92 -2.4 2.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.491 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -67.04 124.89 24.3 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.043 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 t -86.63 100.37 12.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.572 0.701 . . . . 0.0 111.129 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 34' ' ' ILE . 59.9 mt -49.15 140.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.899 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.437 HD23 ' CD2' ' A' ' 3' ' ' TYR . 2.6 mp -121.71 -32.36 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.552 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -150.86 164.23 36.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.791 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.9 t -141.92 97.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 t30 69.6 -65.84 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.111 0.482 . . . . 0.0 109.875 -178.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 32.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.709 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.5 t -120.78 142.25 37.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.579 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -103.97 110.8 23.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.26 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 20.2 m -94.43 34.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -25.63 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.877 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -146.21 60.68 1.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.036 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.408 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 26.8 m -133.48 150.06 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.182 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -69.18 154.51 41.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.341 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.568 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 2.6 t-160 -49.85 -34.49 20.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 t -70.32 -34.02 72.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.24 -41.58 80.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -63.62 -46.67 84.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 95.7 t -57.54 -50.45 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.0 -29.86 60.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.966 178.55 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.94 -51.23 68.96 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.023 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.3 mt -55.89 -37.59 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.452 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.39 -25.13 50.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.913 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -91.8 3.01 56.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.174 -179.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.672 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -89.14 16.55 7.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.04 -124.91 35.11 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.728 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 m -100.45 -88.4 0.36 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.7 tp -83.06 111.52 19.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 9.7 p -130.21 137.7 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 24.4 mtt180 -84.93 103.12 13.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' HB2' HG21 ' A' ' 6' ' ' ILE . 12.5 mt -91.91 141.2 28.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -101.67 128.13 48.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.648 179.985 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 179.937 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.464 ' CD1' HD21 ' A' ' 58' ' ' LEU . 7.3 m-30 . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.856 0.36 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.43 151.8 37.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -102.84 144.71 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.69 109.36 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.405 179.873 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.68 121.23 23.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.133 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 tp -131.24 127.23 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 pt-20 -86.73 100.29 12.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.261 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.453 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 22.7 mtp85 -41.18 91.45 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.145 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.474 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.921 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.558 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 17.9 mt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.983 0.421 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.96 36.75 0.27 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.403 -0.904 . . . . 0.0 113.162 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.744 ' HB3' HG22 ' A' ' 39' ' ' ILE . 11.8 p90 -163.27 134.19 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.039 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.443 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.26 137.15 32.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.622 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.39 150.1 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.691 0.758 . . . . 0.0 112.02 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB2' ' CG ' ' A' ' 27' ' ' HIS . . . -143.64 132.85 23.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.971 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.96 0.88 0.74 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.871 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.48 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.74 -177.82 0.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.671 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.416 ' CG2' ' HB3' ' A' ' 32' ' ' PRO . 16.0 p -72.0 -21.55 61.54 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.01 -24.22 17.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.723 0.296 . . . . 0.0 111.501 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -124.36 87.3 54.13 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.59 65.03 0.54 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.292 1.994 . . . . 0.0 112.446 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.728 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 31.1 t60 -48.44 -27.88 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.469 179.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.62 -154.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.449 179.597 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.21 -47.82 56.44 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.664 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 t70 179.97 47.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.41 157.29 76.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.416 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 6.1 Cg_exo -77.77 0.6 9.67 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.833 2.355 . . . . 0.0 112.693 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -53.32 120.57 6.19 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.124 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -85.61 120.19 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.339 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.728 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.66 146.75 36.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.346 0.593 . . . . 0.0 110.681 178.89 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.96 155.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.977 -176.774 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.89 -34.38 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.617 -179.175 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.07 143.5 3.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.5 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.744 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.83 131.77 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.292 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 120.74 75.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.883 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.01 137.09 60.17 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.667 2.244 . . . . 0.0 112.279 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.99 14.85 50.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.372 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.09 177.14 16.34 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.14 -31.2 61.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 39' ' ' ILE . . . -73.14 -57.4 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.611 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.91 -28.92 64.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.396 -179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.04 -32.63 67.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -81.53 -58.04 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.692 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.86 39.89 9.16 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.482 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.423 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.3 mmt180 -116.11 1.57 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.552 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -129.56 154.92 46.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.128 0.489 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.552 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.2 ttt180 -133.43 136.02 44.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.686 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 56.0 t -49.88 157.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.589 . . . . 0.0 111.747 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.2 t-20 75.65 -1.75 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -66.11 125.01 24.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.907 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.5 103.31 14.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.533 0.682 . . . . 0.0 111.305 -178.76 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 34' ' ' ILE . 51.3 mt -53.13 134.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.213 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 3' ' ' TYR . 1.5 pp -134.79 13.56 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.884 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 169.98 138.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.169 0.509 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 77' ' ' LEU . 21.5 t -127.39 97.36 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.611 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.43 ' HB2' HG21 ' A' ' 84' ' ' VAL . 1.7 t-20 70.95 -62.81 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -163.35 31.62 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.0 t -120.92 117.34 52.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -82.36 109.55 16.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.585 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -93.79 41.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.284 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -64.58 -35.52 81.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.835 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.11 71.67 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.541 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 9.3 m -136.49 142.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.44 156.23 10.7 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.313 0.578 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.48 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 1.9 p-80 -49.74 -34.1 18.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.635 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -69.76 -33.64 72.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.828 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.541 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -65.48 -45.05 85.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.29 0.567 . . . . 0.0 109.631 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.441 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -63.02 -45.67 91.23 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.512 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 78.9 t -56.3 -50.36 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.033 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.605 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.52 -34.66 37.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.787 179.569 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.553 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.39 -57.37 5.99 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.323 -0.551 . . . . 0.0 112.074 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.45 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 1.6 mt -60.32 -40.97 92.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.577 . . . . 0.0 110.237 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.605 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.75 -19.74 57.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.8 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -111.33 20.47 17.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.302 179.373 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -83.6 16.47 2.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.701 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.32 -101.87 0.87 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.4 m -123.7 -90.73 0.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.2 tp -86.88 109.93 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.872 0.368 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 10.3 p -124.28 137.25 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 11.6 mtt180 -85.94 103.58 14.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.909 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.459 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 17.4 mt -93.63 135.45 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.489 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.77 126.77 48.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.251 179.472 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.975 -179.826 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.458 ' CG ' HD23 ' A' ' 58' ' ' LEU . 3.5 m-30 . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.782 0.325 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -143.39 141.15 30.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 2.8 pt-20 -99.84 144.65 28.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.482 HG23 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -138.81 109.46 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.028 0.442 . . . . 0.0 111.362 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.23 119.46 22.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.858 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 tp -127.63 126.79 42.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.6 pt-20 -84.97 100.57 11.73 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.306 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.86 88.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.226 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.517 0.218 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.659 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.2 tp . . . . . 0 N--CA 1.457 -0.112 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 131.88 19.36 1.15 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.572 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.751 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.6 p90 -162.04 134.52 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.816 0.808 . . . . 0.0 111.259 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.76 138.63 31.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.498 -179.336 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.25 147.25 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.672 0.748 . . . . 0.0 112.091 -179.923 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 27' ' ' HIS . . . -141.12 132.3 26.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.062 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.24 -3.13 0.87 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.676 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.495 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.81 179.73 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.764 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 p -70.92 -20.06 62.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.84 -23.94 16.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.245 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -124.39 87.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.188 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 64.53 0.55 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.402 2.068 . . . . 0.0 112.649 -179.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 30.0 t60 -49.93 -27.34 5.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.243 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.626 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.91 -154.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.369 179.597 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -66.77 -47.32 68.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.659 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 177.52 46.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.29 159.86 70.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.51 1.66 8.83 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.665 2.244 . . . . 0.0 112.8 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.65 118.25 4.04 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.008 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -84.83 121.03 36.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.476 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.715 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.23 147.68 38.68 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.334 0.588 . . . . 0.0 110.808 178.529 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.01 155.45 7.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.757 -176.892 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.49 -33.55 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.612 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.85 142.11 1.86 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.627 -179.743 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.751 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -103.86 132.2 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.209 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.93 114.23 52.78 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.647 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.0 Cg_exo -56.36 139.03 85.9 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.723 2.282 . . . . 0.0 112.241 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 8.53 64.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.433 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.31 176.23 17.7 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.79 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.31 -36.35 61.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 111.199 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -67.81 -57.49 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.576 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.19 -28.91 66.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.325 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.93 -33.14 68.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -82.1 -57.98 3.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.77 40.74 9.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.552 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.477 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.4 mtp180 -117.74 8.21 12.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.811 0.339 . . . . 0.0 110.843 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.4 tp -133.49 155.35 49.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.058 0.456 . . . . 0.0 110.804 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.68 136.1 44.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.757 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.2 t -51.77 157.79 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.533 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.3 -2.03 2.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.361 179.775 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -67.66 124.91 24.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.56 101.68 13.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.574 0.702 . . . . 0.0 111.424 -178.608 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' A' ' 34' ' ' ILE . 50.1 mt -51.59 133.43 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.661 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.1 pp -123.5 -19.48 5.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.781 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -159.49 147.76 17.58 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 111.027 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 62' ' ' GLU . 38.8 t -130.22 99.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.033 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' A' ' 84' ' ' VAL . 1.5 t-20 67.65 -67.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.0 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.3 29.56 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.94 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 84.5 t -117.99 141.96 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.212 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.6 p30 -104.86 109.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.475 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -96.7 32.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.52 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -62.42 -32.17 72.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.91 66.0 1.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 8.8 m -133.51 144.48 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.75 154.04 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.954 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.495 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 12.1 t-160 -49.61 -33.78 16.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.4 m -66.68 -33.92 76.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.65 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.582 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.0 -41.56 82.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 34' ' ' ILE . . . -65.13 -46.22 81.86 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 58.4 t -56.61 -50.42 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.022 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -52.12 -34.35 43.97 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.853 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.42 -57.53 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.927 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.454 HD12 ' CE1' ' A' ' 17' ' ' PHE . 1.5 mt -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.345 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.06 -20.32 55.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.048 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.576 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.5 pt-20 -110.43 21.36 16.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.519 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -83.93 16.57 2.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.778 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.8 0.28 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.862 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -137.87 -91.18 0.22 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.0 tp -84.8 101.96 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.519 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -117.53 135.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.827 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.5 mtp180 -86.55 103.44 15.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.81 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.45 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 25.6 mt -94.06 133.59 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.295 -179.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.471 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.01 123.56 46.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.287 179.632 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.62 -179.745 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 26.5 m-85 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.813 0.339 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -147.77 136.98 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.46 144.64 26.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.63 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -137.64 109.56 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.644 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.41 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 120.04 21.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.569 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 tp -130.82 126.86 37.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -84.49 99.73 10.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.039 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.62 87.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 179.155 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.196 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.65 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.476 HD21 ' CE2' ' A' ' 17' ' ' PHE . 5.8 tp . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.805 0.336 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 72.17 31.0 64.38 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.738 ' HB3' HG22 ' A' ' 39' ' ' ILE . 4.7 p90 -164.5 129.74 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.075 0.937 . . . . 0.0 111.574 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -96.1 140.2 31.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.937 -179.116 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -120.19 147.03 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.763 0.792 . . . . 0.0 112.221 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -139.77 133.43 30.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.044 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.75 3.29 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.724 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.513 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.68 -177.87 1.37 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.658 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 25.2 p -67.25 -28.87 68.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -92.74 -19.59 21.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.614 0.245 . . . . 0.0 111.369 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -124.15 87.0 53.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.8 61.7 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.385 2.057 . . . . 0.0 112.795 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.729 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 50.4 t60 -49.78 -27.6 5.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.949 178.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.705 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.2 -152.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.355 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.421 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.24 52.54 4.53 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.733 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 74.6 32.07 0.92 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.927 0.394 . . . . 0.0 110.462 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.09 149.64 45.97 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.25 -4.47 15.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.753 2.302 . . . . 0.0 112.615 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.0 m -52.21 115.98 1.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 111.287 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -83.75 120.14 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.729 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.15 147.14 36.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.253 0.549 . . . . 0.0 110.692 178.994 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.07 155.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.841 -176.794 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.458 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.72 -30.26 4.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.176 -179.2 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.23 128.81 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.36 -179.524 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.738 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.76 126.64 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.691 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.47 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.26 119.19 72.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.684 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.1 Cg_exo -54.37 139.57 73.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.242 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.34 12.72 69.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.539 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.36 -157.59 21.72 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -75.97 -40.73 53.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' CB ' HG22 ' A' ' 39' ' ' ILE . . . -72.78 -54.44 8.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.13 -29.09 69.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 65.1 mt-30 -72.38 -39.17 68.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.119 0.485 . . . . 0.0 110.3 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -81.39 -57.87 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.848 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.23 37.0 10.22 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.561 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.447 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.82 -5.38 14.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.698 179.531 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.0 tp -119.93 154.06 34.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.31 137.18 47.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.901 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.4 t -51.98 157.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.264 0.554 . . . . 0.0 111.533 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.39 -1.28 3.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.359 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.7 m-20 -69.54 127.61 33.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.56 101.47 13.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.577 0.703 . . . . 0.0 111.428 -178.662 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 HG21 ' A' ' 19' ' ' ILE . 10.9 mt -48.07 139.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.84 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.9 mm? -116.6 -44.62 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.092 179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.2 m-85 -142.57 174.69 10.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 62' ' ' GLU . 31.0 t -151.98 98.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.923 179.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.485 ' HB2' HG23 ' A' ' 84' ' ' VAL . 1.2 t-20 66.34 -68.23 0.14 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.226 0.536 . . . . 0.0 109.807 -178.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -155.2 31.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.8 t -117.77 142.41 32.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.596 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.5 p-10 -111.1 108.49 18.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 26.1 m -94.24 44.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.433 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -32.71 74.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.39 61.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.528 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 13.7 m -120.47 147.18 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.439 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -62.36 155.71 24.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 -179.071 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.513 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.6 p-80 -49.33 -34.28 15.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.787 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.7 p -70.19 -33.78 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.936 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.528 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.11 -45.73 80.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.265 0.555 . . . . 0.0 109.716 178.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -62.67 -45.5 92.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.532 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 94.1 t -56.47 -50.46 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.156 178.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.594 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.49 -34.36 35.44 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.924 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.84 -57.52 5.45 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.232 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.434 HD11 ' CZ ' ' A' ' 17' ' ' PHE . 5.2 mt -61.51 -39.74 92.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.429 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.76 -19.84 57.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.544 179.608 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -110.61 17.75 20.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.129 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -80.8 16.54 1.4 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.702 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.55 -99.43 0.59 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.679 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.5 p -127.8 -91.59 0.49 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.2 tp -84.27 106.19 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.061 0.457 . . . . 0.0 110.933 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 11.9 p -122.14 139.0 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.519 -178.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.412 ' N ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -85.95 103.76 14.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.916 178.812 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.517 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 18.0 mt -95.28 138.48 32.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.65 -178.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -102.07 141.56 34.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.462 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.023 -179.868 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 20.9 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.799 0.333 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.49 134.93 34.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.75 134.91 38.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.408 ' CG2' ' CB ' ' A' ' 50' ' ' ARG . 1.2 mt -129.36 109.29 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.263 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -76.95 123.07 25.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.841 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 3.2 tp -133.49 127.29 32.94 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.4 pt-20 -85.37 103.39 14.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.819 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 10.1 mtp180 -47.58 92.96 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.319 0.581 . . . . 0.0 110.745 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.538 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.935 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.535 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 10.9 mt . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.85 40.99 0.11 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.29 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.757 ' HB3' HG22 ' A' ' 39' ' ' ILE . 34.7 p90 -163.96 136.35 5.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.004 0.431 . . . . 0.0 111.25 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.01 132.72 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.397 -179.507 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.739 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -109.86 167.43 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.768 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -166.17 132.99 2.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.339 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.42 -1.88 1.23 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.437 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.53 -172.06 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.93 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 p -75.18 -22.17 58.21 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -94.82 -25.55 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.417 -179.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -124.35 87.32 54.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.222 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.79 62.95 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.411 2.074 . . . . 0.0 112.763 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.699 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 28.4 t60 -48.01 -28.95 3.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.074 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.32 -155.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.143 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.32 -49.45 45.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.348 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -177.86 51.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.802 0.334 . . . . 0.0 111.175 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.21 159.91 64.4 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.076 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.48 5.49 6.06 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.711 2.274 . . . . 0.0 112.671 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -57.02 118.59 5.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.99 118.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.602 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.699 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.38 146.12 34.58 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.586 0.708 . . . . 0.0 110.79 178.824 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.739 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.79 156.01 7.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.294 -176.652 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.87 -30.24 4.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.395 -178.588 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.31 128.34 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.876 -179.368 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -96.84 132.18 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.619 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.3 113.82 50.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.6 143.83 44.53 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.743 2.295 . . . . 0.0 112.482 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.51 83.03 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.85 176.68 20.77 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.111 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . -54.49 -33.34 59.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.525 0.202 . . . . 0.0 111.389 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -74.29 -56.25 5.1 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.778 0.323 . . . . 0.0 111.488 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.91 70.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.187 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -72.16 -31.81 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.934 0.397 . . . . 0.0 110.44 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.76 -57.87 3.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.063 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.62 32.11 19.74 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.422 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.408 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 51.9 mtt180 -115.23 -13.45 11.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.687 0.28 . . . . 0.0 110.96 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.61 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 38.7 tp -112.57 162.4 15.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.183 0.516 . . . . 0.0 111.305 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.08 135.74 23.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.633 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 56.2 t -49.2 157.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 111.586 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.473 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER 74.24 2.39 4.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.255 -179.893 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.9 m-20 -72.12 127.11 31.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 10.4 p -86.61 100.02 12.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.552 0.691 . . . . 0.0 111.464 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 34' ' ' ILE . 63.9 mt -45.25 149.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.055 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -128.91 -46.96 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.706 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -141.54 169.11 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.769 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 62' ' ' GLU . 16.6 t -143.91 95.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.121 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.418 ' HB2' HG21 ' A' ' 84' ' ' VAL . 5.4 t-20 68.34 -66.69 0.22 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -156.54 32.47 0.32 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.134 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 60.8 t -119.02 142.54 33.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.776 -178.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.1 p30 -112.06 113.14 25.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.122 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.448 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 35.3 m -86.41 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.89 100.94 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.77 52.51 0.55 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 29.1 m -122.26 143.43 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 179.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.08 150.33 25.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.514 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.7 t-160 -49.09 -33.34 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 20.1 m -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.588 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.37 -38.49 81.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -68.03 -46.91 69.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.639 0.733 . . . . 0.0 109.168 178.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.63 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 78.2 t -57.81 -48.03 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.214 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.74 -36.31 69.6 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.594 178.572 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.514 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.34 -51.2 67.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 0.0 110.105 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.434 ' CD1' HD13 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.06 -35.7 67.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.3 mmmt -77.29 -23.28 51.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.484 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -96.81 2.54 51.96 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 111.418 -179.016 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 84' ' ' VAL . . . -82.54 16.32 2.18 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.709 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.79 -119.18 16.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.9 t -104.97 -87.73 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 5.2 tp -87.7 109.18 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.682 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 80' ' ' ALA . 2.8 p -122.67 138.53 52.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.296 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.2 mtt-85 -86.72 102.86 14.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 60' ' ' VAL . 8.2 mt -91.29 142.6 27.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.33 -178.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.92 139.08 38.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.782 -179.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.724 179.908 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.426 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 52.2 m-85 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.959 0.409 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.53 151.42 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -110.12 144.71 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.446 ' O ' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.36 109.46 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.482 179.841 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.466 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.48 120.29 23.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.047 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.613 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -130.71 127.96 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 pt-20 -85.4 101.05 12.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.004 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 5.0 mtp-105 -47.84 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.132 178.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.386 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.228 -179.22 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 139.38 44.36 0.07 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.918 -1.134 . . . . 0.0 114.024 178.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.741 ' HB3' HG21 ' A' ' 39' ' ' ILE . 17.9 p90 -164.0 131.53 3.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.304 0.552 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -93.2 134.4 35.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.669 -179.089 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -112.19 172.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.795 179.957 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB3' ' CG ' ' A' ' 27' ' ' HIS . . . -168.96 132.29 1.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.288 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.444 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.34 1.08 0.94 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.652 179.593 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.55 -172.07 0.1 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.869 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 68' ' ' VAL . 16.8 p -74.44 -21.72 59.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -97.0 -23.38 16.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 111.486 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.36 87.54 53.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.26 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.9 62.36 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.44 2.093 . . . . 0.0 112.738 -179.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.745 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.7 t60 -48.34 -28.08 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.104 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.672 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.82 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.325 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -56.48 -50.44 62.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.608 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.937 0.399 . . . . 0.0 110.747 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.9 168.48 13.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.86 9.02 4.11 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.727 2.284 . . . . 0.0 112.893 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -61.03 114.15 2.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.867 0.365 . . . . 0.0 110.65 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -81.85 119.84 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.745 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.45 143.41 32.59 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.683 0.754 . . . . 0.0 110.819 178.936 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -68.89 155.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.102 -176.495 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.439 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.44 -26.96 4.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.376 -178.525 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.25 131.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.005 -179.645 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.43 132.73 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.681 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.459 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.4 123.75 74.47 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.853 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.0 Cg_endo -66.88 133.8 32.56 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.747 2.298 . . . . 0.0 112.267 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.62 17.2 31.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.315 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.48 178.31 16.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.169 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . -53.97 -34.02 58.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.779 0.323 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -71.21 -57.48 4.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.897 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.59 -28.79 65.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.336 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -71.73 -29.95 65.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.391 . . . . 0.0 110.312 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.99 -58.08 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.06 37.85 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.569 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.6 mtt85 -112.71 -17.23 12.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.716 0.293 . . . . 0.0 110.962 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.4 tp -110.21 155.25 22.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.073 0.463 . . . . 0.0 111.222 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.52 135.12 45.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.801 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 65.5 t -51.86 158.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.31 0.576 . . . . 0.0 111.636 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.1 t30 73.19 5.58 5.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.001 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.4 m-20 -76.82 128.12 34.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.47 100.17 12.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.621 0.724 . . . . 0.0 111.317 -178.701 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' ILE . 16.1 mt -48.08 136.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.67 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.2 mm? -116.11 -44.86 2.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.6 m-85 -137.76 170.14 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.158 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 62' ' ' GLU . 26.9 t -149.59 96.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.965 179.359 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.427 ' HB2' HG21 ' A' ' 84' ' ' VAL . 3.7 t-20 67.09 -68.22 0.15 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 109.805 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mt-10 -154.44 32.32 0.42 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.603 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.2 t -118.71 142.42 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.478 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.0 p-10 -113.42 96.27 5.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.446 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.81 57.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.303 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -79.93 -30.13 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.73 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -151.61 62.86 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.777 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.1 m -128.85 146.09 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.207 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.48 151.1 33.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.522 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 16.3 t-160 -48.33 -33.72 9.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.722 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -67.25 -34.36 77.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.08 -42.66 80.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -61.81 -46.5 89.26 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.654 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 90.8 t -56.51 -50.8 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.364 178.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.647 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.24 -30.37 64.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.371 178.887 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.48 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.2 -49.83 75.58 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.293 0.568 . . . . 0.0 110.179 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.482 HD23 ' CE1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -60.44 -34.55 74.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.907 179.298 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.13 -26.23 52.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.191 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.405 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -103.07 14.73 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.302 -178.775 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.638 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -80.87 0.74 33.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.61 -112.62 3.79 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.009 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.25 -90.54 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.997 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.6 tp -87.87 87.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.218 0.532 . . . . 0.0 109.691 178.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.638 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 9.1 p -98.87 138.42 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 4.7 ttp180 -89.34 103.15 15.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.198 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.413 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 14.1 mt -91.7 140.31 29.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.91 142.76 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.99 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.646 179.94 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CB ' ' CE2' ' A' ' 87' ' ' TYR . 2.3 m-85 . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.792 0.329 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.27 152.28 43.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 3.6 tt0 -106.76 144.6 33.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.986 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.497 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -134.2 109.45 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.501 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.05 119.29 20.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.851 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.517 ' HB3' HD21 ' A' ' 15' ' ' LEU . 5.0 tp -130.55 127.6 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.5 pt-20 -83.85 100.53 11.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.659 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -44.48 88.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.174 179.193 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.52 0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.792 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 8' ' ' LEU . 17.3 mt . . . . . 0 C--O 1.225 -0.236 0 CA-C-O 121.017 0.437 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.99 39.49 1.98 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.362 179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.778 ' HB3' HG21 ' A' ' 39' ' ' ILE . 15.8 p90 -161.4 130.33 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.036 0.418 . . . . 0.0 111.424 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.27 134.77 34.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.66 -179.415 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -112.21 167.95 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 111.766 179.893 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -165.84 131.44 2.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.464 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.64 0.97 0.9 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.588 179.6 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.53 -168.55 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.987 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 32' ' ' PRO . 11.2 p -76.25 -23.8 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -23.61 16.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.753 0.311 . . . . 0.0 111.669 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.22 87.41 53.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.03 63.08 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.388 2.058 . . . . 0.0 112.629 -179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.716 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 37.9 t60 -48.12 -27.86 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.308 179.027 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.656 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.71 -154.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.356 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -61.98 -49.01 79.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.588 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.31 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -125.17 163.46 37.83 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.418 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 5.5 Cg_exo -79.14 3.41 7.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.978 2.452 . . . . 0.0 112.715 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.79 115.45 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 111.104 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.57 120.64 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.382 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.716 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.64 145.93 33.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.553 0.692 . . . . 0.0 110.567 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.86 155.8 7.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.275 -176.507 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.448 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.09 -30.72 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.253 -178.849 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.8 130.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.99 -179.419 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.778 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.03 131.56 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.518 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.457 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 126.32 69.88 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 28.8 Cg_endo -62.6 134.47 47.77 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.718 2.279 . . . . 0.0 112.415 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.13 4.74 61.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.7 -179.48 25.64 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.991 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' A' ' 8' ' ' LEU . . . -57.42 -34.87 69.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.518 0.199 . . . . 0.0 111.325 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -74.25 -55.63 5.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.84 -30.93 71.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.869 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -72.13 -35.65 69.17 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.045 0.45 . . . . 0.0 110.1 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.46 -57.92 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.37 39.74 8.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.891 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.477 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -109.08 -4.65 16.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.578 179.476 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.7 tp -123.7 154.67 39.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.693 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 4.4 tpt85 -132.63 136.39 46.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.835 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.44 157.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.482 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.471 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.1 t30 74.8 0.28 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.78 125.35 26.31 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.849 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.6 p -86.43 100.27 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 34' ' ' ILE . 20.6 mt -50.76 136.01 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.911 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.45 HD11 ' CG ' ' A' ' 3' ' ' TYR . 7.8 mt -120.05 -28.13 5.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.705 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -153.4 156.14 37.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.034 0.445 . . . . 0.0 111.008 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 62' ' ' GLU . 46.3 t -133.76 95.62 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.909 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB2' HG22 ' A' ' 84' ' ' VAL . 5.8 t30 67.78 -67.83 0.18 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.117 0.484 . . . . 0.0 110.031 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -153.4 31.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.739 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 65.7 t -119.44 142.19 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.355 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.1 p-10 -107.49 100.9 10.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 22.9 m -86.87 53.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.493 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.84 -33.17 34.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.83 58.61 1.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.766 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.9 m -128.19 143.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.92 150.66 28.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.541 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.3 t-160 -48.29 -33.63 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.441 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.37 -34.06 75.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.96 179.633 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.612 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -38.57 81.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 109.453 178.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -66.67 -46.92 74.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.066 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 92.5 t -57.55 -49.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.2 178.563 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.612 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.84 -34.04 67.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.688 178.65 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -56.74 -50.76 71.27 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.331 0.586 . . . . 0.0 109.906 179.332 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.15 -37.57 69.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.384 178.948 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER -77.33 -23.73 50.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.092 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.1 mm-40 -91.72 -17.05 26.01 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.971 0.415 . . . . 0.0 110.951 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -55.47 -19.87 10.85 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.295 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.99 -98.66 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.025 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.488 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 34.3 m -126.76 -91.38 0.51 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 tp -87.26 98.61 7.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.666 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.566 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 13.6 p -115.81 138.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 mtt180 -85.83 103.14 14.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.274 177.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' A' ' 6' ' ' ILE . 14.3 mt -91.9 138.7 31.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.263 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.69 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.809 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.683 179.879 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.426 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 10.3 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.837 0.351 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.46 142.27 49.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.21 144.58 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -138.8 109.42 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.376 179.856 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.425 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.25 116.47 20.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.067 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 tp -124.14 126.74 46.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 pt-20 -87.46 100.27 12.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.564 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.87 87.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.229 179.283 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.215 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.49 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.519 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 2.3 tp . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 131.26 17.77 1.39 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.529 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.756 ' HB3' HG21 ' A' ' 39' ' ' ILE . 8.9 p90 -160.7 135.73 7.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.965 0.882 . . . . 0.0 111.196 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.9 139.3 32.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.376 -179.477 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.75 147.95 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.887 0.851 . . . . 0.0 112.359 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB1' ' CG ' ' A' ' 27' ' ' HIS . . . -141.11 133.2 27.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.055 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.14 2.92 0.68 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.798 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.09 -176.52 0.84 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.682 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 25.2 p -67.53 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.11 -21.05 21.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -124.38 87.02 54.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.671 0.272 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.81 62.62 0.91 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.332 2.021 . . . . 0.0 112.585 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 38.5 t60 -47.45 -28.66 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.413 179.023 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.01 -154.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.281 179.531 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -61.31 -49.23 79.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.6 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.99 39.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.38 163.5 38.02 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 3.9 Cg_exo -76.73 1.47 8.5 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.984 2.456 . . . . 0.0 112.773 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.77 115.52 2.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.17 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -84.87 119.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.482 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.715 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.52 147.81 38.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.427 0.632 . . . . 0.0 110.869 178.776 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.953 -176.85 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.71 -31.37 4.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.217 -179.014 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.57 131.1 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.226 -179.42 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.96 130.89 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.594 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.13 114.03 51.86 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.874 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 42.4 Cg_exo -56.95 139.31 89.37 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.726 2.284 . . . . 0.0 112.378 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 12.75 59.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.431 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.69 179.36 16.87 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.919 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.7 -38.61 69.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.841 0.353 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -64.84 -57.65 8.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.577 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.47 -28.77 66.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.353 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.99 -33.06 67.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 110.162 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.28 -58.01 3.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.748 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.87 37.71 12.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.622 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' CB ' HG12 ' A' ' 6' ' ' ILE . 18.2 mtm180 -118.96 9.05 11.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.728 0.299 . . . . 0.0 110.987 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.555 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.8 tp -135.24 154.4 51.59 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.01 0.433 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.94 134.42 42.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 179.996 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -49.15 159.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.13 0.491 . . . . 0.0 111.491 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 3.0 m120 72.24 1.43 3.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.506 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.01 127.22 31.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.693 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 100.17 12.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 111.693 -178.437 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 19' ' ' ILE . 10.1 mt -46.76 132.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.76 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.97 -40.41 3.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.138 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -145.27 167.49 22.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.763 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 62' ' ' GLU . 56.1 t -145.3 97.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.442 ' HB2' HG21 ' A' ' 84' ' ' VAL . 1.2 t30 66.25 -67.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 109.947 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' VAL . 10.2 mm-40 -154.14 32.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.921 179.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.7 t -119.64 142.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.412 -179.322 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.5 t0 -111.33 99.72 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.455 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.5 m -85.3 55.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.294 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -32.51 59.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.851 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -152.67 62.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.667 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.542 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 13.2 m -124.6 144.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.447 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.88 155.06 20.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.973 0.416 . . . . 0.0 111.097 -179.117 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.508 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.2 p-80 -48.66 -34.09 11.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.859 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -33.88 73.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.139 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.542 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.18 -44.23 84.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.241 0.543 . . . . 0.0 109.674 178.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' HG22 ' A' ' 34' ' ' ILE . . . -63.92 -45.89 87.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.162 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.51 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 59.4 t -57.06 -48.37 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.287 178.544 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.664 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -53.68 -33.82 56.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.33 179.134 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.559 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -64.66 -56.91 10.77 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.598 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 HD13 ' CE1' ' A' ' 17' ' ' PHE . 0.8 OUTLIER -63.02 -42.93 99.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.879 -179.645 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.589 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.08 -20.59 55.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.748 -179.264 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.664 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 6.7 mm-40 -103.27 -8.8 20.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.088 0.471 . . . . 0.0 110.563 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.514 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -48.1 -20.49 0.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.791 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.79 -90.21 0.93 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.712 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -133.73 -92.42 0.34 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.871 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 9.1 tp -88.05 102.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.116 0.484 . . . . 0.0 110.531 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.514 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 7.3 p -118.32 136.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.724 -178.13 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.9 mtt85 -85.88 103.88 15.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.058 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.48 ' HB2' HG21 ' A' ' 6' ' ' ILE . 18.3 mt -95.49 137.8 34.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.576 -179.189 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.88 140.42 36.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.494 179.795 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.991 179.886 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.427 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 10.7 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.749 0.309 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -131.6 151.04 51.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -109.96 143.89 39.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.78 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.484 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.32 109.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.975 0.416 . . . . 0.0 111.699 179.791 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.49 118.87 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.508 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.555 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -131.59 127.16 36.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.2 pt-20 -84.51 100.44 11.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.258 179.392 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.454 ' HG3' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.41 90.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.21 179.67 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.337 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.88 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 18.8 mt . . . . . 0 C--O 1.227 -0.108 0 CA-C-O 120.938 0.399 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.15 35.93 0.45 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.419 179.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.776 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.1 p90 -160.04 135.42 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.128 0.464 . . . . 0.0 111.242 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.33 137.63 33.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.427 -179.612 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.684 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.45 149.75 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.654 0.74 . . . . 0.0 111.954 -179.86 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -142.73 133.02 24.73 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.93 179.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.31 -7.65 1.16 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.462 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.6 -178.87 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.087 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 29.9 p -65.06 -31.13 72.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.227 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 12.5 m-20 -91.45 -20.46 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.237 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.48 82.48 58.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.958 0.409 . . . . 0.0 110.131 179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.25 62.67 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.886 2.391 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.748 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.6 t60 -52.58 -22.35 4.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.386 178.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.693 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -95.21 -151.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.572 179.814 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -82.89 48.87 4.11 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.861 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.77 45.46 0.07 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.981 0.419 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -135.22 155.24 78.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 -0.94 10.72 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.525 2.15 . . . . 0.0 112.776 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 5.7 m -54.24 115.75 2.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.746 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.529 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.58 119.02 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.748 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.67 145.72 35.26 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.301 0.572 . . . . 0.0 110.527 178.53 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.684 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.98 155.48 7.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.094 -176.476 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.5 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.37 -33.44 4.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.766 -179.124 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.587 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.65 141.96 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.585 -179.749 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.776 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.7 132.31 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.266 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.1 125.16 73.26 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.685 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.1 Cg_endo -67.33 132.06 26.54 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.838 2.358 . . . . 0.0 112.381 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.68 14.39 32.17 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.474 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.87 178.07 16.42 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.0 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.37 -36.26 61.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 111.416 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB1' ' CG2' ' A' ' 39' ' ' ILE . . . -68.9 -57.43 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.833 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.478 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -33.92 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 110.174 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.15 -57.92 3.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.691 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.02 9.59 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.602 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.484 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.9 mmt180 -116.31 1.59 13.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.702 -0.293 . . . . 0.0 110.837 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.3 tp -126.96 154.15 44.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 110.657 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.57 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.9 ttp85 -131.52 137.45 48.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -53.33 158.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 111.678 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER 74.53 0.19 3.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.184 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 3.1 m-20 -70.38 126.26 29.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.3 p -86.53 100.31 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 0.0 111.383 -178.607 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 34' ' ' ILE . 69.1 mt -46.88 140.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.065 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.5 mm? -118.76 -44.8 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.3 m-85 -139.86 169.43 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.793 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 62' ' ' GLU . 26.5 t -151.4 100.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.41 ' CB ' HG23 ' A' ' 84' ' ' VAL . 11.3 t30 66.27 -67.86 0.14 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.131 0.491 . . . . 0.0 109.979 -178.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -156.67 32.05 0.31 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.495 179.124 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.6 t -117.8 142.51 31.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.55 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.7 p-10 -112.69 89.34 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.4 m -75.77 61.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -82.38 -32.94 28.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.753 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -148.66 50.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.798 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.4 m -114.09 150.89 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.421 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -66.95 153.66 43.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.029 -179.389 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.546 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.2 t-160 -49.68 -34.19 17.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.628 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -69.8 -34.04 73.19 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.04 -42.25 80.85 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -63.12 -46.75 85.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.555 0.693 . . . . 0.0 109.201 177.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 89.3 t -57.58 -50.18 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.15 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.636 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.01 -32.9 64.39 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.631 178.656 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.503 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -57.99 -52.63 64.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.228 0.537 . . . . 0.0 110.012 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.472 ' CD1' HD12 ' A' ' 19' ' ' ILE . 2.5 mt -54.16 -36.47 63.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.283 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.19 -26.66 53.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.09 178.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -89.01 -16.65 31.16 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -178.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -57.41 -18.57 18.53 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.33 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.02 -108.02 3.6 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.164 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 1.3 p -118.78 -91.2 0.56 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 8.4 tp -86.92 95.09 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.079 0.466 . . . . 0.0 109.85 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 12.1 p -111.86 138.06 42.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.297 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.9 102.89 14.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.411 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 11.6 mt -90.18 141.15 28.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 141.38 34.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.771 -179.759 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.852 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 65.7 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.732 0.301 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -126.35 155.56 41.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 17.7 mt-10 -117.43 144.63 44.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.84 109.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.647 179.893 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.24 122.0 24.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.912 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.613 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.1 tp -134.14 127.31 31.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.149 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -86.37 100.76 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.632 179.551 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 12.0 mtp180 -42.45 91.93 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.064 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.477 0 CA-C-N 115.186 -0.916 . . . . 0.0 113.058 -179.538 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 8.3 mt . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.7 0.286 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 135.46 40.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.745 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.761 ' HB3' HG22 ' A' ' 39' ' ' ILE . 8.1 p90 -162.02 134.51 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.494 . . . . 0.0 110.971 178.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.51 135.16 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.459 -179.351 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.707 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.53 146.5 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.496 179.552 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -126.74 122.88 36.11 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.586 178.935 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 157.92 -132.0 3.03 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.605 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.45 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 75.76 167.36 22.75 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.263 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 68' ' ' VAL . 27.4 p -68.47 -6.68 26.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.074 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.11 -24.34 9.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.223 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.5 t30 -124.62 87.18 54.86 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.478 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.91 64.69 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.39 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.736 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.0 t60 -53.05 -24.12 9.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.31 179.221 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.678 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -92.64 -150.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 179.63 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.66 52.47 4.58 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.931 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 75.7 41.23 0.26 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.116 0.484 . . . . 0.0 110.488 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.3 161.46 62.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 97.3 Cg_endo -79.29 4.18 6.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.625 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -55.04 118.39 4.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.078 0.466 . . . . 0.0 111.258 -179.814 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.494 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.32 116.62 31.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.188 179.598 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.736 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.06 147.6 37.07 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.363 0.601 . . . . 0.0 110.573 179.256 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.707 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.26 155.74 7.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.834 -177.127 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.29 -33.02 3.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.677 -179.076 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.567 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.14 142.01 2.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 111.276 -179.78 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.761 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -105.32 132.32 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.48 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.01 114.48 54.53 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.674 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.1 Cg_exo -57.68 136.96 78.83 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.7 2.267 . . . . 0.0 112.365 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 16.97 39.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.562 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.54 178.76 16.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.175 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.84 -33.86 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.3 . . . . 0.0 111.402 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -70.81 -57.39 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.908 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.53 -28.67 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.525 -179.427 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.71 -30.43 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 110.335 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.68 -57.77 3.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.708 -179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.78 37.0 12.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.572 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -111.28 -20.92 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.4 tp -106.16 153.86 21.5 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.275 0.559 . . . . 0.0 111.361 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -131.78 135.4 46.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.57 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.567 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 52.5 t -49.21 157.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.536 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER 75.15 0.26 3.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.223 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -68.24 124.71 24.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.991 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.5 p -86.63 99.78 11.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.564 0.697 . . . . 0.0 111.377 -178.46 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 34' ' ' ILE . 11.0 mt -46.35 129.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.229 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HG ' ' CE1' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -113.06 -41.44 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.005 179.653 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.4 m-85 -144.72 146.82 32.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.166 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.51 109.78 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.84 179.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 52.78 35.93 19.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 80.72 32.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.445 -179.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 74.7 t -121.01 112.75 37.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.699 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -72.05 116.83 12.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.711 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 m -98.45 27.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.197 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -68.77 -27.76 66.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -138.52 52.67 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.082 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.442 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.4 m -127.63 146.08 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.83 155.61 38.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.384 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.45 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.5 p-80 -48.15 -35.44 11.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 -179.65 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.33 -33.67 65.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.115 179.716 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.68 -39.39 88.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.808 179.161 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.494 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -66.69 -46.88 74.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.584 0.707 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.613 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.5 t -58.07 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.362 178.556 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -58.22 -35.64 71.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.46 178.574 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.08 -49.39 71.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.237 0.542 . . . . 0.0 109.976 179.597 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.451 ' CD1' HD11 ' A' ' 19' ' ' ILE . 2.4 mt -57.84 -36.47 72.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 178.709 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.2 mmmt -77.33 -25.86 51.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.879 179.441 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -96.96 5.31 50.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -178.703 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.631 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -80.45 16.1 1.43 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.769 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.63 -110.5 3.43 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.294 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.506 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 35.8 m -118.96 -89.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.324 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.5 tp -86.27 96.43 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.257 0.551 . . . . 0.0 110.263 179.019 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 8.6 p -111.1 138.4 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.57 102.8 14.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.388 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.425 HD11 ' CD1' ' A' ' 15' ' ' LEU . 10.9 mt -88.74 137.86 31.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.118 -178.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 145.95 28.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.923 -179.689 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 55' ' ' ASP . 35.4 m . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.139 179.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.72 0.295 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -145.22 151.0 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.981 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -110.36 144.77 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.484 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -134.71 109.5 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.926 0.393 . . . . 0.0 111.545 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.423 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 112.46 17.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.959 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.5 tp -122.87 126.81 48.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.269 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.62 100.46 10.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.059 179.09 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.51 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.169 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.337 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.539 -179.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 6.9 tp . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 108.67 25.78 5.58 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.326 -0.94 . . . . 0.0 115.263 177.706 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.759 ' HB3' HG22 ' A' ' 39' ' ' ILE . 4.3 p90 -164.52 136.72 4.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.018 0.909 . . . . 0.0 111.072 178.779 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -98.68 133.44 43.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.636 -179.28 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.778 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -110.07 169.9 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.608 0.718 . . . . 0.0 111.501 179.729 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -167.33 131.5 1.87 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.424 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.427 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.45 2.09 0.71 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.436 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.13 -167.15 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.102 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 68' ' ' VAL . 17.5 p -75.96 -28.16 57.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -95.31 -20.63 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.66 82.54 59.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.76 63.89 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -179.316 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.713 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.3 t60 -50.09 -24.09 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.661 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.7 -155.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.367 179.716 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -59.9 -49.92 73.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.575 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.49 39.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.919 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -124.69 163.48 36.69 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 5.9 Cg_exo -78.91 3.46 7.36 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.0 112.861 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.1 m -56.61 115.53 2.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 111.1 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.47 120.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.524 179.833 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.713 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.44 145.39 33.73 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.48 0.657 . . . . 0.0 110.704 178.842 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.778 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.84 155.83 7.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.473 -176.409 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.9 -28.36 4.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.509 -178.565 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.72 129.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.197 -179.486 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.759 HG22 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -94.6 133.23 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.392 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 122.98 75.6 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.725 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 23.3 Cg_endo -61.59 137.41 68.96 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.642 2.228 . . . . 0.0 112.36 -179.661 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 -1.87 83.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.442 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.72 175.22 36.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.033 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' GLU . . . -54.12 -34.38 60.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -74.43 -56.94 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.239 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.12 -28.87 70.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -71.67 -31.57 66.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 109.934 179.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.38 -57.91 2.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.552 179.87 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.04 40.83 8.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.491 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.484 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.9 mmt85 -117.03 6.58 12.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.71 0.29 . . . . 0.0 110.951 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.555 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.5 tp -133.74 153.81 51.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.004 0.431 . . . . 0.0 110.819 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.13 140.1 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 179.96 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 56.5 t -56.69 158.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.242 0.544 . . . . 0.0 111.638 179.757 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 t-20 74.15 3.5 4.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.179 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.5 m-20 -75.06 127.1 32.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.49 103.03 14.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.517 0.675 . . . . 0.0 111.131 -178.853 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 34' ' ' ILE . 62.5 mt -49.92 133.37 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.052 -179.775 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 4.0 mm? -108.64 -42.6 4.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -147.33 140.58 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.301 179.987 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' HA ' HD21 ' A' ' 86' ' ' LEU . 58.3 t -123.72 97.29 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.754 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 t30 70.04 -62.84 0.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.05 0.453 . . . . 0.0 109.819 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.58 30.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.152 179.143 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 16.7 t -121.03 109.62 25.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.679 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.467 ' N ' ' CE1' ' A' ' 59' ' ' PHE . 18.9 t0 -63.08 -23.49 67.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.283 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m 46.07 28.96 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.639 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -61.91 -37.76 85.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.77 61.93 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.4 m -127.83 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.315 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.59 151.34 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -179.706 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.526 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.6 t-160 -48.11 -33.89 8.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.675 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -34.07 75.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.933 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.66 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.07 -42.38 80.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -62.75 -46.81 86.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.677 0.751 . . . . 0.0 109.047 177.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.578 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.5 t -57.31 -50.48 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.328 178.546 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -29.47 60.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.898 178.556 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.55 -51.57 68.03 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.273 0.559 . . . . 0.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.423 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.5 mt -55.78 -37.96 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.48 -23.28 50.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.034 178.978 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.72 7.94 45.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.397 -178.795 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -86.19 16.2 4.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.3 179.873 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.34 -99.62 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.575 179.849 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -129.18 -91.9 0.46 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.0 tp -81.95 97.14 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.187 0.518 . . . . 0.0 110.405 179.336 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.62 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -114.21 137.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.733 . . . . 0.0 112.947 -178.2 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 4.6 mtt180 -86.35 103.03 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.164 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 60' ' ' VAL . 13.3 mt -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.165 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.415 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.62 142.88 32.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.552 -179.902 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.639 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.457 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 66.1 m-85 . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.795 0.331 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -155.48 152.45 28.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 pt-20 -105.68 144.75 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.481 HD11 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.25 109.17 12.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.956 0.408 . . . . 0.0 111.59 179.723 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.59 118.82 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.255 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 tp -130.26 127.02 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.407 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.14 100.18 10.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.244 0.545 . . . . 0.0 112.239 179.812 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -53.55 89.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.137 178.448 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.199 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.325 -179.02 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.494 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 5.7 tp . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 128.24 27.43 0.91 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.091 177.951 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG22 ' A' ' 39' ' ' ILE . 7.3 p90 -164.15 134.91 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 118.013 0.906 . . . . 0.0 111.17 178.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.29 134.41 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.611 -179.2 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.51 146.98 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.327 179.299 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.45 123.17 33.02 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.649 179.098 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 25' ' ' ASN . . . 159.58 -119.23 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.097 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 64.06 173.82 3.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.515 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 4.6 p -76.89 -3.83 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.005 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.1 -25.15 9.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.7 t30 -125.05 86.1 57.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.453 0.168 . . . . 0.0 110.667 -179.824 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.63 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.0 1.8 . . . . 0.0 112.216 -179.767 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.712 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 35.5 t60 -53.52 -24.11 12.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.271 179.056 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.61 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -88.62 -153.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.423 179.438 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.22 -51.41 55.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.624 -179.22 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 3.3 p-10 -178.68 35.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.615 0.245 . . . . 0.0 111.519 -179.378 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -125.47 164.15 34.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -179.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.454 ' HB3' ' HA ' ' A' ' 23' ' ' THR . 79.0 Cg_endo -84.05 44.47 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.665 2.243 . . . . 0.0 112.337 179.925 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -90.43 123.38 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.92 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -90.37 109.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.487 179.926 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.712 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -135.66 147.13 48.46 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.392 0.615 . . . . 0.0 110.287 178.842 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.17 155.6 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.751 -176.738 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.61 -32.69 3.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.606 -179.05 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.557 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.74 140.57 2.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.915 0.388 . . . . 0.0 111.406 -179.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.748 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -102.66 133.63 45.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.206 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 117.38 68.51 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.332 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.7 Cg_exo -57.69 135.19 67.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.833 2.355 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.32 1.51 64.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.672 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.19 179.84 28.54 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.076 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -57.68 -33.23 68.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.979 179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.476 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -74.03 -56.43 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.729 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.39 -31.25 72.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -72.13 -32.63 67.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -58.07 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.676 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 41.47 9.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.552 179.681 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' CB ' HG12 ' A' ' 6' ' ' ILE . 13.9 mmt180 -108.98 -17.35 13.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.897 0.38 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.59 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.7 tp -109.35 155.93 20.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.59 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 133.49 44.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 179.778 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.557 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.08 158.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.358 0.599 . . . . 0.0 111.989 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.8 t30 74.47 3.97 4.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.463 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -74.86 126.24 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.052 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 t -86.48 101.23 12.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.554 0.692 . . . . 0.0 111.269 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 34' ' ' ILE . 65.3 mt -47.13 131.56 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.815 179.833 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.457 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.3 mm? -110.37 -44.19 3.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.843 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -142.29 162.17 36.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.768 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.8 t -152.29 114.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.974 179.795 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.401 ' CB ' HG21 ' A' ' 84' ' ' VAL . 26.7 t30 46.6 46.0 14.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 75.42 31.7 0.76 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 64.9 t -120.77 142.16 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 34.3 t0 -105.5 112.12 25.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.81 24.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.369 179.989 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -58.88 -28.92 66.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 60.58 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.446 ' N ' HG22 ' A' ' 23' ' ' THR . 28.3 m -132.89 142.76 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.352 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 152.47 28.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 -179.926 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.508 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.2 t-160 -48.15 -33.95 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.685 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -68.59 -34.1 75.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.173 179.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.94 -38.49 79.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.731 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -66.51 -46.83 74.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 84.5 t -57.62 -50.42 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 178.489 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.647 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.08 -29.81 58.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.786 178.44 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.475 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.37 -53.61 54.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.163 0.506 . . . . 0.0 109.785 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.6 mt -51.75 -40.31 60.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.487 178.871 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -77.55 -25.56 50.22 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.454 179.314 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' GLU . 2.7 pt-20 -93.84 7.57 44.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 0.0 111.311 -178.615 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.543 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -84.99 16.3 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.508 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.82 -83.98 0.09 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.409 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -147.74 -90.09 0.08 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.439 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.4 tp -82.32 96.72 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 109.938 179.134 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 10.1 p -116.04 136.9 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.507 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -86.06 102.79 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.491 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 11.3 mt -90.81 138.58 31.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.303 -178.71 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.66 137.34 40.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.423 179.818 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.307 179.999 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.466 ' CD2' HD21 ' A' ' 58' ' ' LEU . 3.2 m-30 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.608 0.242 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.91 139.76 36.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 111.253 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -97.87 144.9 26.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.516 HD12 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.26 109.38 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.086 0.47 . . . . 0.0 111.545 179.911 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.33 125.37 29.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.459 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 tp -135.01 126.91 29.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.669 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.17 100.18 10.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.371 179.262 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.23 89.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.166 178.798 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.322 -0.204 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.357 -179.09 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.548 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 2.6 tp . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 120.03 22.98 3.1 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.959 -1.115 . . . . 0.0 115.342 177.458 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.752 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -163.48 135.8 5.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.353 1.077 . . . . 0.0 111.502 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.44 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 134.55 35.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.276 -179.674 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -112.4 162.85 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.551 0.691 . . . . 0.0 111.655 179.938 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' A' ' 27' ' ' HIS . . . -158.82 132.79 7.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.354 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.14 1.68 1.27 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.501 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.21 -172.94 0.37 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.955 -179.763 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 32.1 p -68.41 -27.53 66.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.225 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 10.6 m-20 -96.8 -18.78 19.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -124.27 87.21 53.99 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.27 59.86 1.01 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.28 1.987 . . . . 0.0 112.6 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.732 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 40.3 t60 -47.63 -28.3 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 178.834 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -89.35 -154.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.332 179.315 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -60.05 -49.53 77.53 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.663 -179.692 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.83 39.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.08 166.27 21.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.65 6.83 5.2 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.64 2.227 . . . . 0.0 112.802 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -58.56 115.41 3.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.775 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.03 120.13 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.706 -179.896 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.732 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.32 144.57 33.3 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.358 0.599 . . . . 0.0 110.386 178.501 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.74 155.72 7.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.321 -176.374 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.4 -34.69 3.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.777 -178.784 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.566 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.12 142.36 2.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.46 -179.566 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.95 133.17 49.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 178.345 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.86 114.95 57.35 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.606 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 52.2 Cg_exo -55.71 137.76 79.26 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.256 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.02 6.71 66.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.77 177.36 21.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.992 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -54.45 -31.26 55.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.502 ' CA ' HD22 ' A' ' 8' ' ' LEU . . . -73.91 -57.5 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.712 -179.712 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.1 -28.57 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.259 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.72 -31.16 66.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.001 0.429 . . . . 0.0 110.084 179.428 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.42 -57.82 2.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.43 40.32 9.15 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.672 179.589 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.8 mtt85 -111.77 -19.16 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.663 0.268 . . . . 0.0 110.815 179.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -107.81 155.23 20.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.154 0.502 . . . . 0.0 111.177 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.56 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.58 134.82 45.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.676 179.746 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.566 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.0 157.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.317 0.58 . . . . 0.0 111.72 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.89 1.57 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.235 179.837 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.95 124.47 24.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.059 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.37 12.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.604 0.716 . . . . 0.0 111.419 -178.615 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 34' ' ' ILE . 20.3 mt -51.72 130.7 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.791 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.466 HD21 ' CD2' ' A' ' 3' ' ' TYR . 1.4 pp -126.95 3.41 6.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.604 179.389 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.5 OUTLIER 179.07 140.54 0.1 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.207 0.527 . . . . 0.0 110.583 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.429 ' CG1' ' CB ' ' A' ' 76' ' ' ALA . 2.4 p -147.57 118.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 51.78 33.44 11.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 110.076 -179.006 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 77.62 34.75 0.34 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.4 t -120.91 108.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.2 p-10 -73.19 106.43 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.485 179.271 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 29.5 m -93.78 40.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.363 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -22.01 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.163 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -146.99 59.8 1.18 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.148 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 32.8 m -134.52 148.86 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.527 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.37 153.11 43.59 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.034 -179.344 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.534 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.8 t-160 -49.85 -34.02 18.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -33.99 73.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.772 179.41 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.58 -40.56 80.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.675 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.538 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -64.94 -46.71 80.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.009 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.576 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.9 t -57.97 -50.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.2 178.612 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.6 OUTLIER -56.4 -35.24 67.54 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.739 178.537 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.429 ' CB ' ' CG1' ' A' ' 60' ' ' VAL . . . -55.34 -52.49 63.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 110.142 179.528 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 15' ' ' LEU . 3.4 mt -53.88 -38.72 65.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.241 178.585 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -20.65 53.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.413 179.011 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.2 mt-10 -97.21 -12.67 22.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.288 -178.687 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.547 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -57.9 -15.46 8.74 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.393 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 -91.28 1.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.903 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.4 p -139.45 -91.59 0.18 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 9.7 tp -84.22 93.97 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.235 0.54 . . . . 0.0 110.007 178.813 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 9.7 p -113.21 136.86 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 8.5 ptp180 -87.49 102.94 15.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.471 177.969 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 17.7 mt -91.13 132.75 35.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.136 -179.079 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.52 126.18 48.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.719 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.452 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 40.5 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.93 0.395 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.4 mt-10 -129.93 170.57 13.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.32 144.59 49.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.973 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.475 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -140.36 109.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 111.801 179.968 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.6 118.72 20.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.392 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.1 tp -129.42 127.09 40.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.058 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 pt-20 -84.66 100.28 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.011 179.324 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -46.07 89.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.486 179.81 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.52 0.357 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.812 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 22.7 mt . . . . . 0 C--O 1.227 -0.092 0 CA-C-O 120.937 0.399 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 130.12 31.55 0.58 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.297 179.479 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.23 138.09 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.033 0.416 . . . . 0.0 110.561 179.096 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.98 135.03 40.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.425 -179.476 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -113.05 146.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.546 0.689 . . . . 0.0 111.388 179.596 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 37' ' ' THR . . . -128.66 123.86 34.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.736 179.0 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 25' ' ' ASN . . . 159.47 -124.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.742 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 70.09 174.06 13.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.794 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.454 HG21 ' N ' ' A' ' 68' ' ' VAL . 12.2 p -76.93 -1.33 28.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.92 -23.06 8.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -124.85 86.83 55.83 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -179.89 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 65.72 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.051 1.834 . . . . 0.0 112.196 -179.812 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.701 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.2 t60 -53.18 -23.69 9.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.262 179.286 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -91.34 -152.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.481 179.526 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.87 -46.89 63.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.8 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.56 77.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.2 170.28 5.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.65 179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 96.1 Cg_endo -84.47 16.54 1.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.548 2.165 . . . . 0.0 112.829 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.6 m -62.74 145.61 54.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.067 0.461 . . . . 0.0 111.047 -179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -116.73 114.82 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 -179.914 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.701 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -139.9 148.11 41.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.393 0.616 . . . . 0.0 110.545 179.16 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.22 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.968 -176.894 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.78 -30.03 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.372 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.78 129.57 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.049 -179.366 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.06 130.08 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.586 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.462 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 115.3 59.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.588 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 39.1 Cg_exo -57.52 135.79 71.87 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.741 2.294 . . . . 0.0 112.212 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.36 14.62 40.88 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.65 177.47 16.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.997 179.693 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -52.32 -38.23 57.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.834 0.349 . . . . 0.0 111.224 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -65.16 -57.53 8.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.909 -179.608 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.26 -28.64 64.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.509 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -71.94 -32.79 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.008 0.432 . . . . 0.0 110.306 179.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -77.6 -58.02 3.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 36.0 16.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.564 179.562 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CB ' HG12 ' A' ' 6' ' ' ILE . 59.0 mtt180 -118.29 5.26 11.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.602 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 10.9 tp -130.61 156.53 44.72 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.057 0.456 . . . . 0.0 110.932 179.644 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.602 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.54 135.18 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.684 179.846 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -48.98 157.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.305 0.574 . . . . 0.0 111.749 -179.746 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.475 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 7.8 t-20 76.59 0.66 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.275 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.17 125.45 26.71 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.063 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.54 100.14 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 0.0 111.298 -178.958 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' ILE . 61.2 mt -45.36 145.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.996 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -128.83 -44.61 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.5 m-85 -140.66 146.41 37.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.063 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.0 t -140.4 111.41 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.703 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 50.46 37.42 15.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.398 . . . . 0.0 110.185 -179.125 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 79.55 34.24 0.19 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.493 -179.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 97.3 t -120.95 108.44 22.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.424 -179.851 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.0 t0 -78.28 93.32 4.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.902 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 m -64.53 -122.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.372 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 70.16 -65.69 0.31 Allowed 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.03 0.443 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -93.61 40.22 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.725 179.585 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.476 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.7 m -137.92 142.34 36.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 179.88 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.36 155.06 12.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.234 0.54 . . . . 0.0 111.274 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 1.7 p-80 -49.55 -33.78 15.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.873 179.646 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -72.05 -33.67 68.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.327 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.14 -44.13 85.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.247 0.546 . . . . 0.0 109.663 179.023 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.457 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -61.19 -46.88 88.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.609 0.719 . . . . 0.0 109.182 178.045 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 85.1 t -57.99 -50.43 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.416 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.672 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.93 -29.71 63.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.842 178.614 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.85 -51.09 70.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.818 179.493 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.2 mt -56.59 -37.89 71.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.705 179.016 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.3 -22.8 51.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.143 179.059 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -102.23 13.17 35.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.328 -178.655 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.586 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -85.56 16.34 3.93 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.357 179.966 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.61 -93.69 0.56 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.303 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 19.3 m -139.79 -89.23 0.19 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.8 tp -85.44 91.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.113 0.482 . . . . 0.0 109.874 178.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 11.1 p -106.99 137.41 37.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.693 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.35 102.76 14.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.458 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.468 ' HB2' HG21 ' A' ' 6' ' ' ILE . 11.9 mt -90.64 140.65 29.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.41 -178.697 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -101.95 131.87 48.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.273 179.569 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 6.8 m . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 -179.654 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.425 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 27.1 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.912 0.387 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -137.6 146.53 44.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.0 pm0 -108.49 144.56 35.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -136.81 110.33 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.531 179.779 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.95 116.95 20.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.711 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.9 tp -126.68 127.07 44.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.509 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pt-20 -85.52 100.41 11.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.327 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -48.52 88.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.254 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.554 -179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.536 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.8 tp . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.391 0.138 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.4 21.37 1.05 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.89 -1.148 . . . . 0.0 114.726 178.537 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.749 ' HB3' HG22 ' A' ' 39' ' ' ILE . 6.2 p90 -161.6 135.96 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.935 0.868 . . . . 0.0 111.113 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.0 138.75 32.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.45 -179.459 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.66 148.81 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.727 0.775 . . . . 0.0 112.365 -179.642 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -142.15 134.21 27.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.281 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.68 -0.52 1.04 Allowed Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.807 179.491 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.494 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.88 -170.31 0.13 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.929 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' N ' ' A' ' 68' ' ' VAL . 18.1 p -74.9 -21.59 59.13 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.141 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.15 -25.14 15.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.719 0.295 . . . . 0.0 111.643 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -124.34 87.52 53.87 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.176 179.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.11 63.84 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.276 1.984 . . . . 0.0 112.576 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.726 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.3 t60 -49.52 -26.23 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.664 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.43 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.386 179.543 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -55.96 -50.83 59.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.704 -179.644 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.03 39.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.7 170.02 10.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.35 6.59 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.653 2.235 . . . . 0.0 112.843 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.97 113.41 1.5 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.931 0.396 . . . . 0.0 110.57 179.722 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.65 119.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.023 -179.633 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.726 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.67 146.96 36.76 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.646 178.485 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.97 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.194 -176.566 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.77 -31.31 4.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.154 -179.038 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.84 132.14 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.114 -179.363 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.749 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.35 132.9 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.549 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.17 126.72 69.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.655 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.2 Cg_endo -66.16 132.3 29.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.658 2.239 . . . . 0.0 112.355 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.02 1.72 58.34 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.476 -179.833 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.91 173.97 22.08 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.957 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . . . -52.25 -35.57 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -71.03 -57.21 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.748 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.38 -35.21 80.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 -179.161 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -72.08 -30.4 65.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.43 179.705 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.98 -58.13 3.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.647 179.929 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 41.43 10.09 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.579 179.451 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.499 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.2 mtt180 -116.44 7.95 13.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.1 tp -136.72 154.18 50.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.73 179.577 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.79 136.49 48.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.89 157.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.403 0.621 . . . . 0.0 111.513 179.839 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.52 -0.78 3.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.245 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.78 127.52 33.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.972 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.0 p -86.57 100.2 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.471 0.653 . . . . 0.0 111.605 -178.568 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.509 HD13 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -47.03 141.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.087 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.6 mm? -118.58 -45.03 2.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.183 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 m-85 -140.33 169.93 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 t -149.46 96.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.058 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.401 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 67.3 -68.15 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.176 0.512 . . . . 0.0 109.936 -178.784 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.47 30.75 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.683 179.244 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.3 t -117.28 142.18 32.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.386 -179.333 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 35.7 t0 -114.72 87.91 2.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.494 179.431 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 31.7 m -70.53 63.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 111.355 -179.543 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -29.62 30.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -154.68 64.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.817 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.458 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.7 m -128.15 146.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.78 153.62 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.067 0.46 . . . . 0.0 110.811 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.494 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 7.0 p-80 -49.6 -33.62 15.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.988 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -70.64 -33.82 71.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.416 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.78 -44.42 85.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 109.807 179.178 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' A' ' 34' ' ' ILE . . . -62.19 -46.84 87.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.569 0.7 . . . . 0.0 109.307 178.095 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 89.9 t -57.16 -49.33 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.281 178.647 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.72 -33.06 66.13 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.598 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.526 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -57.51 -51.42 69.51 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.522 . . . . 0.0 109.991 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.443 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -55.39 -37.54 67.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.472 178.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.53 -26.67 51.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.502 179.332 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -91.74 -12.62 33.42 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.579 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -55.97 -18.77 10.1 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.334 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.38 -100.34 2.32 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.142 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -126.9 -91.74 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.008 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 tp -87.78 94.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.205 0.526 . . . . 0.0 109.723 178.745 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 8.9 p -110.14 138.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.506 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.1 mtm105 -87.77 103.11 15.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.148 177.838 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 6' ' ' ILE . 15.9 mt -92.5 139.04 30.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.175 -178.993 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.78 147.88 25.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.425 179.857 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.468 ' CG ' ' CD1' ' A' ' 58' ' ' LEU . 2.7 m-30 . . . . . 0 C--O 1.229 0.023 0 CA-C-O 120.9 0.381 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -140.82 148.88 41.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -103.48 141.64 35.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' CD1' ' CD1' ' A' ' 51' ' ' LEU . 1.3 mt -130.66 109.33 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.19 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.475 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.85 112.14 15.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.708 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.574 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 4.5 tp -121.44 126.83 50.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.145 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 8.8 mt-10 -81.57 100.33 9.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.06 88.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.926 179.562 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.221 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.66 -179.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.7 tp . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.433 0.159 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 134.14 20.16 0.84 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.599 178.675 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.736 ' HB3' HG21 ' A' ' 39' ' ' ILE . 8.6 p90 -162.76 134.53 5.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.986 0.893 . . . . 0.0 111.455 179.019 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.463 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.81 139.1 30.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.402 -179.566 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.69 147.37 23.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.68 0.752 . . . . 0.0 112.328 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.93 135.4 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.06 179.438 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.71 3.39 0.96 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.559 179.584 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.61 -168.36 0.29 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.874 -179.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 40.5 p -72.46 -30.01 64.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -96.09 -17.27 21.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.035 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.417 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.0 OUTLIER -124.84 82.66 60.32 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.248 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.36 62.32 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.777 2.318 . . . . 0.0 112.294 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.723 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.4 t60 -50.17 -23.45 2.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.538 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.659 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.81 -154.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.325 179.693 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.64 -50.19 69.69 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.537 -179.681 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.55 39.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.736 0.303 . . . . 0.0 110.766 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.75 164.67 33.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.999 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.25 3.69 6.02 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.05 2.5 . . . . 0.0 112.826 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 m -54.8 114.32 1.67 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.499 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.06 119.81 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.742 -179.898 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.723 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.17 148.5 38.35 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 178.722 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.22 155.59 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -176.73 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.468 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -34.06 3.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.595 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.561 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.56 141.61 2.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.552 -179.677 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.736 HG21 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -104.29 133.07 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.166 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 113.74 49.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -177.763 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 45.2 Cg_exo -56.74 140.53 91.11 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.756 2.304 . . . . 0.0 112.506 -179.828 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.37 13.01 64.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.421 -179.91 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.32 -176.91 19.08 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.038 179.751 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.429 ' O ' HD11 ' A' ' 8' ' ' LEU . . . -59.62 -35.62 74.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.846 0.355 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -70.88 -57.26 4.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.886 -179.615 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.31 -33.32 75.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.765 -179.041 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -72.34 -30.4 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 110.56 179.773 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.31 -58.22 3.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.059 -179.552 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 41.29 8.99 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.384 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -120.44 -2.14 10.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.696 0.284 . . . . 0.0 110.935 179.667 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.621 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 36.0 tp -124.37 162.96 22.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.147 0.499 . . . . 0.0 111.402 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.621 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.37 134.38 25.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.241 179.302 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.561 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.6 t -49.18 156.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.842 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.473 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.4 OUTLIER 76.54 -1.43 2.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.332 179.885 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -67.18 126.82 30.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.966 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.6 102.74 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.545 0.688 . . . . 0.0 111.533 -178.747 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 34' ' ' ILE . 69.3 mt -49.36 136.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.784 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.468 ' CD1' ' CG ' ' A' ' 3' ' ' TYR . 48.4 mt -120.61 -30.08 4.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.609 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -152.94 158.36 41.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.952 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.0 t -152.41 109.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 179.888 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.417 ' CB ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER 49.77 47.92 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.84 179.999 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 73.13 31.4 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.823 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 73.6 t -120.2 142.06 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.832 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 8.9 p-10 -113.05 91.35 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.556 179.519 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 2.2 m -55.9 -102.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.17 -179.646 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.404 ' H ' ' CG2' ' A' ' 65' ' ' VAL . 5.1 mtp180 61.99 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.773 0.32 . . . . 0.0 111.24 179.74 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -88.25 51.92 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 -179.655 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 30.4 m -139.17 144.41 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.053 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.47 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.36 154.59 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.429 . . . . 0.0 111.038 -179.484 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.515 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.4 p-80 -48.15 -34.26 9.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.194 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -70.29 -33.89 72.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.393 179.921 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.604 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.77 -47.34 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.194 0.521 . . . . 0.0 109.624 179.079 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -59.31 -46.74 87.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.654 0.74 . . . . 0.0 109.36 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 85.1 t -56.86 -50.4 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.357 178.516 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.9 -28.59 57.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.991 178.649 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.98 -51.59 67.46 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.344 0.592 . . . . 0.0 109.691 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -56.75 -36.89 70.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.874 179.098 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.4 -30.52 53.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.852 179.712 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.429 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -97.85 19.76 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.42 -178.417 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -89.14 16.3 7.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 179.656 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.53 -93.44 0.81 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.225 -179.835 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.2 m -142.18 -90.6 0.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.0 tp -83.11 89.22 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.561 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.615 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 8.8 p -105.75 137.6 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.644 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.17 102.92 14.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.659 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.44 HD12 ' CD2' ' A' ' 15' ' ' LEU . 9.3 mt -92.77 137.7 32.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.172 -178.906 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CE2' ' CB ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 138.5 38.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.587 179.877 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 29.8 m . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.996 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CG ' HD11 ' A' ' 58' ' ' LEU . 6.4 m-85 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.46 146.18 31.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.887 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -102.53 144.66 30.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.896 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.75 109.23 9.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.446 179.679 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.2 119.86 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.095 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.3 tp -131.07 126.9 37.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.48 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 pt-20 -84.29 100.49 11.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 179.354 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.7 89.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.042 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.603 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.8 tp . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.29 0.091 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.22 22.11 0.92 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 119.693 -1.242 . . . . 0.0 114.914 178.38 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.754 ' HB3' HG21 ' A' ' 39' ' ' ILE . 10.4 p90 -161.17 135.96 7.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.073 0.936 . . . . 0.0 111.351 179.101 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.75 135.36 36.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.528 -179.571 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -115.2 146.83 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.418 179.638 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.487 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -128.14 123.59 34.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.446 178.956 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.48 -124.91 1.41 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.939 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.453 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 73.14 168.71 13.9 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.214 179.877 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 6.3 p -75.53 -6.29 49.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -106.64 -26.92 11.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' HIS . 5.2 t-20 -124.91 86.97 55.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.579 -179.762 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.23 66.93 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.127 1.885 . . . . 0.0 112.455 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.748 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 37.4 t60 -52.39 -24.91 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.252 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.1 -153.71 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.388 179.723 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -52.33 -51.62 41.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.85 -179.366 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 169.8 41.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 0.0 110.846 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.06 173.59 5.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 23' ' ' THR . 80.9 Cg_endo -84.66 41.6 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.734 2.289 . . . . 0.0 112.438 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -90.41 119.49 30.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.003 0.43 . . . . 0.0 111.267 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -90.69 112.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.044 179.643 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.748 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -138.29 147.42 43.58 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.369 0.604 . . . . 0.0 110.283 179.249 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.15 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.111 -176.663 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.67 -33.55 4.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.574 -179.225 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.98 142.19 2.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.911 0.386 . . . . 0.0 111.457 -179.762 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.754 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.75 132.96 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.967 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 125.13 73.96 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.278 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 41.4 Cg_endo -67.05 129.92 21.73 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.936 2.424 . . . . 0.0 112.189 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.91 49.93 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.02 178.84 19.8 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.878 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -54.92 -38.81 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.749 0.309 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -66.62 -57.47 7.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.634 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.47 -28.89 67.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.487 -179.684 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -33.57 68.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.966 0.413 . . . . 0.0 110.175 179.594 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.1 -57.99 2.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.66 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 41.27 9.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.604 179.638 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -111.21 -10.24 14.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.885 0.374 . . . . 0.0 110.78 179.621 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.6 tp -117.14 153.45 32.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.93 137.8 51.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -52.24 158.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.828 -179.967 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 3.5 t30 75.93 -0.09 3.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.325 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -69.11 125.53 26.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.18 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.69 100.69 12.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.672 . . . . 0.0 111.366 -178.837 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ILE . 61.4 mt -47.11 129.15 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.911 179.927 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.439 HD11 ' CG ' ' A' ' 3' ' ' TYR . 3.6 mt -114.95 -32.05 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.586 179.437 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -151.94 155.78 38.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 62' ' ' GLU . 46.0 t -142.2 102.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.631 179.572 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.13 -68.13 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.088 0.47 . . . . 0.0 110.462 -179.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' VAL . 8.3 pt-20 -155.06 30.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.907 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.0 t -117.87 142.09 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.2 t0 -109.93 87.77 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.366 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -63.37 -138.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.868 -179.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.2 -59.73 0.5 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.092 -179.184 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -100.8 30.16 4.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.293 179.03 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 12.2 m -127.55 142.77 42.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.389 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.41 152.97 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 22.7 t-160 -47.91 -33.96 8.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -65.25 -34.17 77.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.091 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.662 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.816 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB3' HD13 ' A' ' 34' ' ' ILE . . . -63.07 -46.93 85.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.908 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.658 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 76.3 t -56.25 -50.91 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.287 178.601 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.58 -29.27 61.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.253 178.944 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.467 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.42 -56.83 16.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.962 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 2.2 mp -53.4 -36.84 61.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.983 178.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.42 -27.4 52.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.642 179.521 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -99.44 14.64 29.07 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.435 -178.267 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.586 ' HB2' HG23 ' A' ' 84' ' ' VAL . . . -85.47 16.29 3.9 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.3 -86.71 0.05 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.191 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 13.3 p -144.14 -89.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.456 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 9.0 tp -84.21 92.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.176 0.512 . . . . 0.0 110.077 179.127 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 80' ' ' ALA . 7.1 p -108.1 137.92 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.898 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 11.0 ptp180 -88.29 102.7 15.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.188 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' CD2' ' CG1' ' A' ' 60' ' ' VAL . 11.2 mt -91.65 138.8 31.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.427 -178.52 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.49 137.36 39.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.138 179.584 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 55' ' ' ASP . 11.6 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.213 -179.4 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.449 ' CE2' ' HG ' ' A' ' 58' ' ' LEU . 3.2 m-85 . . . . . 0 C--O 1.231 0.092 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.61 166.98 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 111.493 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -119.52 144.95 46.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.87 111.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.99 0.424 . . . . 0.0 111.856 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.417 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.5 120.15 23.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.972 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 tp -129.83 126.8 38.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.613 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.6 pt-20 -86.68 100.74 12.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.233 179.312 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -47.86 88.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.325 179.531 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.237 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.781 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.526 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.1 tp . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . 129.96 22.14 1.16 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.909 -1.138 . . . . 0.0 114.632 178.446 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.743 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.1 p90 -162.89 134.79 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.76 0.78 . . . . 0.0 111.228 179.02 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.38 139.41 31.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.672 -179.287 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.74 147.18 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.661 0.743 . . . . 0.0 112.306 -179.92 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -139.86 132.62 29.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.876 179.202 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 149.76 -6.48 0.75 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.491 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.32 179.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.977 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 19.1 p -65.03 -34.62 78.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.231 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.93 -17.58 29.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.557 -179.552 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -124.43 81.99 58.8 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.45 63.38 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.832 2.354 . . . . 0.0 112.522 -179.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.717 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 t60 -53.16 -22.3 6.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.674 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.43 -152.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.448 179.73 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -83.97 50.37 4.39 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.643 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 78.04 47.34 0.05 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.028 0.442 . . . . 0.0 110.455 179.744 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.98 151.46 72.18 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.45 -2.7 12.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.456 2.104 . . . . 0.0 112.576 179.976 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.16 119.25 4.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.537 179.695 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -86.55 120.34 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 -179.462 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.717 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.18 147.19 36.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.337 0.589 . . . . 0.0 110.564 178.479 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.12 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.943 -176.767 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.51 -30.95 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.783 -1.098 . . . . 0.0 112.215 -179.091 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.68 131.41 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.043 -179.408 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.743 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.84 132.14 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.492 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.32 124.22 74.08 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.719 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 34.9 Cg_endo -64.59 135.38 45.25 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.675 2.25 . . . . 0.0 112.242 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.94 7.13 60.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.486 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.09 174.51 17.65 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.904 179.804 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.64 -32.75 52.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.642 0.258 . . . . 0.0 111.209 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -72.18 -57.42 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.547 -179.965 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.32 -28.91 67.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.446 -179.535 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -71.9 -31.58 66.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.197 179.596 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -83.83 -57.85 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.932 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.4 40.81 8.8 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.385 179.714 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.6 mtp85 -112.64 -9.23 13.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.017 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.3 tp -119.35 155.88 31.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.605 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.1 mpt_? -131.99 135.47 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.98 157.72 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.296 0.57 . . . . 0.0 111.721 179.889 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.3 OUTLIER 76.23 -1.27 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.715 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.3 m-20 -69.53 127.71 33.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.69 100.02 12.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.549 0.69 . . . . 0.0 111.281 -178.97 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.472 HD12 HG22 ' A' ' 19' ' ' ILE . 10.6 mt -45.74 144.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.026 -179.927 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.449 ' HG ' ' CE2' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -123.26 -44.36 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.205 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -140.97 165.78 26.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 62' ' ' GLU . 42.0 t -150.75 103.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.523 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.416 ' HB2' HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 64.51 -71.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.108 0.48 . . . . 0.0 110.226 -179.24 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -151.14 28.56 0.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.816 179.3 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 21.5 t -116.04 142.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.21 -179.485 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 38.4 p-10 -103.59 -0.96 28.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.422 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 m 43.65 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.559 -179.645 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -51.92 99.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.765 179.91 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 11.3 pt-20 44.85 57.66 4.46 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 -179.58 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.55 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 4.9 m -108.51 145.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.25 156.84 14.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.337 -178.925 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.508 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.0 p-80 -48.9 -34.29 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.932 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -67.91 -33.86 75.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.55 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.29 -46.1 78.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.181 0.515 . . . . 0.0 109.649 178.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB2' HG23 ' A' ' 34' ' ' ILE . . . -62.37 -45.4 93.35 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.506 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 66.9 t -56.52 -50.43 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.113 178.517 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.595 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.48 -34.65 36.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.862 179.534 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.559 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.49 -57.34 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.437 HD13 ' CE1' ' A' ' 17' ' ' PHE . 2.4 mt -59.98 -41.32 91.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.38 0.61 . . . . 0.0 110.231 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.595 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.92 -20.13 56.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.766 179.641 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -112.22 23.44 13.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 179.271 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.52 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -82.92 16.57 2.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.752 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.52 -91.24 0.48 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.676 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.461 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.0 m -138.29 -90.73 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.859 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.1 tp -86.55 100.23 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.526 179.361 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.52 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 7.3 p -114.11 139.95 37.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.793 -178.171 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -88.12 103.51 15.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.603 178.441 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.491 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 17.7 mt -94.1 136.63 34.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -178.942 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 138.17 39.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.377 179.562 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.992 -179.679 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.447 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 71.1 m-85 . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.721 0.296 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -144.7 137.32 26.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.8 pt-20 -103.43 144.61 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.651 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.49 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -139.91 109.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 111.887 179.925 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.35 121.14 24.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.612 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 tp -130.44 127.2 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.233 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 3.1 mt-10 -77.78 99.72 6.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.201 179.59 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -62.57 90.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.235 178.455 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.996 -179.47 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.4 tp . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 110.591 -0.152 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 133.61 19.12 0.96 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.942 -1.123 . . . . 0.0 114.775 178.596 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.755 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.7 p90 -161.31 137.05 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.755 0.778 . . . . 0.0 110.996 179.114 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.69 138.01 33.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.528 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.22 147.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.669 0.747 . . . . 0.0 112.302 -179.781 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -139.56 133.67 31.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.168 179.454 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.76 -7.48 1.08 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.531 179.57 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.54 -177.86 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.337 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 30.3 p -64.03 -33.72 76.39 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.914 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.78 -19.02 25.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.13 86.94 53.86 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.46 179.897 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.0 61.25 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.407 2.071 . . . . 0.0 112.4 -179.729 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.722 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 54.8 t60 -49.83 -26.12 3.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.187 178.967 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.686 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.99 -151.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.525 179.616 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -83.25 49.87 4.31 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.828 -178.951 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.18 45.11 0.09 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.088 0.47 . . . . 0.0 110.511 179.558 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.13 78.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.913 179.912 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.77 -1.16 10.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.38 2.053 . . . . 0.0 112.546 179.847 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -51.99 115.91 1.92 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.91 0.386 . . . . 0.0 110.462 179.524 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.526 HD12 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.06 118.21 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.145 -179.346 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.722 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.94 146.96 38.06 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.372 0.606 . . . . 0.0 110.474 178.42 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.1 155.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.191 -176.52 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.462 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.17 -30.96 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.133 -178.846 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.86 132.93 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.113 -179.496 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.755 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.53 132.05 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.889 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.17 116.17 63.66 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.627 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.39 135.56 68.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.757 2.304 . . . . 0.0 112.273 179.742 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.55 9.49 57.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.655 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.71 179.76 18.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.033 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.38 -36.52 66.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.755 0.312 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -68.98 -57.35 5.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.029 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.77 -29.94 68.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.02 -178.964 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.424 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.6 pt20 -72.04 -33.42 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.45 -58.04 3.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 41.09 9.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.594 179.479 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.49 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.2 mtt-85 -115.38 9.05 15.5 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.751 179.584 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.3 tp -136.19 154.58 50.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.627 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.15 135.59 46.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.85 179.841 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.558 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -51.4 157.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.437 0.637 . . . . 0.0 111.552 179.998 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.49 0.17 3.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.356 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.8 m-20 -71.35 127.73 33.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.0 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.4 p -86.49 100.41 12.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.576 0.703 . . . . 0.0 111.381 -178.597 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 34' ' ' ILE . 68.1 mt -45.46 151.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.127 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -128.91 -46.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.278 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -141.15 163.98 31.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 62' ' ' GLU . 24.4 t -148.67 101.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.603 179.573 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.72 -68.83 0.12 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.1 0.476 . . . . 0.0 110.389 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.8 mm-40 -154.13 30.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.799 179.29 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 19.7 t -117.66 142.2 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.165 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 34.5 p-10 -105.54 1.35 27.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.389 179.77 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m 43.62 30.84 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.813 0.339 . . . . 0.0 111.319 -179.638 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 95.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.992 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 57.04 63.0 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.745 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 19.7 m -119.29 147.72 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.447 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.06 155.6 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.214 -179.17 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.542 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.1 p-80 -48.17 -34.93 10.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.181 -179.454 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 m -69.83 -33.79 72.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.381 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.87 -47.29 75.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.0 109.645 178.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -60.3 -46.77 88.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.551 0.691 . . . . 0.0 109.493 178.2 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.7 t -57.41 -48.45 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.296 178.606 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.96 -34.87 68.48 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.518 178.553 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.56 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.46 -51.3 67.39 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.258 0.551 . . . . 0.0 110.016 179.337 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.434 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -55.28 -37.19 66.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.307 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.47 -26.74 51.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -96.2 6.1 49.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 111.437 -178.647 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -79.14 16.19 1.0 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.65 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.91 -91.11 0.5 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.347 -179.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 10' ' ' ARG . 38.6 m -143.87 -91.15 0.11 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.198 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.9 tp -81.68 92.69 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 109.726 178.693 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -110.89 137.05 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.262 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.8 ptt85 -87.04 103.09 15.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.196 177.676 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 6' ' ' ILE . 18.5 mt -91.51 141.83 28.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.162 -178.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 144.32 30.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.624 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.435 179.714 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 3.6 m-30 . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.856 0.36 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -164.2 147.1 9.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -102.58 144.65 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -135.56 109.44 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.487 179.846 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.406 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.47 113.29 17.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.047 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 tp -123.81 127.22 47.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.563 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 pt-20 -86.35 100.13 12.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.275 179.898 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HG2' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.16 89.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.266 178.328 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.186 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.345 -178.983 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 127.94 24.7 1.17 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.854 178.139 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG21 ' A' ' 39' ' ' ILE . 6.1 p90 -162.18 134.95 5.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.985 0.892 . . . . 0.0 111.498 178.923 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.31 134.78 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.173 -179.679 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -111.68 166.74 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.706 0.765 . . . . 0.0 111.655 179.936 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -163.62 131.93 3.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.296 179.997 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.46 0.53 1.15 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.456 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.529 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.966 -179.976 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 68' ' ' VAL . 15.0 p -74.78 -20.03 59.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.18 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -98.39 -24.15 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 111.661 -179.376 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -124.53 87.89 53.9 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 179.814 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 63.07 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.317 2.011 . . . . 0.0 112.792 -179.368 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.75 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 38.9 t60 -48.29 -27.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 178.859 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.675 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.39 -154.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.557 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -56.53 -50.41 63.11 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.582 -179.708 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.01 40.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.914 0.388 . . . . 0.0 110.711 -179.98 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.26 167.22 16.95 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.999 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.92 8.55 4.25 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.645 2.23 . . . . 0.0 112.83 -179.995 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -60.49 113.76 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 110.772 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -81.34 119.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.446 179.962 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.75 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.42 145.0 33.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.37 0.605 . . . . 0.0 110.568 178.792 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.91 155.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.332 -176.333 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.11 -34.28 4.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.81 143.01 2.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 111.55 -179.602 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.748 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -105.77 132.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.097 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.436 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.02 125.91 71.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.475 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.1 Cg_endo -66.89 131.09 24.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 4.82 55.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.457 -179.649 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.78 177.67 21.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.726 179.685 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.19 -36.19 65.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.66 0.267 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -69.42 -57.53 5.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.517 -179.87 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.01 -28.92 67.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.12 -35.44 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.441 . . . . 0.0 110.0 179.318 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -83.59 -57.99 3.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.03 9.42 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.49 ' CB ' HG12 ' A' ' 6' ' ' ILE . 42.5 mtp180 -113.72 8.85 17.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.699 0.285 . . . . 0.0 110.662 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.6 tp -135.08 153.88 51.88 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.609 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.56 136.65 49.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.879 179.937 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.581 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.9 t -51.18 158.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.331 0.586 . . . . 0.0 111.676 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.29 2.17 4.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.023 179.911 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -71.02 126.03 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.988 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -86.48 101.95 13.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.652 0.739 . . . . 0.0 111.346 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.4 mt -49.74 136.27 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.38 -38.29 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.174 179.545 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.1 m-85 -147.34 172.01 14.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.798 -179.73 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.7 t -150.27 96.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.996 179.351 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.417 ' HB2' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 68.44 -67.17 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.193 0.52 . . . . 0.0 109.775 -178.789 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -156.28 32.34 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.555 179.209 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.8 t -119.23 142.33 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.57 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.9 p-10 -111.07 106.77 15.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.214 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 31.4 m -91.88 43.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.52 -179.517 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.58 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.736 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.43 66.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.6 m -134.6 145.63 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 151.69 28.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.753 -179.884 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.529 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.8 t-160 -48.98 -33.67 11.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 t -67.15 -34.06 76.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.045 179.642 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.39 -40.39 81.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.829 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB3' HD12 ' A' ' 34' ' ' ILE . . . -65.55 -46.76 78.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.112 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 97.4 t -57.19 -50.29 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.143 178.563 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.25 -33.04 62.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.693 178.646 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.218 0.533 . . . . 0.0 110.124 179.453 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.429 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.4 mt -53.12 -37.57 61.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.212 178.857 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.47 -27.58 52.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.305 178.953 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -87.63 -17.65 31.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.021 0.438 . . . . 0.0 111.092 -178.825 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -52.32 -21.42 3.51 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.489 179.828 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.04 -91.31 1.44 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.045 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -134.49 -92.87 0.31 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.7 tp -86.57 93.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.34 0.59 . . . . 0.0 109.983 178.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.576 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 11.7 p -110.17 139.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.232 -177.493 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.43 103.07 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.863 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' HB2' HG23 ' A' ' 6' ' ' ILE . 13.8 mt -93.81 135.73 34.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -101.73 139.92 36.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 -179.946 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 25.9 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.992 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CG ' HD22 ' A' ' 58' ' ' LEU . 9.9 m-30 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.893 0.378 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.19 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.624 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 4.4 tt0 -130.36 141.65 50.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.683 0.278 . . . . 0.0 111.098 -179.822 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.493 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -138.1 112.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.026 0.441 . . . . 0.0 111.87 179.755 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -80.77 121.95 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.698 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 4.9 tp -131.14 127.14 37.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.368 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.4 pt-20 -82.96 100.36 10.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.208 179.276 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.03 88.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.107 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.61 -180.0 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.244 0.068 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 128.02 28.15 0.88 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.922 178.33 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.754 ' HB3' HG21 ' A' ' 39' ' ' ILE . 5.7 p90 -162.9 132.92 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.879 0.84 . . . . 0.0 111.03 178.771 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -90.83 134.88 34.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.437 -179.2 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -113.03 163.63 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.703 0.763 . . . . 0.0 111.756 -179.944 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -159.06 130.67 6.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.931 179.452 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 146.91 -1.03 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.319 179.82 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.61 -172.08 0.25 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.91 -179.857 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 28.6 p -69.77 -34.38 73.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.308 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.43 -19.56 25.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.416 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -124.68 82.41 59.78 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 0.0 110.292 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.98 62.48 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.803 2.335 . . . . 0.0 112.224 -179.594 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.5 t60 -50.73 -23.39 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.413 179.016 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.666 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -93.92 -154.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.308 179.582 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.57 -50.26 68.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.584 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.13 40.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -127.84 168.52 14.99 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.022 -179.913 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.18 3.2 6.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.01 2.473 . . . . 0.0 112.702 -179.81 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -53.96 112.17 0.9 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.863 0.363 . . . . 0.0 111.092 -179.917 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.526 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.34 119.64 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.388 179.914 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.58 144.48 32.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.505 0.669 . . . . 0.0 110.585 178.952 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.07 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.88 -176.593 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.471 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.57 -31.9 4.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.809 -178.842 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.47 142.12 2.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.384 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.754 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -103.89 133.82 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.26 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.94 119.28 73.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.18 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.8 Cg_exo -58.87 132.6 48.61 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.757 2.304 . . . . 0.0 112.137 179.748 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.82 -1.16 59.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.763 -179.976 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.36 177.39 28.47 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.873 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -54.78 -35.53 63.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.969 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -70.26 -57.39 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 -179.997 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.89 -28.97 68.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.318 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -71.81 -34.23 69.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.13 0.491 . . . . 0.0 109.889 179.509 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.08 -57.74 2.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.49 42.01 9.54 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.362 179.655 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.493 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtp180 -110.27 -18.64 13.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.688 179.765 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.8 tp -106.69 153.26 22.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.089 0.471 . . . . 0.0 110.666 179.371 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.588 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -127.85 135.89 50.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.919 179.825 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -50.29 160.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.49 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.2 m120 71.45 4.1 4.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.154 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -71.06 124.35 24.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.589 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.6 p -86.42 100.0 12.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.561 0.696 . . . . 0.0 111.709 -178.193 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' ILE . 9.9 mt -53.12 129.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.861 179.792 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.4 pp -122.53 -18.61 6.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.521 178.974 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -157.36 162.36 39.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.026 0.441 . . . . 0.0 110.652 -179.979 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 62' ' ' GLU . 24.8 t -143.92 97.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.86 179.41 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.477 ' HB2' HG22 ' A' ' 84' ' ' VAL . 1.3 t-20 66.59 -69.02 0.13 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.159 0.504 . . . . 0.0 109.889 -178.572 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -152.89 29.66 0.51 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.866 179.174 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.5 t -115.98 141.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.359 -179.402 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.5 p-10 -113.47 97.18 6.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.492 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.422 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 31.4 m -69.62 64.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.191 -179.781 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -91.31 101.02 13.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.547 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.41 51.01 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.019 -179.902 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.432 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 19.1 m -116.41 142.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 179.639 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.475 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.54 153.29 23.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.025 -179.129 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.485 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.1 p-80 -47.95 -33.82 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.963 -179.671 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -33.96 70.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.947 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.35 -44.56 82.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 109.724 179.321 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -62.01 -46.88 87.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.773 0.797 . . . . 0.0 109.161 178.095 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.631 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 90.0 t -56.22 -50.45 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.299 178.601 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.11 -29.84 61.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.379 179.071 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.94 -50.3 72.68 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.404 0.621 . . . . 0.0 109.986 179.57 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' CD2' ' CD1' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -59.05 -36.13 74.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.771 179.271 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -24.03 50.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.889 178.788 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -101.78 16.27 26.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.792 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.607 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -87.28 16.21 5.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.75 -93.97 0.75 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.316 -179.999 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.479 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.7 m -141.42 -89.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 6.8 tp -84.07 89.02 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.646 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.607 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 11.6 p -105.38 136.29 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.182 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.01 102.94 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.664 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 38.0 mt -89.12 137.34 32.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.389 -178.836 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.542 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.1 122.84 44.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.529 179.679 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.565 -179.938 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CG ' HD11 ' A' ' 58' ' ' LEU . 6.4 m-85 . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.849 0.357 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 11.2 pt-20 -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.73 144.71 46.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.495 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -136.7 109.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 111.863 179.857 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.91 116.37 20.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.525 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.595 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.9 tp -126.06 127.36 45.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.249 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.8 pm0 -86.84 100.46 12.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.713 179.596 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.569 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 1.3 mtm180 -44.32 91.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.682 179.109 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.342 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.256 -179.19 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 16.4 mt . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.0 34.62 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.71 179.318 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.752 ' HB3' HG21 ' A' ' 39' ' ' ILE . 7.7 p90 -159.64 138.08 10.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.137 0.469 . . . . 0.0 110.938 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.412 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.99 132.19 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.811 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.765 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -108.2 165.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.77 . . . . 0.0 111.803 -179.905 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -164.27 131.3 3.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.356 179.845 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.66 0.2 0.97 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.632 179.614 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.52 -170.96 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.977 -179.871 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 68' ' ' VAL . 13.2 p -75.34 -20.79 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.187 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.85 -24.96 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 -179.347 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -124.39 87.66 53.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.208 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 63.12 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.418 2.079 . . . . 0.0 112.686 -179.484 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.69 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.0 t60 -47.96 -27.9 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 178.887 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.617 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.59 -155.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.357 179.301 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.8 -46.78 59.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.562 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 176.71 73.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.731 -179.96 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -165.67 165.69 10.85 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.21 5.7 6.07 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.674 2.249 . . . . 0.0 112.923 -179.947 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.0 112.87 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -83.51 119.16 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 -179.911 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.69 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.26 145.9 34.54 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.505 0.669 . . . . 0.0 110.847 178.653 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.765 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.73 155.97 7.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.008 -176.897 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.432 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.88 -27.47 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.622 -178.411 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.64 128.67 0.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.211 -179.444 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.752 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.98 130.51 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.662 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.437 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 114.74 56.63 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.569 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.5 Cg_exo -57.94 135.58 69.73 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.781 2.32 . . . . 0.0 112.217 179.918 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.12 15.27 39.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.97 179.58 16.09 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.037 179.773 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -53.33 -38.55 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.734 0.302 . . . . 0.0 111.343 -179.982 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -65.98 -57.65 7.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.012 -179.538 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.2 -28.76 64.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 -179.4 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -32.87 67.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.916 0.389 . . . . 0.0 110.264 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -79.63 -58.1 3.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.582 179.967 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.5 9.92 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.645 179.433 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.479 ' CB ' HG12 ' A' ' 6' ' ' ILE . 25.9 mtt180 -119.36 7.23 11.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.868 0.334 . . . . 0.0 110.941 179.68 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.5 tp -134.3 154.8 51.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.917 179.555 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 135.1 43.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.863 179.995 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 59.9 t -49.14 158.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.278 0.561 . . . . 0.0 111.55 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t-20 73.69 4.19 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.992 -179.807 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.4 m-20 -73.27 124.23 25.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.46 101.77 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.693 0.759 . . . . 0.0 111.63 -178.395 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.8 mt -49.46 137.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.436 HD11 ' CG ' ' A' ' 3' ' ' TYR . 3.9 mt -117.1 -34.03 4.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 179.246 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -149.55 169.24 21.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 62' ' ' GLU . 21.8 t -146.56 97.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.278 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.451 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.3 t30 67.26 -68.1 0.16 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.256 0.55 . . . . 0.0 109.82 -178.655 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -155.68 32.87 0.36 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.527 179.106 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 57.3 t -119.38 142.27 35.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.523 -179.12 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -110.0 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.294 179.052 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 30.6 m -92.48 40.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.36 . . . . 0.0 111.414 -179.66 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.831 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -151.59 66.33 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.438 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.6 m -133.08 145.42 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.75 151.89 24.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 -179.808 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.527 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.2 t-160 -49.49 -33.61 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 t -67.12 -33.99 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.994 179.583 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.611 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -40.07 80.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.772 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -65.68 -46.88 77.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.014 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.593 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 85.8 t -57.32 -49.99 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.251 178.533 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.611 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.15 -34.33 66.04 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.669 178.633 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -56.66 -51.07 70.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.182 0.515 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.426 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.2 mt -56.7 -36.35 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.476 178.955 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.26 -22.48 52.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.209 179.053 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -97.39 -11.99 23.3 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.38 -178.879 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -57.33 -18.99 19.64 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 179.944 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.07 -101.19 2.56 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.994 -179.825 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.569 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.9 p -127.67 -90.4 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.871 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 tp -87.19 91.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.589 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 10.3 p -107.16 137.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.296 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.2 ttt85 -86.71 103.1 14.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.131 177.762 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 6' ' ' ILE . 11.4 mt -91.67 142.98 27.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.451 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.04 134.23 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.476 179.789 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 111.211 -179.724 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.425 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 53.0 m-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -142.7 148.23 36.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.48 144.88 31.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.694 179.78 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.459 HD12 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.51 109.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.933 -179.779 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.42 123.41 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.774 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 tp -133.69 126.78 31.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.089 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -85.19 99.83 11.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.926 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' HB2' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -55.91 86.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.362 179.188 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.56 -179.509 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 5.8 tp . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.828 0.346 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 74.14 31.08 60.0 Favored Glycine 0 CA--C 1.519 0.281 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 177.829 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.754 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.5 p90 -164.52 131.38 3.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.282 1.041 . . . . 0.0 111.628 178.559 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -97.33 138.96 34.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.866 -179.083 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.7 148.93 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 112.01 179.864 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . . . -142.62 133.19 25.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.937 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.14 -3.32 0.9 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.586 179.783 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.49 179.97 0.12 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.454 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 26.5 p -65.24 -35.11 80.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.419 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.03 -17.14 29.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.628 0.251 . . . . 0.0 111.519 -179.486 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.56 82.05 59.45 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.043 0.449 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.14 62.87 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.853 2.368 . . . . 0.0 112.541 -179.291 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.713 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.5 t60 -52.28 -22.71 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 178.78 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.646 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.71 -154.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.645 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -60.03 -49.8 74.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.551 -179.798 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.51 39.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.56 167.44 17.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.833 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.11 1.93 8.74 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.668 2.245 . . . . 0.0 112.755 179.995 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.78 115.27 1.73 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -86.5 121.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.566 -179.831 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.713 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.08 146.88 35.94 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.315 0.579 . . . . 0.0 110.59 178.824 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.98 155.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.69 -176.897 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.52 -30.72 4.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.174 -178.971 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.75 128.32 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.212 -0.595 . . . . 0.0 112.33 -179.362 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.754 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.47 127.03 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.69 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.467 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.24 119.39 73.14 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -177.814 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.5 Cg_exo -54.36 140.32 73.3 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.718 2.279 . . . . 0.0 112.297 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.75 12.98 70.77 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.537 -179.923 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.61 -158.68 21.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.978 179.779 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -75.96 -38.85 57.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.869 0.334 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -74.13 -54.46 7.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.586 -179.63 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -60.59 -32.48 71.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 2.6 mm100 -72.36 -37.31 68.82 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.03 0.443 . . . . 0.0 110.308 179.514 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.62 -57.85 3.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.28 35.6 14.38 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.529 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.427 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.9 mmm180 -110.7 -12.56 14.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.701 179.584 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.2 tp -113.66 155.84 24.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.57 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.0 tpt180 -134.87 135.11 41.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.47 157.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.279 0.561 . . . . 0.0 111.638 179.935 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 4.9 t-20 75.7 -1.65 2.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.277 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.5 m-20 -68.48 126.6 30.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.936 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 p -86.57 100.14 12.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 111.471 -178.616 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.464 HD11 HG23 ' A' ' 19' ' ' ILE . 11.6 mt -45.47 153.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.813 179.999 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -136.79 -46.23 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.64 -179.669 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -142.21 167.11 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 62' ' ' GLU . 24.5 t -142.36 100.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.897 179.34 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.436 ' HB2' HG22 ' A' ' 84' ' ' VAL . 3.1 t-20 66.36 -68.04 0.14 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.199 0.523 . . . . 0.0 109.667 -178.517 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.2 mt-10 -156.65 31.28 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.38 178.974 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -116.36 142.52 29.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.452 -179.006 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 3.7 p-10 -108.29 120.18 41.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.505 179.176 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 19.1 m -93.79 37.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.15 -179.983 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -71.06 100.89 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.06 50.02 1.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 14.0 m -114.92 142.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.732 179.464 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.454 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.96 153.0 26.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.069 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.523 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 11.0 t-160 -48.79 -33.98 11.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.516 -179.964 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -34.12 76.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.301 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.96 -42.69 80.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.478 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB3' HD13 ' A' ' 34' ' ' ILE . . . -63.81 -46.66 84.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.003 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.511 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 58.0 t -57.17 -50.35 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.1 178.639 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.655 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.34 -32.55 38.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.772 179.222 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.38 -57.11 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.845 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.463 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 4.2 mt -64.1 -39.79 94.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.009 -179.436 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.578 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -77.1 -20.06 56.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.334 -179.73 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.655 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 4.4 mm-40 -104.1 -10.78 17.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.02 0.438 . . . . 0.0 110.873 178.894 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.51 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -48.17 -20.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.566 179.944 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.62 -104.33 2.99 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -117.8 -92.89 0.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.764 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.3 tp -87.58 102.7 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.058 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 8.4 p -118.04 138.75 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.6 -178.6 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.6 mtm180 -87.05 103.56 15.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.638 178.817 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.515 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 18.4 mt -93.58 139.17 31.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.018 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 137.99 39.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.763 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.422 179.837 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.467 ' CD1' ' CD2' ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.834 0.35 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -109.55 125.43 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.922 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 12.2 pt-20 -94.7 144.62 25.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -142.26 109.51 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.715 179.935 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.45 122.01 24.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.031 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.591 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.3 tp -132.02 128.03 37.45 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.556 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.4 pt-20 -86.43 100.5 12.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.32 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.459 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 6.1 mtp-105 -42.74 91.56 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.105 179.592 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.521 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.878 -179.545 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 11.5 mt . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.945 0.403 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 134.21 38.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.397 179.505 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.736 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -164.12 134.06 4.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.195 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.54 136.93 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.638 -179.34 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.31 148.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.643 0.735 . . . . 0.0 112.032 179.934 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -141.98 131.83 24.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.688 179.264 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.82 -3.72 0.84 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.787 179.644 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.496 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.04 179.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.675 179.91 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.403 HG23 ' CB ' ' A' ' 32' ' ' PRO . 17.5 p -70.34 -21.55 62.89 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.43 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -92.02 -26.58 18.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.792 0.33 . . . . 0.0 111.271 -179.679 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -124.48 87.52 54.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.33 64.94 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.362 2.042 . . . . 0.0 112.653 -179.432 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.716 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.0 t60 -48.96 -27.43 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.404 178.998 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.636 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.54 -154.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.428 179.439 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -60.03 -49.45 78.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.691 -179.709 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.44 39.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.65 165.59 25.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 -179.929 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.403 ' CB ' HG23 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.03 1.98 8.69 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.656 2.237 . . . . 0.0 112.747 -179.822 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.57 116.66 2.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -86.32 120.05 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.592 -179.966 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.716 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.14 147.81 37.27 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.327 0.584 . . . . 0.0 110.726 178.762 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.12 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.828 -177.008 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.485 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -33.38 4.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.662 -179.173 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.26 142.84 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.0 111.41 -179.881 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.736 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.5 131.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.39 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.435 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -83.98 121.26 75.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.976 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.4 Cg_endo -63.89 136.95 55.5 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.836 2.358 . . . . 0.0 112.418 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 18.29 37.2 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.303 -179.894 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.63 179.42 16.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.233 179.886 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -56.09 -31.4 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.684 0.278 . . . . 0.0 111.384 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . . . -74.18 -56.57 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.511 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.71 -30.31 65.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.066 -178.992 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.414 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 15.6 pt20 -71.96 -31.61 66.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.999 0.428 . . . . 0.0 110.331 179.534 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.38 -57.99 3.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.682 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.4 9.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.62 179.521 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.437 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.3 mtt-85 -114.87 -7.59 12.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.925 179.697 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.583 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.1 tp -119.93 155.73 32.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.085 0.469 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.6 tpt180 -134.05 135.08 43.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.6 t -49.91 157.43 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.368 0.604 . . . . 0.0 111.56 -179.95 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 7.5 t-20 75.0 -0.89 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.118 -179.98 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.15 124.95 24.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 178.851 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.55 100.32 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.649 . . . . 0.0 111.573 -178.386 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 34' ' ' ILE . 10.4 mt -47.86 131.28 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.875 179.865 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.467 ' CD2' ' CD1' ' A' ' 3' ' ' TYR . 57.0 tp -114.3 -35.08 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.499 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -150.51 155.36 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.736 -179.817 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 62' ' ' GLU . 27.8 t -130.82 96.51 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.974 179.288 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.44 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.9 t30 67.59 -67.9 0.17 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.173 0.511 . . . . 0.0 109.797 -178.777 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 60' ' ' VAL . 15.7 mt-10 -153.6 31.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.752 179.122 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.8 t -119.8 142.19 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.39 -179.277 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 27.8 t0 -107.96 107.33 17.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.538 179.211 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.24 42.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -65.61 -30.76 71.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.799 179.907 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -154.68 69.03 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.493 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 10.1 m -133.14 144.75 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.075 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.02 152.59 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.726 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.496 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 14.2 t-160 -48.17 -33.92 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.903 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -33.94 76.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 179.335 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.83 -43.45 79.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.606 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB2' HG23 ' A' ' 34' ' ' ILE . . . -62.85 -45.67 91.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.996 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.512 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 56.8 t -57.89 -50.31 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.191 178.635 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.691 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.95 -30.36 34.2 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.353 178.882 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.496 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.59 -56.98 6.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.596 -179.587 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 1.6 mt -65.19 -40.44 94.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.16 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.645 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -76.82 -20.23 56.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.701 -179.398 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.691 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.8 mm-40 -109.11 -5.49 15.97 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 179.179 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.517 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -48.21 -22.07 0.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.594 179.957 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.61 -101.62 1.97 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.599 -179.77 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.84 -91.45 0.55 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.626 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 2.3 tp -90.99 98.98 9.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.089 0.471 . . . . 0.0 110.265 179.108 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.517 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 12.3 p -113.07 138.18 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -177.792 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.0 ttt180 -86.93 103.86 15.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.143 178.933 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.457 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 16.7 mt -93.59 132.91 37.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.563 -179.253 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -101.99 151.5 22.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.539 179.691 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.343 -179.895 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD1' ' CD1' ' A' ' 58' ' ' LEU . 8.4 m-30 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.81 0.338 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.53 143.55 48.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.888 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.41 144.87 29.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.053 179.957 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.435 HD12 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.16 109.36 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.078 0.466 . . . . 0.0 111.411 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.445 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.26 120.98 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.319 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.9 tp -129.71 126.69 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.634 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -86.66 100.88 12.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.185 179.178 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.65 88.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.211 179.599 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.247 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.608 -179.949 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.514 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.7 tp . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.404 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 129.22 19.4 1.55 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.021 -1.085 . . . . 0.0 114.513 178.404 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.734 ' HB3' HG22 ' A' ' 39' ' ' ILE . 6.6 p90 -162.09 137.33 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.844 0.822 . . . . 0.0 111.245 179.223 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.47 136.2 38.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.615 -179.426 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.54 156.62 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.736 0.779 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB2' ' CG ' ' A' ' 27' ' ' HIS . . . -152.22 132.38 13.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.456 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.75 -3.18 1.11 Allowed Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.669 179.639 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.36 178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.918 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 29.1 p -65.98 -27.38 68.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.246 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -93.43 -19.95 20.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.672 0.273 . . . . 0.0 111.63 -179.647 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.24 86.86 54.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.392 179.897 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 62.4 0.84 Allowed 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.396 2.064 . . . . 0.0 112.705 -179.409 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.701 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 26.4 t60 -48.1 -28.87 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.019 178.977 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.12 -155.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.121 179.277 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.421 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.2 -49.44 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.276 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -177.46 51.29 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.911 0.386 . . . . 0.0 111.153 -179.585 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 158.27 70.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.53 0.86 9.57 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.677 2.251 . . . . 0.0 112.661 179.978 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.9 m -54.31 119.85 5.73 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.958 0.408 . . . . 0.0 111.291 -179.912 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -85.43 119.93 34.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 179.824 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.701 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.82 146.67 36.14 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.399 0.618 . . . . 0.0 110.762 178.749 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.76 155.84 7.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.055 -176.636 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.452 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.81 -30.38 4.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.307 -178.624 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.81 129.05 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.174 -179.321 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.734 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.91 131.68 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.569 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.23 113.88 51.11 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.825 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 49.7 Cg_exo -56.21 140.15 87.09 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.739 2.292 . . . . 0.0 112.392 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.82 10.37 64.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.483 -179.898 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.87 178.34 18.3 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.874 179.808 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.38 66.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.796 0.331 . . . . 0.0 111.067 -179.995 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -68.87 -57.56 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.55 -28.73 67.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -71.88 -31.68 66.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.239 179.521 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 -57.78 3.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.96 35.77 14.87 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.439 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.427 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.3 mtt-85 -115.32 -2.06 12.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 111.227 179.874 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.9 tp -127.2 154.61 44.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.158 0.504 . . . . 0.0 111.34 179.98 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.546 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.71 135.29 43.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.543 179.93 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.558 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.47 157.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.496 179.934 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.8 0.43 3.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 -179.865 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 m-20 -69.67 126.08 28.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.931 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.2 p -86.49 100.39 12.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.467 0.651 . . . . 0.0 111.673 -178.322 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 34' ' ' ILE . 61.7 mt -48.72 146.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.077 -179.961 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.46 ' CD1' ' CD1' ' A' ' 3' ' ' TYR . 12.4 mt -128.25 -38.96 1.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.424 179.615 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -145.72 155.31 42.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.899 -179.758 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 62' ' ' GLU . 42.1 t -136.42 100.55 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.407 ' HB2' HG23 ' A' ' 84' ' ' VAL . 6.2 t-20 67.53 -67.04 0.19 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.958 0.408 . . . . 0.0 110.046 -179.14 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.3 mt-10 -157.29 32.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.751 179.289 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -120.72 142.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.539 -179.23 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.3 t0 -106.04 107.93 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.293 179.208 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 21.8 m -93.81 35.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.522 -179.623 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.48 -37.25 80.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 110.78 179.974 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.42 54.59 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -179.897 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 32.9 m -116.12 148.95 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.896 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.433 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -64.8 154.69 36.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.033 -179.378 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.534 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 19.1 t-160 -50.57 -33.94 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -34.03 75.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.133 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.586 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.62 -41.76 79.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 109.266 178.522 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -64.8 -46.12 83.37 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 73.1 t -57.4 -50.51 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.029 178.564 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -51.58 -34.16 35.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.694 179.417 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.81 -57.59 5.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.248 -179.508 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 2.1 mt -60.53 -40.85 93.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.244 -179.772 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.78 -20.06 56.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.768 179.669 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 4.1 pt-20 -112.24 22.3 14.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 111.24 179.579 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.511 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -83.19 16.64 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.829 -179.729 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.91 -85.59 0.21 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.83 -179.783 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.459 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 40.3 m -142.3 -89.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.7 tp -86.37 105.64 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.869 0.366 . . . . 0.0 110.662 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 5.0 p -120.89 136.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.392 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.7 mtm105 -85.79 103.39 14.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.373 178.17 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.471 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 18.1 mt -93.98 134.8 35.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.394 -178.822 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -101.84 142.58 32.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.89 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 24.9 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.951 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.43 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 15.9 m-30 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -134.77 165.87 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.98 144.78 43.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 -179.837 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -133.83 109.51 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.402 179.876 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.41 119.68 21.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.65 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.9 tp -130.75 128.08 40.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.403 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.6 pt-20 -86.71 100.21 12.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.354 179.685 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -42.87 90.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.364 179.496 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.419 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.638 179.77 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.544 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . 129.42 33.02 0.54 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.515 179.458 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.776 ' HB3' HG21 ' A' ' 39' ' ' ILE . 7.0 p90 -157.86 137.41 12.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.977 0.389 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.437 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.88 136.71 37.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.302 -179.499 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.56 146.6 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.703 0.763 . . . . 0.0 112.264 -179.935 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -139.18 133.61 31.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.241 179.338 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.7 3.84 0.79 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.696 179.577 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.69 -169.26 0.5 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.902 -179.917 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 43.0 p -72.39 -27.86 62.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.104 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -93.75 -22.0 18.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.047 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -124.39 87.52 53.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.579 0.228 . . . . 0.0 110.485 -179.991 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 62.51 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.271 1.981 . . . . 0.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.8 t60 -47.16 -28.24 1.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.396 179.049 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.54 -154.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.362 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -59.5 -49.96 72.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.53 -179.697 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.03 40.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.6 164.06 36.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.81 1.77 7.26 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.0 112.776 -179.88 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -52.75 113.43 1.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.978 0.418 . . . . 0.0 111.07 -179.814 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.43 117.85 30.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.999 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.711 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.13 147.46 40.23 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.276 0.56 . . . . 0.0 110.644 178.673 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.06 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.042 -176.771 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.43 -30.1 4.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.321 -178.846 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.547 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.09 130.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.065 -179.447 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.776 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.96 130.53 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.636 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.456 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 123.84 74.61 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.752 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.1 Cg_endo -66.14 132.0 28.53 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.798 2.332 . . . . 0.0 112.256 -179.879 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.66 16.74 23.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.331 -179.916 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.46 178.69 16.82 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.985 179.862 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.15 -38.78 63.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -65.44 -57.49 8.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.892 -179.502 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.83 -28.85 63.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -179.434 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -72.12 -34.15 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.543 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.12 -58.04 3.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.687 -179.936 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 38.08 13.93 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.624 179.452 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.482 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.9 mmt180 -117.9 7.05 12.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.776 0.322 . . . . 0.0 110.842 179.686 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -133.22 154.53 50.57 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 110.835 179.585 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.556 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.19 135.47 45.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.957 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.547 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.61 157.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 111.751 179.965 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.45 -0.55 3.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.27 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.67 126.37 29.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.035 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.57 103.31 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 111.316 -178.812 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 34' ' ' ILE . 67.0 mt -51.21 134.21 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.723 -179.999 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 3' ' ' TYR . 2.2 mt -116.19 -28.11 6.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.662 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -153.77 165.99 34.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -148.18 98.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.018 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.4 t30 67.79 -67.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 -178.844 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.48 32.47 0.27 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.621 179.218 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.2 t -119.34 142.24 35.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.597 -179.293 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.7 p-10 -111.19 88.04 2.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.331 179.258 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 29.5 m -69.99 63.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.563 -179.522 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptm85 -86.93 -32.77 19.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -145.47 59.02 1.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.8 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.9 m -124.55 147.72 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.457 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.36 154.65 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 -179.464 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.524 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.4 p-80 -48.59 -34.32 11.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.137 -179.573 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -33.69 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.639 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.67 -45.44 82.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HB3' HD12 ' A' ' 34' ' ' ILE . . . -60.9 -46.77 89.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 178.069 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 86.3 t -57.6 -48.22 83.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.94 -33.07 68.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.583 178.717 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -57.55 -50.12 74.14 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.286 0.565 . . . . 0.0 109.817 179.317 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -56.99 -36.61 70.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.449 178.868 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.8 mmmt -77.15 -24.72 51.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.97 -12.9 27.73 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.067 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -56.74 -19.29 16.09 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 179.721 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.19 -108.18 3.39 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.034 -179.881 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.88 -90.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.03 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 1.2 tp -89.63 91.54 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.388 0.613 . . . . 0.0 109.674 178.719 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -105.81 139.88 25.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.357 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -87.45 103.18 15.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.647 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 6' ' ' ILE . 13.4 mt -91.36 139.82 30.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.17 -178.985 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.77 134.1 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.618 179.893 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.188 179.846 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' CD2' ' A' ' 58' ' ' LEU . 21.1 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.934 0.397 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -105.01 170.75 7.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.722 179.647 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -131.83 144.77 51.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.486 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -138.91 111.07 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.909 0.385 . . . . 0.0 111.909 179.912 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.75 117.87 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.475 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 tp -127.26 127.22 44.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.255 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.34 100.08 11.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.522 179.432 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.37 87.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.181 179.258 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.518 0.249 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.605 -179.825 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.509 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.7 tp . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.76 25.21 1.03 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 119.789 -1.196 . . . . 0.0 114.801 178.409 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -162.97 135.19 5.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.873 0.836 . . . . 0.0 111.066 178.887 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.87 137.89 33.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.506 -179.242 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.8 146.24 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 112.404 179.929 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -138.32 133.82 33.48 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.174 179.348 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.62 3.87 0.8 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.643 179.585 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.65 -168.85 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.893 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 41.5 p -72.14 -29.41 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.193 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.06 -20.76 20.22 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.162 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 35.7 t-20 -124.42 87.57 53.99 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.496 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.81 61.91 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.283 1.989 . . . . 0.0 112.388 -179.768 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.707 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 47.5 t60 -47.16 -28.45 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.185 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.655 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.0 -154.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.183 179.386 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -57.7 -50.01 69.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.57 -179.815 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 171.87 40.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.36 166.69 21.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.04 2.33 6.77 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.037 2.491 . . . . 0.0 112.733 -179.734 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.24 111.67 0.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.16 118.27 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.675 179.987 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.707 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.77 147.91 39.84 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.303 0.573 . . . . 0.0 110.725 178.629 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.09 155.61 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.986 -176.829 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.58 -30.78 4.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.039 -178.98 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.47 132.29 0.6 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -179.53 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.748 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.56 132.26 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.739 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.45 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.25 130.12 55.48 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.486 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 50.9 Cg_endo -69.14 129.97 19.24 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 -179.996 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 2.08 55.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.495 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.65 174.37 21.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.751 179.676 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -52.7 -35.34 55.36 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.649 -0.324 . . . . 0.0 111.11 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -70.85 -57.39 4.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.601 -179.799 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.47 -29.07 68.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -72.19 -35.38 68.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.048 0.451 . . . . 0.0 109.969 179.346 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -84.69 -57.94 2.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.614 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.22 41.38 9.37 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.556 179.625 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.486 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.7 mtp85 -112.05 8.88 20.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.9 tp -136.16 154.06 51.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.687 179.641 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.99 135.21 48.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.824 179.869 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.47 157.82 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.31 0.576 . . . . 0.0 111.595 -180.0 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.6 t-20 77.33 -2.96 2.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.473 179.866 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.17 125.12 24.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.085 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.61 100.25 12.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.503 0.668 . . . . 0.0 111.504 -178.579 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 34' ' ' ILE . 59.0 mt -49.97 134.92 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.433 179.507 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -133.69 12.08 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.614 179.367 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 170.83 141.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.962 -179.894 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 62' ' ' GLU . 25.3 t -131.56 99.7 4.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.879 179.274 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.434 ' HB2' HG21 ' A' ' 84' ' ' VAL . 2.9 t-20 69.76 -65.0 0.33 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 109.848 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -161.57 31.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.927 179.407 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.6 t -120.82 124.86 73.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.55 -179.337 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 21.0 p-10 -93.04 100.07 12.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.577 179.113 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 33.7 m -80.69 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -179.755 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -29.25 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -148.88 60.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 32.8 m -126.5 146.43 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.991 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.475 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.76 153.94 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 111.076 -179.353 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.508 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.4 p-80 -48.34 -34.08 10.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.983 -179.515 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -33.83 69.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.181 179.757 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.632 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.68 -45.22 83.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 109.765 179.093 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -61.83 -46.69 88.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.536 0.684 . . . . 0.0 109.35 178.177 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 84.6 t -57.55 -48.06 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.369 178.586 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.632 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.62 -32.88 67.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.624 178.602 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -57.63 -50.39 73.31 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.837 179.241 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.1 mt -56.61 -37.26 70.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.555 178.891 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -77.56 -26.06 50.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.395 179.327 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -92.84 -12.4 31.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.061 -178.843 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.592 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -55.17 -20.17 9.73 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.268 179.763 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -95.34 1.35 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.12 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 39.5 m -134.61 -92.17 0.32 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.096 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.0 tp -85.72 89.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.28 0.562 . . . . 0.0 109.676 178.591 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.592 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 10.7 p -105.91 136.47 40.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.457 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 ttp180 -88.2 102.8 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.747 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.449 ' HB2' HG22 ' A' ' 6' ' ' ILE . 20.2 mt -90.59 136.24 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.813 -179.15 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.539 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.86 120.13 39.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.782 -179.889 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.829 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 5.2 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.791 0.329 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -146.7 154.0 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.31 144.78 31.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.972 -179.934 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.502 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.25 109.97 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 111.623 179.819 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.24 119.11 20.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.75 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 tp -129.73 127.15 39.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.164 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.8 pt-20 -83.55 100.83 11.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.855 179.524 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HG3' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -54.01 89.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.102 178.657 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.41 -179.115 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.526 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 102.78 19.3 13.5 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.422 -0.894 . . . . 0.0 114.808 177.912 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.79 ' HB3' HG21 ' A' ' 39' ' ' ILE . 3.7 p90 -155.23 135.76 13.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.912 0.856 . . . . 0.0 110.89 179.126 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.431 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.68 135.98 37.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.404 -179.421 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.727 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.46 146.12 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.603 0.716 . . . . 0.0 111.928 179.79 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.498 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -124.81 118.65 26.85 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.51 177.988 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 146.08 165.61 11.56 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.575 -179.006 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.93 173.53 13.57 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.244 -179.691 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.4 p -67.14 -17.79 65.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.366 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -106.39 -27.28 11.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.686 0.279 . . . . 0.0 111.417 -179.67 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -124.32 87.0 54.29 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.9 64.39 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.362 2.041 . . . . 0.0 112.607 -179.653 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.785 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.2 t60 -47.72 -28.92 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.525 179.207 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.643 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.65 -152.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.687 179.776 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.84 52.53 4.61 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.87 -178.761 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t0 76.59 44.9 0.11 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.494 179.575 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -137.14 157.31 74.68 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -179.941 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.12 -2.2 11.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.699 2.266 . . . . 0.0 112.508 179.823 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.47 112.6 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.006 0.432 . . . . 0.0 111.561 -179.654 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.71 119.89 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.757 179.219 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.785 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.14 147.9 37.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.485 0.659 . . . . 0.0 110.844 179.369 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.727 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.32 156.04 7.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.565 -177.319 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.67 -28.78 4.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.134 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.25 129.14 0.36 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.17 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.79 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -93.3 125.02 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.79 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.525 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 132.73 46.59 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.783 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_exo -64.37 70.05 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.492 2.128 . . . . 0.0 110.887 178.9 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -104.82 -25.5 6.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.888 -179.076 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.742 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . 121.65 -30.59 5.29 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.397 -179.87 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' HD11 ' A' ' 8' ' ' LEU . . . -77.69 -70.32 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.152 179.707 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -75.92 -45.63 34.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.368 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.49 -42.22 95.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.741 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.742 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -72.15 -33.31 67.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.11 -58.36 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.08 0.467 . . . . 0.0 111.028 -179.015 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.84 25.83 63.87 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.502 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtm-85 -108.11 -23.34 12.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.895 0.379 . . . . 0.0 110.303 179.553 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.3 tp -104.17 154.24 19.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.428 179.005 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 ttp85 -134.85 135.7 41.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -49.04 157.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.308 0.575 . . . . 0.0 111.539 179.994 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.6 OUTLIER 73.32 3.03 4.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.084 -179.746 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -71.61 125.86 28.19 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.958 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -86.68 101.39 13.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.608 0.718 . . . . 0.0 111.74 -178.408 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 34' ' ' ILE . 12.4 mt -49.33 131.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.923 179.84 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 3' ' ' TYR . 2.3 mt -114.74 -35.03 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.073 179.281 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -148.8 167.53 25.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.833 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.74 98.43 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.034 179.471 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.416 ' HB2' HG23 ' A' ' 84' ' ' VAL . 5.5 t30 68.62 -66.61 0.23 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.071 0.462 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.16 32.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.741 179.312 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 62.1 t -120.88 142.21 37.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.523 -179.33 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -104.16 110.2 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.328 179.103 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -91.52 19.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.773 -179.523 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -59.55 -28.25 66.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.7 56.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.411 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 18.4 m -125.7 143.12 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.32 151.74 35.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.692 -179.833 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.474 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 0.9 OUTLIER -47.88 -34.32 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.658 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -71.45 -33.88 69.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.932 179.521 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.58 -40.47 84.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -63.93 -46.96 82.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.644 0.735 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.615 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 73.5 t -58.67 -50.66 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.198 178.676 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.644 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.35 -31.08 63.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -59.68 -50.45 73.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.367 0.603 . . . . 0.0 109.91 179.643 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 HD12 ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -59.23 -36.83 76.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.084 179.291 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.61 -25.38 49.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.631 179.595 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -101.4 13.96 33.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.736 0.303 . . . . 0.0 111.647 -178.344 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.617 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -85.32 11.78 9.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.66 -90.16 0.85 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 179.735 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.1 p -144.63 -90.22 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 9.1 tp -84.08 90.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.191 0.52 . . . . 0.0 109.714 178.67 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 8.7 p -107.54 139.3 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.361 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 10.1 mtp180 -86.92 103.12 15.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.742 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.493 ' HB2' HG23 ' A' ' 6' ' ' ILE . 15.5 mt -92.95 138.28 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 -178.788 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -101.84 136.44 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.647 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 6.8 m . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.521 -179.89 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.435 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 29.2 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.811 0.338 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.45 146.85 40.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.946 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -103.28 144.38 31.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.966 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.36 109.13 8.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.924 0.392 . . . . 0.0 111.6 179.882 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.25 113.65 16.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.93 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.7 tp -124.87 126.94 46.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.9 pt-20 -85.82 100.77 12.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.073 179.29 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -46.97 89.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.323 179.893 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.456 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.639 -179.93 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.512 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 5.3 tp . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.361 0.124 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.51 25.82 1.12 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.422 178.437 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.768 ' HB3' HG22 ' A' ' 39' ' ' ILE . 5.5 p90 -164.8 131.68 3.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.565 0.682 . . . . 0.0 110.849 178.86 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -91.67 138.36 31.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.653 -179.006 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -121.78 142.29 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 121.711 0.767 . . . . 0.0 112.222 179.78 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . . . -105.64 117.85 35.09 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.695 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 34' ' ' ILE . . . -73.21 -159.27 5.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -176.258 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.68 -42.93 0.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.783 -0.709 . . . . 0.0 114.15 -177.935 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.668 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -73.1 -54.06 9.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.039 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -81.25 -43.58 18.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.071 0.462 . . . . 0.0 111.004 -179.621 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.4 OUTLIER -124.83 83.45 59.41 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.479 179.462 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.95 69.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.638 2.225 . . . . 0.0 112.378 -179.104 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.799 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 12.5 t60 -58.23 -18.24 24.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.254 179.31 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.653 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.26 -154.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.409 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.422 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.35 -49.5 69.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.57 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 167.98 41.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 179.995 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.22 155.6 75.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.64 55.76 4.39 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.941 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -117.12 107.12 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 179.697 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.614 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 3.1 mt -79.01 130.63 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.994 -179.632 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.799 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.98 152.53 42.07 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.214 0.531 . . . . 0.0 110.389 179.495 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -69.42 155.57 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.489 -177.096 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.456 ' CG2' ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.09 -28.43 4.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.974 -179.27 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.86 130.6 0.41 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.943 -179.625 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.768 HG22 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -95.33 132.58 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.557 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 114.77 56.74 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.651 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 47.9 Cg_exo -56.36 137.79 81.43 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.733 2.289 . . . . 0.0 112.201 179.913 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.91 66.35 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.67 -179.994 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.98 -178.13 22.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -59.48 -33.55 71.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -179.955 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -72.95 -56.92 4.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.781 -179.885 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.45 -31.1 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.855 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -72.15 -32.51 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.035 0.445 . . . . 0.0 110.138 179.615 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -80.75 -57.96 3.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.553 179.94 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.54 9.3 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.715 179.564 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.6 mtt180 -114.96 7.46 15.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 179.544 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.9 tp -136.42 154.31 50.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.107 0.479 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.35 135.22 46.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.614 179.833 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 60.6 t -49.06 157.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 0.0 111.815 -179.878 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t30 78.22 -5.32 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.469 179.972 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -64.03 127.93 33.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.169 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.89 105.2 16.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -178.846 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' A' ' 34' ' ' ILE . 64.1 mt -48.92 134.87 6.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.522 179.792 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -120.17 -43.49 2.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.444 179.865 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -144.55 158.65 43.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.903 -179.893 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -140.03 98.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.256 179.444 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 t30 67.74 -67.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.46 . . . . 0.0 110.22 -178.973 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -155.12 31.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.927 179.361 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.4 t -120.81 142.39 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.403 -179.312 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.4 p-10 -103.28 108.84 20.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.473 179.402 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' CG2' ' CG2' ' A' ' 57' ' ' ILE . 29.2 m -97.32 29.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -38.01 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.413 . . . . 0.0 110.683 179.762 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -144.23 57.91 1.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.786 179.803 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.552 ' O ' HG21 ' A' ' 23' ' ' THR . 27.6 m -121.19 140.05 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.341 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.668 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 2.5 p -52.2 150.92 4.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.011 -178.425 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.52 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . 1.9 t-160 -47.07 -33.36 4.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.368 179.552 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -71.54 -33.76 69.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 179.713 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.38 -31.7 67.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 109.753 178.827 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.44 -46.91 58.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.537 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.632 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 94.6 t -60.87 -50.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.728 178.735 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.8 pt-20 -57.45 -29.56 64.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.66 178.543 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -60.59 -51.4 69.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.795 179.456 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.489 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -58.2 -35.12 71.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.178 179.191 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.15 -31.75 55.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.859 179.912 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.0 pt-20 -96.07 17.22 16.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.527 -178.523 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.642 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -89.54 16.34 7.88 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.323 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.01 -103.51 1.01 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.509 179.858 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.529 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -127.15 -89.41 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.466 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.4 tp -84.68 94.73 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 109.878 178.909 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.642 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 7.6 p -111.06 136.43 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.444 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 10.4 ptt85 -85.58 102.87 13.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.457 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 15.9 mt -92.09 139.72 30.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.549 -178.499 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.64 135.47 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.963 179.39 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 6.6 m . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.758 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.77 137.74 46.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.727 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 89' ' ' MET . 4.0 m-30 -94.48 119.1 32.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.12 161.93 18.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -115.92 144.63 43.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.48 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.84 111.69 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.773 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.5 115.63 20.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.557 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -126.05 127.11 45.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -85.5 100.66 12.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.054 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.35 89.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.188 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.09 176.02 0.07 OUTLIER Glycine 0 C--N 1.321 -0.287 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.496 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -54.87 -24.05 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.739 0.305 . . . . 0.0 111.115 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -97.36 -24.82 15.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.2 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.86 -163.53 28.28 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.196 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.557 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.3 tp -66.12 -63.6 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.68 0.24 . . . . 0.0 110.81 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 131.55 22.35 0.96 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 119.725 -1.226 . . . . 0.0 114.97 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.752 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.6 p90 -161.59 135.35 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.063 0.932 . . . . 0.0 111.224 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.434 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.55 135.47 34.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.16 147.7 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.541 0.686 . . . . 0.0 111.568 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.51 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -126.64 119.72 27.73 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.43 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 143.66 159.3 7.93 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.551 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 145.09 173.64 16.56 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.384 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 24.3 p -63.67 -14.44 52.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.79 -25.79 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -124.25 86.77 54.29 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.486 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 64.13 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.306 2.004 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.778 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.0 t60 -49.05 -27.16 3.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.527 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.653 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.45 -152.29 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.693 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.79 52.65 4.62 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.941 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 76.54 43.36 0.14 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 158.78 74.15 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.929 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 0.33 9.49 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.507 2.138 . . . . 0.0 112.569 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.1 114.92 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -89.23 119.62 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.984 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.778 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.41 147.65 36.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.34 155.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.655 -177.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.0 -32.86 4.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.753 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.33 142.11 2.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 111.424 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.51 133.35 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 122.69 76.2 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.429 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.4 Cg_endo -64.63 132.18 32.12 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.23 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.96 5.31 56.47 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.412 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.07 179.17 21.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.804 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.426 ' HB3' ' HG ' ' A' ' 8' ' ' LEU . . . -55.66 -39.08 70.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 111.121 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . . . -66.4 -57.4 7.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.466 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.8 -28.82 67.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.382 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -72.25 -34.61 68.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.069 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.72 -57.97 3.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.16 41.23 9.53 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.474 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.4 mmp_? -113.14 -4.72 13.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.773 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.0 tp -121.44 153.66 37.58 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.019 0.438 . . . . 0.0 110.822 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.12 135.28 48.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.689 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.14 157.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 111.758 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.47 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 t30 75.41 0.99 3.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.17 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -68.55 125.18 25.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -86.55 102.23 13.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.625 . . . . 0.0 111.602 -178.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 34' ' ' ILE . 16.4 mt -49.8 124.94 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.866 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.42 HD12 ' CG ' ' A' ' 3' ' ' TYR . 3.6 mt -109.76 -34.14 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.972 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.8 m-85 -150.27 161.22 42.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 ' CG1' ' CB ' ' A' ' 76' ' ' ALA . 6.9 p -148.7 103.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.626 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.4 ' CB ' HG22 ' A' ' 84' ' ' VAL . 6.8 t-20 70.42 -66.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.289 0.566 . . . . 0.0 109.907 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.39 29.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 1.4 t -121.01 142.0 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.492 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.0 p-10 -101.07 111.45 23.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.859 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 21.3 m -89.68 24.1 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -67.85 -22.13 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 110.734 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -145.97 44.62 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 19.0 m -117.87 148.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.403 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -67.52 151.99 46.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.54 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 9.8 t-160 -49.55 -34.1 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.533 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 20.0 m -71.76 -33.66 68.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.495 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.605 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.49 -39.72 81.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -64.32 -46.88 81.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.616 0.722 . . . . 0.0 109.226 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.7 t -59.97 -50.63 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.333 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 2.2 pt-20 -57.75 -35.12 70.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.637 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.425 ' CB ' ' CG1' ' A' ' 60' ' ' VAL . . . -55.33 -51.92 65.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.269 0.557 . . . . 0.0 110.228 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD13 ' CE1' ' A' ' 17' ' ' PHE . 6.2 mt -56.42 -36.64 69.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.533 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.32 -25.67 51.42 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.478 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.3 mt-10 -96.6 -6.96 35.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.294 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -57.62 -17.74 16.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.147 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.54 -100.74 2.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.468 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.9 m -130.45 -91.31 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.584 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 5.4 tp -87.03 86.27 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.254 0.55 . . . . 0.0 109.559 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.62 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 11.6 p -101.29 138.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.5 mtt180 -88.68 103.2 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.041 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.406 HD11 ' CD2' ' A' ' 15' ' ' LEU . 12.3 mt -92.6 138.04 31.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.722 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 133.53 46.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.404 ' CB ' ' HB3' ' A' ' 55' ' ' ASP . 3.7 m -139.72 167.9 18.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.144 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.422 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 92.7 mtp -103.18 151.18 22.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.701 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -140.54 115.72 9.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.022 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.761 0.315 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -99.95 112.6 24.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 4.0 m-30 -82.19 129.29 34.8 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.663 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -139.83 160.2 40.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.2 mt-10 -117.08 144.9 44.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.835 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.82 111.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.886 0.374 . . . . 0.0 111.73 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.42 115.6 20.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.542 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 5.0 tp -126.09 127.08 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.25 100.4 11.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.126 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.78 88.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.067 179.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.41 176.07 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.628 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -55.21 -23.81 24.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.776 0.322 . . . . 0.0 111.058 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -96.8 -24.87 15.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.47 -162.89 28.24 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.23 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.7 tp -67.89 -63.49 1.05 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.174 -0.211 . . . . 0.0 110.725 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.65 21.01 1.05 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.716 -1.23 . . . . 0.0 114.754 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.754 ' HB3' HG21 ' A' ' 39' ' ' ILE . 6.5 p90 -161.62 135.6 6.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.999 0.9 . . . . 0.0 111.12 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.47 138.55 32.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.455 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.14 146.5 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.691 0.757 . . . . 0.0 112.228 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -138.43 134.59 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.198 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.3 -5.32 1.4 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.573 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.57 -175.36 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.113 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 68' ' ' VAL . 16.1 p -71.43 -19.23 62.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.62 -24.91 15.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.591 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 2.2 t30 -124.41 87.91 53.66 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.099 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.96 63.07 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.463 2.109 . . . . 0.0 112.631 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.73 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 50.3 t60 -50.59 -25.74 4.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.165 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.69 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.73 -151.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.513 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -82.56 49.75 4.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.843 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 76.88 45.38 0.09 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.03 153.75 78.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.39 -0.17 9.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.468 2.112 . . . . 0.0 112.657 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.87 115.24 1.9 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.943 0.402 . . . . 0.0 110.495 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.08 119.8 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.092 -179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.73 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.05 147.41 36.78 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.348 0.594 . . . . 0.0 110.461 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.14 155.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.059 -176.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.05 -31.83 4.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.986 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.559 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.41 134.24 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.042 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.754 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.52 132.93 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.26 123.84 74.65 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 36.9 Cg_endo -65.18 132.68 32.56 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 112.289 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.2 5.5 57.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.48 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.84 178.56 20.93 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.928 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.65 -37.72 68.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.757 0.313 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.42 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . . . -67.78 -57.51 6.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.417 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.53 -28.87 68.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -72.13 -34.52 68.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.063 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.5 -58.07 2.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.6 41.02 9.25 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.481 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.485 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mtm180 -113.8 6.24 16.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.6 tp -132.8 154.6 50.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.071 0.462 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.594 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -130.86 136.1 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -51.74 157.78 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.315 0.578 . . . . 0.0 111.663 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.6 -2.01 2.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.352 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.4 m-20 -67.82 126.34 29.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.65 104.14 15.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.489 0.661 . . . . 0.0 111.259 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 34' ' ' ILE . 67.8 mt -52.71 133.84 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.96 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.469 ' CD1' ' CD2' ' A' ' 3' ' ' TYR . 14.2 mt -116.62 -28.56 6.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.661 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.3 m-85 -156.29 149.54 24.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.8 t -139.44 105.94 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.168 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 t30 55.04 38.68 30.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 110.108 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 78.86 33.43 0.25 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.475 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 92.7 t -120.99 107.82 21.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.596 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.5 t0 -74.01 111.6 9.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.744 0.307 . . . . 0.0 110.564 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 35.0 m -96.56 29.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -59.86 -22.71 62.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -150.8 76.27 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 111.106 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.418 ' N ' HG23 ' A' ' 23' ' ' THR . 35.4 m -149.81 145.75 17.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.19 155.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.212 0.529 . . . . 0.0 111.154 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.514 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.6 p-80 -50.89 -33.7 25.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.886 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.5 t -72.14 -33.96 68.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.32 -40.8 90.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.196 0.522 . . . . 0.0 109.874 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -65.48 -46.85 78.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.668 0.747 . . . . 0.0 109.168 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 86.2 t -56.9 -50.27 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.255 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.92 -29.24 59.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.917 178.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -62.32 -51.9 65.81 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 109.81 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.444 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -55.03 -37.52 66.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.558 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -27.41 52.13 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.244 179.225 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.28 14.72 25.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.313 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.592 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -86.77 16.42 4.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.517 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.27 -92.0 0.56 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.276 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.6 m -142.19 -90.25 0.14 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.3 tp -84.67 90.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.283 0.563 . . . . 0.0 109.723 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 10.8 p -105.82 138.11 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.4 ttt180 -88.29 102.87 15.27 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 14.4 mt -91.45 138.49 31.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.239 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.65 134.51 44.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 6.2 m -139.74 166.47 20.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -137.07 138.57 40.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 111.159 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.89 120.69 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.024 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.813 0.34 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -98.67 114.14 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' CD2' HD12 ' A' ' 58' ' ' LEU . 4.0 m-85 -91.4 115.02 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.693 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -118.84 153.01 35.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.15 144.91 31.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.481 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.492 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -137.19 110.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.443 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.73 117.61 20.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.55 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 5.0 tp -127.6 127.0 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.4 pt-20 -83.96 100.45 11.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.296 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -51.4 88.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.03 175.41 0.14 Allowed Glycine 0 C--N 1.322 -0.23 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.586 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -54.44 -24.45 20.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 111.066 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -96.24 -24.75 16.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.36 -163.67 28.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.156 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.55 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.5 tp -66.55 -63.52 1.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.789 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 131.81 21.28 1.01 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.707 -1.235 . . . . 0.0 114.614 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.767 ' HB3' HG22 ' A' ' 39' ' ' ILE . 5.3 p90 -161.31 134.7 6.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.874 0.837 . . . . 0.0 110.981 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.32 135.43 34.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.566 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.88 146.07 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.593 0.711 . . . . 0.0 111.385 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.512 ' HB1' HG22 ' A' ' 37' ' ' THR . . . -125.34 122.69 37.55 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.457 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 140.01 157.77 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.787 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.71 176.09 22.55 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 68' ' ' VAL . 17.4 p -66.54 -18.37 65.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -107.06 -27.26 10.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.69 0.281 . . . . 0.0 111.635 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.42 87.38 54.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.494 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.27 64.53 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.405 2.07 . . . . 0.0 112.545 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.746 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.8 t60 -46.23 -29.76 1.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.545 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.596 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -83.13 -155.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.412 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.31 -52.63 51.5 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.698 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 4.1 p-10 -179.34 42.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.615 0.245 . . . . 0.0 111.322 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.47 174.08 5.13 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.992 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 88.6 Cg_endo -81.4 10.78 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.658 2.239 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 112.1 1.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.079 0.466 . . . . 0.0 111.316 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -90.11 119.87 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.9 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.746 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.63 149.75 39.35 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.38 0.61 . . . . 0.0 110.897 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.41 155.72 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.436 -177.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.512 HG22 ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.72 -32.25 4.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.609 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 141.23 2.0 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.91 0.386 . . . . 0.0 111.337 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.767 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -103.38 132.98 48.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.0 124.59 74.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.2 Cg_endo -65.63 132.58 31.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.769 2.312 . . . . 0.0 112.1 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.51 5.15 56.98 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.473 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.86 176.1 19.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.797 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.43 -37.11 62.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 111.295 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -68.11 -57.41 6.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.527 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.31 -29.07 67.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.345 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -72.06 -36.08 69.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 109.979 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.35 -57.9 3.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.91 41.5 9.57 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.466 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.492 ' CB ' HG12 ' A' ' 6' ' ' ILE . 74.7 mtp180 -113.2 8.23 18.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.848 0.356 . . . . 0.0 110.644 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.599 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.8 tp -133.48 155.48 49.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.599 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.77 134.89 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.619 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -49.08 157.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.627 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.03 -2.31 2.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.203 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -64.86 124.05 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.58 100.06 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.567 0.698 . . . . 0.0 111.867 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 34' ' ' ILE . 35.2 mt -47.82 126.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.616 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.582 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -122.08 -5.72 8.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.585 179.161 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -171.61 143.9 1.8 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.977 0.418 . . . . 0.0 110.728 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.3 t -141.97 109.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.3 t30 52.85 38.59 27.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.161 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 78.73 32.29 0.3 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.92 103.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.6 p-10 -66.68 113.43 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.532 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 25.8 m -92.51 18.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.497 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -65.47 -21.29 66.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.981 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.56 45.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.425 ' N ' HG22 ' A' ' 23' ' ' THR . 17.2 m -127.35 142.74 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.059 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 153.47 31.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.011 0.434 . . . . 0.0 110.62 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 8.0 t-160 -49.33 -33.88 14.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.591 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -70.33 -33.7 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.834 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.639 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.47 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -71.42 -46.9 58.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.614 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 78.6 t -60.08 -50.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.334 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 9.2 pt-20 -57.9 -30.22 65.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.629 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -59.68 -51.12 71.15 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.329 0.585 . . . . 0.0 109.861 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.488 HD13 ' CE1' ' A' ' 17' ' ' PHE . 1.3 mt -57.46 -37.55 73.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.891 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.28 -27.51 53.13 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.603 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 5.8 pt-20 -101.06 18.03 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.309 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.596 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -86.15 16.33 4.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.408 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.33 -92.4 0.66 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.27 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.469 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -142.84 -90.05 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.3 tp -84.74 87.24 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.286 0.565 . . . . 0.0 109.745 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.596 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 10.8 p -102.29 137.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.4 mtt-85 -88.36 102.69 15.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.477 ' HB2' HG23 ' A' ' 6' ' ' ILE . 19.1 mt -91.61 132.53 36.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.582 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.46 115.11 29.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.075 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.436 ' CA ' HD22 ' A' ' 58' ' ' LEU . 1.7 m -119.7 138.06 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.661 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.406 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . 2.5 ptt? -96.65 158.76 15.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.018 0.437 . . . . 0.0 111.271 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.79 114.85 9.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.828 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.035 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.801 0.334 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.49 124.77 30.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.429 ' CE1' ' HG2' ' A' ' 89' ' ' MET . 4.0 m-30 -91.38 111.4 22.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.699 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 25.1 mt-10 -111.68 166.04 11.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 13.1 pt-20 -126.76 144.81 50.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.491 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -138.32 109.47 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.955 0.407 . . . . 0.0 112.016 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.89 121.55 25.0 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.617 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.3 tp -130.54 128.48 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 mt-10 -83.65 100.68 11.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.49 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 12' ' ' ASN . 11.8 mtp180 -44.76 92.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.984 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -63.08 70.3 0.03 OUTLIER Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.896 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' ARG . 61.1 t-20 64.65 -74.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.688 0.28 . . . . 0.0 111.37 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.63 -24.24 62.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.519 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 155.17 -170.2 33.27 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.637 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.617 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 4.5 mt -66.33 -63.59 1.04 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.616 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 136.63 42.1 0.11 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.877 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.742 ' HB3' HG22 ' A' ' 39' ' ' ILE . 9.2 p90 -163.39 133.09 4.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.121 0.461 . . . . 0.0 110.895 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.441 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.32 136.64 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.548 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.73 148.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.669 0.747 . . . . 0.0 111.972 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -141.94 134.38 28.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.267 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 141.56 3.61 1.14 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.684 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.548 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.89 -175.75 1.49 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 40.8 p -66.39 -26.9 67.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.5 -19.21 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.42 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.34 87.53 53.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.415 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.93 60.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.292 1.995 . . . . 0.0 112.562 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.728 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.3 t60 -48.16 -27.77 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.088 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.657 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.39 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.276 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.13 -50.22 68.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.679 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.8 40.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.87 168.18 15.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.0 5.34 5.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.546 2.164 . . . . 0.0 112.81 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -54.92 113.16 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.391 . . . . 0.0 110.757 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.19 119.49 33.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.845 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.728 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.82 145.93 35.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.328 0.585 . . . . 0.0 110.436 178.572 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.136 -176.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.82 -31.65 4.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.146 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.549 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -171.55 136.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.748 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.742 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -100.46 131.91 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.445 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 116.19 63.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.5 Cg_exo -58.98 136.49 73.78 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.785 2.324 . . . . 0.0 112.288 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.2 15.87 42.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.604 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.19 178.27 16.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.182 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.452 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . . . -52.23 -36.18 51.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 111.397 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . . . -70.28 -56.75 5.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.36 -30.47 66.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.4 pp0? -72.12 -29.93 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.265 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.65 -57.94 3.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.529 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 40.64 9.47 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.624 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -117.83 -3.71 11.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.3 tp -123.3 153.11 40.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.956 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.38 135.88 47.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.549 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.17 157.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.337 0.589 . . . . 0.0 111.424 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.47 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.4 -3.02 2.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -64.86 125.3 24.39 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.006 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 14.2 p -86.72 100.24 12.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.5 0.667 . . . . 0.0 111.74 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.495 HD11 HG21 ' A' ' 19' ' ' ILE . 11.2 mt -52.99 127.41 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.698 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -120.0 -10.98 9.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.579 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -167.02 143.29 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.06 0.457 . . . . 0.0 110.71 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.6 t -139.47 112.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.233 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.87 37.0 16.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 0.0 110.164 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 79.55 34.0 0.19 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.552 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 88.9 t -120.97 107.84 21.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.479 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -71.59 110.33 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.606 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.406 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 34.7 m -95.97 40.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -24.96 59.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -143.87 61.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 26.9 m -135.62 146.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.023 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.443 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.66 155.62 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.055 0.455 . . . . 0.0 111.267 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.548 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.2 p-80 -48.23 -35.14 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.17 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -72.35 -33.85 67.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.153 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.649 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -42.87 88.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.813 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -63.06 -46.82 85.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.619 0.723 . . . . 0.0 109.169 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.602 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 91.7 t -56.85 -50.29 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.194 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.649 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.21 -30.05 61.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.902 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.492 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.64 -50.14 74.7 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.327 0.584 . . . . 0.0 109.735 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.422 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -58.85 -36.53 74.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.825 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.5 -25.25 50.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.452 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -103.09 17.87 23.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 111.213 -178.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.622 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -87.82 16.31 5.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.83 -109.85 2.95 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -120.68 -89.38 0.6 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -88.2 95.42 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 109.842 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.622 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -108.07 135.2 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.7 ptm180 -87.52 102.87 15.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.415 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HB2' HG21 ' A' ' 6' ' ' ILE . 19.4 mt -89.78 132.94 34.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.563 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.77 120.01 39.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.5 m -125.04 153.38 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.429 ' HG2' ' CE1' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -106.77 154.84 20.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.893 0.377 . . . . 0.0 110.863 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -140.5 106.98 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.914 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.935 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ttm . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.906 0.384 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.79 166.7 13.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.025 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.45 ' CE1' ' HG3' ' A' ' 89' ' ' MET . 40.1 m-85 -118.87 125.55 49.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.791 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -117.17 159.47 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.93 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 pt-20 -120.23 144.67 47.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.462 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -136.85 109.56 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.988 0.423 . . . . 0.0 111.768 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.18 112.2 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 tp -122.91 127.19 48.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.4 pt-20 -83.92 100.29 10.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.287 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -47.83 88.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.254 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.06 174.03 0.11 Allowed Glycine 0 C--N 1.323 -0.178 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.6 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -25.87 12.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.859 0.361 . . . . 0.0 111.031 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.1 t -96.01 -24.81 16.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.48 -163.8 27.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.165 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.507 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.9 tp -65.11 -63.55 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.659 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 127.67 26.16 1.07 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 114.77 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.762 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.9 p90 -163.71 132.11 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.016 0.908 . . . . 0.0 111.266 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.7 139.62 30.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.707 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -121.37 146.57 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -138.46 135.43 35.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.353 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.91 -3.41 1.52 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.655 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.519 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.33 -174.78 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.06 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.4 p -71.52 -21.27 61.93 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -22.29 16.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 111.48 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 1.5 t-20 -124.27 87.66 53.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.166 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.72 62.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.368 2.045 . . . . 0.0 112.71 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.739 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 46.6 t60 -50.98 -26.16 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.031 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.686 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.25 -151.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.477 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -82.89 49.01 4.14 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.858 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.23 45.88 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.475 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 154.14 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.98 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.71 0.26 9.39 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.497 2.131 . . . . 0.0 112.692 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.71 115.65 2.27 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.917 0.389 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.482 HD12 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.21 119.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.075 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.739 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.24 147.05 35.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.358 0.599 . . . . 0.0 110.492 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.674 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.12 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.339 -176.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.14 -31.77 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.52 134.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.051 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.762 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.83 132.51 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 125.37 72.83 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.6 Cg_endo -65.94 132.26 29.72 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.738 2.292 . . . . 0.0 112.226 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.01 56.66 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.486 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.68 177.07 20.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.944 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.425 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.95 -37.46 63.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.763 0.315 . . . . 0.0 111.173 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -68.7 -57.6 5.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.54 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.18 -34.74 68.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.226 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.81 -58.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.4 40.88 9.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.726 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.462 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mmt180 -111.13 -5.98 14.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.846 0.355 . . . . 0.0 110.759 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.603 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.4 tp -119.13 156.15 30.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.751 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.39 134.91 45.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.818 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.558 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -51.51 157.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 121.243 0.544 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.1 OUTLIER 75.29 -1.54 3.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.36 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 m-20 -69.76 129.35 39.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.76 104.03 15.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.646 0.736 . . . . 0.0 111.491 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 34' ' ' ILE . 72.5 mt -50.71 138.65 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 2.1 mm? -116.67 -44.15 2.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.372 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -143.62 172.71 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.783 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 62' ' ' GLU . 44.9 t -149.88 97.11 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.821 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.491 ' HB2' HG22 ' A' ' 84' ' ' VAL . 1.5 t-20 67.82 -67.56 0.18 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.138 0.494 . . . . 0.0 109.775 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mt-10 -156.41 32.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.479 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -118.58 142.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.559 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 16.1 p-10 -111.09 108.93 18.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.173 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.6 m -92.82 40.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 111.66 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.51 70.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.78 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -152.87 70.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.95 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 27.6 m -135.87 146.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.7 152.58 26.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 0.0 110.826 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.519 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.6 p-80 -48.55 -33.86 10.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.01 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.19 -33.82 70.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.542 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.4 -42.14 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -64.48 -46.89 81.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.582 0.706 . . . . 0.0 109.123 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 83.9 t -56.57 -50.39 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.205 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.86 -30.11 60.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.053 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.49 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.3 -50.42 73.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 109.909 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -58.53 -36.05 73.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.861 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.5 -29.21 52.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.494 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -99.64 18.46 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -178.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.604 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -87.22 16.17 5.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.273 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.66 -94.11 0.66 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.18 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.0 p -140.49 -90.65 0.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.576 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.0 tp -83.84 89.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.185 0.517 . . . . 0.0 109.718 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.604 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 11.5 p -105.17 137.01 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.96 103.0 15.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 15.5 mt -91.24 142.68 27.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.174 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.76 139.58 37.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.692 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.22 167.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.788 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.45 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 2.7 ttt -115.29 142.33 46.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.057 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.15 141.16 47.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.907 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -112.65 145.45 40.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 2.4 m-30 -103.37 155.86 18.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.9 153.86 39.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 85' ' ' ARG . 1.8 tt0 -108.01 138.36 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.645 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.422 ' CD1' ' CD1' ' A' ' 51' ' ' LEU . 1.1 mt -132.69 109.17 14.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.05 112.16 15.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 tp -121.91 126.84 49.58 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -87.81 99.54 12.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.021 178.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -57.79 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.573 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.04 173.56 17.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.889 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 58.45 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.622 0.248 . . . . 0.0 111.057 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.3 -2.2 19.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.583 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.489 ' HA2' ' HG3' ' A' ' 10' ' ' ARG . . . 132.03 -148.02 18.94 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.951 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 8' ' ' LEU . 6.4 tp -70.31 -12.87 61.88 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.689 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 72.64 30.24 64.39 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.751 ' HB3' HG21 ' A' ' 39' ' ' ILE . 10.0 p90 -164.64 135.38 4.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.354 1.077 . . . . 0.0 111.745 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.463 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -100.91 137.63 39.03 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.659 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -116.74 150.84 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.723 0.773 . . . . 0.0 112.293 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -145.79 134.58 22.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.31 2.92 0.92 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.633 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.561 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.67 -173.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.005 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 33.2 p -70.57 -26.01 63.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -94.24 -24.05 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 4.0 m-20 -124.47 87.98 53.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 63.89 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.316 2.011 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.744 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 40.9 t60 -47.26 -28.32 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.315 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.675 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.06 -155.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.385 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -56.25 -50.91 59.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.691 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.89 39.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.18 166.08 23.78 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.838 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.76 7.28 4.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.52 2.147 . . . . 0.0 112.727 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -57.01 114.25 2.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.85 0.357 . . . . 0.0 110.779 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.39 118.07 29.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.795 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.744 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.48 147.21 37.49 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.187 0.518 . . . . 0.0 110.732 178.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.71 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.92 155.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.902 -176.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.49 -29.93 4.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.223 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.38 125.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.291 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.751 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.49 127.43 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 125.37 72.49 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -60.9 138.39 78.67 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.716 2.278 . . . . 0.0 112.206 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 14.1 64.4 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.377 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . -107.05 -159.16 21.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.886 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -75.97 -38.72 57.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.832 0.316 . . . . 0.0 110.987 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -74.41 -54.19 8.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.893 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.95 -33.72 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.162 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 13.5 mm-40 -72.45 -32.39 66.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.41 -57.98 3.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.63 38.34 8.91 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -120.29 1.92 10.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 29.5 tp -128.07 162.98 25.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.163 0.506 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.608 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.45 137.35 26.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.708 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.99 157.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.328 0.585 . . . . 0.0 111.629 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t-20 75.73 -0.52 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.328 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -69.34 126.75 30.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.66 101.99 13.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.585 0.707 . . . . 0.0 111.492 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' ILE . 68.0 mt -48.81 137.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.581 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 5.2 mt -119.01 -32.9 4.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -150.13 160.13 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.577 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 t -152.42 110.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 t30 47.92 50.19 16.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 73.29 31.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 77.8 t -120.85 141.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.0 p-10 -109.47 109.57 20.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.664 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 32.5 m -94.01 43.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.247 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -30.17 68.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -149.87 67.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.768 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.5 m -135.02 148.1 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.433 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.04 154.35 39.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.561 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 7.4 p-80 -49.17 -34.15 13.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.098 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -69.57 -33.93 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.37 -42.58 83.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 109.793 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -64.09 -46.62 83.42 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 88.0 t -56.61 -50.4 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.21 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.616 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.29 -29.85 59.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.949 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.96 -50.77 70.81 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.2 mt -57.01 -37.16 71.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.484 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.64 -23.62 49.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.957 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 5.0 pt-20 -93.6 3.21 55.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.032 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.689 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -90.28 16.3 8.92 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.46 -121.86 27.96 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.748 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -104.19 -87.12 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.2 tp -82.59 107.82 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.689 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 7.1 p -127.05 137.72 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.424 ' N ' HG21 ' A' ' 84' ' ' VAL . 13.2 mtp180 -83.49 103.07 12.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.373 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mt -94.92 142.12 27.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.017 0.436 . . . . 0.0 111.363 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.66 131.43 49.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.304 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.3 m -131.8 167.93 25.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.447 ' HG3' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -106.81 158.74 16.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -140.51 124.04 17.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.409 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.854 0.359 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.32 138.77 35.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.494 ' CG ' HD21 ' A' ' 58' ' ' LEU . 5.8 m-30 -96.83 127.82 43.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.19 141.93 51.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 17.0 pt-20 -99.46 144.66 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.483 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -136.43 109.42 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.372 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.81 118.39 20.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.563 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 5.0 tp -128.51 127.18 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.1 pt-20 -84.06 100.63 11.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.195 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -51.63 89.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.111 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.65 175.62 0.17 Allowed Glycine 0 C--N 1.32 -0.339 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.613 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -55.08 -24.1 23.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.303 . . . . 0.0 111.126 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.5 p -96.56 -24.65 15.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.205 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.94 -163.12 28.35 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.203 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.563 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.9 tp -67.51 -63.56 1.03 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.844 -0.21 . . . . 0.0 110.637 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 133.93 20.27 0.86 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.928 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.733 ' HB3' HG22 ' A' ' 39' ' ' ILE . 7.0 p90 -161.18 135.91 7.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.055 0.927 . . . . 0.0 111.381 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.44 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 135.82 34.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -115.27 148.03 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -130.46 124.85 32.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.71 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 25' ' ' ASN . . . 158.3 -120.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.874 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.477 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 63.83 168.29 1.27 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.12 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.401 ' N ' ' HA ' ' A' ' 69' ' ' THR . 25.1 p -70.18 -1.98 11.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.411 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 35.4 t70 -117.08 -22.52 8.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' HIS . 4.3 m-80 -124.72 85.89 56.41 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.61 65.74 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.008 1.805 . . . . 0.0 112.477 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.738 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 48.7 t60 -55.09 -23.62 21.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.173 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.678 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -94.75 -150.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.377 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -82.26 51.65 4.52 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.692 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 t0 76.25 43.53 0.15 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 110.414 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.53 156.77 79.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.9 0.03 10.22 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.507 2.138 . . . . 0.0 112.599 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -55.2 120.09 6.5 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.108 0.48 . . . . 0.0 111.313 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.62 118.68 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.738 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.98 146.84 36.07 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.316 0.579 . . . . 0.0 110.463 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.23 155.78 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.042 -176.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.35 -33.51 4.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.772 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.82 142.04 2.37 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.483 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -103.92 133.58 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 115.0 57.79 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.6 Cg_exo -56.07 136.87 77.22 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.89 2.393 . . . . 0.0 112.405 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.91 2.57 66.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.1 176.39 22.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.111 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -52.47 -38.41 59.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . . . -68.18 -57.41 6.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.659 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.59 -35.35 80.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.081 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.1 pp0? -71.96 -30.07 64.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 0.0 110.471 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.89 -58.07 3.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.598 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 41.39 9.81 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.593 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.483 ' CB ' HG12 ' A' ' 6' ' ' ILE . 5.5 mtm180 -117.09 -1.19 11.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -126.56 153.53 45.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.85 135.26 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.688 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.5 157.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.339 0.59 . . . . 0.0 111.619 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 75.79 -0.27 3.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.26 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -67.45 124.4 23.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.59 100.33 12.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 111.549 -178.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 34' ' ' ILE . 12.1 mt -49.89 132.65 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.674 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.494 HD21 ' CG ' ' A' ' 3' ' ' TYR . 1.8 pp -130.04 -0.01 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.114 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 179.16 134.64 0.09 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.409 ' HA ' HD21 ' A' ' 86' ' ' LEU . 40.7 t -120.02 97.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.692 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.7 t30 71.32 -61.82 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -164.3 31.24 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.084 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.3 t -120.99 110.43 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' N ' ' CE1' ' A' ' 59' ' ' PHE . 6.7 t0 -72.47 112.37 8.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.79 0.328 . . . . 0.0 110.593 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 m -94.92 27.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.5 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -67.81 -25.54 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.44 51.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.19 148.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.006 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -68.42 154.53 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 9.2 t-160 -48.29 -34.86 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.044 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 4.0 m -68.6 -33.76 74.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.244 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.642 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.6 -33.09 68.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.21 0.529 . . . . 0.0 109.598 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB3' HD13 ' A' ' 34' ' ' ILE . . . -71.59 -46.76 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.616 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 67.9 t -60.58 -50.86 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.303 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -57.14 -29.32 63.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.69 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.404 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -61.16 -52.19 65.87 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.905 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 19' ' ' ILE . 3.0 mt -56.6 -37.27 70.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.909 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.6 -28.33 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -97.37 15.93 21.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.295 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.614 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -88.11 16.28 6.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.39 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.54 -96.05 0.55 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.422 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -136.09 -90.2 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.0 tp -84.5 93.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 109.879 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 9.1 p -109.81 136.39 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.2 ptt180 -87.01 103.05 14.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.273 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.443 HD12 ' CD2' ' A' ' 15' ' ' LEU . 15.1 mt -91.78 134.51 34.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.119 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.491 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.56 125.35 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.48 157.04 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.728 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.44 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 26.7 mtt -96.84 148.18 23.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.963 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -140.54 113.55 8.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.853 0.358 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -75.53 117.8 17.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.028 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CD2' ' CD1' ' A' ' 58' ' ' LEU . 3.1 m-85 -82.23 121.35 26.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.819 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.4 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 4.3 pt-20 -129.0 164.62 22.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.978 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -121.45 144.77 48.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.94 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.493 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.59 112.12 13.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.638 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.12 115.36 20.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.555 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 4.6 tp -125.44 128.76 48.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -89.48 100.84 13.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.698 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' ASN . 5.1 mtp180 -45.6 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.342 0.591 . . . . 0.0 109.801 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' SER . . . -63.35 63.1 0.04 OUTLIER Glycine 0 C--N 1.319 -0.363 0 CA-C-N 114.835 -1.075 . . . . 0.0 114.168 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 10' ' ' ARG . 4.6 m120 61.78 -65.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.748 0.309 . . . . 0.0 111.503 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' GLY . 36.4 m -69.62 -24.86 63.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.994 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.9 -177.74 32.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.883 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.1 tp -64.06 -63.49 1.14 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.171 . . . . 0.0 110.808 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.403 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 134.93 19.61 0.79 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.674 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.759 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -161.04 135.08 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.006 0.903 . . . . 0.0 111.19 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.37 138.86 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.466 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.65 147.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 112.037 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -139.98 134.98 32.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.283 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.4 1.23 0.92 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.409 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.34 -173.79 0.92 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.885 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.444 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 28.7 p -66.83 -32.6 73.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -90.43 -20.7 22.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 20.7 t-20 -124.28 87.29 53.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.617 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.91 61.49 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.277 1.985 . . . . 0.0 112.387 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 49.2 t60 -47.9 -27.75 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.202 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.66 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.43 -153.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -57.2 -50.17 66.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.681 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.48 40.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.724 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 168.5 14.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.87 6.5 4.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.814 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 113.34 1.36 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.513 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.31 119.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.72 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.23 147.46 36.53 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.265 0.555 . . . . 0.0 110.456 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.02 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.121 -176.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.65 -34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.661 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.15 143.14 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.044 0.449 . . . . 0.0 111.737 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.759 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.46 132.79 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.458 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.2 124.54 73.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.0 Cg_endo -65.39 133.14 33.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 112.209 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.53 5.96 57.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.384 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.66 175.06 18.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.868 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' HB1' ' HG ' ' A' ' 8' ' ' LEU . . . -52.8 -36.15 57.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.721 0.296 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -68.89 -57.46 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.466 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.6 -29.04 67.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.401 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.02 -34.99 69.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.101 0.477 . . . . 0.0 110.005 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -84.75 -58.05 2.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.602 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 41.78 9.46 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.464 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.493 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.4 mmt85 -112.88 9.01 18.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.704 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.6 tp -134.34 155.1 50.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.635 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -132.09 133.52 44.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.881 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -49.4 157.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.79 -1.11 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.368 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.83 126.46 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.61 103.88 15.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.525 0.678 . . . . 0.0 111.361 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ILE . 64.2 mt -50.83 152.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.863 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -136.58 -39.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.474 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -142.58 159.52 42.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.402 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 35.9 t -152.5 113.78 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 49.84 44.87 25.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.773 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 72.86 32.62 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.595 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 68.6 t -120.37 142.19 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.7 p-10 -108.8 111.05 22.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.54 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 30.3 m -79.21 57.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.967 0.413 . . . . 0.0 110.948 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.62 103.02 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.85 53.81 1.41 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.442 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 16.7 m -119.85 142.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.444 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -62.99 154.21 31.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.075 0.465 . . . . 0.0 111.226 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.52 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.8 p-80 -48.09 -34.16 9.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -70.69 -33.98 71.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.94 -45.06 83.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 0.0 109.764 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -62.21 -46.92 86.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.299 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 84.9 t -56.55 -50.35 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.319 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.585 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.06 -29.35 57.31 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.971 178.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.78 -52.07 65.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.397 0.618 . . . . 0.0 109.759 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.461 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.1 mt -56.61 -36.16 69.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.872 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.61 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.36 -30.53 53.84 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.674 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -98.29 19.82 13.63 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.406 -178.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.617 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -88.99 16.26 7.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.37 -101.4 1.15 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.237 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.1 t -130.28 -89.29 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.595 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 2.1 tp -88.41 91.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 109.919 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 8.9 p -105.11 137.18 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.72 102.63 14.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.485 ' HB2' HG21 ' A' ' 6' ' ' ILE . 15.9 mt -89.48 139.62 30.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.75 132.86 47.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.718 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -138.82 165.34 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.387 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.446 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 12.2 ptt? -138.34 131.8 30.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.419 . . . . 0.0 111.185 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 111.74 7.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.978 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.799 0.333 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.42 147.64 23.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 1.4 m-85 -104.25 106.17 16.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.608 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -102.04 170.78 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.13 144.95 51.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.538 HG21 HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.97 109.65 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.992 0.425 . . . . 0.0 111.966 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.27 119.53 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.1 tp -132.03 127.15 35.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.3 pm0 -83.94 100.38 10.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.823 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HA ' HD21 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.77 89.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -49.48 -179.36 0.02 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.788 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -45.25 -36.95 4.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 p -99.31 -24.76 14.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.194 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 148.37 -164.65 29.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.956 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 21.3 mt -56.08 -63.48 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.98 0.419 . . . . 0.0 110.548 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.85 32.82 0.54 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.436 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.768 ' HB3' HG22 ' A' ' 39' ' ' ILE . 10.8 p90 -158.86 135.97 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.068 0.434 . . . . 0.0 111.026 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.44 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.76 137.93 34.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.38 146.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.762 0.792 . . . . 0.0 112.377 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -139.77 133.59 30.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.096 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.463 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.36 -0.43 1.09 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.731 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.65 -173.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.919 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 37.2 p -69.09 -30.65 69.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.21 -20.86 21.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.35 87.23 54.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.425 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.63 61.79 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.349 2.033 . . . . 0.0 112.635 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 46.2 t60 -48.89 -27.55 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.671 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -91.23 -152.27 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.195 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.449 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -83.89 49.4 4.22 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.591 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.29 48.21 0.06 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 110.223 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.88 150.45 71.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.18 -5.23 15.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.674 2.249 . . . . 0.0 112.669 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.1 113.96 1.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.041 0.448 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -83.69 118.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.512 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.66 147.36 39.17 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.357 0.599 . . . . 0.0 110.69 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.05 155.71 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.017 -176.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.45 -29.6 4.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.252 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.76 130.57 0.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.176 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.768 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.61 129.75 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.27 116.87 67.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.7 134.47 60.89 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.67 2.247 . . . . 0.0 112.287 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.73 31.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.551 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.84 177.61 17.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -52.32 -34.77 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.425 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -70.77 -56.65 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.97 -31.1 65.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -72.0 -30.12 64.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.375 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.0 -57.96 3.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.97 9.57 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.615 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.492 ' CB ' HG12 ' A' ' 6' ' ' ILE . 44.1 mtt-85 -118.14 5.81 12.01 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.95 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -134.59 153.39 51.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.189 0.519 . . . . 0.0 111.026 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.58 137.35 49.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -52.19 157.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.344 0.592 . . . . 0.0 111.563 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.08 0.01 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.35 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.48 127.42 32.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 103.8 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.539 0.685 . . . . 0.0 111.339 -178.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ILE . 69.6 mt -51.0 139.95 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.633 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.41 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.85 -37.08 3.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.5 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -148.68 165.41 31.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.76 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 62' ' ' GLU . 39.4 t -142.07 97.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.73 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.417 ' HB2' HG22 ' A' ' 84' ' ' VAL . 3.7 t-20 68.53 -67.07 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.076 0.465 . . . . 0.0 109.771 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.4 mt-10 -157.37 33.36 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.582 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.4 t -120.59 142.36 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -107.19 108.38 19.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.393 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 21.1 m -92.23 45.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.347 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -25.47 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -149.58 58.07 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.996 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 27.2 m -128.27 149.05 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.434 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.44 153.79 42.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 111.018 -179.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.557 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 2.2 t-160 -49.86 -34.14 19.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -69.62 -33.87 73.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.749 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.32 -42.68 79.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.498 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -62.79 -46.89 85.89 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.3 t -57.49 -50.41 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.259 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.663 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -30.03 61.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.889 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.476 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.76 -50.21 74.38 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.341 0.591 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -59.53 -35.82 74.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.961 179.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.44 -25.79 50.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.348 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -102.58 16.78 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.36 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.585 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -85.9 16.27 4.26 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 -92.49 0.69 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.061 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 22.5 t -143.06 -89.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 8.8 tp -84.47 88.23 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.217 0.532 . . . . 0.0 109.811 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 12.4 p -103.93 139.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.0 mtt-85 -88.15 102.82 15.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.434 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 12.9 mt -91.8 138.61 31.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.259 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.6 m-85 -101.66 138.66 38.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 m -139.52 168.01 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.409 ' HE3' ' CZ ' ' A' ' 3' ' ' TYR . 2.3 ttm -110.79 148.06 33.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.34 . . . . 0.0 110.865 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.52 132.46 27.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.78 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.964 179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.938 0.399 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -99.44 133.67 43.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.993 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.431 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 22.5 m-85 -94.3 156.38 16.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 142.36 18.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -106.24 144.63 32.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -137.03 109.41 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.46 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.39 121.22 24.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.633 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -132.05 127.38 36.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 pt-20 -85.57 101.07 12.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.853 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.453 ' NE ' ' HA ' ' A' ' 78' ' ' LYS . 11.2 mtp180 -47.79 94.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -46.38 -104.28 0.01 OUTLIER Glycine 0 C--N 1.319 -0.384 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.317 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -109.94 -41.44 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.505 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 m -108.14 -5.06 17.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.553 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 151.76 -157.04 27.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.518 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.633 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -74.68 -63.47 1.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.427 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.17 44.14 0.07 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.978 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.738 ' HB3' HG21 ' A' ' 39' ' ' ILE . 12.5 p90 -164.55 134.16 3.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.149 0.474 . . . . 0.0 110.875 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.443 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.75 136.52 33.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.525 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.26 146.81 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.753 0.787 . . . . 0.0 112.247 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -140.0 132.86 29.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.13 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.5 3.61 0.71 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.707 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.75 -171.11 0.67 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.8 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 39.1 p -70.42 -29.14 65.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.97 -21.0 20.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.9 OUTLIER -124.38 87.32 54.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.524 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 62.2 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.266 1.977 . . . . 0.0 112.459 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.706 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.5 t60 -47.46 -28.12 2.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.327 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.651 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.49 -154.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.3 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.68 -50.09 70.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.604 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.37 40.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.48 165.84 25.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 3.5 Cg_exo -74.98 1.21 7.98 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.967 2.445 . . . . 0.0 112.815 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.46 112.3 0.79 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.034 0.445 . . . . 0.0 111.16 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.513 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.05 118.54 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.47 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.706 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.99 147.2 38.33 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.352 0.596 . . . . 0.0 110.841 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.11 155.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.911 -176.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.83 -29.02 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.189 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.4 131.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.998 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.738 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.59 132.29 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.32 114.23 53.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.436 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.8 Cg_exo -57.83 137.43 81.0 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.709 2.273 . . . . 0.0 112.326 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.77 54.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.568 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 179.5 16.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.113 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -54.69 -36.44 64.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.188 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -68.05 -57.68 5.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 0.0 111.87 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.75 -28.29 65.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.53 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.64 -30.21 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.362 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.91 -57.87 3.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.14 37.74 10.91 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.574 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.434 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.6 mtt85 -112.44 -13.36 13.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.2 tp -114.69 154.82 27.76 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 111.408 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -133.11 135.71 45.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.691 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.84 157.41 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.195 0.521 . . . . 0.0 111.747 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.86 0.28 3.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.329 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.95 126.26 29.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.567 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.3 t -86.58 100.25 12.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.715 0.769 . . . . 0.0 111.316 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 34' ' ' ILE . 69.9 mt -46.83 135.21 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.708 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.45 -42.29 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.052 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.2 m-85 -142.36 169.99 16.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.73 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.3 t -150.04 99.12 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.218 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.6 t30 67.04 -67.61 0.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.167 0.508 . . . . 0.0 109.874 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.42 32.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.668 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.7 t -119.46 142.25 35.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.564 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.7 t0 -112.08 87.55 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 65' ' ' VAL . 24.9 m -70.22 63.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -29.9 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.691 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -149.03 58.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.493 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.8 m -123.91 146.67 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.246 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -65.81 154.94 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.533 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.5 p-80 -48.21 -34.65 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.1 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 p -71.58 -33.75 69.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.169 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.623 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.93 -45.49 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -60.86 -46.85 88.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.587 0.708 . . . . 0.0 109.162 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.649 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 86.8 t -57.12 -49.25 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.403 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.97 -30.15 63.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.957 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.77 -49.71 76.4 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.333 0.587 . . . . 0.0 109.679 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.425 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 0.7 OUTLIER -59.94 -34.65 73.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.859 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.9 mmmt -77.36 -28.1 52.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.426 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.86 18.49 19.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 -178.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.48 16.29 6.71 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.39 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -111.03 3.42 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.155 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -119.68 -90.26 0.58 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.0 tp -87.28 93.68 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.976 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.637 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -105.81 138.59 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 49.1 mtp180 -88.67 102.96 15.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 13.0 mt -90.56 141.61 28.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.213 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 136.03 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.683 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 m -139.81 136.76 39.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -104.33 146.89 28.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 0.0 110.936 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -140.57 116.71 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.016 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HG3' ' HB3' ' A' ' 91' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.829 0.347 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.76 110.97 23.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.955 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' A' ' 89' ' ' MET . 4.2 m-85 -82.23 113.48 20.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 1.6 mp0 -115.42 153.01 31.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -107.84 144.82 34.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.456 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.461 HD13 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.77 109.63 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 111.704 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -80.0 122.3 26.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.3 tp -131.54 126.85 35.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 12.8 mt-10 -80.31 99.99 8.17 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.279 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.28 88.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.085 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.6 171.31 0.77 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.441 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -52.8 -25.0 10.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.817 0.342 . . . . 0.0 110.991 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 m -94.09 -22.74 18.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.38 -164.47 26.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.315 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.545 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.8 tp -68.73 -63.48 1.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.41 0.148 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 132.42 20.64 0.99 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.765 -1.207 . . . . 0.0 114.486 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.796 ' HB3' HG22 ' A' ' 39' ' ' ILE . 6.0 p90 -159.28 135.52 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.608 0.704 . . . . 0.0 110.847 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.425 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -95.27 135.2 37.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -113.89 146.6 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.543 0.687 . . . . 0.0 111.552 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB1' HG21 ' A' ' 37' ' ' THR . . . -126.59 120.7 30.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.628 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 141.92 159.24 7.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.783 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.64 175.56 22.02 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 26.6 p -65.87 -12.19 52.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -114.96 -26.35 7.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.53 87.37 54.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.466 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.94 66.06 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.365 2.043 . . . . 0.0 112.329 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.75 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 31.7 t60 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.656 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.648 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -85.96 -155.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.438 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.441 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.01 -50.1 69.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.746 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.03 76.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 110.701 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' CB ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -166.63 176.69 1.71 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 31' ' ' ASP . 94.1 Cg_endo -85.36 26.77 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.729 2.286 . . . . 0.0 112.543 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 m -77.21 112.29 13.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.59 118.85 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.009 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.75 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.34 148.15 37.47 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.259 0.552 . . . . 0.0 110.789 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.31 155.87 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.81 -177.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.502 HG21 ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.31 -30.65 4.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.098 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.46 132.59 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.896 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.26 131.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.417 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 115.69 61.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.5 Cg_exo -57.72 134.79 65.23 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.731 2.288 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 8.12 56.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.43 179.75 18.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.903 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.08 -38.8 68.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 111.064 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.522 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -65.44 -57.46 8.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.25 -28.93 66.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.27 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.76 -57.94 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.632 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.06 9.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.602 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.1 mtt-85 -115.25 -6.18 12.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.4 tp -121.23 154.06 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.162 0.506 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.586 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.46 135.45 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.552 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.21 157.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 0.0 111.538 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.466 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER 77.06 -2.27 2.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -64.94 124.63 22.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.49 100.22 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.472 0.653 . . . . 0.0 111.615 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 34' ' ' ILE . 38.0 mt -48.51 125.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.565 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.585 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -117.42 -16.46 10.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.739 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -164.64 142.59 6.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.114 0.483 . . . . 0.0 110.94 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.4 ' CG1' ' CD2' ' A' ' 86' ' ' LEU . 38.6 t -136.98 112.18 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.393 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 50.69 39.29 21.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.918 0.389 . . . . 0.0 110.276 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.67 33.83 0.36 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.564 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.7 t -120.9 103.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.307 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 10.3 t0 -65.99 108.05 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 25.3 m -87.39 8.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.638 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.64 -21.32 53.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.634 0.254 . . . . 0.0 111.051 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -139.21 42.04 2.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.185 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.419 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 8.3 m -124.42 144.71 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.412 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.48 153.92 41.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.93 0.395 . . . . 0.0 110.613 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.46 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 13.3 t-160 -48.76 -34.43 12.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 2.7 m -70.06 -33.68 72.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.608 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.04 -33.2 71.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -70.64 -46.79 62.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.612 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.8 t -59.57 -50.76 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.352 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 3.5 pt-20 -57.69 -31.82 66.75 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.605 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -58.11 -49.75 75.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.328 0.585 . . . . 0.0 110.022 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.47 HD12 ' CE1' ' A' ' 17' ' ' PHE . 1.3 mt -59.8 -37.33 78.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.983 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.31 -25.74 51.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.699 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 6.4 pt-20 -103.26 17.75 23.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.191 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.602 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -85.73 16.15 4.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.16 -93.77 0.6 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.321 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 28.1 t -141.06 -90.63 0.15 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.552 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -84.2 86.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.3 0.571 . . . . 0.0 109.706 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 9.7 p -100.27 137.57 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.114 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 6.0 ttt180 -89.4 102.65 15.32 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.43 HD12 HD23 ' A' ' 77' ' ' LEU . 19.0 mt -91.46 133.65 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.585 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.99 114.77 29.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.826 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.413 ' CA ' HD22 ' A' ' 58' ' ' LEU . 3.7 m -120.34 129.31 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.779 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.44 ' HB3' ' CD2' ' A' ' 3' ' ' TYR . 25.8 ptt? -96.77 133.73 40.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.139 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -114.22 146.51 40.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.822 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 5.9 ppt_? . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.978 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.792 0.329 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.55 119.69 35.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.451 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 6.4 m-30 -82.15 136.16 35.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -143.86 149.79 37.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.6 mt-10 -104.51 144.62 31.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.489 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.91 109.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.382 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.72 114.95 19.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 tp -125.78 127.27 45.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.4 pt-20 -84.24 100.49 11.24 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.38 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.09 89.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.257 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.25 174.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.736 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -53.33 -25.54 15.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.81 0.338 . . . . 0.0 111.078 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -97.75 -24.74 15.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.57 -165.57 27.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.244 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 5.1 tp -61.9 -63.52 1.23 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.638 0.219 . . . . 0.0 110.505 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 128.82 25.91 0.97 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.765 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.737 ' HB3' HG21 ' A' ' 39' ' ' ILE . 5.7 p90 -164.27 132.27 3.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.862 0.831 . . . . 0.0 111.363 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.39 137.13 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.331 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -116.22 161.76 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.767 0.794 . . . . 0.0 112.092 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -155.51 131.91 10.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.777 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 15.01 0.26 Allowed Glycine 0 C--O 1.229 -0.16 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.468 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -73.04 -174.14 26.45 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 22.2 p -66.93 -32.71 74.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -85.09 -33.35 22.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.514 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.65 77.21 64.14 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 28' ' ' ILE . 3.6 Cg_endo -46.02 -24.25 2.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.736 2.29 . . . . 0.0 112.679 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.692 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.4 t60 58.94 -59.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.251 0.548 . . . . 0.0 111.497 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.627 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -66.28 -158.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.659 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.45 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -60.99 -49.45 78.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.484 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 179.39 75.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.56 156.99 14.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.2 5.73 4.38 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.857 2.371 . . . . 0.0 112.937 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -60.51 111.76 1.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.804 0.335 . . . . 0.0 110.707 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -79.76 121.45 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.263 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.692 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.2 OUTLIER -142.23 147.2 36.13 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.419 0.628 . . . . 0.0 110.446 178.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.51 155.35 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.142 -0.935 . . . . 0.0 113.139 -176.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.98 -32.94 4.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.803 -179.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.563 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.13 143.67 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.616 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.737 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.27 132.27 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.44 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 116.78 66.43 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.8 Cg_exo -56.62 136.87 78.46 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.594 2.196 . . . . 0.0 112.305 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.61 1.98 67.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.689 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.55 174.83 24.06 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.864 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.418 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -52.84 -35.32 57.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.868 0.334 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -70.55 -57.44 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.485 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.0 -28.92 68.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.397 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -72.05 -35.36 69.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.049 0.452 . . . . 0.0 109.968 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.58 -57.77 3.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.523 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 40.88 9.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.599 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.489 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.49 9.55 19.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.794 0.33 . . . . 0.0 110.689 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.7 tp -136.3 153.8 51.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.549 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -131.2 134.37 46.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.563 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -48.98 157.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 111.83 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.5 t-20 76.56 -0.26 3.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.387 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.02 125.93 28.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.46 102.61 14.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.614 0.721 . . . . 0.0 111.199 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' ILE . 61.6 mt -50.91 134.74 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.776 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.412 HD13 ' CG ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -117.47 -30.54 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -152.47 163.69 39.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 62' ' ' GLU . 19.3 t -144.05 97.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.029 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.415 ' HB2' HG22 ' A' ' 84' ' ' VAL . 4.7 t30 68.13 -67.36 0.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 6.2 pt-20 -156.54 32.41 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.691 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 59.0 t -119.78 142.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.496 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 p-10 -110.0 99.51 8.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.437 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 30.8 m -83.54 56.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.906 0.384 . . . . 0.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -29.09 26.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -147.36 56.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 31.7 m -126.22 144.39 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.14 151.77 34.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.556 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.4 t-160 -47.95 -33.98 8.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.717 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -33.99 75.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.977 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.671 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.18 -42.16 80.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -63.04 -46.65 86.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.631 0.729 . . . . 0.0 109.124 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.6 t -57.62 -50.56 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.193 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.34 -29.57 61.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.89 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.04 -50.66 72.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.318 0.58 . . . . 0.0 109.862 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.1 mt -58.11 -37.14 73.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.836 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.51 -28.31 52.06 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.15 18.11 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 -178.316 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -87.04 16.38 5.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.246 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 -97.08 0.8 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.275 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.483 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.4 m -136.9 -90.44 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 8.7 tp -84.86 89.97 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.23 0.538 . . . . 0.0 109.737 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 11.4 p -104.84 138.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.9 ttm-85 -87.95 103.12 15.39 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 14.6 mt -92.37 138.6 31.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.241 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.69 132.44 47.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.3 m -139.77 153.62 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.451 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 8.6 ptt? -121.39 131.24 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 111.013 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.53 121.76 14.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.819 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.034 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.795 0.331 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -87.19 132.61 33.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CE1' ' HG2' ' A' ' 89' ' ' MET . 4.0 m-30 -99.12 153.37 18.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -154.98 159.64 40.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -109.57 144.68 37.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.448 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.69 109.6 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 111.599 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.444 ' CG2' ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.38 121.03 23.22 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.542 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -132.3 127.25 35.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.5 mt-10 -83.29 100.2 10.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.841 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' HA ' HD22 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -46.57 89.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.338 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.85 -174.4 0.03 OUTLIER Glycine 0 C--N 1.321 -0.301 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.747 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -45.98 -45.04 15.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.745 0.307 . . . . 0.0 111.581 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.4 t -92.82 -22.84 19.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.171 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.42 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 145.58 -162.6 28.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.928 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 20.1 mt -54.39 -63.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.036 0.418 . . . . 0.0 110.712 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.89 34.72 0.47 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.446 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.76 ' HB3' HG21 ' A' ' 39' ' ' ILE . 10.1 p90 -160.1 136.56 8.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.133 0.466 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.5 137.05 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.294 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.26 148.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.729 0.776 . . . . 0.0 112.355 -179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.75 133.8 27.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.065 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.41 4.77 0.88 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.725 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -61.49 -169.72 0.72 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.902 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 43.4 p -70.95 -29.89 66.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -93.54 -19.85 20.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.42 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 3.8 t-20 -124.46 87.43 54.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.91 61.24 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.32 2.013 . . . . 0.0 112.46 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.714 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.8 t60 -47.19 -28.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -88.79 -154.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.208 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -59.45 -49.9 73.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.51 40.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 0.0 110.799 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.85 165.59 27.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.22 1.6 7.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.956 2.437 . . . . 0.0 112.754 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 t -52.62 112.07 0.76 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.978 0.418 . . . . 0.0 111.185 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.507 HD12 ' HB1' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.88 118.52 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.524 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.714 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.31 147.2 37.76 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.422 0.629 . . . . 0.0 110.622 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.7 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.94 155.72 7.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.064 -176.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.06 -30.4 4.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.165 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.25 130.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.995 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.76 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.19 130.86 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 126.06 70.67 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.4 Cg_endo -67.71 132.11 26.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.71 2.273 . . . . 0.0 112.34 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.39 26.89 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.333 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.24 177.54 16.9 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.022 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.49 -34.39 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.747 0.308 . . . . 0.0 111.487 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 39' ' ' ILE . . . -70.62 -57.45 4.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.832 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.48 -28.82 64.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.603 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.74 -32.83 68.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 110.337 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.14 -57.89 3.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.685 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.57 9.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.717 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.448 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.7 mtm180 -113.93 -7.62 13.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.739 0.304 . . . . 0.0 110.821 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.5 tp -121.2 154.02 36.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.079 0.466 . . . . 0.0 111.209 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.564 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -130.95 135.88 48.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.604 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -49.03 157.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.244 0.545 . . . . 0.0 111.454 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.9 t30 76.87 -2.02 2.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.111 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -65.47 124.54 22.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.1 p -86.5 100.76 12.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.52 0.676 . . . . 0.0 111.233 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' ILE . 65.8 mt -49.99 130.37 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.875 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HG ' ' CG ' ' A' ' 89' ' ' MET . 3.7 mt -112.91 -34.04 5.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.113 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.7 m-85 -151.09 159.41 44.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.438 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 76' ' ' ALA . 7.7 p -146.69 105.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.409 ' CB ' HG21 ' A' ' 84' ' ' VAL . 18.7 t30 68.62 -67.18 0.21 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.137 0.494 . . . . 0.0 109.992 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -162.46 29.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.047 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 1.4 t -121.01 142.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.279 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 18.0 t0 -106.36 90.75 3.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.445 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 30.3 m -70.54 63.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.429 . . . . 0.0 111.567 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -26.64 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -147.6 55.27 1.07 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 29.4 m -124.69 146.97 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.61 154.44 40.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.226 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.8 p-80 -48.12 -34.61 10.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.2 p -71.95 -33.75 68.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.197 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.668 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -45.39 80.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -60.61 -46.58 89.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.582 0.706 . . . . 0.0 109.203 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.639 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 93.7 t -57.5 -50.47 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.245 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.668 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.86 -30.36 63.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.091 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.494 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.07 -49.79 75.9 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.28 0.562 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.451 HD13 ' CE1' ' A' ' 17' ' ' PHE . 4.0 mt -59.25 -35.54 73.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.739 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -77.31 -23.26 51.06 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.12 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -105.34 16.96 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.042 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.599 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -85.54 16.21 4.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.147 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -97.16 0.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.171 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.42 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 25.8 t -138.07 -89.09 0.24 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -85.98 87.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.264 0.554 . . . . 0.0 109.626 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.599 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 12.4 p -101.94 140.18 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -87.97 103.18 15.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.458 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 11.8 mt -91.76 139.01 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.64 131.98 47.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.244 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.2 m -139.87 158.68 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.855 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.493 ' HB2' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -113.12 150.08 32.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 110.747 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 120.99 14.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.903 0.382 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.38 119.16 17.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.009 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 3.7 m-30 -82.88 130.85 35.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.684 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.1 144.57 38.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.085 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 43.9 mt-10 -102.33 144.69 30.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -138.19 109.39 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 111.563 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.33 121.53 23.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.605 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -132.27 128.2 37.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.7 pt-20 -86.96 100.9 12.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 6.6 mtp180 -43.72 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.935 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.71 74.42 0.03 OUTLIER Glycine 0 C--N 1.318 -0.433 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.042 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 63.08 -76.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 111.24 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.2 t -69.98 -24.68 63.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.39 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 154.15 -172.2 32.76 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.038 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.605 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 10.2 mt -59.74 -63.7 1.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.827 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 135.67 39.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.484 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.749 ' HB3' HG21 ' A' ' 39' ' ' ILE . 7.5 p90 -161.79 137.31 7.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.986 0.393 . . . . 0.0 110.708 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.8 134.33 40.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.624 -179.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -113.51 146.92 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.588 0.709 . . . . 0.0 111.684 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -127.37 121.57 31.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.464 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 140.69 159.62 8.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.007 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 148.86 175.59 21.47 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.359 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 25.0 p -66.71 -11.69 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -114.62 -26.59 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 111.684 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.44 87.2 54.41 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.57 66.21 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.301 2.001 . . . . 0.0 112.579 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.753 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.8 t60 -48.43 -27.81 2.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.376 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.643 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -87.13 -155.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.437 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -52.83 -51.7 43.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.964 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.958 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.52 175.73 3.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.99 35.41 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.671 2.247 . . . . 0.0 112.445 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -84.84 114.77 22.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 110.903 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -90.69 118.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.066 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.753 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.15 148.03 37.61 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.344 0.593 . . . . 0.0 110.719 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.726 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.39 155.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.516 -177.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.492 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.13 -29.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.163 -178.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.34 130.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.785 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.62 132.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.438 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.33 125.56 71.71 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.1 Cg_endo -68.05 132.55 26.52 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 112.365 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.33 19.26 21.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.346 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.86 179.12 16.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.349 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -54.39 -33.31 59.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.653 0.263 . . . . 0.0 111.479 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -73.36 -56.0 5.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.45 -29.08 63.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.4 pt20 -72.19 -31.85 66.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.274 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.88 -57.94 3.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.4 11.9 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.592 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.407 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.67 -15.76 13.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.766 0.283 . . . . 0.0 110.863 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.5 tp -113.9 153.37 29.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.21 0.529 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.546 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.99 136.28 48.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.574 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.2 t -49.08 157.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.363 0.601 . . . . 0.0 111.543 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER 76.82 -1.04 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.302 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -66.51 124.52 23.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -86.54 100.48 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.55 0.691 . . . . 0.0 111.432 -178.58 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.485 ' N ' ' O ' ' A' ' 34' ' ' ILE . 27.4 mt -48.3 135.61 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.596 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' CD2' ' CG ' ' A' ' 3' ' ' TYR . 3.0 pp -139.92 12.79 2.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 170.82 134.74 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.317 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -123.91 95.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.299 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 73.26 -60.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 27.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.475 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 40.8 t -121.27 109.11 24.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.993 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -70.48 120.81 16.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.512 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.401 ' HA ' ' CG2' ' A' ' 68' ' ' VAL . 22.1 m -93.99 20.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -22.63 66.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.116 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.26 44.18 1.89 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.059 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 65' ' ' VAL . 16.7 m -124.41 145.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.036 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.407 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.4 OUTLIER -66.07 153.65 41.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.558 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.447 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 14.9 t-160 -49.14 -34.2 13.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.744 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -70.86 -33.76 70.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.7 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.648 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.05 -31.67 69.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.471 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -71.56 -46.96 57.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.631 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 81.8 t -60.48 -50.54 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.283 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -58.33 -34.89 71.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.39 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.22 -49.34 72.22 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.426 0.631 . . . . 0.0 110.09 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD11 ' CE1' ' A' ' 17' ' ' PHE . 1.8 mt -59.65 -36.01 75.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.591 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.36 -21.95 52.51 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mt-10 -102.05 -6.33 23.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.684 0.278 . . . . 0.0 111.383 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.626 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -59.71 -17.74 37.04 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.251 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.0 -117.04 5.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.921 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 m -110.68 -89.29 0.5 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 1.1 tp -90.92 90.91 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.296 0.569 . . . . 0.0 109.732 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.626 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -103.89 138.29 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.05 102.89 15.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.457 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 14.1 mt -89.78 134.7 34.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.423 ' CD2' ' HG3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -101.91 116.52 32.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.271 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.83 150.97 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.462 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 1.2 ptt? -118.58 144.54 46.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.397 . . . . 0.0 111.234 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -138.11 120.06 15.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.793 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.003 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 2.6 ttt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.969 0.414 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.82 136.39 38.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.353 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.446 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 56.2 m-85 -111.74 109.83 19.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -113.2 163.87 14.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 111.065 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 68.8 mt-10 -114.16 144.6 42.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.78 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.444 ' O ' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -132.39 109.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.501 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.455 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.26 120.67 23.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.595 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -132.29 127.22 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.6 pt-20 -85.9 100.84 12.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.192 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 9.7 mtp180 -42.77 91.85 0.0 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.35 0.595 . . . . 0.0 110.835 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -61.86 75.72 0.02 OUTLIER Glycine 0 C--N 1.316 -0.56 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.117 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 10' ' ' ARG . 3.3 m120 62.29 -76.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.865 0.364 . . . . 0.0 111.25 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.9 m -70.13 -23.77 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.261 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 152.08 -172.07 31.39 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.026 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 11.9 mt -57.86 -63.64 1.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.781 0.324 . . . . 0.0 110.924 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . 131.97 38.25 0.26 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.594 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HB3' HG21 ' A' ' 39' ' ' ILE . 8.1 p90 -160.44 135.36 7.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.006 0.403 . . . . 0.0 110.729 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.41 136.84 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.525 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.21 148.84 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.743 0.783 . . . . 0.0 112.337 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -143.25 133.22 24.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.12 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.89 -2.95 1.24 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.184 -1.007 . . . . 0.0 113.879 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.04 -173.16 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.951 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 68' ' ' VAL . 19.9 p -73.09 -20.9 60.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -96.35 -24.61 16.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.585 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.36 87.52 53.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.211 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.73 63.17 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.384 2.056 . . . . 0.0 112.652 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.4 t60 -49.78 -26.58 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.647 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.15 -154.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.323 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.91 -50.04 71.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.615 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.72 40.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.09 169.19 12.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -79.35 3.5 7.42 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.566 2.178 . . . . 0.0 112.74 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -53.61 111.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.883 0.373 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -83.55 119.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.838 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.715 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.23 147.22 36.15 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 121.361 0.601 . . . . 0.0 110.779 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.96 155.6 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.803 -177.011 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.452 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.6 -29.53 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.286 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.99 130.19 0.49 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.001 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.769 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.5 131.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.448 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 124.33 74.25 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.0 Cg_endo -66.2 132.58 30.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.348 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.81 17.46 25.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.437 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 177.39 17.27 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.042 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.68 -32.76 52.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 111.444 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.458 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -71.55 -57.3 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.799 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.15 -29.02 63.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.477 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -71.95 -33.32 68.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.148 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -79.37 -58.05 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.38 39.97 10.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.592 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 6' ' ' ILE . 19.2 mmt180 -115.88 -4.75 12.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 110.814 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.1 tp -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.577 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 134.55 42.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.487 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.09 157.5 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.319 0.58 . . . . 0.0 111.681 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.5 OUTLIER 77.01 -1.61 2.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.174 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.17 125.55 26.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.594 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.26 12.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.753 0.787 . . . . 0.0 111.435 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 34' ' ' ILE . 65.8 mt -47.35 138.35 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.887 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.31 -44.42 2.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.1 m-85 -142.52 167.14 22.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.771 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 62' ' ' GLU . 23.4 t -142.22 97.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.788 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.439 ' HB2' HG23 ' A' ' 84' ' ' VAL . 3.8 t-20 67.57 -67.99 0.17 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.093 0.473 . . . . 0.0 109.775 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.2 tt0 -155.71 33.71 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.481 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.1 t -120.73 142.49 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.636 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.7 p-10 -106.95 111.23 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.29 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 18.2 m -95.32 31.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.801 0.334 . . . . 0.0 111.54 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -29.16 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.766 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.85 65.91 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 27.2 m -136.19 147.12 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.274 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.54 153.01 33.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.544 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 2.0 t-160 -50.51 -33.75 22.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -34.02 73.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.756 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.29 -39.96 81.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.469 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -65.11 -46.99 78.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.644 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 84.6 t -57.02 -50.34 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.253 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.38 -30.69 63.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.026 178.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.475 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.44 -49.78 76.2 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.405 0.622 . . . . 0.0 109.908 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -60.27 -34.76 74.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.48 -26.77 51.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.361 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.84 15.54 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.383 -178.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.637 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.22 16.28 6.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.172 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.98 -114.01 5.57 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.989 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.4 m -114.99 -89.36 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.1 tp -86.77 97.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.993 0.425 . . . . 0.0 110.222 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.637 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -111.37 138.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 mtt85 -88.16 103.24 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 12.8 mt -91.12 142.97 27.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.74 136.07 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.768 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.2 m -139.87 143.93 29.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.46 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 9.1 ptt? -108.11 136.87 47.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.61 0.243 . . . . 0.0 110.758 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 106.89 5.16 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.942 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.776 0.322 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -112.54 134.44 54.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.415 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 20.6 m-85 -91.79 146.09 24.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -144.42 147.46 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.968 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -104.63 144.74 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 HG23 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.23 109.26 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.033 0.444 . . . . 0.0 111.439 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.25 122.96 25.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.588 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tp -134.23 127.05 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -82.4 100.43 10.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -50.33 92.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.514 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 13' ' ' SER . . . -63.29 68.22 0.03 OUTLIER Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.286 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER 63.97 -71.33 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.584 179.412 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' GLY . 4.4 t -70.05 -24.73 63.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.29 -170.32 32.77 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.771 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.588 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 8.4 mt -69.87 -63.61 1.04 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.501 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 138.2 39.12 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.632 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.765 ' HB3' HG21 ' A' ' 39' ' ' ILE . 7.8 p90 -160.17 134.29 7.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.093 0.446 . . . . 0.0 110.764 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.68 133.43 37.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.714 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -111.67 162.98 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.711 0.767 . . . . 0.0 111.632 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB2' ' CG ' ' A' ' 27' ' ' HIS . . . -160.36 132.61 6.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.357 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.462 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 -2.8 1.47 Allowed Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.464 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.547 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.74 -175.57 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.138 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 32.2 p -67.97 -29.1 68.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.78 -20.49 20.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -124.17 87.02 53.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.71 61.74 0.86 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.354 2.036 . . . . 0.0 112.645 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 28.8 t60 -47.57 -29.09 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.033 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.607 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.74 -155.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.194 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.88 -49.52 47.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.46 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -178.17 49.01 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.897 0.379 . . . . 0.0 111.231 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.08 159.16 70.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.1 3.41 7.45 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.647 2.232 . . . . 0.0 112.691 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.43 119.43 5.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.976 0.417 . . . . 0.0 110.931 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -84.71 119.19 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.567 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.72 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.24 144.71 33.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.48 0.657 . . . . 0.0 110.783 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.714 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.74 155.94 7.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.311 -176.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.12 -29.82 4.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.343 -178.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.552 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.97 131.57 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.931 -179.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.765 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.37 115.3 59.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.5 Cg_exo -58.11 136.48 75.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.697 2.265 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 19.96 27.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.48 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.48 179.54 16.83 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.175 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -52.65 -36.55 57.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.859 0.361 . . . . 0.0 111.531 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -68.86 -57.41 5.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.2 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.55 -28.39 62.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.781 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -29.91 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.257 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.49 -57.86 3.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.88 37.19 11.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.602 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.417 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtt180 -112.33 -14.43 13.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.713 0.292 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.604 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 7.1 tp -113.75 156.82 23.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.267 0.556 . . . . 0.0 111.374 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -135.09 134.66 40.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.413 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.552 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 52.9 t -49.04 157.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.248 0.547 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.4 OUTLIER 75.15 2.51 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.091 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.62 127.07 31.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.48 102.5 14.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 111.306 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.3 mt -49.7 131.2 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.814 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 3.4 mm? -109.63 -43.17 4.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.106 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -143.16 164.94 28.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.813 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -143.61 98.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.991 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 68.09 -66.89 0.21 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.126 0.488 . . . . 0.0 109.992 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -157.65 33.24 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.687 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.7 t -120.73 142.4 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.582 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.1 t0 -109.04 95.29 5.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.337 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.4 m -80.28 58.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 0.0 111.48 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -85.22 -31.52 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.757 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.68 52.69 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.4 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 27.3 m -121.16 148.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.436 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.06 153.4 43.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.547 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.4 t-160 -49.44 -34.1 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.792 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.9 m -68.71 -34.09 75.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.785 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.35 -42.05 79.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.491 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -63.4 -46.91 84.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.661 0.743 . . . . 0.0 109.076 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.602 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 84.5 t -57.31 -50.39 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.231 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.82 -29.89 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.864 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.482 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.14 -50.22 74.09 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.305 0.574 . . . . 0.0 109.847 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -58.78 -36.31 74.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.955 179.115 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.61 -25.16 49.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.452 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.53 16.38 26.53 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.32 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.616 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -87.38 16.3 5.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.241 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.35 -98.32 0.82 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.063 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 8.5 p -136.4 -90.38 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.5 tp -83.37 88.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 109.875 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.616 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 9.2 p -104.14 139.6 24.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.87 103.06 15.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB2' ' CG2' ' A' ' 6' ' ' ILE . 12.2 mt -90.96 141.17 29.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.442 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.85 138.48 38.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.92 167.86 20.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.407 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -114.61 138.12 51.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.47 115.06 9.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.937 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 3.9 mtm . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.86 0.362 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.19 147.85 26.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 89' ' ' MET . 78.1 m-85 -110.98 148.09 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.892 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -138.32 167.24 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HG3' ' CD1' ' A' ' 87' ' ' TYR . 5.6 tt0 -121.18 144.64 48.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.13 109.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.866 0.365 . . . . 0.0 111.739 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -82.02 112.19 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.9 tp -121.68 127.31 50.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.9 pt-20 -83.83 100.54 11.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.07 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.72 89.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.078 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.59 175.87 0.1 Allowed Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.556 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -54.94 -24.09 22.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 111.09 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.21 -24.82 15.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.111 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.66 -163.76 28.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.187 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.5 tp -66.77 -63.54 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.618 0.209 . . . . 0.0 110.731 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.28 22.05 1.01 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 119.745 -1.216 . . . . 0.0 114.809 178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.75 ' HB3' HG22 ' A' ' 39' ' ' ILE . 10.5 p90 -161.4 136.51 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.035 0.918 . . . . 0.0 111.143 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.42 135.22 38.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.656 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.719 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -115.44 146.93 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.628 0.728 . . . . 0.0 111.367 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -128.83 124.07 34.41 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.706 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 25' ' ' ASN . . . 159.85 -121.81 1.07 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.074 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 69.54 172.22 9.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.361 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 68' ' ' VAL . 4.3 p -77.85 -5.55 51.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.17 -23.14 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.516 ' O ' ' O ' ' A' ' 21' ' ' GLY . 2.6 t-20 -124.91 85.96 56.95 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.488 0.185 . . . . 0.0 110.57 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.153 1.902 . . . . 0.0 112.425 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.733 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.1 t60 -53.8 -24.36 15.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.053 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.649 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.79 -153.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.337 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -65.35 -47.62 77.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.757 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.19 79.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 110.676 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -172.75 164.01 3.69 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.67 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.7 50.94 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.503 2.135 . . . . 0.0 112.174 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -99.28 116.65 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -89.99 112.49 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.459 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.733 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -137.31 146.76 45.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.125 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.719 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.05 155.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.169 -176.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.481 HG22 ' HB1' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.52 -30.36 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.04 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.12 131.04 0.48 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.031 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.75 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.88 132.8 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 115.26 59.32 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.3 Cg_exo -57.19 134.45 64.19 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.824 2.349 . . . . 0.0 112.201 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.25 4.02 59.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.642 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.55 179.39 22.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.801 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -55.66 -37.61 68.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -67.35 -57.45 6.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.56 -28.84 68.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.296 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.35 68.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 110.001 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -82.86 -58.02 3.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 40.88 9.22 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.539 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.485 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER -115.6 6.98 14.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.94 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.7 tp -135.24 154.76 51.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.993 0.425 . . . . 0.0 110.843 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.09 137.07 47.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.7 t -51.6 159.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.138 0.494 . . . . 0.0 111.716 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.485 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 m120 71.95 3.68 4.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.32 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.7 m-20 -74.63 128.37 35.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.85 105.25 16.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.564 0.697 . . . . 0.0 111.388 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' ILE . 68.5 mt -51.09 141.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.602 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -121.61 -44.31 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.496 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -143.18 148.61 36.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.335 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 54.5 t -139.54 112.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.026 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 50.81 35.8 13.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.129 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 80.23 33.94 0.16 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.501 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 78.1 t -120.93 108.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 t0 -71.26 117.18 12.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.713 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.8 m -101.89 23.45 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.301 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -62.84 -25.52 68.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -146.07 57.4 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.181 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.454 ' N ' HG22 ' A' ' 23' ' ' THR . 31.8 m -132.79 141.83 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.231 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.68 152.35 26.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.84 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 20.1 t-160 -47.99 -34.02 8.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.883 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -34.24 77.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.66 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.27 -40.62 77.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -64.0 -46.93 82.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.9 t -56.09 -50.86 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.391 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.76 -29.29 62.45 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.153 178.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.11 -56.72 18.18 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.359 0.6 . . . . 0.0 110.044 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.544 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 2.0 mp -53.86 -36.4 62.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.662 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.34 -27.29 52.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.659 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.417 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.26 15.67 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.0 111.47 -178.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.58 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -86.81 16.32 4.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.316 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.03 -89.33 0.13 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.384 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.501 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -143.44 -88.87 0.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.569 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 4.2 tp -84.4 91.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.58 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 9.4 p -107.06 135.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.1 ptt180 -86.81 102.96 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.48 ' HB2' HG23 ' A' ' 6' ' ' ILE . 12.8 mt -91.63 143.56 26.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.083 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.412 ' CD1' ' HG3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -101.68 139.71 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.523 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 28.9 m -139.62 167.93 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.805 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.419 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 38.1 ttp -111.49 159.9 17.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.104 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 130.03 24.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.411 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.056 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttm . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.834 0.349 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -88.38 150.86 22.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.969 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 36.1 m-85 -105.83 150.07 25.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.795 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 133.31 21.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -97.17 144.61 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.474 HG23 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -139.0 109.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.863 0.364 . . . . 0.0 111.833 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -79.83 114.55 18.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 tp -120.78 127.05 51.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.819 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.8 pt-20 -80.59 99.92 8.36 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' NE ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -56.44 88.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.901 178.11 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.1 171.63 21.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.225 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 54.56 -89.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.64 0.257 . . . . 0.0 110.817 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.9 t -108.35 20.88 18.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.106 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.531 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 107.89 -138.77 14.77 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.086 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.5 tp -73.74 -63.7 1.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.003 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.6 25.19 1.3 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.849 178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.751 ' HB3' HG22 ' A' ' 39' ' ' ILE . 4.5 p90 -161.82 134.75 6.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.854 0.827 . . . . 0.0 111.256 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.444 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.67 134.16 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -110.96 168.26 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.686 0.755 . . . . 0.0 111.677 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -165.43 132.2 2.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.319 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.452 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.4 0.54 1.16 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.545 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.551 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.015 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 68' ' ' VAL . 16.6 p -74.42 -22.45 59.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -97.18 -23.76 16.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.693 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.32 87.7 53.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.365 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.84 63.16 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.339 2.026 . . . . 0.0 112.742 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.718 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.0 t60 -47.53 -28.47 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.638 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.85 -155.1 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.239 179.46 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.47 -47.49 56.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.597 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t0 177.23 76.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.818 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.37 165.26 7.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.861 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.12 6.68 5.42 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.657 2.238 . . . . 0.0 112.79 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.39 112.17 1.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -82.52 119.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.585 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.718 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.44 146.0 34.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.522 0.677 . . . . 0.0 110.668 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.79 155.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.415 -176.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.21 -30.46 4.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.347 -178.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.45 132.21 0.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.051 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.751 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.88 132.0 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.432 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.3 118.12 70.41 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.8 Cg_exo -58.01 135.29 67.72 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.363 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.1 3.02 62.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.845 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.77 178.49 23.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.057 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -55.58 -34.62 64.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.011 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HA ' HD23 ' A' ' 8' ' ' LEU . . . -71.82 -56.92 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.679 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.19 -30.28 70.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.94 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -72.06 -33.45 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -57.93 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.71 9.16 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.614 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.455 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.2 mtp85 -113.27 8.12 17.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.804 0.335 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.565 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -136.65 154.73 50.56 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.053 0.454 . . . . 0.0 110.816 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.565 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 tpm_? -131.76 136.3 47.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.56 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -51.58 157.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 111.564 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.2 t30 74.07 3.15 4.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.177 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -73.73 127.0 31.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.42 100.97 12.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.659 0.743 . . . . 0.0 111.296 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' ILE . 62.5 mt -46.24 149.51 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.813 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.439 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -127.62 -45.71 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.387 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -143.03 157.78 44.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.081 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 62' ' ' GLU . 41.7 t -132.55 95.73 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.873 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.42 ' HB2' HG23 ' A' ' 84' ' ' VAL . 2.9 t-20 68.85 -66.93 0.23 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.166 0.508 . . . . 0.0 109.896 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -155.59 32.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.654 179.171 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 86.4 t -120.7 142.2 37.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.512 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 24.5 t0 -107.86 112.15 24.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.424 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 23.8 m -94.18 36.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 111.513 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -65.07 -31.54 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.721 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.28 68.09 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.423 ' N ' HG21 ' A' ' 23' ' ' THR . 27.0 m -137.62 145.05 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.281 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.2 150.56 34.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.757 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.551 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.7 t-160 -48.1 -33.78 8.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.75 -34.1 76.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.027 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.67 -39.91 80.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -65.82 -46.92 76.81 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.646 0.736 . . . . 0.0 109.081 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 97.2 t -57.2 -50.55 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.206 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.57 -30.48 60.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.953 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.482 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.63 -50.57 72.97 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.41 0.624 . . . . 0.0 110.018 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.1 mt -58.55 -37.17 75.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.045 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -26.41 50.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.505 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.43 18.89 20.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 0.0 111.306 -178.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.584 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -87.77 16.25 6.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.531 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.31 -86.69 0.41 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.635 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' LEU . 38.1 m -147.67 -90.87 0.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.4 tp -84.17 90.68 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.452 0.644 . . . . 0.0 109.743 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.584 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 7.8 p -105.92 135.06 45.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.294 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.6 ttt180 -85.21 102.89 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 15.3 mt -92.05 140.9 29.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.969 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.55 141.18 34.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.713 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.1 m -135.6 167.03 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.581 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.43 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -115.55 145.31 42.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.929 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.82 134.63 32.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.983 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.907 0.384 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -107.87 120.23 41.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 4.6 m-30 -85.46 144.32 28.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -151.18 146.15 25.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.8 pt-20 -100.74 144.57 29.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.45 110.0 9.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.895 0.379 . . . . 0.0 111.521 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.43 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -76.92 121.48 23.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.603 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.4 tp -134.22 127.1 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.1 pt-20 -85.89 100.88 12.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.344 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.441 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 8.0 mtp-105 -44.94 92.37 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.22 0.533 . . . . 0.0 110.897 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -60.64 73.36 0.01 OUTLIER Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.13 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER 64.15 -71.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.713 0.292 . . . . 0.0 111.586 179.539 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -74.97 -21.15 59.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.469 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . 150.87 -173.19 30.45 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.93 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.603 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 11.3 mt -58.31 -63.57 1.22 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.84 0.353 . . . . 0.0 110.793 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.77 39.17 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.086 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.767 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.9 p90 -162.51 132.38 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.345 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -92.48 137.29 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.134 0.492 . . . . 0.0 111.724 -179.046 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -120.3 142.11 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.661 0.744 . . . . 0.0 111.95 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.606 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -106.06 117.2 33.41 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 34' ' ' ILE . . . -71.21 -158.72 3.09 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.44 -44.09 0.12 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.734 -0.746 . . . . 0.0 114.571 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.754 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -69.02 -58.9 3.47 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.67 -34.2 30.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.09 0.471 . . . . 0.0 110.52 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' HIS . 11.1 t-20 -124.44 87.7 53.92 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.248 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.75 64.98 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.288 1.992 . . . . 0.0 112.538 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.76 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.3 t60 -57.53 -21.82 40.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.724 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.692 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -96.61 -150.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.459 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -85.19 44.22 3.35 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.885 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 76.18 30.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.961 0.41 . . . . 0.0 110.738 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.47 146.92 38.56 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.9 55.27 3.84 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.52 2.146 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -121.01 108.88 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.581 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 2.7 mp -79.49 131.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.76 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.0 OUTLIER -142.89 152.82 42.5 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.213 0.53 . . . . 0.0 110.27 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -69.41 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.553 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.432 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -123.08 -26.12 4.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.978 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -176.53 131.73 0.21 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.868 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.767 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.49 130.37 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.446 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.36 114.16 53.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.1 Cg_exo -56.22 139.96 86.8 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.599 2.199 . . . . 0.0 112.205 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.2 15.24 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.522 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.55 174.69 16.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.986 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -30.64 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.251 . . . . 0.0 111.129 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -72.94 -57.52 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 111.823 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.66 -28.58 63.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.535 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -72.02 -30.84 65.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 110.382 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.53 -57.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.16 37.0 10.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.711 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.95 4.57 11.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.821 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.587 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 16.3 tp -132.73 159.81 38.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.218 0.532 . . . . 0.0 111.173 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -139.44 152.77 47.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 77.8 t -65.75 158.9 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.054 0.454 . . . . 0.0 111.271 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 55.3 m-80 77.27 -6.35 2.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.714 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -64.44 125.86 25.99 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.87 104.39 16.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.611 0.719 . . . . 0.0 111.773 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.498 ' CD1' HG21 ' A' ' 34' ' ' ILE . 46.1 mt -48.2 138.89 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.794 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 HD13 ' CG ' ' A' ' 3' ' ' TYR . 1.1 mt -126.4 -37.75 2.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.471 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -147.17 156.67 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.405 ' CG1' ' CD2' ' A' ' 86' ' ' LEU . 47.8 t -141.21 102.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.232 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.95 -68.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.098 0.475 . . . . 0.0 110.247 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.86 31.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.929 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.8 t -120.79 142.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.281 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.8 p-10 -101.65 108.18 19.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 ' CG2' ' CG2' ' A' ' 57' ' ' ILE . 26.7 m -97.26 30.72 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.311 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.53 -37.45 75.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 110.725 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.25 56.32 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.505 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 23' ' ' THR . 33.6 m -114.59 141.03 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.159 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.754 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 1.8 p -51.06 150.16 3.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.223 0.535 . . . . 0.0 112.0 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.563 ' HA ' ' HA3' ' A' ' 21' ' ' GLY . 0.4 OUTLIER -47.09 -32.99 4.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.527 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 3.6 m -73.81 -33.31 64.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.387 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.632 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.79 -32.12 70.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.042 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.55 -46.89 58.2 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.636 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 94.0 t -60.29 -50.66 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.733 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.7 pt-20 -58.31 -31.48 67.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.497 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -58.39 -49.26 77.9 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.308 0.575 . . . . 0.0 109.795 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 1.5 mt -61.25 -34.67 75.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.186 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.14 -29.06 54.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.512 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.7 pt-20 -98.79 15.39 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.525 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.652 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -88.57 16.3 6.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.35 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.21 -114.76 6.57 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.078 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.424 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.9 OUTLIER -113.59 -88.87 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.1 tp -86.72 100.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.122 0.487 . . . . 0.0 110.113 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.652 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -114.96 139.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.3 103.02 15.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.483 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 15.2 mt -91.84 137.22 32.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.511 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.87 131.56 48.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 2.5 m -139.72 152.45 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.134 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.425 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 25.5 ptt? -118.23 149.53 40.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.12 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -140.5 125.16 18.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.087 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -107.07 118.47 36.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 3.0 m-30 -96.6 107.45 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.575 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -115.16 165.02 13.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 111.251 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -120.0 145.01 47.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.836 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.511 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -134.15 110.98 14.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 111.931 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.435 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.35 117.15 20.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.1 tp -128.28 126.83 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.0 pt-20 -85.24 100.45 11.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.537 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.0 88.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.15 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.99 176.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.703 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -55.12 -24.03 23.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 111.099 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.7 p -97.06 -24.78 15.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.273 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.25 -163.25 28.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.164 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.55 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.2 tp -66.47 -63.39 1.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.698 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.77 21.95 0.97 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.65 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.743 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.8 p90 -161.42 137.46 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.736 0.768 . . . . 0.0 111.055 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.44 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.04 133.21 40.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.38 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -110.03 165.06 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.657 0.741 . . . . 0.0 111.76 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -162.64 132.11 4.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.262 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.84 0.66 0.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.42 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.15 -170.7 0.34 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.859 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.462 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 23.9 p -69.81 -32.62 71.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.79 -19.72 23.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.14 86.79 53.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.633 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.59 60.2 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.292 1.995 . . . . 0.0 112.547 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.675 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.8 t60 -47.8 -28.71 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.145 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.23 -153.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.14 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.438 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -66.29 -47.83 68.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.413 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.32 46.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.349 . . . . 0.0 110.835 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.97 161.74 61.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.03 -2.78 12.54 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.864 2.376 . . . . 0.0 112.689 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -49.16 113.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.929 0.395 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -85.7 119.19 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.46 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.675 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.46 146.45 34.8 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.526 0.679 . . . . 0.0 110.794 178.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.747 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.92 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.954 -176.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.443 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.19 -28.68 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.337 -178.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.56 129.64 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.071 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.743 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.49 133.05 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.33 129.95 55.93 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 56.0 Cg_endo -70.0 130.24 18.71 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.784 2.323 . . . . 0.0 112.304 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 2.65 55.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.64 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.49 179.23 24.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.078 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . . . -56.79 -35.48 68.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 111.065 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -71.9 -56.75 5.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.82 -31.89 72.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.93 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.1 pt20 -72.11 -33.73 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 110.159 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.43 -57.91 3.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.01 41.27 9.65 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.627 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.494 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -113.31 7.02 17.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.947 0.403 . . . . 0.0 110.795 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.3 tp -135.97 154.16 51.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.564 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.37 135.54 48.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.551 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -49.7 157.95 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.556 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.4 t30 75.05 2.18 3.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -70.45 123.37 21.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.53 100.42 12.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.889 0.852 . . . . 0.0 111.54 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 34' ' ' ILE . 20.0 mt -49.18 142.79 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.392 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD21 ' CZ ' ' A' ' 3' ' ' TYR . 1.4 mt -124.54 -37.84 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.069 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 m-85 -143.8 164.3 30.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -151.54 103.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.264 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.26 42.46 31.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.86 32.68 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.599 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 88.9 t -120.92 112.75 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.417 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 t0 -80.8 110.43 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 33.4 m -83.09 55.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.8 105.67 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.12 48.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 11.8 m -116.1 142.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.977 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.462 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -61.29 152.01 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.505 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.2 t-160 -49.6 -33.76 16.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.211 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.761 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.596 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.64 -43.22 80.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -63.89 -46.88 82.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.569 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 94.0 t -57.48 -48.45 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.285 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.596 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.88 -31.74 63.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.764 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.511 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -59.8 -53.11 61.83 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.211 0.529 . . . . 0.0 109.797 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.44 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.2 mt -52.49 -37.44 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.262 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.57 -27.8 51.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.082 178.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.2 mm-40 -84.08 -19.97 33.41 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 110.602 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB1' HG22 ' A' ' 84' ' ' VAL . . . -53.03 -18.81 2.24 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.628 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.78 -92.75 1.83 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.8 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -129.99 -92.34 0.44 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.8 tp -86.59 100.97 10.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.178 0.513 . . . . 0.0 110.442 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.62 HG22 ' HB1' ' A' ' 80' ' ' ALA . 7.4 p -116.06 138.77 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 102.87 14.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.511 ' HB2' HG22 ' A' ' 6' ' ' ILE . 12.2 mt -93.37 135.59 34.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.57 135.46 43.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.743 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.65 159.77 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.808 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.441 ' HB3' ' CE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -121.51 137.69 54.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 111.033 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.76 134.92 34.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.955 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HB2' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.806 0.336 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -99.69 128.94 45.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.064 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CE1' ' HG2' ' A' ' 89' ' ' MET . 11.2 m-30 -90.38 150.5 21.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.9 mm-40 -145.13 168.29 20.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 0.0 111.287 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -118.05 144.79 45.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.5 HG21 HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -133.88 110.53 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 111.653 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.48 120.5 22.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.614 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.2 tp -132.58 127.45 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.0 pt-20 -86.56 100.88 12.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.588 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 2.6 mtp-105 -42.76 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.994 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.27 73.53 0.02 OUTLIER Glycine 0 C--N 1.318 -0.418 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.061 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.9 OUTLIER 63.2 -75.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 0.0 111.342 179.684 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 11' ' ' GLY . 29.0 t -70.05 -24.65 63.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.376 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 153.57 -172.63 32.37 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.801 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.614 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 10.5 mt -59.46 -63.59 1.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.645 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . 135.34 39.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.598 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.755 ' HB3' HG22 ' A' ' 39' ' ' ILE . 7.4 p90 -161.69 133.85 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.483 . . . . 0.0 111.161 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.08 134.62 34.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.287 -179.489 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -112.93 162.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.675 0.75 . . . . 0.0 111.731 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -158.76 131.76 7.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.046 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.51 -1.3 0.98 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.504 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.14 -168.93 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.94 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.2 p -77.09 -23.49 51.86 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -94.87 -25.32 16.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.329 . . . . 0.0 111.557 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 27' ' ' HIS . 23.6 m-80 -124.65 82.82 59.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.6 64.24 0.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.912 2.408 . . . . 0.0 112.66 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.746 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.4 t60 -50.68 -24.27 3.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.374 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.713 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.12 -154.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.762 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -80.1 52.48 4.27 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.733 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 74.76 30.53 0.99 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.08 147.76 40.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.073 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -70.76 -2.71 11.33 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.812 2.342 . . . . 0.0 112.88 -179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -53.99 116.55 2.62 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.035 0.445 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.518 HD11 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.84 120.19 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.375 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.746 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.52 144.93 33.17 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.456 0.646 . . . . 0.0 110.642 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.78 155.68 7.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.307 -176.529 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.486 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.67 -33.79 4.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.846 -178.905 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.52 142.49 2.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.517 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.755 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.19 132.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.321 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.96 125.17 73.54 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 46.2 Cg_endo -68.15 131.94 24.86 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.784 2.322 . . . . 0.0 112.413 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.04 27.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.27 178.96 16.37 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.203 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.459 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . . . -52.35 -38.86 59.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.732 0.301 . . . . 0.0 111.461 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HB1' ' CG2' ' A' ' 39' ' ' ILE . . . -67.98 -57.11 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.43 -30.32 65.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -72.08 -30.59 65.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.948 0.404 . . . . 0.0 110.354 179.67 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 -58.03 3.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.514 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.92 9.62 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.527 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.49 ' CB ' HG12 ' A' ' 6' ' ' ILE . 23.8 mtm180 -115.75 -3.99 12.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.808 0.304 . . . . 0.0 110.944 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.1 tp -122.57 153.94 38.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.883 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.562 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -131.8 135.86 47.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.865 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.41 158.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.307 0.575 . . . . 0.0 111.725 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.27 1.87 3.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.028 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -70.06 124.85 25.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.41 101.06 12.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.16 -178.694 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 34' ' ' ILE . 55.8 mt -49.44 129.68 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.703 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.433 HD13 ' CG ' ' A' ' 3' ' ' TYR . 7.9 mt -110.75 -31.7 7.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -151.05 166.42 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 t -148.91 100.45 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.219 179.418 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.411 ' CB ' HG23 ' A' ' 84' ' ' VAL . 14.0 t30 67.58 -67.31 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 110.065 -178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -157.92 32.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.711 179.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 49.5 t -119.57 142.21 36.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.529 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 30.1 t0 -111.65 84.96 2.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.362 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 32.6 m -69.39 64.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.55 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -87.03 -28.09 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -151.31 59.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.5 m -127.78 145.38 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.261 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 150.66 27.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.526 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 2.4 t-160 -48.29 -33.42 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -68.22 -34.04 75.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.072 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.11 -40.87 82.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.518 ' HB1' HD11 ' A' ' 34' ' ' ILE . . . -64.26 -46.84 81.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.021 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 89.0 t -57.74 -50.31 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.308 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -56.16 -34.31 66.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.647 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.458 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -56.58 -51.38 68.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.241 0.543 . . . . 0.0 110.109 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.426 ' CD1' HD13 ' A' ' 19' ' ' ILE . 2.9 mt -56.22 -36.43 68.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.416 179.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.2 mmmt -77.47 -24.62 50.18 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.33 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -95.81 -10.11 29.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 111.327 -178.858 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.611 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -57.81 -17.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.387 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.98 -109.76 3.74 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.8 m -118.84 -90.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.808 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.575 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.9 tp -89.21 89.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.257 0.551 . . . . 0.0 109.735 178.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.611 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -103.54 140.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -87.73 102.98 15.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.083 177.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.431 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 13.2 mt -91.89 137.67 32.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.109 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.68 134.39 44.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.091 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.7 167.94 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.154 -179.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.439 ' HG2' ' CE1' ' A' ' 3' ' ' TYR . 27.6 mtm -98.32 134.46 41.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.653 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.27 106.77 11.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.503 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.291 -0.862 . . . . 0.0 110.774 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.836 0.351 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.42 113.92 13.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.451 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.3 m-30 -82.11 121.15 26.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.954 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -132.65 160.61 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -107.37 144.67 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -135.04 109.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.91 0.386 . . . . 0.0 111.507 179.796 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.22 119.08 20.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.5 tp -130.81 127.33 38.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -86.68 99.41 11.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.647 179.443 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -54.49 92.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.868 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 13' ' ' SER . . . -65.6 59.89 0.12 Allowed Glycine 0 C--O 1.229 -0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 114.597 -177.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 64.04 -58.87 0.21 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.892 0.346 . . . . 0.0 111.777 178.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 11' ' ' GLY . 69.8 m -69.31 -25.04 64.03 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.923 -179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . 147.89 171.87 17.34 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.326 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 6.1 tp -65.6 -14.49 61.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.361 -0.419 . . . . 0.0 111.021 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 81.7 25.0 54.76 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.77 ' HB3' HG22 ' A' ' 39' ' ' ILE . 8.0 p90 -161.75 132.23 4.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.424 1.112 . . . . 0.0 111.857 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.53 138.75 32.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.83 -179.302 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.52 147.12 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.608 0.718 . . . . 0.0 111.939 179.756 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.491 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 134.4 31.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.183 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.463 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.9 -3.12 1.49 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.631 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.568 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.78 -176.19 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.045 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 43.1 p -66.81 -30.33 70.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -93.56 -18.33 22.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 87.0 54.06 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.08 61.13 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.329 2.019 . . . . 0.0 112.606 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 30.7 t60 -48.34 -28.32 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.04 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.611 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -85.47 -154.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.218 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.44 -49.82 48.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.439 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -178.44 47.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.383 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.66 160.89 64.8 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.142 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.51 2.46 8.09 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 112.749 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -53.49 117.31 3.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.004 0.43 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.512 HD12 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.69 118.51 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.71 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.715 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.25 147.51 40.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.362 0.601 . . . . 0.0 110.599 178.453 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.06 155.5 7.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.8 -176.796 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.07 -33.71 3.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.528 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 142.29 2.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.063 0.458 . . . . 0.0 111.679 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.77 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.23 128.62 60.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.625 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 127.54 66.41 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 19.4 Cg_endo -60.2 137.99 78.61 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.759 2.306 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.65 -0.46 82.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.454 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.71 -179.99 38.82 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.084 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -55.26 -40.5 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.518 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . -73.05 -54.99 7.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.468 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -63.94 -28.96 70.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.283 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -72.35 -36.54 68.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.005 0.431 . . . . 0.0 110.069 179.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -57.93 2.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.07 39.27 8.06 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.751 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.472 ' CB ' HG12 ' A' ' 6' ' ' ILE . 69.6 mtt-85 -112.98 8.5 18.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.906 0.353 . . . . 0.0 110.711 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.543 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.2 tp -133.02 153.72 51.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.543 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.1 137.75 49.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.836 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -51.65 157.88 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 111.732 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.475 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.5 t-20 76.92 -2.4 2.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.491 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -67.04 124.89 24.3 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.043 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 t -86.63 100.37 12.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.572 0.701 . . . . 0.0 111.129 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 34' ' ' ILE . 59.9 mt -49.15 140.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.899 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.437 HD23 ' CD2' ' A' ' 3' ' ' TYR . 2.6 mp -121.71 -32.36 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.552 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -150.86 164.23 36.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.791 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.9 t -141.92 97.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 t30 69.6 -65.84 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.111 0.482 . . . . 0.0 109.875 -178.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 32.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.709 179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.5 t -120.78 142.25 37.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.579 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -103.97 110.8 23.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.26 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.414 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 20.2 m -94.43 34.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -25.63 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.877 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -146.21 60.68 1.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.036 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.408 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 26.8 m -133.48 150.06 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.182 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -69.18 154.51 41.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.341 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.568 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 2.6 t-160 -49.85 -34.49 20.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 t -70.32 -34.02 72.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.658 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.24 -41.58 80.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -63.62 -46.67 84.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 95.7 t -57.54 -50.45 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.0 -29.86 60.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.966 178.55 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.94 -51.23 68.96 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.023 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.3 mt -55.89 -37.59 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.452 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.56 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.39 -25.13 50.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.913 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -91.8 3.01 56.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.174 -179.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.672 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -89.14 16.55 7.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.04 -124.91 35.11 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.728 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 m -100.45 -88.4 0.36 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.7 tp -83.06 111.52 19.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.672 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 9.7 p -130.21 137.7 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 24.4 mtt180 -84.93 103.12 13.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' HB2' HG21 ' A' ' 6' ' ' ILE . 12.5 mt -91.91 141.2 28.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -101.67 128.13 48.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.648 179.985 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.3 m -139.78 158.68 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.414 ' CG ' ' HB3' ' A' ' 56' ' ' SER . 15.3 ptp -121.45 132.81 54.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.875 0.369 . . . . 0.0 111.114 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -140.57 135.87 32.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.983 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.658 0.266 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -122.07 141.9 50.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.369 . . . . 0.0 111.033 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.464 ' CD1' HD21 ' A' ' 58' ' ' LEU . 7.3 m-30 -106.73 121.29 44.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.682 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.43 151.8 37.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -102.84 144.71 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -135.69 109.36 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.405 179.873 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.68 121.23 23.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.133 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 tp -131.24 127.23 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.3 pt-20 -86.73 100.29 12.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.261 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.453 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 22.7 mtp85 -41.18 91.45 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.145 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -61.69 76.58 0.02 OUTLIER Glycine 0 C--N 1.317 -0.474 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.921 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 10' ' ' ARG . 1.4 m-80 63.29 -76.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.318 . . . . 0.0 111.168 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -70.09 -19.69 63.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.403 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.428 ' HA2' ' NH1' ' A' ' 10' ' ' ARG . . . 145.78 -173.4 26.15 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.95 -179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.558 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 17.9 mt -51.85 -63.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.983 0.421 . . . . 0.0 110.885 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.96 36.75 0.27 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.403 -0.904 . . . . 0.0 113.162 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.744 ' HB3' HG22 ' A' ' 39' ' ' ILE . 11.8 p90 -163.27 134.19 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.039 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.443 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.26 137.15 32.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.622 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.39 150.1 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.691 0.758 . . . . 0.0 112.02 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB2' ' CG ' ' A' ' 27' ' ' HIS . . . -143.64 132.85 23.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.971 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.96 0.88 0.74 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.871 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.48 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.74 -177.82 0.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.671 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.416 ' CG2' ' HB3' ' A' ' 32' ' ' PRO . 16.0 p -72.0 -21.55 61.54 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.01 -24.22 17.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.723 0.296 . . . . 0.0 111.501 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -124.36 87.3 54.13 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.59 65.03 0.54 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.292 1.994 . . . . 0.0 112.446 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.728 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 31.1 t60 -48.44 -27.88 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.469 179.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.62 -154.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.449 179.597 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.21 -47.82 56.44 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.664 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 t70 179.97 47.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.41 157.29 76.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.416 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 6.1 Cg_exo -77.77 0.6 9.67 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.833 2.355 . . . . 0.0 112.693 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -53.32 120.57 6.19 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.124 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -85.61 120.19 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.339 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.728 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.66 146.75 36.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.346 0.593 . . . . 0.0 110.681 178.89 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.96 155.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.977 -176.774 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.48 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.89 -34.38 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.617 -179.175 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.07 143.5 3.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.5 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.744 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.83 131.77 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.292 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 120.74 75.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.883 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -63.01 137.09 60.17 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.667 2.244 . . . . 0.0 112.279 -179.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.99 14.85 50.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.372 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.09 177.14 16.34 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.14 -31.2 61.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 39' ' ' ILE . . . -73.14 -57.4 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.611 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.91 -28.92 64.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.396 -179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.04 -32.63 67.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -81.53 -58.04 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.692 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.86 39.89 9.16 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.482 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.423 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.3 mmt180 -116.11 1.57 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.552 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -129.56 154.92 46.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.128 0.489 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.552 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.2 ttt180 -133.43 136.02 44.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.686 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 56.0 t -49.88 157.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.589 . . . . 0.0 111.747 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.2 t-20 75.65 -1.75 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -66.11 125.01 24.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.907 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.5 103.31 14.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.533 0.682 . . . . 0.0 111.305 -178.76 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 34' ' ' ILE . 51.3 mt -53.13 134.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.213 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.464 HD21 ' CD1' ' A' ' 3' ' ' TYR . 1.5 pp -134.79 13.56 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.884 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 169.98 138.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.169 0.509 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.406 HG22 ' CD2' ' A' ' 77' ' ' LEU . 21.5 t -127.39 97.36 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.611 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.43 ' HB2' HG21 ' A' ' 84' ' ' VAL . 1.7 t-20 70.95 -62.81 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -163.35 31.62 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.0 t -120.92 117.34 52.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -82.36 109.55 16.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.585 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -93.79 41.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.284 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -64.58 -35.52 81.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.835 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.11 71.67 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.541 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 9.3 m -136.49 142.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.44 156.23 10.7 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.313 0.578 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.48 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 1.9 p-80 -49.74 -34.1 18.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.635 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -69.76 -33.64 72.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.828 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.541 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -65.48 -45.05 85.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.29 0.567 . . . . 0.0 109.631 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.441 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -63.02 -45.67 91.23 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.512 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 78.9 t -56.3 -50.36 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.033 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.605 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.52 -34.66 37.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.787 179.569 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.553 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.39 -57.37 5.99 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.323 -0.551 . . . . 0.0 112.074 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.45 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 1.6 mt -60.32 -40.97 92.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.577 . . . . 0.0 110.237 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.605 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.75 -19.74 57.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.8 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -111.33 20.47 17.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.302 179.373 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -83.6 16.47 2.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.701 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.32 -101.87 0.87 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.4 m -123.7 -90.73 0.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.2 tp -86.88 109.93 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.872 0.368 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 10.3 p -124.28 137.25 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 11.6 mtt180 -85.94 103.58 14.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.909 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.459 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 17.4 mt -93.63 135.45 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.489 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.77 126.77 48.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.251 179.472 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.1 m -128.41 166.07 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.975 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.45 ' HG2' ' CE1' ' A' ' 3' ' ' TYR . 30.3 mtt -96.55 146.76 24.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.92 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.37 106.54 5.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.043 -179.729 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.814 0.34 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.86 117.73 22.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.458 ' CG ' HD23 ' A' ' 58' ' ' LEU . 3.5 m-30 -82.12 132.27 35.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -143.39 141.15 30.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 2.8 pt-20 -99.84 144.65 28.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.482 HG23 HD11 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -138.81 109.46 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.028 0.442 . . . . 0.0 111.362 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.23 119.46 22.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.858 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 tp -127.63 126.79 42.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.6 pt-20 -84.97 100.57 11.73 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.306 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.86 88.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.226 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.01 177.76 0.05 OUTLIER Glycine 0 CA--C 1.517 0.218 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.659 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -55.47 -23.71 27.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.704 0.287 . . . . 0.0 111.165 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.95 -24.74 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.126 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.6 -163.24 28.24 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.09 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.2 tp -65.58 -63.34 1.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.561 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 131.88 19.36 1.15 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.572 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.751 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.6 p90 -162.04 134.52 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.816 0.808 . . . . 0.0 111.259 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.76 138.63 31.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.498 -179.336 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.25 147.25 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.672 0.748 . . . . 0.0 112.091 -179.923 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB2' ' CG ' ' A' ' 27' ' ' HIS . . . -141.12 132.3 26.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.062 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.24 -3.13 0.87 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.676 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.495 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.81 179.73 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.764 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.3 p -70.92 -20.06 62.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.84 -23.94 16.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.245 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -124.39 87.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.188 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 64.53 0.55 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.402 2.068 . . . . 0.0 112.649 -179.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 30.0 t60 -49.93 -27.34 5.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.243 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.626 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.91 -154.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.369 179.597 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -66.77 -47.32 68.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.659 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 177.52 46.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.29 159.86 70.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.51 1.66 8.83 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.665 2.244 . . . . 0.0 112.8 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.65 118.25 4.04 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.008 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -84.83 121.03 36.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.476 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.715 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.23 147.68 38.68 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.334 0.588 . . . . 0.0 110.808 178.529 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.01 155.45 7.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.757 -176.892 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.479 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.49 -33.55 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.612 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.85 142.11 1.86 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.627 -179.743 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.751 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -103.86 132.2 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.209 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.93 114.23 52.78 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.647 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.0 Cg_exo -56.36 139.03 85.9 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.723 2.282 . . . . 0.0 112.241 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 8.53 64.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.433 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.31 176.23 17.7 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.79 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.31 -36.35 61.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 111.199 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -67.81 -57.49 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.576 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.19 -28.91 66.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.325 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.93 -33.14 68.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -82.1 -57.98 3.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.77 40.74 9.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.552 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.4 mtp180 -117.74 8.21 12.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.811 0.339 . . . . 0.0 110.843 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.4 tp -133.49 155.35 49.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.058 0.456 . . . . 0.0 110.804 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.68 136.1 44.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.757 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.2 t -51.77 157.79 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.533 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.3 -2.03 2.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.361 179.775 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -67.66 124.91 24.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.56 101.68 13.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.574 0.702 . . . . 0.0 111.424 -178.608 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.497 ' N ' ' O ' ' A' ' 34' ' ' ILE . 50.1 mt -51.59 133.43 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.661 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.1 pp -123.5 -19.48 5.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.781 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -159.49 147.76 17.58 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 111.027 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 62' ' ' GLU . 38.8 t -130.22 99.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.033 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' A' ' 84' ' ' VAL . 1.5 t-20 67.65 -67.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.0 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.3 29.56 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.94 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 84.5 t -117.99 141.96 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.212 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.6 p30 -104.86 109.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.475 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -96.7 32.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.52 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -62.42 -32.17 72.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.91 66.0 1.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.491 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 8.8 m -133.51 144.48 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.75 154.04 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.954 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.495 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 12.1 t-160 -49.61 -33.78 16.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.4 m -66.68 -33.92 76.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.65 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.582 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.0 -41.56 82.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 34' ' ' ILE . . . -65.13 -46.22 81.86 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.525 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 58.4 t -56.61 -50.42 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.022 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.587 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -52.12 -34.35 43.97 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.853 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.42 -57.53 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.927 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.454 HD12 ' CE1' ' A' ' 17' ' ' PHE . 1.5 mt -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.345 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.06 -20.32 55.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.048 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.576 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.5 pt-20 -110.43 21.36 16.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.519 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -83.93 16.57 2.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.778 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.8 0.28 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.862 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -137.87 -91.18 0.22 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.547 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.0 tp -84.8 101.96 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.519 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -117.53 135.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.827 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.5 mtp180 -86.55 103.44 15.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.81 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.45 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 25.6 mt -94.06 133.59 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.295 -179.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.471 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.01 123.56 46.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.287 179.632 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.4 m -126.33 151.79 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.62 -179.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.454 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 2.4 ptt? -122.73 135.31 54.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.829 0.347 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -128.0 120.6 27.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ttm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.75 0.309 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.69 160.0 21.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 26.5 m-85 -115.46 153.09 31.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -147.77 136.98 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.46 144.64 26.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.63 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.488 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -137.64 109.56 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.644 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.41 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 120.04 21.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.569 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 tp -130.82 126.86 37.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.006 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -84.49 99.73 10.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.039 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.62 87.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 179.155 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -55.23 179.61 0.29 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.65 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -53.73 -27.16 26.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.838 0.351 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.4 p -88.51 -24.88 22.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.04 -165.92 23.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.346 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.476 HD21 ' CE2' ' A' ' 17' ' ' PHE . 5.8 tp -69.12 -13.19 62.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.336 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 72.17 31.0 64.38 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.738 ' HB3' HG22 ' A' ' 39' ' ' ILE . 4.7 p90 -164.5 129.74 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.075 0.937 . . . . 0.0 111.574 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -96.1 140.2 31.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.937 -179.116 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -120.19 147.03 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.763 0.792 . . . . 0.0 112.221 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -139.77 133.43 30.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.044 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.75 3.29 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.724 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.513 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.68 -177.87 1.37 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.658 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 25.2 p -67.25 -28.87 68.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -92.74 -19.59 21.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.614 0.245 . . . . 0.0 111.369 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -124.15 87.0 53.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.8 61.7 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.385 2.057 . . . . 0.0 112.795 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.729 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 50.4 t60 -49.78 -27.6 5.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.949 178.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.705 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.2 -152.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.355 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.24 52.54 4.53 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.733 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 74.6 32.07 0.92 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.927 0.394 . . . . 0.0 110.462 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.09 149.64 45.97 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.25 -4.47 15.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.753 2.302 . . . . 0.0 112.615 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.0 m -52.21 115.98 1.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 111.287 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -83.75 120.14 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.729 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.15 147.14 36.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.253 0.549 . . . . 0.0 110.692 178.994 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.686 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.07 155.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.841 -176.794 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.458 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.72 -30.26 4.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.176 -179.2 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.23 128.81 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.36 -179.524 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.738 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.76 126.64 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.691 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.47 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.26 119.19 72.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.684 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.1 Cg_exo -54.37 139.57 73.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.242 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.34 12.72 69.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.539 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.426 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.36 -157.59 21.72 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' LEU . . . -75.97 -40.73 53.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' CB ' HG22 ' A' ' 39' ' ' ILE . . . -72.78 -54.44 8.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.13 -29.09 69.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 65.1 mt-30 -72.38 -39.17 68.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.119 0.485 . . . . 0.0 110.3 179.416 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -81.39 -57.87 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.848 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.23 37.0 10.22 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.561 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.447 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.82 -5.38 14.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.698 179.531 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.537 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.0 tp -119.93 154.06 34.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.31 137.18 47.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.901 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.4 t -51.98 157.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.264 0.554 . . . . 0.0 111.533 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.39 -1.28 3.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.359 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.7 m-20 -69.54 127.61 33.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.56 101.47 13.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.577 0.703 . . . . 0.0 111.428 -178.662 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 HG21 ' A' ' 19' ' ' ILE . 10.9 mt -48.07 139.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.84 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.9 mm? -116.6 -44.62 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.092 179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.2 m-85 -142.57 174.69 10.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 62' ' ' GLU . 31.0 t -151.98 98.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.923 179.35 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.485 ' HB2' HG23 ' A' ' 84' ' ' VAL . 1.2 t-20 66.34 -68.23 0.14 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.226 0.536 . . . . 0.0 109.807 -178.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -155.2 31.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.8 t -117.77 142.41 32.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.596 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.5 p-10 -111.1 108.49 18.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 26.1 m -94.24 44.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.433 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -32.71 74.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.39 61.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.528 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 13.7 m -120.47 147.18 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.439 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -62.36 155.71 24.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 -179.071 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.513 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.6 p-80 -49.33 -34.28 15.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.787 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.7 p -70.19 -33.78 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.936 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.528 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.11 -45.73 80.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.265 0.555 . . . . 0.0 109.716 178.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -62.67 -45.5 92.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.532 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 94.1 t -56.47 -50.46 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.156 178.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.594 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.49 -34.36 35.44 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.924 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.542 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.84 -57.52 5.45 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.232 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.434 HD11 ' CZ ' ' A' ' 17' ' ' PHE . 5.2 mt -61.51 -39.74 92.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.429 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.76 -19.84 57.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.544 179.608 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -110.61 17.75 20.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.129 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -80.8 16.54 1.4 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.702 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.55 -99.43 0.59 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.679 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.5 p -127.8 -91.59 0.49 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.2 tp -84.27 106.19 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.061 0.457 . . . . 0.0 110.933 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 11.9 p -122.14 139.0 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.519 -178.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.412 ' N ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -85.95 103.76 14.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.916 178.812 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.517 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 18.0 mt -95.28 138.48 32.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.65 -178.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -102.07 141.56 34.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.462 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.0 m -138.83 165.09 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.023 -179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.433 ' HG3' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -105.98 145.63 31.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.706 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -140.52 142.41 35.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.111 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.865 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.827 0.346 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.35 160.25 15.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 20.9 m-85 -113.4 144.47 42.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.49 134.93 34.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.75 134.91 38.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' CG2' ' CB ' ' A' ' 50' ' ' ARG . 1.2 mt -129.36 109.29 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.263 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -76.95 123.07 25.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.841 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 3.2 tp -133.49 127.29 32.94 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.4 pt-20 -85.37 103.39 14.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.819 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 10.1 mtp180 -47.58 92.96 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.319 0.581 . . . . 0.0 110.745 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.42 73.15 0.02 OUTLIER Glycine 0 C--N 1.316 -0.538 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.935 -179.472 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' ARG . 26.9 t-20 63.25 -75.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.732 0.301 . . . . 0.0 111.349 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 11' ' ' GLY . 2.6 p -70.08 -24.84 63.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.274 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 155.04 -173.45 33.34 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.923 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.535 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 10.9 mt -59.04 -63.94 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.683 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.85 40.99 0.11 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.29 179.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.757 ' HB3' HG22 ' A' ' 39' ' ' ILE . 34.7 p90 -163.96 136.35 5.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.004 0.431 . . . . 0.0 111.25 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.01 132.72 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.397 -179.507 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.739 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -109.86 167.43 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.768 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -166.17 132.99 2.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.339 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.42 -1.88 1.23 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.437 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.53 -172.06 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.93 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.5 p -75.18 -22.17 58.21 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -94.82 -25.55 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.417 -179.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -124.35 87.32 54.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.222 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.79 62.95 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.411 2.074 . . . . 0.0 112.763 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.699 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 28.4 t60 -48.01 -28.95 3.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.074 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.32 -155.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.143 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.32 -49.45 45.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.348 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -177.86 51.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.802 0.334 . . . . 0.0 111.175 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.21 159.91 64.4 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.076 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -80.48 5.49 6.06 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.711 2.274 . . . . 0.0 112.671 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -57.02 118.59 5.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.99 118.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.602 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.699 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.38 146.12 34.58 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.586 0.708 . . . . 0.0 110.79 178.824 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.739 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.79 156.01 7.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.294 -176.652 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.445 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.87 -30.24 4.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.395 -178.588 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.31 128.34 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.876 -179.368 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -96.84 132.18 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.619 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.3 113.82 50.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.959 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.6 143.83 44.53 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.743 2.295 . . . . 0.0 112.482 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.51 83.03 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.85 176.68 20.77 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.111 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . -54.49 -33.34 59.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.525 0.202 . . . . 0.0 111.389 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -74.29 -56.25 5.1 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.778 0.323 . . . . 0.0 111.488 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.91 70.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.187 -179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -72.16 -31.81 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.934 0.397 . . . . 0.0 110.44 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.76 -57.87 3.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.063 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.62 32.11 19.74 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.422 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.408 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 51.9 mtt180 -115.23 -13.45 11.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.687 0.28 . . . . 0.0 110.96 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.61 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 38.7 tp -112.57 162.4 15.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.183 0.516 . . . . 0.0 111.305 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.08 135.74 23.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.633 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 56.2 t -49.2 157.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 111.586 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.473 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER 74.24 2.39 4.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.255 -179.893 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.9 m-20 -72.12 127.11 31.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.53 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 10.4 p -86.61 100.02 12.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.552 0.691 . . . . 0.0 111.464 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 34' ' ' ILE . 63.9 mt -45.25 149.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.055 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -128.91 -46.96 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.706 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -141.54 169.11 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.769 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 62' ' ' GLU . 16.6 t -143.91 95.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.121 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.418 ' HB2' HG21 ' A' ' 84' ' ' VAL . 5.4 t-20 68.34 -66.69 0.22 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -156.54 32.47 0.32 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.134 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 60.8 t -119.02 142.54 33.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.776 -178.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.1 p30 -112.06 113.14 25.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.122 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.448 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 35.3 m -86.41 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.89 100.94 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.77 52.51 0.55 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 29.1 m -122.26 143.43 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 179.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.08 150.33 25.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.514 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.7 t-160 -49.09 -33.34 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 20.1 m -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.588 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.37 -38.49 81.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -68.03 -46.91 69.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.639 0.733 . . . . 0.0 109.168 178.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.63 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 78.2 t -57.81 -48.03 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.214 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.588 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.74 -36.31 69.6 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.594 178.572 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.514 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.34 -51.2 67.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 0.0 110.105 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.434 ' CD1' HD13 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.06 -35.7 67.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.3 mmmt -77.29 -23.28 51.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.484 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -96.81 2.54 51.96 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 111.418 -179.016 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 84' ' ' VAL . . . -82.54 16.32 2.18 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.709 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.79 -119.18 16.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.9 t -104.97 -87.73 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.644 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 5.2 tp -87.7 109.18 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.682 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 80' ' ' ALA . 2.8 p -122.67 138.53 52.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.296 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.2 mtt-85 -86.72 102.86 14.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 60' ' ' VAL . 8.2 mt -91.29 142.6 27.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.33 -178.614 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.92 139.08 38.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.782 -179.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 m -138.13 149.13 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.724 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.447 ' HG3' ' CD1' ' A' ' 3' ' ' TYR . 0.6 OUTLIER -96.88 138.67 34.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 0.0 110.975 -179.883 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.63 113.68 8.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.935 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.854 0.359 . . . . 0.0 111.069 . . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -152.19 174.76 13.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.337 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.426 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 52.2 m-85 -141.74 140.78 33.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.959 0.409 . . . . 0.0 111.183 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.53 151.42 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -110.12 144.71 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.446 ' O ' HG21 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.36 109.46 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.482 179.841 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.466 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.48 120.29 23.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.047 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.613 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -130.71 127.96 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.275 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 pt-20 -85.4 101.05 12.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.004 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 5.0 mtp-105 -47.84 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.132 178.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -45.38 -101.68 0.01 OUTLIER Glycine 0 C--N 1.319 -0.386 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.228 -179.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.22 -40.66 3.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 p -108.24 -6.65 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.374 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 154.81 -156.24 26.77 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.495 -179.717 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -78.12 -63.48 1.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.522 179.68 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 139.38 44.36 0.07 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.918 -1.134 . . . . 0.0 114.024 178.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.741 ' HB3' HG21 ' A' ' 39' ' ' ILE . 17.9 p90 -164.0 131.53 3.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.304 0.552 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -93.2 134.4 35.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.669 -179.089 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -112.19 172.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.795 179.957 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB3' ' CG ' ' A' ' 27' ' ' HIS . . . -168.96 132.29 1.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.288 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.444 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.34 1.08 0.94 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.652 179.593 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.522 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.55 -172.07 0.1 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.869 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 68' ' ' VAL . 16.8 p -74.44 -21.72 59.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -97.0 -23.38 16.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 111.486 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.36 87.54 53.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.26 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.9 62.36 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.44 2.093 . . . . 0.0 112.738 -179.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.745 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.7 t60 -48.34 -28.08 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.104 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.672 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.82 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.325 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -56.48 -50.44 62.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.608 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.937 0.399 . . . . 0.0 110.747 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.9 168.48 13.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.86 9.02 4.11 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.727 2.284 . . . . 0.0 112.893 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -61.03 114.15 2.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.867 0.365 . . . . 0.0 110.65 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -81.85 119.84 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.745 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.45 143.41 32.59 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.683 0.754 . . . . 0.0 110.819 178.936 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.783 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -68.89 155.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.102 -176.495 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.439 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.44 -26.96 4.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.376 -178.525 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.553 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.25 131.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.005 -179.645 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.741 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.43 132.73 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.681 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.4 123.75 74.47 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.853 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.0 Cg_endo -66.88 133.8 32.56 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.747 2.298 . . . . 0.0 112.267 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.62 17.2 31.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.315 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.48 178.31 16.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.169 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . -53.97 -34.02 58.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.779 0.323 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -71.21 -57.48 4.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.897 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.59 -28.79 65.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.336 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -71.73 -29.95 65.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.391 . . . . 0.0 110.312 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.99 -58.08 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.06 37.85 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.569 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.6 mtt85 -112.71 -17.23 12.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.716 0.293 . . . . 0.0 110.962 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.574 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.4 tp -110.21 155.25 22.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.073 0.463 . . . . 0.0 111.222 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.52 135.12 45.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.801 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 65.5 t -51.86 158.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.31 0.576 . . . . 0.0 111.636 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.1 t30 73.19 5.58 5.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.001 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.4 m-20 -76.82 128.12 34.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.47 100.17 12.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.621 0.724 . . . . 0.0 111.317 -178.701 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' ILE . 16.1 mt -48.08 136.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.67 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.2 mm? -116.11 -44.86 2.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.6 m-85 -137.76 170.14 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.158 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 62' ' ' GLU . 26.9 t -149.59 96.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.965 179.359 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.427 ' HB2' HG21 ' A' ' 84' ' ' VAL . 3.7 t-20 67.09 -68.22 0.15 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 109.805 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mt-10 -154.44 32.32 0.42 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.603 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.2 t -118.71 142.42 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.478 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.0 p-10 -113.42 96.27 5.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.446 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.81 57.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.303 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -79.93 -30.13 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.73 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -151.61 62.86 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.777 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.1 m -128.85 146.09 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.207 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.48 151.1 33.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.522 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 16.3 t-160 -48.33 -33.72 9.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.722 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -67.25 -34.36 77.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.08 -42.66 80.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -61.81 -46.5 89.26 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.654 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 90.8 t -56.51 -50.8 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.364 178.588 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.647 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.24 -30.37 64.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.371 178.887 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.48 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.2 -49.83 75.58 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.293 0.568 . . . . 0.0 110.179 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.482 HD23 ' CE1' ' A' ' 17' ' ' PHE . 0.4 OUTLIER -60.44 -34.55 74.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.907 179.298 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.13 -26.23 52.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.191 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.405 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -103.07 14.73 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.302 -178.775 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.638 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -80.87 0.74 33.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.61 -112.62 3.79 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.009 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.25 -90.54 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.997 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.575 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.6 tp -87.87 87.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.218 0.532 . . . . 0.0 109.691 178.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.638 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 9.1 p -98.87 138.42 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 4.7 ttp180 -89.34 103.15 15.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.198 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.413 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 14.1 mt -91.7 140.31 29.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.91 142.76 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.99 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.7 m -133.03 167.91 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.646 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.401 ' N ' ' O ' ' A' ' 56' ' ' SER . 13.4 ttt -100.99 160.47 14.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.141 -179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -140.66 106.6 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.998 179.928 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.028 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.892 0.377 . . . . 0.0 111.186 . . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.82 162.98 16.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.035 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CB ' ' CE2' ' A' ' 87' ' ' TYR . 2.3 m-85 -119.86 130.47 54.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.78 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.27 152.28 43.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 3.6 tt0 -106.76 144.6 33.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.986 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.497 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -134.2 109.45 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.501 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.05 119.29 20.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.851 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.517 ' HB3' HD21 ' A' ' 15' ' ' LEU . 5.0 tp -130.55 127.6 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.5 pt-20 -83.85 100.53 11.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.659 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -44.48 88.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.174 179.193 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -53.16 -170.17 0.03 OUTLIER Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.792 -179.713 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -51.57 -35.2 40.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 111.366 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 p -108.06 4.4 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.585 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.402 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . 117.94 -167.08 12.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.051 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD21 ' HB3' ' A' ' 8' ' ' LEU . 17.3 mt -53.89 -44.23 70.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.017 0.437 . . . . 0.0 110.832 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.99 39.49 1.98 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.362 179.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.778 ' HB3' HG21 ' A' ' 39' ' ' ILE . 15.8 p90 -161.4 130.33 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.036 0.418 . . . . 0.0 111.424 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.27 134.77 34.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.66 -179.415 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -112.21 167.95 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 111.766 179.893 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -165.84 131.44 2.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.464 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.64 0.97 0.9 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.588 179.6 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.53 -168.55 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.987 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.418 ' CG2' ' HB3' ' A' ' 32' ' ' PRO . 11.2 p -76.25 -23.8 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -23.61 16.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.753 0.311 . . . . 0.0 111.669 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.22 87.41 53.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.03 63.08 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.388 2.058 . . . . 0.0 112.629 -179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.716 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 37.9 t60 -48.12 -27.86 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.308 179.027 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.656 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.71 -154.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.356 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -61.98 -49.01 79.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.588 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.31 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -125.17 163.46 37.83 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.418 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 5.5 Cg_exo -79.14 3.41 7.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.978 2.452 . . . . 0.0 112.715 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.79 115.45 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 111.104 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.512 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.57 120.64 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.382 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.716 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.64 145.93 33.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.553 0.692 . . . . 0.0 110.567 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.722 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.86 155.8 7.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.275 -176.507 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.448 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.09 -30.72 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.253 -178.849 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.8 130.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.99 -179.419 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.778 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.03 131.56 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.518 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.457 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 126.32 69.88 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 28.8 Cg_endo -62.6 134.47 47.77 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.718 2.279 . . . . 0.0 112.415 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.13 4.74 61.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.7 -179.48 25.64 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.991 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' A' ' 8' ' ' LEU . . . -57.42 -34.87 69.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.518 0.199 . . . . 0.0 111.325 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HB2' ' CD2' ' A' ' 8' ' ' LEU . . . -74.25 -55.63 5.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.84 -30.93 71.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.869 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -72.13 -35.65 69.17 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.045 0.45 . . . . 0.0 110.1 179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.46 -57.92 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.37 39.74 8.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.891 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.477 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -109.08 -4.65 16.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.578 179.476 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.7 tp -123.7 154.67 39.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.693 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 4.4 tpt85 -132.63 136.39 46.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.835 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.44 157.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.482 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.471 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.1 t30 74.8 0.28 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.78 125.35 26.31 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.849 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.6 p -86.43 100.27 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 34' ' ' ILE . 20.6 mt -50.76 136.01 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.911 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.45 HD11 ' CG ' ' A' ' 3' ' ' TYR . 7.8 mt -120.05 -28.13 5.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.705 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -153.4 156.14 37.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.034 0.445 . . . . 0.0 111.008 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 62' ' ' GLU . 46.3 t -133.76 95.62 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.909 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB2' HG22 ' A' ' 84' ' ' VAL . 5.8 t30 67.78 -67.83 0.18 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.117 0.484 . . . . 0.0 110.031 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -153.4 31.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.739 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 65.7 t -119.44 142.19 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.355 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.1 p-10 -107.49 100.9 10.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 22.9 m -86.87 53.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.493 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.84 -33.17 34.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.83 58.61 1.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.766 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.9 m -128.19 143.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.92 150.66 28.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.541 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.3 t-160 -48.29 -33.63 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.441 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.37 -34.06 75.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.96 179.633 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.612 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -38.57 81.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 109.453 178.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -66.67 -46.92 74.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.066 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 92.5 t -57.55 -49.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.2 178.563 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.612 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.84 -34.04 67.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.688 178.65 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.47 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -56.74 -50.76 71.27 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.331 0.586 . . . . 0.0 109.906 179.332 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.15 -37.57 69.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.384 178.948 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER -77.33 -23.73 50.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.092 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.1 mm-40 -91.72 -17.05 26.01 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.971 0.415 . . . . 0.0 110.951 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.566 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -55.47 -19.87 10.85 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.295 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.99 -98.66 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.025 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.488 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 34.3 m -126.76 -91.38 0.51 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 2.2 tp -87.26 98.61 7.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.666 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.566 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 13.6 p -115.81 138.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 mtt180 -85.83 103.14 14.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.274 177.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.497 ' HB2' HG22 ' A' ' 6' ' ' ILE . 14.3 mt -91.9 138.7 31.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.263 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.69 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.809 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.5 m -139.56 162.25 26.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.683 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.421 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 1.6 ttp -96.85 147.68 23.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.94 135.13 47.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.897 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.051 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.811 0.338 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -132.2 123.13 26.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.426 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 10.3 m-85 -97.33 131.23 44.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.46 142.27 49.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.21 144.58 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.48 HG21 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -138.8 109.42 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.376 179.856 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.425 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.25 116.47 20.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.067 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 tp -124.14 126.74 46.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 pt-20 -87.46 100.27 12.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.564 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.87 87.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.229 179.283 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.03 -179.45 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.49 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -56.36 -21.82 27.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.699 0.285 . . . . 0.0 111.209 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -102.98 -12.79 17.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.689 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.444 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 132.1 -164.06 23.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.304 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.519 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 2.3 tp -64.66 -63.29 1.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.205 -0.198 . . . . 0.0 110.572 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 131.26 17.77 1.39 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.529 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.756 ' HB3' HG21 ' A' ' 39' ' ' ILE . 8.9 p90 -160.7 135.73 7.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.965 0.882 . . . . 0.0 111.196 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.9 139.3 32.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.376 -179.477 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.75 147.95 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.887 0.851 . . . . 0.0 112.359 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' HB1' ' CG ' ' A' ' 27' ' ' HIS . . . -141.11 133.2 27.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.055 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.14 2.92 0.68 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.798 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.09 -176.52 0.84 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.682 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 25.2 p -67.53 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.11 -21.05 21.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -124.38 87.02 54.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.671 0.272 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.81 62.62 0.91 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.332 2.021 . . . . 0.0 112.585 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 38.5 t60 -47.45 -28.66 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.413 179.023 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.01 -154.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.281 179.531 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -61.31 -49.23 79.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.6 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.99 39.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.38 163.5 38.02 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 3.9 Cg_exo -76.73 1.47 8.5 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.984 2.456 . . . . 0.0 112.773 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.77 115.52 2.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.17 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -84.87 119.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.482 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.715 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.52 147.81 38.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.427 0.632 . . . . 0.0 110.869 178.776 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.953 -176.85 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.71 -31.37 4.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.217 -179.014 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.57 131.1 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.226 -179.42 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.96 130.89 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.594 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.13 114.03 51.86 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.874 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 42.4 Cg_exo -56.95 139.31 89.37 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.726 2.284 . . . . 0.0 112.378 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 12.75 59.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.431 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.69 179.36 16.87 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.919 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.7 -38.61 69.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.841 0.353 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -64.84 -57.65 8.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.577 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.47 -28.77 66.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.353 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.99 -33.06 67.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 110.162 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.28 -58.01 3.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.748 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.87 37.71 12.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.622 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' CB ' HG12 ' A' ' 6' ' ' ILE . 18.2 mtm180 -118.96 9.05 11.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.728 0.299 . . . . 0.0 110.987 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.555 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.8 tp -135.24 154.4 51.59 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.01 0.433 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.94 134.42 42.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 179.996 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -49.15 159.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.13 0.491 . . . . 0.0 111.491 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 3.0 m120 72.24 1.43 3.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.506 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.01 127.22 31.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.693 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 100.17 12.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 111.693 -178.437 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.498 HD11 HG21 ' A' ' 19' ' ' ILE . 10.1 mt -46.76 132.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.76 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.97 -40.41 3.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.138 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -145.27 167.49 22.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.763 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 62' ' ' GLU . 56.1 t -145.3 97.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.442 ' HB2' HG21 ' A' ' 84' ' ' VAL . 1.2 t30 66.25 -67.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 109.947 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' VAL . 10.2 mm-40 -154.14 32.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.921 179.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.7 t -119.64 142.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.412 -179.322 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.5 t0 -111.33 99.72 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.455 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.5 m -85.3 55.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.294 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -32.51 59.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.851 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -152.67 62.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.667 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.542 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 13.2 m -124.6 144.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.447 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.88 155.06 20.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.973 0.416 . . . . 0.0 111.097 -179.117 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.508 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.2 p-80 -48.66 -34.09 11.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.859 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -33.88 73.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.139 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.542 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.18 -44.23 84.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.241 0.543 . . . . 0.0 109.674 178.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB3' HG22 ' A' ' 34' ' ' ILE . . . -63.92 -45.89 87.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.162 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.51 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 59.4 t -57.06 -48.37 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.287 178.544 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.664 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -53.68 -33.82 56.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.33 179.134 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.559 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -64.66 -56.91 10.77 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.598 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 HD13 ' CE1' ' A' ' 17' ' ' PHE . 0.8 OUTLIER -63.02 -42.93 99.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.879 -179.645 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.589 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.08 -20.59 55.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.748 -179.264 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.664 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 6.7 mm-40 -103.27 -8.8 20.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.088 0.471 . . . . 0.0 110.563 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -48.1 -20.49 0.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.791 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.79 -90.21 0.93 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.712 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -133.73 -92.42 0.34 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.871 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 9.1 tp -88.05 102.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.116 0.484 . . . . 0.0 110.531 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.514 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 7.3 p -118.32 136.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.724 -178.13 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.9 mtt85 -85.88 103.88 15.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.058 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.48 ' HB2' HG21 ' A' ' 6' ' ' ILE . 18.3 mt -95.49 137.8 34.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.576 -179.189 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.88 140.42 36.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.494 179.795 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 m -139.84 138.32 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.991 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -107.01 135.37 48.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.65 146.59 38.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HG3' ' HG2' ' A' ' 89' ' ' MET . 1.3 pmm? . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.791 0.329 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.59 125.69 32.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.427 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 10.7 m-85 -91.06 144.71 25.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.815 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -131.6 151.04 51.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -109.96 143.89 39.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.78 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.484 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.32 109.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.975 0.416 . . . . 0.0 111.699 179.791 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.49 118.87 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.508 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.555 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -131.59 127.16 36.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.2 pt-20 -84.51 100.44 11.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.258 179.392 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.454 ' HG3' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.41 90.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.21 179.67 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -53.36 -168.71 0.02 OUTLIER Glycine 0 C--N 1.32 -0.337 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.88 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -51.71 -36.67 47.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.578 0.227 . . . . 0.0 111.471 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 t -108.05 4.54 25.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.817 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.06 -167.18 13.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.986 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 18.8 mt -52.17 -63.48 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.0 110.784 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.15 35.93 0.45 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.419 179.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.776 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.1 p90 -160.04 135.42 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.128 0.464 . . . . 0.0 111.242 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.33 137.63 33.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.427 -179.612 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.684 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.45 149.75 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.654 0.74 . . . . 0.0 111.954 -179.86 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -142.73 133.02 24.73 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.93 179.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.31 -7.65 1.16 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.462 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.6 -178.87 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.087 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 29.9 p -65.06 -31.13 72.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.227 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 12.5 m-20 -91.45 -20.46 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.237 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.48 82.48 58.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.958 0.409 . . . . 0.0 110.131 179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.25 62.67 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.886 2.391 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.748 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.6 t60 -52.58 -22.35 4.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.386 178.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.693 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -95.21 -151.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.572 179.814 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -82.89 48.87 4.11 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.861 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.77 45.46 0.07 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.981 0.419 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -135.22 155.24 78.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.57 -0.94 10.72 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.525 2.15 . . . . 0.0 112.776 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 5.7 m -54.24 115.75 2.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.746 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.529 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.58 119.02 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.748 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.67 145.72 35.26 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.301 0.572 . . . . 0.0 110.527 178.53 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.684 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.98 155.48 7.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.094 -176.476 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.5 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.37 -33.44 4.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.766 -179.124 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.587 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.65 141.96 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.585 -179.749 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.776 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.7 132.31 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.266 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.1 125.16 73.26 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.685 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.1 Cg_endo -67.33 132.06 26.54 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.838 2.358 . . . . 0.0 112.381 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.68 14.39 32.17 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.474 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.87 178.07 16.42 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.0 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.37 -36.26 61.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 111.416 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' HB1' ' CG2' ' A' ' 39' ' ' ILE . . . -68.9 -57.43 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.833 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.478 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -33.92 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 110.174 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.15 -57.92 3.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.691 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.02 9.59 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.602 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.484 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.9 mmt180 -116.31 1.59 13.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.702 -0.293 . . . . 0.0 110.837 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.3 tp -126.96 154.15 44.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 110.657 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.57 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.9 ttp85 -131.52 137.45 48.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.587 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -53.33 158.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 111.678 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER 74.53 0.19 3.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.184 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 3.1 m-20 -70.38 126.26 29.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.905 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.3 p -86.53 100.31 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 0.0 111.383 -178.607 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 34' ' ' ILE . 69.1 mt -46.88 140.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.065 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.5 mm? -118.76 -44.8 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.3 m-85 -139.86 169.43 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.793 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 62' ' ' GLU . 26.5 t -151.4 100.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.41 ' CB ' HG23 ' A' ' 84' ' ' VAL . 11.3 t30 66.27 -67.86 0.14 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.131 0.491 . . . . 0.0 109.979 -178.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -156.67 32.05 0.31 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.495 179.124 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.6 t -117.8 142.51 31.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.55 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.7 p-10 -112.69 89.34 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.4 m -75.77 61.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -82.38 -32.94 28.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.753 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -148.66 50.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.798 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.427 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.4 m -114.09 150.89 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.421 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -66.95 153.66 43.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.029 -179.389 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.546 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.2 t-160 -49.68 -34.19 17.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.628 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -69.8 -34.04 73.19 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.636 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.04 -42.25 80.85 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.638 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -63.12 -46.75 85.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.555 0.693 . . . . 0.0 109.201 177.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 89.3 t -57.58 -50.18 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.15 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.636 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.01 -32.9 64.39 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.631 178.656 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.503 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -57.99 -52.63 64.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.228 0.537 . . . . 0.0 110.012 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.472 ' CD1' HD12 ' A' ' 19' ' ' ILE . 2.5 mt -54.16 -36.47 63.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.283 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.19 -26.66 53.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.09 178.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -89.01 -16.65 31.16 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -178.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -57.41 -18.57 18.53 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.33 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.02 -108.02 3.6 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.164 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 1.3 p -118.78 -91.2 0.56 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 8.4 tp -86.92 95.09 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.079 0.466 . . . . 0.0 109.85 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 12.1 p -111.86 138.06 42.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.297 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.9 102.89 14.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.411 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 11.6 mt -90.18 141.15 28.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 141.38 34.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.771 -179.759 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.89 167.88 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.454 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 2.0 mtp -109.13 142.88 39.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.768 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -140.66 106.89 5.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.398 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.45 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.834 179.651 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.536 0.208 . . . . 0.0 111.01 . . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -161.7 138.81 8.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 111.077 179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CE1' ' HG ' ' A' ' 58' ' ' LEU . 65.7 m-85 -123.65 127.37 48.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.659 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -126.35 155.56 41.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 17.7 mt-10 -117.43 144.63 44.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -134.84 109.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.647 179.893 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.24 122.0 24.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.912 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.613 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.1 tp -134.14 127.31 31.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.149 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -86.37 100.76 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.632 179.551 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 12.0 mtp180 -42.45 91.93 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.064 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -61.65 72.64 0.02 OUTLIER Glycine 0 C--N 1.317 -0.477 0 CA-C-N 115.186 -0.916 . . . . 0.0 113.058 -179.538 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER 64.01 -73.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.743 0.306 . . . . 0.0 111.525 179.672 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER -72.7 -23.92 60.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.519 -179.59 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 155.15 -172.88 33.45 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.828 -179.672 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 8.3 mt -60.5 -63.64 1.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.024 0.412 . . . . 0.0 110.67 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 135.46 40.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.745 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.761 ' HB3' HG22 ' A' ' 39' ' ' ILE . 8.1 p90 -162.02 134.51 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.494 . . . . 0.0 110.971 178.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.51 135.16 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.459 -179.351 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.707 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.53 146.5 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.496 179.552 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB2' HG22 ' A' ' 37' ' ' THR . . . -126.74 122.88 36.11 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.586 178.935 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 157.92 -132.0 3.03 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.605 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 75.76 167.36 22.75 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.263 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.413 HG21 ' N ' ' A' ' 68' ' ' VAL . 27.4 p -68.47 -6.68 26.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.074 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -113.11 -24.34 9.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.223 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.5 t30 -124.62 87.18 54.86 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.478 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.91 64.69 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.39 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.736 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.0 t60 -53.05 -24.12 9.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.31 179.221 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.678 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -92.64 -150.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 179.63 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.66 52.47 4.58 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.931 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 75.7 41.23 0.26 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.116 0.484 . . . . 0.0 110.488 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -132.3 161.46 62.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.909 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 97.3 Cg_endo -79.29 4.18 6.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.625 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -55.04 118.39 4.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.078 0.466 . . . . 0.0 111.258 -179.814 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.494 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.32 116.62 31.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.188 179.598 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.736 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.06 147.6 37.07 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.363 0.601 . . . . 0.0 110.573 179.256 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.707 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.26 155.74 7.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.834 -177.127 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.29 -33.02 3.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.677 -179.076 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.567 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.14 142.01 2.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 111.276 -179.78 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.761 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -105.32 132.32 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.48 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.01 114.48 54.53 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.674 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.1 Cg_exo -57.68 136.96 78.83 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.7 2.267 . . . . 0.0 112.365 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 16.97 39.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.562 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.54 178.76 16.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.175 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.84 -33.86 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.3 . . . . 0.0 111.402 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -70.81 -57.39 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.908 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.53 -28.67 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.525 -179.427 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.71 -30.43 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 110.335 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.68 -57.77 3.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.708 -179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.78 37.0 12.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.572 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -111.28 -20.92 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.4 tp -106.16 153.86 21.5 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.275 0.559 . . . . 0.0 111.361 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -131.78 135.4 46.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.57 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.567 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 52.5 t -49.21 157.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.536 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER 75.15 0.26 3.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.223 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -68.24 124.71 24.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.991 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.5 p -86.63 99.78 11.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.564 0.697 . . . . 0.0 111.377 -178.46 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 34' ' ' ILE . 11.0 mt -46.35 129.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.229 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' HG ' ' CE1' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -113.06 -41.44 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.005 179.653 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.4 m-85 -144.72 146.82 32.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.166 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.51 109.78 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.84 179.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 52.78 35.93 19.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 80.72 32.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.445 -179.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 74.7 t -121.01 112.75 37.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.699 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -72.05 116.83 12.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.711 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 m -98.45 27.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.197 179.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -68.77 -27.76 66.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -138.52 52.67 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.082 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.442 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.4 m -127.63 146.08 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.83 155.61 38.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.384 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.45 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.5 p-80 -48.15 -35.44 11.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 -179.65 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.33 -33.67 65.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.115 179.716 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.68 -39.39 88.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.808 179.161 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.494 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -66.69 -46.88 74.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.584 0.707 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.613 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.5 t -58.07 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.362 178.556 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -58.22 -35.64 71.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.46 178.574 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.435 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.08 -49.39 71.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.237 0.542 . . . . 0.0 109.976 179.597 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.451 ' CD1' HD11 ' A' ' 19' ' ' ILE . 2.4 mt -57.84 -36.47 72.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 178.709 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.2 mmmt -77.33 -25.86 51.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.879 179.441 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -96.96 5.31 50.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -178.703 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.631 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -80.45 16.1 1.43 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.769 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.63 -110.5 3.43 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.294 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.506 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 35.8 m -118.96 -89.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.324 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.5 tp -86.27 96.43 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.257 0.551 . . . . 0.0 110.263 179.019 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.631 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 8.6 p -111.1 138.4 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.57 102.8 14.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.388 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.425 HD11 ' CD1' ' A' ' 15' ' ' LEU . 10.9 mt -88.74 137.86 31.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.118 -178.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 145.95 28.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.923 -179.689 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.409 ' CG1' ' HB3' ' A' ' 55' ' ' ASP . 35.4 m -139.62 144.54 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.139 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.403 ' HG2' ' HB2' ' A' ' 56' ' ' SER . 7.0 ptt? -96.74 159.84 14.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.855 0.359 . . . . 0.0 111.132 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -139.5 106.86 5.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.899 -179.602 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.941 179.805 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.838 0.352 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -91.44 175.73 6.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 179.72 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -133.13 156.88 46.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.786 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -145.22 151.0 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.981 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -110.36 144.77 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.484 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -134.71 109.5 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.926 0.393 . . . . 0.0 111.545 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.423 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 112.46 17.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.959 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.5 tp -122.87 126.81 48.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.269 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.62 100.46 10.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.059 179.09 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.51 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.169 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -54.86 167.96 2.17 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.539 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.63 -26.54 9.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.56 -24.73 18.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.944 179.736 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.57 -170.8 24.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.081 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.489 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 6.9 tp -62.15 -42.61 99.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.403 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 108.67 25.78 5.58 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.326 -0.94 . . . . 0.0 115.263 177.706 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.759 ' HB3' HG22 ' A' ' 39' ' ' ILE . 4.3 p90 -164.52 136.72 4.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.018 0.909 . . . . 0.0 111.072 178.779 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -98.68 133.44 43.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.636 -179.28 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.778 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -110.07 169.9 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.608 0.718 . . . . 0.0 111.501 179.729 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -167.33 131.5 1.87 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.424 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.45 2.09 0.71 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.436 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.13 -167.15 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.102 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 68' ' ' VAL . 17.5 p -75.96 -28.16 57.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -95.31 -20.63 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.66 82.54 59.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.76 63.89 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -179.316 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.713 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.3 t60 -50.09 -24.09 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.661 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.7 -155.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.367 179.716 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -59.9 -49.92 73.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.575 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.49 39.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.919 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -124.69 163.48 36.69 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.405 ' HB3' ' CG2' ' A' ' 23' ' ' THR . 5.9 Cg_exo -78.91 3.46 7.36 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.0 112.861 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.1 m -56.61 115.53 2.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 111.1 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.47 120.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.524 179.833 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.713 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.44 145.39 33.73 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.48 0.657 . . . . 0.0 110.704 178.842 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.778 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.84 155.83 7.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.473 -176.409 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.456 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.9 -28.36 4.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.509 -178.565 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.575 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.72 129.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.197 -179.486 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.759 HG22 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -94.6 133.23 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.392 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 122.98 75.6 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.725 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 23.3 Cg_endo -61.59 137.41 68.96 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.642 2.228 . . . . 0.0 112.36 -179.661 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 -1.87 83.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.442 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.72 175.22 36.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.033 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 9' ' ' GLU . . . -54.12 -34.38 60.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.441 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -74.43 -56.94 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.239 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.12 -28.87 70.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -71.67 -31.57 66.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 109.934 179.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.38 -57.91 2.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.552 179.87 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.04 40.83 8.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.491 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.484 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.9 mmt85 -117.03 6.58 12.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.71 0.29 . . . . 0.0 110.951 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.555 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.5 tp -133.74 153.81 51.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.004 0.431 . . . . 0.0 110.819 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.555 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.13 140.1 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 179.96 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.575 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 56.5 t -56.69 158.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.242 0.544 . . . . 0.0 111.638 179.757 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 t-20 74.15 3.5 4.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.179 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.5 m-20 -75.06 127.1 32.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.49 103.03 14.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.517 0.675 . . . . 0.0 111.131 -178.853 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 34' ' ' ILE . 62.5 mt -49.92 133.37 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.052 -179.775 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 4.0 mm? -108.64 -42.6 4.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -147.33 140.58 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.301 179.987 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' HA ' HD21 ' A' ' 86' ' ' LEU . 58.3 t -123.72 97.29 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.754 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 t30 70.04 -62.84 0.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.05 0.453 . . . . 0.0 109.819 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -160.58 30.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.152 179.143 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 16.7 t -121.03 109.62 25.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.679 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.467 ' N ' ' CE1' ' A' ' 59' ' ' PHE . 18.9 t0 -63.08 -23.49 67.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.283 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.4 m 46.07 28.96 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.639 -179.763 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -61.91 -37.76 85.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.77 61.93 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.4 m -127.83 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.315 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.59 151.34 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -179.706 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.526 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.6 t-160 -48.11 -33.89 8.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.675 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -34.07 75.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.933 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.66 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.07 -42.38 80.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.643 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.511 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -62.75 -46.81 86.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.677 0.751 . . . . 0.0 109.047 177.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.578 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 96.5 t -57.31 -50.48 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.328 178.546 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -29.47 60.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.898 178.556 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.55 -51.57 68.03 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.273 0.559 . . . . 0.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.423 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.5 mt -55.78 -37.96 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.48 -23.28 50.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.034 178.978 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.72 7.94 45.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.397 -178.795 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.62 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -86.19 16.2 4.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.3 179.873 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.34 -99.62 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.575 179.849 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -129.18 -91.9 0.46 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.0 tp -81.95 97.14 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.187 0.518 . . . . 0.0 110.405 179.336 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.62 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -114.21 137.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.733 . . . . 0.0 112.947 -178.2 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 4.6 mtt180 -86.35 103.03 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.164 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 60' ' ' VAL . 13.3 mt -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.165 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.415 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.62 142.88 32.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.552 -179.902 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 m -139.48 168.17 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.0 mtm -96.52 150.85 20.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.56 106.86 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 -179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 179.837 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HG2' ' HB2' ' A' ' 89' ' ' MET . 4.2 tpp . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.785 0.326 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.93 128.28 49.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.107 -179.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.457 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 66.1 m-85 -100.89 146.19 27.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 179.746 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -155.48 152.45 28.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 pt-20 -105.68 144.75 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.481 HD11 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.25 109.17 12.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.956 0.408 . . . . 0.0 111.59 179.723 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.59 118.82 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.255 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 tp -130.26 127.02 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.407 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.14 100.18 10.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.244 0.545 . . . . 0.0 112.239 179.812 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -53.55 89.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.137 178.448 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.62 176.63 18.49 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.325 -179.02 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m120 54.69 -92.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.508 0.194 . . . . 0.0 110.84 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -108.4 11.61 26.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.576 0.226 . . . . 0.0 111.104 179.663 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.92 -139.67 11.86 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.674 -179.516 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.494 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 5.7 tp -72.06 -63.44 1.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.377 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 128.24 27.43 0.91 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.091 177.951 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG22 ' A' ' 39' ' ' ILE . 7.3 p90 -164.15 134.91 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 118.013 0.906 . . . . 0.0 111.17 178.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.426 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.29 134.41 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.611 -179.2 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.51 146.98 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.327 179.299 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.45 123.17 33.02 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.649 179.098 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 25' ' ' ASN . . . 159.58 -119.23 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.097 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 64.06 173.82 3.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.515 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 4.6 p -76.89 -3.83 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.005 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.1 -25.15 9.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.7 t30 -125.05 86.1 57.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.453 0.168 . . . . 0.0 110.667 -179.824 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.63 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.0 1.8 . . . . 0.0 112.216 -179.767 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.712 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 35.5 t60 -53.52 -24.11 12.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.271 179.056 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.61 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -88.62 -153.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.423 179.438 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.22 -51.41 55.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.624 -179.22 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 3.3 p-10 -178.68 35.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.615 0.245 . . . . 0.0 111.519 -179.378 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -125.47 164.15 34.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -179.897 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.454 ' HB3' ' HA ' ' A' ' 23' ' ' THR . 79.0 Cg_endo -84.05 44.47 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.665 2.243 . . . . 0.0 112.337 179.925 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -90.43 123.38 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.92 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -90.37 109.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.487 179.926 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.712 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -135.66 147.13 48.46 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.392 0.615 . . . . 0.0 110.287 178.842 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.17 155.6 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.751 -176.738 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.61 -32.69 3.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.606 -179.05 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.557 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.74 140.57 2.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.915 0.388 . . . . 0.0 111.406 -179.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.748 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -102.66 133.63 45.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.206 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 117.38 68.51 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.332 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.7 Cg_exo -57.69 135.19 67.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.833 2.355 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.32 1.51 64.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.672 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.19 179.84 28.54 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.076 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -57.68 -33.23 68.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.979 179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' HA ' HD13 ' A' ' 8' ' ' LEU . . . -74.03 -56.43 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.729 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.39 -31.25 72.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -72.13 -32.63 67.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -58.07 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.676 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 41.47 9.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.552 179.681 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' CB ' HG12 ' A' ' 6' ' ' ILE . 13.9 mmt180 -108.98 -17.35 13.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.897 0.38 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.59 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.7 tp -109.35 155.93 20.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.59 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 133.49 44.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 179.778 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.557 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.08 158.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.358 0.599 . . . . 0.0 111.989 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.8 t30 74.47 3.97 4.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.463 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -74.86 126.24 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.052 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 t -86.48 101.23 12.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.554 0.692 . . . . 0.0 111.269 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.536 ' N ' ' O ' ' A' ' 34' ' ' ILE . 65.3 mt -47.13 131.56 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.815 179.833 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.457 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.3 mm? -110.37 -44.19 3.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.843 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -142.29 162.17 36.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.768 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.8 t -152.29 114.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.974 179.795 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.401 ' CB ' HG21 ' A' ' 84' ' ' VAL . 26.7 t30 46.6 46.0 14.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 75.42 31.7 0.76 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 64.9 t -120.77 142.16 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 34.3 t0 -105.5 112.12 25.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.81 24.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.369 179.989 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -58.88 -28.92 66.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 60.58 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.446 ' N ' HG22 ' A' ' 23' ' ' THR . 28.3 m -132.89 142.76 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.352 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 152.47 28.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 -179.926 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.508 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.2 t-160 -48.15 -33.95 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.685 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -68.59 -34.1 75.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.173 179.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.94 -38.49 79.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.731 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -66.51 -46.83 74.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 84.5 t -57.62 -50.42 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 178.489 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.647 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.08 -29.81 58.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.786 178.44 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.475 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.37 -53.61 54.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.163 0.506 . . . . 0.0 109.785 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.6 mt -51.75 -40.31 60.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.487 178.871 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -77.55 -25.56 50.22 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.454 179.314 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' GLU . 2.7 pt-20 -93.84 7.57 44.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 0.0 111.311 -178.615 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.543 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -84.99 16.3 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.508 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.82 -83.98 0.09 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.409 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.455 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -147.74 -90.09 0.08 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.439 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 9.4 tp -82.32 96.72 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 109.938 179.134 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 10.1 p -116.04 136.9 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.507 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -86.06 102.79 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.491 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 11.3 mt -90.81 138.58 31.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.303 -178.71 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.66 137.34 40.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.423 179.818 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.7 m -139.66 165.22 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.307 179.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.441 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.2 ptt? -133.32 145.2 50.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 111.201 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.59 133.07 28.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.196 -179.897 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.909 179.773 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.841 0.353 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' MET . 1.7 mt-10 -85.49 116.46 23.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.953 179.921 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.466 ' CD2' HD21 ' A' ' 58' ' ' LEU . 3.2 m-30 -82.12 126.78 32.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.554 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.91 139.76 36.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 111.253 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -97.87 144.9 26.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.516 HD12 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.26 109.38 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.086 0.47 . . . . 0.0 111.545 179.911 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.33 125.37 29.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.459 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 tp -135.01 126.91 29.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.669 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.17 100.18 10.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.371 179.262 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.23 89.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.166 178.798 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -131.82 178.0 18.23 Favored Glycine 0 C--N 1.322 -0.204 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.357 -179.09 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 55.43 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.511 0.196 . . . . 0.0 110.748 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -108.29 9.88 27.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.558 0.218 . . . . 0.0 110.924 179.448 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.39 -138.13 10.75 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.653 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.548 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 2.6 tp -73.1 -52.42 14.31 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.22 179.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 120.03 22.98 3.1 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.959 -1.115 . . . . 0.0 115.342 177.458 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.752 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -163.48 135.8 5.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.353 1.077 . . . . 0.0 111.502 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.44 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 134.55 35.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.276 -179.674 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -112.4 162.85 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.551 0.691 . . . . 0.0 111.655 179.938 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HB3' ' CG ' ' A' ' 27' ' ' HIS . . . -158.82 132.79 7.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.354 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.14 1.68 1.27 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.501 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.21 -172.94 0.37 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.955 -179.763 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 32.1 p -68.41 -27.53 66.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.225 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 10.6 m-20 -96.8 -18.78 19.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -124.27 87.21 53.99 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.27 59.86 1.01 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.28 1.987 . . . . 0.0 112.6 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.732 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 40.3 t60 -47.63 -28.3 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 178.834 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.658 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -89.35 -154.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.332 179.315 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -60.05 -49.53 77.53 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.663 -179.692 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.83 39.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.08 166.27 21.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.65 6.83 5.2 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.64 2.227 . . . . 0.0 112.802 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -58.56 115.41 3.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.775 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.03 120.13 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.706 -179.896 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.732 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.32 144.57 33.3 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.358 0.599 . . . . 0.0 110.386 178.501 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.74 155.72 7.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.321 -176.374 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.488 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.4 -34.69 3.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.777 -178.784 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.566 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.12 142.36 2.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.46 -179.566 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.752 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.95 133.17 49.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 178.345 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.86 114.95 57.35 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.606 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 52.2 Cg_exo -55.71 137.76 79.26 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.256 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.02 6.71 66.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.77 177.36 21.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.992 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 8' ' ' LEU . . . -54.45 -31.26 55.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' CA ' HD22 ' A' ' 8' ' ' LEU . . . -73.91 -57.5 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.712 -179.712 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.1 -28.57 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.259 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.72 -31.16 66.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.001 0.429 . . . . 0.0 110.084 179.428 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.42 -57.82 2.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.43 40.32 9.15 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.672 179.589 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.8 mtt85 -111.77 -19.16 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.663 0.268 . . . . 0.0 110.815 179.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -107.81 155.23 20.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.154 0.502 . . . . 0.0 111.177 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.58 134.82 45.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.676 179.746 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.566 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.0 157.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.317 0.58 . . . . 0.0 111.72 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.89 1.57 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.235 179.837 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.95 124.47 24.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.059 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.37 12.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.604 0.716 . . . . 0.0 111.419 -178.615 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.476 ' N ' ' O ' ' A' ' 34' ' ' ILE . 20.3 mt -51.72 130.7 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.791 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.466 HD21 ' CD2' ' A' ' 3' ' ' TYR . 1.4 pp -126.95 3.41 6.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.604 179.389 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.5 OUTLIER 179.07 140.54 0.1 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.207 0.527 . . . . 0.0 110.583 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.429 ' CG1' ' CB ' ' A' ' 76' ' ' ALA . 2.4 p -147.57 118.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 51.78 33.44 11.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 110.076 -179.006 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 77.62 34.75 0.34 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.4 t -120.91 108.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.2 p-10 -73.19 106.43 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.485 179.271 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 29.5 m -93.78 40.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.363 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -22.01 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.163 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -146.99 59.8 1.18 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.148 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.418 ' CG2' ' HB ' ' A' ' 65' ' ' VAL . 32.8 m -134.52 148.86 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.527 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.37 153.11 43.59 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.034 -179.344 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.534 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 3.8 t-160 -49.85 -34.02 18.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -33.99 73.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.772 179.41 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.58 -40.56 80.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.675 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.538 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -64.94 -46.71 80.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.009 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.576 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.9 t -57.97 -50.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.2 178.612 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.6 OUTLIER -56.4 -35.24 67.54 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.739 178.537 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.429 ' CB ' ' CG1' ' A' ' 60' ' ' VAL . . . -55.34 -52.49 63.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 110.142 179.528 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 15' ' ' LEU . 3.4 mt -53.88 -38.72 65.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.241 178.585 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -20.65 53.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.413 179.011 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.2 mt-10 -97.21 -12.67 22.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.288 -178.687 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.547 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -57.9 -15.46 8.74 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.393 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 -91.28 1.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.903 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.4 p -139.45 -91.59 0.18 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.894 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 9.7 tp -84.22 93.97 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.235 0.54 . . . . 0.0 110.007 178.813 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 9.7 p -113.21 136.86 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 8.5 ptp180 -87.49 102.94 15.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.471 177.969 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 17.7 mt -91.13 132.75 35.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.136 -179.079 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.52 126.18 48.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 m -129.32 153.12 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.719 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.455 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 2.9 ptt? -121.77 133.65 54.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 111.251 -179.888 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 123.39 19.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.863 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.877 0.37 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.4 116.41 23.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.81 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 40.5 m-85 -83.22 128.77 34.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.102 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.4 mt-10 -129.93 170.57 13.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.32 144.59 49.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.973 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.475 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -140.36 109.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 111.801 179.968 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.6 118.72 20.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.392 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.1 tp -129.42 127.09 40.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.058 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 pt-20 -84.66 100.28 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.011 179.324 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -46.07 89.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.486 179.81 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -49.87 -178.27 0.02 OUTLIER Glycine 0 CA--C 1.52 0.357 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.812 179.835 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -45.02 -38.31 4.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -98.75 -24.74 14.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.356 . . . . 0.0 111.28 -179.807 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.34 -165.14 29.43 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.923 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 22.7 mt -53.77 -63.39 1.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.937 0.399 . . . . 0.0 110.698 179.963 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 130.12 31.55 0.58 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.297 179.479 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.23 138.09 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.033 0.416 . . . . 0.0 110.561 179.096 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.422 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.98 135.03 40.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.425 -179.476 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -113.05 146.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.546 0.689 . . . . 0.0 111.388 179.596 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 37' ' ' THR . . . -128.66 123.86 34.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.736 179.0 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 25' ' ' ASN . . . 159.47 -124.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.742 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 70.09 174.06 13.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.794 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 HG21 ' N ' ' A' ' 68' ' ' VAL . 12.2 p -76.93 -1.33 28.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.92 -23.06 8.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -124.85 86.83 55.83 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -179.89 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 65.72 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.051 1.834 . . . . 0.0 112.196 -179.812 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.701 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.2 t60 -53.18 -23.69 9.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.262 179.286 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.622 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -91.34 -152.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.481 179.526 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.87 -46.89 63.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.8 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.56 77.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.2 170.28 5.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.65 179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 96.1 Cg_endo -84.47 16.54 1.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.548 2.165 . . . . 0.0 112.829 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.6 m -62.74 145.61 54.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.067 0.461 . . . . 0.0 111.047 -179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.484 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -116.73 114.82 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 -179.914 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.701 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -139.9 148.11 41.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.393 0.616 . . . . 0.0 110.545 179.16 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.22 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.968 -176.894 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.78 -30.03 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.372 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.78 129.57 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.049 -179.366 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.06 130.08 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.586 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.462 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 115.3 59.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.588 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 39.1 Cg_exo -57.52 135.79 71.87 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.741 2.294 . . . . 0.0 112.212 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.36 14.62 40.88 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.65 177.47 16.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.997 179.693 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -52.32 -38.23 57.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.834 0.349 . . . . 0.0 111.224 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.487 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -65.16 -57.53 8.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.909 -179.608 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.26 -28.64 64.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.509 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -71.94 -32.79 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.008 0.432 . . . . 0.0 110.306 179.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -77.6 -58.02 3.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 36.0 16.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.564 179.562 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CB ' HG12 ' A' ' 6' ' ' ILE . 59.0 mtt180 -118.29 5.26 11.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.602 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 10.9 tp -130.61 156.53 44.72 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.057 0.456 . . . . 0.0 110.932 179.644 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.602 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.54 135.18 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.684 179.846 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -48.98 157.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.305 0.574 . . . . 0.0 111.749 -179.746 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.475 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 7.8 t-20 76.59 0.66 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.275 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.17 125.45 26.71 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.063 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.54 100.14 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 0.0 111.298 -178.958 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' ILE . 61.2 mt -45.36 145.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.996 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.452 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -128.83 -44.61 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.5 m-85 -140.66 146.41 37.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.063 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.0 t -140.4 111.41 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.703 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 50.46 37.42 15.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.398 . . . . 0.0 110.185 -179.125 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 79.55 34.24 0.19 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.493 -179.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 97.3 t -120.95 108.44 22.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.424 -179.851 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.0 t0 -78.28 93.32 4.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.902 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 m -64.53 -122.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.372 179.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 70.16 -65.69 0.31 Allowed 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.03 0.443 . . . . 0.0 110.662 -179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -93.61 40.22 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.725 179.585 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.476 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.7 m -137.92 142.34 36.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 179.88 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.36 155.06 12.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.234 0.54 . . . . 0.0 111.274 -179.558 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.462 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 1.7 p-80 -49.55 -33.78 15.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.873 179.646 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -72.05 -33.67 68.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.327 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.14 -44.13 85.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.247 0.546 . . . . 0.0 109.663 179.023 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.457 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -61.19 -46.88 88.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.609 0.719 . . . . 0.0 109.182 178.045 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 85.1 t -57.99 -50.43 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.416 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.672 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.93 -29.71 63.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.842 178.614 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.85 -51.09 70.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.818 179.493 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 1.2 mt -56.59 -37.89 71.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.705 179.016 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.3 -22.8 51.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.143 179.059 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -102.23 13.17 35.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.328 -178.655 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.586 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -85.56 16.34 3.93 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.357 179.966 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.61 -93.69 0.56 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.303 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 19.3 m -139.79 -89.23 0.19 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.8 tp -85.44 91.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.113 0.482 . . . . 0.0 109.874 178.804 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.586 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 11.1 p -106.99 137.41 37.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.693 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.35 102.76 14.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.458 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.468 ' HB2' HG21 ' A' ' 6' ' ' ILE . 11.9 mt -90.64 140.65 29.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.41 -178.697 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -101.95 131.87 48.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.273 179.569 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 6.8 m -139.79 136.55 39.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 -179.654 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.471 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 3.0 ptt? -105.92 138.74 41.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.911 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.36 146.51 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.025 179.883 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -149.73 177.95 9.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.522 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.425 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 27.1 m-85 -143.56 150.15 38.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -137.6 146.53 44.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.0 pm0 -108.49 144.56 35.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -136.81 110.33 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.531 179.779 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.95 116.95 20.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.711 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.9 tp -126.68 127.07 44.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.509 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pt-20 -85.52 100.41 11.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.327 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -48.52 88.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.254 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.41 177.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.554 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -55.39 -23.49 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.331 . . . . 0.0 111.139 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -98.76 -24.72 14.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.184 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.38 -163.94 28.41 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.182 -179.753 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.536 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.8 tp -64.99 -63.56 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.644 0.222 . . . . 0.0 110.695 179.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.4 21.37 1.05 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.89 -1.148 . . . . 0.0 114.726 178.537 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.749 ' HB3' HG22 ' A' ' 39' ' ' ILE . 6.2 p90 -161.6 135.96 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.935 0.868 . . . . 0.0 111.113 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.0 138.75 32.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.45 -179.459 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.66 148.81 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.727 0.775 . . . . 0.0 112.365 -179.642 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -142.15 134.21 27.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.281 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.68 -0.52 1.04 Allowed Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.807 179.491 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.494 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.88 -170.31 0.13 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.929 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.42 HG23 ' N ' ' A' ' 68' ' ' VAL . 18.1 p -74.9 -21.59 59.13 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.141 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.15 -25.14 15.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.719 0.295 . . . . 0.0 111.643 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -124.34 87.52 53.87 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.176 179.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.11 63.84 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.276 1.984 . . . . 0.0 112.576 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.726 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.3 t60 -49.52 -26.23 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.664 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.43 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.386 179.543 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -55.96 -50.83 59.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.704 -179.644 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.03 39.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.7 170.02 10.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.35 6.59 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.653 2.235 . . . . 0.0 112.843 -179.872 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.97 113.41 1.5 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.931 0.396 . . . . 0.0 110.57 179.722 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.65 119.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.023 -179.633 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.726 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.67 146.96 36.76 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.646 178.485 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.678 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.97 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.194 -176.566 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.77 -31.31 4.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.154 -179.038 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.84 132.14 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.114 -179.363 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.749 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.35 132.9 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.549 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.17 126.72 69.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.655 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.2 Cg_endo -66.16 132.3 29.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.658 2.239 . . . . 0.0 112.355 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.02 1.72 58.34 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.476 -179.833 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.91 173.97 22.08 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.957 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' A' ' 47' ' ' GLN . . . -52.25 -35.57 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -71.03 -57.21 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.748 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.38 -35.21 80.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 -179.161 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.426 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -72.08 -30.4 65.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.43 179.705 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.98 -58.13 3.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.647 179.929 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 41.43 10.09 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.579 179.451 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.499 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.2 mtt180 -116.44 7.95 13.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.1 tp -136.72 154.18 50.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.73 179.577 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.79 136.49 48.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.89 157.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.403 0.621 . . . . 0.0 111.513 179.839 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.52 -0.78 3.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.245 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.78 127.52 33.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.972 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.0 p -86.57 100.2 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.471 0.653 . . . . 0.0 111.605 -178.568 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.509 HD13 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -47.03 141.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.087 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.6 mm? -118.58 -45.03 2.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.183 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 m-85 -140.33 169.93 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.4 t -149.46 96.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.058 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.401 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 67.3 -68.15 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.176 0.512 . . . . 0.0 109.936 -178.784 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -154.47 30.75 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.683 179.244 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.3 t -117.28 142.18 32.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.386 -179.333 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 35.7 t0 -114.72 87.91 2.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.494 179.431 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 31.7 m -70.53 63.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 111.355 -179.543 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -29.62 30.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -154.68 64.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.817 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.458 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 34.7 m -128.15 146.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.78 153.62 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.067 0.46 . . . . 0.0 110.811 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.494 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 7.0 p-80 -49.6 -33.62 15.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.988 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -70.64 -33.82 71.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.416 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.78 -44.42 85.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 109.807 179.178 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.511 ' HB3' HD12 ' A' ' 34' ' ' ILE . . . -62.19 -46.84 87.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.569 0.7 . . . . 0.0 109.307 178.095 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.563 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 89.9 t -57.16 -49.33 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.281 178.647 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.72 -33.06 66.13 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.598 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.526 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -57.51 -51.42 69.51 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.522 . . . . 0.0 109.991 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.443 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -55.39 -37.54 67.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.472 178.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.53 -26.67 51.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.502 179.332 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -91.74 -12.62 33.42 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.579 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -55.97 -18.77 10.1 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.334 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.38 -100.34 2.32 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.142 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -126.9 -91.74 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.008 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.7 tp -87.78 94.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.205 0.526 . . . . 0.0 109.723 178.745 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 8.9 p -110.14 138.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.506 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.1 mtm105 -87.77 103.11 15.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.148 177.838 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.501 ' HB2' HG22 ' A' ' 6' ' ' ILE . 15.9 mt -92.5 139.04 30.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.175 -178.993 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.78 147.88 25.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.3 m -138.81 167.93 20.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.425 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.433 ' N ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER -101.49 156.88 17.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.336 . . . . 0.0 110.996 -179.932 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.62 106.71 5.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 -179.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.981 179.858 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' CE1' ' A' ' 3' ' ' TYR . 4.8 ttm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.799 0.333 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -78.47 141.43 38.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.468 ' CG ' ' CD1' ' A' ' 58' ' ' LEU . 2.7 m-30 -105.09 146.37 29.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -140.82 148.88 41.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -103.48 141.64 35.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' CD1' ' CD1' ' A' ' 51' ' ' LEU . 1.3 mt -130.66 109.33 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.19 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.475 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.85 112.14 15.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.708 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.574 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 4.5 tp -121.44 126.83 50.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.145 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 8.8 mt-10 -81.57 100.33 9.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.06 88.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.926 179.562 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -53.22 173.84 0.37 Allowed Glycine 0 N--CA 1.453 -0.221 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.66 -179.859 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -53.03 -25.82 13.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.713 0.292 . . . . 0.0 110.941 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 p -93.59 -24.73 17.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.161 179.896 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.72 -163.37 27.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.247 -179.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.7 tp -67.2 -63.56 1.03 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.433 0.159 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 134.14 20.16 0.84 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.599 178.675 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.736 ' HB3' HG21 ' A' ' 39' ' ' ILE . 8.6 p90 -162.76 134.53 5.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.986 0.893 . . . . 0.0 111.455 179.019 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.463 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.81 139.1 30.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.402 -179.566 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.69 147.37 23.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.68 0.752 . . . . 0.0 112.328 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.93 135.4 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.06 179.438 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.436 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.71 3.39 0.96 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.559 179.584 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.61 -168.36 0.29 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.874 -179.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.47 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 40.5 p -72.46 -30.01 64.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -96.09 -17.27 21.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.035 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.417 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.0 OUTLIER -124.84 82.66 60.32 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.248 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.36 62.32 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.777 2.318 . . . . 0.0 112.294 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.723 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.4 t60 -50.17 -23.45 2.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.538 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.659 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.81 -154.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.325 179.693 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.64 -50.19 69.69 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.537 -179.681 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.55 39.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.736 0.303 . . . . 0.0 110.766 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.75 164.67 33.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.999 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.25 3.69 6.02 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.05 2.5 . . . . 0.0 112.826 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 m -54.8 114.32 1.67 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.499 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.06 119.81 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.742 -179.898 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.723 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.17 148.5 38.35 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 178.722 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.22 155.59 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -176.73 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.468 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -34.06 3.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.595 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.561 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.56 141.61 2.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.552 -179.677 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.736 HG21 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -104.29 133.07 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.166 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 113.74 49.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -177.763 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.407 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 45.2 Cg_exo -56.74 140.53 91.11 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.756 2.304 . . . . 0.0 112.506 -179.828 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.37 13.01 64.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.421 -179.91 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.32 -176.91 19.08 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.038 179.751 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.429 ' O ' HD11 ' A' ' 8' ' ' LEU . . . -59.62 -35.62 74.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.846 0.355 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -70.88 -57.26 4.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.886 -179.615 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.407 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.31 -33.32 75.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.765 -179.041 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -72.34 -30.4 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 110.56 179.773 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.31 -58.22 3.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.059 -179.552 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 41.29 8.99 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.384 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -120.44 -2.14 10.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.696 0.284 . . . . 0.0 110.935 179.667 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.621 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 36.0 tp -124.37 162.96 22.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.147 0.499 . . . . 0.0 111.402 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.621 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.37 134.38 25.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.241 179.302 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.561 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.6 t -49.18 156.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.842 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.473 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.4 OUTLIER 76.54 -1.43 2.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.332 179.885 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -67.18 126.82 30.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.966 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.6 102.74 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.545 0.688 . . . . 0.0 111.533 -178.747 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 34' ' ' ILE . 69.3 mt -49.36 136.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.784 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.468 ' CD1' ' CG ' ' A' ' 3' ' ' TYR . 48.4 mt -120.61 -30.08 4.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.609 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -152.94 158.36 41.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.952 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.0 t -152.41 109.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 179.888 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.417 ' CB ' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER 49.77 47.92 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.84 179.999 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 73.13 31.4 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.823 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 73.6 t -120.2 142.06 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.832 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 8.9 p-10 -113.05 91.35 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.556 179.519 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 2.2 m -55.9 -102.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.17 -179.646 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.404 ' H ' ' CG2' ' A' ' 65' ' ' VAL . 5.1 mtp180 61.99 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.773 0.32 . . . . 0.0 111.24 179.74 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -88.25 51.92 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 -179.655 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.483 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 30.4 m -139.17 144.41 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.053 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.47 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.36 154.59 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.429 . . . . 0.0 111.038 -179.484 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.515 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.4 p-80 -48.15 -34.26 9.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.194 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -70.29 -33.89 72.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.393 179.921 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.604 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.77 -47.34 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.194 0.521 . . . . 0.0 109.624 179.079 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.499 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -59.31 -46.74 87.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.654 0.74 . . . . 0.0 109.36 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.596 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 85.1 t -56.86 -50.4 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.357 178.516 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.9 -28.59 57.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.991 178.649 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.98 -51.59 67.46 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.344 0.592 . . . . 0.0 109.691 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -56.75 -36.89 70.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.874 179.098 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.596 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.4 -30.52 53.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.852 179.712 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.429 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -97.85 19.76 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.42 -178.417 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -89.14 16.3 7.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 179.656 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.53 -93.44 0.81 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.225 -179.835 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.2 m -142.18 -90.6 0.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 6.0 tp -83.11 89.22 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.561 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.615 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 8.8 p -105.75 137.6 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.644 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.17 102.92 14.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.659 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.44 HD12 ' CD2' ' A' ' 15' ' ' LEU . 9.3 mt -92.77 137.7 32.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.172 -178.906 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CE2' ' CB ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 138.5 38.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.587 179.877 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 29.8 m -139.61 167.94 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.996 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.422 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 22.0 mtm -100.95 152.51 20.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.884 0.374 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.44 110.36 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.964 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.955 179.886 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttm . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.751 0.31 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.93 155.72 40.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CG ' HD11 ' A' ' 58' ' ' LEU . 6.4 m-85 -107.02 147.77 29.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.46 146.18 31.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.887 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -102.53 144.66 30.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.896 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.75 109.23 9.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.446 179.679 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.2 119.86 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.095 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.3 tp -131.07 126.9 37.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.48 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 pt-20 -84.29 100.49 11.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 179.354 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.7 89.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.042 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.27 174.38 0.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.603 -179.912 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -54.51 -24.23 19.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.72 -23.65 16.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.52 -163.66 27.85 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.147 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.8 tp -68.13 -63.56 1.04 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.836 -0.214 . . . . 0.0 110.798 -179.96 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.22 22.11 0.92 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 119.693 -1.242 . . . . 0.0 114.914 178.38 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.754 ' HB3' HG21 ' A' ' 39' ' ' ILE . 10.4 p90 -161.17 135.96 7.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.073 0.936 . . . . 0.0 111.351 179.101 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.75 135.36 36.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.528 -179.571 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -115.2 146.83 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.418 179.638 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.487 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -128.14 123.59 34.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.446 178.956 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.48 -124.91 1.41 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.939 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.453 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 73.14 168.71 13.9 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.214 179.877 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.437 ' HA ' ' HB3' ' A' ' 32' ' ' PRO . 6.3 p -75.53 -6.29 49.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -106.64 -26.92 11.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' HIS . 5.2 t-20 -124.91 86.97 55.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.579 -179.762 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.23 66.93 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.127 1.885 . . . . 0.0 112.455 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.748 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 37.4 t60 -52.39 -24.91 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.252 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.673 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.1 -153.71 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.388 179.723 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -52.33 -51.62 41.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.85 -179.366 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 169.8 41.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 0.0 110.846 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.06 173.59 5.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.437 ' HB3' ' HA ' ' A' ' 23' ' ' THR . 80.9 Cg_endo -84.66 41.6 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.734 2.289 . . . . 0.0 112.438 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -90.41 119.49 30.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.003 0.43 . . . . 0.0 111.267 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -90.69 112.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.044 179.643 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.748 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -138.29 147.42 43.58 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.369 0.604 . . . . 0.0 110.283 179.249 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.15 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.111 -176.663 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.482 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.67 -33.55 4.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.574 -179.225 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.98 142.19 2.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.911 0.386 . . . . 0.0 111.457 -179.762 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.754 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -104.75 132.96 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.967 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 125.13 73.96 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.278 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 41.4 Cg_endo -67.05 129.92 21.73 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.936 2.424 . . . . 0.0 112.189 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.91 49.93 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.02 178.84 19.8 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.878 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -54.92 -38.81 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.749 0.309 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -66.62 -57.47 7.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.634 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.47 -28.89 67.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.487 -179.684 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -33.57 68.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.966 0.413 . . . . 0.0 110.175 179.594 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -84.1 -57.99 2.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.66 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 41.27 9.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.604 179.638 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -111.21 -10.24 14.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.885 0.374 . . . . 0.0 110.78 179.621 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.6 tp -117.14 153.45 32.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.93 137.8 51.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.573 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -52.24 158.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.828 -179.967 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 3.5 t30 75.93 -0.09 3.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.325 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -69.11 125.53 26.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.18 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.69 100.69 12.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.672 . . . . 0.0 111.366 -178.837 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.507 ' N ' ' O ' ' A' ' 34' ' ' ILE . 61.4 mt -47.11 129.15 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.911 179.927 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD11 ' CG ' ' A' ' 3' ' ' TYR . 3.6 mt -114.95 -32.05 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.586 179.437 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.492 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -151.94 155.78 38.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 62' ' ' GLU . 46.0 t -142.2 102.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.631 179.572 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.13 -68.13 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.088 0.47 . . . . 0.0 110.462 -179.508 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' VAL . 8.3 pt-20 -155.06 30.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.907 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.0 t -117.87 142.09 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.2 t0 -109.93 87.77 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.366 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -63.37 -138.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.868 -179.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.2 -59.73 0.5 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.092 -179.184 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -100.8 30.16 4.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.293 179.03 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.446 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 12.2 m -127.55 142.77 42.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.389 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.41 152.97 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 21' ' ' GLY . 22.7 t-160 -47.91 -33.96 8.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -65.25 -34.17 77.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.091 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.662 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.816 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB3' HD13 ' A' ' 34' ' ' ILE . . . -63.07 -46.93 85.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.908 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.658 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 76.3 t -56.25 -50.91 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.287 178.601 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.58 -29.27 61.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.253 178.944 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.467 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -60.42 -56.83 16.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.962 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 74' ' ' VAL . 2.2 mp -53.4 -36.84 61.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.983 178.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.658 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.42 -27.4 52.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.642 179.521 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -99.44 14.64 29.07 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.435 -178.267 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.586 ' HB2' HG23 ' A' ' 84' ' ' VAL . . . -85.47 16.29 3.9 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.763 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.3 -86.71 0.05 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.191 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 13.3 p -144.14 -89.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.456 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 9.0 tp -84.21 92.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.176 0.512 . . . . 0.0 110.077 179.127 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 80' ' ' ALA . 7.1 p -108.1 137.92 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.898 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 11.0 ptp180 -88.29 102.7 15.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.188 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' CD2' ' CG1' ' A' ' 60' ' ' VAL . 11.2 mt -91.65 138.8 31.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.427 -178.52 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.49 137.36 39.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.138 179.584 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 55' ' ' ASP . 11.6 m -139.63 168.12 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.213 -179.4 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.419 ' HG3' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -102.4 150.83 22.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.97 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.58 106.96 5.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HB2' ' HG3' ' A' ' 91' ' ' ARG . 2.8 ttp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.889 0.375 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.21 132.21 53.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.478 -179.426 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.449 ' CE2' ' HG ' ' A' ' 58' ' ' LEU . 3.2 m-85 -108.88 109.75 20.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.346 179.426 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.61 166.98 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 111.493 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -119.52 144.95 46.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.87 111.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.99 0.424 . . . . 0.0 111.856 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.417 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.5 120.15 23.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.972 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.8 tp -129.83 126.8 38.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.613 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.6 pt-20 -86.68 100.74 12.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.233 179.312 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -47.86 88.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.325 179.531 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.14 177.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.781 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.14 -25.08 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.642 0.258 . . . . 0.0 111.06 -179.877 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t -97.64 -24.79 15.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.106 -179.909 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.7 -163.43 27.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.149 -179.791 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.526 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.1 tp -63.9 -63.45 1.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.485 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.409 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . 129.96 22.14 1.16 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.909 -1.138 . . . . 0.0 114.632 178.446 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.743 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.1 p90 -162.89 134.79 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.76 0.78 . . . . 0.0 111.228 179.02 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.38 139.41 31.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.672 -179.287 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -119.74 147.18 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.661 0.743 . . . . 0.0 112.306 -179.92 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -139.86 132.62 29.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.876 179.202 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 149.76 -6.48 0.75 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.491 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.32 179.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.977 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 19.1 p -65.03 -34.62 78.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.231 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.93 -17.58 29.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.557 -179.552 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -124.43 81.99 58.8 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.45 63.38 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.832 2.354 . . . . 0.0 112.522 -179.316 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.717 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 t60 -53.16 -22.3 6.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.674 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.43 -152.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.448 179.73 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -83.97 50.37 4.39 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.643 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 78.04 47.34 0.05 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.028 0.442 . . . . 0.0 110.455 179.744 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.98 151.46 72.18 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.45 -2.7 12.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.456 2.104 . . . . 0.0 112.576 179.976 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.16 119.25 4.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.537 179.695 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -86.55 120.34 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 -179.462 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.717 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.18 147.19 36.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.337 0.589 . . . . 0.0 110.564 178.479 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.676 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.12 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.943 -176.767 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.463 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.51 -30.95 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.783 -1.098 . . . . 0.0 112.215 -179.091 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.564 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.68 131.41 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.043 -179.408 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.743 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.84 132.14 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.492 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.446 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.32 124.22 74.08 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.719 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 34.9 Cg_endo -64.59 135.38 45.25 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.675 2.25 . . . . 0.0 112.242 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.94 7.13 60.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.486 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.09 174.51 17.65 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.904 179.804 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.64 -32.75 52.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.642 0.258 . . . . 0.0 111.209 -179.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -72.18 -57.42 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.547 -179.965 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.32 -28.91 67.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.446 -179.535 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -71.9 -31.58 66.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.197 179.596 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -83.83 -57.85 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.932 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.4 40.81 8.8 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.385 179.714 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.6 mtp85 -112.64 -9.23 13.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.017 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.3 tp -119.35 155.88 31.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.605 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.1 mpt_? -131.99 135.47 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.564 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.98 157.72 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.296 0.57 . . . . 0.0 111.721 179.889 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.3 OUTLIER 76.23 -1.27 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.715 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.3 m-20 -69.53 127.71 33.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.69 100.02 12.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.549 0.69 . . . . 0.0 111.281 -178.97 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.472 HD12 HG22 ' A' ' 19' ' ' ILE . 10.6 mt -45.74 144.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.026 -179.927 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.449 ' HG ' ' CE2' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -123.26 -44.36 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.205 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -140.97 165.78 26.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 62' ' ' GLU . 42.0 t -150.75 103.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.523 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' HB2' HG22 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 64.51 -71.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.108 0.48 . . . . 0.0 110.226 -179.24 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -151.14 28.56 0.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.816 179.3 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 21.5 t -116.04 142.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.21 -179.485 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 38.4 p-10 -103.59 -0.96 28.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.422 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 m 43.65 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.559 -179.645 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -51.92 99.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.765 179.91 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 11.3 pt-20 44.85 57.66 4.46 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 -179.58 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.55 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 4.9 m -108.51 145.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.25 156.84 14.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.337 -178.925 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.508 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.0 p-80 -48.9 -34.29 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.932 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -67.91 -33.86 75.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.55 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.29 -46.1 78.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.181 0.515 . . . . 0.0 109.649 178.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB2' HG23 ' A' ' 34' ' ' ILE . . . -62.37 -45.4 93.35 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.506 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 66.9 t -56.52 -50.43 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.113 178.517 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.595 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.48 -34.65 36.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.862 179.534 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.559 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.49 -57.34 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.437 HD13 ' CE1' ' A' ' 17' ' ' PHE . 2.4 mt -59.98 -41.32 91.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.38 0.61 . . . . 0.0 110.231 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.595 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.92 -20.13 56.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.766 179.641 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -112.22 23.44 13.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 179.271 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.52 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -82.92 16.57 2.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.752 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.52 -91.24 0.48 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.676 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.461 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.0 m -138.29 -90.73 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.859 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.1 tp -86.55 100.23 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.526 179.361 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.52 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 7.3 p -114.11 139.95 37.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.793 -178.171 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 11.7 mtt180 -88.12 103.51 15.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.603 178.441 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.491 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 17.7 mt -94.1 136.63 34.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -178.942 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 138.17 39.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.377 179.562 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 m -139.79 137.63 39.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.7 ptt? -108.37 135.44 49.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.776 179.781 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.403 ' C ' ' HG3' ' A' ' 1' ' ' MET . 0.4 OUTLIER -133.15 112.39 11.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.608 -179.491 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.289 -0.863 . . . . 0.0 110.914 179.818 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.856 0.36 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.92 133.56 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 71.1 m-85 -93.98 165.55 12.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.489 179.672 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -144.7 137.32 26.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.8 pt-20 -103.43 144.61 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.651 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.49 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -139.91 109.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 111.887 179.925 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.35 121.14 24.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.612 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 tp -130.44 127.2 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.233 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 3.1 mt-10 -77.78 99.72 6.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.201 179.59 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -62.57 90.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.235 178.455 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -136.74 179.59 17.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.996 -179.47 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 54.01 -91.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.578 0.228 . . . . 0.0 110.782 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m -108.38 14.65 24.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.652 0.263 . . . . 0.0 111.127 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 120.08 -138.54 13.13 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.868 -179.676 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.4 tp -75.25 -63.29 1.31 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.66 0.23 . . . . 0.0 110.591 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 133.61 19.12 0.96 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.942 -1.123 . . . . 0.0 114.775 178.596 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.755 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.7 p90 -161.31 137.05 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.755 0.778 . . . . 0.0 110.996 179.114 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.69 138.01 33.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.528 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.22 147.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.669 0.747 . . . . 0.0 112.302 -179.781 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -139.56 133.67 31.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.168 179.454 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.76 -7.48 1.08 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.531 179.57 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.542 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.54 -177.86 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.337 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 30.3 p -64.03 -33.72 76.39 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.914 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.78 -19.02 25.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.13 86.94 53.86 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.46 179.897 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.0 61.25 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.407 2.071 . . . . 0.0 112.4 -179.729 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.722 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 54.8 t60 -49.83 -26.12 3.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.187 178.967 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.686 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.99 -151.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.525 179.616 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -83.25 49.87 4.31 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.828 -178.951 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.18 45.11 0.09 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.088 0.47 . . . . 0.0 110.511 179.558 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.13 78.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.913 179.912 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.77 -1.16 10.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.38 2.053 . . . . 0.0 112.546 179.847 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -51.99 115.91 1.92 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.91 0.386 . . . . 0.0 110.462 179.524 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.526 HD12 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.06 118.21 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.145 -179.346 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.722 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.94 146.96 38.06 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.372 0.606 . . . . 0.0 110.474 178.42 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.1 155.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.191 -176.52 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.462 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.17 -30.96 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.133 -178.846 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.86 132.93 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.113 -179.496 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.755 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.53 132.05 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.889 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.17 116.17 63.66 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.627 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.39 135.56 68.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.757 2.304 . . . . 0.0 112.273 179.742 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.55 9.49 57.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.655 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.71 179.76 18.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.033 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.38 -36.52 66.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.755 0.312 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -68.98 -57.35 5.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.029 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.77 -29.94 68.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.02 -178.964 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.424 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.6 pt20 -72.04 -33.42 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.45 -58.04 3.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 41.09 9.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.594 179.479 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.49 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.2 mtt-85 -115.38 9.05 15.5 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.751 179.584 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.3 tp -136.19 154.58 50.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.627 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.15 135.59 46.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.85 179.841 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.558 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -51.4 157.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.437 0.637 . . . . 0.0 111.552 179.998 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.49 0.17 3.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.356 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.8 m-20 -71.35 127.73 33.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.0 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.4 p -86.49 100.41 12.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.576 0.703 . . . . 0.0 111.381 -178.597 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 34' ' ' ILE . 68.1 mt -45.46 151.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.127 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -128.91 -46.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.278 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -141.15 163.98 31.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 62' ' ' GLU . 24.4 t -148.67 101.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.603 179.573 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.72 -68.83 0.12 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.1 0.476 . . . . 0.0 110.389 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.8 mm-40 -154.13 30.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.799 179.29 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 19.7 t -117.66 142.2 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.165 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 34.5 p-10 -105.54 1.35 27.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.389 179.77 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m 43.62 30.84 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.813 0.339 . . . . 0.0 111.319 -179.638 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 95.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.992 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 57.04 63.0 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.745 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 19.7 m -119.29 147.72 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.447 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.06 155.6 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.214 -179.17 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.542 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.1 p-80 -48.17 -34.93 10.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.181 -179.454 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 m -69.83 -33.79 72.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.381 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.87 -47.29 75.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.0 109.645 178.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -60.3 -46.77 88.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.551 0.691 . . . . 0.0 109.493 178.2 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 87.7 t -57.41 -48.45 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.296 178.606 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.96 -34.87 68.48 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.518 178.553 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.56 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.46 -51.3 67.39 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.258 0.551 . . . . 0.0 110.016 179.337 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.434 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -55.28 -37.19 66.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.307 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.47 -26.74 51.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -96.2 6.1 49.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 111.437 -178.647 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -79.14 16.19 1.0 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.65 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.91 -91.11 0.5 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.347 -179.954 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 10' ' ' ARG . 38.6 m -143.87 -91.15 0.11 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.198 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 8.9 tp -81.68 92.69 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 109.726 178.693 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -110.89 137.05 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.262 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.8 ptt85 -87.04 103.09 15.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.196 177.676 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.476 ' HB2' HG22 ' A' ' 6' ' ' ILE . 18.5 mt -91.51 141.83 28.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.162 -178.983 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 144.32 30.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.624 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.73 167.52 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.435 179.714 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.406 ' N ' ' O ' ' A' ' 56' ' ' SER . 0.8 OUTLIER -104.29 139.82 38.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.998 -179.962 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.61 106.76 5.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.847 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.94 179.823 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.759 0.314 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.42 127.05 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.803 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.438 ' CD1' ' HG2' ' A' ' 89' ' ' MET . 3.6 m-30 -93.39 169.15 10.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.021 -179.867 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -164.2 147.1 9.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -102.58 144.65 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.499 HG23 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -135.56 109.44 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.487 179.846 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.406 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.47 113.29 17.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.047 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 tp -123.81 127.22 47.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.563 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 pt-20 -86.35 100.13 12.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.275 179.898 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HG2' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.16 89.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.266 178.328 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -125.12 173.03 17.26 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.345 -178.983 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m120 53.97 -91.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.481 0.181 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -108.46 12.83 25.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.636 0.255 . . . . 0.0 111.178 179.673 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.2 -143.23 14.67 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.777 -179.696 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.3 tp -67.37 -63.39 1.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.44 -179.998 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 127.94 24.7 1.17 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.854 178.139 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG21 ' A' ' 39' ' ' ILE . 6.1 p90 -162.18 134.95 5.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.985 0.892 . . . . 0.0 111.498 178.923 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.31 134.78 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.173 -179.679 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -111.68 166.74 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.706 0.765 . . . . 0.0 111.655 179.936 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -163.62 131.93 3.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.296 179.997 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.451 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.46 0.53 1.15 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.456 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.529 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.966 -179.976 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 68' ' ' VAL . 15.0 p -74.78 -20.03 59.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.18 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -98.39 -24.15 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 111.661 -179.376 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -124.53 87.89 53.9 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 179.814 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 63.07 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.317 2.011 . . . . 0.0 112.792 -179.368 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.75 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 38.9 t60 -48.29 -27.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 178.859 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.675 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.39 -154.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.557 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.435 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -56.53 -50.41 63.11 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.582 -179.708 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.01 40.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.914 0.388 . . . . 0.0 110.711 -179.98 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.26 167.22 16.95 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.999 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.92 8.55 4.25 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.645 2.23 . . . . 0.0 112.83 -179.995 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -60.49 113.76 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 110.772 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 HD12 ' HB3' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -81.34 119.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.446 179.962 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.75 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.42 145.0 33.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.37 0.605 . . . . 0.0 110.568 178.792 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.717 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.91 155.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.332 -176.333 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.11 -34.28 4.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.81 143.01 2.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 111.55 -179.602 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.748 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -105.77 132.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.097 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.436 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.02 125.91 71.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.475 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.1 Cg_endo -66.89 131.09 24.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 4.82 55.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.457 -179.649 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.78 177.67 21.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.726 179.685 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -55.19 -36.19 65.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.66 0.267 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -69.42 -57.53 5.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.517 -179.87 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.01 -28.92 67.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.12 -35.44 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.441 . . . . 0.0 110.0 179.318 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -83.59 -57.99 3.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.03 9.42 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.49 ' CB ' HG12 ' A' ' 6' ' ' ILE . 42.5 mtp180 -113.72 8.85 17.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.699 0.285 . . . . 0.0 110.662 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.6 tp -135.08 153.88 51.88 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.609 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.56 136.65 49.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.879 179.937 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.581 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.9 t -51.18 158.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.331 0.586 . . . . 0.0 111.676 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.29 2.17 4.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.023 179.911 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -71.02 126.03 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.988 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -86.48 101.95 13.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.652 0.739 . . . . 0.0 111.346 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.4 mt -49.74 136.27 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.38 -38.29 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.174 179.545 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.1 m-85 -147.34 172.01 14.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.798 -179.73 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.7 t -150.27 96.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.996 179.351 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.417 ' HB2' HG21 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 68.44 -67.17 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.193 0.52 . . . . 0.0 109.775 -178.789 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -156.28 32.34 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.555 179.209 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.8 t -119.23 142.33 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.57 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.9 p-10 -111.07 106.77 15.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.214 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 31.4 m -91.88 43.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.52 -179.517 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.58 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.736 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.43 66.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.6 m -134.6 145.63 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 151.69 28.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.753 -179.884 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.529 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 4.8 t-160 -48.98 -33.67 11.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 t -67.15 -34.06 76.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.045 179.642 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.637 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.39 -40.39 81.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.829 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' HB3' HD12 ' A' ' 34' ' ' ILE . . . -65.55 -46.76 78.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.112 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 97.4 t -57.19 -50.29 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.143 178.563 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.25 -33.04 62.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.693 178.646 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.515 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.218 0.533 . . . . 0.0 110.124 179.453 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.429 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.4 mt -53.12 -37.57 61.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.212 178.857 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.55 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.47 -27.58 52.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.305 178.953 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -87.63 -17.65 31.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.021 0.438 . . . . 0.0 111.092 -178.825 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -52.32 -21.42 3.51 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.489 179.828 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.04 -91.31 1.44 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.045 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -134.49 -92.87 0.31 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.7 tp -86.57 93.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.34 0.59 . . . . 0.0 109.983 178.961 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.576 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 11.7 p -110.17 139.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.232 -177.493 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.43 103.07 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.863 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' HB2' HG23 ' A' ' 6' ' ' ILE . 13.8 mt -93.81 135.73 34.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -101.73 139.92 36.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 -179.946 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 25.9 m -139.8 167.88 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.992 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.438 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 8.9 mtp -118.14 146.26 44.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -140.65 106.91 5.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.874 179.978 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.852 0.358 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.94 140.03 30.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.817 179.957 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CG ' HD22 ' A' ' 58' ' ' LEU . 9.9 m-30 -99.03 112.19 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.967 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.19 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.624 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 4.4 tt0 -130.36 141.65 50.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.683 0.278 . . . . 0.0 111.098 -179.822 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.493 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -138.1 112.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.026 0.441 . . . . 0.0 111.87 179.755 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -80.77 121.95 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.698 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' A' ' 15' ' ' LEU . 4.9 tp -131.14 127.14 37.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.368 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.4 pt-20 -82.96 100.36 10.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.208 179.276 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.03 88.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.107 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.75 174.02 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.61 -180.0 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -52.98 -25.51 12.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 0.0 111.028 179.997 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -96.01 -24.78 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.7 -164.1 27.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.368 -179.8 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 6.1 tp -63.95 -63.57 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.278 -0.169 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 128.02 28.15 0.88 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.922 178.33 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.754 ' HB3' HG21 ' A' ' 39' ' ' ILE . 5.7 p90 -162.9 132.92 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.879 0.84 . . . . 0.0 111.03 178.771 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -90.83 134.88 34.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.437 -179.2 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -113.03 163.63 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.703 0.763 . . . . 0.0 111.756 -179.944 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -159.06 130.67 6.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.931 179.452 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 146.91 -1.03 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.319 179.82 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.61 -172.08 0.25 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.91 -179.857 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 28.6 p -69.77 -34.38 73.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.308 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.43 -19.56 25.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.416 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -124.68 82.41 59.78 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 0.0 110.292 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.98 62.48 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.803 2.335 . . . . 0.0 112.224 -179.594 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.5 t60 -50.73 -23.39 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.413 179.016 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.666 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -93.92 -154.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.308 179.582 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -58.57 -50.26 68.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.584 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.13 40.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -127.84 168.52 14.99 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.022 -179.913 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.18 3.2 6.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.01 2.473 . . . . 0.0 112.702 -179.81 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -53.96 112.17 0.9 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.863 0.363 . . . . 0.0 111.092 -179.917 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.526 HD13 ' HB1' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.34 119.64 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.388 179.914 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.725 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.58 144.48 32.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.505 0.669 . . . . 0.0 110.585 178.952 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.07 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.88 -176.593 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.471 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.57 -31.9 4.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.809 -178.842 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.47 142.12 2.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.384 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.754 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -103.89 133.82 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.26 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.94 119.28 73.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.18 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.473 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.8 Cg_exo -58.87 132.6 48.61 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.757 2.304 . . . . 0.0 112.137 179.748 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.82 -1.16 59.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.763 -179.976 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.36 177.39 28.47 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.873 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -54.78 -35.53 63.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.969 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HB3' ' CG2' ' A' ' 39' ' ' ILE . . . -70.26 -57.39 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 -179.997 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.89 -28.97 68.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.318 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -71.81 -34.23 69.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.13 0.491 . . . . 0.0 109.889 179.509 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.08 -57.74 2.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.49 42.01 9.54 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.362 179.655 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.493 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtp180 -110.27 -18.64 13.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.688 179.765 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.588 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.8 tp -106.69 153.26 22.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.089 0.471 . . . . 0.0 110.666 179.371 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.588 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -127.85 135.89 50.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.919 179.825 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.569 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -50.29 160.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.49 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.2 m120 71.45 4.1 4.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.154 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -71.06 124.35 24.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.589 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.6 p -86.42 100.0 12.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.561 0.696 . . . . 0.0 111.709 -178.193 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' ILE . 9.9 mt -53.12 129.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.861 179.792 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.4 pp -122.53 -18.61 6.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.521 178.974 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -157.36 162.36 39.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.026 0.441 . . . . 0.0 110.652 -179.979 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 62' ' ' GLU . 24.8 t -143.92 97.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.86 179.41 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.477 ' HB2' HG22 ' A' ' 84' ' ' VAL . 1.3 t-20 66.59 -69.02 0.13 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.159 0.504 . . . . 0.0 109.889 -178.572 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -152.89 29.66 0.51 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.866 179.174 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.5 t -115.98 141.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.359 -179.402 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.5 p-10 -113.47 97.18 6.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.492 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.422 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 31.4 m -69.62 64.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.191 -179.781 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -91.31 101.02 13.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.547 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.41 51.01 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.019 -179.902 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.432 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 19.1 m -116.41 142.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 179.639 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.475 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.54 153.29 23.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.025 -179.129 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.485 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 6.1 p-80 -47.95 -33.82 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.963 -179.671 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -33.96 70.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.947 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.35 -44.56 82.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 109.724 179.321 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.526 ' HB1' HD13 ' A' ' 34' ' ' ILE . . . -62.01 -46.88 87.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.773 0.797 . . . . 0.0 109.161 178.095 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.631 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 90.0 t -56.22 -50.45 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.299 178.601 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.11 -29.84 61.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.379 179.071 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.471 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -61.94 -50.3 72.68 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.404 0.621 . . . . 0.0 109.986 179.57 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' CD2' ' CD1' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -59.05 -36.13 74.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.771 179.271 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.631 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -24.03 50.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.889 178.788 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -101.78 16.27 26.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.792 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.607 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -87.28 16.21 5.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.75 -93.97 0.75 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.316 -179.999 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.479 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.7 m -141.42 -89.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.581 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 6.8 tp -84.07 89.02 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.646 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.607 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 11.6 p -105.38 136.29 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.182 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.01 102.94 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.664 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 38.0 mt -89.12 137.34 32.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.389 -178.836 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.542 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.1 122.84 44.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.529 179.679 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 17.0 m -128.89 151.49 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.435 ' HG2' ' CE1' ' A' ' 3' ' ' TYR . 2.0 mtp -96.71 149.57 21.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.722 0.296 . . . . 0.0 110.874 -179.989 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.18 136.06 36.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.995 179.893 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.781 0.324 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -134.16 124.37 25.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.68 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CG ' HD11 ' A' ' 58' ' ' LEU . 6.4 m-85 -89.22 144.35 26.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.038 -179.775 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 11.2 pt-20 -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.73 144.71 46.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.495 HG22 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -136.7 109.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 111.863 179.857 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.91 116.37 20.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.525 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.595 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.9 tp -126.06 127.36 45.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.249 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.8 pm0 -86.84 100.46 12.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.713 179.596 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.569 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 1.3 mtm180 -44.32 91.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.682 179.109 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.34 70.54 0.02 OUTLIER Glycine 0 C--N 1.32 -0.342 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.256 -179.19 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 10' ' ' ARG . 4.4 t30 63.31 -72.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.815 0.34 . . . . 0.0 111.496 179.575 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 11' ' ' GLY . 74.7 m -69.98 -24.76 63.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.293 -179.692 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA2' ' CD ' ' A' ' 10' ' ' ARG . . . 153.11 -172.71 32.06 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.038 -179.776 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 16.4 mt -63.5 -63.59 1.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.493 179.9 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.0 34.62 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.71 179.318 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.752 ' HB3' HG21 ' A' ' 39' ' ' ILE . 7.7 p90 -159.64 138.08 10.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.137 0.469 . . . . 0.0 110.938 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.412 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.99 132.19 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.811 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.765 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -108.2 165.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.77 . . . . 0.0 111.803 -179.905 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -164.27 131.3 3.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.356 179.845 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.66 0.2 0.97 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.632 179.614 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.52 -170.96 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.977 -179.871 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 68' ' ' VAL . 13.2 p -75.34 -20.79 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.187 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.85 -24.96 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 -179.347 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -124.39 87.66 53.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.208 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 63.12 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.418 2.079 . . . . 0.0 112.686 -179.484 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.69 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.0 t60 -47.96 -27.9 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 178.887 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.617 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.59 -155.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.357 179.301 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.44 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.8 -46.78 59.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.562 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 176.71 73.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.731 -179.96 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -165.67 165.69 10.85 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -81.21 5.7 6.07 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.674 2.249 . . . . 0.0 112.923 -179.947 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.0 112.87 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -83.51 119.16 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 -179.911 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.69 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.26 145.9 34.54 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.505 0.669 . . . . 0.0 110.847 178.653 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.765 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.73 155.97 7.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.008 -176.897 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.432 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.88 -27.47 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.622 -178.411 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.64 128.67 0.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.211 -179.444 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.752 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.98 130.51 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.662 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.437 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 114.74 56.63 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.569 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.5 Cg_exo -57.94 135.58 69.73 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.781 2.32 . . . . 0.0 112.217 179.918 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.12 15.27 39.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.97 179.58 16.09 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.037 179.773 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 15' ' ' LEU . . . -53.33 -38.55 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.734 0.302 . . . . 0.0 111.343 -179.982 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -65.98 -57.65 7.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.012 -179.538 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.2 -28.76 64.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 -179.4 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -32.87 67.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.916 0.389 . . . . 0.0 110.264 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -79.63 -58.1 3.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.582 179.967 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.5 9.92 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.645 179.433 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.479 ' CB ' HG12 ' A' ' 6' ' ' ILE . 25.9 mtt180 -119.36 7.23 11.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.868 0.334 . . . . 0.0 110.941 179.68 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.5 tp -134.3 154.8 51.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.917 179.555 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 135.1 43.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.863 179.995 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 59.9 t -49.14 158.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.278 0.561 . . . . 0.0 111.55 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t-20 73.69 4.19 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.992 -179.807 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.4 m-20 -73.27 124.23 25.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.46 101.77 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.693 0.759 . . . . 0.0 111.63 -178.395 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.51 ' N ' ' O ' ' A' ' 34' ' ' ILE . 57.8 mt -49.46 137.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.436 HD11 ' CG ' ' A' ' 3' ' ' TYR . 3.9 mt -117.1 -34.03 4.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 179.246 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -149.55 169.24 21.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 62' ' ' GLU . 21.8 t -146.56 97.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.278 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.451 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.3 t30 67.26 -68.1 0.16 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.256 0.55 . . . . 0.0 109.82 -178.655 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -155.68 32.87 0.36 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.527 179.106 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 57.3 t -119.38 142.27 35.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.523 -179.12 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -110.0 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.294 179.052 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 30.6 m -92.48 40.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.36 . . . . 0.0 111.414 -179.66 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.831 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -151.59 66.33 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.438 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.6 m -133.08 145.42 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.75 151.89 24.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 -179.808 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.527 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.2 t-160 -49.49 -33.61 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 t -67.12 -33.99 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.994 179.583 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.611 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -40.07 80.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.772 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' HD12 ' A' ' 34' ' ' ILE . . . -65.68 -46.88 77.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.014 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.593 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 85.8 t -57.32 -49.99 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.251 178.533 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.611 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.15 -34.33 66.04 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.669 178.633 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.491 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -56.66 -51.07 70.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.182 0.515 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.426 ' CD1' ' CD1' ' A' ' 19' ' ' ILE . 1.2 mt -56.7 -36.35 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.476 178.955 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.26 -22.48 52.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.209 179.053 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -97.39 -11.99 23.3 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.38 -178.879 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB3' ' CG2' ' A' ' 84' ' ' VAL . . . -57.33 -18.99 19.64 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 179.944 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.07 -101.19 2.56 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.994 -179.825 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.569 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.9 p -127.67 -90.4 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.871 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 1.6 tp -87.19 91.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.589 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' A' ' 80' ' ' ALA . 10.3 p -107.16 137.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.296 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.2 ttt85 -86.71 103.1 14.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.131 177.762 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.495 ' HB2' HG22 ' A' ' 6' ' ' ILE . 11.4 mt -91.67 142.98 27.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.451 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.04 134.23 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.476 179.789 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.94 167.88 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 111.211 -179.724 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.456 ' HB2' ' OG ' ' A' ' 56' ' ' SER . 9.3 mtt -100.8 151.64 21.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.012 -179.991 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.6 106.35 5.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.148 179.946 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.944 179.774 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG3' ' HA ' ' A' ' 91' ' ' ARG . 3.9 mtm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.848 0.356 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.67 177.95 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.995 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.425 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 53.0 m-85 -145.01 144.46 31.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.002 179.998 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -142.7 148.23 36.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.48 144.88 31.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.694 179.78 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.459 HD12 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.51 109.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.933 -179.779 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.42 123.41 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.774 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 tp -133.69 126.78 31.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.089 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.1 OUTLIER -85.19 99.83 11.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.926 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' HB2' HD13 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -55.91 86.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.362 179.188 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -55.52 177.32 0.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.56 -179.509 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -52.36 -26.61 12.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.34 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 p -88.06 -24.96 23.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.956 179.868 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.28 -170.05 21.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.357 179.915 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 5.8 tp -65.57 -15.8 63.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.828 0.346 . . . . 0.0 110.985 179.906 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 43' ' ' GLY . . . 74.14 31.08 60.0 Favored Glycine 0 CA--C 1.519 0.281 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 177.829 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.754 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.5 p90 -164.52 131.38 3.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.282 1.041 . . . . 0.0 111.628 178.559 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -97.33 138.96 34.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.866 -179.083 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.7 148.93 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 112.01 179.864 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . . . -142.62 133.19 25.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.937 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.14 -3.32 0.9 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.586 179.783 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.49 179.97 0.12 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 26.5 p -65.24 -35.11 80.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.419 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.03 -17.14 29.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.628 0.251 . . . . 0.0 111.519 -179.486 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.56 82.05 59.45 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.043 0.449 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.14 62.87 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.853 2.368 . . . . 0.0 112.541 -179.291 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.713 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.5 t60 -52.28 -22.71 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 178.78 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.646 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.71 -154.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.645 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.429 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -60.03 -49.8 74.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.551 -179.798 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.51 39.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.56 167.44 17.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.833 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.11 1.93 8.74 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.668 2.245 . . . . 0.0 112.755 179.995 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.78 115.27 1.73 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -86.5 121.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.566 -179.831 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.713 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.08 146.88 35.94 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.315 0.579 . . . . 0.0 110.59 178.824 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.694 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.98 155.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.69 -176.897 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.449 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.52 -30.72 4.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.174 -178.971 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.75 128.32 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.212 -0.595 . . . . 0.0 112.33 -179.362 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.754 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.47 127.03 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.69 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.467 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.24 119.39 73.14 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -177.814 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.5 Cg_exo -54.36 140.32 73.3 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.718 2.279 . . . . 0.0 112.297 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.75 12.98 70.77 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.537 -179.923 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.61 -158.68 21.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.978 179.779 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -75.96 -38.85 57.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.869 0.334 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -74.13 -54.46 7.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.586 -179.63 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -60.59 -32.48 71.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 2.6 mm100 -72.36 -37.31 68.82 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.03 0.443 . . . . 0.0 110.308 179.514 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.62 -57.85 3.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.28 35.6 14.38 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.529 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.427 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.9 mmm180 -110.7 -12.56 14.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.701 179.584 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.2 tp -113.66 155.84 24.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.57 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.0 tpt180 -134.87 135.11 41.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.47 157.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.279 0.561 . . . . 0.0 111.638 179.935 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 4.9 t-20 75.7 -1.65 2.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.277 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.5 m-20 -68.48 126.6 30.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.936 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 p -86.57 100.14 12.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 111.471 -178.616 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.464 HD11 HG23 ' A' ' 19' ' ' ILE . 11.6 mt -45.47 153.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.813 179.999 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -136.79 -46.23 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.64 -179.669 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -142.21 167.11 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 62' ' ' GLU . 24.5 t -142.36 100.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.897 179.34 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.436 ' HB2' HG22 ' A' ' 84' ' ' VAL . 3.1 t-20 66.36 -68.04 0.14 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.199 0.523 . . . . 0.0 109.667 -178.517 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.2 mt-10 -156.65 31.28 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.38 178.974 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -116.36 142.52 29.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.452 -179.006 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 3.7 p-10 -108.29 120.18 41.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.505 179.176 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 19.1 m -93.79 37.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.15 -179.983 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -71.06 100.89 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.06 50.02 1.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 14.0 m -114.92 142.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.732 179.464 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.454 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.96 153.0 26.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.069 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.523 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 11.0 t-160 -48.79 -33.98 11.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.516 -179.964 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -34.12 76.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.301 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.96 -42.69 80.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.478 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' HB3' HD13 ' A' ' 34' ' ' ILE . . . -63.81 -46.66 84.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.003 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.511 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 58.0 t -57.17 -50.35 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.1 178.639 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.655 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.34 -32.55 38.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.772 179.222 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.533 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.38 -57.11 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.845 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.463 HD12 ' CZ ' ' A' ' 17' ' ' PHE . 4.2 mt -64.1 -39.79 94.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.009 -179.436 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.578 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -77.1 -20.06 56.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.334 -179.73 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.655 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 4.4 mm-40 -104.1 -10.78 17.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.02 0.438 . . . . 0.0 110.873 178.894 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.51 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -48.17 -20.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.566 179.944 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.62 -104.33 2.99 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -117.8 -92.89 0.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.764 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.3 tp -87.58 102.7 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.058 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 8.4 p -118.04 138.75 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.6 -178.6 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.6 mtm180 -87.05 103.56 15.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.638 178.817 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.515 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 18.4 mt -93.58 139.17 31.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.018 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.438 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 137.99 39.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.763 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.0 m -125.9 168.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.422 179.837 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 56' ' ' SER . 3.0 ttt -129.31 144.35 51.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 111.027 -179.931 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -121.55 129.77 53.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.887 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.42 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 3.1 ppt_? . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.078 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.861 0.362 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.07 123.35 43.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.467 ' CD1' ' CD2' ' A' ' 58' ' ' LEU . 4.0 m-30 -101.38 110.68 22.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -109.55 125.43 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.922 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 12.2 pt-20 -94.7 144.62 25.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -142.26 109.51 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.715 179.935 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.45 122.01 24.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.031 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.591 ' CD2' ' HB3' ' A' ' 15' ' ' LEU . 4.3 tp -132.02 128.03 37.45 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.556 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.4 pt-20 -86.43 100.5 12.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.32 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.459 ' HG3' ' CD2' ' A' ' 15' ' ' LEU . 6.1 mtp-105 -42.74 91.56 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.105 179.592 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.09 75.75 0.02 OUTLIER Glycine 0 C--N 1.317 -0.521 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.878 -179.545 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 10' ' ' ARG . 2.8 m120 62.97 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.358 179.688 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.1 m -70.08 -22.15 63.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.581 -179.641 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 150.33 -172.16 30.16 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.937 -179.709 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 11.5 mt -57.08 -63.64 1.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.945 0.403 . . . . 0.0 110.776 -179.907 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 134.21 38.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.397 179.505 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.736 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -164.12 134.06 4.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.195 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.439 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.54 136.93 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.638 -179.34 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.31 148.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.643 0.735 . . . . 0.0 112.032 179.934 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -141.98 131.83 24.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.688 179.264 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.82 -3.72 0.84 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.787 179.644 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.496 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.04 179.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.675 179.91 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.403 HG23 ' CB ' ' A' ' 32' ' ' PRO . 17.5 p -70.34 -21.55 62.89 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.43 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -92.02 -26.58 18.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.792 0.33 . . . . 0.0 111.271 -179.679 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -124.48 87.52 54.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.33 64.94 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.362 2.042 . . . . 0.0 112.653 -179.432 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.716 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.0 t60 -48.96 -27.43 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.404 178.998 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.636 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.54 -154.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.428 179.439 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -60.03 -49.45 78.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.691 -179.709 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.44 39.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.65 165.59 25.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 -179.929 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.403 ' CB ' HG23 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.03 1.98 8.69 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.656 2.237 . . . . 0.0 112.747 -179.822 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.57 116.66 2.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -86.32 120.05 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.592 -179.966 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.716 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.14 147.81 37.27 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.327 0.584 . . . . 0.0 110.726 178.762 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.69 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.12 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.828 -177.008 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.485 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -33.38 4.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.662 -179.173 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.576 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.26 142.84 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.0 111.41 -179.881 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.736 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -106.5 131.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.39 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.435 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -83.98 121.26 75.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.976 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.4 Cg_endo -63.89 136.95 55.5 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.836 2.358 . . . . 0.0 112.418 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 18.29 37.2 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.303 -179.894 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.63 179.42 16.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.233 179.886 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -56.09 -31.4 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.684 0.278 . . . . 0.0 111.384 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . . . -74.18 -56.57 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.511 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.71 -30.31 65.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.066 -178.992 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.414 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 15.6 pt20 -71.96 -31.61 66.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.999 0.428 . . . . 0.0 110.331 179.534 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.38 -57.99 3.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.682 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.4 9.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.62 179.521 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.437 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.3 mtt-85 -114.87 -7.59 12.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.925 179.697 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.583 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.1 tp -119.93 155.73 32.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.085 0.469 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.583 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.6 tpt180 -134.05 135.08 43.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 55.6 t -49.91 157.43 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.368 0.604 . . . . 0.0 111.56 -179.95 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 7.5 t-20 75.0 -0.89 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.118 -179.98 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.15 124.95 24.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 178.851 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 89' ' ' MET . 0.1 OUTLIER -86.55 100.32 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.649 . . . . 0.0 111.573 -178.386 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' N ' ' O ' ' A' ' 34' ' ' ILE . 10.4 mt -47.86 131.28 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.875 179.865 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.467 ' CD2' ' CD1' ' A' ' 3' ' ' TYR . 57.0 tp -114.3 -35.08 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.499 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -150.51 155.36 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.736 -179.817 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 62' ' ' GLU . 27.8 t -130.82 96.51 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.974 179.288 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.44 ' HB2' HG23 ' A' ' 84' ' ' VAL . 4.9 t30 67.59 -67.9 0.17 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.173 0.511 . . . . 0.0 109.797 -178.777 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 60' ' ' VAL . 15.7 mt-10 -153.6 31.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.752 179.122 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.8 t -119.8 142.19 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.39 -179.277 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 27.8 t0 -107.96 107.33 17.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.538 179.211 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.24 42.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -65.61 -30.76 71.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.799 179.907 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -154.68 69.03 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.493 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 10.1 m -133.14 144.75 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.075 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.02 152.59 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.726 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.496 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 14.2 t-160 -48.17 -33.92 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.903 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -33.94 76.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 179.335 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.555 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.83 -43.45 79.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.606 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HB2' HG23 ' A' ' 34' ' ' ILE . . . -62.85 -45.67 91.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.996 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.512 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 56.8 t -57.89 -50.31 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.191 178.635 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.691 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.95 -30.36 34.2 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.353 178.882 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.496 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.59 -56.98 6.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.596 -179.587 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.466 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 1.6 mt -65.19 -40.44 94.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.16 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.645 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -76.82 -20.23 56.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.701 -179.398 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.691 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.8 mm-40 -109.11 -5.49 15.97 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 179.179 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.517 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -48.21 -22.07 0.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.594 179.957 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.61 -101.62 1.97 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.599 -179.77 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.84 -91.45 0.55 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.626 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 2.3 tp -90.99 98.98 9.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.089 0.471 . . . . 0.0 110.265 179.108 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.517 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 12.3 p -113.07 138.18 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -177.792 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.0 ttt180 -86.93 103.86 15.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.143 178.933 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.457 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 16.7 mt -93.59 132.91 37.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.563 -179.253 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -101.99 151.5 22.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.539 179.691 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.5 m -139.68 119.61 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.343 -179.895 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.575 ' N ' ' O ' ' A' ' 56' ' ' SER . 1.4 ptt? -96.76 111.85 23.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.928 0.394 . . . . 0.0 111.371 179.875 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -117.05 146.68 42.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.066 179.965 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.83 179.859 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 1.7 mtm . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.735 0.302 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -132.29 144.88 50.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 -179.912 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD1' ' CD1' ' A' ' 58' ' ' LEU . 8.4 m-30 -111.4 135.7 51.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.898 179.8 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.53 143.55 48.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.888 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.41 144.87 29.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.053 179.957 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.435 HD12 ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.16 109.36 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.078 0.466 . . . . 0.0 111.411 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.445 ' CG2' HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.26 120.98 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.319 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.9 tp -129.71 126.69 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.634 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -86.66 100.88 12.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.185 179.178 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.65 88.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.211 179.599 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.5 178.02 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.608 -179.949 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -54.92 -25.32 28.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 111.125 -179.918 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -96.03 -24.62 16.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.207 -179.932 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.15 -162.3 27.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.059 -179.779 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 3.7 tp -66.16 -60.42 2.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.75 0.275 . . . . 0.0 110.441 179.94 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.404 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 129.22 19.4 1.55 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.021 -1.085 . . . . 0.0 114.513 178.404 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.734 ' HB3' HG22 ' A' ' 39' ' ' ILE . 6.6 p90 -162.09 137.33 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.844 0.822 . . . . 0.0 111.245 179.223 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.442 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.47 136.2 38.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.615 -179.426 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.54 156.62 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.736 0.779 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB2' ' CG ' ' A' ' 27' ' ' HIS . . . -152.22 132.38 13.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.75 -3.18 1.11 Allowed Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.669 179.639 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.36 178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.918 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 29.1 p -65.98 -27.38 68.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.246 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -93.43 -19.95 20.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.672 0.273 . . . . 0.0 111.63 -179.647 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.24 86.86 54.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.392 179.897 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 62.4 0.84 Allowed 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.396 2.064 . . . . 0.0 112.705 -179.409 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.701 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 26.4 t60 -48.1 -28.87 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.019 178.977 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.609 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.12 -155.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.121 179.277 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.421 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -68.2 -49.44 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.276 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -177.46 51.29 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.911 0.386 . . . . 0.0 111.153 -179.585 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 158.27 70.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.53 0.86 9.57 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.677 2.251 . . . . 0.0 112.661 179.978 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.9 m -54.31 119.85 5.73 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.958 0.408 . . . . 0.0 111.291 -179.912 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -85.43 119.93 34.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 179.824 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.701 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -141.82 146.67 36.14 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.399 0.618 . . . . 0.0 110.762 178.749 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -68.76 155.84 7.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.055 -176.636 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.452 ' O ' HG11 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.81 -30.38 4.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.307 -178.624 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.81 129.05 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.174 -179.321 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.734 HG22 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -94.91 131.68 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.569 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.23 113.88 51.11 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.825 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 49.7 Cg_exo -56.21 140.15 87.09 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.739 2.292 . . . . 0.0 112.392 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.82 10.37 64.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.483 -179.898 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.87 178.34 18.3 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.874 179.808 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.38 66.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.796 0.331 . . . . 0.0 111.067 -179.995 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HA ' HD12 ' A' ' 8' ' ' LEU . . . -68.87 -57.56 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.55 -28.73 67.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -71.88 -31.68 66.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.239 179.521 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 -57.78 3.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.96 35.77 14.87 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.439 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.427 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.3 mtt-85 -115.32 -2.06 12.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 111.227 179.874 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.9 tp -127.2 154.61 44.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.158 0.504 . . . . 0.0 111.34 179.98 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.546 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.71 135.29 43.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.543 179.93 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.558 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.47 157.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.496 179.934 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.8 0.43 3.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 -179.865 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 m-20 -69.67 126.08 28.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.931 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.2 p -86.49 100.39 12.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.467 0.651 . . . . 0.0 111.673 -178.322 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 34' ' ' ILE . 61.7 mt -48.72 146.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.077 -179.961 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.46 ' CD1' ' CD1' ' A' ' 3' ' ' TYR . 12.4 mt -128.25 -38.96 1.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.424 179.615 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -145.72 155.31 42.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.899 -179.758 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 62' ' ' GLU . 42.1 t -136.42 100.55 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.407 ' HB2' HG23 ' A' ' 84' ' ' VAL . 6.2 t-20 67.53 -67.04 0.19 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.958 0.408 . . . . 0.0 110.046 -179.14 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.3 mt-10 -157.29 32.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.751 179.289 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -120.72 142.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.539 -179.23 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.3 t0 -106.04 107.93 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.293 179.208 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 21.8 m -93.81 35.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.522 -179.623 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.48 -37.25 80.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 110.78 179.974 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.42 54.59 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -179.897 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 32.9 m -116.12 148.95 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.896 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.433 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -64.8 154.69 36.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.033 -179.378 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.534 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 19.1 t-160 -50.57 -33.94 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -34.03 75.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.133 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.586 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.62 -41.76 79.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 109.266 178.522 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -64.8 -46.12 83.37 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 78' ' ' LYS . 73.1 t -57.4 -50.51 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.029 178.564 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -51.58 -34.16 35.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.694 179.417 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -68.81 -57.59 5.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.248 -179.508 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CZ ' ' A' ' 17' ' ' PHE . 2.1 mt -60.53 -40.85 93.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.244 -179.772 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.78 -20.06 56.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.768 179.669 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 4.1 pt-20 -112.24 22.3 14.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 111.24 179.579 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.511 ' CB ' ' CG1' ' A' ' 84' ' ' VAL . . . -83.19 16.64 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.829 -179.729 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.91 -85.59 0.21 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.83 -179.783 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.459 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 40.3 m -142.3 -89.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 7.7 tp -86.37 105.64 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.869 0.366 . . . . 0.0 110.662 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' CG1' ' CB ' ' A' ' 80' ' ' ALA . 5.0 p -120.89 136.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.392 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.7 mtm105 -85.79 103.39 14.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.373 178.17 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.471 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 18.1 mt -93.98 134.8 35.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.394 -178.822 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -101.84 142.58 32.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.89 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 24.9 m -138.53 167.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 56' ' ' SER . 35.4 ttm -117.16 142.16 47.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 -179.914 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -129.13 133.56 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.668 179.9 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.444 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.005 -179.809 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.809 0.338 . . . . 0.0 111.215 . . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -127.88 124.06 36.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 15.9 m-30 -94.07 127.78 40.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.935 179.907 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -134.77 165.87 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.98 144.78 43.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 -179.837 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -133.83 109.51 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.402 179.876 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.41 119.68 21.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.65 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.9 tp -130.75 128.08 40.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.403 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.6 pt-20 -86.71 100.21 12.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.354 179.685 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -42.87 90.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.364 179.496 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.9 -171.66 0.03 OUTLIER Glycine 0 C--N 1.318 -0.419 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.638 179.77 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.98 -35.76 35.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.593 0.235 . . . . 0.0 111.552 -179.839 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -108.24 4.86 25.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.574 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 120.99 -168.45 14.11 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.843 -179.752 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.544 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . 18.4 mt -51.87 -63.54 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' HB1' ' A' ' 45' ' ' ALA . . . 129.42 33.02 0.54 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.515 179.458 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.776 ' HB3' HG21 ' A' ' 39' ' ' ILE . 7.0 p90 -157.86 137.41 12.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.977 0.389 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.437 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.88 136.71 37.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.302 -179.499 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -117.56 146.6 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.703 0.763 . . . . 0.0 112.264 -179.935 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -139.18 133.61 31.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.241 179.338 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.7 3.84 0.79 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.696 179.577 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.69 -169.26 0.5 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.902 -179.917 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.457 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 43.0 p -72.39 -27.86 62.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.104 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -93.75 -22.0 18.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.047 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -124.39 87.52 53.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.579 0.228 . . . . 0.0 110.485 -179.991 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 62.51 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.271 1.981 . . . . 0.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.8 t60 -47.16 -28.24 1.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.396 179.049 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.652 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.54 -154.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.362 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -59.5 -49.96 72.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.53 -179.697 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.03 40.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.6 164.06 36.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.81 1.77 7.26 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.0 112.776 -179.88 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -52.75 113.43 1.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.978 0.418 . . . . 0.0 111.07 -179.814 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.43 117.85 30.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.999 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.711 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.13 147.46 40.23 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.276 0.56 . . . . 0.0 110.644 178.673 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.711 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.06 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.042 -176.771 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.43 -30.1 4.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.321 -178.846 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.547 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.09 130.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.065 -179.447 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.776 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -95.96 130.53 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.636 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.456 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 123.84 74.61 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.752 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.1 Cg_endo -66.14 132.0 28.53 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.798 2.332 . . . . 0.0 112.256 -179.879 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.66 16.74 23.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.331 -179.916 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.46 178.69 16.82 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.985 179.862 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -53.15 -38.78 63.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.456 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . . . -65.44 -57.49 8.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.892 -179.502 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.83 -28.85 63.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -179.434 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -72.12 -34.15 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.543 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.12 -58.04 3.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.687 -179.936 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 38.08 13.93 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.624 179.452 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.482 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.9 mmt180 -117.9 7.05 12.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.776 0.322 . . . . 0.0 110.842 179.686 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.556 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.2 tp -133.22 154.53 50.57 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 110.835 179.585 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.556 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.19 135.47 45.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.957 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.547 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.61 157.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 111.751 179.965 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.45 -0.55 3.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.27 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.67 126.37 29.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.035 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.57 103.31 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 111.316 -178.812 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 34' ' ' ILE . 67.0 mt -51.21 134.21 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.723 -179.999 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 3' ' ' TYR . 2.2 mt -116.19 -28.11 6.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.662 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -153.77 165.99 34.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -148.18 98.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.018 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.4 t30 67.79 -67.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 -178.844 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.48 32.47 0.27 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.621 179.218 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.2 t -119.34 142.24 35.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.597 -179.293 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.7 p-10 -111.19 88.04 2.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.331 179.258 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 29.5 m -69.99 63.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.563 -179.522 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptm85 -86.93 -32.77 19.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.688 179.643 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -145.47 59.02 1.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.8 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 35.9 m -124.55 147.72 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.457 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.36 154.65 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 -179.464 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.524 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.4 p-80 -48.59 -34.32 11.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.137 -179.573 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -33.69 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.639 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.67 -45.44 82.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.525 ' HB3' HD12 ' A' ' 34' ' ' ILE . . . -60.9 -46.77 89.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 178.069 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 86.3 t -57.6 -48.22 83.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.94 -33.07 68.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.583 178.717 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -57.55 -50.12 74.14 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.286 0.565 . . . . 0.0 109.817 179.317 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -56.99 -36.61 70.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.449 178.868 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.8 mmmt -77.15 -24.72 51.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.97 -12.9 27.73 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.067 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.602 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -56.74 -19.29 16.09 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 179.721 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.19 -108.18 3.39 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.034 -179.881 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.88 -90.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.03 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.55 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 1.2 tp -89.63 91.54 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.388 0.613 . . . . 0.0 109.674 178.719 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -105.81 139.88 25.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.357 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -87.45 103.18 15.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.647 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 6' ' ' ILE . 13.4 mt -91.36 139.82 30.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.17 -178.985 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.77 134.1 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.618 179.893 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.1 m -139.69 167.96 18.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.188 179.846 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.414 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 4.1 ptt? -129.35 138.03 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.004 0.43 . . . . 0.0 111.158 179.896 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -112.14 141.23 46.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.814 179.911 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.419 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.052 -179.965 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.704 0.287 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -87.62 179.56 6.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 179.922 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' CD2' ' A' ' 58' ' ' LEU . 21.1 m-85 -136.26 111.98 9.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.971 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -105.01 170.75 7.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.722 179.647 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -131.83 144.77 51.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.486 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -138.91 111.07 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.909 0.385 . . . . 0.0 111.909 179.912 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -81.75 117.87 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.475 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 tp -127.26 127.22 44.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.255 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.34 100.08 11.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.522 179.432 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.37 87.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.181 179.258 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.57 175.15 0.06 OUTLIER Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.605 -179.825 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.13 -24.68 18.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.726 0.298 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.6 m -97.36 -23.69 15.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.982 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.82 -164.03 27.54 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.136 -179.889 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.509 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.7 tp -65.54 -63.59 1.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.549 179.934 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 128.76 25.21 1.03 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 119.789 -1.196 . . . . 0.0 114.801 178.409 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -162.97 135.19 5.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.873 0.836 . . . . 0.0 111.066 178.887 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.87 137.89 33.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.506 -179.242 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -118.8 146.24 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 112.404 179.929 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 27' ' ' HIS . . . -138.32 133.82 33.48 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.174 179.348 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.62 3.87 0.8 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.643 179.585 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.65 -168.85 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.893 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 41.5 p -72.14 -29.41 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.193 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.06 -20.76 20.22 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.162 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 35.7 t-20 -124.42 87.57 53.99 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.496 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.81 61.91 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.283 1.989 . . . . 0.0 112.388 -179.768 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.707 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 47.5 t60 -47.16 -28.45 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.185 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.655 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.0 -154.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.183 179.386 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -57.7 -50.01 69.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.57 -179.815 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 171.87 40.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.36 166.69 21.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.04 2.33 6.77 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.037 2.491 . . . . 0.0 112.733 -179.734 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.24 111.67 0.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.16 118.27 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.675 179.987 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.707 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -140.77 147.91 39.84 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.303 0.573 . . . . 0.0 110.725 178.629 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.698 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.09 155.61 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.986 -176.829 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.454 ' O ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.58 -30.78 4.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.039 -178.98 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.47 132.29 0.6 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -179.53 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.748 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -96.56 132.26 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.739 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.45 HD13 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.25 130.12 55.48 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.486 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 50.9 Cg_endo -69.14 129.97 19.24 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 -179.996 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 2.08 55.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.495 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.65 174.37 21.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.751 179.676 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' GLU . . . -52.7 -35.34 55.36 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.649 -0.324 . . . . 0.0 111.11 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HA ' HD22 ' A' ' 8' ' ' LEU . . . -70.85 -57.39 4.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.601 -179.799 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.47 -29.07 68.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -72.19 -35.38 68.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.048 0.451 . . . . 0.0 109.969 179.346 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -84.69 -57.94 2.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.614 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.22 41.38 9.37 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.556 179.625 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.486 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.7 mtp85 -112.05 8.88 20.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 4.9 tp -136.16 154.06 51.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.687 179.641 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.99 135.21 48.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.824 179.869 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.543 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.47 157.82 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.31 0.576 . . . . 0.0 111.595 -180.0 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.6 t-20 77.33 -2.96 2.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.473 179.866 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.17 125.12 24.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.085 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.61 100.25 12.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.503 0.668 . . . . 0.0 111.504 -178.579 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 34' ' ' ILE . 59.0 mt -49.97 134.92 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.433 179.507 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -133.69 12.08 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.614 179.367 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 170.83 141.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.962 -179.894 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 62' ' ' GLU . 25.3 t -131.56 99.7 4.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.879 179.274 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.434 ' HB2' HG21 ' A' ' 84' ' ' VAL . 2.9 t-20 69.76 -65.0 0.33 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 109.848 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -161.57 31.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.927 179.407 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.6 t -120.82 124.86 73.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.55 -179.337 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 21.0 p-10 -93.04 100.07 12.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.577 179.113 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.411 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 33.7 m -80.69 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -179.755 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -29.25 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -148.88 60.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 32.8 m -126.5 146.43 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.991 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.475 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.76 153.94 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 111.076 -179.353 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.508 ' N ' ' HA3' ' A' ' 22' ' ' GLY . 5.4 p-80 -48.34 -34.08 10.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.983 -179.515 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -33.83 69.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.181 179.757 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.632 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.68 -45.22 83.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 109.765 179.093 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.524 ' HB2' HD13 ' A' ' 34' ' ' ILE . . . -61.83 -46.69 88.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.536 0.684 . . . . 0.0 109.35 178.177 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.581 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 84.6 t -57.55 -48.06 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.369 178.586 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.632 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.62 -32.88 67.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.624 178.602 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -57.63 -50.39 73.31 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.837 179.241 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.1 mt -56.61 -37.26 70.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.555 178.891 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -77.56 -26.06 50.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.395 179.327 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -92.84 -12.4 31.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.061 -178.843 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.592 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -55.17 -20.17 9.73 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.268 179.763 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -95.34 1.35 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.12 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 39.5 m -134.61 -92.17 0.32 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.096 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.578 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.0 tp -85.72 89.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.28 0.562 . . . . 0.0 109.676 178.591 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.592 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 10.7 p -105.91 136.47 40.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.457 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 ttp180 -88.2 102.8 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.747 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.449 ' HB2' HG22 ' A' ' 6' ' ' ILE . 20.2 mt -90.59 136.24 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.813 -179.15 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.539 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.86 120.13 39.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.782 -179.889 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.3 m -123.22 142.95 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.829 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.42 ' HG2' ' CB ' ' A' ' 56' ' ' SER . 16.5 ptp -96.96 152.57 18.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 111.402 -179.676 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -140.57 145.0 36.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.014 179.904 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.939 179.799 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.28 143.73 42.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 -179.974 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.424 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 5.2 m-85 -109.31 147.45 32.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 179.814 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -146.7 154.0 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.31 144.78 31.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.972 -179.934 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.502 HG12 ' CB ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -135.25 109.97 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 111.623 179.819 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.24 119.11 20.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.75 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 tp -129.73 127.15 39.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.164 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.8 pt-20 -83.55 100.83 11.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.855 179.524 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HG3' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -54.01 89.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.102 178.657 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -130.38 176.03 19.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.41 -179.115 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 m120 54.96 -92.41 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.498 0.19 . . . . 0.0 110.73 -179.853 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 p -108.27 11.38 27.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.62 0.247 . . . . 0.0 110.975 179.669 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 126.03 -140.12 11.91 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.641 -179.595 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.526 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 4.3 tp -70.57 -36.15 73.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.401 179.699 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 45' ' ' ALA . . . 102.78 19.3 13.5 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.422 -0.894 . . . . 0.0 114.808 177.912 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.79 ' HB3' HG21 ' A' ' 39' ' ' ILE . 3.7 p90 -155.23 135.76 13.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.912 0.856 . . . . 0.0 110.89 179.126 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.431 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.68 135.98 37.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.404 -179.421 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.727 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -114.46 146.12 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.603 0.716 . . . . 0.0 111.928 179.79 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.498 ' CB ' ' CG ' ' A' ' 27' ' ' HIS . . . -124.81 118.65 26.85 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.51 177.988 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 146.08 165.61 11.56 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.575 -179.006 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.93 173.53 13.57 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.244 -179.691 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.4 p -67.14 -17.79 65.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.366 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -106.39 -27.28 11.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.686 0.279 . . . . 0.0 111.417 -179.67 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -124.32 87.0 54.29 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.9 64.39 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.362 2.041 . . . . 0.0 112.607 -179.653 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.785 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.2 t60 -47.72 -28.92 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.525 179.207 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.643 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.65 -152.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.687 179.776 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -81.84 52.53 4.61 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.87 -178.761 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t0 76.59 44.9 0.11 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.494 179.575 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -137.14 157.31 74.68 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -179.941 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.12 -2.2 11.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.699 2.266 . . . . 0.0 112.508 179.823 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.47 112.6 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.006 0.432 . . . . 0.0 111.561 -179.654 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.3 OUTLIER -88.71 119.89 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.757 179.219 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.785 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.14 147.9 37.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.485 0.659 . . . . 0.0 110.844 179.369 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.727 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -69.32 156.04 7.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.565 -177.319 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.67 -28.78 4.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.134 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.25 129.14 0.36 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.17 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.79 HG21 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -93.3 125.02 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.79 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.525 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 132.73 46.59 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.783 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_exo -64.37 70.05 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.492 2.128 . . . . 0.0 110.887 178.9 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -104.82 -25.5 6.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.888 -179.076 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.742 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . 121.65 -30.59 5.29 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.397 -179.87 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' HD11 ' A' ' 8' ' ' LEU . . . -77.69 -70.32 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.152 179.707 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -75.92 -45.63 34.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.368 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.49 -42.22 95.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.741 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.742 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -72.15 -33.31 67.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.11 -58.36 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.08 0.467 . . . . 0.0 111.028 -179.015 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.84 25.83 63.87 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.502 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtm-85 -108.11 -23.34 12.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.895 0.379 . . . . 0.0 110.303 179.553 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.569 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 6.3 tp -104.17 154.24 19.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.428 179.005 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 ttp85 -134.85 135.7 41.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.554 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -49.04 157.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.308 0.575 . . . . 0.0 111.539 179.994 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 36' ' ' ILE . 0.6 OUTLIER 73.32 3.03 4.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.084 -179.746 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -71.61 125.86 28.19 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.958 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -86.68 101.39 13.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.608 0.718 . . . . 0.0 111.74 -178.408 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 34' ' ' ILE . 12.4 mt -49.33 131.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.923 179.84 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 3' ' ' TYR . 2.3 mt -114.74 -35.03 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.073 179.281 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -148.8 167.53 25.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.833 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -147.74 98.43 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.034 179.471 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' HB2' HG23 ' A' ' 84' ' ' VAL . 5.5 t30 68.62 -66.61 0.23 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.071 0.462 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.16 32.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.741 179.312 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 62.1 t -120.88 142.21 37.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.523 -179.33 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -104.16 110.2 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.328 179.103 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 m -91.52 19.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.773 -179.523 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -59.55 -28.25 66.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.7 56.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.411 ' HB ' ' CB ' ' A' ' 72' ' ' ALA . 18.4 m -125.7 143.12 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.32 151.74 35.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.692 -179.833 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.474 ' CD2' ' C ' ' A' ' 70' ' ' HIS . 0.9 OUTLIER -47.88 -34.32 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.658 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -71.45 -33.88 69.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.932 179.521 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.644 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.58 -40.47 84.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 34' ' ' ILE . . . -63.93 -46.96 82.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.644 0.735 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.615 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 73.5 t -58.67 -50.66 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.198 178.676 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.644 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.35 -31.08 63.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -59.68 -50.45 73.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.367 0.603 . . . . 0.0 109.91 179.643 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 HD12 ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -59.23 -36.83 76.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.084 179.291 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.61 -25.38 49.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.631 179.595 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -101.4 13.96 33.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.736 0.303 . . . . 0.0 111.647 -178.344 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.617 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . . . -85.32 11.78 9.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.66 -90.16 0.85 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 179.735 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.1 p -144.63 -90.22 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 9.1 tp -84.08 90.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.191 0.52 . . . . 0.0 109.714 178.67 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.617 ' CG1' ' HB3' ' A' ' 80' ' ' ALA . 8.7 p -107.54 139.3 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.361 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 10.1 mtp180 -86.92 103.12 15.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.742 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.493 ' HB2' HG23 ' A' ' 6' ' ' ILE . 15.5 mt -92.95 138.28 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 -178.788 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -101.84 136.44 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.647 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 6.8 m -139.67 167.84 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.521 -179.89 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.44 ' HB2' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -115.55 150.48 36.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.348 . . . . 0.0 110.869 179.904 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -140.39 140.64 35.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 179.911 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 3.6 ttt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.89 0.376 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.18 -169.91 2.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.3 -179.462 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.435 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 29.2 m-85 -136.18 139.81 43.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.741 -179.988 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.45 146.85 40.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.946 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -103.28 144.38 31.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.966 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.36 109.13 8.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.924 0.392 . . . . 0.0 111.6 179.882 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -78.25 113.65 16.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.93 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 83' ' ' ILE . 4.7 tp -124.87 126.94 46.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.9 pt-20 -85.82 100.77 12.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.073 179.29 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -46.97 89.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.323 179.893 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.41 177.72 0.04 OUTLIER Glycine 0 C--N 1.318 -0.456 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.639 -179.93 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -53.82 -26.72 25.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.145 -179.934 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.2 p -97.4 -22.93 16.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.154 179.998 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.93 -164.6 27.12 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.982 -179.774 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.512 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 5.3 tp -59.64 -63.29 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.737 -179.976 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.51 25.82 1.12 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.422 178.437 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.768 ' HB3' HG22 ' A' ' 39' ' ' ILE . 5.5 p90 -164.8 131.68 3.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.565 0.682 . . . . 0.0 110.849 178.86 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -91.67 138.36 31.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.653 -179.006 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -121.78 142.29 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 121.711 0.767 . . . . 0.0 112.222 179.78 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB3' ' HB2' ' A' ' 27' ' ' HIS . . . -105.64 117.85 35.09 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.695 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 34' ' ' ILE . . . -73.21 -159.27 5.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -176.258 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.68 -42.93 0.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.783 -0.709 . . . . 0.0 114.15 -177.935 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.668 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -73.1 -54.06 9.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.039 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -81.25 -43.58 18.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.071 0.462 . . . . 0.0 111.004 -179.621 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.4 OUTLIER -124.83 83.45 59.41 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.479 179.462 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.95 69.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.638 2.225 . . . . 0.0 112.378 -179.104 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.799 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 12.5 t60 -58.23 -18.24 24.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.254 179.31 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.653 ' HB ' ' CE1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.26 -154.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.409 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.35 -49.5 69.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.57 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 167.98 41.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 179.995 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.22 155.6 75.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.64 55.76 4.39 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.941 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -117.12 107.12 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 179.697 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.614 ' HA ' ' HA2' ' A' ' 21' ' ' GLY . 3.1 mt -79.01 130.63 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.994 -179.632 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.799 ' CZ ' ' CD2' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -142.98 152.53 42.07 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.214 0.531 . . . . 0.0 110.389 179.495 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 19' ' ' ILE . 0.3 OUTLIER -69.42 155.57 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.489 -177.096 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.456 ' CG2' ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.09 -28.43 4.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.974 -179.27 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.86 130.6 0.41 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.943 -179.625 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.768 HG22 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -95.33 132.58 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.557 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 114.77 56.74 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.651 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 47.9 Cg_exo -56.36 137.79 81.43 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.733 2.289 . . . . 0.0 112.201 179.913 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.91 66.35 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.67 -179.994 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.98 -178.13 22.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 8' ' ' LEU . . . -59.48 -33.55 71.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -179.955 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -72.95 -56.92 4.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.781 -179.885 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.45 -31.1 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.855 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -72.15 -32.51 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.035 0.445 . . . . 0.0 110.138 179.615 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -80.75 -57.96 3.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.553 179.94 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.54 9.3 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.715 179.564 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.6 mtt180 -114.96 7.46 15.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 179.544 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 52' ' ' ARG . 5.9 tp -136.42 154.31 50.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.107 0.479 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.35 135.22 46.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.614 179.833 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.53 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 60.6 t -49.06 157.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 0.0 111.815 -179.878 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t30 78.22 -5.32 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.469 179.972 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -64.03 127.93 33.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.169 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.89 105.2 16.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -178.846 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.495 ' CD1' HG21 ' A' ' 34' ' ' ILE . 64.1 mt -48.92 134.87 6.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.522 179.792 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -120.17 -43.49 2.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.444 179.865 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -144.55 158.65 43.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.903 -179.893 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.3 t -140.03 98.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.256 179.444 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 t30 67.74 -67.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.46 . . . . 0.0 110.22 -178.973 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -155.12 31.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.927 179.361 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.4 t -120.81 142.39 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.403 -179.312 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.4 p-10 -103.28 108.84 20.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.473 179.402 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' CG2' ' CG2' ' A' ' 57' ' ' ILE . 29.2 m -97.32 29.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -38.01 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.413 . . . . 0.0 110.683 179.762 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -144.23 57.91 1.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.786 179.803 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.552 ' O ' HG21 ' A' ' 23' ' ' THR . 27.6 m -121.19 140.05 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.341 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.668 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 2.5 p -52.2 150.92 4.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.011 -178.425 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.52 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . 1.9 t-160 -47.07 -33.36 4.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.368 179.552 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -71.54 -33.76 69.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 179.713 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.38 -31.7 67.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 109.753 178.827 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.44 -46.91 58.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.537 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.632 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 94.6 t -60.87 -50.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.728 178.735 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.8 pt-20 -57.45 -29.56 64.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.66 178.543 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -60.59 -51.4 69.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.795 179.456 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.489 ' CD1' ' CE1' ' A' ' 17' ' ' PHE . 1.2 mt -58.2 -35.12 71.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.178 179.191 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.15 -31.75 55.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.859 179.912 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.0 pt-20 -96.07 17.22 16.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.527 -178.523 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.642 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . . . -89.54 16.34 7.88 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.323 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.01 -103.51 1.01 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.509 179.858 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.529 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -127.15 -89.41 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.466 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 9' ' ' GLU . 7.4 tp -84.68 94.73 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 109.878 178.909 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.642 ' CG1' ' HB2' ' A' ' 80' ' ' ALA . 7.6 p -111.06 136.43 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.444 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 10.4 ptt85 -85.58 102.87 13.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.457 ' CD1' ' HZ ' ' A' ' 17' ' ' PHE . 15.9 mt -92.09 139.72 30.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.549 -178.499 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.64 135.47 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.963 179.39 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 55' ' ' ASP . 6.6 m -137.69 168.07 21.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.758 -179.526 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -108.01 141.64 39.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.649 0.261 . . . . 0.0 110.733 -179.989 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.62 106.84 5.23 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.271 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.03 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.437 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.0 m-30 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -117.12 161.93 18.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.2 tt0 -115.92 144.63 43.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.085 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.84 111.69 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.773 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.5 115.63 20.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.085 HD13 HD11 ' A' ' 6' ' ' ILE . 4.8 tp -126.05 127.11 45.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -85.5 100.66 12.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.054 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.35 89.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.188 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.321 -0.287 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.496 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.992 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.81 -0.071 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.55 22.35 0.96 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 119.725 -1.226 . . . . 0.0 114.97 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.6 p90 -161.59 135.35 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.063 0.932 . . . . 0.0 111.224 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.495 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.55 135.47 34.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.98 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.16 147.7 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.541 0.686 . . . . 0.0 111.568 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.637 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.64 119.72 27.73 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.43 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 143.66 159.3 7.93 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.551 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 145.09 173.64 16.56 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.384 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 68' ' ' VAL . 24.3 p -63.67 -14.44 52.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.79 -25.79 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -124.25 86.77 54.29 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.486 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 64.13 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.306 2.004 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.58 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 10.8 t-80 -49.05 -27.16 3.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.527 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.45 -152.29 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.693 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.79 52.65 4.62 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.941 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 76.54 43.36 0.14 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 158.78 74.15 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.929 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 72.9 Cg_endo -76.19 0.33 9.49 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.507 2.138 . . . . 0.0 112.569 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.1 114.92 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.23 119.62 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.984 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.41 147.65 36.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.119 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.34 155.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.655 -177.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.0 -32.86 4.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.753 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.33 142.11 2.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 111.424 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.51 133.35 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.044 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 122.69 76.2 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.4 Cg_endo -64.63 132.18 32.12 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.23 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.96 5.31 56.47 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.412 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.07 179.17 21.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.804 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.66 -39.08 70.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 111.121 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.825 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -66.4 -57.4 7.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.466 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.8 -28.82 67.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.382 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -72.25 -34.61 68.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.069 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.72 -57.97 3.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.16 41.23 9.53 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.474 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.4 mmp_? -113.14 -4.72 13.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.773 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.119 HD21 HD12 ' A' ' 36' ' ' ILE . 5.0 tp -121.44 153.66 37.58 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.019 0.438 . . . . 0.0 110.822 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.12 135.28 48.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.689 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.14 157.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 111.758 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.47 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 t30 75.41 0.99 3.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.17 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -68.55 125.18 25.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 102.23 13.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.625 . . . . 0.0 111.602 -178.581 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.98 HD11 HG21 ' A' ' 19' ' ' ILE . 16.4 mt -49.8 124.94 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.866 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mt -109.76 -34.14 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.972 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.8 m-85 -150.27 161.22 42.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 76' ' ' ALA . 6.9 p -148.7 103.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.626 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 70.42 -66.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.289 0.566 . . . . 0.0 109.907 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.39 29.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' HG13 ' A' ' 60' ' ' VAL . 1.4 t -121.01 142.0 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.492 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.0 p-10 -101.07 111.45 23.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.859 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.689 HG21 HG22 ' A' ' 57' ' ' ILE . 21.3 m -89.68 24.1 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -67.85 -22.13 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 110.734 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -145.97 44.62 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 23' ' ' THR . 19.0 m -117.87 148.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.459 HG22 ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -67.52 151.99 46.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.54 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.798 ' O ' HG23 ' A' ' 74' ' ' VAL . 9.8 t-160 -49.55 -34.1 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.533 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 20.0 m -71.76 -33.66 68.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.495 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.49 -39.72 81.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -64.32 -46.88 81.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.616 0.722 . . . . 0.0 109.226 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.7 t -59.97 -50.63 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.333 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 2.2 pt-20 -57.75 -35.12 70.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.637 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -55.33 -51.92 65.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.269 0.557 . . . . 0.0 110.228 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 19' ' ' ILE . 6.2 mt -56.42 -36.64 69.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.533 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.32 -25.67 51.42 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.478 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.3 mt-10 -96.6 -6.96 35.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.294 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.921 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.62 -17.74 16.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.147 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.54 -100.74 2.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.9 m -130.45 -91.31 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 7' ' ' THR . 5.4 tp -87.03 86.27 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.254 0.55 . . . . 0.0 109.559 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.921 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.6 p -101.29 138.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HG2' HG23 ' A' ' 7' ' ' THR . 2.5 mtt180 -88.68 103.2 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.041 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.907 ' CD2' HG23 ' A' ' 60' ' ' VAL . 12.3 mt -92.6 138.04 31.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.722 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 133.53 46.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.7 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.144 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.8 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.762 0.315 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -139.83 160.2 40.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.2 mt-10 -117.08 144.9 44.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.835 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.074 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.82 111.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.886 0.374 . . . . 0.0 111.73 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.806 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.42 115.6 20.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.074 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -126.09 127.08 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.25 100.4 11.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.126 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.78 88.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.067 179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.628 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.65 21.01 1.05 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.716 -1.23 . . . . 0.0 114.754 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.5 p90 -161.62 135.6 6.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.999 0.9 . . . . 0.0 111.12 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.47 138.55 32.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.455 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.096 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.14 146.5 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.691 0.757 . . . . 0.0 112.228 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.43 134.59 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.198 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.3 -5.32 1.4 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.573 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.57 -175.36 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.113 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 68' ' ' VAL . 16.1 p -71.43 -19.23 62.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.62 -24.91 15.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.591 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 2.2 t30 -124.41 87.91 53.66 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.099 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.96 63.07 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.463 2.109 . . . . 0.0 112.631 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.596 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 14.4 t-80 -50.59 -25.74 4.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.165 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.774 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.73 -151.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.513 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.56 49.75 4.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.843 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 76.88 45.38 0.09 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.03 153.75 78.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.636 ' CB ' HG22 ' A' ' 23' ' ' THR . 74.2 Cg_endo -75.39 -0.17 9.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.468 2.112 . . . . 0.0 112.657 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.87 115.24 1.9 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.943 0.402 . . . . 0.0 110.495 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.08 119.8 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.092 -179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.774 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.05 147.41 36.78 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.348 0.594 . . . . 0.0 110.461 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.014 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.14 155.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.059 -176.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.05 -31.83 4.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.986 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.41 134.24 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.042 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.986 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.52 132.93 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.26 123.84 74.65 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 36.9 Cg_endo -65.18 132.68 32.56 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 112.289 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.2 5.5 57.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.48 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.84 178.56 20.93 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.928 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.65 -37.72 68.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.757 0.313 . . . . 0.0 111.179 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.819 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -67.78 -57.51 6.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.417 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.53 -28.87 68.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -72.13 -34.52 68.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.063 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.5 -58.07 2.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.6 41.02 9.25 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.481 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.514 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mtm180 -113.8 6.24 16.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.014 HD21 HD12 ' A' ' 36' ' ' ILE . 5.6 tp -132.8 154.6 50.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.071 0.462 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.606 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -130.86 136.1 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -51.74 157.78 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.315 0.578 . . . . 0.0 111.663 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.6 -2.01 2.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.352 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.652 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.4 m-20 -67.82 126.34 29.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.65 104.14 15.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.489 0.661 . . . . 0.0 111.259 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.096 HD11 HG21 ' A' ' 19' ' ' ILE . 67.8 mt -52.71 133.84 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.96 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 3' ' ' TYR . 14.2 mt -116.62 -28.56 6.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.661 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -156.29 149.54 24.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.826 HG13 ' CD2' ' A' ' 86' ' ' LEU . 39.8 t -139.44 105.94 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.168 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 t30 55.04 38.68 30.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 110.108 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 78.86 33.43 0.25 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.475 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 60' ' ' VAL . 92.7 t -120.99 107.82 21.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.596 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.5 t0 -74.01 111.6 9.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.744 0.307 . . . . 0.0 110.564 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 35.0 m -96.56 29.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -59.86 -22.71 62.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -150.8 76.27 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 111.106 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 23' ' ' THR . 35.4 m -149.81 145.75 17.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.19 155.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.212 0.529 . . . . 0.0 111.154 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.6 p-80 -50.89 -33.7 25.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.886 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.5 t -72.14 -33.96 68.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.686 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.32 -40.8 90.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.196 0.522 . . . . 0.0 109.874 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.48 -46.85 78.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.668 0.747 . . . . 0.0 109.168 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.2 t -56.9 -50.27 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.255 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.92 -29.24 59.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.917 178.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.619 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -62.32 -51.9 65.81 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 109.81 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.025 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.03 -37.52 66.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.558 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -27.41 52.13 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.244 179.225 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.28 14.72 25.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.313 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.924 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.77 16.42 4.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.517 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.27 -92.0 0.56 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.276 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.6 m -142.19 -90.25 0.14 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.806 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -84.67 90.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.283 0.563 . . . . 0.0 109.723 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.924 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -105.82 138.11 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.4 ttt180 -88.29 102.87 15.27 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.826 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.4 mt -91.45 138.49 31.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.239 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.65 134.51 44.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.652 HG21 ' OD2' ' A' ' 55' ' ' ASP . 6.2 m . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-85 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.732 0.301 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 8.6 mt-10 -118.84 153.01 35.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.15 144.91 31.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.481 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.028 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.19 110.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.443 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.821 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.73 117.61 20.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.028 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -127.6 127.0 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.4 pt-20 -83.96 100.45 11.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.296 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -51.4 88.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.322 -0.23 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.586 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.986 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.5 tp . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.283 0.087 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.81 21.28 1.01 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.707 -1.235 . . . . 0.0 114.614 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.86 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.3 p90 -161.31 134.7 6.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.874 0.837 . . . . 0.0 110.981 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.32 135.43 34.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.566 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.88 146.07 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.593 0.711 . . . . 0.0 111.385 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -125.34 122.69 37.55 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.457 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 140.01 157.77 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.787 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.71 176.09 22.55 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 68' ' ' VAL . 17.4 p -66.54 -18.37 65.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -107.06 -27.26 10.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.69 0.281 . . . . 0.0 111.635 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.42 87.38 54.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.494 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.27 64.53 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.405 2.07 . . . . 0.0 112.545 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.545 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 11.2 t-80 -46.23 -29.76 1.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.545 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.979 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -83.13 -155.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.412 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.675 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.31 -52.63 51.5 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.698 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 4.1 p-10 -179.34 42.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.615 0.245 . . . . 0.0 111.322 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.47 174.08 5.13 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.992 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 88.6 Cg_endo -81.4 10.78 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.658 2.239 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 112.1 1.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.079 0.466 . . . . 0.0 111.316 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.872 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.11 119.87 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.9 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.979 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.63 149.75 39.35 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.38 0.61 . . . . 0.0 110.897 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.066 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.41 155.72 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.436 -177.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.72 -32.25 4.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.609 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 141.23 2.0 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.91 0.386 . . . . 0.0 111.337 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.959 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.38 132.98 48.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.309 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.0 124.59 74.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.2 Cg_endo -65.63 132.58 31.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.769 2.312 . . . . 0.0 112.1 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.51 5.15 56.98 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.473 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.86 176.1 19.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.797 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.43 -37.11 62.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 111.295 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.85 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.11 -57.41 6.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.527 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.31 -29.07 67.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.345 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -72.06 -36.08 69.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 109.979 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.35 -57.9 3.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.91 41.5 9.57 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.466 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 6' ' ' ILE . 74.7 mtp180 -113.2 8.23 18.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.848 0.356 . . . . 0.0 110.644 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.066 HD21 HD12 ' A' ' 36' ' ' ILE . 5.8 tp -133.48 155.48 49.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.77 134.89 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.619 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -49.08 157.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.627 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.03 -2.31 2.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.203 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -64.86 124.05 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.58 100.06 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.567 0.698 . . . . 0.0 111.867 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 19' ' ' ILE . 35.2 mt -47.82 126.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.616 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -122.08 -5.72 8.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.585 179.161 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -171.61 143.9 1.8 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.977 0.418 . . . . 0.0 110.728 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.876 HG13 ' CD2' ' A' ' 86' ' ' LEU . 25.3 t -141.97 109.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 84' ' ' VAL . 7.3 t30 52.85 38.59 27.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.161 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 78.73 32.29 0.3 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 60' ' ' VAL . 59.1 t -120.92 103.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.6 p-10 -66.68 113.43 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.532 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 57' ' ' ILE . 25.8 m -92.51 18.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.497 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -65.47 -21.29 66.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.981 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.56 45.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 23' ' ' THR . 17.2 m -127.35 142.74 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.059 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 153.47 31.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.011 0.434 . . . . 0.0 110.62 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.615 ' O ' HG23 ' A' ' 74' ' ' VAL . 8.0 t-160 -49.33 -33.88 14.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.591 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -33.7 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.834 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.872 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -71.42 -46.9 58.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.621 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 78.6 t -60.08 -50.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.334 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.668 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 9.2 pt-20 -57.9 -30.22 65.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.629 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.68 -51.12 71.15 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.329 0.585 . . . . 0.0 109.861 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.936 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -57.46 -37.55 73.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.891 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.28 -27.51 53.13 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.603 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 5.8 pt-20 -101.06 18.03 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.309 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.927 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.15 16.33 4.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.408 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.33 -92.4 0.66 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.27 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -142.84 -90.05 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.821 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -84.74 87.24 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.286 0.565 . . . . 0.0 109.745 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.927 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -102.29 137.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.683 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.4 mtt-85 -88.36 102.69 15.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.876 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.1 mt -91.61 132.53 36.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.597 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.46 115.11 29.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.075 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 57' ' ' ILE . 1.7 m . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.661 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.766 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.847 0.356 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 25.1 mt-10 -111.68 166.04 11.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.445 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 13.1 pt-20 -126.76 144.81 50.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.072 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.32 109.47 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.955 0.407 . . . . 0.0 112.016 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.842 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.89 121.55 25.0 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.072 HD13 HD11 ' A' ' 6' ' ' ILE . 4.3 tp -130.54 128.48 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 5.7 mt-10 -83.65 100.68 11.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.49 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CG ' HD23 ' A' ' 15' ' ' LEU . 11.8 mtp180 -44.76 92.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.984 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.405 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.896 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.985 ' HB3' HD23 ' A' ' 8' ' ' LEU . 4.5 mt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.617 0.246 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 136.63 42.1 0.11 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.877 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.782 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.2 p90 -163.39 133.09 4.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.121 0.461 . . . . 0.0 110.895 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.453 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.32 136.64 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.548 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.02 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -117.73 148.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.669 0.747 . . . . 0.0 111.972 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.94 134.38 28.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.267 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 141.56 3.61 1.14 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.684 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.89 -175.75 1.49 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 68' ' ' VAL . 40.8 p -66.39 -26.9 67.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.5 -19.21 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.34 87.53 53.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.415 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.93 60.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.292 1.995 . . . . 0.0 112.562 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.629 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.8 t-80 -48.16 -27.77 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.088 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.797 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.39 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.276 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.13 -50.22 68.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.679 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.8 40.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.87 168.18 15.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.7 ' HB3' HG22 ' A' ' 23' ' ' THR . 90.2 Cg_endo -79.0 5.34 5.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.546 2.164 . . . . 0.0 112.81 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -54.92 113.16 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.391 . . . . 0.0 110.757 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.859 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.19 119.49 33.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.845 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.797 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.82 145.93 35.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.328 0.585 . . . . 0.0 110.436 178.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.035 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.136 -176.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.437 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.82 -31.65 4.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.146 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -171.55 136.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.748 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.99 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -100.46 131.91 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.074 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 116.19 63.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.5 Cg_exo -58.98 136.49 73.78 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.785 2.324 . . . . 0.0 112.288 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.2 15.87 42.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.604 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.19 178.27 16.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.182 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.23 -36.18 51.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 111.397 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.826 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -70.28 -56.75 5.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.36 -30.47 66.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.4 pp0? -72.12 -29.93 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.265 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.65 -57.94 3.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.529 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 40.64 9.47 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.624 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -117.83 -3.71 11.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.035 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -123.3 153.11 40.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.956 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.38 135.88 47.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.17 157.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.337 0.589 . . . . 0.0 111.424 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.4 -3.02 2.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -64.86 125.3 24.39 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.006 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 14.2 p -86.72 100.24 12.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.5 0.667 . . . . 0.0 111.74 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.013 HD11 HG21 ' A' ' 19' ' ' ILE . 11.2 mt -52.99 127.41 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.698 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.766 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.8 OUTLIER -120.0 -10.98 9.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.579 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -167.02 143.29 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.06 0.457 . . . . 0.0 110.71 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.838 HG13 ' CD2' ' A' ' 86' ' ' LEU . 39.6 t -139.47 112.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.87 37.0 16.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 0.0 110.164 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 79.55 34.0 0.19 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.552 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 60' ' ' VAL . 88.9 t -120.97 107.84 21.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.479 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -71.59 110.33 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.606 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 34.7 m -95.97 40.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -24.96 59.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -143.87 61.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 23' ' ' THR . 26.9 m -135.62 146.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.023 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.66 155.62 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.055 0.455 . . . . 0.0 111.267 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.858 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 p-80 -48.23 -35.14 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.17 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -72.35 -33.85 67.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.153 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -42.87 88.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.813 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.859 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.06 -46.82 85.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.619 0.723 . . . . 0.0 109.169 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 70' ' ' HIS . 91.7 t -56.85 -50.29 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.194 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.21 -30.05 61.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.902 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -60.64 -50.14 74.7 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.327 0.584 . . . . 0.0 109.735 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.02 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -58.85 -36.53 74.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.825 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.5 -25.25 50.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.452 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -103.09 17.87 23.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 111.213 -178.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.881 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.82 16.31 5.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.83 -109.85 2.95 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -120.68 -89.38 0.6 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.842 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.0 OUTLIER -88.2 95.42 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 109.842 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.881 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -108.07 135.2 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.7 ptm180 -87.52 102.87 15.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.415 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.838 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.4 mt -89.78 132.94 34.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.58 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.77 120.01 39.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 57' ' ' ILE . 12.5 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.435 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 40.1 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.729 0.299 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -117.17 159.47 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.93 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 pt-20 -120.23 144.67 47.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.005 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.85 109.56 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.988 0.423 . . . . 0.0 111.768 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.807 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.18 112.2 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -122.91 127.19 48.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.4 pt-20 -83.92 100.29 10.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.287 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -47.83 88.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.254 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.323 -0.178 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.6 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.952 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.9 tp . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 110.659 -0.126 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.67 26.16 1.07 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 114.77 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.798 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.9 p90 -163.71 132.11 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.016 0.908 . . . . 0.0 111.266 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.7 139.62 30.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.707 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.047 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -121.37 146.57 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.46 135.43 35.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.353 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.91 -3.41 1.52 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.655 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.33 -174.78 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.06 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 68' ' ' VAL . 17.4 p -71.52 -21.27 61.93 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -22.29 16.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 111.48 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 1.5 t-20 -124.27 87.66 53.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.166 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.72 62.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.368 2.045 . . . . 0.0 112.71 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.614 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.4 t-80 -50.98 -26.16 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.031 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.762 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.25 -151.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.477 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.89 49.01 4.14 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.858 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.23 45.88 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.475 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 154.14 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.98 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.666 ' CB ' HG22 ' A' ' 23' ' ' THR . 73.9 Cg_endo -75.71 0.26 9.39 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.497 2.131 . . . . 0.0 112.692 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.71 115.65 2.27 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.917 0.389 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.21 119.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.075 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.762 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.24 147.05 35.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.358 0.599 . . . . 0.0 110.492 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.99 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.339 -176.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.14 -31.77 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.52 134.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.051 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.971 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.83 132.51 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 125.37 72.83 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.6 Cg_endo -65.94 132.26 29.72 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.738 2.292 . . . . 0.0 112.226 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.01 56.66 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.486 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.68 177.07 20.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.944 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.95 -37.46 63.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.763 0.315 . . . . 0.0 111.173 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.836 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.7 -57.6 5.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.54 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.18 -34.74 68.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.226 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.81 -58.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.4 40.88 9.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.726 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.493 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mmt180 -111.13 -5.98 14.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.846 0.355 . . . . 0.0 110.759 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.99 HD21 HD12 ' A' ' 36' ' ' ILE . 6.4 tp -119.13 156.15 30.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.751 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.39 134.91 45.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.818 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -51.51 157.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 121.243 0.544 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER 75.29 -1.54 3.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.36 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 m-20 -69.76 129.35 39.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.76 104.03 15.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.646 0.736 . . . . 0.0 111.491 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.047 HD11 HG21 ' A' ' 19' ' ' ILE . 72.5 mt -50.71 138.65 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 2.1 mm? -116.67 -44.15 2.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.372 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -143.62 172.71 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.783 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.906 HG13 ' CD2' ' A' ' 86' ' ' LEU . 44.9 t -149.88 97.11 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.821 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.573 ' OD1' HG23 ' A' ' 84' ' ' VAL . 9.4 t30 67.82 -67.56 0.18 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.138 0.494 . . . . 0.0 109.775 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mt-10 -156.41 32.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.479 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -118.58 142.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.559 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 16.1 p-10 -111.09 108.93 18.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.173 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.6 m -92.82 40.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 111.66 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.51 70.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.78 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -152.87 70.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.95 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 23' ' ' THR . 27.6 m -135.87 146.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.7 152.58 26.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 0.0 110.826 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.866 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.6 p-80 -48.55 -33.86 10.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.01 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.19 -33.82 70.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.542 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.4 -42.14 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.48 -46.89 81.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.582 0.706 . . . . 0.0 109.123 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 70' ' ' HIS . 83.9 t -56.57 -50.39 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.205 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.86 -30.11 60.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.053 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.3 -50.42 73.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 109.909 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -58.53 -36.05 73.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.861 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.5 -29.21 52.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.494 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -99.64 18.46 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -178.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.907 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.22 16.17 5.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.273 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.66 -94.11 0.66 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.18 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.0 p -140.49 -90.65 0.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.807 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -83.84 89.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.185 0.517 . . . . 0.0 109.718 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.907 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.5 p -105.17 137.01 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.96 103.0 15.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.906 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.5 mt -91.24 142.68 27.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.174 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.76 139.58 37.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.692 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 HD11 ' A' ' 51' ' ' LEU . 4.3 m . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.788 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.427 ' CG ' HD13 ' A' ' 58' ' ' LEU . 2.4 m-30 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.836 0.351 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.9 153.86 39.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.428 ' CG ' ' HB3' ' A' ' 85' ' ' ARG . 1.8 tt0 -108.01 138.36 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.645 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.805 HD13 HD13 ' A' ' 51' ' ' LEU . 1.1 mt -132.69 109.17 14.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.873 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.05 112.16 15.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.893 HD21 ' CA ' ' A' ' 45' ' ' ALA . 4.3 tp -121.91 126.84 49.58 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -87.81 99.54 12.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.021 178.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -57.79 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.573 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.889 -179.231 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.888 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.4 tp . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 72.64 30.24 64.39 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.0 p90 -164.64 135.38 4.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.354 1.077 . . . . 0.0 111.745 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -100.91 137.63 39.03 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.659 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.035 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -116.74 150.84 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.723 0.773 . . . . 0.0 112.293 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -145.79 134.58 22.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.31 2.92 0.92 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.633 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.67 -173.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.005 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 33.2 p -70.57 -26.01 63.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 43.4 t0 -94.24 -24.05 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 4.0 m-20 -124.47 87.98 53.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 63.89 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.316 2.011 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.601 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.2 t-80 -47.26 -28.32 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.315 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.818 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.06 -155.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.385 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.682 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.25 -50.91 59.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.691 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.89 39.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.18 166.08 23.78 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.838 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.659 ' CB ' HG22 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.76 7.28 4.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.52 2.147 . . . . 0.0 112.727 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -57.01 114.25 2.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.85 0.357 . . . . 0.0 110.779 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.39 118.07 29.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.795 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.818 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.48 147.21 37.49 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.187 0.518 . . . . 0.0 110.732 178.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.021 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.92 155.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.902 -176.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.457 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.49 -29.93 4.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.223 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.38 125.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.291 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.798 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.49 127.43 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.5 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.2 125.37 72.49 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_endo -60.9 138.39 78.67 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.716 2.278 . . . . 0.0 112.206 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 14.1 64.4 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.377 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . -107.05 -159.16 21.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.886 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.589 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.97 -38.72 57.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.832 0.316 . . . . 0.0 110.987 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.893 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.41 -54.19 8.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.893 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.95 -33.72 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.162 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 13.5 mm-40 -72.45 -32.39 66.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.5 ' HB2' HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -79.41 -57.98 3.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.63 38.34 8.91 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.701 ' CB ' HG23 ' A' ' 6' ' ' ILE . 22.0 mmt180 -120.29 1.92 10.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.021 HD21 HD12 ' A' ' 36' ' ' ILE . 29.5 tp -128.07 162.98 25.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.163 0.506 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.45 137.35 26.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.708 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.99 157.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.328 0.585 . . . . 0.0 111.629 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t-20 75.73 -0.52 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.328 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -69.34 126.75 30.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.66 101.99 13.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.585 0.707 . . . . 0.0 111.492 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.009 HD11 HG21 ' A' ' 19' ' ' ILE . 68.0 mt -48.81 137.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.581 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 5.2 mt -119.01 -32.9 4.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -150.13 160.13 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.577 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.849 HG13 ' CD2' ' A' ' 86' ' ' LEU . 28.3 t -152.42 110.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 t30 47.92 50.19 16.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 73.29 31.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 77.8 t -120.85 141.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.0 p-10 -109.47 109.57 20.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.664 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 32.5 m -94.01 43.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.247 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -30.17 68.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -149.87 67.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.768 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 35.5 m -135.02 148.1 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.438 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.04 154.35 39.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 74' ' ' VAL . 7.4 p-80 -49.17 -34.15 13.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.098 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -69.57 -33.93 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.642 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.37 -42.58 83.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 109.793 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.852 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.09 -46.62 83.42 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 70' ' ' HIS . 88.0 t -56.61 -50.4 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.21 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.29 -29.85 59.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.949 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -61.96 -50.77 70.81 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -57.01 -37.16 71.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.484 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.64 -23.62 49.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.957 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 5.0 pt-20 -93.6 3.21 55.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.032 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.931 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -90.28 16.3 8.92 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.46 -121.86 27.96 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.748 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -104.19 -87.12 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.873 HG13 HG22 ' A' ' 7' ' ' THR . 8.2 tp -82.59 107.82 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.931 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -127.05 137.72 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.72 ' HG2' HG23 ' A' ' 7' ' ' THR . 13.2 mtp180 -83.49 103.07 12.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.373 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.849 ' CD2' HG13 ' A' ' 60' ' ' VAL . 8.1 mt -94.92 142.12 27.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.017 0.436 . . . . 0.0 111.363 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.66 131.43 49.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.304 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.459 HG21 HD11 ' A' ' 6' ' ' ILE . 3.3 m . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.441 ' HB3' HD21 ' A' ' 58' ' ' LEU . 5.8 m-30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.822 0.344 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.19 141.93 51.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 17.0 pt-20 -99.46 144.66 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.132 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.43 109.42 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.372 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.898 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.81 118.39 20.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.132 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -128.51 127.18 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.1 pt-20 -84.06 100.63 11.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.195 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -51.63 89.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.111 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.339 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.613 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.004 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.9 tp . . . . . 0 CA--C 1.527 0.068 0 N-CA-C 110.637 -0.135 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 133.93 20.27 0.86 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.928 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.856 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.0 p90 -161.18 135.91 7.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.055 0.927 . . . . 0.0 111.381 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 135.82 34.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.019 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.27 148.03 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -130.46 124.85 32.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.71 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 158.3 -120.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.874 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 63.83 168.29 1.27 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.12 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 68' ' ' VAL . 25.1 p -70.18 -1.98 11.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 35.4 t70 -117.08 -22.52 8.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' HIS . 4.3 m-80 -124.72 85.89 56.41 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.61 65.74 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.008 1.805 . . . . 0.0 112.477 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.542 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 14.2 t-80 -55.09 -23.62 21.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.173 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -94.75 -150.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.377 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.689 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.26 51.65 4.52 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.692 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 t0 76.25 43.53 0.15 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 110.414 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.53 156.77 79.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 95.9 Cg_endo -77.9 0.03 10.22 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.507 2.138 . . . . 0.0 112.599 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -55.2 120.09 6.5 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.108 0.48 . . . . 0.0 111.313 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.885 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.62 118.68 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.98 146.84 36.07 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.316 0.579 . . . . 0.0 110.463 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.23 155.78 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.042 -176.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.35 -33.51 4.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.772 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.82 142.04 2.37 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.483 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.962 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.92 133.58 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 115.0 57.79 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.6 Cg_exo -56.07 136.87 77.22 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.89 2.393 . . . . 0.0 112.405 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.91 2.57 66.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.1 176.39 22.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.111 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -38.41 59.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.87 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.18 -57.41 6.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.659 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.59 -35.35 80.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.081 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.1 pp0? -71.96 -30.07 64.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 0.0 110.471 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.678 ' OD2' HD12 ' A' ' 8' ' ' LEU . 49.1 m-20 -79.89 -58.07 3.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 41.39 9.81 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.593 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.513 ' CB ' HG12 ' A' ' 6' ' ' ILE . 5.5 mtm180 -117.09 -1.19 11.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -126.56 153.53 45.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.586 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.85 135.26 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.688 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.631 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.5 157.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.339 0.59 . . . . 0.0 111.619 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 75.79 -0.27 3.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.26 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -67.45 124.4 23.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.59 100.33 12.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 111.549 -178.485 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.019 HD11 HG21 ' A' ' 19' ' ' ILE . 12.1 mt -49.89 132.65 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.674 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.8 pp -130.04 -0.01 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.114 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 179.16 134.64 0.09 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.892 HG13 ' CD2' ' A' ' 86' ' ' LEU . 40.7 t -120.02 97.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.692 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.865 ' OD1' HG23 ' A' ' 84' ' ' VAL . 3.7 t30 71.32 -61.82 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -164.3 31.24 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.084 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.3 t -120.99 110.43 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' N ' ' CE1' ' A' ' 59' ' ' PHE . 6.7 t0 -72.47 112.37 8.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.79 0.328 . . . . 0.0 110.593 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.663 HG21 HG22 ' A' ' 57' ' ' ILE . 19.1 m -94.92 27.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.5 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -67.81 -25.54 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.44 51.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -126.19 148.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.006 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -68.42 154.53 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.848 ' O ' HG23 ' A' ' 74' ' ' VAL . 9.2 t-160 -48.29 -34.86 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.044 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 4.0 m -68.6 -33.76 74.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.244 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.6 -33.09 68.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.21 0.529 . . . . 0.0 109.598 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -71.59 -46.76 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 70' ' ' HIS . 67.9 t -60.58 -50.86 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.303 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -57.14 -29.32 63.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.69 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.788 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -61.16 -52.19 65.87 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.905 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.015 HD11 HD12 ' A' ' 19' ' ' ILE . 3.0 mt -56.6 -37.27 70.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.909 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.6 -28.33 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -97.37 15.93 21.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.295 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.924 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.11 16.28 6.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.39 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.54 -96.05 0.55 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.422 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -136.09 -90.2 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.898 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.5 93.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 109.879 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.924 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 p -109.81 136.39 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.2 ptt180 -87.01 103.05 14.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.273 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.892 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.1 mt -91.78 134.51 34.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.119 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.507 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.56 125.35 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.8 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.728 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.907 ' CD2' HD13 ' A' ' 58' ' ' LEU . 3.1 m-85 . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.66 0.267 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.451 ' HG2' HG23 ' A' ' 88' ' ' VAL . 4.3 pt-20 -129.0 164.62 22.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.978 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -121.45 144.77 48.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.94 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.03 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.59 112.12 13.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.638 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.717 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.12 115.36 20.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 6' ' ' ILE . 4.6 tp -125.44 128.76 48.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -89.48 100.84 13.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.698 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 5.1 mtp180 -45.6 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.342 0.591 . . . . 0.0 109.801 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.363 0 CA-C-N 114.835 -1.075 . . . . 0.0 114.168 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.975 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.1 tp . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.397 0.141 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.511 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.93 19.61 0.79 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.674 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.8 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.1 p90 -161.04 135.08 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.006 0.903 . . . . 0.0 111.19 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.37 138.86 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.466 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.65 147.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 112.037 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.98 134.98 32.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.283 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.4 1.23 0.92 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.409 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.34 -173.79 0.92 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.885 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 68' ' ' VAL . 28.7 p -66.83 -32.6 73.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -90.43 -20.7 22.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 20.7 t-20 -124.28 87.29 53.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.617 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.91 61.49 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.277 1.985 . . . . 0.0 112.387 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.624 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 14.3 t-80 -47.9 -27.75 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.202 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.792 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.43 -153.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -57.2 -50.17 66.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.681 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.48 40.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.724 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 168.5 14.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' A' ' 23' ' ' THR . 87.0 Cg_endo -78.87 6.5 4.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.814 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 113.34 1.36 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.848 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.31 119.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.792 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.23 147.46 36.53 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.265 0.555 . . . . 0.0 110.456 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.053 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.02 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.121 -176.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.65 -34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.661 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.63 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.15 143.14 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.044 0.449 . . . . 0.0 111.737 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.46 132.79 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.449 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.2 124.54 73.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.0 Cg_endo -65.39 133.14 33.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 112.209 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.53 5.96 57.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.384 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.66 175.06 18.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.868 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.8 -36.15 57.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.721 0.296 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.846 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.89 -57.46 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.466 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.6 -29.04 67.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.401 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.02 -34.99 69.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.101 0.477 . . . . 0.0 110.005 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -84.75 -58.05 2.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.602 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 41.78 9.46 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.464 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.521 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.4 mmt85 -112.88 9.01 18.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.704 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.053 HD21 HD12 ' A' ' 36' ' ' ILE . 5.6 tp -134.34 155.1 50.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.635 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.607 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -132.09 133.52 44.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.881 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -49.4 157.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.79 -1.11 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.368 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.83 126.46 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.61 103.88 15.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.525 0.678 . . . . 0.0 111.361 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.088 HD11 HG21 ' A' ' 19' ' ' ILE . 64.2 mt -50.83 152.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.863 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.907 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -136.58 -39.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.474 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -142.58 159.52 42.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.888 HG13 ' CD2' ' A' ' 86' ' ' LEU . 35.9 t -152.5 113.78 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 49.84 44.87 25.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.773 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 72.86 32.62 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.595 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 68.6 t -120.37 142.19 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.7 p-10 -108.8 111.05 22.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.54 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 65' ' ' VAL . 30.3 m -79.21 57.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.967 0.413 . . . . 0.0 110.948 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.62 103.02 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.85 53.81 1.41 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 23' ' ' THR . 16.7 m -119.85 142.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -62.99 154.21 31.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.075 0.465 . . . . 0.0 111.226 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.8 p-80 -48.09 -34.16 9.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -70.69 -33.98 71.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.94 -45.06 83.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 0.0 109.764 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.848 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.21 -46.92 86.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.299 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.9 t -56.55 -50.35 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.319 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.06 -29.35 57.31 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.971 178.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -61.78 -52.07 65.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.397 0.618 . . . . 0.0 109.759 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -56.61 -36.16 69.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.872 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.36 -30.53 53.84 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.674 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' OE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -98.29 19.82 13.63 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.406 -178.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.99 16.26 7.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.37 -101.4 1.15 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.237 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 18.1 t -130.28 -89.29 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.717 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.1 tp -88.41 91.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 109.919 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.887 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.9 p -105.11 137.18 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.72 102.63 14.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.888 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.9 mt -89.48 139.62 30.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.75 132.86 47.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.718 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.8 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.387 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.783 ' CD2' HD13 ' A' ' 58' ' ' LEU . 1.4 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.795 0.331 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -102.04 170.78 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.13 144.95 51.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.97 109.65 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.992 0.425 . . . . 0.0 111.966 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.861 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.27 119.53 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 6' ' ' ILE . 5.1 tp -132.03 127.15 35.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.3 pm0 -83.94 100.38 10.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.823 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.549 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.77 89.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.519 0.326 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.788 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.988 ' HB3' HD23 ' A' ' 8' ' ' LEU . 21.3 mt . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.98 0.419 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.85 32.82 0.54 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.436 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.783 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.8 p90 -158.86 135.97 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.068 0.434 . . . . 0.0 111.026 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.76 137.93 34.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.075 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.38 146.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.762 0.792 . . . . 0.0 112.377 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.77 133.59 30.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.096 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.36 -0.43 1.09 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.731 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.65 -173.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.919 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.865 HG22 ' HB3' ' A' ' 32' ' ' PRO . 37.2 p -69.09 -30.65 69.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.21 -20.86 21.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.35 87.23 54.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.425 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.63 61.79 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.349 2.033 . . . . 0.0 112.635 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.609 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.5 t-80 -48.89 -27.55 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.78 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -91.23 -152.27 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.195 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.688 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.89 49.4 4.22 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.591 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.29 48.21 0.06 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 110.223 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.88 150.45 71.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.865 ' HB3' HG22 ' A' ' 23' ' ' THR . 12.1 Cg_exo -70.18 -5.23 15.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.674 2.249 . . . . 0.0 112.669 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.1 113.96 1.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.041 0.448 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.833 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.69 118.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.512 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.78 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.66 147.36 39.17 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.357 0.599 . . . . 0.0 110.69 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.044 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.05 155.71 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.017 -176.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.455 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.45 -29.6 4.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.252 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.76 130.57 0.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.176 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.003 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.61 129.75 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.27 116.87 67.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.7 134.47 60.89 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.67 2.247 . . . . 0.0 112.287 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.73 31.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.551 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.84 177.61 17.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.32 -34.77 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.425 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.787 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.77 -56.65 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.97 -31.1 65.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -72.0 -30.12 64.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.375 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.0 -57.96 3.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.97 9.57 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.615 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.523 ' CB ' HG12 ' A' ' 6' ' ' ILE . 44.1 mtt-85 -118.14 5.81 12.01 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.95 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.044 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -134.59 153.39 51.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.189 0.519 . . . . 0.0 111.026 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.576 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.58 137.35 49.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -52.19 157.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.344 0.592 . . . . 0.0 111.563 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.08 0.01 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.35 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.48 127.42 32.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 103.8 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.539 0.685 . . . . 0.0 111.339 -178.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 19' ' ' ILE . 69.6 mt -51.0 139.95 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.633 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.85 -37.08 3.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.5 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -148.68 165.41 31.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.76 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.685 HG11 ' HB1' ' A' ' 76' ' ' ALA . 39.4 t -142.07 97.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.73 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.7 t-20 68.53 -67.07 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.076 0.465 . . . . 0.0 109.771 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.4 mt-10 -157.37 33.36 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.582 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.4 t -120.59 142.36 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -107.19 108.38 19.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.393 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' VAL . 21.1 m -92.23 45.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.347 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -25.47 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -149.58 58.07 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.996 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.768 ' O ' HG23 ' A' ' 23' ' ' THR . 27.2 m -128.27 149.05 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.438 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.44 153.79 42.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 111.018 -179.443 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.2 t-160 -49.86 -34.14 19.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -69.62 -33.87 73.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.749 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.683 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.32 -42.68 79.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.833 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.79 -46.89 85.89 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.3 t -57.49 -50.41 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.259 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -30.03 61.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.889 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.76 -50.21 74.38 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.341 0.591 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.017 HD11 HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -59.53 -35.82 74.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.961 179.211 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.44 -25.79 50.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.348 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -102.58 16.78 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.36 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.908 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.9 16.27 4.26 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 -92.49 0.69 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.061 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 22.5 t -143.06 -89.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.861 HG13 HG22 ' A' ' 7' ' ' THR . 8.8 tp -84.47 88.23 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.217 0.532 . . . . 0.0 109.811 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.908 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.4 p -103.93 139.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.608 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.0 mtt-85 -88.15 102.82 15.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.61 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.9 mt -91.8 138.61 31.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.259 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.748 ' HB3' HD12 ' A' ' 58' ' ' LEU . 1.6 m-85 -101.66 138.66 38.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.773 ' O ' HD11 ' A' ' 58' ' ' LEU . 14.8 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.439 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 22.5 m-85 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 142.36 18.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -106.24 144.63 32.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.993 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.03 109.41 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.925 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.39 121.22 24.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 6' ' ' ILE . 4.0 tp -132.05 127.38 36.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 pt-20 -85.57 101.07 12.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.853 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.566 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.2 mtp180 -47.79 94.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.384 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.317 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.97 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.17 44.14 0.07 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.978 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.774 ' HB3' HG23 ' A' ' 39' ' ' ILE . 12.5 p90 -164.55 134.16 3.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.149 0.474 . . . . 0.0 110.875 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.75 136.52 33.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.525 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.062 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.26 146.81 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.753 0.787 . . . . 0.0 112.247 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -140.0 132.86 29.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.13 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.5 3.61 0.71 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.707 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.75 -171.11 0.67 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.8 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.829 HG22 ' HB3' ' A' ' 32' ' ' PRO . 39.1 p -70.42 -29.14 65.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.97 -21.0 20.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.9 OUTLIER -124.38 87.32 54.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.524 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 62.2 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.266 1.977 . . . . 0.0 112.459 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.617 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.2 t-80 -47.46 -28.12 2.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.327 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.822 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.49 -154.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.3 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.68 -50.09 70.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.604 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.37 40.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.48 165.84 25.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.829 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.5 Cg_exo -74.98 1.21 7.98 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.967 2.445 . . . . 0.0 112.815 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.46 112.3 0.79 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.034 0.445 . . . . 0.0 111.16 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.05 118.54 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.47 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.822 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.99 147.2 38.33 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.352 0.596 . . . . 0.0 110.841 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.011 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.11 155.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.911 -176.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.46 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.83 -29.02 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.189 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.4 131.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.998 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.969 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.59 132.29 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.32 114.23 53.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.8 Cg_exo -57.83 137.43 81.0 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.709 2.273 . . . . 0.0 112.326 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.77 54.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.568 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 179.5 16.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.113 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.69 -36.44 64.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.188 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.813 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.05 -57.68 5.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 0.0 111.87 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.75 -28.29 65.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.53 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.64 -30.21 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.362 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' OD2' HD12 ' A' ' 8' ' ' LEU . 1.7 m-20 -82.91 -57.87 3.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.14 37.74 10.91 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.574 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.6 mtt85 -112.44 -13.36 13.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.011 HD21 HD12 ' A' ' 36' ' ' ILE . 6.2 tp -114.69 154.82 27.76 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 111.408 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -133.11 135.71 45.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.691 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.84 157.41 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.195 0.521 . . . . 0.0 111.747 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.86 0.28 3.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.329 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.95 126.26 29.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.3 t -86.58 100.25 12.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.715 0.769 . . . . 0.0 111.316 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.062 HD11 HG21 ' A' ' 19' ' ' ILE . 69.9 mt -46.83 135.21 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.708 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.45 -42.29 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.052 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.2 m-85 -142.36 169.99 16.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.73 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.861 HG13 ' CD2' ' A' ' 86' ' ' LEU . 19.3 t -150.04 99.12 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.218 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 84' ' ' VAL . 8.6 t30 67.04 -67.61 0.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.167 0.508 . . . . 0.0 109.874 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -156.42 32.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.668 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.7 t -119.46 142.25 35.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.564 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.7 t0 -112.08 87.55 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 65' ' ' VAL . 24.9 m -70.22 63.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -29.9 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.691 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -149.03 58.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.76 ' O ' HG23 ' A' ' 23' ' ' THR . 34.8 m -123.91 146.67 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.246 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.458 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -65.81 154.94 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.868 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.5 p-80 -48.21 -34.65 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.1 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 p -71.58 -33.75 69.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.169 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.65 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.93 -45.49 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.86 -46.85 88.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.587 0.708 . . . . 0.0 109.162 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.8 t -57.12 -49.25 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.403 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.97 -30.15 63.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.957 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.77 -49.71 76.4 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.333 0.587 . . . . 0.0 109.679 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.986 HD11 HD12 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -59.94 -34.65 73.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.859 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.9 mmmt -77.36 -28.1 52.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.426 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.86 18.49 19.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 -178.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.48 16.29 6.71 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.39 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -111.03 3.42 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.155 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -119.68 -90.26 0.58 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.925 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -87.28 93.68 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.976 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.887 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -105.81 138.59 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.764 ' HG3' HG23 ' A' ' 7' ' ' THR . 49.1 mtp180 -88.67 102.96 15.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.861 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.0 mt -90.56 141.61 28.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.213 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 136.03 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.683 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.2 m-85 . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.625 0.25 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 1.6 mp0 -115.42 153.01 31.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 85' ' ' ARG . 1.9 pm0 -107.84 144.82 34.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.456 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.994 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.77 109.63 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 111.704 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.0 122.3 26.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.004 HD23 ' HG ' ' A' ' 15' ' ' LEU . 5.3 tp -131.54 126.85 35.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 12.8 mt-10 -80.31 99.99 8.17 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.279 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.28 88.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.085 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.441 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.004 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.8 tp . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.41 0.148 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.42 20.64 0.99 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.765 -1.207 . . . . 0.0 114.486 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.868 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.0 p90 -159.28 135.52 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.608 0.704 . . . . 0.0 110.847 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -95.27 135.2 37.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.89 146.6 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.543 0.687 . . . . 0.0 111.552 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.59 120.7 30.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.628 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 141.92 159.24 7.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.783 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.64 175.56 22.02 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 68' ' ' VAL . 26.6 p -65.87 -12.19 52.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -114.96 -26.35 7.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.53 87.37 54.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.466 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.94 66.06 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.365 2.043 . . . . 0.0 112.329 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.552 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 9.8 t-80 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.656 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -85.96 -155.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.438 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.01 -50.1 69.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.746 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.03 76.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 110.701 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' CB ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -166.63 176.69 1.71 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 31' ' ' ASP . 94.1 Cg_endo -85.36 26.77 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.729 2.286 . . . . 0.0 112.543 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 m -77.21 112.29 13.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.903 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.59 118.85 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.009 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.34 148.15 37.47 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.259 0.552 . . . . 0.0 110.789 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.06 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.31 155.87 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.81 -177.237 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.64 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.31 -30.65 4.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.098 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.46 132.59 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.896 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.978 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.26 131.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 115.69 61.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.499 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.5 Cg_exo -57.72 134.79 65.23 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.731 2.288 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 8.12 56.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.43 179.75 18.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.903 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.08 -38.8 68.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 111.064 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.792 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -65.44 -57.46 8.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.25 -28.93 66.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.27 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.76 -57.94 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.632 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.06 9.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.602 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.1 mtt-85 -115.25 -6.18 12.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.06 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -121.23 154.06 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.162 0.506 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.46 135.45 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.552 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.21 157.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 0.0 111.538 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 77.06 -2.27 2.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -64.94 124.63 22.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.49 100.22 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.472 0.653 . . . . 0.0 111.615 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 19' ' ' ILE . 38.0 mt -48.51 125.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.565 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -117.42 -16.46 10.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.739 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -164.64 142.59 6.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.114 0.483 . . . . 0.0 110.94 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.913 HG13 ' CD2' ' A' ' 86' ' ' LEU . 38.6 t -136.98 112.18 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.393 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.6 t30 50.69 39.29 21.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.918 0.389 . . . . 0.0 110.276 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.67 33.83 0.36 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.564 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 60' ' ' VAL . 88.7 t -120.9 103.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.307 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 10.3 t0 -65.99 108.05 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.616 HG21 HG22 ' A' ' 57' ' ' ILE . 25.3 m -87.39 8.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.638 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.64 -21.32 53.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.634 0.254 . . . . 0.0 111.051 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -139.21 42.04 2.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.185 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.758 ' O ' HG23 ' A' ' 23' ' ' THR . 8.3 m -124.42 144.71 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.418 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.48 153.92 41.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.93 0.395 . . . . 0.0 110.613 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.714 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.3 t-160 -48.76 -34.43 12.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 2.7 m -70.06 -33.68 72.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.04 -33.2 71.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.903 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -70.64 -46.79 62.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.8 t -59.57 -50.76 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.352 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 3.5 pt-20 -57.69 -31.82 66.75 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.605 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.11 -49.75 75.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.328 0.585 . . . . 0.0 110.022 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -59.8 -37.33 78.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.983 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.31 -25.74 51.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.699 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 6.4 pt-20 -103.26 17.75 23.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.191 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.94 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.73 16.15 4.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.16 -93.77 0.6 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.321 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 28.1 t -141.06 -90.63 0.15 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER -84.2 86.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.3 0.571 . . . . 0.0 109.706 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.94 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -100.27 137.57 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.114 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 6.0 ttt180 -89.4 102.65 15.32 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.913 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.0 mt -91.46 133.65 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.601 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.99 114.77 29.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.826 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.7 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.779 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 6.4 m-30 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.825 0.345 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -143.86 149.79 37.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.6 mt-10 -104.51 144.62 31.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.058 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.91 109.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.382 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.879 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 114.95 19.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.058 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -125.78 127.27 45.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.4 pt-20 -84.24 100.49 11.24 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.38 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.09 89.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.257 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.736 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.968 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.1 tp . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.82 25.91 0.97 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.765 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -164.27 132.27 3.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.862 0.831 . . . . 0.0 111.363 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.39 137.13 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.331 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.038 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -116.22 161.76 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.767 0.794 . . . . 0.0 112.092 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -155.51 131.91 10.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.777 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 15.01 0.26 Allowed Glycine 0 C--O 1.229 -0.16 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.468 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.565 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -73.04 -174.14 26.45 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.712 HG23 ' C ' ' A' ' 68' ' ' VAL . 22.2 p -66.93 -32.71 74.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -85.09 -33.35 22.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.514 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -124.65 77.21 64.14 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.015 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 28' ' ' ILE . 3.6 Cg_endo -46.02 -24.25 2.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.736 2.29 . . . . 0.0 112.679 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.547 ' HB3' ' HA2' ' A' ' 21' ' ' GLY . 11.7 t-80 58.94 -59.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.251 0.548 . . . . 0.0 111.497 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.837 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -66.28 -158.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.659 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.678 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.99 -49.45 78.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.484 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 179.39 75.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.56 156.99 14.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.2 5.73 4.38 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.857 2.371 . . . . 0.0 112.937 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -60.51 111.76 1.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.804 0.335 . . . . 0.0 110.707 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.853 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -79.76 121.45 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.263 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.837 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -142.23 147.2 36.13 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.419 0.628 . . . . 0.0 110.446 178.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.094 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.51 155.35 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.142 -0.935 . . . . 0.0 113.139 -176.388 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.98 -32.94 4.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.803 -179.043 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.13 143.67 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.616 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.02 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.27 132.27 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 116.78 66.43 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.8 Cg_exo -56.62 136.87 78.46 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.594 2.196 . . . . 0.0 112.305 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.61 1.98 67.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.689 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.55 174.83 24.06 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.864 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.84 -35.32 57.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.868 0.334 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.786 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.55 -57.44 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.485 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.0 -28.92 68.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.397 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -72.05 -35.36 69.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.049 0.452 . . . . 0.0 109.968 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.58 -57.77 3.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.523 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 40.88 9.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.599 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.49 9.55 19.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.794 0.33 . . . . 0.0 110.689 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.094 HD21 HD12 ' A' ' 36' ' ' ILE . 4.7 tp -136.3 153.8 51.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -131.2 134.37 46.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -48.98 157.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 111.83 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.5 t-20 76.56 -0.26 3.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.387 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.02 125.93 28.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.46 102.61 14.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.614 0.721 . . . . 0.0 111.199 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 61.6 mt -50.91 134.74 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.776 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.47 -30.54 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.576 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -152.47 163.69 39.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.773 HG13 ' CD2' ' A' ' 86' ' ' LEU . 19.3 t -144.05 97.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.029 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.873 ' OD1' HG23 ' A' ' 84' ' ' VAL . 4.7 t30 68.13 -67.36 0.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 6.2 pt-20 -156.54 32.41 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.691 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 59.0 t -119.78 142.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.496 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 p-10 -110.0 99.51 8.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.437 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 65' ' ' VAL . 30.8 m -83.54 56.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.906 0.384 . . . . 0.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -29.09 26.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -147.36 56.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.712 ' C ' HG23 ' A' ' 23' ' ' THR . 31.7 m -126.22 144.39 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -62.14 151.77 34.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.4 t-160 -47.95 -33.98 8.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.717 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -33.99 75.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.977 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.18 -42.16 80.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.853 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.04 -46.65 86.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.631 0.729 . . . . 0.0 109.124 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.6 t -57.62 -50.56 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.193 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.34 -29.57 61.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.89 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.738 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.04 -50.66 72.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.318 0.58 . . . . 0.0 109.862 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.986 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -58.11 -37.14 73.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.836 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.51 -28.31 52.06 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.15 18.11 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 -178.316 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.904 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.04 16.38 5.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.246 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 -97.08 0.8 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.275 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.4 m -136.9 -90.44 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.879 HG13 HG22 ' A' ' 7' ' ' THR . 8.7 tp -84.86 89.97 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.23 0.538 . . . . 0.0 109.737 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.904 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.4 p -104.84 138.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.9 ttm-85 -87.95 103.12 15.39 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.773 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.6 mt -92.37 138.6 31.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.241 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.69 132.44 47.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.3 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.445 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 4.0 m-30 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.819 0.343 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -154.98 159.64 40.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 mt-10 -109.57 144.68 37.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.957 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.69 109.6 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 111.599 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.872 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.38 121.03 23.22 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.003 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -132.3 127.25 35.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.5 mt-10 -83.29 100.2 10.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.841 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.559 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -46.57 89.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.338 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.321 -0.301 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.747 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.003 ' HB3' HD23 ' A' ' 8' ' ' LEU . 20.1 mt . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.87 0.367 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 129.89 34.72 0.47 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.446 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.778 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.1 p90 -160.1 136.56 8.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.133 0.466 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.497 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.5 137.05 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.294 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.26 148.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.729 0.776 . . . . 0.0 112.355 -179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.75 133.8 27.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.065 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.474 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.41 4.77 0.88 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.725 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.545 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -61.49 -169.72 0.72 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.902 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.82 HG22 ' HB3' ' A' ' 32' ' ' PRO . 43.4 p -70.95 -29.89 66.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -93.54 -19.85 20.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 3.8 t-20 -124.46 87.43 54.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.91 61.24 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.32 2.013 . . . . 0.0 112.46 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.625 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.6 t-80 -47.19 -28.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.814 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -88.79 -154.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.208 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.45 -49.9 73.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.51 40.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 0.0 110.799 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.85 165.59 27.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.82 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.4 Cg_exo -75.22 1.6 7.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.956 2.437 . . . . 0.0 112.754 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 t -52.62 112.07 0.76 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.978 0.418 . . . . 0.0 111.185 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.88 118.52 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.524 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.814 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.31 147.2 37.76 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.422 0.629 . . . . 0.0 110.622 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.076 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.94 155.72 7.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.064 -176.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.06 -30.4 4.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.165 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.25 130.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.995 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.007 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.19 130.86 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 126.06 70.67 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.4 Cg_endo -67.71 132.11 26.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.71 2.273 . . . . 0.0 112.34 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.39 26.89 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.333 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.24 177.54 16.9 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.022 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.49 -34.39 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.747 0.308 . . . . 0.0 111.487 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.62 -57.45 4.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.832 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.48 -28.82 64.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.603 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.74 -32.83 68.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 110.337 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.14 -57.89 3.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.685 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.57 9.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.717 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.7 mtm180 -113.93 -7.62 13.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.739 0.304 . . . . 0.0 110.821 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.076 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -121.2 154.02 36.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.079 0.466 . . . . 0.0 111.209 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -130.95 135.88 48.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.604 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -49.03 157.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.244 0.545 . . . . 0.0 111.454 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.9 t30 76.87 -2.02 2.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.111 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -65.47 124.54 22.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.1 p -86.5 100.76 12.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.52 0.676 . . . . 0.0 111.233 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 19' ' ' ILE . 65.8 mt -49.99 130.37 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.875 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.7 mt -112.91 -34.04 5.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.113 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -151.09 159.41 44.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.438 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.032 HG11 ' HB1' ' A' ' 76' ' ' ALA . 7.7 p -146.69 105.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 84' ' ' VAL . 18.7 t30 68.62 -67.18 0.21 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.137 0.494 . . . . 0.0 109.992 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.9 mm-40 -162.46 29.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.047 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 60' ' ' VAL . 1.4 t -121.01 142.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.279 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 18.0 t0 -106.36 90.75 3.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 65' ' ' VAL . 30.3 m -70.54 63.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.429 . . . . 0.0 111.567 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -26.64 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -147.6 55.27 1.07 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 29.4 m -124.69 146.97 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.455 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.61 154.44 40.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.226 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.869 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.8 p-80 -48.12 -34.61 10.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.2 p -71.95 -33.75 68.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.197 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.691 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -45.39 80.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.61 -46.58 89.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.582 0.706 . . . . 0.0 109.203 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 70' ' ' HIS . 93.7 t -57.5 -50.47 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.245 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.691 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.86 -30.36 63.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.091 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 1.032 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.07 -49.79 75.9 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.28 0.562 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.976 HD11 HD12 ' A' ' 19' ' ' ILE . 4.0 mt -59.25 -35.54 73.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.739 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -77.31 -23.26 51.06 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.12 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -105.34 16.96 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.042 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.896 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.54 16.21 4.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.147 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -97.16 0.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.171 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 25.8 t -138.07 -89.09 0.24 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.872 ' CD1' HG22 ' A' ' 7' ' ' THR . 0.7 OUTLIER -85.98 87.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.264 0.554 . . . . 0.0 109.626 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.896 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.4 p -101.94 140.18 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.609 ' HG2' HG23 ' A' ' 7' ' ' THR . 56.5 mtm180 -87.97 103.18 15.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.802 ' CD2' HG23 ' A' ' 60' ' ' VAL . 11.8 mt -91.76 139.01 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.64 131.98 47.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.244 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 57' ' ' ILE . 14.2 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.855 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.665 ' CE2' HD13 ' A' ' 58' ' ' LEU . 3.7 m-30 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.703 0.287 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.1 144.57 38.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.085 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 43.9 mt-10 -102.33 144.69 30.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.982 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.19 109.39 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 111.563 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.836 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.33 121.53 23.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.012 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -132.27 128.2 37.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 5.7 pt-20 -86.96 100.9 12.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.57 ' CG ' HD23 ' A' ' 15' ' ' LEU . 6.6 mtp180 -43.72 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.935 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.433 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.042 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.012 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.727 0.299 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 135.67 39.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.484 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.789 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.5 p90 -161.79 137.31 7.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.986 0.393 . . . . 0.0 110.708 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.8 134.33 40.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.624 -179.265 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.04 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.51 146.92 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.588 0.709 . . . . 0.0 111.684 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -127.37 121.57 31.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.464 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 140.69 159.62 8.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.007 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.455 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 148.86 175.59 21.47 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.359 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 68' ' ' VAL . 25.0 p -66.71 -11.69 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 23.7 t70 -114.62 -26.59 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.44 87.2 54.41 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.57 66.21 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.301 2.001 . . . . 0.0 112.579 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.553 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 10.6 t-80 -48.43 -27.81 2.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.376 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.981 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -87.13 -155.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.437 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -52.83 -51.7 43.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.964 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.958 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.52 175.73 3.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.99 35.41 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.671 2.247 . . . . 0.0 112.445 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -84.84 114.77 22.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 110.903 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.926 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.69 118.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.066 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.981 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.15 148.03 37.61 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.344 0.593 . . . . 0.0 110.719 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.028 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.39 155.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.516 -177.224 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.13 -29.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.163 -178.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.34 130.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.785 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.983 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.62 132.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.802 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.466 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 125.56 71.71 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.1 Cg_endo -68.05 132.55 26.52 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 112.365 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.33 19.26 21.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.346 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.86 179.12 16.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.349 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.39 -33.31 59.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.653 0.263 . . . . 0.0 111.479 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.823 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -73.36 -56.0 5.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.45 -29.08 63.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 10.8 pt20 -72.19 -31.85 66.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.274 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.88 -57.94 3.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.4 11.9 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.592 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.67 -15.76 13.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.766 0.283 . . . . 0.0 110.863 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.028 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -113.9 153.37 29.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.21 0.529 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.99 136.28 48.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.574 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.2 t -49.08 157.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.363 0.601 . . . . 0.0 111.543 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER 76.82 -1.04 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.302 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -66.51 124.52 23.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.54 100.48 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.55 0.691 . . . . 0.0 111.432 -178.58 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 19' ' ' ILE . 27.4 mt -48.3 135.61 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.596 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' A' ' 3' ' ' TYR . 3.0 pp -139.92 12.79 2.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 170.82 134.74 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.317 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.799 HG21 ' CB ' ' A' ' 76' ' ' ALA . 37.5 t -123.91 95.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.299 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.626 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.6 t-20 73.26 -60.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 27.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.475 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 40.8 t -121.27 109.11 24.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.993 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -70.48 120.81 16.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.512 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.727 HG21 HG22 ' A' ' 57' ' ' ILE . 22.1 m -93.99 20.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -22.63 66.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.116 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.26 44.18 1.89 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.059 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 23' ' ' THR . 16.7 m -124.41 145.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.036 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.506 ' HG1' ' HG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -66.07 153.65 41.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.558 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.9 t-160 -49.14 -34.2 13.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.744 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.506 ' HG ' ' HG1' ' A' ' 69' ' ' THR . 0.1 OUTLIER -70.86 -33.76 70.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.7 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.676 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.05 -31.67 69.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.926 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -71.56 -46.96 57.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.636 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 81.8 t -60.48 -50.54 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.283 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -58.33 -34.89 71.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.39 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.799 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -55.22 -49.34 72.22 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.426 0.631 . . . . 0.0 110.09 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.918 HD11 HD12 ' A' ' 19' ' ' ILE . 1.8 mt -59.65 -36.01 75.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.591 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.36 -21.95 52.51 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mt-10 -102.05 -6.33 23.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.684 0.278 . . . . 0.0 111.383 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.921 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -59.71 -17.74 37.04 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.251 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.0 -117.04 5.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.921 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 m -110.68 -89.29 0.5 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.836 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.1 tp -90.92 90.91 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.296 0.569 . . . . 0.0 109.732 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.921 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -103.89 138.29 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.05 102.89 15.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.788 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.1 mt -89.78 134.7 34.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -101.91 116.52 32.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.271 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.5 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.644 0.259 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -113.2 163.87 14.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 111.065 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 68.8 mt-10 -114.16 144.6 42.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.78 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.948 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -132.39 109.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.501 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.938 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.26 120.67 23.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.043 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -132.29 127.22 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.6 pt-20 -85.9 100.84 12.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.192 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.588 ' CG ' HD23 ' A' ' 15' ' ' LEU . 9.7 mtp180 -42.77 91.85 0.0 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.35 0.595 . . . . 0.0 110.835 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.56 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.117 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.043 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.9 mt . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.781 0.324 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 131.97 38.25 0.26 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.594 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.801 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -160.44 135.36 7.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.006 0.403 . . . . 0.0 110.729 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.41 136.84 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.525 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.065 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.21 148.84 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.743 0.783 . . . . 0.0 112.337 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -143.25 133.22 24.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.12 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.89 -2.95 1.24 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.184 -1.007 . . . . 0.0 113.879 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.552 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.04 -173.16 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.951 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.802 HG22 ' CB ' ' A' ' 32' ' ' PRO . 19.9 p -73.09 -20.9 60.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -96.35 -24.61 16.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.585 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.36 87.52 53.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.211 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.73 63.17 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.384 2.056 . . . . 0.0 112.652 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.639 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.4 t-80 -49.78 -26.58 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.842 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.15 -154.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.323 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.91 -50.04 71.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.615 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.72 40.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.09 169.19 12.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.802 ' CB ' HG22 ' A' ' 23' ' ' THR . 98.0 Cg_endo -79.35 3.5 7.42 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.566 2.178 . . . . 0.0 112.74 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -53.61 111.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.883 0.373 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.838 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.55 119.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.838 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.842 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.23 147.22 36.15 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 121.361 0.601 . . . . 0.0 110.779 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.96 155.6 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.803 -177.011 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.451 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.6 -29.53 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.286 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.99 130.19 0.49 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.001 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.003 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.5 131.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.481 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 124.33 74.25 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.69 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.0 Cg_endo -66.2 132.58 30.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.348 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.81 17.46 25.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.437 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 177.39 17.27 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.042 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.68 -32.76 52.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 111.444 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.812 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -71.55 -57.3 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.799 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.15 -29.02 63.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.477 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -71.95 -33.32 68.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.148 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -79.37 -58.05 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.38 39.97 10.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.592 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.468 ' CB ' HG12 ' A' ' 6' ' ' ILE . 19.2 mmt180 -115.88 -4.75 12.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 110.814 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 6.1 tp -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.589 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 134.55 42.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.487 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.09 157.5 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.319 0.58 . . . . 0.0 111.681 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER 77.01 -1.61 2.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.174 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.17 125.55 26.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.653 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.26 12.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.753 0.787 . . . . 0.0 111.435 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.065 HD11 HG21 ' A' ' 19' ' ' ILE . 65.8 mt -47.35 138.35 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.887 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.508 HD11 HH21 ' A' ' 66' ' ' ARG . 0.2 OUTLIER -117.31 -44.42 2.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.073 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -142.52 167.14 22.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.771 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 86' ' ' LEU . 23.4 t -142.22 97.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.788 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.501 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.8 t-20 67.57 -67.99 0.17 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.093 0.473 . . . . 0.0 109.775 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.2 tt0 -155.71 33.71 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.481 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.1 t -120.73 142.49 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.636 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.7 p-10 -106.95 111.23 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.29 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HB ' HD12 ' A' ' 34' ' ' ILE . 18.2 m -95.32 31.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.801 0.334 . . . . 0.0 111.54 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.508 HH21 HD11 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -63.33 -29.16 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.766 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.85 65.91 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.729 ' O ' HG23 ' A' ' 23' ' ' THR . 27.2 m -136.19 147.12 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.274 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.54 153.01 33.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.0 t-160 -50.51 -33.75 22.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -34.02 73.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.756 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.29 -39.96 81.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.838 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.11 -46.99 78.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.6 t -57.02 -50.34 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.253 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.38 -30.69 63.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.026 178.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.672 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -60.44 -49.78 76.2 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.405 0.622 . . . . 0.0 109.908 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.996 HD11 HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -60.27 -34.76 74.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.48 -26.77 51.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.361 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.84 15.54 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.383 -178.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.22 16.28 6.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.172 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.98 -114.01 5.57 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.989 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.4 m -114.99 -89.36 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.938 HG13 HG22 ' A' ' 7' ' ' THR . 7.1 tp -86.77 97.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.993 0.425 . . . . 0.0 110.222 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.901 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -111.37 138.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.573 ' HG2' HG23 ' A' ' 7' ' ' THR . 7.2 mtt85 -88.16 103.24 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.8 mt -91.12 142.97 27.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.74 136.07 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.768 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 51' ' ' LEU . 17.2 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.42 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 20.6 m-85 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.778 0.323 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -144.42 147.46 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.968 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 39.6 mt-10 -104.63 144.74 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.963 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.23 109.26 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.033 0.444 . . . . 0.0 111.439 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.25 122.96 25.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.016 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.6 tp -134.23 127.05 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -82.4 100.43 10.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.542 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -50.33 92.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.514 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.286 -179.173 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.016 ' HB3' HD23 ' A' ' 8' ' ' LEU . 8.4 mt . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 120.733 0.302 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 138.2 39.12 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.632 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.795 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.8 p90 -160.17 134.29 7.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.093 0.446 . . . . 0.0 110.764 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.68 133.43 37.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.071 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.67 162.98 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.711 0.767 . . . . 0.0 111.632 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.687 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -160.36 132.61 6.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.357 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 -2.8 1.47 Allowed Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.464 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.74 -175.57 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.138 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 32.2 p -67.97 -29.1 68.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.78 -20.49 20.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -124.17 87.02 53.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.71 61.74 0.86 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.354 2.036 . . . . 0.0 112.645 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.687 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 9.0 t-80 -47.57 -29.09 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.033 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.847 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.74 -155.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.194 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.67 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.88 -49.52 47.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.46 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -178.17 49.01 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.897 0.379 . . . . 0.0 111.231 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.08 159.16 70.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CB ' HG22 ' A' ' 23' ' ' THR . 96.6 Cg_endo -79.1 3.41 7.45 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.647 2.232 . . . . 0.0 112.691 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.43 119.43 5.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.976 0.417 . . . . 0.0 110.931 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.856 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.71 119.19 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.567 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.24 144.71 33.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.48 0.657 . . . . 0.0 110.783 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.056 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.74 155.94 7.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.311 -176.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.455 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.12 -29.82 4.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.343 -178.503 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.646 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.97 131.57 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.931 -179.432 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.955 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.471 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.37 115.3 59.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.5 Cg_exo -58.11 136.48 75.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.697 2.265 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 19.96 27.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.48 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.48 179.54 16.83 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.175 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.65 -36.55 57.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.859 0.361 . . . . 0.0 111.531 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -68.86 -57.41 5.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.2 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.55 -28.39 62.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.781 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -29.91 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.257 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.498 ' OD2' HD12 ' A' ' 8' ' ' LEU . 5.2 m-20 -82.49 -57.86 3.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.88 37.19 11.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.602 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.443 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtt180 -112.33 -14.43 13.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.713 0.292 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.056 HD21 HD12 ' A' ' 36' ' ' ILE . 7.1 tp -113.75 156.82 23.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.267 0.556 . . . . 0.0 111.374 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.616 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -135.09 134.66 40.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.413 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 38' ' ' LYS . 52.9 t -49.04 157.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.248 0.547 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.485 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 75.15 2.51 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.091 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.62 127.07 31.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.076 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.48 102.5 14.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 111.306 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.071 HD11 HG21 ' A' ' 19' ' ' ILE . 57.3 mt -49.7 131.2 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.814 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 3.4 mm? -109.63 -43.17 4.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.106 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -143.16 164.94 28.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.813 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.747 HG11 ' HB1' ' A' ' 76' ' ' ALA . 21.4 t -143.61 98.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.991 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 68.09 -66.89 0.21 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.126 0.488 . . . . 0.0 109.992 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -157.65 33.24 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.687 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.7 t -120.73 142.4 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.582 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.1 t0 -109.04 95.29 5.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.337 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 65' ' ' VAL . 27.4 m -80.28 58.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 0.0 111.48 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -85.22 -31.52 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.757 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.68 52.69 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 27.3 m -121.16 148.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.06 153.4 43.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 t-160 -49.44 -34.1 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.792 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.9 m -68.71 -34.09 75.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.785 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.35 -42.05 79.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.856 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.4 -46.91 84.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.661 0.743 . . . . 0.0 109.076 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.5 t -57.31 -50.39 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.231 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.82 -29.89 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.864 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.747 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.14 -50.22 74.09 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.305 0.574 . . . . 0.0 109.847 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -58.78 -36.31 74.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.955 179.115 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.61 -25.16 49.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.452 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.53 16.38 26.53 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.32 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.38 16.3 5.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.241 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.35 -98.32 0.82 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.063 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 8.5 p -136.4 -90.38 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 7' ' ' THR . 8.5 tp -83.37 88.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 109.875 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.2 p -104.14 139.6 24.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.87 103.06 15.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.744 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.2 mt -90.96 141.17 29.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.442 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.85 138.48 38.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 51' ' ' LEU . 13.0 m . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.41 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 78.1 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.791 0.329 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HG2' HG23 ' A' ' 88' ' ' VAL . 2.6 pt-20 -138.32 167.24 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 5.6 tt0 -121.18 144.64 48.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.991 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.13 109.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.866 0.365 . . . . 0.0 111.739 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -82.02 112.19 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.991 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -121.68 127.31 50.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.9 pt-20 -83.83 100.54 11.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.07 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.72 89.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.078 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.238 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.556 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.5 tp . . . . . 0 N--CA 1.457 -0.09 0 N-CA-C 110.731 -0.1 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.28 22.05 1.01 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 119.745 -1.216 . . . . 0.0 114.809 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.875 ' CE2' HD23 ' A' ' 15' ' ' LEU . 10.5 p90 -161.4 136.51 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.035 0.918 . . . . 0.0 111.143 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.42 135.22 38.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.656 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.09 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.44 146.93 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.628 0.728 . . . . 0.0 111.367 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.83 124.07 34.41 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.706 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.85 -121.81 1.07 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.074 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 69.54 172.22 9.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.361 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 32' ' ' PRO . 4.3 p -77.85 -5.55 51.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.17 -23.14 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.516 ' O ' ' O ' ' A' ' 21' ' ' GLY . 2.6 t-20 -124.91 85.96 56.95 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.488 0.185 . . . . 0.0 110.57 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.153 1.902 . . . . 0.0 112.425 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.536 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 11.7 t-80 -53.8 -24.36 15.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.053 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.841 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.79 -153.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.337 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.682 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -65.35 -47.62 77.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.757 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.19 79.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 110.676 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -172.75 164.01 3.69 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.67 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.827 ' HB2' HG22 ' A' ' 23' ' ' THR . 96.0 Cg_endo -79.7 50.94 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.503 2.135 . . . . 0.0 112.174 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -99.28 116.65 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.873 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -89.99 112.49 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.459 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -137.31 146.76 45.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.125 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.103 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.05 155.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.169 -176.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.52 -30.36 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.04 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.12 131.04 0.48 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.031 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.98 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.88 132.8 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 115.26 59.32 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.123 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.3 Cg_exo -57.19 134.45 64.19 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.824 2.349 . . . . 0.0 112.201 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.25 4.02 59.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.642 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.55 179.39 22.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.801 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.66 -37.61 68.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.807 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.35 -57.45 6.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.56 -28.84 68.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.296 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.35 68.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 110.001 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.631 ' OD2' HD12 ' A' ' 8' ' ' LEU . 24.0 m-20 -82.86 -58.02 3.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.559 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 40.88 9.22 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.539 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER -115.6 6.98 14.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.94 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.103 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -135.24 154.76 51.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.993 0.425 . . . . 0.0 110.843 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.584 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.09 137.07 47.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.7 t -51.6 159.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.138 0.494 . . . . 0.0 111.716 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.4 m120 71.95 3.68 4.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.32 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.654 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.7 m-20 -74.63 128.37 35.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.85 105.25 16.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.564 0.697 . . . . 0.0 111.388 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.09 HD11 HG21 ' A' ' 19' ' ' ILE . 68.5 mt -51.09 141.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.602 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.41 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -121.61 -44.31 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.496 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -143.18 148.61 36.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.335 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.916 HG13 ' CD2' ' A' ' 86' ' ' LEU . 54.5 t -139.54 112.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.026 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.2 t30 50.81 35.8 13.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.129 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 80.23 33.94 0.16 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.501 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 60' ' ' VAL . 78.1 t -120.93 108.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 t0 -71.26 117.18 12.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.713 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 57' ' ' ILE . 33.8 m -101.89 23.45 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.301 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -62.84 -25.52 68.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -146.07 57.4 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.181 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.782 ' C ' HG23 ' A' ' 23' ' ' THR . 31.8 m -132.79 141.83 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.231 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.68 152.35 26.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.84 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 20.1 t-160 -47.99 -34.02 8.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.883 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -34.24 77.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.681 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.27 -40.62 77.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.873 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.0 -46.93 82.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.9 t -56.09 -50.86 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.391 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.681 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.76 -29.29 62.45 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.153 178.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.11 -56.72 18.18 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.359 0.6 . . . . 0.0 110.044 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 73' ' ' ALA . 2.0 mp -53.86 -36.4 62.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.34 -27.29 52.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.659 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.26 15.67 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.0 111.47 -178.411 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.991 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.81 16.32 4.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.316 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.03 -89.33 0.13 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.384 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -143.44 -88.87 0.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.763 HG13 HG22 ' A' ' 7' ' ' THR . 4.2 tp -84.4 91.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.991 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.4 p -107.06 135.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.1 ptt180 -86.81 102.96 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.916 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.8 mt -91.63 143.56 26.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.083 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CD1' ' HG3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -101.68 139.71 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.523 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG21 ' OD2' ' A' ' 55' ' ' ASP . 28.9 m . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.805 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.451 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 36.1 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.769 0.318 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 133.31 21.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -97.17 144.61 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.076 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.0 109.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.863 0.364 . . . . 0.0 111.833 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.796 HG23 HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -79.83 114.55 18.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.076 HD13 HD11 ' A' ' 6' ' ' ILE . 5.6 tp -120.78 127.05 51.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.819 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.73 ' N ' HD12 ' A' ' 83' ' ' ILE . 3.8 pt-20 -80.59 99.92 8.36 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -56.44 88.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.901 178.11 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.225 -179.012 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.982 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.5 tp . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.306 0.098 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 126.6 25.19 1.3 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.849 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.843 ' CE2' HD23 ' A' ' 15' ' ' LEU . 4.5 p90 -161.82 134.75 6.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.854 0.827 . . . . 0.0 111.256 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.67 134.16 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.105 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.96 168.26 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.686 0.755 . . . . 0.0 111.677 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -165.43 132.2 2.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.319 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.4 0.54 1.16 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.545 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.562 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.015 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.777 HG22 ' CB ' ' A' ' 32' ' ' PRO . 16.6 p -74.42 -22.45 59.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -97.18 -23.76 16.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.693 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.32 87.7 53.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.365 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.84 63.16 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.339 2.026 . . . . 0.0 112.742 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.644 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.3 t-80 -47.53 -28.47 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.859 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.85 -155.1 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.239 179.46 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.47 -47.49 56.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.597 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.8 t0 177.23 76.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.37 165.26 7.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.861 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.777 ' CB ' HG22 ' A' ' 23' ' ' THR . 89.9 Cg_endo -81.12 6.68 5.42 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.657 2.238 . . . . 0.0 112.79 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.39 112.17 1.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.52 119.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.585 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.859 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.44 146.0 34.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.522 0.677 . . . . 0.0 110.668 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.049 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.79 155.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.415 -176.427 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.21 -30.46 4.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.347 -178.751 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.45 132.21 0.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.051 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.99 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.88 132.0 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.435 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.3 118.12 70.41 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.506 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.8 Cg_exo -58.01 135.29 67.72 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.363 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.1 3.02 62.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.845 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.77 178.49 23.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.057 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.58 -34.62 64.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.011 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.793 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -71.82 -56.92 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.679 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.19 -30.28 70.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.94 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 12.1 pt20 -72.06 -33.45 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -57.93 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.71 9.16 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.614 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.485 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.2 mtp85 -113.27 8.12 17.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.804 0.335 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.049 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -136.65 154.73 50.56 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.053 0.454 . . . . 0.0 110.816 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 tpm_? -131.76 136.3 47.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -51.58 157.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 111.564 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.2 t30 74.07 3.15 4.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.177 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.664 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -73.73 127.0 31.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.42 100.97 12.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.659 0.743 . . . . 0.0 111.296 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.105 HD11 HG21 ' A' ' 19' ' ' ILE . 62.5 mt -46.24 149.51 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.813 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -127.62 -45.71 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.387 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -143.03 157.78 44.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.081 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.85 HG11 ' HB1' ' A' ' 76' ' ' ALA . 41.7 t -132.55 95.73 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.873 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.9 t-20 68.85 -66.93 0.23 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.166 0.508 . . . . 0.0 109.896 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -155.59 32.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.654 179.171 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 86.4 t -120.7 142.2 37.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.512 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 24.5 t0 -107.86 112.15 24.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 23.8 m -94.18 36.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 111.513 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -65.07 -31.54 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.721 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.28 68.09 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.713 ' O ' HG23 ' A' ' 23' ' ' THR . 27.0 m -137.62 145.05 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.281 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.2 150.56 34.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.757 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.7 t-160 -48.1 -33.78 8.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.75 -34.1 76.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.027 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.67 -39.91 80.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.82 -46.92 76.81 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.646 0.736 . . . . 0.0 109.081 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 70' ' ' HIS . 97.2 t -57.2 -50.55 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.206 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.57 -30.48 60.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.953 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.63 -50.57 72.97 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.41 0.624 . . . . 0.0 110.018 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.064 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -58.55 -37.17 75.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.045 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -26.41 50.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.505 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.43 18.89 20.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 0.0 111.306 -178.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.77 16.25 6.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.531 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.31 -86.69 0.41 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.635 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' LEU . 38.1 m -147.67 -90.87 0.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.796 HD11 HG23 ' A' ' 7' ' ' THR . 8.4 tp -84.17 90.68 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.452 0.644 . . . . 0.0 109.743 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.949 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.8 p -105.92 135.06 45.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.294 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.6 ttt180 -85.21 102.89 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.565 HD12 ' HZ ' ' A' ' 17' ' ' PHE . 15.3 mt -92.05 140.9 29.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.969 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.55 141.18 34.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.713 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.664 HG21 ' OD2' ' A' ' 55' ' ' ASP . 25.1 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.581 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 4.6 m-30 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.828 0.347 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -151.18 146.15 25.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.8 pt-20 -100.74 144.57 29.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.978 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.45 110.0 9.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.895 0.379 . . . . 0.0 111.521 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.909 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -76.92 121.48 23.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.03 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.4 tp -134.22 127.1 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 83' ' ' ILE . 4.1 pt-20 -85.89 100.88 12.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.344 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.634 ' CG ' HD23 ' A' ' 15' ' ' LEU . 8.0 mtp-105 -44.94 92.37 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.22 0.533 . . . . 0.0 110.897 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.315 -0.608 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.13 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.03 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.3 mt . . . . . 0 N--CA 1.455 -0.221 0 CA-C-O 120.84 0.353 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.77 39.17 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.086 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.9 p90 -162.51 132.38 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.345 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -92.48 137.29 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.134 0.492 . . . . 0.0 111.724 -179.046 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -120.3 142.11 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.661 0.744 . . . . 0.0 111.95 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -106.06 117.2 33.41 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.814 ' HA2' HG23 ' A' ' 34' ' ' ILE . . . -71.21 -158.72 3.09 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.44 -44.09 0.12 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.734 -0.746 . . . . 0.0 114.571 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.759 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -69.02 -58.9 3.47 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.672 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 4.0 m-20 -81.67 -34.2 30.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.09 0.471 . . . . 0.0 110.52 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' HIS . 11.1 t-20 -124.44 87.7 53.92 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.248 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.75 64.98 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.288 1.992 . . . . 0.0 112.538 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.572 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.2 t-80 -57.53 -21.82 40.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.724 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.764 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -96.61 -150.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.688 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -85.19 44.22 3.35 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.885 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 76.18 30.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.961 0.41 . . . . 0.0 110.738 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.47 146.92 38.56 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CB ' HG22 ' A' ' 23' ' ' THR . 74.4 Cg_endo -74.9 55.27 3.84 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.52 2.146 . . . . 0.0 112.508 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -121.01 108.88 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.964 HD11 ' O ' ' A' ' 68' ' ' VAL . 2.7 mp -79.49 131.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.764 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -142.89 152.82 42.5 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.213 0.53 . . . . 0.0 110.27 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.888 HD12 HD21 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -69.41 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.553 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.521 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.08 -26.12 4.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.978 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -176.53 131.73 0.21 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.868 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.8 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.49 130.37 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.36 114.16 53.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.897 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.1 Cg_exo -56.22 139.96 86.8 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.599 2.199 . . . . 0.0 112.205 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.2 15.24 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.522 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.55 174.69 16.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.986 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -30.64 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.251 . . . . 0.0 111.129 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.836 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -72.94 -57.52 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 111.823 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.66 -28.58 63.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.535 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -72.02 -30.84 65.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 110.382 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 8' ' ' LEU . 2.5 m-20 -80.53 -57.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.16 37.0 10.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.711 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -118.95 4.57 11.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.821 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 36' ' ' ILE . 16.3 tp -132.73 159.81 38.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.218 0.532 . . . . 0.0 111.173 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.595 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -139.44 152.77 47.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 38' ' ' LYS . 77.8 t -65.75 158.9 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.054 0.454 . . . . 0.0 111.271 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 53' ' ' VAL . 55.3 m-80 77.27 -6.35 2.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.714 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -64.44 125.86 25.99 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.87 104.39 16.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.611 0.719 . . . . 0.0 111.773 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.03 HG22 HG21 ' A' ' 65' ' ' VAL . 46.1 mt -48.2 138.89 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.794 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.667 ' C ' HG22 ' A' ' 65' ' ' VAL . 1.1 mt -126.4 -37.75 2.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.471 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -147.17 156.67 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.917 HG13 ' CD2' ' A' ' 86' ' ' LEU . 47.8 t -141.21 102.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.232 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 66.95 -68.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.098 0.475 . . . . 0.0 110.247 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.86 31.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.929 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.8 t -120.79 142.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.281 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.8 p-10 -101.65 108.18 19.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.03 HG21 HG22 ' A' ' 57' ' ' ILE . 26.7 m -97.26 30.72 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.311 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.53 -37.45 75.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 110.725 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.25 56.32 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.505 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.964 ' O ' HD11 ' A' ' 34' ' ' ILE . 33.6 m -114.59 141.03 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.159 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.759 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 1.8 p -51.06 150.16 3.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.223 0.535 . . . . 0.0 112.0 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.803 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -47.09 -32.99 4.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.527 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 3.6 m -73.81 -33.31 64.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.387 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.66 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.79 -32.12 70.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.042 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.92 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.55 -46.89 58.2 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.0 t -60.29 -50.66 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.733 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.7 pt-20 -58.31 -31.48 67.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.497 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.786 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -58.39 -49.26 77.9 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.308 0.575 . . . . 0.0 109.795 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.814 ' CD1' HD12 ' A' ' 19' ' ' ILE . 1.5 mt -61.25 -34.67 75.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.186 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.14 -29.06 54.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.512 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.7 pt-20 -98.79 15.39 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.525 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.57 16.3 6.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.35 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.21 -114.76 6.57 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.078 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.9 OUTLIER -113.59 -88.87 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.894 HG13 HG22 ' A' ' 7' ' ' THR . 7.1 tp -86.72 100.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.122 0.487 . . . . 0.0 110.113 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -114.96 139.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.909 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.3 103.02 15.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.917 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.2 mt -91.84 137.22 32.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.511 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.87 131.56 48.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.5 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.134 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.755 ' CE2' HD22 ' A' ' 58' ' ' LEU . 3.0 m-30 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.751 0.31 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -115.16 165.02 13.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 111.251 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -120.0 145.01 47.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.836 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.15 110.98 14.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 111.931 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.924 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.35 117.15 20.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 5.1 tp -128.28 126.83 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.0 pt-20 -85.24 100.45 11.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.537 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.0 88.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.15 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.703 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.005 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.2 tp . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.361 0.124 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.77 21.95 0.97 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.65 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.866 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.8 p90 -161.42 137.46 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.736 0.768 . . . . 0.0 111.055 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.04 133.21 40.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.38 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.055 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.03 165.06 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.657 0.741 . . . . 0.0 111.76 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -162.64 132.11 4.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.262 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.84 0.66 0.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.42 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.15 -170.7 0.34 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.859 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.844 HG22 ' HB3' ' A' ' 32' ' ' PRO . 23.9 p -69.81 -32.62 71.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.79 -19.72 23.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.14 86.79 53.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.633 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.59 60.2 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.292 1.995 . . . . 0.0 112.547 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.636 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.4 t-80 -47.8 -28.71 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.145 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.844 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.23 -153.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.14 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.677 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -66.29 -47.83 68.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.413 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.32 46.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.349 . . . . 0.0 110.835 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.97 161.74 61.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.844 ' HB3' HG22 ' A' ' 23' ' ' THR . 7.5 Cg_exo -73.03 -2.78 12.54 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.864 2.376 . . . . 0.0 112.689 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -49.16 113.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.929 0.395 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.832 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -85.7 119.19 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.46 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.844 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.46 146.45 34.8 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.526 0.679 . . . . 0.0 110.794 178.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.075 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.92 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.954 -176.717 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.19 -28.68 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.337 -178.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.56 129.64 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.071 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.981 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.49 133.05 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.424 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 129.95 55.93 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 56.0 Cg_endo -70.0 130.24 18.71 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.784 2.323 . . . . 0.0 112.304 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 2.65 55.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.64 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.49 179.23 24.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.078 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.79 -35.48 68.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 111.065 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.859 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -71.9 -56.75 5.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.82 -31.89 72.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.93 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.1 pt20 -72.11 -33.73 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 110.159 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.43 -57.91 3.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.01 41.27 9.65 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.627 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.524 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -113.31 7.02 17.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.947 0.403 . . . . 0.0 110.795 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.075 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -135.97 154.16 51.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.37 135.54 48.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -49.7 157.95 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.556 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.4 t30 75.05 2.18 3.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -70.45 123.37 21.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.53 100.42 12.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.889 0.852 . . . . 0.0 111.54 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 19' ' ' ILE . 20.0 mt -49.18 142.79 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.392 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.755 HD22 ' CE2' ' A' ' 3' ' ' TYR . 1.4 mt -124.54 -37.84 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.069 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 m-85 -143.8 164.3 30.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.887 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.8 t -151.54 103.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.26 42.46 31.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.86 32.68 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.599 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 88.9 t -120.92 112.75 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.417 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 t0 -80.8 110.43 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 65' ' ' VAL . 33.4 m -83.09 55.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.8 105.67 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.12 48.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' THR . 11.8 m -116.1 142.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.977 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -61.29 152.01 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.867 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 t-160 -49.6 -33.76 16.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.211 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.761 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.64 -43.22 80.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.89 -46.88 82.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.0 t -57.48 -48.45 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.285 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.88 -31.74 63.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.764 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.652 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.8 -53.11 61.83 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.211 0.529 . . . . 0.0 109.797 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.037 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -52.49 -37.44 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.262 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.57 -27.8 51.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.082 178.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.2 mm-40 -84.08 -19.97 33.41 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 110.602 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -53.03 -18.81 2.24 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.628 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.78 -92.75 1.83 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.8 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -129.99 -92.34 0.44 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.924 HG13 HG22 ' A' ' 7' ' ' THR . 8.8 tp -86.59 100.97 10.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.178 0.513 . . . . 0.0 110.442 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.936 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.4 p -116.06 138.77 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.2 102.87 14.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.292 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.887 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.2 mt -93.37 135.59 34.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.57 135.46 43.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.743 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 57' ' ' ILE . 19.0 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.808 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.408 ' CD1' HD11 ' A' ' 58' ' ' LEU . 11.2 m-30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.746 0.308 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.9 mm-40 -145.13 168.29 20.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 0.0 111.287 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -118.05 144.79 45.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.88 110.53 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 111.653 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.841 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.48 120.5 22.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 4.2 tp -132.58 127.45 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.433 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.636 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.0 pt-20 -86.56 100.88 12.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.588 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' CG ' HD23 ' A' ' 15' ' ' LEU . 2.6 mtp-105 -42.76 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.994 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.418 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.061 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.005 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.799 0.333 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 135.34 39.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.598 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.785 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.4 p90 -161.69 133.85 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.483 . . . . 0.0 111.161 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.492 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.08 134.62 34.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.287 -179.489 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.107 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.93 162.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.675 0.75 . . . . 0.0 111.731 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -158.76 131.76 7.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.046 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.51 -1.3 0.98 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.504 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.14 -168.93 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.94 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.848 HG22 ' HB3' ' A' ' 32' ' ' PRO . 12.2 p -77.09 -23.49 51.86 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -94.87 -25.32 16.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.329 . . . . 0.0 111.557 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 27' ' ' HIS . 23.6 m-80 -124.65 82.82 59.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.6 64.24 0.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.912 2.408 . . . . 0.0 112.66 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.631 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.1 t-80 -50.68 -24.27 3.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.374 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.794 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.12 -154.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.762 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.633 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -80.1 52.48 4.27 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.733 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 74.76 30.53 0.99 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -117.08 147.76 40.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.848 ' HB3' HG22 ' A' ' 23' ' ' THR . 11.8 Cg_exo -70.76 -2.71 11.33 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.812 2.342 . . . . 0.0 112.88 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -53.99 116.55 2.62 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.035 0.445 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.865 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.84 120.19 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.375 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.794 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.52 144.93 33.17 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.456 0.646 . . . . 0.0 110.642 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.065 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.78 155.68 7.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.307 -176.529 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.67 -33.79 4.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.846 -178.905 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.52 142.49 2.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.517 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.005 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.19 132.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.321 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.96 125.17 73.54 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 46.2 Cg_endo -68.15 131.94 24.86 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.784 2.322 . . . . 0.0 112.413 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.04 27.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.27 178.96 16.37 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.203 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.35 -38.86 59.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.732 0.301 . . . . 0.0 111.461 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.793 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.98 -57.11 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.43 -30.32 65.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -72.08 -30.59 65.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.948 0.404 . . . . 0.0 110.354 179.67 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.448 ' CG ' HE21 ' A' ' 47' ' ' GLN . 1.4 m-20 -81.95 -58.03 3.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.514 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.92 9.62 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.527 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 23.8 mtm180 -115.75 -3.99 12.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.808 0.304 . . . . 0.0 110.944 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.065 HD21 HD12 ' A' ' 36' ' ' ILE . 5.1 tp -122.57 153.94 38.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.883 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -131.8 135.86 47.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.865 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.41 158.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.307 0.575 . . . . 0.0 111.725 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.27 1.87 3.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.028 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -70.06 124.85 25.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.41 101.06 12.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.16 -178.694 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.107 HD11 HG21 ' A' ' 19' ' ' ILE . 55.8 mt -49.44 129.68 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.703 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 7.9 mt -110.75 -31.7 7.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -151.05 166.42 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.3 t -148.91 100.45 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.219 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.649 ' OD1' HG23 ' A' ' 84' ' ' VAL . 14.0 t30 67.58 -67.31 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 110.065 -178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.0 mt-10 -157.92 32.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 49.5 t -119.57 142.21 36.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.529 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 30.1 t0 -111.65 84.96 2.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.362 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 65' ' ' VAL . 32.6 m -69.39 64.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.55 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -87.03 -28.09 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -151.31 59.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.688 ' O ' HG23 ' A' ' 23' ' ' THR . 34.5 m -127.78 145.38 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.261 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 150.66 27.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.822 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -48.29 -33.42 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -68.22 -34.04 75.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.072 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.11 -40.87 82.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.865 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.26 -46.84 81.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.021 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.0 t -57.74 -50.31 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.308 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -56.16 -34.31 66.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.647 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.618 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.58 -51.38 68.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.241 0.543 . . . . 0.0 110.109 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.021 HD11 HD12 ' A' ' 19' ' ' ILE . 2.9 mt -56.22 -36.43 68.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.416 179.065 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.2 mmmt -77.47 -24.62 50.18 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.33 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -95.81 -10.11 29.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 111.327 -178.858 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.91 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.81 -17.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.387 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.98 -109.76 3.74 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.8 m -118.84 -90.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.808 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.841 HG13 HG22 ' A' ' 7' ' ' THR . 7.9 tp -89.21 89.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.257 0.551 . . . . 0.0 109.735 178.574 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.91 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -103.54 140.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.497 ' HG3' HG23 ' A' ' 7' ' ' THR . 3.7 mtt180 -87.73 102.98 15.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.083 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.65 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.2 mt -91.89 137.67 32.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.109 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.68 134.39 44.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.091 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.6 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.154 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.469 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.3 m-30 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.771 0.319 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -132.65 160.61 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -107.37 144.67 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.044 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.04 109.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.91 0.386 . . . . 0.0 111.507 179.796 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.883 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.22 119.08 20.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.709 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.044 HD13 HD11 ' A' ' 6' ' ' ILE . 5.5 tp -130.81 127.33 38.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -86.68 99.41 11.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.647 179.443 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -54.49 92.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.868 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--O 1.229 -0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 114.597 -177.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.927 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.706 0.289 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 81.7 25.0 54.76 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.798 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -161.75 132.23 4.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.424 1.112 . . . . 0.0 111.857 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.53 138.75 32.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.83 -179.302 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.098 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.52 147.12 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.608 0.718 . . . . 0.0 111.939 179.756 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.673 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 134.4 31.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.183 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.9 -3.12 1.49 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.631 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.58 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.78 -176.19 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.045 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 68' ' ' VAL . 43.1 p -66.81 -30.33 70.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 9.6 t70 -93.56 -18.33 22.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -124.23 87.0 54.06 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.533 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.08 61.13 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.329 2.019 . . . . 0.0 112.606 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.673 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 9.4 t-80 -48.34 -28.32 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.04 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.851 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -85.47 -154.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.218 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.666 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.44 -49.82 48.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.439 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -178.44 47.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.383 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.66 160.89 64.8 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.142 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CB ' HG22 ' A' ' 23' ' ' THR . 94.5 Cg_endo -78.51 2.46 8.09 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 112.749 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -53.49 117.31 3.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.004 0.43 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.69 118.51 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.71 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.25 147.51 40.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.362 0.601 . . . . 0.0 110.599 178.453 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.077 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.06 155.5 7.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.8 -176.796 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.07 -33.71 3.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.528 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 142.29 2.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.063 0.458 . . . . 0.0 111.679 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.005 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.23 128.62 60.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.625 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.05 127.54 66.41 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 19.4 Cg_endo -60.2 137.99 78.61 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.759 2.306 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.65 -0.46 82.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.454 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.44 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.71 -179.99 38.82 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.084 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.26 -40.5 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.518 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.907 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -73.05 -54.99 7.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.468 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -63.94 -28.96 70.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.283 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -72.35 -36.54 68.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.005 0.431 . . . . 0.0 110.069 179.301 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -57.93 2.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.07 39.27 8.06 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.751 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' CB ' HG12 ' A' ' 6' ' ' ILE . 69.6 mtt-85 -112.98 8.5 18.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.906 0.353 . . . . 0.0 110.711 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.077 HD21 HD12 ' A' ' 36' ' ' ILE . 4.2 tp -133.02 153.72 51.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.1 137.75 49.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.836 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -51.65 157.88 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 111.732 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.475 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.5 t-20 76.92 -2.4 2.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.491 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -67.04 124.89 24.3 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.043 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 t -86.63 100.37 12.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.572 0.701 . . . . 0.0 111.129 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.098 HD11 HG21 ' A' ' 19' ' ' ILE . 59.9 mt -49.15 140.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.899 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 88' ' ' VAL . 2.6 mp -121.71 -32.36 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.552 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -150.86 164.23 36.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.791 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.665 HG21 ' CB ' ' A' ' 76' ' ' ALA . 25.9 t -141.92 97.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.758 ' OD1' HG23 ' A' ' 84' ' ' VAL . 10.4 t30 69.6 -65.84 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.111 0.482 . . . . 0.0 109.875 -178.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -159.41 32.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.709 179.2 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.5 t -120.78 142.25 37.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.579 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -103.97 110.8 23.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.26 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 20.2 m -94.43 34.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -25.63 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.877 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -146.21 60.68 1.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.036 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.796 ' O ' HG23 ' A' ' 23' ' ' THR . 26.8 m -133.48 150.06 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.182 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -69.18 154.51 41.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.341 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.6 t-160 -49.85 -34.49 20.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 t -70.32 -34.02 72.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.24 -41.58 80.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.62 -46.67 84.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 70' ' ' HIS . 95.7 t -57.54 -50.45 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.0 -29.86 60.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.966 178.55 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.665 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -61.94 -51.23 68.96 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.023 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -55.89 -37.59 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.452 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.39 -25.13 50.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.913 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -91.8 3.01 56.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.174 -179.019 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.14 16.55 7.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.04 -124.91 35.11 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.728 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 m -100.45 -88.4 0.36 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.883 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -83.06 111.52 19.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -130.21 137.7 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.812 ' HG3' HG23 ' A' ' 7' ' ' THR . 24.4 mtt180 -84.93 103.12 13.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.626 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.5 mt -91.91 141.2 28.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -101.67 128.13 48.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.648 179.985 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.3 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD1' HD22 ' A' ' 58' ' ' LEU . 7.3 m-30 . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.856 0.36 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.43 151.8 37.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -102.84 144.71 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.972 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.69 109.36 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.405 179.873 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.968 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.68 121.23 23.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.133 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.052 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -131.24 127.23 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.468 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.669 ' N ' HD12 ' A' ' 83' ' ' ILE . 4.3 pt-20 -86.73 100.29 12.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.261 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.585 ' HG3' HD23 ' A' ' 15' ' ' LEU . 22.7 mtp85 -41.18 91.45 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.145 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.474 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.921 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.052 ' HB3' HD23 ' A' ' 8' ' ' LEU . 17.9 mt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.983 0.421 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 132.96 36.75 0.27 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.403 -0.904 . . . . 0.0 113.162 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -163.27 134.19 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.039 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.26 137.15 32.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.622 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.39 150.1 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.691 0.758 . . . . 0.0 112.02 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -143.64 132.85 23.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.971 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.96 0.88 0.74 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.871 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.492 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.74 -177.82 0.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.671 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.81 HG22 ' HB3' ' A' ' 32' ' ' PRO . 16.0 p -72.0 -21.55 61.54 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.01 -24.22 17.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.723 0.296 . . . . 0.0 111.501 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -124.36 87.3 54.13 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.59 65.03 0.54 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.292 1.994 . . . . 0.0 112.446 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.662 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 9.5 t-80 -48.44 -27.88 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.469 179.086 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.849 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.62 -154.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.449 179.597 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.21 -47.82 56.44 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.664 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 t70 179.97 47.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.41 157.29 76.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.81 ' HB3' HG22 ' A' ' 23' ' ' THR . 6.1 Cg_exo -77.77 0.6 9.67 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.833 2.355 . . . . 0.0 112.693 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -53.32 120.57 6.19 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.124 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.826 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.61 120.19 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.339 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.849 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.66 146.75 36.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.346 0.593 . . . . 0.0 110.681 178.89 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.061 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.96 155.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.977 -176.774 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.89 -34.38 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.617 -179.175 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.629 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.07 143.5 3.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.5 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.996 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.83 131.77 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.292 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 120.74 75.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.883 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 29.3 Cg_endo -63.01 137.09 60.17 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.667 2.244 . . . . 0.0 112.279 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.99 14.85 50.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.372 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.09 177.14 16.34 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.14 -31.2 61.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.798 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -73.14 -57.4 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.611 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.91 -28.92 64.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.396 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.04 -32.63 67.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.48 ' OD2' HD12 ' A' ' 8' ' ' LEU . 11.7 m-20 -81.53 -58.04 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.692 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.86 39.89 9.16 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.482 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.444 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.3 mmt180 -116.11 1.57 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.061 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -129.56 154.92 46.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.128 0.489 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.563 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.2 ttt180 -133.43 136.02 44.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.686 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.0 t -49.88 157.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.589 . . . . 0.0 111.747 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.2 t-20 75.65 -1.75 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -66.11 125.01 24.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.907 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.5 103.31 14.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.533 0.682 . . . . 0.0 111.305 -178.76 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.033 HD11 HG21 ' A' ' 19' ' ' ILE . 51.3 mt -53.13 134.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.213 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD22 ' CD1' ' A' ' 3' ' ' TYR . 1.5 pp -134.79 13.56 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.884 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 169.98 138.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.169 0.509 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.5 t -127.39 97.36 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.611 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.6 ' OD1' HG23 ' A' ' 84' ' ' VAL . 9.6 t30 70.95 -62.81 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -163.35 31.62 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.0 t -120.92 117.34 52.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -82.36 109.55 16.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.585 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -93.79 41.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.284 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -64.58 -35.52 81.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.835 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.11 71.67 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.739 ' C ' HG23 ' A' ' 23' ' ' THR . 9.3 m -136.49 142.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.44 156.23 10.7 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.313 0.578 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.9 p-80 -49.74 -34.1 18.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.635 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -69.76 -33.64 72.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.828 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -65.48 -45.05 85.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.29 0.567 . . . . 0.0 109.631 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.826 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.02 -45.67 91.23 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.219 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 70' ' ' HIS . 78.9 t -56.3 -50.36 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.033 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.614 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.52 -34.66 37.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.787 179.569 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.39 -57.37 5.99 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.323 -0.551 . . . . 0.0 112.074 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.861 HD12 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -60.32 -40.97 92.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.577 . . . . 0.0 110.237 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.614 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.75 -19.74 57.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.8 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -111.33 20.47 17.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.302 179.373 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.86 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -83.6 16.47 2.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.701 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.32 -101.87 0.87 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.4 m -123.7 -90.73 0.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.968 HG13 HG22 ' A' ' 7' ' ' THR . 6.2 tp -86.88 109.93 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.872 0.368 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.86 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.3 p -124.28 137.25 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.19 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.591 ' CG ' HG23 ' A' ' 7' ' ' THR . 11.6 mtt180 -85.94 103.58 14.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.909 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 17.4 mt -93.63 135.45 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.489 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.77 126.77 48.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.251 179.472 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 HD11 ' A' ' 51' ' ' LEU . 6.1 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.975 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.745 ' CE2' HD13 ' A' ' 58' ' ' LEU . 3.5 m-30 . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.782 0.325 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -143.39 141.15 30.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 2.8 pt-20 -99.84 144.65 28.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.953 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.81 109.46 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.028 0.442 . . . . 0.0 111.362 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.877 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.23 119.46 22.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.858 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 6' ' ' ILE . 5.2 tp -127.63 126.79 42.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.6 pt-20 -84.97 100.57 11.73 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.306 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.86 88.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.226 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.517 0.218 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.659 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.927 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.2 tp . . . . . 0 N--CA 1.457 -0.112 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.88 19.36 1.15 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.572 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.86 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.6 p90 -162.04 134.52 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.816 0.808 . . . . 0.0 111.259 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.76 138.63 31.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.498 -179.336 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.062 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.25 147.25 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.672 0.748 . . . . 0.0 112.091 -179.923 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.12 132.3 26.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.062 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.24 -3.13 0.87 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.676 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.81 179.73 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.764 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.816 HG22 ' CB ' ' A' ' 32' ' ' PRO . 15.3 p -70.92 -20.06 62.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.84 -23.94 16.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.245 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -124.39 87.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.188 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 64.53 0.55 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.402 2.068 . . . . 0.0 112.649 -179.427 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.668 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 9.3 t-80 -49.93 -27.34 5.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.243 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.855 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.91 -154.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.369 179.597 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.68 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -66.77 -47.32 68.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.659 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 177.52 46.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.29 159.86 70.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.816 ' CB ' HG22 ' A' ' 23' ' ' THR . 86.6 Cg_endo -78.51 1.66 8.83 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.665 2.244 . . . . 0.0 112.8 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.65 118.25 4.04 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.008 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.858 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.83 121.03 36.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.476 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.855 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.23 147.68 38.68 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.334 0.588 . . . . 0.0 110.808 178.529 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.042 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.45 7.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.757 -176.892 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.454 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.49 -33.55 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.612 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.85 142.11 1.86 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.627 -179.743 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.976 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.86 132.2 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.209 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.93 114.23 52.78 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.647 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.0 Cg_exo -56.36 139.03 85.9 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.723 2.282 . . . . 0.0 112.241 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 8.53 64.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.433 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.31 176.23 17.7 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.79 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.31 -36.35 61.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 111.199 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.755 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.81 -57.49 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.576 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.19 -28.91 66.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.325 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.93 -33.14 68.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -82.1 -57.98 3.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.77 40.74 9.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.552 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.502 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.4 mtp180 -117.74 8.21 12.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.811 0.339 . . . . 0.0 110.843 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.042 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -133.49 155.35 49.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.058 0.456 . . . . 0.0 110.804 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.68 136.1 44.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.757 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.2 t -51.77 157.79 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.533 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.3 -2.03 2.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.361 179.775 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -67.66 124.91 24.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.56 101.68 13.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.574 0.702 . . . . 0.0 111.424 -178.608 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.062 HD11 HG21 ' A' ' 19' ' ' ILE . 50.1 mt -51.59 133.43 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.661 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.745 HD13 ' CE2' ' A' ' 3' ' ' TYR . 1.1 pp -123.5 -19.48 5.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.781 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -159.49 147.76 17.58 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 111.027 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.882 HG13 ' CD2' ' A' ' 86' ' ' LEU . 38.8 t -130.22 99.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.033 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.513 ' OD1' HG23 ' A' ' 84' ' ' VAL . 7.7 t30 67.65 -67.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.0 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.3 29.56 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.94 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 84.5 t -117.99 141.96 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.212 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.6 p30 -104.86 109.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.475 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 57' ' ' ILE . 33.0 m -96.7 32.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.52 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -62.42 -32.17 72.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.91 66.0 1.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.711 ' C ' HG23 ' A' ' 23' ' ' THR . 8.8 m -133.51 144.48 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.75 154.04 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.954 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.1 t-160 -49.61 -33.78 16.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.4 m -66.68 -33.92 76.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.65 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.603 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.0 -41.56 82.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.858 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.13 -46.22 81.86 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 70' ' ' HIS . 58.4 t -56.61 -50.42 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.022 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -52.12 -34.35 43.97 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.853 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.867 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.42 -57.53 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.927 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.882 HD12 HD12 ' A' ' 19' ' ' ILE . 1.5 mt -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.345 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.599 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.06 -20.32 55.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.048 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.5 pt-20 -110.43 21.36 16.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.905 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -83.93 16.57 2.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.778 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.8 0.28 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.862 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.499 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -137.87 -91.18 0.22 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.872 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.8 101.96 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.905 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -117.53 135.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.827 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.877 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.5 mtp180 -86.55 103.44 15.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.81 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.882 ' CD2' HG13 ' A' ' 60' ' ' VAL . 25.6 mt -94.06 133.59 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.295 -179.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.01 123.56 46.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.287 179.632 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.4 m . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.62 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 26.5 m-85 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.813 0.339 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -147.77 136.98 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.46 144.64 26.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.63 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.039 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.64 109.56 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.644 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.941 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 120.04 21.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.569 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.039 HD13 HD11 ' A' ' 6' ' ' ILE . 5.6 tp -130.82 126.86 37.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.006 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.589 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -84.49 99.73 10.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.039 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.62 87.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 179.155 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.196 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.65 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.91 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.8 tp . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.805 0.336 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 72.17 31.0 64.38 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.802 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 4.7 p90 -164.5 129.74 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.075 0.937 . . . . 0.0 111.574 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -96.1 140.2 31.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.937 -179.116 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.021 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -120.19 147.03 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.763 0.792 . . . . 0.0 112.221 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.599 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.77 133.43 30.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.044 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.75 3.29 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.724 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.68 -177.87 1.37 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.658 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.826 HG22 ' HB3' ' A' ' 32' ' ' PRO . 25.2 p -67.25 -28.87 68.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -92.74 -19.59 21.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.614 0.245 . . . . 0.0 111.369 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -124.15 87.0 53.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.8 61.7 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.385 2.057 . . . . 0.0 112.795 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.599 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 14.5 t-80 -49.78 -27.6 5.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.949 178.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.77 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.2 -152.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.355 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.24 52.54 4.53 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.733 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 74.6 32.07 0.92 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.927 0.394 . . . . 0.0 110.462 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -118.09 149.64 45.97 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.826 ' HB3' HG22 ' A' ' 23' ' ' THR . 9.8 Cg_exo -71.25 -4.47 15.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.753 2.302 . . . . 0.0 112.615 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.0 m -52.21 115.98 1.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 111.287 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.75 120.14 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.77 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.15 147.14 36.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.253 0.549 . . . . 0.0 110.692 178.994 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.054 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.07 155.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.841 -176.794 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.461 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.72 -30.26 4.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.176 -179.2 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.23 128.81 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.36 -179.524 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.76 126.64 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.691 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.26 119.19 72.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.684 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.1 Cg_exo -54.37 139.57 73.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.242 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.34 12.72 69.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.539 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.36 -157.59 21.72 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.97 -40.73 53.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.901 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -72.78 -54.44 8.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.13 -29.09 69.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -72.38 -39.17 68.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.119 0.485 . . . . 0.0 110.3 179.416 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 8' ' ' LEU . 2.4 m-20 -81.39 -57.87 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.848 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.23 37.0 10.22 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.561 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.474 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.82 -5.38 14.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.698 179.531 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.054 HD21 HD12 ' A' ' 36' ' ' ILE . 5.0 tp -119.93 154.06 34.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.547 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.31 137.18 47.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.901 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.4 t -51.98 157.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.264 0.554 . . . . 0.0 111.533 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.39 -1.28 3.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.359 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.7 m-20 -69.54 127.61 33.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.56 101.47 13.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.577 0.703 . . . . 0.0 111.428 -178.662 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.021 HD11 HG21 ' A' ' 19' ' ' ILE . 10.9 mt -48.07 139.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.84 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.9 mm? -116.6 -44.62 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.092 179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.2 m-85 -142.57 174.69 10.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.925 HG13 ' CD2' ' A' ' 86' ' ' LEU . 31.0 t -151.98 98.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.923 179.35 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.635 ' OD1' HG23 ' A' ' 84' ' ' VAL . 7.1 t30 66.34 -68.23 0.14 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.226 0.536 . . . . 0.0 109.807 -178.676 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -155.2 31.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.8 t -117.77 142.41 32.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.596 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.5 p-10 -111.1 108.49 18.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 26.1 m -94.24 44.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.433 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -32.71 74.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.39 61.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.713 ' C ' HG23 ' A' ' 23' ' ' THR . 13.7 m -120.47 147.18 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -62.36 155.71 24.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 -179.071 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.917 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 p-80 -49.33 -34.28 15.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.787 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.7 p -70.19 -33.78 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.936 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.545 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.11 -45.73 80.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.265 0.555 . . . . 0.0 109.716 178.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.67 -45.5 92.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.153 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.1 t -56.47 -50.46 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.156 178.485 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.49 -34.36 35.44 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.924 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.697 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.84 -57.52 5.45 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.232 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.955 HD12 HD12 ' A' ' 19' ' ' ILE . 5.2 mt -61.51 -39.74 92.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.429 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.604 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.76 -19.84 57.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.544 179.608 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -110.61 17.75 20.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.129 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.861 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.8 16.54 1.4 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.702 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.55 -99.43 0.59 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.679 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.5 p -127.8 -91.59 0.49 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.941 HG13 HG22 ' A' ' 7' ' ' THR . 7.2 tp -84.27 106.19 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.061 0.457 . . . . 0.0 110.933 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.861 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.9 p -122.14 139.0 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.519 -178.364 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.928 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -85.95 103.76 14.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.916 178.812 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.925 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.0 mt -95.28 138.48 32.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.65 -178.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -102.07 141.56 34.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.462 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 51' ' ' LEU . 24.0 m . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.023 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.445 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 20.9 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.799 0.333 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.49 134.93 34.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.75 134.91 38.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.877 HG23 ' HB3' ' A' ' 50' ' ' ARG . 1.2 mt -129.36 109.29 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.263 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.998 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -76.95 123.07 25.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.841 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.97 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.2 tp -133.49 127.29 32.94 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.701 ' N ' HD12 ' A' ' 83' ' ' ILE . 1.4 pt-20 -85.37 103.39 14.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.819 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.627 ' CG ' HD23 ' A' ' 15' ' ' LEU . 10.1 mtp180 -47.58 92.96 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.319 0.581 . . . . 0.0 110.745 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.538 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.935 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.97 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.9 mt . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 136.85 40.99 0.11 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.29 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.785 ' HB3' HG23 ' A' ' 39' ' ' ILE . 34.7 p90 -163.96 136.35 5.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.004 0.431 . . . . 0.0 111.25 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.01 132.72 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.397 -179.507 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.092 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -109.86 167.43 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.768 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.696 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -166.17 132.99 2.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.339 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.42 -1.88 1.23 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.437 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.53 -172.06 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.93 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.726 HG23 ' C ' ' A' ' 68' ' ' VAL . 8.5 p -75.18 -22.17 58.21 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -94.82 -25.55 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.417 -179.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -124.35 87.32 54.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.222 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.79 62.95 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.411 2.074 . . . . 0.0 112.763 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.696 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 8.9 t-80 -48.01 -28.95 3.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.074 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.871 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.32 -155.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.143 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.32 -49.45 45.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.348 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -177.86 51.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.802 0.334 . . . . 0.0 111.175 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.21 159.91 64.4 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.076 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.685 ' CB ' HG22 ' A' ' 23' ' ' THR . 93.8 Cg_endo -80.48 5.49 6.06 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.711 2.274 . . . . 0.0 112.671 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -57.02 118.59 5.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.866 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.99 118.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.602 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.871 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.38 146.12 34.58 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.586 0.708 . . . . 0.0 110.79 178.824 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.79 156.01 7.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.294 -176.652 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.47 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.87 -30.24 4.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.395 -178.588 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.31 128.34 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.876 -179.368 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.808 ' CD1' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -96.84 132.18 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.619 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.483 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.3 113.82 50.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.959 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 54.3 Cg_exo -52.6 143.83 44.53 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.743 2.295 . . . . 0.0 112.482 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.51 83.03 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.85 176.68 20.77 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.111 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.49 -33.34 59.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.525 0.202 . . . . 0.0 111.389 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.839 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.29 -56.25 5.1 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.778 0.323 . . . . 0.0 111.488 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.83 -29.91 70.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.187 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -72.16 -31.81 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.934 0.397 . . . . 0.0 110.44 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -75.76 -57.87 3.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.063 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.62 32.11 19.74 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.422 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.877 ' HB3' HG23 ' A' ' 6' ' ' ILE . 51.9 mtt180 -115.23 -13.45 11.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.687 0.28 . . . . 0.0 110.96 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 36' ' ' ILE . 38.7 tp -112.57 162.4 15.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.183 0.516 . . . . 0.0 111.305 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.08 135.74 23.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.633 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.2 t -49.2 157.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 111.586 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER 74.24 2.39 4.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.255 -179.893 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.654 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.9 m-20 -72.12 127.11 31.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 10.4 p -86.61 100.02 12.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.552 0.691 . . . . 0.0 111.464 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.092 HD11 HG21 ' A' ' 19' ' ' ILE . 63.9 mt -45.25 149.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.055 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -128.91 -46.96 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.706 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -141.54 169.11 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.769 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 16.6 t -143.91 95.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.121 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.444 ' HB2' HG23 ' A' ' 84' ' ' VAL . 33.3 t30 68.34 -66.69 0.22 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -156.54 32.47 0.32 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.134 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 60.8 t -119.02 142.54 33.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.776 -178.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.1 p30 -112.06 113.14 25.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.122 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 35.3 m -86.41 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.89 100.94 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' C ' HG21 ' A' ' 23' ' ' THR . 0.5 OUTLIER 68.77 52.51 0.55 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.726 ' C ' HG23 ' A' ' 23' ' ' THR . 29.1 m -122.26 143.43 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 179.508 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.08 150.33 25.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.7 t-160 -49.09 -33.34 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.37 -38.49 81.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.788 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -68.03 -46.91 69.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.639 0.733 . . . . 0.0 109.168 178.184 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 70' ' ' HIS . 78.2 t -57.81 -48.03 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.214 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.74 -36.31 69.6 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.594 178.572 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -55.34 -51.2 67.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 0.0 110.105 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.02 HD11 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.06 -35.7 67.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.3 mmmt -77.29 -23.28 51.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.484 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -96.81 2.54 51.96 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 111.418 -179.016 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.891 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -82.54 16.32 2.18 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.709 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.79 -119.18 16.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.9 t -104.97 -87.73 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.998 HG13 HG22 ' A' ' 7' ' ' THR . 5.2 tp -87.7 109.18 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.682 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.891 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 2.8 p -122.67 138.53 52.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.296 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.846 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.2 mtt-85 -86.72 102.86 14.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.0 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 8.2 mt -91.29 142.6 27.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.33 -178.614 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.415 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.92 139.08 38.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.782 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG21 ' OD2' ' A' ' 55' ' ' ASP . 13.8 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.724 179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 52.2 m-85 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.959 0.409 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.53 151.42 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 4.9 pt-20 -110.12 144.71 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.998 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.36 109.46 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.482 179.841 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.48 120.29 23.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.047 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.998 HD13 HD11 ' A' ' 6' ' ' ILE . 4.0 tp -130.71 127.96 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.275 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 pt-20 -85.4 101.05 12.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.004 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.523 ' CG ' HD23 ' A' ' 15' ' ' LEU . 5.0 mtp-105 -47.84 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.132 178.955 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.386 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.228 -179.22 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.952 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.38 44.36 0.07 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.918 -1.134 . . . . 0.0 114.024 178.948 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.793 ' HB3' HG23 ' A' ' 39' ' ' ILE . 17.9 p90 -164.0 131.53 3.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.304 0.552 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -93.2 134.4 35.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.669 -179.089 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.038 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.19 172.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.795 179.957 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -168.96 132.29 1.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.288 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.34 1.08 0.94 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.652 179.593 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.55 -172.07 0.1 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.869 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.818 HG22 ' CB ' ' A' ' 32' ' ' PRO . 16.8 p -74.44 -21.72 59.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.448 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -97.0 -23.38 16.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 111.486 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.36 87.54 53.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.26 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.9 62.36 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.44 2.093 . . . . 0.0 112.738 -179.449 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.611 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.6 t-80 -48.34 -28.08 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.104 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.82 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.325 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.48 -50.44 62.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.608 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.937 0.399 . . . . 0.0 110.747 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.9 168.48 13.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.818 ' CB ' HG22 ' A' ' 23' ' ' THR . 83.0 Cg_endo -81.86 9.02 4.11 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.727 2.284 . . . . 0.0 112.893 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -61.03 114.15 2.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.867 0.365 . . . . 0.0 110.65 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.849 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -81.85 119.84 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.45 143.41 32.59 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.683 0.754 . . . . 0.0 110.819 178.936 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.024 HD12 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -68.89 155.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.102 -176.495 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.487 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.44 -26.96 4.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.376 -178.525 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.25 131.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.005 -179.645 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.023 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.43 132.73 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.681 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.4 123.75 74.47 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.853 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.0 Cg_endo -66.88 133.8 32.56 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.747 2.298 . . . . 0.0 112.267 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.62 17.2 31.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.315 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.48 178.31 16.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.169 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.97 -34.02 58.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.779 0.323 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.844 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -71.21 -57.48 4.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.897 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.59 -28.79 65.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.336 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -71.73 -29.95 65.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.391 . . . . 0.0 110.312 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.433 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -81.99 -58.08 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.941 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.06 37.85 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.569 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.45 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.6 mtt85 -112.71 -17.23 12.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.716 0.293 . . . . 0.0 110.962 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 36' ' ' ILE . 6.4 tp -110.21 155.25 22.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.073 0.463 . . . . 0.0 111.222 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.52 135.12 45.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.801 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 38' ' ' LYS . 65.5 t -51.86 158.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.31 0.576 . . . . 0.0 111.636 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.1 t30 73.19 5.58 5.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.001 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.4 m-20 -76.82 128.12 34.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.47 100.17 12.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.621 0.724 . . . . 0.0 111.317 -178.701 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 16.1 mt -48.08 136.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.67 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.2 mm? -116.11 -44.86 2.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.6 m-85 -137.76 170.14 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.158 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.789 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.9 t -149.59 96.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.965 179.359 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.458 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.7 t-20 67.09 -68.22 0.15 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 109.805 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mt-10 -154.44 32.32 0.42 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.603 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.2 t -118.71 142.42 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.478 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.0 p-10 -113.42 96.27 5.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.446 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 65' ' ' VAL . 26.9 m -81.81 57.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.303 -179.712 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -79.93 -30.13 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.73 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -151.61 62.86 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.777 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.724 ' O ' HG23 ' A' ' 23' ' ' THR . 35.1 m -128.85 146.09 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.207 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.48 151.1 33.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.3 t-160 -48.33 -33.72 9.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.722 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -67.25 -34.36 77.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.08 -42.66 80.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.7 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.849 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.81 -46.5 89.26 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 70' ' ' HIS . 90.8 t -56.51 -50.8 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.364 178.588 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.24 -30.37 64.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.371 178.887 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.2 -49.83 75.58 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.293 0.568 . . . . 0.0 110.179 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.853 HD23 ' CD1' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -60.44 -34.55 74.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.907 179.298 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.13 -26.23 52.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.191 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -103.07 14.73 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.302 -178.775 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.892 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.87 0.74 33.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.61 -112.62 3.79 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.009 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.461 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.25 -90.54 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.997 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.96 HG13 HG22 ' A' ' 7' ' ' THR . 7.6 tp -87.87 87.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.218 0.532 . . . . 0.0 109.691 178.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.892 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 p -98.87 138.42 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.399 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 4.7 ttp180 -89.34 103.15 15.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.198 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.853 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.1 mt -91.7 140.31 29.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.91 142.76 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.99 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 51' ' ' LEU . 29.7 m . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.646 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CG ' HD13 ' A' ' 58' ' ' LEU . 2.3 m-85 . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.792 0.329 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.27 152.28 43.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 3.6 tt0 -106.76 144.6 33.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.986 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.094 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.2 109.45 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.501 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.05 119.29 20.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.851 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.094 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -130.55 127.6 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.352 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 7.5 pt-20 -83.85 100.53 11.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.659 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -44.48 88.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.174 179.193 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.52 0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.792 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.061 ' HB3' HD23 ' A' ' 8' ' ' LEU . 17.3 mt . . . . . 0 C--O 1.225 -0.236 0 CA-C-O 121.017 0.437 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 106.99 39.49 1.98 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.362 179.517 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.808 ' HB3' HG23 ' A' ' 39' ' ' ILE . 15.8 p90 -161.4 130.33 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.036 0.418 . . . . 0.0 111.424 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.27 134.77 34.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.66 -179.415 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -112.21 167.95 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 111.766 179.893 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -165.84 131.44 2.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.464 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.64 0.97 0.9 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.588 179.6 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.53 -168.55 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.987 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.836 HG22 ' HB3' ' A' ' 32' ' ' PRO . 11.2 p -76.25 -23.8 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -23.61 16.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.753 0.311 . . . . 0.0 111.669 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -124.22 87.41 53.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.03 63.08 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.388 2.058 . . . . 0.0 112.629 -179.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.644 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.2 t-80 -48.12 -27.86 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.308 179.027 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.83 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.71 -154.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.356 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.673 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -61.98 -49.01 79.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.588 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.31 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -125.17 163.46 37.83 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.836 ' HB3' HG22 ' A' ' 23' ' ' THR . 5.5 Cg_exo -79.14 3.41 7.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.978 2.452 . . . . 0.0 112.715 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.79 115.45 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 111.104 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.862 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.57 120.64 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.382 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.64 145.93 33.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.553 0.692 . . . . 0.0 110.567 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.051 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.86 155.8 7.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.275 -176.507 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.09 -30.72 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.253 -178.849 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.8 130.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.99 -179.419 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.021 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.03 131.56 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.518 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 126.32 69.88 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 28.8 Cg_endo -62.6 134.47 47.77 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.718 2.279 . . . . 0.0 112.415 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.13 4.74 61.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.7 -179.48 25.64 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.991 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -57.42 -34.87 69.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.518 0.199 . . . . 0.0 111.325 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.739 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.25 -55.63 5.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.84 -30.93 71.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.869 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.0 pt20 -72.13 -35.65 69.17 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.045 0.45 . . . . 0.0 110.1 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.46 -57.92 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.37 39.74 8.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.891 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.506 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -109.08 -4.65 16.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.578 179.476 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.051 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -123.7 154.67 39.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.693 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 4.4 tpt85 -132.63 136.39 46.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.835 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.44 157.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.482 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.1 t30 74.8 0.28 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.78 125.35 26.31 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.849 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.6 p -86.43 100.27 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.084 HD11 HG21 ' A' ' 19' ' ' ILE . 20.6 mt -50.76 136.01 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.911 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.489 HD13 ' CG ' ' A' ' 3' ' ' TYR . 7.8 mt -120.05 -28.13 5.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.705 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -153.4 156.14 37.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.034 0.445 . . . . 0.0 111.008 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.896 HG11 ' HB1' ' A' ' 76' ' ' ALA . 46.3 t -133.76 95.62 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.909 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.632 ' OD1' HG23 ' A' ' 84' ' ' VAL . 5.8 t30 67.78 -67.83 0.18 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.117 0.484 . . . . 0.0 110.031 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -153.4 31.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.739 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 65.7 t -119.44 142.19 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.355 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.1 p-10 -107.49 100.9 10.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' VAL . 22.9 m -86.87 53.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.493 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.84 -33.17 34.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.678 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.83 58.61 1.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.766 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.721 ' C ' HG23 ' A' ' 23' ' ' THR . 34.9 m -128.19 143.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.92 150.66 28.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.82 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.3 t-160 -48.29 -33.63 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.441 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.37 -34.06 75.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.96 179.633 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -38.57 81.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 109.453 178.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.67 -46.92 74.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.066 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 70' ' ' HIS . 92.5 t -57.55 -49.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.2 178.563 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.84 -34.04 67.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.688 178.65 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.74 -50.76 71.27 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.331 0.586 . . . . 0.0 109.906 179.332 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.15 -37.57 69.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.384 178.948 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER -77.33 -23.73 50.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.092 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.1 mm-40 -91.72 -17.05 26.01 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.971 0.415 . . . . 0.0 110.951 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.966 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.47 -19.87 10.85 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.295 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.99 -98.66 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.025 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 34.3 m -126.76 -91.38 0.51 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.76 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.2 tp -87.26 98.61 7.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.666 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.966 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 13.6 p -115.81 138.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.65 ' HG3' HG23 ' A' ' 7' ' ' THR . 7.2 mtt180 -85.83 103.14 14.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.274 177.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.6 HD11 ' CD1' ' A' ' 15' ' ' LEU . 14.3 mt -91.9 138.7 31.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.263 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.69 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.809 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 55' ' ' ASP . 21.5 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.683 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.447 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 10.3 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.837 0.351 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.46 142.27 49.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.21 144.58 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.023 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.8 109.42 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.376 179.856 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.907 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.25 116.47 20.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.067 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.023 HD13 HD11 ' A' ' 6' ' ' ILE . 4.8 tp -124.14 126.74 46.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 pt-20 -87.46 100.27 12.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.564 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.87 87.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.229 179.283 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.215 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.49 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.934 ' HG ' HD23 ' A' ' 8' ' ' LEU . 2.3 tp . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.26 17.77 1.39 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.529 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.861 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.9 p90 -160.7 135.73 7.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.965 0.882 . . . . 0.0 111.196 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.9 139.3 32.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.376 -179.477 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.007 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.75 147.95 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.887 0.851 . . . . 0.0 112.359 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.11 133.2 27.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.055 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.14 2.92 0.68 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.798 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.09 -176.52 0.84 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.682 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.85 HG22 ' HB3' ' A' ' 32' ' ' PRO . 25.2 p -67.53 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.11 -21.05 21.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -124.38 87.02 54.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.671 0.272 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.81 62.62 0.91 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.332 2.021 . . . . 0.0 112.585 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.633 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.4 t-80 -47.45 -28.66 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.413 179.023 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.836 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.01 -154.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.281 179.531 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -61.31 -49.23 79.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.6 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.99 39.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.38 163.5 38.02 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.85 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.9 Cg_exo -76.73 1.47 8.5 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.984 2.456 . . . . 0.0 112.773 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.77 115.52 2.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.17 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.87 119.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.482 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.836 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.52 147.81 38.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.427 0.632 . . . . 0.0 110.869 178.776 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.997 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.953 -176.85 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.71 -31.37 4.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.217 -179.014 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.57 131.1 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.226 -179.42 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.984 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.96 130.89 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.594 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.457 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.13 114.03 51.86 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.874 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 42.4 Cg_exo -56.95 139.31 89.37 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.726 2.284 . . . . 0.0 112.378 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 12.75 59.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.431 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.69 179.36 16.87 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.919 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.7 -38.61 69.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.841 0.353 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.78 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -64.84 -57.65 8.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.577 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.47 -28.77 66.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.353 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.99 -33.06 67.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 110.162 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.28 -58.01 3.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.748 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.87 37.71 12.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.622 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CB ' HG12 ' A' ' 6' ' ' ILE . 18.2 mtm180 -118.96 9.05 11.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.728 0.299 . . . . 0.0 110.987 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.997 HD21 HD12 ' A' ' 36' ' ' ILE . 5.8 tp -135.24 154.4 51.59 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.01 0.433 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.563 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.94 134.42 42.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 179.996 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.631 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -49.15 159.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.13 0.491 . . . . 0.0 111.491 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 53' ' ' VAL . 3.0 m120 72.24 1.43 3.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.506 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.01 127.22 31.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.693 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 100.17 12.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 111.693 -178.437 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 19' ' ' ILE . 10.1 mt -46.76 132.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.76 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.97 -40.41 3.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.138 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -145.27 167.49 22.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.763 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.937 HG13 ' CD2' ' A' ' 86' ' ' LEU . 56.1 t -145.3 97.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.878 ' OD1' HG23 ' A' ' 84' ' ' VAL . 1.2 t30 66.25 -67.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 109.947 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' VAL . 10.2 mm-40 -154.14 32.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.921 179.145 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.7 t -119.64 142.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.412 -179.322 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.5 t0 -111.33 99.72 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.455 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 65' ' ' VAL . 24.5 m -85.3 55.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.294 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -32.51 59.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.851 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -152.67 62.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.667 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' THR . 13.2 m -124.6 144.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.88 155.06 20.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.973 0.416 . . . . 0.0 111.097 -179.117 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.945 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.2 p-80 -48.66 -34.09 11.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.859 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -33.88 73.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.139 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.558 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.18 -44.23 84.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.241 0.543 . . . . 0.0 109.674 178.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.92 -45.89 87.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.162 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 70' ' ' HIS . 59.4 t -57.06 -48.37 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.287 178.544 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.664 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -53.68 -33.82 56.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.33 179.134 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -64.66 -56.91 10.77 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.598 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.841 HD12 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -63.02 -42.93 99.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.879 -179.645 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.6 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.08 -20.59 55.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.748 -179.264 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.664 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 6.7 mm-40 -103.27 -8.8 20.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.088 0.471 . . . . 0.0 110.563 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.867 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.1 -20.49 0.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.791 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.79 -90.21 0.93 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.712 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -133.73 -92.42 0.34 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.871 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.907 HG13 HG22 ' A' ' 7' ' ' THR . 9.1 tp -88.05 102.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.116 0.484 . . . . 0.0 110.531 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.878 HG23 ' OD1' ' A' ' 61' ' ' ASN . 7.3 p -118.32 136.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.724 -178.13 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.857 ' HG2' HG23 ' A' ' 7' ' ' THR . 2.9 mtt85 -85.88 103.88 15.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.058 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.937 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.3 mt -95.49 137.8 34.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.576 -179.189 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.88 140.42 36.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.494 179.795 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.991 179.886 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.434 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 10.7 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.749 0.309 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -131.6 151.04 51.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -109.96 143.89 39.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.78 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.034 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.32 109.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.975 0.416 . . . . 0.0 111.699 179.791 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.49 118.87 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.508 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.061 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -131.59 127.16 36.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 7.2 pt-20 -84.51 100.44 11.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.258 179.392 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.533 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.41 90.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.21 179.67 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.337 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.88 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.061 ' HB3' HD23 ' A' ' 8' ' ' LEU . 18.8 mt . . . . . 0 C--O 1.227 -0.108 0 CA-C-O 120.938 0.399 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.15 35.93 0.45 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.419 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.797 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.1 p90 -160.04 135.42 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.128 0.464 . . . . 0.0 111.242 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.33 137.63 33.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.427 -179.612 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.45 149.75 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.654 0.74 . . . . 0.0 111.954 -179.86 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.661 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.73 133.02 24.73 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.93 179.345 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.31 -7.65 1.16 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.462 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.558 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.6 -178.87 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.087 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 68' ' ' VAL . 29.9 p -65.06 -31.13 72.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.227 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.45 -20.46 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.237 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 0.4 OUTLIER -124.48 82.48 58.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.958 0.409 . . . . 0.0 110.131 179.77 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.25 62.67 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.886 2.391 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.661 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.5 t-80 -52.58 -22.35 4.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.386 178.92 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.781 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -95.21 -151.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.572 179.814 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.673 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.89 48.87 4.11 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.861 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.77 45.46 0.07 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.981 0.419 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 28' ' ' ILE . 8.2 m-20 -135.22 155.24 78.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 23' ' ' THR . 73.5 Cg_endo -75.57 -0.94 10.72 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.525 2.15 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.411 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 5.7 m -54.24 115.75 2.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.746 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.58 119.02 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.781 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.67 145.72 35.26 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.301 0.572 . . . . 0.0 110.527 178.53 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.053 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.98 155.48 7.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.094 -176.476 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.37 -33.44 4.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.766 -179.124 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.657 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.65 141.96 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.585 -179.749 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.962 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.7 132.31 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.266 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.1 125.16 73.26 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.685 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.1 Cg_endo -67.33 132.06 26.54 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.838 2.358 . . . . 0.0 112.381 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.68 14.39 32.17 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.474 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.87 178.07 16.42 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.0 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.37 -36.26 61.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 111.416 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.795 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.9 -57.43 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.833 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.478 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -33.92 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 110.174 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.15 -57.92 3.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.691 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.02 9.59 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.602 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.9 mmt180 -116.31 1.59 13.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.702 -0.293 . . . . 0.0 110.837 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.053 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -126.96 154.15 44.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 110.657 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.9 ttp85 -131.52 137.45 48.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -53.33 158.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 111.678 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER 74.53 0.19 3.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.184 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 3.1 m-20 -70.38 126.26 29.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.3 p -86.53 100.31 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 0.0 111.383 -178.607 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.036 HD11 HG21 ' A' ' 19' ' ' ILE . 69.1 mt -46.88 140.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.065 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.434 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.5 mm? -118.76 -44.8 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.3 m-85 -139.86 169.43 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.793 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.749 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.5 t -151.4 100.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.584 ' OD1' HG23 ' A' ' 84' ' ' VAL . 11.3 t30 66.27 -67.86 0.14 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.131 0.491 . . . . 0.0 109.979 -178.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -156.67 32.05 0.31 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.495 179.124 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.6 t -117.8 142.51 31.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.55 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.7 p-10 -112.69 89.34 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 65' ' ' VAL . 27.4 m -75.77 61.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -82.38 -32.94 28.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.753 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -148.66 50.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.798 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.762 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -114.09 150.89 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.428 HG22 ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -66.95 153.66 43.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.029 -179.389 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.86 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.2 t-160 -49.68 -34.19 17.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.628 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -69.8 -34.04 73.19 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.653 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.04 -42.25 80.85 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.638 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.883 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.12 -46.75 85.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.555 0.693 . . . . 0.0 109.201 177.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.3 t -57.58 -50.18 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.15 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.653 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.01 -32.9 64.39 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.631 178.656 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.99 -52.63 64.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.228 0.537 . . . . 0.0 110.012 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 19' ' ' ILE . 2.5 mt -54.16 -36.47 63.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.283 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.19 -26.66 53.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.09 178.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -89.01 -16.65 31.16 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -178.998 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.41 -18.57 18.53 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.33 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.02 -108.02 3.6 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.164 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 1.3 p -118.78 -91.2 0.56 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 7' ' ' THR . 8.4 tp -86.92 95.09 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.079 0.466 . . . . 0.0 109.85 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.933 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.1 p -111.86 138.06 42.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.297 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.9 102.89 14.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.411 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.749 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.6 mt -90.18 141.15 28.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.72 141.38 34.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.771 -179.759 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.852 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 65.7 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.732 0.301 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -126.35 155.56 41.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 17.7 mt-10 -117.43 144.63 44.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.967 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.84 109.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.647 179.893 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.899 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 122.0 24.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.912 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.036 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.1 tp -134.14 127.31 31.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.149 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -86.37 100.76 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.632 179.551 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.55 ' CG ' HD23 ' A' ' 15' ' ' LEU . 12.0 mtp180 -42.45 91.93 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.064 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.477 0 CA-C-N 115.186 -0.916 . . . . 0.0 113.058 -179.538 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.036 ' HB3' HD23 ' A' ' 8' ' ' LEU . 8.3 mt . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.7 0.286 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 135.46 40.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.745 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.789 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -162.02 134.51 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.494 . . . . 0.0 110.971 178.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.51 135.16 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.459 -179.351 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.052 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.53 146.5 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.496 179.552 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.74 122.88 36.11 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.586 178.935 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 157.92 -132.0 3.03 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.605 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 75.76 167.36 22.75 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.263 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 68' ' ' VAL . 27.4 p -68.47 -6.68 26.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.074 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.7 m-20 -113.11 -24.34 9.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.5 t30 -124.62 87.18 54.86 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.478 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.91 64.69 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.39 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.549 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 12.6 t-80 -53.05 -24.12 9.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.31 179.221 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.866 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -92.64 -150.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 179.63 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.68 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.66 52.47 4.58 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.931 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 75.7 41.23 0.26 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.116 0.484 . . . . 0.0 110.488 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -132.3 161.46 62.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.909 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 97.3 Cg_endo -79.29 4.18 6.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.625 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -55.04 118.39 4.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.078 0.466 . . . . 0.0 111.258 -179.814 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.835 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.32 116.62 31.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.188 179.598 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.866 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.06 147.6 37.07 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.363 0.601 . . . . 0.0 110.573 179.256 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.089 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.26 155.74 7.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.834 -177.127 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.29 -33.02 3.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.677 -179.076 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.14 142.01 2.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 111.276 -179.78 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.958 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -105.32 132.32 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.48 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.446 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.01 114.48 54.53 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.674 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.1 Cg_exo -57.68 136.96 78.83 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.7 2.267 . . . . 0.0 112.365 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 16.97 39.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.562 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.54 178.76 16.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.175 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.84 -33.86 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.3 . . . . 0.0 111.402 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.829 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.81 -57.39 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.908 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.53 -28.67 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.525 -179.427 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.71 -30.43 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 110.335 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' OD2' HD12 ' A' ' 8' ' ' LEU . 6.0 m-20 -82.68 -57.77 3.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.708 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.78 37.0 12.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.572 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.449 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -111.28 -20.92 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.089 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -106.16 153.86 21.5 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.275 0.559 . . . . 0.0 111.361 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.578 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -131.78 135.4 46.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.57 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 38' ' ' LYS . 52.5 t -49.21 157.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.536 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER 75.15 0.26 3.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.223 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.639 ' HB3' HG11 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -68.24 124.71 24.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.991 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.5 p -86.63 99.78 11.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.564 0.697 . . . . 0.0 111.377 -178.46 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 11.0 mt -46.35 129.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.229 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -113.06 -41.44 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.005 179.653 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.4 m-85 -144.72 146.82 32.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.166 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.712 ' CG1' ' HB1' ' A' ' 76' ' ' ALA . 48.9 t -135.51 109.78 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.44 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 0.4 OUTLIER 52.78 35.93 19.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.843 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 80.72 32.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.445 -179.236 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 60' ' ' VAL . 74.7 t -121.01 112.75 37.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.699 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -72.05 116.83 12.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.711 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 57' ' ' ILE . 25.6 m -98.45 27.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.197 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -68.77 -27.76 66.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -138.52 52.67 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.082 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -127.63 146.08 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -67.83 155.61 38.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.384 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.5 p-80 -48.15 -35.44 11.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 -179.65 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.33 -33.67 65.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.115 179.716 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.628 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.68 -39.39 88.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.808 179.161 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.835 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.69 -46.88 74.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.584 0.707 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.5 t -58.07 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.362 178.556 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -58.22 -35.64 71.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.46 178.574 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -55.08 -49.39 71.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.237 0.542 . . . . 0.0 109.976 179.597 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.052 HD11 HD12 ' A' ' 19' ' ' ILE . 2.4 mt -57.84 -36.47 72.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 178.709 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.2 mmmt -77.33 -25.86 51.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.879 179.441 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -96.96 5.31 50.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -178.703 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.911 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.45 16.1 1.43 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.769 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.63 -110.5 3.43 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.294 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 35.8 m -118.96 -89.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.324 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.899 HG13 HG22 ' A' ' 7' ' ' THR . 7.5 tp -86.27 96.43 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.257 0.551 . . . . 0.0 110.263 179.019 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.911 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.6 p -111.1 138.4 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.807 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.57 102.8 14.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.388 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.711 ' CD2' HG13 ' A' ' 60' ' ' VAL . 10.9 mt -88.74 137.86 31.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.118 -178.79 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 145.95 28.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.923 -179.689 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 55' ' ' ASP . 35.4 m . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.139 179.748 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.72 0.295 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -145.22 151.0 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.981 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -110.36 144.77 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.71 109.5 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.926 0.393 . . . . 0.0 111.545 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.845 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 112.46 17.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.959 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 6' ' ' ILE . 5.5 tp -122.87 126.81 48.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.269 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.62 100.46 10.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.059 179.09 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.51 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.169 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.337 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.539 -179.807 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.011 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.9 tp . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 108.67 25.78 5.58 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.326 -0.94 . . . . 0.0 115.263 177.706 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 4.3 p90 -164.52 136.72 4.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.018 0.909 . . . . 0.0 111.072 178.779 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -98.68 133.44 43.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.636 -179.28 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.095 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.07 169.9 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.608 0.718 . . . . 0.0 111.501 179.729 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -167.33 131.5 1.87 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.424 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.45 2.09 0.71 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.436 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.13 -167.15 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.102 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.839 HG22 ' HB3' ' A' ' 32' ' ' PRO . 17.5 p -75.96 -28.16 57.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -95.31 -20.63 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.66 82.54 59.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.76 63.89 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -179.316 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.646 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.8 t-80 -50.09 -24.09 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.855 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.7 -155.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.367 179.716 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.66 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.9 -49.92 73.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.575 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.49 39.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.919 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -124.69 163.48 36.69 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.839 ' HB3' HG22 ' A' ' 23' ' ' THR . 5.9 Cg_exo -78.91 3.46 7.36 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.0 112.861 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.1 m -56.61 115.53 2.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 111.1 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.47 120.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.524 179.833 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.855 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.44 145.39 33.73 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.48 0.657 . . . . 0.0 110.704 178.842 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.046 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.84 155.83 7.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.473 -176.409 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.469 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.9 -28.36 4.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.509 -178.565 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.686 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.72 129.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.197 -179.486 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.997 HD11 HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -94.6 133.23 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.392 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 122.98 75.6 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.725 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 23.3 Cg_endo -61.59 137.41 68.96 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.642 2.228 . . . . 0.0 112.36 -179.661 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 -1.87 83.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.442 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.72 175.22 36.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.033 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.12 -34.38 60.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.814 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -74.43 -56.94 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.239 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.12 -28.87 70.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -71.67 -31.57 66.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 109.934 179.347 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.38 -57.91 2.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.552 179.87 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.04 40.83 8.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.491 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.9 mmt85 -117.03 6.58 12.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.71 0.29 . . . . 0.0 110.951 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -133.74 153.81 51.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.004 0.431 . . . . 0.0 110.819 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.13 140.1 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 179.96 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.5 t -56.69 158.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.242 0.544 . . . . 0.0 111.638 179.757 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.4 t-20 74.15 3.5 4.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.179 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.5 m-20 -75.06 127.1 32.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.978 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.49 103.03 14.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.517 0.675 . . . . 0.0 111.131 -178.853 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.095 HD11 HG21 ' A' ' 19' ' ' ILE . 62.5 mt -49.92 133.37 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.052 -179.775 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.77 HD23 ' C ' ' A' ' 88' ' ' VAL . 4.0 mm? -108.64 -42.6 4.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -147.33 140.58 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.301 179.987 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.77 HG11 ' HB1' ' A' ' 76' ' ' ALA . 58.3 t -123.72 97.29 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.754 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 t30 70.04 -62.84 0.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.05 0.453 . . . . 0.0 109.819 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -160.58 30.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.152 179.143 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 16.7 t -121.03 109.62 25.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.679 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 65' ' ' VAL . 18.9 t0 -63.08 -23.49 67.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.283 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 64' ' ' ASP . 13.4 m 46.07 28.96 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.639 -179.763 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -61.91 -37.76 85.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.77 61.93 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.708 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -127.83 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.315 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.405 ' HA ' ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -61.59 151.34 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -179.706 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.854 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 t-160 -48.11 -33.89 8.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.675 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -34.07 75.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.933 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.07 -42.38 80.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.643 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.75 -46.81 86.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.677 0.751 . . . . 0.0 109.047 177.939 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.5 t -57.31 -50.48 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.328 178.546 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.682 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -29.47 60.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.898 178.556 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.77 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.55 -51.57 68.03 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.273 0.559 . . . . 0.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.056 HD11 HD12 ' A' ' 19' ' ' ILE . 1.5 mt -55.78 -37.96 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.48 -23.28 50.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.034 178.978 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.72 7.94 45.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.397 -178.795 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.19 16.2 4.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.3 179.873 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.34 -99.62 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.575 179.849 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -129.18 -91.9 0.46 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.845 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -81.95 97.14 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.187 0.518 . . . . 0.0 110.405 179.336 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.936 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -114.21 137.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.733 . . . . 0.0 112.947 -178.2 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.812 ' HG3' HG23 ' A' ' 7' ' ' THR . 4.6 mtt180 -86.35 103.03 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.164 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.3 mt -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.165 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.62 142.88 32.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.552 -179.902 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.77 ' C ' HD23 ' A' ' 58' ' ' LEU . 14.3 m . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.466 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 66.1 m-85 . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.795 0.331 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -155.48 152.45 28.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 pt-20 -105.68 144.75 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.019 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.25 109.17 12.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.956 0.408 . . . . 0.0 111.59 179.723 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.832 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.59 118.82 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.255 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.019 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -130.26 127.02 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.407 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.14 100.18 10.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.244 0.545 . . . . 0.0 112.239 179.812 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -53.55 89.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.137 178.448 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.199 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.325 -179.02 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.997 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.7 tp . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.24 27.43 0.91 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.091 177.951 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.766 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.3 p90 -164.15 134.91 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 118.013 0.906 . . . . 0.0 111.17 178.708 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.29 134.41 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.611 -179.2 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.06 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.51 146.98 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.327 179.299 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.598 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.45 123.17 33.02 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.649 179.098 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.58 -119.23 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.097 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 64.06 173.82 3.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.515 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.771 HG23 ' C ' ' A' ' 68' ' ' VAL . 4.6 p -76.89 -3.83 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.005 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.1 -25.15 9.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.7 t30 -125.05 86.1 57.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.453 0.168 . . . . 0.0 110.667 -179.824 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.63 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.0 1.8 . . . . 0.0 112.216 -179.767 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' ASN . 10.6 t-80 -53.52 -24.11 12.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.271 179.056 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -88.62 -153.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.423 179.438 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.663 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -63.22 -51.41 55.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.624 -179.22 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 3.3 p-10 -178.68 35.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.615 0.245 . . . . 0.0 111.519 -179.378 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -125.47 164.15 34.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -179.897 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.547 ' HB2' HG22 ' A' ' 23' ' ' THR . 79.0 Cg_endo -84.05 44.47 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.665 2.243 . . . . 0.0 112.337 179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -90.43 123.38 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.92 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.37 109.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.487 179.926 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -135.66 147.13 48.46 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.392 0.615 . . . . 0.0 110.287 178.842 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.17 155.6 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.751 -176.738 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.61 -32.69 3.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.606 -179.05 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.74 140.57 2.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.915 0.388 . . . . 0.0 111.406 -179.941 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.971 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -102.66 133.63 45.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.206 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.479 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 117.38 68.51 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.332 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.7 Cg_exo -57.69 135.19 67.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.833 2.355 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.32 1.51 64.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.672 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.19 179.84 28.54 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.076 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -57.68 -33.23 68.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.979 179.873 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.797 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -74.03 -56.43 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.729 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.39 -31.25 72.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -72.13 -32.63 67.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -58.07 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.676 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 41.47 9.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.552 179.681 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 13.9 mmt180 -108.98 -17.35 13.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.897 0.38 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -109.35 155.93 20.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 133.49 44.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 179.778 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.08 158.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.358 0.599 . . . . 0.0 111.989 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.8 t30 74.47 3.97 4.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.463 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -74.86 126.24 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.052 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 t -86.48 101.23 12.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.554 0.692 . . . . 0.0 111.269 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 19' ' ' ILE . 65.3 mt -47.13 131.56 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.815 179.833 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.3 mm? -110.37 -44.19 3.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.843 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.61 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -142.29 162.17 36.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.768 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.896 HG13 ' CD2' ' A' ' 86' ' ' LEU . 43.8 t -152.29 114.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.974 179.795 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 84' ' ' VAL . 26.7 t30 46.6 46.0 14.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 75.42 31.7 0.76 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 64.9 t -120.77 142.16 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 34.3 t0 -105.5 112.12 25.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.484 HG12 HG21 ' A' ' 68' ' ' VAL . 28.5 m -95.81 24.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.369 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -58.88 -28.92 66.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 60.58 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.771 ' C ' HG23 ' A' ' 23' ' ' THR . 28.3 m -132.89 142.76 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.352 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 152.47 28.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 -179.926 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.832 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.2 t-160 -48.15 -33.95 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.685 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -68.59 -34.1 75.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.173 179.812 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.661 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.94 -38.49 79.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.731 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.852 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.51 -46.83 74.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.5 t -57.62 -50.42 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 178.489 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.661 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.08 -29.81 58.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.786 178.44 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.696 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -61.37 -53.61 54.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.163 0.506 . . . . 0.0 109.785 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.06 HD11 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -51.75 -40.31 60.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.487 178.871 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -77.55 -25.56 50.22 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.454 179.314 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' GLU . 2.7 pt-20 -93.84 7.57 44.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 0.0 111.311 -178.615 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.942 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -84.99 16.3 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.508 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.82 -83.98 0.09 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.409 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -147.74 -90.09 0.08 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.439 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.832 HG13 HG22 ' A' ' 7' ' ' THR . 9.4 tp -82.32 96.72 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 109.938 179.134 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.942 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.1 p -116.04 136.9 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.507 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -86.06 102.79 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.491 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.896 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.3 mt -90.81 138.58 31.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.303 -178.71 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.66 137.34 40.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.423 179.818 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 55' ' ' ASP . 15.7 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.307 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.695 ' CD2' HD13 ' A' ' 58' ' ' LEU . 3.2 m-30 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.608 0.242 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.91 139.76 36.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 111.253 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -97.87 144.9 26.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.787 ' CD1' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.26 109.38 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.086 0.47 . . . . 0.0 111.545 179.911 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.843 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.33 125.37 29.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.459 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.885 HD11 ' HA ' ' A' ' 45' ' ' ALA . 2.3 tp -135.01 126.91 29.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.669 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.17 100.18 10.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.371 179.262 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.23 89.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.166 178.798 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.322 -0.204 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.357 -179.09 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.833 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.6 tp . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 120.03 22.98 3.1 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.959 -1.115 . . . . 0.0 115.342 177.458 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -163.48 135.8 5.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.353 1.077 . . . . 0.0 111.502 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 134.55 35.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.276 -179.674 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.052 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.4 162.85 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.551 0.691 . . . . 0.0 111.655 179.938 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -158.82 132.79 7.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.354 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.14 1.68 1.27 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.501 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.21 -172.94 0.37 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.955 -179.763 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 68' ' ' VAL . 32.1 p -68.41 -27.53 66.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.225 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 10.6 m-20 -96.8 -18.78 19.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -124.27 87.21 53.99 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.27 59.86 1.01 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.28 1.987 . . . . 0.0 112.6 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.634 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.0 t-80 -47.63 -28.3 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 178.834 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.805 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -89.35 -154.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.332 179.315 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.05 -49.53 77.53 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.663 -179.692 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.83 39.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.08 166.27 21.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CB ' HG22 ' A' ' 23' ' ' THR . 91.6 Cg_endo -80.65 6.83 5.2 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.64 2.227 . . . . 0.0 112.802 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -58.56 115.41 3.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.775 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.878 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.03 120.13 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.706 -179.896 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.32 144.57 33.3 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.358 0.599 . . . . 0.0 110.386 178.501 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.077 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.74 155.72 7.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.321 -176.374 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.4 -34.69 3.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.777 -178.784 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.12 142.36 2.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.46 -179.566 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.968 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.95 133.17 49.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 178.345 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.86 114.95 57.35 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.606 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 52.2 Cg_exo -55.71 137.76 79.26 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.256 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.02 6.71 66.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.77 177.36 21.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.992 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.45 -31.26 55.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.885 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -73.91 -57.5 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.712 -179.712 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.1 -28.57 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.259 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.72 -31.16 66.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.001 0.429 . . . . 0.0 110.084 179.428 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.42 -57.82 2.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.43 40.32 9.15 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.672 179.589 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.8 mtt85 -111.77 -19.16 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.663 0.268 . . . . 0.0 110.815 179.796 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.077 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -107.81 155.23 20.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.154 0.502 . . . . 0.0 111.177 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.58 134.82 45.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.676 179.746 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.0 157.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.317 0.58 . . . . 0.0 111.72 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.89 1.57 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.235 179.837 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.95 124.47 24.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.059 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.37 12.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.604 0.716 . . . . 0.0 111.419 -178.615 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 19' ' ' ILE . 20.3 mt -51.72 130.7 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.791 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.695 HD13 ' CD2' ' A' ' 3' ' ' TYR . 1.4 pp -126.95 3.41 6.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.604 179.389 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.5 OUTLIER 179.07 140.54 0.1 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.207 0.527 . . . . 0.0 110.583 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.908 HG23 ' CD2' ' A' ' 86' ' ' LEU . 2.4 p -147.57 118.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.402 ' HB2' HG21 ' A' ' 84' ' ' VAL . 46.4 t30 51.78 33.44 11.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 110.076 -179.006 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 77.62 34.75 0.34 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.711 ' HB ' HG13 ' A' ' 60' ' ' VAL . 58.4 t -120.91 108.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.2 p-10 -73.19 106.43 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.485 179.271 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 29.5 m -93.78 40.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.363 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -22.01 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.163 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -146.99 59.8 1.18 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.148 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -134.52 148.86 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.527 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.37 153.11 43.59 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.034 -179.344 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.8 t-160 -49.85 -34.02 18.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -33.99 73.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.772 179.41 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.58 -40.56 80.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.675 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.878 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.94 -46.71 80.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.009 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.9 t -57.97 -50.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.2 178.612 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.6 OUTLIER -56.4 -35.24 67.54 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.739 178.537 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -55.34 -52.49 63.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 110.142 179.528 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.0 HD11 HD12 ' A' ' 19' ' ' ILE . 3.4 mt -53.88 -38.72 65.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.241 178.585 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -20.65 53.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.413 179.011 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.2 mt-10 -97.21 -12.67 22.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.288 -178.687 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.896 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.9 -15.46 8.74 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.393 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 -91.28 1.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.903 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.4 p -139.45 -91.59 0.18 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.894 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.843 HG13 HG22 ' A' ' 7' ' ' THR . 9.7 tp -84.22 93.97 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.235 0.54 . . . . 0.0 110.007 178.813 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.896 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -113.21 136.86 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 8.5 ptp180 -87.49 102.94 15.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.471 177.969 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.908 ' CD2' HG23 ' A' ' 60' ' ' VAL . 17.7 mt -91.13 132.75 35.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.136 -179.079 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.52 126.18 48.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.6 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.719 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.458 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 40.5 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.93 0.395 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.4 mt-10 -129.93 170.57 13.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.32 144.59 49.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.973 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.015 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -140.36 109.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 111.801 179.968 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.751 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.6 118.72 20.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.392 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.039 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.1 tp -129.42 127.09 40.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.058 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 4.8 pt-20 -84.66 100.28 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.011 179.324 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.539 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.07 89.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.486 179.81 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.52 0.357 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.812 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.039 ' HB3' HD23 ' A' ' 8' ' ' LEU . 22.7 mt . . . . . 0 C--O 1.227 -0.092 0 CA-C-O 120.937 0.399 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 130.12 31.55 0.58 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.297 179.479 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.809 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.23 138.09 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.033 0.416 . . . . 0.0 110.561 179.096 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.98 135.03 40.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.425 -179.476 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.076 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.05 146.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.546 0.689 . . . . 0.0 111.388 179.596 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.66 123.86 34.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.736 179.0 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 159.47 -124.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.742 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 32' ' ' PRO . . . 70.09 174.06 13.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.794 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.766 HG22 ' HB2' ' A' ' 32' ' ' PRO . 12.2 p -76.93 -1.33 28.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.903 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.92 -23.06 8.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -124.85 86.83 55.83 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -179.89 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 65.72 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.051 1.834 . . . . 0.0 112.196 -179.812 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.508 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 13.2 t-80 -53.18 -23.69 9.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.262 179.286 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.87 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -91.34 -152.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.481 179.526 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.671 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.87 -46.89 63.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.8 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.56 77.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.2 170.28 5.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.65 179.91 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.766 ' HB2' HG22 ' A' ' 23' ' ' THR . 96.1 Cg_endo -84.47 16.54 1.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.548 2.165 . . . . 0.0 112.829 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.6 m -62.74 145.61 54.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.067 0.461 . . . . 0.0 111.047 -179.933 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.806 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -116.73 114.82 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 -179.914 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.87 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -139.9 148.11 41.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.393 0.616 . . . . 0.0 110.545 179.16 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.01 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.22 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.968 -176.894 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.78 -30.03 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.372 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.78 129.57 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.049 -179.366 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.93 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.06 130.08 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.586 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 115.3 59.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.588 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 39.1 Cg_exo -57.52 135.79 71.87 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.741 2.294 . . . . 0.0 112.212 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.36 14.62 40.88 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.65 177.47 16.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.997 179.693 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.32 -38.23 57.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.834 0.349 . . . . 0.0 111.224 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.833 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.16 -57.53 8.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.909 -179.608 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.26 -28.64 64.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.509 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -71.94 -32.79 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.008 0.432 . . . . 0.0 110.306 179.603 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -77.6 -58.02 3.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 36.0 16.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.564 179.562 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.508 ' CB ' HG12 ' A' ' 6' ' ' ILE . 59.0 mtt180 -118.29 5.26 11.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.01 HD21 HD12 ' A' ' 36' ' ' ILE . 10.9 tp -130.61 156.53 44.72 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.057 0.456 . . . . 0.0 110.932 179.644 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.612 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.54 135.18 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.684 179.846 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -48.98 157.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.305 0.574 . . . . 0.0 111.749 -179.746 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' HG12 ' A' ' 53' ' ' VAL . 41.1 t30 76.59 0.66 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.275 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.17 125.45 26.71 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.063 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.54 100.14 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 0.0 111.298 -178.958 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.076 HD11 HG21 ' A' ' 19' ' ' ILE . 61.2 mt -45.36 145.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.996 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -128.83 -44.61 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -140.66 146.41 37.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.063 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 40.0 t -140.4 111.41 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.703 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 50.46 37.42 15.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.398 . . . . 0.0 110.185 -179.125 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 79.55 34.24 0.19 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.493 -179.353 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 60' ' ' VAL . 97.3 t -120.95 108.44 22.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.424 -179.851 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.0 t0 -78.28 93.32 4.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.902 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG12 HG21 ' A' ' 68' ' ' VAL . 14.8 m -64.53 -122.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 65' ' ' VAL . 7.3 ttm180 70.16 -65.69 0.31 Allowed 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.03 0.443 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -93.61 40.22 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.725 179.585 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.592 ' C ' HG23 ' A' ' 23' ' ' THR . 34.7 m -137.92 142.34 36.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 179.88 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -58.36 155.06 12.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.234 0.54 . . . . 0.0 111.274 -179.558 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.7 p-80 -49.55 -33.78 15.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.873 179.646 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -72.05 -33.67 68.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.327 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.688 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.14 -44.13 85.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.247 0.546 . . . . 0.0 109.663 179.023 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.806 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.19 -46.88 88.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.609 0.719 . . . . 0.0 109.182 178.045 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.1 t -57.99 -50.43 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.416 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.93 -29.71 63.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.842 178.614 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -60.85 -51.09 70.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.818 179.493 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.037 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.59 -37.89 71.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.705 179.016 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.3 -22.8 51.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.143 179.059 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -102.23 13.17 35.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.328 -178.655 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.912 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.56 16.34 3.93 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.357 179.966 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.61 -93.69 0.56 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.303 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 19.3 m -139.79 -89.23 0.19 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.751 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.8 tp -85.44 91.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.113 0.482 . . . . 0.0 109.874 178.804 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.912 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.1 p -106.99 137.41 37.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.693 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.35 102.76 14.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.458 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.9 mt -90.64 140.65 29.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.41 -178.697 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -101.95 131.87 48.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.273 179.569 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.435 HG21 ' OD2' ' A' ' 55' ' ' ASP . 6.8 m . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 -179.654 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.443 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 27.1 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.912 0.387 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -137.6 146.53 44.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.0 pm0 -108.49 144.56 35.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.058 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.81 110.33 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.531 179.779 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.709 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.95 116.95 20.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.711 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.058 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -126.68 127.07 44.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.509 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pt-20 -85.52 100.41 11.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.327 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -48.52 88.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.254 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.554 -179.955 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.972 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.8 tp . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.391 0.138 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.4 21.37 1.05 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.89 -1.148 . . . . 0.0 114.726 178.537 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.855 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.2 p90 -161.6 135.96 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.935 0.868 . . . . 0.0 111.113 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.0 138.75 32.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.45 -179.459 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.038 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -119.66 148.81 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.727 0.775 . . . . 0.0 112.365 -179.642 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.15 134.21 27.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.281 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.68 -0.52 1.04 Allowed Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.807 179.491 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.88 -170.31 0.13 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.929 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 32' ' ' PRO . 18.1 p -74.9 -21.59 59.13 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.141 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.15 -25.14 15.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.719 0.295 . . . . 0.0 111.643 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.421 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 62.7 t30 -124.34 87.52 53.87 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.176 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.11 63.84 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.276 1.984 . . . . 0.0 112.576 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.61 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.2 t-80 -49.52 -26.23 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.43 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.386 179.543 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -55.96 -50.83 59.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.704 -179.644 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.03 39.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.7 170.02 10.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.769 ' HB3' HG22 ' A' ' 23' ' ' THR . 93.6 Cg_endo -80.35 6.59 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.653 2.235 . . . . 0.0 112.843 -179.872 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.97 113.41 1.5 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.931 0.396 . . . . 0.0 110.57 179.722 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.65 119.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.023 -179.633 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.67 146.96 36.76 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.646 178.485 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.034 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.97 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.194 -176.566 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.77 -31.31 4.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.154 -179.038 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.84 132.14 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.114 -179.363 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.35 132.9 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.549 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.17 126.72 69.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.655 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.2 Cg_endo -66.16 132.3 29.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.658 2.239 . . . . 0.0 112.355 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.02 1.72 58.34 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.476 -179.833 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.91 173.97 22.08 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.957 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.25 -35.57 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.837 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -71.03 -57.21 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.748 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.38 -35.21 80.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 -179.161 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.2 pp0? -72.08 -30.4 65.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.43 179.705 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.98 -58.13 3.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.647 179.929 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 41.43 10.09 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.579 179.451 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.2 mtt180 -116.44 7.95 13.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.034 HD21 HD12 ' A' ' 36' ' ' ILE . 5.1 tp -136.72 154.18 50.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.73 179.577 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.79 136.49 48.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.89 157.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.403 0.621 . . . . 0.0 111.513 179.839 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.52 -0.78 3.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.245 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.693 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -69.78 127.52 33.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.972 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.0 p -86.57 100.2 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.471 0.653 . . . . 0.0 111.605 -178.568 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.97 HD11 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -47.03 141.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.087 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.6 mm? -118.58 -45.03 2.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.183 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 m-85 -140.33 169.93 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.81 HG13 ' CD2' ' A' ' 86' ' ' LEU . 18.4 t -149.46 96.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.058 179.355 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.3 -68.15 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.176 0.512 . . . . 0.0 109.936 -178.784 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.2 tt0 -154.47 30.75 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.683 179.244 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.3 t -117.28 142.18 32.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.386 -179.333 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 35.7 t0 -114.72 87.91 2.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.494 179.431 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 65' ' ' VAL . 31.7 m -70.53 63.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 111.355 -179.543 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -29.62 30.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -154.68 64.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.817 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.745 ' O ' HG23 ' A' ' 23' ' ' THR . 34.7 m -128.15 146.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.78 153.62 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.067 0.46 . . . . 0.0 110.811 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 74' ' ' VAL . 7.0 p-80 -49.6 -33.62 15.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.988 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -70.64 -33.82 71.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.416 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.657 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.78 -44.42 85.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 109.807 179.178 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.19 -46.84 87.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.569 0.7 . . . . 0.0 109.307 178.095 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.9 t -57.16 -49.33 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.281 178.647 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.657 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.72 -33.06 66.13 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.598 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.51 -51.42 69.51 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.522 . . . . 0.0 109.991 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.39 -37.54 67.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.472 178.927 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.53 -26.67 51.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.502 179.332 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -91.74 -12.62 33.42 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.928 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.97 -18.77 10.1 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.334 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.38 -100.34 2.32 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.142 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -126.9 -91.74 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.008 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.709 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.7 tp -87.78 94.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.205 0.526 . . . . 0.0 109.723 178.745 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.928 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.9 p -110.14 138.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.506 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.1 mtm105 -87.77 103.11 15.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.148 177.838 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.81 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.9 mt -92.5 139.04 30.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.175 -178.993 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.78 147.88 25.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.693 HG21 ' OD2' ' A' ' 55' ' ' ASP . 30.3 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.425 179.857 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 58' ' ' LEU . 2.7 m-30 . . . . . 0 C--O 1.229 0.023 0 CA-C-O 120.9 0.381 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -140.82 148.88 41.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -103.48 141.64 35.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.904 HG23 ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt -130.66 109.33 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.19 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.982 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.85 112.14 15.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.708 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.969 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.5 tp -121.44 126.83 50.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.145 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.817 ' CG ' HD13 ' A' ' 83' ' ' ILE . 8.8 mt-10 -81.57 100.33 9.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.06 88.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.926 179.562 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.221 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.66 -179.859 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.433 0.159 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.14 20.16 0.84 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.599 178.675 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.847 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.6 p90 -162.76 134.53 5.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.986 0.893 . . . . 0.0 111.455 179.019 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.81 139.1 30.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.402 -179.566 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.054 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.69 147.37 23.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.68 0.752 . . . . 0.0 112.328 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.93 135.4 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.06 179.438 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.71 3.39 0.96 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.559 179.584 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.61 -168.36 0.29 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.874 -179.837 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.808 HG22 ' HB3' ' A' ' 32' ' ' PRO . 40.5 p -72.46 -30.01 64.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -96.09 -17.27 21.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.035 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.0 OUTLIER -124.84 82.66 60.32 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.248 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.36 62.32 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.777 2.318 . . . . 0.0 112.294 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.655 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.2 t-80 -50.17 -23.45 2.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.538 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.82 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.81 -154.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.325 179.693 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.66 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.64 -50.19 69.69 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.537 -179.681 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.55 39.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.736 0.303 . . . . 0.0 110.766 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.75 164.67 33.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.999 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.808 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.25 3.69 6.02 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.05 2.5 . . . . 0.0 112.826 -179.849 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 m -54.8 114.32 1.67 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.06 119.81 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.742 -179.898 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.82 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.17 148.5 38.35 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 178.722 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.093 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.22 155.59 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -176.73 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -34.06 3.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.595 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.588 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.56 141.61 2.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.552 -179.677 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.767 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -104.29 133.07 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.166 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 113.74 49.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -177.763 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 45.2 Cg_exo -56.74 140.53 91.11 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.756 2.304 . . . . 0.0 112.506 -179.828 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.37 13.01 64.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.421 -179.91 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.32 -176.91 19.08 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.038 179.751 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -59.62 -35.62 74.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.846 0.355 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.88 -57.26 4.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.886 -179.615 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.31 -33.32 75.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.765 -179.041 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.8 pt20 -72.34 -30.4 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 110.56 179.773 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.45 ' OD2' HD12 ' A' ' 8' ' ' LEU . 3.5 m-20 -76.31 -58.22 3.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.059 -179.552 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 41.29 8.99 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.384 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.904 ' HB3' HG23 ' A' ' 6' ' ' ILE . 8.6 mmt180 -120.44 -2.14 10.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.696 0.284 . . . . 0.0 110.935 179.667 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.093 HD21 HD12 ' A' ' 36' ' ' ILE . 36.0 tp -124.37 162.96 22.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.147 0.499 . . . . 0.0 111.402 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.63 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.37 134.38 25.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.241 179.302 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.6 t -49.18 156.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.842 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.473 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.4 OUTLIER 76.54 -1.43 2.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.332 179.885 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -67.18 126.82 30.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.966 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.6 102.74 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.545 0.688 . . . . 0.0 111.533 -178.747 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.054 HD11 HG21 ' A' ' 19' ' ' ILE . 69.3 mt -49.36 136.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.784 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.552 HD11 ' CD1' ' A' ' 3' ' ' TYR . 48.4 mt -120.61 -30.08 4.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.618 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -152.94 158.36 41.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.952 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.893 HG13 ' CD2' ' A' ' 86' ' ' LEU . 43.0 t -152.41 109.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.77 47.92 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.84 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 73.13 31.4 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.823 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 73.6 t -120.2 142.06 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.832 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 8.9 p-10 -113.05 91.35 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.556 179.519 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.736 HG12 HG21 ' A' ' 68' ' ' VAL . 2.2 m -55.9 -102.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.17 -179.646 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.583 ' H ' HG23 ' A' ' 65' ' ' VAL . 5.1 mtp180 61.99 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.773 0.32 . . . . 0.0 111.24 179.74 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -88.25 51.92 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 -179.655 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 30.4 m -139.17 144.41 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.053 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.475 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.36 154.59 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.429 . . . . 0.0 111.038 -179.484 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.4 p-80 -48.15 -34.26 9.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.194 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -70.29 -33.89 72.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.393 179.921 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.77 -47.34 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.194 0.521 . . . . 0.0 109.624 179.079 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -59.31 -46.74 87.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.654 0.74 . . . . 0.0 109.36 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.1 t -56.86 -50.4 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.357 178.516 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.9 -28.59 57.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.991 178.649 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.98 -51.59 67.46 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.344 0.592 . . . . 0.0 109.691 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -56.75 -36.89 70.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.874 179.098 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.4 -30.52 53.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.852 179.712 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -97.85 19.76 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.42 -178.417 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.14 16.3 7.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 179.656 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.53 -93.44 0.81 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.225 -179.835 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.477 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.2 m -142.18 -90.6 0.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.982 HG13 HG22 ' A' ' 7' ' ' THR . 6.0 tp -83.11 89.22 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.561 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.895 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.8 p -105.75 137.6 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.644 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.852 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.17 102.92 14.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.659 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.893 ' CD2' HG13 ' A' ' 60' ' ' VAL . 9.3 mt -92.77 137.7 32.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.172 -178.906 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 138.5 38.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.587 179.877 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.996 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CG ' HD13 ' A' ' 58' ' ' LEU . 6.4 m-85 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.46 146.18 31.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.887 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -102.53 144.66 30.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.896 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.016 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.75 109.23 9.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.446 179.679 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.884 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.2 119.86 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.095 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.019 HD23 ' HG ' ' A' ' 15' ' ' LEU . 5.3 tp -131.07 126.9 37.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.48 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 pt-20 -84.29 100.49 11.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 179.354 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.7 89.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.042 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.603 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.019 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.8 tp . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.29 0.091 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 132.22 22.11 0.92 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 119.693 -1.242 . . . . 0.0 114.914 178.38 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.862 ' CE2' HD23 ' A' ' 15' ' ' LEU . 10.4 p90 -161.17 135.96 7.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.073 0.936 . . . . 0.0 111.351 179.101 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.75 135.36 36.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.528 -179.571 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.2 146.83 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.418 179.638 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.14 123.59 34.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.446 178.956 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.48 -124.91 1.41 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.939 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 73.14 168.71 13.9 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.214 179.877 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 32' ' ' PRO . 6.3 p -75.53 -6.29 49.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -106.64 -26.92 11.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' HIS . 5.2 t-20 -124.91 86.97 55.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.579 -179.762 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.23 66.93 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.127 1.885 . . . . 0.0 112.455 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.56 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 11.2 t-80 -52.39 -24.91 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.252 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.852 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.1 -153.71 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.388 179.723 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -52.33 -51.62 41.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.85 -179.366 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 169.8 41.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 0.0 110.846 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.06 173.59 5.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.849 ' HB2' HG22 ' A' ' 23' ' ' THR . 80.9 Cg_endo -84.66 41.6 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.734 2.289 . . . . 0.0 112.438 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -90.41 119.49 30.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.003 0.43 . . . . 0.0 111.267 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.915 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.69 112.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.044 179.643 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.852 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -138.29 147.42 43.58 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.369 0.604 . . . . 0.0 110.283 179.249 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.045 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.15 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.111 -176.663 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.592 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.67 -33.55 4.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.574 -179.225 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.639 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.98 142.19 2.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.911 0.386 . . . . 0.0 111.457 -179.762 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.75 132.96 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.967 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 125.13 73.96 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.278 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 41.4 Cg_endo -67.05 129.92 21.73 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.936 2.424 . . . . 0.0 112.189 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.91 49.93 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.02 178.84 19.8 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.878 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.92 -38.81 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.749 0.309 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.784 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -66.62 -57.47 7.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.634 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.47 -28.89 67.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.487 -179.684 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -33.57 68.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.966 0.413 . . . . 0.0 110.175 179.594 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' OD2' HD12 ' A' ' 8' ' ' LEU . 4.3 m-20 -84.1 -57.99 2.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.66 -179.904 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 41.27 9.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.604 179.638 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.479 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -111.21 -10.24 14.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.885 0.374 . . . . 0.0 110.78 179.621 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.045 HD21 HD12 ' A' ' 36' ' ' ILE . 4.6 tp -117.14 153.45 32.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.93 137.8 51.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -52.24 158.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.828 -179.967 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 3.5 t30 75.93 -0.09 3.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.325 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -69.11 125.53 26.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.18 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.69 100.69 12.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.672 . . . . 0.0 111.366 -178.837 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.088 HD11 HG21 ' A' ' 19' ' ' ILE . 61.4 mt -47.11 129.15 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.911 179.927 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.619 HD23 ' HD3' ' A' ' 66' ' ' ARG . 3.6 mt -114.95 -32.05 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.586 179.437 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -151.94 155.78 38.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.916 HG13 ' CD2' ' A' ' 86' ' ' LEU . 46.0 t -142.2 102.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.631 179.572 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.13 -68.13 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.088 0.47 . . . . 0.0 110.462 -179.508 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' VAL . 8.3 pt-20 -155.06 30.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.907 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.529 HG21 ' OE2' ' A' ' 79' ' ' GLU . 47.0 t -117.87 142.09 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.2 t0 -109.93 87.77 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.366 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 57' ' ' ILE . 29.9 m -63.37 -138.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.868 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HD3' HD23 ' A' ' 58' ' ' LEU . 0.0 OUTLIER 76.2 -59.73 0.5 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.092 -179.184 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -100.8 30.16 4.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.293 179.03 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.757 ' C ' HG23 ' A' ' 23' ' ' THR . 12.2 m -127.55 142.77 42.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.389 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.41 152.97 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.89 ' O ' HG23 ' A' ' 74' ' ' VAL . 22.7 t-160 -47.91 -33.96 8.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.881 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -65.25 -34.17 77.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.091 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.816 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -63.07 -46.93 85.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.908 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 70' ' ' HIS . 76.3 t -56.25 -50.91 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.287 178.601 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.58 -29.27 61.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.253 178.944 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.9 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.42 -56.83 16.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.962 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 73' ' ' ALA . 2.2 mp -53.4 -36.84 61.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.983 178.976 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.42 -27.4 52.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.642 179.521 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -99.44 14.64 29.07 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.435 -178.267 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.946 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.47 16.29 3.9 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.3 -86.71 0.05 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.191 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 13.3 p -144.14 -89.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.456 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.884 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.21 92.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.176 0.512 . . . . 0.0 110.077 179.127 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.946 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -108.1 137.92 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.898 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 11.0 ptp180 -88.29 102.7 15.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.188 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.916 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.2 mt -91.65 138.8 31.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.427 -178.52 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.49 137.36 39.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.138 179.584 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.468 HG21 ' OD2' ' A' ' 55' ' ' ASP . 11.6 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.213 -179.4 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 3.2 m-85 . . . . . 0 C--O 1.231 0.092 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.61 166.98 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 111.493 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -119.52 144.95 46.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.979 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.87 111.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.99 0.424 . . . . 0.0 111.856 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.5 120.15 23.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.972 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.98 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -129.83 126.8 38.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.613 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.6 pt-20 -86.68 100.74 12.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.233 179.312 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -47.86 88.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.325 179.531 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.237 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.781 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.98 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.1 tp . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.96 22.14 1.16 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.909 -1.138 . . . . 0.0 114.632 178.446 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.829 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.1 p90 -162.89 134.79 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.76 0.78 . . . . 0.0 111.228 179.02 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.38 139.41 31.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.672 -179.287 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.029 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.74 147.18 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.661 0.743 . . . . 0.0 112.306 -179.92 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 132.62 29.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.876 179.202 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 149.76 -6.48 0.75 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.491 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.32 179.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.977 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 68' ' ' VAL . 19.1 p -65.03 -34.62 78.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.231 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.93 -17.58 29.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.557 -179.552 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -124.43 81.99 58.8 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.45 63.38 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.832 2.354 . . . . 0.0 112.522 -179.316 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.631 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.2 t-80 -53.16 -22.3 6.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.805 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.43 -152.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.448 179.73 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.674 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.97 50.37 4.39 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.643 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 78.04 47.34 0.05 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.028 0.442 . . . . 0.0 110.455 179.744 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.98 151.46 72.18 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CB ' HG22 ' A' ' 23' ' ' THR . 68.8 Cg_endo -74.45 -2.7 12.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.456 2.104 . . . . 0.0 112.576 179.976 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.402 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -52.16 119.25 4.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.537 179.695 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.823 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -86.55 120.34 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 -179.462 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.18 147.19 36.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.337 0.589 . . . . 0.0 110.564 178.479 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.992 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.943 -176.767 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.51 -30.95 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.783 -1.098 . . . . 0.0 112.215 -179.091 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.68 131.41 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.043 -179.408 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.0 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.84 132.14 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.492 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.44 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.32 124.22 74.08 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.719 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 34.9 Cg_endo -64.59 135.38 45.25 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.675 2.25 . . . . 0.0 112.242 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.94 7.13 60.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.486 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.09 174.51 17.65 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.904 179.804 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.64 -32.75 52.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.642 0.258 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.746 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -72.18 -57.42 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.547 -179.965 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.32 -28.91 67.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.446 -179.535 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -71.9 -31.58 66.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.197 179.596 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -83.83 -57.85 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.932 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.4 40.81 8.8 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.385 179.714 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.456 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.6 mtp85 -112.64 -9.23 13.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.017 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.0 HD23 HD11 ' A' ' 39' ' ' ILE . 6.3 tp -119.35 155.88 31.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.619 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.1 mpt_? -131.99 135.47 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.98 157.72 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.296 0.57 . . . . 0.0 111.721 179.889 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.3 OUTLIER 76.23 -1.27 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.715 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.3 m-20 -69.53 127.71 33.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.99 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.69 100.02 12.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.549 0.69 . . . . 0.0 111.281 -178.97 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 19' ' ' ILE . 10.6 mt -45.74 144.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.026 -179.927 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.455 ' HG ' ' CD2' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -123.26 -44.36 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.205 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -140.97 165.78 26.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.818 HG13 ' CD2' ' A' ' 86' ' ' LEU . 42.0 t -150.75 103.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.523 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -71.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.108 0.48 . . . . 0.0 110.226 -179.24 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -151.14 28.56 0.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.816 179.3 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.833 HG12 ' H ' ' A' ' 65' ' ' VAL . 21.5 t -116.04 142.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.21 -179.485 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 38.4 p-10 -103.59 -0.96 28.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.422 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.833 ' H ' HG12 ' A' ' 63' ' ' VAL . 16.7 m 43.65 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.559 -179.645 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -51.92 99.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.765 179.91 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' O ' HG21 ' A' ' 23' ' ' THR . 11.3 pt-20 44.85 57.66 4.46 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 -179.58 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.741 ' C ' HG23 ' A' ' 23' ' ' THR . 4.9 m -108.51 145.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.25 156.84 14.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.337 -178.925 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.923 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.0 p-80 -48.9 -34.29 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.932 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -67.91 -33.86 75.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.568 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.29 -46.1 78.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.181 0.515 . . . . 0.0 109.649 178.898 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.823 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.37 -45.4 93.35 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 70' ' ' HIS . 66.9 t -56.52 -50.43 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.113 178.517 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.48 -34.65 36.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.862 179.534 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.793 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.49 -57.34 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.94 HD12 HD12 ' A' ' 19' ' ' ILE . 2.4 mt -59.98 -41.32 91.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.38 0.61 . . . . 0.0 110.231 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.604 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.92 -20.13 56.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.766 179.641 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -112.22 23.44 13.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 179.271 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.879 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -82.92 16.57 2.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.752 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.52 -91.24 0.48 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.676 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.0 m -138.29 -90.73 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.859 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 7' ' ' THR . 8.1 tp -86.55 100.23 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.526 179.361 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.879 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.3 p -114.11 139.95 37.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.793 -178.171 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.714 ' HG3' HG23 ' A' ' 7' ' ' THR . 11.7 mtt180 -88.12 103.51 15.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.603 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.818 ' CD2' HG13 ' A' ' 60' ' ' VAL . 17.7 mt -94.1 136.63 34.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -178.942 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 138.17 39.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.377 179.562 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.441 HG11 HD11 ' A' ' 51' ' ' LEU . 5.6 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 71.1 m-85 . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.721 0.296 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -144.7 137.32 26.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.8 pt-20 -103.43 144.61 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.651 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.039 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.91 109.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 111.887 179.925 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.889 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.35 121.14 24.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.612 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.039 HD13 HD11 ' A' ' 6' ' ' ILE . 5.2 tp -130.44 127.2 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.233 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.1 mt-10 -77.78 99.72 6.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.201 179.59 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -62.57 90.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.235 178.455 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.996 -179.47 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.4 tp . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 110.591 -0.152 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.519 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 133.61 19.12 0.96 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.942 -1.123 . . . . 0.0 114.775 178.596 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.865 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.7 p90 -161.31 137.05 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.755 0.778 . . . . 0.0 110.996 179.114 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.69 138.01 33.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.528 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.07 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.22 147.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.669 0.747 . . . . 0.0 112.302 -179.781 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.56 133.67 31.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.168 179.454 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.76 -7.48 1.08 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.531 179.57 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.54 -177.86 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.337 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 30.3 p -64.03 -33.72 76.39 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.914 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 12.2 t70 -89.78 -19.02 25.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.957 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.13 86.94 53.86 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.46 179.897 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.0 61.25 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.407 2.071 . . . . 0.0 112.4 -179.729 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.575 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 15.6 t-80 -49.83 -26.12 3.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.187 178.967 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.774 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.99 -151.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.525 179.616 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.69 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.25 49.87 4.31 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.828 -178.951 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.18 45.11 0.09 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.088 0.47 . . . . 0.0 110.511 179.558 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.13 78.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.913 179.912 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.502 ' HB3' HG22 ' A' ' 23' ' ' THR . 68.7 Cg_endo -74.77 -1.16 10.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.38 2.053 . . . . 0.0 112.546 179.847 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -51.99 115.91 1.92 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.91 0.386 . . . . 0.0 110.462 179.524 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.06 118.21 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.145 -179.346 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.774 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.94 146.96 38.06 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.372 0.606 . . . . 0.0 110.474 178.42 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.005 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.1 155.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.191 -176.52 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.17 -30.96 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.133 -178.846 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.86 132.93 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.113 -179.496 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.53 132.05 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.889 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.435 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.17 116.17 63.66 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.627 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.39 135.56 68.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.757 2.304 . . . . 0.0 112.273 179.742 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.55 9.49 57.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.655 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.71 179.76 18.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.033 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.38 -36.52 66.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.755 0.312 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.98 -57.35 5.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.029 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.77 -29.94 68.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.02 -178.964 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 11.4 pt20 -72.04 -33.42 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.45 -58.04 3.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 41.09 9.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.594 179.479 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.2 mtt-85 -115.38 9.05 15.5 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.751 179.584 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.005 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -136.19 154.58 50.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.627 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.15 135.59 46.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.85 179.841 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -51.4 157.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.437 0.637 . . . . 0.0 111.552 179.998 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.49 0.17 3.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.356 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.8 m-20 -71.35 127.73 33.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.0 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.4 p -86.49 100.41 12.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.576 0.703 . . . . 0.0 111.381 -178.597 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.07 HD11 HG21 ' A' ' 19' ' ' ILE . 68.1 mt -45.46 151.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.127 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -128.91 -46.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.278 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -141.15 163.98 31.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.835 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.4 t -148.67 101.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.603 179.573 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.72 -68.83 0.12 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.1 0.476 . . . . 0.0 110.389 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.8 mm-40 -154.13 30.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.799 179.29 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.832 HG12 ' H ' ' A' ' 65' ' ' VAL . 19.7 t -117.66 142.2 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.165 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 34.5 p-10 -105.54 1.35 27.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.389 179.77 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.832 ' H ' HG12 ' A' ' 63' ' ' VAL . 15.4 m 43.62 30.84 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.813 0.339 . . . . 0.0 111.319 -179.638 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 95.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.992 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 57.04 63.0 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.745 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 19.7 m -119.29 147.72 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.06 155.6 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.214 -179.17 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.1 p-80 -48.17 -34.93 10.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.181 -179.454 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 m -69.83 -33.79 72.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.381 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.87 -47.29 75.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.0 109.645 178.982 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.3 -46.77 88.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.551 0.691 . . . . 0.0 109.493 178.2 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.7 t -57.41 -48.45 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.296 178.606 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.96 -34.87 68.48 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.518 178.553 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.565 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.46 -51.3 67.39 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.258 0.551 . . . . 0.0 110.016 179.337 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.033 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.28 -37.19 66.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.307 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.47 -26.74 51.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -96.2 6.1 49.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 111.437 -178.647 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -79.14 16.19 1.0 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.65 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.91 -91.11 0.5 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.347 -179.954 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 10' ' ' ARG . 38.6 m -143.87 -91.15 0.11 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.198 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.889 HG13 HG22 ' A' ' 7' ' ' THR . 8.9 tp -81.68 92.69 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 109.726 178.693 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.913 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -110.89 137.05 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.262 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.8 ptt85 -87.04 103.09 15.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.196 177.676 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.835 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.5 mt -91.51 141.83 28.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.162 -178.983 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 144.32 30.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.624 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.435 179.714 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.445 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.856 0.36 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -164.2 147.1 9.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -102.58 144.65 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.56 109.44 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.487 179.846 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.834 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.47 113.29 17.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.047 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -123.81 127.22 47.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.563 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 pt-20 -86.35 100.13 12.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.275 179.898 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.16 89.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.266 178.328 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.186 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.345 -178.983 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.908 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.94 24.7 1.17 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.854 178.139 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.77 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.1 p90 -162.18 134.95 5.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.985 0.892 . . . . 0.0 111.498 178.923 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.31 134.78 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.173 -179.679 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.085 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.68 166.74 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.706 0.765 . . . . 0.0 111.655 179.936 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -163.62 131.93 3.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.296 179.997 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.46 0.53 1.15 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.456 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.966 -179.976 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.79 HG22 ' CB ' ' A' ' 32' ' ' PRO . 15.0 p -74.78 -20.03 59.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.18 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -98.39 -24.15 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 111.661 -179.376 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -124.53 87.89 53.9 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 179.814 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 63.07 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.317 2.011 . . . . 0.0 112.792 -179.368 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.627 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.8 t-80 -48.29 -27.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 178.859 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.814 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.39 -154.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.557 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.53 -50.41 63.11 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.582 -179.708 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.01 40.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.914 0.388 . . . . 0.0 110.711 -179.98 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.26 167.22 16.95 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.999 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.79 ' CB ' HG22 ' A' ' 23' ' ' THR . 89.0 Cg_endo -80.92 8.55 4.25 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.645 2.23 . . . . 0.0 112.83 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -60.49 113.76 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 110.772 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.876 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -81.34 119.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.446 179.962 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.814 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.42 145.0 33.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.37 0.605 . . . . 0.0 110.568 178.792 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.052 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.91 155.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.332 -176.333 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.11 -34.28 4.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.81 143.01 2.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 111.55 -179.602 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.011 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -105.77 132.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.097 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.427 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.02 125.91 71.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.475 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.1 Cg_endo -66.89 131.09 24.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 4.82 55.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.457 -179.649 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.78 177.67 21.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.726 179.685 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.19 -36.19 65.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.66 0.267 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.806 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -69.42 -57.53 5.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.517 -179.87 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.01 -28.92 67.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.12 -35.44 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.441 . . . . 0.0 110.0 179.318 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -83.59 -57.99 3.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.03 9.42 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' CB ' HG12 ' A' ' 6' ' ' ILE . 42.5 mtp180 -113.72 8.85 17.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.699 0.285 . . . . 0.0 110.662 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.052 HD21 HD12 ' A' ' 36' ' ' ILE . 4.6 tp -135.08 153.88 51.88 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.609 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.56 136.65 49.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.879 179.937 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.9 t -51.18 158.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.331 0.586 . . . . 0.0 111.676 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.29 2.17 4.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.023 179.911 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -71.02 126.03 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.988 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -86.48 101.95 13.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.652 0.739 . . . . 0.0 111.346 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.085 HD11 HG21 ' A' ' 19' ' ' ILE . 57.4 mt -49.74 136.27 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.38 -38.29 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.174 179.545 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -147.34 172.01 14.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.798 -179.73 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.858 HG13 ' CD2' ' A' ' 86' ' ' LEU . 36.7 t -150.27 96.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.996 179.351 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.764 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 68.44 -67.17 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.193 0.52 . . . . 0.0 109.775 -178.789 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -156.28 32.34 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.555 179.209 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.8 t -119.23 142.33 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.57 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.9 p-10 -111.07 106.77 15.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.214 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.454 HG12 HG21 ' A' ' 68' ' ' VAL . 31.4 m -91.88 43.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.52 -179.517 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.58 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.736 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.43 66.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 23' ' ' THR . 35.6 m -134.6 145.63 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 151.69 28.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.753 -179.884 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.8 t-160 -48.98 -33.67 11.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 t -67.15 -34.06 76.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.045 179.642 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.39 -40.39 81.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.829 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.876 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.55 -46.76 78.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.112 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 97.4 t -57.19 -50.29 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.143 178.563 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.25 -33.04 62.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.693 178.646 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.218 0.533 . . . . 0.0 110.124 179.453 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.048 HD11 HD12 ' A' ' 19' ' ' ILE . 1.4 mt -53.12 -37.57 61.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.212 178.857 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.47 -27.58 52.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.305 178.953 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -87.63 -17.65 31.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.021 0.438 . . . . 0.0 111.092 -178.825 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.973 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -52.32 -21.42 3.51 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.489 179.828 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.04 -91.31 1.44 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.045 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -134.49 -92.87 0.31 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.834 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -86.57 93.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.34 0.59 . . . . 0.0 109.983 178.961 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.973 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.7 p -110.17 139.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.232 -177.493 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.724 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.43 103.07 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.863 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.858 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.8 mt -93.81 135.73 34.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -101.73 139.92 36.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 -179.946 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 55' ' ' ASP . 25.9 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.992 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CG ' HD22 ' A' ' 58' ' ' LEU . 9.9 m-30 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.893 0.378 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.19 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.624 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.424 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 4.4 tt0 -130.36 141.65 50.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.683 0.278 . . . . 0.0 111.098 -179.822 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.023 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.1 112.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.026 0.441 . . . . 0.0 111.87 179.755 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.77 121.95 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.698 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.064 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.9 tp -131.14 127.14 37.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.368 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.4 pt-20 -82.96 100.36 10.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.208 179.276 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.03 88.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.107 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.61 -180.0 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.064 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.244 0.068 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.02 28.15 0.88 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.922 178.33 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.7 p90 -162.9 132.92 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.879 0.84 . . . . 0.0 111.03 178.771 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.568 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -90.83 134.88 34.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.437 -179.2 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.03 163.63 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.703 0.763 . . . . 0.0 111.756 -179.944 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -159.06 130.67 6.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.931 179.452 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 146.91 -1.03 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.319 179.82 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.61 -172.08 0.25 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.91 -179.857 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.818 HG22 ' HB3' ' A' ' 32' ' ' PRO . 28.6 p -69.77 -34.38 73.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.308 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.43 -19.56 25.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -124.68 82.41 59.78 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 0.0 110.292 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.98 62.48 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.803 2.335 . . . . 0.0 112.224 -179.594 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.663 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.4 t-80 -50.73 -23.39 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.413 179.016 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.85 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -93.92 -154.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.308 179.582 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.57 -50.26 68.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.584 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.13 40.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -127.84 168.52 14.99 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.022 -179.913 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.18 3.2 6.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.01 2.473 . . . . 0.0 112.702 -179.81 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 2.7 m -53.96 112.17 0.9 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.863 0.363 . . . . 0.0 111.092 -179.917 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.867 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.34 119.64 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.388 179.914 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.85 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.58 144.48 32.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.505 0.669 . . . . 0.0 110.585 178.952 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.151 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.07 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.88 -176.593 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.463 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.57 -31.9 4.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.809 -178.842 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.47 142.12 2.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.384 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.952 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.89 133.82 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.26 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.476 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.94 119.28 73.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.18 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.8 Cg_exo -58.87 132.6 48.61 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.757 2.304 . . . . 0.0 112.137 179.748 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.82 -1.16 59.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.763 -179.976 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.36 177.39 28.47 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.873 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.78 -35.53 63.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.969 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.843 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.26 -57.39 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 -179.997 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.89 -28.97 68.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.318 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -71.81 -34.23 69.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.13 0.491 . . . . 0.0 109.889 179.509 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.08 -57.74 2.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.49 42.01 9.54 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.362 179.655 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtp180 -110.27 -18.64 13.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.688 179.765 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.151 HD21 HD12 ' A' ' 36' ' ' ILE . 4.8 tp -106.69 153.26 22.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.089 0.471 . . . . 0.0 110.666 179.371 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -127.85 135.89 50.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.919 179.825 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -50.29 160.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.495 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.2 m120 71.45 4.1 4.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.154 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.556 ' CG ' HG21 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -71.06 124.35 24.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.589 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.6 p -86.42 100.0 12.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.561 0.696 . . . . 0.0 111.709 -178.193 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.036 HD11 HG21 ' A' ' 19' ' ' ILE . 9.9 mt -53.12 129.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.861 179.792 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.4 pp -122.53 -18.61 6.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.521 178.974 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.524 ' HD1' HD12 ' A' ' 58' ' ' LEU . 1.9 m-85 -157.36 162.36 39.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.026 0.441 . . . . 0.0 110.652 -179.979 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.914 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.8 t -143.92 97.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.86 179.41 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.832 ' CG ' HG23 ' A' ' 84' ' ' VAL . 1.3 t-20 66.59 -69.02 0.13 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.159 0.504 . . . . 0.0 109.889 -178.572 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -152.89 29.66 0.51 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.866 179.174 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.5 t -115.98 141.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.359 -179.402 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.5 p-10 -113.47 97.18 6.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.492 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 65' ' ' VAL . 31.4 m -69.62 64.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.191 -179.781 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -91.31 101.02 13.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.547 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.41 51.01 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.019 -179.902 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.762 ' C ' HG23 ' A' ' 23' ' ' THR . 19.1 m -116.41 142.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 179.639 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.481 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.54 153.29 23.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.025 -179.129 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.881 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.1 p-80 -47.95 -33.82 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.963 -179.671 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -33.96 70.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.947 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.631 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.35 -44.56 82.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 109.724 179.321 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.867 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.01 -46.88 87.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.773 0.797 . . . . 0.0 109.161 178.095 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.911 HG22 HD11 ' A' ' 19' ' ' ILE . 90.0 t -56.22 -50.45 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.299 178.601 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.631 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.11 -29.84 61.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.379 179.071 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -61.94 -50.3 72.68 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.404 0.621 . . . . 0.0 109.986 179.57 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -59.05 -36.13 74.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.771 179.271 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -24.03 50.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.889 178.788 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -101.78 16.27 26.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.792 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.28 16.21 5.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.75 -93.97 0.75 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.316 -179.999 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.7 m -141.42 -89.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 7' ' ' THR . 6.8 tp -84.07 89.02 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.646 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.901 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.6 p -105.38 136.29 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.182 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.01 102.94 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.664 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.914 ' CD2' HG13 ' A' ' 60' ' ' VAL . 38.0 mt -89.12 137.34 32.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.389 -178.836 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.559 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.1 122.84 44.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.529 179.679 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 57' ' ' ILE . 17.0 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' HD11 ' A' ' 58' ' ' LEU . 6.4 m-85 . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.849 0.357 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 11.2 pt-20 -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -118.73 144.71 46.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 -179.978 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.013 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.7 109.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 111.863 179.857 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.719 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.91 116.37 20.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.525 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.047 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.9 tp -126.06 127.36 45.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.249 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.8 pm0 -86.84 100.46 12.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.713 179.596 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.587 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 1.3 mtm180 -44.32 91.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.682 179.109 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.342 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.256 -179.19 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.047 ' HB3' HD23 ' A' ' 8' ' ' LEU . 16.4 mt . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 137.0 34.62 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.71 179.318 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.7 p90 -159.64 138.08 10.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.137 0.469 . . . . 0.0 110.938 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.99 132.19 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.811 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.052 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -108.2 165.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.77 . . . . 0.0 111.803 -179.905 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -164.27 131.3 3.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.356 179.845 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.66 0.2 0.97 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.632 179.614 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.52 -170.96 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.977 -179.871 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.798 HG22 ' CB ' ' A' ' 32' ' ' PRO . 13.2 p -75.34 -20.79 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.187 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.85 -24.96 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 -179.347 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -124.39 87.66 53.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.208 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 63.12 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.418 2.079 . . . . 0.0 112.686 -179.484 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.64 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.2 t-80 -47.96 -27.9 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 178.887 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.874 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.59 -155.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.357 179.301 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.678 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.8 -46.78 59.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.562 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.2 m-20 176.71 73.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -165.67 165.69 10.85 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.798 ' CB ' HG22 ' A' ' 23' ' ' THR . 82.9 Cg_endo -81.21 5.7 6.07 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.674 2.249 . . . . 0.0 112.923 -179.947 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.405 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -56.0 112.87 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.948 179.953 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.846 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.51 119.16 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 -179.911 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.874 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.26 145.9 34.54 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.505 0.669 . . . . 0.0 110.847 178.653 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.05 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.73 155.97 7.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.008 -176.897 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.469 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.88 -27.47 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.622 -178.411 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.64 128.67 0.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.211 -179.444 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.031 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.98 130.51 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.662 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 114.74 56.63 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.569 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.5 Cg_exo -57.94 135.58 69.73 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.781 2.32 . . . . 0.0 112.217 179.918 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.12 15.27 39.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.97 179.58 16.09 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.037 179.773 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.33 -38.55 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.734 0.302 . . . . 0.0 111.343 -179.982 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.817 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.98 -57.65 7.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.012 -179.538 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.2 -28.76 64.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 -179.4 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -32.87 67.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.916 0.389 . . . . 0.0 110.264 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -79.63 -58.1 3.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.582 179.967 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.5 9.92 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.645 179.433 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.512 ' CB ' HG12 ' A' ' 6' ' ' ILE . 25.9 mtt180 -119.36 7.23 11.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.868 0.334 . . . . 0.0 110.941 179.68 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.05 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -134.3 154.8 51.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.917 179.555 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 135.1 43.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.863 179.995 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 38' ' ' LYS . 59.9 t -49.14 158.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.278 0.561 . . . . 0.0 111.55 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.3 t-20 73.69 4.19 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.992 -179.807 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.4 m-20 -73.27 124.23 25.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.46 101.77 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.693 0.759 . . . . 0.0 111.63 -178.395 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 19' ' ' ILE . 57.8 mt -49.46 137.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 3' ' ' TYR . 3.9 mt -117.1 -34.03 4.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 179.246 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -149.55 169.24 21.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.734 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.8 t -146.56 97.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.278 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.903 ' OD1' HG23 ' A' ' 84' ' ' VAL . 4.3 t30 67.26 -68.1 0.16 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.256 0.55 . . . . 0.0 109.82 -178.655 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -155.68 32.87 0.36 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.527 179.106 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 57.3 t -119.38 142.27 35.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.523 -179.12 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -110.0 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.294 179.052 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.467 HG12 HG21 ' A' ' 68' ' ' VAL . 30.6 m -92.48 40.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.36 . . . . 0.0 111.414 -179.66 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.831 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -151.59 66.33 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 23' ' ' THR . 35.6 m -133.08 145.42 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.75 151.89 24.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 -179.808 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 t-160 -49.49 -33.61 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 t -67.12 -33.99 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.994 179.583 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -40.07 80.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.772 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.846 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.68 -46.88 77.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.014 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.8 t -57.32 -49.99 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.251 178.533 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.15 -34.33 66.04 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.669 178.633 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.699 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.66 -51.07 70.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.182 0.515 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.034 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.7 -36.35 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.476 178.955 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.26 -22.48 52.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.209 179.053 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -97.39 -11.99 23.3 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.38 -178.879 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.957 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.33 -18.99 19.64 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 179.944 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.07 -101.19 2.56 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.994 -179.825 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.587 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.9 p -127.67 -90.4 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.871 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.719 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.6 tp -87.19 91.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.589 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.957 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.3 p -107.16 137.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.296 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.2 ttt85 -86.71 103.1 14.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.131 177.762 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.734 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.4 mt -91.67 142.98 27.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.451 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 134.23 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.476 179.789 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.544 HG11 HD11 ' A' ' 51' ' ' LEU . 29.0 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 111.211 -179.724 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 53.0 m-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -142.7 148.23 36.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.48 144.88 31.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.694 179.78 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.953 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.51 109.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.933 -179.779 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.899 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.42 123.41 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.774 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -133.69 126.78 31.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.089 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -85.19 99.83 11.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.926 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.91 86.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.362 179.188 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.56 -179.509 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.922 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.8 tp . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.828 0.346 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 74.14 31.08 60.0 Favored Glycine 0 CA--C 1.519 0.281 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 177.829 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.806 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 6.5 p90 -164.52 131.38 3.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.282 1.041 . . . . 0.0 111.628 178.559 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -97.33 138.96 34.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.866 -179.083 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.027 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.7 148.93 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 112.01 179.864 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.676 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.62 133.19 25.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.937 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.14 -3.32 0.9 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.586 179.783 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.49 179.97 0.12 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' C ' ' A' ' 68' ' ' VAL . 26.5 p -65.24 -35.11 80.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.419 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.03 -17.14 29.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.628 0.251 . . . . 0.0 111.519 -179.486 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.56 82.05 59.45 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.043 0.449 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.14 62.87 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.853 2.368 . . . . 0.0 112.541 -179.291 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.676 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.4 t-80 -52.28 -22.71 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 178.78 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.853 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.71 -154.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.645 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.662 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.03 -49.8 74.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.551 -179.798 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.51 39.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.56 167.44 17.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.833 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.717 ' CB ' HG22 ' A' ' 23' ' ' THR . 98.6 Cg_endo -79.11 1.93 8.74 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.668 2.245 . . . . 0.0 112.755 179.995 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.78 115.27 1.73 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.821 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -86.5 121.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.566 -179.831 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.853 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.08 146.88 35.94 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.315 0.579 . . . . 0.0 110.59 178.824 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.017 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.98 155.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.69 -176.897 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.52 -30.72 4.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.174 -178.971 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.75 128.32 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.212 -0.595 . . . . 0.0 112.33 -179.362 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.98 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.47 127.03 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.69 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.24 119.39 73.14 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -177.814 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.5 Cg_exo -54.36 140.32 73.3 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.718 2.279 . . . . 0.0 112.297 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.75 12.98 70.77 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.537 -179.923 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.61 -158.68 21.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.978 179.779 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.96 -38.85 57.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.869 0.334 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.88 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.13 -54.46 7.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.586 -179.63 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -60.59 -32.48 71.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -72.36 -37.31 68.82 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.03 0.443 . . . . 0.0 110.308 179.514 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.62 -57.85 3.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.28 35.6 14.38 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.529 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.9 mmm180 -110.7 -12.56 14.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.701 179.584 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.017 HD21 HD12 ' A' ' 36' ' ' ILE . 6.2 tp -113.66 155.84 24.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.579 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.0 tpt180 -134.87 135.11 41.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.47 157.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.279 0.561 . . . . 0.0 111.638 179.935 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' HG12 ' A' ' 53' ' ' VAL . 4.9 t-20 75.7 -1.65 2.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.277 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.5 m-20 -68.48 126.6 30.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.936 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 p -86.57 100.14 12.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 111.471 -178.616 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -45.47 153.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.813 179.999 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -136.79 -46.23 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.64 -179.669 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -142.21 167.11 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.928 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.5 t -142.36 100.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.897 179.34 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.639 ' HB2' HG23 ' A' ' 84' ' ' VAL . 3.1 t-20 66.36 -68.04 0.14 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.199 0.523 . . . . 0.0 109.667 -178.517 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.2 mt-10 -156.65 31.28 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.38 178.974 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -116.36 142.52 29.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.452 -179.006 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 3.7 p-10 -108.29 120.18 41.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.505 179.176 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 19.1 m -93.79 37.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.15 -179.983 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -71.06 100.89 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.06 50.02 1.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.751 ' C ' HG23 ' A' ' 23' ' ' THR . 14.0 m -114.92 142.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.732 179.464 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.462 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.96 153.0 26.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.069 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.939 ' O ' HG23 ' A' ' 74' ' ' VAL . 11.0 t-160 -48.79 -33.98 11.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.516 -179.964 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -34.12 76.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.301 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.96 -42.69 80.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.478 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.821 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.81 -46.66 84.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.003 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 70' ' ' HIS . 58.0 t -57.17 -50.35 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.1 178.639 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.655 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.34 -32.55 38.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.772 179.222 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -68.38 -57.11 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.845 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.95 HD12 HD12 ' A' ' 19' ' ' ILE . 4.2 mt -64.1 -39.79 94.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.009 -179.436 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.596 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -77.1 -20.06 56.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.334 -179.73 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.655 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 4.4 mm-40 -104.1 -10.78 17.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.02 0.438 . . . . 0.0 110.873 178.894 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.87 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.17 -20.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.566 179.944 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.62 -104.33 2.99 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -117.8 -92.89 0.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.764 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.889 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -87.58 102.7 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.058 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.87 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -118.04 138.75 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.6 -178.6 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.899 ' HG2' HG23 ' A' ' 7' ' ' THR . 5.6 mtm180 -87.05 103.56 15.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.638 178.817 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.928 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.4 mt -93.58 139.17 31.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.018 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 137.99 39.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.763 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 29.0 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.422 179.837 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.781 ' CD1' HD22 ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.834 0.35 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.7 mt-10 -109.55 125.43 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 12.2 pt-20 -94.7 144.62 25.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.984 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -142.26 109.51 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.715 179.935 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.792 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.45 122.01 24.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.031 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.043 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.3 tp -132.02 128.03 37.45 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.556 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.4 pt-20 -86.43 100.5 12.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.32 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.577 ' CG ' HD23 ' A' ' 15' ' ' LEU . 6.1 mtp-105 -42.74 91.56 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.105 179.592 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.521 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.878 -179.545 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.043 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.5 mt . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.945 0.403 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.21 38.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.397 179.505 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.779 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -164.12 134.06 4.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.195 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.54 136.93 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.638 -179.34 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.31 148.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.643 0.735 . . . . 0.0 112.032 179.934 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.98 131.83 24.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.688 179.264 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.82 -3.72 0.84 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.787 179.644 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.04 179.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.675 179.91 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.851 HG22 ' CB ' ' A' ' 32' ' ' PRO . 17.5 p -70.34 -21.55 62.89 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.43 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -92.02 -26.58 18.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.792 0.33 . . . . 0.0 111.271 -179.679 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -124.48 87.52 54.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.33 64.94 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.362 2.042 . . . . 0.0 112.653 -179.432 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.625 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.0 t-80 -48.96 -27.43 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.404 178.998 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.848 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.54 -154.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.428 179.439 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.03 -49.45 78.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.691 -179.709 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.44 39.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.65 165.59 25.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 -179.929 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.851 ' CB ' HG22 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.03 1.98 8.69 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.656 2.237 . . . . 0.0 112.747 -179.822 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.57 116.66 2.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.829 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -86.32 120.05 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.592 -179.966 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.848 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.14 147.81 37.27 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.327 0.584 . . . . 0.0 110.726 178.762 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.994 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.828 -177.008 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.467 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -33.38 4.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.662 -179.173 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.26 142.84 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.0 111.41 -179.881 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.951 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.5 131.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.39 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.98 121.26 75.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.976 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.4 Cg_endo -63.89 136.95 55.5 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.836 2.358 . . . . 0.0 112.418 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 18.29 37.2 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.303 -179.894 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.63 179.42 16.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.233 179.886 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.09 -31.4 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.684 0.278 . . . . 0.0 111.384 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.792 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -74.18 -56.57 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.511 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.71 -30.31 65.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.066 -178.992 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 15.6 pt20 -71.96 -31.61 66.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.999 0.428 . . . . 0.0 110.331 179.534 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.38 -57.99 3.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.682 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.4 9.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.62 179.521 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.463 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.3 mtt-85 -114.87 -7.59 12.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.925 179.697 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.994 HD21 HD12 ' A' ' 36' ' ' ILE . 6.1 tp -119.93 155.73 32.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.085 0.469 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.594 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.6 tpt180 -134.05 135.08 43.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.6 t -49.91 157.43 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.368 0.604 . . . . 0.0 111.56 -179.95 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 7.5 t-20 75.0 -0.89 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.118 -179.98 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.78 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -68.15 124.95 24.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 178.851 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.55 100.32 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.649 . . . . 0.0 111.573 -178.386 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 19' ' ' ILE . 10.4 mt -47.86 131.28 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.875 179.865 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 3' ' ' TYR . 57.0 tp -114.3 -35.08 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.499 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -150.51 155.36 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.736 -179.817 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.946 HG11 ' HB1' ' A' ' 76' ' ' ALA . 27.8 t -130.82 96.51 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.974 179.288 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.777 ' CG ' HG23 ' A' ' 84' ' ' VAL . 4.9 t30 67.59 -67.9 0.17 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.173 0.511 . . . . 0.0 109.797 -178.777 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 60' ' ' VAL . 15.7 mt-10 -153.6 31.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.752 179.122 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.8 t -119.8 142.19 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.39 -179.277 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 27.8 t0 -107.96 107.33 17.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.538 179.211 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.24 42.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -65.61 -30.76 71.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.799 179.907 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -154.68 69.03 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.721 ' C ' HG23 ' A' ' 23' ' ' THR . 10.1 m -133.14 144.75 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.075 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.02 152.59 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.726 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.93 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.2 t-160 -48.17 -33.92 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.903 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -33.94 76.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 179.335 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.83 -43.45 79.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.606 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.829 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.85 -45.67 91.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.996 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 70' ' ' HIS . 56.8 t -57.89 -50.31 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.191 178.635 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.691 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.95 -30.36 34.2 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.353 178.882 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.946 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.59 -56.98 6.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.596 -179.587 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -65.19 -40.44 94.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.16 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.659 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -76.82 -20.23 56.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.701 -179.398 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.691 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.8 mm-40 -109.11 -5.49 15.97 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 179.179 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.849 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.21 -22.07 0.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.594 179.957 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.61 -101.62 1.97 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.599 -179.77 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -122.84 -91.45 0.55 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.626 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.792 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.3 tp -90.99 98.98 9.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.089 0.471 . . . . 0.0 110.265 179.108 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.849 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.3 p -113.07 138.18 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -177.792 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.0 ttt180 -86.93 103.86 15.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.143 178.933 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.78 HD13 HD22 ' A' ' 77' ' ' LEU . 16.7 mt -93.59 132.91 37.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.563 -179.253 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -101.99 151.5 22.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.539 179.691 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.78 HG21 ' OD2' ' A' ' 55' ' ' ASP . 18.5 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.343 -179.895 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.461 ' CD1' HD11 ' A' ' 58' ' ' LEU . 8.4 m-30 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.81 0.338 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.53 143.55 48.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.888 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.41 144.87 29.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.053 179.957 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.979 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.16 109.36 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.078 0.466 . . . . 0.0 111.411 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.925 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.26 120.98 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.319 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.979 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -129.71 126.69 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.634 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.567 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -86.66 100.88 12.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.185 179.178 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.65 88.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.211 179.599 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.247 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.608 -179.949 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.974 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.22 19.4 1.55 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.021 -1.085 . . . . 0.0 114.513 178.404 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.858 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.6 p90 -162.09 137.33 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.844 0.822 . . . . 0.0 111.245 179.223 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.47 136.2 38.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.615 -179.426 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.54 156.62 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.736 0.779 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -152.22 132.38 13.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.75 -3.18 1.11 Allowed Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.669 179.639 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.36 178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.918 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 68' ' ' VAL . 29.1 p -65.98 -27.38 68.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.246 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -93.43 -19.95 20.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.672 0.273 . . . . 0.0 111.63 -179.647 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 70' ' ' HIS . 0.5 OUTLIER -124.24 86.86 54.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.392 179.897 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 62.4 0.84 Allowed 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.396 2.064 . . . . 0.0 112.705 -179.409 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.663 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 8.5 t-80 -48.1 -28.87 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.019 178.977 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.863 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.12 -155.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.121 179.277 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.2 -49.44 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.276 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -177.46 51.29 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.911 0.386 . . . . 0.0 111.153 -179.585 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 158.27 70.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 23' ' ' THR . 92.7 Cg_endo -78.53 0.86 9.57 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.677 2.251 . . . . 0.0 112.661 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.9 m -54.31 119.85 5.73 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.958 0.408 . . . . 0.0 111.291 -179.912 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.818 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.43 119.93 34.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 179.824 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.863 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.82 146.67 36.14 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.399 0.618 . . . . 0.0 110.762 178.749 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.054 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.76 155.84 7.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.055 -176.636 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.81 -30.38 4.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.307 -178.624 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.81 129.05 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.174 -179.321 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.91 131.68 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.569 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 113.88 51.11 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.825 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 49.7 Cg_exo -56.21 140.15 87.09 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.739 2.292 . . . . 0.0 112.392 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.82 10.37 64.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.483 -179.898 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.87 178.34 18.3 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.874 179.808 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.85 -35.38 66.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.796 0.331 . . . . 0.0 111.067 -179.995 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.756 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.87 -57.56 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.55 -28.73 67.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -71.88 -31.68 66.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.239 179.521 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 -57.78 3.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.96 35.77 14.87 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.439 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.3 mtt-85 -115.32 -2.06 12.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 111.227 179.874 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.054 HD21 HD12 ' A' ' 36' ' ' ILE . 5.9 tp -127.2 154.61 44.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.158 0.504 . . . . 0.0 111.34 179.98 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.71 135.29 43.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.543 179.93 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.47 157.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.496 179.934 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.8 0.43 3.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 -179.865 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.529 ' HB3' HG11 ' A' ' 88' ' ' VAL . 4.8 m-20 -69.67 126.08 28.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.931 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.2 p -86.49 100.39 12.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.467 0.651 . . . . 0.0 111.673 -178.322 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.033 HD11 HG21 ' A' ' 19' ' ' ILE . 61.7 mt -48.72 146.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.077 -179.961 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.461 HD11 ' CD1' ' A' ' 3' ' ' TYR . 12.4 mt -128.25 -38.96 1.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.424 179.615 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -145.72 155.31 42.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.899 -179.758 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.921 HG11 ' HB1' ' A' ' 76' ' ' ALA . 42.1 t -136.42 100.55 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.409 ' HB2' HG23 ' A' ' 84' ' ' VAL . 38.5 t30 67.53 -67.04 0.19 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.958 0.408 . . . . 0.0 110.046 -179.14 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.3 mt-10 -157.29 32.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.751 179.289 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -120.72 142.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.539 -179.23 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.3 t0 -106.04 107.93 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.293 179.208 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG12 HG21 ' A' ' 68' ' ' VAL . 21.8 m -93.81 35.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.522 -179.623 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.48 -37.25 80.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 110.78 179.974 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.42 54.59 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -179.897 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 23' ' ' THR . 32.9 m -116.12 148.95 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.896 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.439 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -64.8 154.69 36.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.033 -179.378 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.919 ' O ' HG23 ' A' ' 74' ' ' VAL . 19.1 t-160 -50.57 -33.94 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -34.03 75.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.133 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.62 -41.76 79.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 109.266 178.522 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.818 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.8 -46.12 83.37 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.1 t -57.4 -50.51 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.029 178.564 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -51.58 -34.16 35.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.694 179.417 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.921 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.81 -57.59 5.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.248 -179.508 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.929 HD12 HD12 ' A' ' 19' ' ' ILE . 2.1 mt -60.53 -40.85 93.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.244 -179.772 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.597 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.78 -20.06 56.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.768 179.669 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 4.1 pt-20 -112.24 22.3 14.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 111.24 179.579 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.926 ' HB1' ' HB ' ' A' ' 84' ' ' VAL . . . -83.19 16.64 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.829 -179.729 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.91 -85.59 0.21 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.83 -179.783 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 40.3 m -142.3 -89.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.925 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -86.37 105.64 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.869 0.366 . . . . 0.0 110.662 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.926 ' HB ' ' HB1' ' A' ' 80' ' ' ALA . 5.0 p -120.89 136.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.392 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.7 mtm105 -85.79 103.39 14.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.373 178.17 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.783 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.1 mt -93.98 134.8 35.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.394 -178.822 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.84 142.58 32.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.89 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 55' ' ' ASP . 24.9 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.951 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CD1' HD11 ' A' ' 58' ' ' LEU . 15.9 m-30 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -134.77 165.87 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.98 144.78 43.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 -179.837 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.089 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.83 109.51 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.402 179.876 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.41 119.68 21.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.65 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.089 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -130.75 128.08 40.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.403 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 4.6 pt-20 -86.71 100.21 12.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.354 179.685 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -42.87 90.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.364 179.496 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.419 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.638 179.77 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 1.008 ' HB3' HD23 ' A' ' 8' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 129.42 33.02 0.54 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.515 179.458 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.815 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.86 137.41 12.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.977 0.389 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.88 136.71 37.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.302 -179.499 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.081 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.56 146.6 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.703 0.763 . . . . 0.0 112.264 -179.935 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.18 133.61 31.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.241 179.338 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.7 3.84 0.79 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.696 179.577 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.69 -169.26 0.5 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.902 -179.917 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.831 HG22 ' HB3' ' A' ' 32' ' ' PRO . 43.0 p -72.39 -27.86 62.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.104 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -93.75 -22.0 18.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.047 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 11.5 t-20 -124.39 87.52 53.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.579 0.228 . . . . 0.0 110.485 -179.991 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 62.51 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.271 1.981 . . . . 0.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.62 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.2 t-80 -47.16 -28.24 1.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.396 179.049 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.822 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.54 -154.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.362 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.5 -49.96 72.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.53 -179.697 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.03 40.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.6 164.06 36.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.831 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.9 Cg_exo -74.81 1.77 7.26 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.0 112.776 -179.88 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -52.75 113.43 1.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.978 0.418 . . . . 0.0 111.07 -179.814 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.43 117.85 30.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.999 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.822 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.13 147.46 40.23 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.276 0.56 . . . . 0.0 110.644 178.673 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.079 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.06 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.042 -176.771 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.43 -30.1 4.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.321 -178.846 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.648 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.09 130.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.065 -179.447 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.028 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.96 130.53 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.636 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.493 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 123.84 74.61 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.752 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.1 Cg_endo -66.14 132.0 28.53 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.798 2.332 . . . . 0.0 112.256 -179.879 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.66 16.74 23.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.331 -179.916 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.46 178.69 16.82 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.985 179.862 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.15 -38.78 63.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.803 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.44 -57.49 8.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.892 -179.502 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.83 -28.85 63.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -179.434 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -72.12 -34.15 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.543 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.12 -58.04 3.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.687 -179.936 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 38.08 13.93 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.624 179.452 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.513 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.9 mmt180 -117.9 7.05 12.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.776 0.322 . . . . 0.0 110.842 179.686 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.079 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -133.22 154.53 50.57 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 110.835 179.585 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.19 135.47 45.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.957 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.61 157.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 111.751 179.965 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.45 -0.55 3.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.27 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.67 126.37 29.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.035 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.57 103.31 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 111.316 -178.812 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.081 HD11 HG21 ' A' ' 19' ' ' ILE . 67.0 mt -51.21 134.21 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.723 -179.999 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' A' ' 3' ' ' TYR . 2.2 mt -116.19 -28.11 6.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.662 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -153.77 165.99 34.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.667 HG11 ' HB1' ' A' ' 76' ' ' ALA . 40.9 t -148.18 98.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.018 179.464 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' HG23 ' A' ' 84' ' ' VAL . 13.4 t30 67.79 -67.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 -178.844 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.48 32.47 0.27 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.621 179.218 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.2 t -119.34 142.24 35.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.597 -179.293 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.7 p-10 -111.19 88.04 2.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.331 179.258 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 65' ' ' VAL . 29.5 m -69.99 63.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.563 -179.522 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 66' ' ' ARG . 4.0 ptm85 -86.93 -32.77 19.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.688 179.643 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -145.47 59.02 1.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.8 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 23' ' ' THR . 35.9 m -124.55 147.72 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.46 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.36 154.65 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 -179.464 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 p-80 -48.59 -34.32 11.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.137 -179.573 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -33.69 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.67 -45.44 82.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.9 -46.77 89.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 178.069 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.3 t -57.6 -48.22 83.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.664 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.94 -33.07 68.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.583 178.717 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.55 -50.12 74.14 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.286 0.565 . . . . 0.0 109.817 179.317 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.04 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.99 -36.61 70.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.449 178.868 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.8 mmmt -77.15 -24.72 51.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.97 -12.9 27.73 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.067 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.914 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -56.74 -19.29 16.09 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 179.721 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.19 -108.18 3.39 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.034 -179.881 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.88 -90.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.03 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.838 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.2 tp -89.63 91.54 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.388 0.613 . . . . 0.0 109.674 178.719 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.914 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -105.81 139.88 25.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.357 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.64 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -87.45 103.18 15.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.647 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.4 mt -91.36 139.82 30.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.17 -178.985 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.77 134.1 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.618 179.893 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.48 HG11 HD11 ' A' ' 51' ' ' LEU . 22.1 m . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.188 179.846 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.839 ' CD1' HD22 ' A' ' 58' ' ' LEU . 21.1 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.934 0.397 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -105.01 170.75 7.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.722 179.647 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -131.83 144.77 51.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.91 111.07 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.909 0.385 . . . . 0.0 111.909 179.912 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.75 117.87 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.475 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -127.26 127.22 44.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.255 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.34 100.08 11.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.522 179.432 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.37 87.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.181 179.258 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.518 0.249 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.605 -179.825 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.951 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.7 tp . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.76 25.21 1.03 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 119.789 -1.196 . . . . 0.0 114.801 178.409 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.788 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -162.97 135.19 5.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.873 0.836 . . . . 0.0 111.066 178.887 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.87 137.89 33.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.506 -179.242 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.1 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.8 146.24 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 112.404 179.929 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.613 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.32 133.82 33.48 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.174 179.348 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.62 3.87 0.8 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.643 179.585 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.516 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.65 -168.85 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.893 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.834 HG22 ' HB3' ' A' ' 32' ' ' PRO . 41.5 p -72.14 -29.41 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.193 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.06 -20.76 20.22 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.162 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 35.7 t-20 -124.42 87.57 53.99 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.496 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.81 61.91 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.283 1.989 . . . . 0.0 112.388 -179.768 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.613 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.8 t-80 -47.16 -28.45 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.185 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.81 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.0 -154.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.183 179.386 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -57.7 -50.01 69.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.57 -179.815 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 171.87 40.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.36 166.69 21.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.834 ' HB3' HG22 ' A' ' 23' ' ' THR . 4.9 Cg_exo -75.04 2.33 6.77 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.037 2.491 . . . . 0.0 112.733 -179.734 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.24 111.67 0.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.842 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.16 118.27 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.675 179.987 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.81 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.77 147.91 39.84 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.303 0.573 . . . . 0.0 110.725 178.629 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.029 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.09 155.61 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.986 -176.829 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.446 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.58 -30.78 4.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.039 -178.98 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.625 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.47 132.29 0.6 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -179.53 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.995 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.56 132.26 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.739 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.25 130.12 55.48 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.486 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 50.9 Cg_endo -69.14 129.97 19.24 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 -179.996 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 2.08 55.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.495 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.65 174.37 21.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.751 179.676 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.7 -35.34 55.36 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.649 -0.324 . . . . 0.0 111.11 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.795 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -70.85 -57.39 4.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.601 -179.799 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.468 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.47 -29.07 68.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -72.19 -35.38 68.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.048 0.451 . . . . 0.0 109.969 179.346 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -84.69 -57.94 2.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.614 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.22 41.38 9.37 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.556 179.625 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.7 mtp85 -112.05 8.88 20.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.029 HD21 HD12 ' A' ' 36' ' ' ILE . 4.9 tp -136.16 154.06 51.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.687 179.641 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.99 135.21 48.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.824 179.869 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.47 157.82 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.31 0.576 . . . . 0.0 111.595 -180.0 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.6 t-20 77.33 -2.96 2.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.473 179.866 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.17 125.12 24.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.085 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.61 100.25 12.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.503 0.668 . . . . 0.0 111.504 -178.579 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.1 HD11 HG21 ' A' ' 19' ' ' ILE . 59.0 mt -49.97 134.92 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.433 179.507 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.839 HD22 ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -133.69 12.08 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.614 179.367 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 170.83 141.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.962 -179.894 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.865 HG13 ' CD2' ' A' ' 86' ' ' LEU . 25.3 t -131.56 99.7 4.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.879 179.274 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 84' ' ' VAL . 17.3 t30 69.76 -65.0 0.33 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 109.848 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -161.57 31.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.927 179.407 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.6 t -120.82 124.86 73.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.55 -179.337 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 21.0 p-10 -93.04 100.07 12.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.577 179.113 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 65' ' ' VAL . 33.7 m -80.69 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -179.755 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -29.25 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -148.88 60.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.753 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -126.5 146.43 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.991 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.481 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.76 153.94 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 111.076 -179.353 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.871 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 p-80 -48.34 -34.08 10.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.983 -179.515 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -33.83 69.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.181 179.757 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.68 -45.22 83.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 109.765 179.093 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.842 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.83 -46.69 88.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.536 0.684 . . . . 0.0 109.35 178.177 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.6 t -57.55 -48.06 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.369 178.586 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.62 -32.88 67.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.624 178.602 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -57.63 -50.39 73.31 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.837 179.241 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.005 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -56.61 -37.26 70.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.555 178.891 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -77.56 -26.06 50.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.395 179.327 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -92.84 -12.4 31.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.061 -178.843 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.926 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.17 -20.17 9.73 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.268 179.763 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -95.34 1.35 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.12 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 39.5 m -134.61 -92.17 0.32 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.096 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.763 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -85.72 89.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.28 0.562 . . . . 0.0 109.676 178.591 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.926 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.7 p -105.91 136.47 40.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.457 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 ttp180 -88.2 102.8 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.747 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.865 ' CD2' HG13 ' A' ' 60' ' ' VAL . 20.2 mt -90.59 136.24 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.813 -179.15 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' HD1' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.86 120.13 39.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.782 -179.889 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG21 ' CG ' ' A' ' 55' ' ' ASP . 29.3 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.829 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 5.2 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.791 0.329 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -146.7 154.0 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -105.31 144.78 31.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.972 -179.934 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.25 109.97 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 111.623 179.819 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.88 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 119.11 20.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.75 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -129.73 127.15 39.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.164 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.8 pt-20 -83.55 100.83 11.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.855 179.524 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.01 89.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.102 178.657 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.41 -179.115 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.935 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 102.78 19.3 13.5 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.422 -0.894 . . . . 0.0 114.808 177.912 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.826 ' HB3' HG23 ' A' ' 39' ' ' ILE . 3.7 p90 -155.23 135.76 13.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.912 0.856 . . . . 0.0 110.89 179.126 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.68 135.98 37.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.404 -179.421 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.036 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.46 146.12 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.603 0.716 . . . . 0.0 111.928 179.79 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -124.81 118.65 26.85 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.51 177.988 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 146.08 165.61 11.56 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.575 -179.006 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 32' ' ' PRO . . . 140.93 173.53 13.57 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.244 -179.691 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.752 HG23 ' C ' ' A' ' 68' ' ' VAL . 18.4 p -67.14 -17.79 65.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.366 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -106.39 -27.28 11.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.686 0.279 . . . . 0.0 111.417 -179.67 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -124.32 87.0 54.29 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 42.7 Cg_endo -67.9 64.39 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.362 2.041 . . . . 0.0 112.607 -179.653 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.585 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 10.8 t-80 -47.72 -28.92 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.525 179.207 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.945 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.65 -152.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.687 179.776 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.683 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.84 52.53 4.61 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.87 -178.761 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HA ' ' HB2' ' A' ' 26' ' ' PRO . 1.8 t0 76.59 44.9 0.11 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.494 179.575 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -137.14 157.31 74.68 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -179.941 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 23' ' ' THR . 7.8 Cg_exo -72.12 -2.2 11.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.699 2.266 . . . . 0.0 112.508 179.823 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.47 112.6 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.006 0.432 . . . . 0.0 111.561 -179.654 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.832 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.71 119.89 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.757 179.219 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.945 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.14 147.9 37.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.485 0.659 . . . . 0.0 110.844 179.369 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.045 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.32 156.04 7.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.565 -177.319 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.67 -28.78 4.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.134 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.25 129.14 0.36 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.17 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.987 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -93.3 125.02 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.79 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 132.73 46.59 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.783 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_exo -64.37 70.05 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.492 2.128 . . . . 0.0 110.887 178.9 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -104.82 -25.5 6.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.888 -179.076 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . 121.65 -30.59 5.29 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.397 -179.87 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -77.69 -70.32 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.152 179.707 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.844 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -75.92 -45.63 34.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.368 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.49 -42.22 95.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.741 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.781 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -72.15 -33.31 67.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -57.11 -58.36 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.08 0.467 . . . . 0.0 111.028 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.84 25.83 63.87 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.534 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtm-85 -108.11 -23.34 12.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.895 0.379 . . . . 0.0 110.303 179.553 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.045 HD21 HD12 ' A' ' 36' ' ' ILE . 6.3 tp -104.17 154.24 19.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.428 179.005 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.578 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 ttp85 -134.85 135.7 41.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -49.04 157.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.308 0.575 . . . . 0.0 111.539 179.994 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 73.32 3.03 4.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.084 -179.746 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -71.61 125.86 28.19 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.958 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.68 101.39 13.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.608 0.718 . . . . 0.0 111.74 -178.408 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.992 HD11 HG21 ' A' ' 19' ' ' ILE . 12.4 mt -49.33 131.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.923 179.84 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -114.74 -35.03 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.073 179.281 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -148.8 167.53 25.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.833 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 86' ' ' LEU . 41.1 t -147.74 98.43 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.034 179.471 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.804 ' OD1' HG23 ' A' ' 84' ' ' VAL . 5.5 t30 68.62 -66.61 0.23 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.071 0.462 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.16 32.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.741 179.312 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 62.1 t -120.88 142.21 37.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.523 -179.33 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -104.16 110.2 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.328 179.103 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.642 HG21 HG22 ' A' ' 57' ' ' ILE . 14.6 m -91.52 19.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.773 -179.523 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -59.55 -28.25 66.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.7 56.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.752 ' C ' HG23 ' A' ' 23' ' ' THR . 18.4 m -125.7 143.12 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 69' ' ' THR . 0.0 OUTLIER -62.32 151.74 35.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.692 -179.833 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.607 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -47.88 -34.32 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.658 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -71.45 -33.88 69.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.932 179.521 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.662 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.58 -40.47 84.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.93 -46.96 82.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.644 0.735 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.628 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 73.5 t -58.67 -50.66 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.198 178.676 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.35 -31.08 63.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.68 -50.45 73.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.367 0.603 . . . . 0.0 109.91 179.643 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -59.23 -36.83 76.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.084 179.291 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.61 -25.38 49.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.631 179.595 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -101.4 13.96 33.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.736 0.303 . . . . 0.0 111.647 -178.344 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.32 11.78 9.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.66 -90.16 0.85 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 179.735 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 10.1 p -144.63 -90.22 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.88 HG13 HG22 ' A' ' 7' ' ' THR . 9.1 tp -84.08 90.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.191 0.52 . . . . 0.0 109.714 178.67 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.913 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -107.54 139.3 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.361 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.546 ' CG ' HG23 ' A' ' 7' ' ' THR . 10.1 mtp180 -86.92 103.12 15.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.742 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.9 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.5 mt -92.95 138.28 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 -178.788 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -101.84 136.44 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.647 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.8 m . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.521 -179.89 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.442 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 29.2 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.811 0.338 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.45 146.85 40.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.946 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -103.28 144.38 31.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.966 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.984 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.36 109.13 8.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.924 0.392 . . . . 0.0 111.6 179.882 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.838 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.25 113.65 16.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.93 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.99 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.7 tp -124.87 126.94 46.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.9 pt-20 -85.82 100.77 12.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.073 179.29 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -46.97 89.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.323 179.893 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.456 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.639 -179.93 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.99 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.3 tp . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.361 0.124 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.51 25.82 1.12 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.422 178.437 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.5 p90 -164.8 131.68 3.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.565 0.682 . . . . 0.0 110.849 178.86 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -91.67 138.36 31.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.653 -179.006 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.938 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -121.78 142.29 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 121.711 0.767 . . . . 0.0 112.222 179.78 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -105.64 117.85 35.09 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.695 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.795 ' HA2' HG23 ' A' ' 34' ' ' ILE . . . -73.21 -159.27 5.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -176.258 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.68 -42.93 0.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.783 -0.709 . . . . 0.0 114.15 -177.935 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.67 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -73.1 -54.06 9.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.039 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.492 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -81.25 -43.58 18.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.071 0.462 . . . . 0.0 111.004 -179.621 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.4 OUTLIER -124.83 83.45 59.41 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.479 179.462 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.95 69.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.638 2.225 . . . . 0.0 112.378 -179.104 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.72 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 4.2 t-80 -58.23 -18.24 24.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.254 179.31 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.824 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.26 -154.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.409 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.674 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -63.35 -49.5 69.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.57 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 167.98 41.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 179.995 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.22 155.6 75.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.403 ' CB ' HG22 ' A' ' 23' ' ' THR . 73.9 Cg_endo -75.64 55.76 4.39 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.941 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -117.12 107.12 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 179.697 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.961 HD11 ' O ' ' A' ' 68' ' ' VAL . 3.1 mt -79.01 130.63 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.994 -179.632 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.824 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.98 152.53 42.07 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.214 0.531 . . . . 0.0 110.389 179.495 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.03 HD12 HD21 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -69.42 155.57 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.489 -177.096 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.09 -28.43 4.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.974 -179.27 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.86 130.6 0.41 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.943 -179.625 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.995 HD11 HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -95.33 132.58 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.557 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 114.77 56.74 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.651 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 47.9 Cg_exo -56.36 137.79 81.43 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.733 2.289 . . . . 0.0 112.201 179.913 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.91 66.35 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.67 -179.994 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.98 -178.13 22.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -59.48 -33.55 71.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -179.955 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -72.95 -56.92 4.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.781 -179.885 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.45 -31.1 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.855 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 13.7 pt20 -72.15 -32.51 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.035 0.445 . . . . 0.0 110.138 179.615 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' OD2' HD12 ' A' ' 8' ' ' LEU . 11.9 m-20 -80.75 -57.96 3.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.553 179.94 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.54 9.3 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.715 179.564 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.6 mtt180 -114.96 7.46 15.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 179.544 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.03 HD21 HD12 ' A' ' 36' ' ' ILE . 5.9 tp -136.42 154.31 50.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.107 0.479 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.35 135.22 46.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.614 179.833 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 38' ' ' LYS . 60.6 t -49.06 157.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 0.0 111.815 -179.878 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.3 t30 78.22 -5.32 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.469 179.972 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -64.03 127.93 33.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.169 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.89 105.2 16.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -178.846 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.067 HG22 HG21 ' A' ' 65' ' ' VAL . 64.1 mt -48.92 134.87 6.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.522 179.792 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' C ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -120.17 -43.49 2.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.444 179.865 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -144.55 158.65 43.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.903 -179.893 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.889 HG13 HD21 ' A' ' 86' ' ' LEU . 60.3 t -140.03 98.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.894 ' OD1' HG23 ' A' ' 84' ' ' VAL . 2.1 t30 67.74 -67.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.46 . . . . 0.0 110.22 -178.973 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -155.12 31.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.927 179.361 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.4 t -120.81 142.39 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.403 -179.312 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.4 p-10 -103.28 108.84 20.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.473 179.402 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.067 HG21 HG22 ' A' ' 57' ' ' ILE . 29.2 m -97.32 29.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -38.01 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.413 . . . . 0.0 110.683 179.762 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -144.23 57.91 1.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.786 179.803 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.961 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -121.19 140.05 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.341 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 2.5 p -52.2 150.92 4.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.011 -178.425 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.83 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.9 t-160 -47.07 -33.36 4.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.368 179.552 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -71.54 -33.76 69.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 179.713 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.652 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.38 -31.7 67.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 109.753 178.827 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.924 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.44 -46.91 58.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.537 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.6 t -60.87 -50.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.728 178.735 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.8 pt-20 -57.45 -29.56 64.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.66 178.543 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.821 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -60.59 -51.4 69.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.795 179.456 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.861 ' CD1' HD12 ' A' ' 19' ' ' ILE . 1.2 mt -58.2 -35.12 71.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.178 179.191 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.15 -31.75 55.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.859 179.912 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.0 pt-20 -96.07 17.22 16.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.527 -178.523 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.916 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.54 16.34 7.88 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.323 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.01 -103.51 1.01 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.509 179.858 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -127.15 -89.41 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.466 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.838 HG13 HG22 ' A' ' 7' ' ' THR . 7.4 tp -84.68 94.73 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 109.878 178.909 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.916 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -111.06 136.43 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.444 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 10.4 ptt85 -85.58 102.87 13.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.889 HD21 HG13 ' A' ' 60' ' ' VAL . 15.9 mt -92.09 139.72 30.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.549 -178.499 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.64 135.47 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.963 179.39 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.594 HG11 HD11 ' A' ' 51' ' ' LEU . 6.6 m . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.758 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.77 137.74 46.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.727 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.437 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.0 m-30 -94.48 119.1 32.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -117.12 161.93 18.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.2 tt0 -115.92 144.63 43.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.085 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.84 111.69 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.773 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.5 115.63 20.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.085 HD13 HD11 ' A' ' 6' ' ' ILE . 4.8 tp -126.05 127.11 45.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -85.5 100.66 12.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.054 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.35 89.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.188 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.09 176.02 0.07 OUTLIER Glycine 0 C--N 1.321 -0.287 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.496 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -54.87 -24.05 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.739 0.305 . . . . 0.0 111.115 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -97.36 -24.82 15.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.2 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.86 -163.53 28.28 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.196 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.992 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp -66.12 -63.6 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.68 0.24 . . . . 0.0 110.81 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.55 22.35 0.96 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 119.725 -1.226 . . . . 0.0 114.97 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.6 p90 -161.59 135.35 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.063 0.932 . . . . 0.0 111.224 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.495 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.55 135.47 34.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.98 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.16 147.7 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.541 0.686 . . . . 0.0 111.568 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.637 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.64 119.72 27.73 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.43 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 143.66 159.3 7.93 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.551 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 145.09 173.64 16.56 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.384 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 68' ' ' VAL . 24.3 p -63.67 -14.44 52.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.79 -25.79 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -124.25 86.77 54.29 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.486 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 64.13 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.306 2.004 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.58 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 10.8 t-80 -49.05 -27.16 3.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.527 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.45 -152.29 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.693 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.79 52.65 4.62 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.941 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 76.54 43.36 0.14 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 158.78 74.15 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.929 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 72.9 Cg_endo -76.19 0.33 9.49 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.507 2.138 . . . . 0.0 112.569 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.1 114.92 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.23 119.62 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.984 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.41 147.65 36.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.119 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.34 155.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.655 -177.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.0 -32.86 4.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.753 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.33 142.11 2.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 111.424 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.51 133.35 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 122.69 76.2 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.4 Cg_endo -64.63 132.18 32.12 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.23 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.96 5.31 56.47 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.412 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.07 179.17 21.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.804 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.66 -39.08 70.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 111.121 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.825 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -66.4 -57.4 7.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.466 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.8 -28.82 67.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.382 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -72.25 -34.61 68.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.069 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.72 -57.97 3.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.16 41.23 9.53 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.474 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.4 mmp_? -113.14 -4.72 13.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.773 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.119 HD21 HD12 ' A' ' 36' ' ' ILE . 5.0 tp -121.44 153.66 37.58 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.019 0.438 . . . . 0.0 110.822 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.12 135.28 48.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.689 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.14 157.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 111.758 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.47 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 t30 75.41 0.99 3.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.17 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -68.55 125.18 25.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 102.23 13.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.625 . . . . 0.0 111.602 -178.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.98 HD11 HG21 ' A' ' 19' ' ' ILE . 16.4 mt -49.8 124.94 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.866 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.82 HD21 ' CG ' ' A' ' 89' ' ' MET . 3.6 mt -109.76 -34.14 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.972 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.8 m-85 -150.27 161.22 42.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 76' ' ' ALA . 6.9 p -148.7 103.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.626 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 70.42 -66.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.289 0.566 . . . . 0.0 109.907 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.39 29.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' HG13 ' A' ' 60' ' ' VAL . 1.4 t -121.01 142.0 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.492 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.0 p-10 -101.07 111.45 23.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.859 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.689 HG21 HG22 ' A' ' 57' ' ' ILE . 21.3 m -89.68 24.1 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -67.85 -22.13 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 110.734 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -145.97 44.62 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 23' ' ' THR . 19.0 m -117.87 148.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.459 HG22 ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -67.52 151.99 46.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.54 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.798 ' O ' HG23 ' A' ' 74' ' ' VAL . 9.8 t-160 -49.55 -34.1 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.533 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 20.0 m -71.76 -33.66 68.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.495 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.49 -39.72 81.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -64.32 -46.88 81.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.616 0.722 . . . . 0.0 109.226 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.7 t -59.97 -50.63 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.333 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 2.2 pt-20 -57.75 -35.12 70.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.637 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -55.33 -51.92 65.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.269 0.557 . . . . 0.0 110.228 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 19' ' ' ILE . 6.2 mt -56.42 -36.64 69.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.533 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.32 -25.67 51.42 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.478 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.3 mt-10 -96.6 -6.96 35.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.294 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.921 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.62 -17.74 16.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.147 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.54 -100.74 2.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.9 m -130.45 -91.31 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 7' ' ' THR . 5.4 tp -87.03 86.27 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.254 0.55 . . . . 0.0 109.559 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.921 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.6 p -101.29 138.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HG2' HG23 ' A' ' 7' ' ' THR . 2.5 mtt180 -88.68 103.2 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.041 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.907 ' CD2' HG23 ' A' ' 60' ' ' VAL . 12.3 mt -92.6 138.04 31.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.722 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 133.53 46.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.7 m -139.72 167.9 18.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.144 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.82 ' CG ' HD21 ' A' ' 58' ' ' LEU . 92.7 mtp -103.18 151.18 22.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.701 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -140.54 115.72 9.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.022 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.761 0.315 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -99.95 112.6 24.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.8 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-30 -82.19 129.29 34.8 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.663 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -139.83 160.2 40.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.2 mt-10 -117.08 144.9 44.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.835 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.074 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.82 111.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.886 0.374 . . . . 0.0 111.73 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.806 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.42 115.6 20.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.074 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -126.09 127.08 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.25 100.4 11.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.126 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.78 88.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.067 179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.41 176.07 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.628 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -55.21 -23.81 24.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.776 0.322 . . . . 0.0 111.058 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -96.8 -24.87 15.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.47 -162.89 28.24 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.23 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp -67.89 -63.49 1.05 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.174 -0.211 . . . . 0.0 110.725 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.65 21.01 1.05 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.716 -1.23 . . . . 0.0 114.754 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.5 p90 -161.62 135.6 6.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.999 0.9 . . . . 0.0 111.12 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.47 138.55 32.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.455 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.096 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.14 146.5 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.691 0.757 . . . . 0.0 112.228 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.43 134.59 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.198 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.3 -5.32 1.4 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.573 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.57 -175.36 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.113 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 68' ' ' VAL . 16.1 p -71.43 -19.23 62.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.62 -24.91 15.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.591 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 2.2 t30 -124.41 87.91 53.66 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.099 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.96 63.07 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.463 2.109 . . . . 0.0 112.631 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.596 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 14.4 t-80 -50.59 -25.74 4.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.165 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.774 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.73 -151.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.513 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.56 49.75 4.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.843 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 76.88 45.38 0.09 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.03 153.75 78.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.636 ' CB ' HG22 ' A' ' 23' ' ' THR . 74.2 Cg_endo -75.39 -0.17 9.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.468 2.112 . . . . 0.0 112.657 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.87 115.24 1.9 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.943 0.402 . . . . 0.0 110.495 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.08 119.8 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.092 -179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.774 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.05 147.41 36.78 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.348 0.594 . . . . 0.0 110.461 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.014 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.14 155.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.059 -176.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.05 -31.83 4.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.986 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.41 134.24 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.042 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.986 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.52 132.93 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.26 123.84 74.65 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 36.9 Cg_endo -65.18 132.68 32.56 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 112.289 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.2 5.5 57.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.48 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.84 178.56 20.93 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.928 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.65 -37.72 68.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.757 0.313 . . . . 0.0 111.179 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.819 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -67.78 -57.51 6.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.417 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.53 -28.87 68.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -72.13 -34.52 68.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.063 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.5 -58.07 2.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.6 41.02 9.25 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.481 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.514 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mtm180 -113.8 6.24 16.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.014 HD21 HD12 ' A' ' 36' ' ' ILE . 5.6 tp -132.8 154.6 50.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.071 0.462 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.606 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -130.86 136.1 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -51.74 157.78 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.315 0.578 . . . . 0.0 111.663 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.6 -2.01 2.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.352 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.652 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.4 m-20 -67.82 126.34 29.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.65 104.14 15.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.489 0.661 . . . . 0.0 111.259 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.096 HD11 HG21 ' A' ' 19' ' ' ILE . 67.8 mt -52.71 133.84 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.96 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.881 HD11 ' HB3' ' A' ' 89' ' ' MET . 14.2 mt -116.62 -28.56 6.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.661 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -156.29 149.54 24.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.826 HG13 ' CD2' ' A' ' 86' ' ' LEU . 39.8 t -139.44 105.94 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.168 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 t30 55.04 38.68 30.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 110.108 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 78.86 33.43 0.25 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.475 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 60' ' ' VAL . 92.7 t -120.99 107.82 21.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.596 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.5 t0 -74.01 111.6 9.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.744 0.307 . . . . 0.0 110.564 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 35.0 m -96.56 29.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -59.86 -22.71 62.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -150.8 76.27 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 111.106 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 23' ' ' THR . 35.4 m -149.81 145.75 17.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.19 155.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.212 0.529 . . . . 0.0 111.154 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.6 p-80 -50.89 -33.7 25.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.886 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.5 t -72.14 -33.96 68.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.686 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.32 -40.8 90.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.196 0.522 . . . . 0.0 109.874 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.48 -46.85 78.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.668 0.747 . . . . 0.0 109.168 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.2 t -56.9 -50.27 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.255 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.92 -29.24 59.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.917 178.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.619 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -62.32 -51.9 65.81 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 109.81 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.025 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.03 -37.52 66.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.558 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -27.41 52.13 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.244 179.225 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.28 14.72 25.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.313 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.924 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.77 16.42 4.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.517 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.27 -92.0 0.56 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.276 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.6 m -142.19 -90.25 0.14 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.806 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -84.67 90.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.283 0.563 . . . . 0.0 109.723 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.924 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -105.82 138.11 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.4 ttt180 -88.29 102.87 15.27 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.826 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.4 mt -91.45 138.49 31.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.239 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.65 134.51 44.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.652 HG21 ' OD2' ' A' ' 55' ' ' ASP . 6.2 m -139.74 166.47 20.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.881 ' HB3' HD11 ' A' ' 58' ' ' LEU . 2.4 ptt? -137.07 138.57 40.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 111.159 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.89 120.69 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.024 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.813 0.34 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -98.67 114.14 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-85 -91.4 115.02 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.693 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 8.6 mt-10 -118.84 153.01 35.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.15 144.91 31.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.481 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.028 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.19 110.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.443 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.821 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.73 117.61 20.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.028 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -127.6 127.0 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.4 pt-20 -83.96 100.45 11.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.296 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -51.4 88.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.03 175.41 0.14 Allowed Glycine 0 C--N 1.322 -0.23 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.586 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -54.44 -24.45 20.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 111.066 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -96.24 -24.75 16.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.36 -163.67 28.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.156 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.986 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.5 tp -66.55 -63.52 1.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.789 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.81 21.28 1.01 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.707 -1.235 . . . . 0.0 114.614 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.86 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.3 p90 -161.31 134.7 6.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.874 0.837 . . . . 0.0 110.981 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.32 135.43 34.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.566 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.88 146.07 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.593 0.711 . . . . 0.0 111.385 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -125.34 122.69 37.55 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.457 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 140.01 157.77 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.787 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.71 176.09 22.55 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 68' ' ' VAL . 17.4 p -66.54 -18.37 65.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -107.06 -27.26 10.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.69 0.281 . . . . 0.0 111.635 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.42 87.38 54.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.494 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.27 64.53 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.405 2.07 . . . . 0.0 112.545 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.545 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 11.2 t-80 -46.23 -29.76 1.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.545 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.979 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -83.13 -155.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.412 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.675 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.31 -52.63 51.5 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.698 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 4.1 p-10 -179.34 42.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.615 0.245 . . . . 0.0 111.322 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.47 174.08 5.13 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.992 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 88.6 Cg_endo -81.4 10.78 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.658 2.239 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 112.1 1.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.079 0.466 . . . . 0.0 111.316 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.872 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.11 119.87 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.9 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.979 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.63 149.75 39.35 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.38 0.61 . . . . 0.0 110.897 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.066 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.41 155.72 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.436 -177.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.72 -32.25 4.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.609 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 141.23 2.0 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.91 0.386 . . . . 0.0 111.337 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.959 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.38 132.98 48.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.0 124.59 74.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.2 Cg_endo -65.63 132.58 31.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.769 2.312 . . . . 0.0 112.1 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.51 5.15 56.98 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.473 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.86 176.1 19.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.797 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.43 -37.11 62.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 111.295 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.85 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.11 -57.41 6.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.527 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.31 -29.07 67.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.345 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -72.06 -36.08 69.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 109.979 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.35 -57.9 3.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.91 41.5 9.57 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.466 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 6' ' ' ILE . 74.7 mtp180 -113.2 8.23 18.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.848 0.356 . . . . 0.0 110.644 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.066 HD21 HD12 ' A' ' 36' ' ' ILE . 5.8 tp -133.48 155.48 49.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.77 134.89 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.619 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -49.08 157.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.627 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.03 -2.31 2.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.203 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -64.86 124.05 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.58 100.06 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.567 0.698 . . . . 0.0 111.867 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 19' ' ' ILE . 35.2 mt -47.82 126.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.616 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -122.08 -5.72 8.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.585 179.161 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -171.61 143.9 1.8 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.977 0.418 . . . . 0.0 110.728 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.876 HG13 ' CD2' ' A' ' 86' ' ' LEU . 25.3 t -141.97 109.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 84' ' ' VAL . 7.3 t30 52.85 38.59 27.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.161 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 78.73 32.29 0.3 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 60' ' ' VAL . 59.1 t -120.92 103.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.6 p-10 -66.68 113.43 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.532 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 57' ' ' ILE . 25.8 m -92.51 18.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.497 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -65.47 -21.29 66.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.981 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.56 45.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 23' ' ' THR . 17.2 m -127.35 142.74 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.059 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 153.47 31.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.011 0.434 . . . . 0.0 110.62 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.615 ' O ' HG23 ' A' ' 74' ' ' VAL . 8.0 t-160 -49.33 -33.88 14.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.591 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -33.7 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.834 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.872 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -71.42 -46.9 58.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.621 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 78.6 t -60.08 -50.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.334 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.668 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 9.2 pt-20 -57.9 -30.22 65.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.629 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.68 -51.12 71.15 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.329 0.585 . . . . 0.0 109.861 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.936 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -57.46 -37.55 73.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.891 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.28 -27.51 53.13 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.603 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 5.8 pt-20 -101.06 18.03 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.309 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.927 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.15 16.33 4.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.408 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.33 -92.4 0.66 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.27 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -142.84 -90.05 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.821 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -84.74 87.24 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.286 0.565 . . . . 0.0 109.745 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.927 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -102.29 137.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.683 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.4 mtt-85 -88.36 102.69 15.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.876 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.1 mt -91.61 132.53 36.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.597 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.46 115.11 29.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.075 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 57' ' ' ILE . 1.7 m -119.7 138.06 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.661 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . 2.5 ptt? -96.65 158.76 15.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.018 0.437 . . . . 0.0 111.271 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.79 114.85 9.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.828 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.572 ' NH2' HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.035 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.801 0.334 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.49 124.77 30.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.766 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-30 -91.38 111.4 22.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.699 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 25.1 mt-10 -111.68 166.04 11.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.445 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 13.1 pt-20 -126.76 144.81 50.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.072 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.32 109.47 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.955 0.407 . . . . 0.0 112.016 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.842 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.89 121.55 25.0 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.072 HD13 HD11 ' A' ' 6' ' ' ILE . 4.3 tp -130.54 128.48 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 5.7 mt-10 -83.65 100.68 11.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.49 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CG ' HD23 ' A' ' 15' ' ' LEU . 11.8 mtp180 -44.76 92.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.984 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -63.08 70.3 0.03 OUTLIER Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.896 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' ARG . 61.1 t-20 64.65 -74.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.688 0.28 . . . . 0.0 111.37 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.63 -24.24 62.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.519 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 155.17 -170.2 33.27 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.637 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.985 ' HB3' HD23 ' A' ' 8' ' ' LEU . 4.5 mt -66.33 -63.59 1.04 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.616 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 136.63 42.1 0.11 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.877 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.782 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.2 p90 -163.39 133.09 4.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.121 0.461 . . . . 0.0 110.895 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.453 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.32 136.64 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.548 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.02 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -117.73 148.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.669 0.747 . . . . 0.0 111.972 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.94 134.38 28.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.267 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 141.56 3.61 1.14 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.684 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.89 -175.75 1.49 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 68' ' ' VAL . 40.8 p -66.39 -26.9 67.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.5 -19.21 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.34 87.53 53.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.415 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.93 60.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.292 1.995 . . . . 0.0 112.562 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.629 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.8 t-80 -48.16 -27.77 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.088 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.797 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.39 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.276 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.13 -50.22 68.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.679 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.8 40.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.87 168.18 15.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.7 ' HB3' HG22 ' A' ' 23' ' ' THR . 90.2 Cg_endo -79.0 5.34 5.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.546 2.164 . . . . 0.0 112.81 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -54.92 113.16 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.391 . . . . 0.0 110.757 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.859 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.19 119.49 33.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.845 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.797 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.82 145.93 35.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.328 0.585 . . . . 0.0 110.436 178.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.035 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.136 -176.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.437 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.82 -31.65 4.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.146 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -171.55 136.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.748 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.99 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -100.46 131.91 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 116.19 63.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.5 Cg_exo -58.98 136.49 73.78 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.785 2.324 . . . . 0.0 112.288 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.2 15.87 42.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.604 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.19 178.27 16.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.182 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.23 -36.18 51.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 111.397 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.826 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -70.28 -56.75 5.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.36 -30.47 66.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.4 pp0? -72.12 -29.93 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.265 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.65 -57.94 3.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.529 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 40.64 9.47 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.624 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -117.83 -3.71 11.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.035 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -123.3 153.11 40.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.956 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.38 135.88 47.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.17 157.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.337 0.589 . . . . 0.0 111.424 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.4 -3.02 2.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -64.86 125.3 24.39 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.006 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 14.2 p -86.72 100.24 12.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.5 0.667 . . . . 0.0 111.74 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.013 HD11 HG21 ' A' ' 19' ' ' ILE . 11.2 mt -52.99 127.41 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.698 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.82 HD22 ' HG2' ' A' ' 89' ' ' MET . 0.8 OUTLIER -120.0 -10.98 9.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.579 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -167.02 143.29 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.06 0.457 . . . . 0.0 110.71 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.838 HG13 ' CD2' ' A' ' 86' ' ' LEU . 39.6 t -139.47 112.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.87 37.0 16.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 0.0 110.164 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 79.55 34.0 0.19 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.552 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 60' ' ' VAL . 88.9 t -120.97 107.84 21.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.479 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -71.59 110.33 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.606 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 34.7 m -95.97 40.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -24.96 59.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -143.87 61.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 23' ' ' THR . 26.9 m -135.62 146.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.023 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.66 155.62 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.055 0.455 . . . . 0.0 111.267 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.858 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 p-80 -48.23 -35.14 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.17 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -72.35 -33.85 67.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.153 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -42.87 88.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.813 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.859 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.06 -46.82 85.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.619 0.723 . . . . 0.0 109.169 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 70' ' ' HIS . 91.7 t -56.85 -50.29 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.194 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.21 -30.05 61.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.902 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -60.64 -50.14 74.7 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.327 0.584 . . . . 0.0 109.735 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.02 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -58.85 -36.53 74.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.825 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.5 -25.25 50.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.452 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -103.09 17.87 23.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 111.213 -178.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.881 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.82 16.31 5.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.83 -109.85 2.95 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -120.68 -89.38 0.6 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.842 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.0 OUTLIER -88.2 95.42 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 109.842 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.881 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -108.07 135.2 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.7 ptm180 -87.52 102.87 15.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.415 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.838 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.4 mt -89.78 132.94 34.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.58 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.77 120.01 39.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 57' ' ' ILE . 12.5 m -125.04 153.38 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.82 ' HG2' HD22 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -106.77 154.84 20.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.893 0.377 . . . . 0.0 110.863 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -140.5 106.98 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.914 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.935 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ttm . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.906 0.384 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.79 166.7 13.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.025 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CE1' ' HG3' ' A' ' 89' ' ' MET . 40.1 m-85 -118.87 125.55 49.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.791 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -117.17 159.47 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.93 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 pt-20 -120.23 144.67 47.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.005 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.85 109.56 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.988 0.423 . . . . 0.0 111.768 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.807 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.18 112.2 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -122.91 127.19 48.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.4 pt-20 -83.92 100.29 10.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.287 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -47.83 88.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.254 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.06 174.03 0.11 Allowed Glycine 0 C--N 1.323 -0.178 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.6 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -25.87 12.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.859 0.361 . . . . 0.0 111.031 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.1 t -96.01 -24.81 16.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.48 -163.8 27.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.165 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.952 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.9 tp -65.11 -63.55 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.659 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.67 26.16 1.07 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 114.77 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.798 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.9 p90 -163.71 132.11 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.016 0.908 . . . . 0.0 111.266 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.7 139.62 30.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.707 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.047 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -121.37 146.57 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.46 135.43 35.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.353 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.91 -3.41 1.52 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.655 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.33 -174.78 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.06 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 68' ' ' VAL . 17.4 p -71.52 -21.27 61.93 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -22.29 16.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 111.48 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 1.5 t-20 -124.27 87.66 53.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.166 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.72 62.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.368 2.045 . . . . 0.0 112.71 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.614 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.4 t-80 -50.98 -26.16 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.031 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.762 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.25 -151.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.477 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.89 49.01 4.14 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.858 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.23 45.88 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.475 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 154.14 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.98 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.666 ' CB ' HG22 ' A' ' 23' ' ' THR . 73.9 Cg_endo -75.71 0.26 9.39 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.497 2.131 . . . . 0.0 112.692 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.71 115.65 2.27 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.917 0.389 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.21 119.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.075 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.762 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.24 147.05 35.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.358 0.599 . . . . 0.0 110.492 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.99 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.339 -176.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.14 -31.77 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.52 134.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.051 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.971 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.83 132.51 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 125.37 72.83 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.6 Cg_endo -65.94 132.26 29.72 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.738 2.292 . . . . 0.0 112.226 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.01 56.66 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.486 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.68 177.07 20.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.944 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.95 -37.46 63.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.763 0.315 . . . . 0.0 111.173 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.836 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.7 -57.6 5.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.54 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.18 -34.74 68.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.226 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.81 -58.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.4 40.88 9.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.726 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.493 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mmt180 -111.13 -5.98 14.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.846 0.355 . . . . 0.0 110.759 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.99 HD21 HD12 ' A' ' 36' ' ' ILE . 6.4 tp -119.13 156.15 30.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.751 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.39 134.91 45.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.818 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -51.51 157.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 121.243 0.544 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER 75.29 -1.54 3.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.36 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 m-20 -69.76 129.35 39.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.76 104.03 15.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.646 0.736 . . . . 0.0 111.491 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.047 HD11 HG21 ' A' ' 19' ' ' ILE . 72.5 mt -50.71 138.65 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 2.1 mm? -116.67 -44.15 2.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.372 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -143.62 172.71 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.783 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.906 HG13 ' CD2' ' A' ' 86' ' ' LEU . 44.9 t -149.88 97.11 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.821 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.573 ' OD1' HG23 ' A' ' 84' ' ' VAL . 9.4 t30 67.82 -67.56 0.18 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.138 0.494 . . . . 0.0 109.775 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mt-10 -156.41 32.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.479 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -118.58 142.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.559 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 16.1 p-10 -111.09 108.93 18.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.173 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.6 m -92.82 40.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 111.66 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.51 70.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.78 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -152.87 70.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.95 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 23' ' ' THR . 27.6 m -135.87 146.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.7 152.58 26.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 0.0 110.826 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.866 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.6 p-80 -48.55 -33.86 10.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.01 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.19 -33.82 70.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.542 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.4 -42.14 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.48 -46.89 81.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.582 0.706 . . . . 0.0 109.123 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 70' ' ' HIS . 83.9 t -56.57 -50.39 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.205 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.86 -30.11 60.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.053 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.3 -50.42 73.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 109.909 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -58.53 -36.05 73.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.861 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.5 -29.21 52.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.494 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -99.64 18.46 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -178.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.907 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.22 16.17 5.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.273 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.66 -94.11 0.66 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.18 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.0 p -140.49 -90.65 0.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.807 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -83.84 89.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.185 0.517 . . . . 0.0 109.718 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.907 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.5 p -105.17 137.01 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.96 103.0 15.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.906 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.5 mt -91.24 142.68 27.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.174 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.76 139.58 37.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.692 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 HD11 ' A' ' 51' ' ' LEU . 4.3 m -139.22 167.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.459 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 2.7 ttt -115.29 142.33 46.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.057 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.15 141.16 47.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.907 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -112.65 145.45 40.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.471 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 2.4 m-30 -103.37 155.86 18.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.9 153.86 39.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.428 ' CG ' ' HB3' ' A' ' 85' ' ' ARG . 1.8 tt0 -108.01 138.36 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.645 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.805 HD13 HD13 ' A' ' 51' ' ' LEU . 1.1 mt -132.69 109.17 14.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.873 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.05 112.16 15.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.893 HD21 ' CA ' ' A' ' 45' ' ' ALA . 4.3 tp -121.91 126.84 49.58 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -87.81 99.54 12.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.021 178.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -57.79 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.573 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.04 173.56 17.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.889 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 58.45 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.622 0.248 . . . . 0.0 111.057 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.3 -2.2 19.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.583 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 10' ' ' ARG . . . 132.03 -148.02 18.94 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.951 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.888 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.4 tp -70.31 -12.87 61.88 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.689 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 72.64 30.24 64.39 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.0 p90 -164.64 135.38 4.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.354 1.077 . . . . 0.0 111.745 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -100.91 137.63 39.03 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.659 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.035 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -116.74 150.84 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.723 0.773 . . . . 0.0 112.293 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -145.79 134.58 22.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.31 2.92 0.92 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.633 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.67 -173.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.005 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 33.2 p -70.57 -26.01 63.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 43.4 t0 -94.24 -24.05 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 4.0 m-20 -124.47 87.98 53.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 63.89 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.316 2.011 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.601 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.2 t-80 -47.26 -28.32 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.315 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.818 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.06 -155.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.385 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.682 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.25 -50.91 59.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.691 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.89 39.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.18 166.08 23.78 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.838 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.659 ' CB ' HG22 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.76 7.28 4.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.52 2.147 . . . . 0.0 112.727 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -57.01 114.25 2.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.85 0.357 . . . . 0.0 110.779 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.39 118.07 29.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.795 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.818 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.48 147.21 37.49 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.187 0.518 . . . . 0.0 110.732 178.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.021 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.92 155.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.902 -176.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.457 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.49 -29.93 4.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.223 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.38 125.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.291 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.798 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.49 127.43 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.5 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.2 125.37 72.49 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_endo -60.9 138.39 78.67 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.716 2.278 . . . . 0.0 112.206 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 14.1 64.4 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.377 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . -107.05 -159.16 21.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.886 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.589 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.97 -38.72 57.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.832 0.316 . . . . 0.0 110.987 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.893 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.41 -54.19 8.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.893 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.95 -33.72 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.162 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 13.5 mm-40 -72.45 -32.39 66.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.5 ' HB2' HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -79.41 -57.98 3.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.63 38.34 8.91 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.701 ' CB ' HG23 ' A' ' 6' ' ' ILE . 22.0 mmt180 -120.29 1.92 10.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.021 HD21 HD12 ' A' ' 36' ' ' ILE . 29.5 tp -128.07 162.98 25.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.163 0.506 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.45 137.35 26.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.708 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.99 157.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.328 0.585 . . . . 0.0 111.629 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t-20 75.73 -0.52 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.328 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -69.34 126.75 30.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.66 101.99 13.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.585 0.707 . . . . 0.0 111.492 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.009 HD11 HG21 ' A' ' 19' ' ' ILE . 68.0 mt -48.81 137.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.581 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SD ' ' A' ' 89' ' ' MET . 5.2 mt -119.01 -32.9 4.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -150.13 160.13 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.577 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.849 HG13 ' CD2' ' A' ' 86' ' ' LEU . 28.3 t -152.42 110.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 t30 47.92 50.19 16.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 73.29 31.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 77.8 t -120.85 141.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.0 p-10 -109.47 109.57 20.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.664 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 32.5 m -94.01 43.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.247 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -30.17 68.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -149.87 67.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.768 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 35.5 m -135.02 148.1 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.438 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.04 154.35 39.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 74' ' ' VAL . 7.4 p-80 -49.17 -34.15 13.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.098 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -69.57 -33.93 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.642 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.37 -42.58 83.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 109.793 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.852 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.09 -46.62 83.42 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 70' ' ' HIS . 88.0 t -56.61 -50.4 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.21 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.29 -29.85 59.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.949 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -61.96 -50.77 70.81 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -57.01 -37.16 71.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.484 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.64 -23.62 49.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.957 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 5.0 pt-20 -93.6 3.21 55.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.032 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.931 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -90.28 16.3 8.92 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.46 -121.86 27.96 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.748 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -104.19 -87.12 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.873 HG13 HG22 ' A' ' 7' ' ' THR . 8.2 tp -82.59 107.82 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.931 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -127.05 137.72 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.72 ' HG2' HG23 ' A' ' 7' ' ' THR . 13.2 mtp180 -83.49 103.07 12.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.373 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.849 ' CD2' HG13 ' A' ' 60' ' ' VAL . 8.1 mt -94.92 142.12 27.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.017 0.436 . . . . 0.0 111.363 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.66 131.43 49.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.304 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.459 HG21 HD11 ' A' ' 6' ' ' ILE . 3.3 m -131.8 167.93 25.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.498 ' SD ' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -106.81 158.74 16.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -140.51 124.04 17.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.422 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.854 0.359 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.32 138.77 35.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.441 ' HB3' HD21 ' A' ' 58' ' ' LEU . 5.8 m-30 -96.83 127.82 43.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.19 141.93 51.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 17.0 pt-20 -99.46 144.66 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.132 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.43 109.42 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.372 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.898 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.81 118.39 20.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.132 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -128.51 127.18 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.1 pt-20 -84.06 100.63 11.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.195 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -51.63 89.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.111 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.65 175.62 0.17 Allowed Glycine 0 C--N 1.32 -0.339 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.613 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -55.08 -24.1 23.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.303 . . . . 0.0 111.126 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.5 p -96.56 -24.65 15.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.205 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.94 -163.12 28.35 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.203 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.004 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.9 tp -67.51 -63.56 1.03 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.844 -0.21 . . . . 0.0 110.637 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 133.93 20.27 0.86 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.928 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.856 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.0 p90 -161.18 135.91 7.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.055 0.927 . . . . 0.0 111.381 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 135.82 34.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.019 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.27 148.03 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -130.46 124.85 32.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.71 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 158.3 -120.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.874 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 63.83 168.29 1.27 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.12 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 68' ' ' VAL . 25.1 p -70.18 -1.98 11.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 35.4 t70 -117.08 -22.52 8.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' HIS . 4.3 m-80 -124.72 85.89 56.41 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.61 65.74 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.008 1.805 . . . . 0.0 112.477 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.542 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 14.2 t-80 -55.09 -23.62 21.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.173 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -94.75 -150.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.377 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.689 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.26 51.65 4.52 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.692 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 t0 76.25 43.53 0.15 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 110.414 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.53 156.77 79.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 95.9 Cg_endo -77.9 0.03 10.22 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.507 2.138 . . . . 0.0 112.599 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -55.2 120.09 6.5 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.108 0.48 . . . . 0.0 111.313 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.885 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.62 118.68 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.98 146.84 36.07 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.316 0.579 . . . . 0.0 110.463 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.23 155.78 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.042 -176.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.35 -33.51 4.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.772 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.82 142.04 2.37 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.483 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.962 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.92 133.58 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 115.0 57.79 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.6 Cg_exo -56.07 136.87 77.22 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.89 2.393 . . . . 0.0 112.405 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.91 2.57 66.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.1 176.39 22.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.111 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -38.41 59.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.87 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.18 -57.41 6.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.659 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.59 -35.35 80.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.081 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.1 pp0? -71.96 -30.07 64.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 0.0 110.471 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.678 ' OD2' HD12 ' A' ' 8' ' ' LEU . 49.1 m-20 -79.89 -58.07 3.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 41.39 9.81 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.593 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.513 ' CB ' HG12 ' A' ' 6' ' ' ILE . 5.5 mtm180 -117.09 -1.19 11.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -126.56 153.53 45.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.586 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.85 135.26 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.688 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.631 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.5 157.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.339 0.59 . . . . 0.0 111.619 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 75.79 -0.27 3.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.26 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -67.45 124.4 23.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.59 100.33 12.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 111.549 -178.485 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.019 HD11 HG21 ' A' ' 19' ' ' ILE . 12.1 mt -49.89 132.65 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.674 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.8 pp -130.04 -0.01 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.114 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 179.16 134.64 0.09 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.892 HG13 ' CD2' ' A' ' 86' ' ' LEU . 40.7 t -120.02 97.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.692 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.865 ' OD1' HG23 ' A' ' 84' ' ' VAL . 3.7 t30 71.32 -61.82 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -164.3 31.24 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.084 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.3 t -120.99 110.43 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' N ' ' CE1' ' A' ' 59' ' ' PHE . 6.7 t0 -72.47 112.37 8.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.79 0.328 . . . . 0.0 110.593 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.663 HG21 HG22 ' A' ' 57' ' ' ILE . 19.1 m -94.92 27.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.5 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -67.81 -25.54 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.44 51.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -126.19 148.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.006 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -68.42 154.53 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.848 ' O ' HG23 ' A' ' 74' ' ' VAL . 9.2 t-160 -48.29 -34.86 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.044 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 4.0 m -68.6 -33.76 74.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.244 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.6 -33.09 68.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.21 0.529 . . . . 0.0 109.598 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -71.59 -46.76 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 70' ' ' HIS . 67.9 t -60.58 -50.86 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.303 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -57.14 -29.32 63.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.69 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.788 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -61.16 -52.19 65.87 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.905 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.015 HD11 HD12 ' A' ' 19' ' ' ILE . 3.0 mt -56.6 -37.27 70.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.909 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.6 -28.33 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -97.37 15.93 21.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.295 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.924 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.11 16.28 6.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.39 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.54 -96.05 0.55 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.422 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -136.09 -90.2 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.898 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.5 93.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 109.879 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.924 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 p -109.81 136.39 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.2 ptt180 -87.01 103.05 14.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.273 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.892 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.1 mt -91.78 134.51 34.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.119 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.507 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.56 125.35 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.8 m -129.48 157.04 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.728 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.506 ' HG2' HD22 ' A' ' 58' ' ' LEU . 26.7 mtt -96.84 148.18 23.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.963 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -140.54 113.55 8.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.853 0.358 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -75.53 117.8 17.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.028 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.907 ' CD2' HD13 ' A' ' 58' ' ' LEU . 3.1 m-85 -82.23 121.35 26.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.819 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.451 ' HG2' HG23 ' A' ' 88' ' ' VAL . 4.3 pt-20 -129.0 164.62 22.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.978 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -121.45 144.77 48.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.94 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.03 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.59 112.12 13.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.638 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.717 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.12 115.36 20.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 6' ' ' ILE . 4.6 tp -125.44 128.76 48.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -89.48 100.84 13.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.698 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' ASN . 5.1 mtp180 -45.6 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.342 0.591 . . . . 0.0 109.801 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' SER . . . -63.35 63.1 0.04 OUTLIER Glycine 0 C--N 1.319 -0.363 0 CA-C-N 114.835 -1.075 . . . . 0.0 114.168 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 10' ' ' ARG . 4.6 m120 61.78 -65.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.748 0.309 . . . . 0.0 111.503 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' GLY . 36.4 m -69.62 -24.86 63.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.994 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.9 -177.74 32.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.883 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.975 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.1 tp -64.06 -63.49 1.14 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.171 . . . . 0.0 110.808 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.511 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.93 19.61 0.79 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.674 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.8 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.1 p90 -161.04 135.08 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.006 0.903 . . . . 0.0 111.19 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.37 138.86 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.466 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.65 147.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 112.037 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.98 134.98 32.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.283 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.4 1.23 0.92 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.409 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.34 -173.79 0.92 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.885 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 68' ' ' VAL . 28.7 p -66.83 -32.6 73.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -90.43 -20.7 22.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 20.7 t-20 -124.28 87.29 53.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.617 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.91 61.49 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.277 1.985 . . . . 0.0 112.387 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.624 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 14.3 t-80 -47.9 -27.75 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.202 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.792 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.43 -153.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -57.2 -50.17 66.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.681 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.48 40.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.724 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 168.5 14.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' A' ' 23' ' ' THR . 87.0 Cg_endo -78.87 6.5 4.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.814 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 113.34 1.36 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.848 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.31 119.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.792 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.23 147.46 36.53 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.265 0.555 . . . . 0.0 110.456 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.053 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.02 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.121 -176.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.65 -34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.661 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.63 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.15 143.14 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.044 0.449 . . . . 0.0 111.737 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.46 132.79 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.449 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.2 124.54 73.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.0 Cg_endo -65.39 133.14 33.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 112.209 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.53 5.96 57.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.384 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.66 175.06 18.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.868 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.8 -36.15 57.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.721 0.296 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.846 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.89 -57.46 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.466 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.6 -29.04 67.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.401 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.02 -34.99 69.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.101 0.477 . . . . 0.0 110.005 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -84.75 -58.05 2.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.602 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 41.78 9.46 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.464 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.521 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.4 mmt85 -112.88 9.01 18.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.704 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.053 HD21 HD12 ' A' ' 36' ' ' ILE . 5.6 tp -134.34 155.1 50.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.635 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.607 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -132.09 133.52 44.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.881 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -49.4 157.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.79 -1.11 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.368 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.83 126.46 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.61 103.88 15.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.525 0.678 . . . . 0.0 111.361 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.088 HD11 HG21 ' A' ' 19' ' ' ILE . 64.2 mt -50.83 152.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.863 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.907 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -136.58 -39.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.474 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -142.58 159.52 42.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.888 HG13 ' CD2' ' A' ' 86' ' ' LEU . 35.9 t -152.5 113.78 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 49.84 44.87 25.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.773 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 72.86 32.62 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.595 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 68.6 t -120.37 142.19 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.7 p-10 -108.8 111.05 22.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.54 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 65' ' ' VAL . 30.3 m -79.21 57.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.967 0.413 . . . . 0.0 110.948 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.62 103.02 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.85 53.81 1.41 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 23' ' ' THR . 16.7 m -119.85 142.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -62.99 154.21 31.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.075 0.465 . . . . 0.0 111.226 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.8 p-80 -48.09 -34.16 9.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -70.69 -33.98 71.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.94 -45.06 83.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 0.0 109.764 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.848 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.21 -46.92 86.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.299 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.9 t -56.55 -50.35 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.319 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.06 -29.35 57.31 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.971 178.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -61.78 -52.07 65.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.397 0.618 . . . . 0.0 109.759 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -56.61 -36.16 69.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.872 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.36 -30.53 53.84 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.674 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' OE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -98.29 19.82 13.63 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.406 -178.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.99 16.26 7.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.37 -101.4 1.15 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.237 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 18.1 t -130.28 -89.29 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.717 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.1 tp -88.41 91.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 109.919 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.887 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.9 p -105.11 137.18 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.72 102.63 14.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.888 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.9 mt -89.48 139.62 30.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.75 132.86 47.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.718 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.8 m -138.82 165.34 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.387 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.754 ' CG ' HD21 ' A' ' 58' ' ' LEU . 12.2 ptt? -138.34 131.8 30.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.419 . . . . 0.0 111.185 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 111.74 7.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.978 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.799 0.333 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.42 147.64 23.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.783 ' CD2' HD13 ' A' ' 58' ' ' LEU . 1.4 m-85 -104.25 106.17 16.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.608 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -102.04 170.78 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.13 144.95 51.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.97 109.65 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.992 0.425 . . . . 0.0 111.966 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.861 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.27 119.53 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 6' ' ' ILE . 5.1 tp -132.03 127.15 35.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.3 pm0 -83.94 100.38 10.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.823 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.549 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.77 89.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -49.48 -179.36 0.02 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.788 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -45.25 -36.95 4.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 p -99.31 -24.76 14.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.194 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 148.37 -164.65 29.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.956 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.988 ' HB3' HD23 ' A' ' 8' ' ' LEU . 21.3 mt -56.08 -63.48 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.98 0.419 . . . . 0.0 110.548 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.85 32.82 0.54 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.436 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.783 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.8 p90 -158.86 135.97 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.068 0.434 . . . . 0.0 111.026 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.76 137.93 34.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.075 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.38 146.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.762 0.792 . . . . 0.0 112.377 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.77 133.59 30.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.096 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.36 -0.43 1.09 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.731 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.65 -173.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.919 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.865 HG22 ' HB3' ' A' ' 32' ' ' PRO . 37.2 p -69.09 -30.65 69.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.21 -20.86 21.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.35 87.23 54.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.425 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.63 61.79 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.349 2.033 . . . . 0.0 112.635 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.609 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.5 t-80 -48.89 -27.55 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.78 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -91.23 -152.27 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.195 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.688 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.89 49.4 4.22 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.591 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.29 48.21 0.06 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 110.223 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.88 150.45 71.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.865 ' HB3' HG22 ' A' ' 23' ' ' THR . 12.1 Cg_exo -70.18 -5.23 15.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.674 2.249 . . . . 0.0 112.669 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.1 113.96 1.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.041 0.448 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.833 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.69 118.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.512 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.78 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.66 147.36 39.17 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.357 0.599 . . . . 0.0 110.69 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.044 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.05 155.71 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.017 -176.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.455 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.45 -29.6 4.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.252 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.76 130.57 0.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.176 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.003 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.61 129.75 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.27 116.87 67.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.7 134.47 60.89 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.67 2.247 . . . . 0.0 112.287 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.73 31.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.551 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.84 177.61 17.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.32 -34.77 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.425 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.787 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.77 -56.65 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.97 -31.1 65.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -72.0 -30.12 64.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.375 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.0 -57.96 3.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.97 9.57 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.615 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.523 ' CB ' HG12 ' A' ' 6' ' ' ILE . 44.1 mtt-85 -118.14 5.81 12.01 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.95 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.044 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -134.59 153.39 51.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.189 0.519 . . . . 0.0 111.026 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.576 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.58 137.35 49.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -52.19 157.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.344 0.592 . . . . 0.0 111.563 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.08 0.01 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.35 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.48 127.42 32.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 103.8 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.539 0.685 . . . . 0.0 111.339 -178.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 19' ' ' ILE . 69.6 mt -51.0 139.95 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.633 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.85 -37.08 3.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.5 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -148.68 165.41 31.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.76 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.685 HG11 ' HB1' ' A' ' 76' ' ' ALA . 39.4 t -142.07 97.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.73 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.7 t-20 68.53 -67.07 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.076 0.465 . . . . 0.0 109.771 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.4 mt-10 -157.37 33.36 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.582 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.4 t -120.59 142.36 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -107.19 108.38 19.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.393 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 65' ' ' VAL . 21.1 m -92.23 45.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.347 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -25.47 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -149.58 58.07 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.996 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.768 ' O ' HG23 ' A' ' 23' ' ' THR . 27.2 m -128.27 149.05 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.438 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.44 153.79 42.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 111.018 -179.443 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.2 t-160 -49.86 -34.14 19.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -69.62 -33.87 73.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.749 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.683 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.32 -42.68 79.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.833 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.79 -46.89 85.89 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.3 t -57.49 -50.41 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.259 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -30.03 61.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.889 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.76 -50.21 74.38 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.341 0.591 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.017 HD11 HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -59.53 -35.82 74.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.961 179.211 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.44 -25.79 50.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.348 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -102.58 16.78 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.36 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.908 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.9 16.27 4.26 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 -92.49 0.69 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.061 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 22.5 t -143.06 -89.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.861 HG13 HG22 ' A' ' 7' ' ' THR . 8.8 tp -84.47 88.23 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.217 0.532 . . . . 0.0 109.811 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.908 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.4 p -103.93 139.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.608 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.0 mtt-85 -88.15 102.82 15.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.61 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.9 mt -91.8 138.61 31.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.259 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.748 ' HB3' HD12 ' A' ' 58' ' ' LEU . 1.6 m-85 -101.66 138.66 38.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.773 ' O ' HD11 ' A' ' 58' ' ' LEU . 14.8 m -139.52 168.01 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.586 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.452 ' N ' HD21 ' A' ' 58' ' ' LEU . 2.3 ttm -110.79 148.06 33.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.34 . . . . 0.0 110.865 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.52 132.46 27.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.78 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.964 179.979 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.938 0.399 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -99.44 133.67 43.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.993 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 22.5 m-85 -94.3 156.38 16.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 142.36 18.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -106.24 144.63 32.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.993 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.03 109.41 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.925 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.39 121.22 24.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 6' ' ' ILE . 4.0 tp -132.05 127.38 36.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 pt-20 -85.57 101.07 12.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.853 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.566 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.2 mtp180 -47.79 94.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -46.38 -104.28 0.01 OUTLIER Glycine 0 C--N 1.319 -0.384 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.317 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -109.94 -41.44 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.505 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 m -108.14 -5.06 17.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.553 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 151.76 -157.04 27.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.518 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.97 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -74.68 -63.47 1.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.427 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.17 44.14 0.07 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.978 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.774 ' HB3' HG23 ' A' ' 39' ' ' ILE . 12.5 p90 -164.55 134.16 3.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.149 0.474 . . . . 0.0 110.875 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.75 136.52 33.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.525 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.062 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.26 146.81 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.753 0.787 . . . . 0.0 112.247 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -140.0 132.86 29.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.13 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.5 3.61 0.71 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.707 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.75 -171.11 0.67 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.8 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.829 HG22 ' HB3' ' A' ' 32' ' ' PRO . 39.1 p -70.42 -29.14 65.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.97 -21.0 20.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.9 OUTLIER -124.38 87.32 54.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.524 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 62.2 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.266 1.977 . . . . 0.0 112.459 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.617 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.2 t-80 -47.46 -28.12 2.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.327 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.822 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.49 -154.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.3 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.68 -50.09 70.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.604 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.37 40.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.48 165.84 25.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.829 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.5 Cg_exo -74.98 1.21 7.98 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.967 2.445 . . . . 0.0 112.815 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.46 112.3 0.79 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.034 0.445 . . . . 0.0 111.16 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.05 118.54 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.47 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.822 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.99 147.2 38.33 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.352 0.596 . . . . 0.0 110.841 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.011 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.11 155.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.911 -176.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.46 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.83 -29.02 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.189 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.4 131.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.998 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.969 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.59 132.29 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.32 114.23 53.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.8 Cg_exo -57.83 137.43 81.0 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.709 2.273 . . . . 0.0 112.326 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.77 54.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.568 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 179.5 16.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.113 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.69 -36.44 64.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.188 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.813 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.05 -57.68 5.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 0.0 111.87 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.75 -28.29 65.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.53 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.64 -30.21 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.362 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' OD2' HD12 ' A' ' 8' ' ' LEU . 1.7 m-20 -82.91 -57.87 3.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.14 37.74 10.91 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.574 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.6 mtt85 -112.44 -13.36 13.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.011 HD21 HD12 ' A' ' 36' ' ' ILE . 6.2 tp -114.69 154.82 27.76 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 111.408 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -133.11 135.71 45.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.691 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.84 157.41 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.195 0.521 . . . . 0.0 111.747 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.86 0.28 3.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.329 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.95 126.26 29.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.3 t -86.58 100.25 12.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.715 0.769 . . . . 0.0 111.316 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.062 HD11 HG21 ' A' ' 19' ' ' ILE . 69.9 mt -46.83 135.21 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.708 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD23 ' HB3' ' A' ' 89' ' ' MET . 0.1 OUTLIER -113.45 -42.29 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.052 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.2 m-85 -142.36 169.99 16.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.73 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.861 HG13 ' CD2' ' A' ' 86' ' ' LEU . 19.3 t -150.04 99.12 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.218 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 84' ' ' VAL . 8.6 t30 67.04 -67.61 0.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.167 0.508 . . . . 0.0 109.874 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -156.42 32.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.668 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.7 t -119.46 142.25 35.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.564 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.7 t0 -112.08 87.55 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 65' ' ' VAL . 24.9 m -70.22 63.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -29.9 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.691 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -149.03 58.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.76 ' O ' HG23 ' A' ' 23' ' ' THR . 34.8 m -123.91 146.67 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.246 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.458 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -65.81 154.94 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.868 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.5 p-80 -48.21 -34.65 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.1 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 p -71.58 -33.75 69.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.169 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.65 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.93 -45.49 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.86 -46.85 88.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.587 0.708 . . . . 0.0 109.162 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.8 t -57.12 -49.25 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.403 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.97 -30.15 63.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.957 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.77 -49.71 76.4 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.333 0.587 . . . . 0.0 109.679 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.986 HD11 HD12 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -59.94 -34.65 73.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.859 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.9 mmmt -77.36 -28.1 52.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.426 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.86 18.49 19.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 -178.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.48 16.29 6.71 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.39 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -111.03 3.42 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.155 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -119.68 -90.26 0.58 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.925 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -87.28 93.68 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.976 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.887 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -105.81 138.59 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.764 ' HG3' HG23 ' A' ' 7' ' ' THR . 49.1 mtp180 -88.67 102.96 15.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.861 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.0 mt -90.56 141.61 28.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.213 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 136.03 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.683 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 m -139.81 136.76 39.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.639 ' HB3' HD23 ' A' ' 58' ' ' LEU . 2.2 ptt? -104.33 146.89 28.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 0.0 110.936 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -140.57 116.71 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.016 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.829 0.347 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.76 110.97 23.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.955 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.2 m-85 -82.23 113.48 20.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 1.6 mp0 -115.42 153.01 31.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 85' ' ' ARG . 1.9 pm0 -107.84 144.82 34.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.456 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.994 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.77 109.63 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 111.704 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.0 122.3 26.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.004 HD23 ' HG ' ' A' ' 15' ' ' LEU . 5.3 tp -131.54 126.85 35.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 12.8 mt-10 -80.31 99.99 8.17 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.279 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.28 88.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.085 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.6 171.31 0.77 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.441 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -52.8 -25.0 10.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.817 0.342 . . . . 0.0 110.991 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 m -94.09 -22.74 18.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.38 -164.47 26.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.315 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.004 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.8 tp -68.73 -63.48 1.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.41 0.148 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.42 20.64 0.99 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.765 -1.207 . . . . 0.0 114.486 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.868 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.0 p90 -159.28 135.52 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.608 0.704 . . . . 0.0 110.847 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -95.27 135.2 37.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.89 146.6 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.543 0.687 . . . . 0.0 111.552 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.59 120.7 30.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.628 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 141.92 159.24 7.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.783 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.64 175.56 22.02 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 68' ' ' VAL . 26.6 p -65.87 -12.19 52.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -114.96 -26.35 7.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.53 87.37 54.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.466 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.94 66.06 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.365 2.043 . . . . 0.0 112.329 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.552 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 9.8 t-80 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.656 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -85.96 -155.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.438 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.01 -50.1 69.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.746 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.03 76.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 110.701 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' CB ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -166.63 176.69 1.71 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 31' ' ' ASP . 94.1 Cg_endo -85.36 26.77 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.729 2.286 . . . . 0.0 112.543 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 m -77.21 112.29 13.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.903 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.59 118.85 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.009 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.34 148.15 37.47 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.259 0.552 . . . . 0.0 110.789 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.06 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.31 155.87 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.81 -177.237 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.64 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.31 -30.65 4.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.098 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.46 132.59 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.896 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.978 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.26 131.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 115.69 61.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.499 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.5 Cg_exo -57.72 134.79 65.23 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.731 2.288 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 8.12 56.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.43 179.75 18.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.903 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.08 -38.8 68.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 111.064 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.792 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -65.44 -57.46 8.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.25 -28.93 66.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.27 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.76 -57.94 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.632 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.06 9.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.602 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.1 mtt-85 -115.25 -6.18 12.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.06 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -121.23 154.06 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.162 0.506 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.46 135.45 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.552 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.21 157.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 0.0 111.538 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 77.06 -2.27 2.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -64.94 124.63 22.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.49 100.22 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.472 0.653 . . . . 0.0 111.615 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 19' ' ' ILE . 38.0 mt -48.51 125.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.565 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -117.42 -16.46 10.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.739 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -164.64 142.59 6.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.114 0.483 . . . . 0.0 110.94 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.913 HG13 ' CD2' ' A' ' 86' ' ' LEU . 38.6 t -136.98 112.18 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.393 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.6 t30 50.69 39.29 21.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.918 0.389 . . . . 0.0 110.276 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.67 33.83 0.36 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.564 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 60' ' ' VAL . 88.7 t -120.9 103.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.307 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 10.3 t0 -65.99 108.05 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.616 HG21 HG22 ' A' ' 57' ' ' ILE . 25.3 m -87.39 8.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.638 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.64 -21.32 53.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.634 0.254 . . . . 0.0 111.051 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -139.21 42.04 2.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.185 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.758 ' O ' HG23 ' A' ' 23' ' ' THR . 8.3 m -124.42 144.71 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.418 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.48 153.92 41.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.93 0.395 . . . . 0.0 110.613 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.714 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.3 t-160 -48.76 -34.43 12.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 2.7 m -70.06 -33.68 72.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.04 -33.2 71.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.903 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -70.64 -46.79 62.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.8 t -59.57 -50.76 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.352 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 3.5 pt-20 -57.69 -31.82 66.75 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.605 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.11 -49.75 75.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.328 0.585 . . . . 0.0 110.022 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -59.8 -37.33 78.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.983 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.31 -25.74 51.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.699 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 6.4 pt-20 -103.26 17.75 23.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.191 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.94 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.73 16.15 4.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.16 -93.77 0.6 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.321 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 28.1 t -141.06 -90.63 0.15 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER -84.2 86.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.3 0.571 . . . . 0.0 109.706 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.94 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -100.27 137.57 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.114 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 6.0 ttt180 -89.4 102.65 15.32 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.913 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.0 mt -91.46 133.65 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.601 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.99 114.77 29.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.826 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.7 m -120.34 129.31 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.779 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.461 ' HB3' ' CD2' ' A' ' 3' ' ' TYR . 25.8 ptt? -96.77 133.73 40.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.139 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -114.22 146.51 40.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.822 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.978 179.904 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' HE3' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.792 0.329 . . . . 0.0 111.217 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.55 119.69 35.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 6.4 m-30 -82.15 136.16 35.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -143.86 149.79 37.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.6 mt-10 -104.51 144.62 31.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.058 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.91 109.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.382 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.879 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 114.95 19.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.058 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -125.78 127.27 45.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.4 pt-20 -84.24 100.49 11.24 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.38 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.09 89.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.257 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.25 174.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.736 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -53.33 -25.54 15.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.81 0.338 . . . . 0.0 111.078 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -97.75 -24.74 15.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.57 -165.57 27.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.244 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.968 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.1 tp -61.9 -63.52 1.23 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.638 0.219 . . . . 0.0 110.505 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.82 25.91 0.97 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.765 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -164.27 132.27 3.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.862 0.831 . . . . 0.0 111.363 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.39 137.13 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.331 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.038 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -116.22 161.76 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.767 0.794 . . . . 0.0 112.092 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -155.51 131.91 10.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.777 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 15.01 0.26 Allowed Glycine 0 C--O 1.229 -0.16 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.468 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.565 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -73.04 -174.14 26.45 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.712 HG23 ' C ' ' A' ' 68' ' ' VAL . 22.2 p -66.93 -32.71 74.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -85.09 -33.35 22.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.514 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -124.65 77.21 64.14 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.015 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 28' ' ' ILE . 3.6 Cg_endo -46.02 -24.25 2.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.736 2.29 . . . . 0.0 112.679 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.547 ' HB3' ' HA2' ' A' ' 21' ' ' GLY . 11.7 t-80 58.94 -59.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.251 0.548 . . . . 0.0 111.497 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.837 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -66.28 -158.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.659 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.678 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.99 -49.45 78.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.484 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 179.39 75.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.56 156.99 14.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.2 5.73 4.38 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.857 2.371 . . . . 0.0 112.937 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -60.51 111.76 1.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.804 0.335 . . . . 0.0 110.707 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.853 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -79.76 121.45 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.263 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.837 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -142.23 147.2 36.13 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.419 0.628 . . . . 0.0 110.446 178.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.094 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.51 155.35 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.142 -0.935 . . . . 0.0 113.139 -176.388 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.98 -32.94 4.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.803 -179.043 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.13 143.67 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.616 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.02 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.27 132.27 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 116.78 66.43 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.8 Cg_exo -56.62 136.87 78.46 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.594 2.196 . . . . 0.0 112.305 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.61 1.98 67.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.689 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.55 174.83 24.06 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.864 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.84 -35.32 57.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.868 0.334 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.786 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.55 -57.44 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.485 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.0 -28.92 68.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.397 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -72.05 -35.36 69.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.049 0.452 . . . . 0.0 109.968 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.58 -57.77 3.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.523 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 40.88 9.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.599 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.49 9.55 19.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.794 0.33 . . . . 0.0 110.689 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.094 HD21 HD12 ' A' ' 36' ' ' ILE . 4.7 tp -136.3 153.8 51.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -131.2 134.37 46.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -48.98 157.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 111.83 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.5 t-20 76.56 -0.26 3.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.387 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.02 125.93 28.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.46 102.61 14.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.614 0.721 . . . . 0.0 111.199 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 61.6 mt -50.91 134.74 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.776 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 89' ' ' MET . 0.9 OUTLIER -117.47 -30.54 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -152.47 163.69 39.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.773 HG13 ' CD2' ' A' ' 86' ' ' LEU . 19.3 t -144.05 97.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.029 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.873 ' OD1' HG23 ' A' ' 84' ' ' VAL . 4.7 t30 68.13 -67.36 0.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 6.2 pt-20 -156.54 32.41 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.691 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 59.0 t -119.78 142.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.496 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 p-10 -110.0 99.51 8.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.437 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 65' ' ' VAL . 30.8 m -83.54 56.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.906 0.384 . . . . 0.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -29.09 26.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -147.36 56.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.712 ' C ' HG23 ' A' ' 23' ' ' THR . 31.7 m -126.22 144.39 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -62.14 151.77 34.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.4 t-160 -47.95 -33.98 8.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.717 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -33.99 75.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.977 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.18 -42.16 80.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.853 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.04 -46.65 86.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.631 0.729 . . . . 0.0 109.124 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.6 t -57.62 -50.56 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.193 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.34 -29.57 61.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.89 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.738 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.04 -50.66 72.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.318 0.58 . . . . 0.0 109.862 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.986 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -58.11 -37.14 73.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.836 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.51 -28.31 52.06 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.15 18.11 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 -178.316 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.904 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.04 16.38 5.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.246 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 -97.08 0.8 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.275 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.4 m -136.9 -90.44 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.879 HG13 HG22 ' A' ' 7' ' ' THR . 8.7 tp -84.86 89.97 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.23 0.538 . . . . 0.0 109.737 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.904 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.4 p -104.84 138.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.9 ttm-85 -87.95 103.12 15.39 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.773 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.6 mt -92.37 138.6 31.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.241 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.69 132.44 47.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.3 m -139.77 153.62 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.686 ' HB3' HD21 ' A' ' 58' ' ' LEU . 8.6 ptt? -121.39 131.24 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 111.013 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.53 121.76 14.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.819 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.46 ' HD3' ' HE3' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.034 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HE2' ' HE2' ' A' ' 89' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.795 0.331 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -87.19 132.61 33.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.445 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 4.0 m-30 -99.12 153.37 18.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -154.98 159.64 40.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 mt-10 -109.57 144.68 37.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.957 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.69 109.6 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 111.599 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.872 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.38 121.03 23.22 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.003 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -132.3 127.25 35.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.5 mt-10 -83.29 100.2 10.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.841 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.559 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -46.57 89.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.338 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.85 -174.4 0.03 OUTLIER Glycine 0 C--N 1.321 -0.301 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.747 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -45.98 -45.04 15.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.745 0.307 . . . . 0.0 111.581 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.4 t -92.82 -22.84 19.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.171 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 145.58 -162.6 28.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.928 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.003 ' HB3' HD23 ' A' ' 8' ' ' LEU . 20.1 mt -54.39 -63.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.036 0.418 . . . . 0.0 110.712 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 129.89 34.72 0.47 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.446 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.778 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.1 p90 -160.1 136.56 8.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.133 0.466 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.497 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.5 137.05 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.294 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.26 148.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.729 0.776 . . . . 0.0 112.355 -179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.75 133.8 27.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.065 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.474 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.41 4.77 0.88 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.725 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.545 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -61.49 -169.72 0.72 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.902 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.82 HG22 ' HB3' ' A' ' 32' ' ' PRO . 43.4 p -70.95 -29.89 66.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -93.54 -19.85 20.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 3.8 t-20 -124.46 87.43 54.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.91 61.24 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.32 2.013 . . . . 0.0 112.46 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.625 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.6 t-80 -47.19 -28.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.814 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -88.79 -154.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.208 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.45 -49.9 73.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.51 40.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 0.0 110.799 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.85 165.59 27.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.82 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.4 Cg_exo -75.22 1.6 7.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.956 2.437 . . . . 0.0 112.754 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 t -52.62 112.07 0.76 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.978 0.418 . . . . 0.0 111.185 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.88 118.52 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.524 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.814 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.31 147.2 37.76 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.422 0.629 . . . . 0.0 110.622 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.076 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.94 155.72 7.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.064 -176.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.06 -30.4 4.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.165 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.25 130.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.995 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.007 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.19 130.86 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 126.06 70.67 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.4 Cg_endo -67.71 132.11 26.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.71 2.273 . . . . 0.0 112.34 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.39 26.89 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.333 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.24 177.54 16.9 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.022 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.49 -34.39 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.747 0.308 . . . . 0.0 111.487 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.62 -57.45 4.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.832 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.48 -28.82 64.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.603 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.74 -32.83 68.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 110.337 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.14 -57.89 3.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.685 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.57 9.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.717 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.7 mtm180 -113.93 -7.62 13.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.739 0.304 . . . . 0.0 110.821 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.076 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -121.2 154.02 36.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.079 0.466 . . . . 0.0 111.209 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -130.95 135.88 48.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.604 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -49.03 157.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.244 0.545 . . . . 0.0 111.454 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.9 t30 76.87 -2.02 2.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.111 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -65.47 124.54 22.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.1 p -86.5 100.76 12.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.52 0.676 . . . . 0.0 111.233 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 19' ' ' ILE . 65.8 mt -49.99 130.37 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.875 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HG ' ' CG ' ' A' ' 89' ' ' MET . 3.7 mt -112.91 -34.04 5.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.113 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -151.09 159.41 44.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.438 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.032 HG11 ' HB1' ' A' ' 76' ' ' ALA . 7.7 p -146.69 105.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 84' ' ' VAL . 18.7 t30 68.62 -67.18 0.21 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.137 0.494 . . . . 0.0 109.992 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.9 mm-40 -162.46 29.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.047 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 60' ' ' VAL . 1.4 t -121.01 142.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.279 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 18.0 t0 -106.36 90.75 3.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 65' ' ' VAL . 30.3 m -70.54 63.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.429 . . . . 0.0 111.567 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -26.64 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -147.6 55.27 1.07 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 29.4 m -124.69 146.97 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.455 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.61 154.44 40.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.226 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.869 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.8 p-80 -48.12 -34.61 10.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.2 p -71.95 -33.75 68.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.197 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.691 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -45.39 80.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.61 -46.58 89.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.582 0.706 . . . . 0.0 109.203 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 70' ' ' HIS . 93.7 t -57.5 -50.47 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.245 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.691 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.86 -30.36 63.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.091 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 1.032 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.07 -49.79 75.9 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.28 0.562 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.976 HD11 HD12 ' A' ' 19' ' ' ILE . 4.0 mt -59.25 -35.54 73.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.739 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -77.31 -23.26 51.06 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.12 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -105.34 16.96 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.042 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.896 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.54 16.21 4.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.147 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -97.16 0.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.171 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 25.8 t -138.07 -89.09 0.24 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.872 ' CD1' HG22 ' A' ' 7' ' ' THR . 0.7 OUTLIER -85.98 87.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.264 0.554 . . . . 0.0 109.626 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.896 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.4 p -101.94 140.18 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.609 ' HG2' HG23 ' A' ' 7' ' ' THR . 56.5 mtm180 -87.97 103.18 15.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.802 ' CD2' HG23 ' A' ' 60' ' ' VAL . 11.8 mt -91.76 139.01 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.64 131.98 47.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.244 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 57' ' ' ILE . 14.2 m -139.87 158.68 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.496 ' HB2' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -113.12 150.08 32.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 110.747 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 120.99 14.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.431 HH22 HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.903 0.382 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.38 119.16 17.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.009 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.665 ' CE2' HD13 ' A' ' 58' ' ' LEU . 3.7 m-30 -82.88 130.85 35.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.684 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.1 144.57 38.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.085 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 43.9 mt-10 -102.33 144.69 30.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.982 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.19 109.39 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 111.563 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.836 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.33 121.53 23.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.012 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -132.27 128.2 37.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 5.7 pt-20 -86.96 100.9 12.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.57 ' CG ' HD23 ' A' ' 15' ' ' LEU . 6.6 mtp180 -43.72 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.935 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.71 74.42 0.03 OUTLIER Glycine 0 C--N 1.318 -0.433 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.042 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 10' ' ' ARG . 8.4 m-20 63.08 -76.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 111.24 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.2 t -69.98 -24.68 63.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.39 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 154.15 -172.2 32.76 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.038 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.012 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.2 mt -59.74 -63.7 1.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.827 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 135.67 39.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.484 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.789 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.5 p90 -161.79 137.31 7.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.986 0.393 . . . . 0.0 110.708 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.8 134.33 40.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.624 -179.265 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.04 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.51 146.92 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.588 0.709 . . . . 0.0 111.684 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -127.37 121.57 31.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.464 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 140.69 159.62 8.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.007 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.455 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 148.86 175.59 21.47 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.359 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 68' ' ' VAL . 25.0 p -66.71 -11.69 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 23.7 t70 -114.62 -26.59 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.44 87.2 54.41 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.57 66.21 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.301 2.001 . . . . 0.0 112.579 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.553 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 10.6 t-80 -48.43 -27.81 2.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.376 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.981 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -87.13 -155.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.437 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -52.83 -51.7 43.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.964 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.958 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.52 175.73 3.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.99 35.41 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.671 2.247 . . . . 0.0 112.445 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -84.84 114.77 22.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 110.903 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.926 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.69 118.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.066 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.981 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.15 148.03 37.61 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.344 0.593 . . . . 0.0 110.719 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.028 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.39 155.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.516 -177.224 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.13 -29.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.163 -178.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.34 130.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.785 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.983 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.62 132.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.466 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 125.56 71.71 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.1 Cg_endo -68.05 132.55 26.52 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 112.365 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.33 19.26 21.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.346 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.86 179.12 16.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.349 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.39 -33.31 59.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.653 0.263 . . . . 0.0 111.479 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.823 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -73.36 -56.0 5.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.45 -29.08 63.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 10.8 pt20 -72.19 -31.85 66.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.274 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.88 -57.94 3.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.4 11.9 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.592 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.67 -15.76 13.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.766 0.283 . . . . 0.0 110.863 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.028 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -113.9 153.37 29.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.21 0.529 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.99 136.28 48.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.574 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.2 t -49.08 157.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.363 0.601 . . . . 0.0 111.543 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER 76.82 -1.04 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.302 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -66.51 124.52 23.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.54 100.48 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.55 0.691 . . . . 0.0 111.432 -178.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 19' ' ' ILE . 27.4 mt -48.3 135.61 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.596 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' A' ' 3' ' ' TYR . 3.0 pp -139.92 12.79 2.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 170.82 134.74 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.317 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.799 HG21 ' CB ' ' A' ' 76' ' ' ALA . 37.5 t -123.91 95.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.299 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.626 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.6 t-20 73.26 -60.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 27.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.475 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 40.8 t -121.27 109.11 24.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.993 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -70.48 120.81 16.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.512 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.727 HG21 HG22 ' A' ' 57' ' ' ILE . 22.1 m -93.99 20.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -22.63 66.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.116 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.26 44.18 1.89 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.059 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 23' ' ' THR . 16.7 m -124.41 145.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.036 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.513 ' HG1' ' HG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -66.07 153.65 41.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.558 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.9 t-160 -49.14 -34.2 13.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.744 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.513 ' HG ' ' HG1' ' A' ' 69' ' ' THR . 0.1 OUTLIER -70.86 -33.76 70.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.7 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.676 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.05 -31.67 69.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.926 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -71.56 -46.96 57.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.636 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 81.8 t -60.48 -50.54 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.283 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -58.33 -34.89 71.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.39 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.799 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -55.22 -49.34 72.22 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.426 0.631 . . . . 0.0 110.09 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.918 HD11 HD12 ' A' ' 19' ' ' ILE . 1.8 mt -59.65 -36.01 75.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.591 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.36 -21.95 52.51 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mt-10 -102.05 -6.33 23.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.684 0.278 . . . . 0.0 111.383 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.921 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -59.71 -17.74 37.04 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.251 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.0 -117.04 5.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.921 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 m -110.68 -89.29 0.5 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.836 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.1 tp -90.92 90.91 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.296 0.569 . . . . 0.0 109.732 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.921 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -103.89 138.29 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.05 102.89 15.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.788 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.1 mt -89.78 134.7 34.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -101.91 116.52 32.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.271 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.5 m -122.83 150.97 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.485 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 1.2 ptt? -118.58 144.54 46.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.397 . . . . 0.0 111.234 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -138.11 120.06 15.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.793 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.565 HH22 HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.003 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 2.6 ttt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.969 0.414 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.82 136.39 38.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.353 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 56.2 m-85 -111.74 109.83 19.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -113.2 163.87 14.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 111.065 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 68.8 mt-10 -114.16 144.6 42.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.78 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.948 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -132.39 109.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.501 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.938 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.26 120.67 23.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.043 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -132.29 127.22 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.6 pt-20 -85.9 100.84 12.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.192 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.588 ' CG ' HD23 ' A' ' 15' ' ' LEU . 9.7 mtp180 -42.77 91.85 0.0 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.35 0.595 . . . . 0.0 110.835 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -61.86 75.72 0.02 OUTLIER Glycine 0 C--N 1.316 -0.56 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.117 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 10' ' ' ARG . 3.3 m120 62.29 -76.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.865 0.364 . . . . 0.0 111.25 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.9 m -70.13 -23.77 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.261 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 152.08 -172.07 31.39 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.026 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.043 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.9 mt -57.86 -63.64 1.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.781 0.324 . . . . 0.0 110.924 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 131.97 38.25 0.26 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.594 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.801 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -160.44 135.36 7.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.006 0.403 . . . . 0.0 110.729 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.41 136.84 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.525 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.065 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.21 148.84 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.743 0.783 . . . . 0.0 112.337 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -143.25 133.22 24.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.12 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.89 -2.95 1.24 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.184 -1.007 . . . . 0.0 113.879 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.552 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.04 -173.16 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.951 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.802 HG22 ' CB ' ' A' ' 32' ' ' PRO . 19.9 p -73.09 -20.9 60.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -96.35 -24.61 16.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.585 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.36 87.52 53.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.211 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.73 63.17 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.384 2.056 . . . . 0.0 112.652 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.639 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.4 t-80 -49.78 -26.58 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.842 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.15 -154.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.323 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.91 -50.04 71.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.615 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.72 40.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.09 169.19 12.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.802 ' CB ' HG22 ' A' ' 23' ' ' THR . 98.0 Cg_endo -79.35 3.5 7.42 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.566 2.178 . . . . 0.0 112.74 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -53.61 111.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.883 0.373 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.838 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.55 119.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.838 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.842 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.23 147.22 36.15 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 121.361 0.601 . . . . 0.0 110.779 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.96 155.6 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.803 -177.011 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.451 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.6 -29.53 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.286 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.99 130.19 0.49 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.001 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.003 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.5 131.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.481 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 124.33 74.25 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.0 Cg_endo -66.2 132.58 30.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.348 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.81 17.46 25.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.437 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 177.39 17.27 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.042 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.68 -32.76 52.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 111.444 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.812 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -71.55 -57.3 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.799 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.15 -29.02 63.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.477 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -71.95 -33.32 68.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.148 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -79.37 -58.05 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.38 39.97 10.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.592 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.468 ' CB ' HG12 ' A' ' 6' ' ' ILE . 19.2 mmt180 -115.88 -4.75 12.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 110.814 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 6.1 tp -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.589 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 134.55 42.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.487 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.09 157.5 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.319 0.58 . . . . 0.0 111.681 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER 77.01 -1.61 2.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.174 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.17 125.55 26.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.653 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.26 12.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.753 0.787 . . . . 0.0 111.435 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.065 HD11 HG21 ' A' ' 19' ' ' ILE . 65.8 mt -47.35 138.35 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.887 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.508 HD11 HH21 ' A' ' 66' ' ' ARG . 0.2 OUTLIER -117.31 -44.42 2.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.073 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -142.52 167.14 22.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.771 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 86' ' ' LEU . 23.4 t -142.22 97.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.788 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.501 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.8 t-20 67.57 -67.99 0.17 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.093 0.473 . . . . 0.0 109.775 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.2 tt0 -155.71 33.71 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.481 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.1 t -120.73 142.49 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.636 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.7 p-10 -106.95 111.23 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.29 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HB ' HD12 ' A' ' 34' ' ' ILE . 18.2 m -95.32 31.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.801 0.334 . . . . 0.0 111.54 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.508 HH21 HD11 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -63.33 -29.16 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.766 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.85 65.91 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.729 ' O ' HG23 ' A' ' 23' ' ' THR . 27.2 m -136.19 147.12 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.274 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.54 153.01 33.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.0 t-160 -50.51 -33.75 22.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -34.02 73.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.756 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.29 -39.96 81.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.838 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.11 -46.99 78.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.6 t -57.02 -50.34 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.253 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.38 -30.69 63.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.026 178.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.672 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -60.44 -49.78 76.2 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.405 0.622 . . . . 0.0 109.908 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.996 HD11 HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -60.27 -34.76 74.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.48 -26.77 51.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.361 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.84 15.54 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.383 -178.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.22 16.28 6.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.172 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.98 -114.01 5.57 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.989 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.4 m -114.99 -89.36 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.938 HG13 HG22 ' A' ' 7' ' ' THR . 7.1 tp -86.77 97.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.993 0.425 . . . . 0.0 110.222 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.901 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -111.37 138.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.573 ' HG2' HG23 ' A' ' 7' ' ' THR . 7.2 mtt85 -88.16 103.24 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.8 mt -91.12 142.97 27.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.74 136.07 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.768 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 51' ' ' LEU . 17.2 m -139.87 143.93 29.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.469 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 9.1 ptt? -108.11 136.87 47.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.61 0.243 . . . . 0.0 110.758 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 106.89 5.16 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.942 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HE2' ' HE3' ' A' ' 89' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.776 0.322 . . . . 0.0 111.223 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -112.54 134.44 54.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 89' ' ' MET . 20.6 m-85 -91.79 146.09 24.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -144.42 147.46 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.968 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 39.6 mt-10 -104.63 144.74 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.963 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.23 109.26 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.033 0.444 . . . . 0.0 111.439 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.25 122.96 25.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.016 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.6 tp -134.23 127.05 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -82.4 100.43 10.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.542 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -50.33 92.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.514 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 13' ' ' SER . . . -63.29 68.22 0.03 OUTLIER Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.286 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER 63.97 -71.33 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.584 179.412 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' GLY . 4.4 t -70.05 -24.73 63.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.29 -170.32 32.77 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.771 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.016 ' HB3' HD23 ' A' ' 8' ' ' LEU . 8.4 mt -69.87 -63.61 1.04 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.501 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 138.2 39.12 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.632 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.795 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.8 p90 -160.17 134.29 7.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.093 0.446 . . . . 0.0 110.764 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.68 133.43 37.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.071 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.67 162.98 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.711 0.767 . . . . 0.0 111.632 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.687 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -160.36 132.61 6.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.357 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 -2.8 1.47 Allowed Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.464 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.74 -175.57 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.138 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 32.2 p -67.97 -29.1 68.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.78 -20.49 20.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -124.17 87.02 53.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.71 61.74 0.86 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.354 2.036 . . . . 0.0 112.645 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.687 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 9.0 t-80 -47.57 -29.09 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.033 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.847 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.74 -155.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.194 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.67 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.88 -49.52 47.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.46 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -178.17 49.01 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.897 0.379 . . . . 0.0 111.231 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.08 159.16 70.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CB ' HG22 ' A' ' 23' ' ' THR . 96.6 Cg_endo -79.1 3.41 7.45 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.647 2.232 . . . . 0.0 112.691 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.43 119.43 5.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.976 0.417 . . . . 0.0 110.931 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.856 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.71 119.19 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.567 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.24 144.71 33.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.48 0.657 . . . . 0.0 110.783 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.056 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.74 155.94 7.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.311 -176.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.455 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.12 -29.82 4.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.343 -178.503 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.646 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.97 131.57 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.931 -179.432 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.955 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.471 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.37 115.3 59.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.5 Cg_exo -58.11 136.48 75.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.697 2.265 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 19.96 27.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.48 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.48 179.54 16.83 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.175 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.65 -36.55 57.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.859 0.361 . . . . 0.0 111.531 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -68.86 -57.41 5.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.2 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.55 -28.39 62.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.781 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -29.91 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.257 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.498 ' OD2' HD12 ' A' ' 8' ' ' LEU . 5.2 m-20 -82.49 -57.86 3.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.88 37.19 11.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.602 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.443 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtt180 -112.33 -14.43 13.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.713 0.292 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.056 HD21 HD12 ' A' ' 36' ' ' ILE . 7.1 tp -113.75 156.82 23.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.267 0.556 . . . . 0.0 111.374 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.616 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -135.09 134.66 40.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.413 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 38' ' ' LYS . 52.9 t -49.04 157.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.248 0.547 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.485 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 75.15 2.51 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.091 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.62 127.07 31.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.076 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.48 102.5 14.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 111.306 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.071 HD11 HG21 ' A' ' 19' ' ' ILE . 57.3 mt -49.7 131.2 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.814 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD21 ' HG3' ' A' ' 89' ' ' MET . 3.4 mm? -109.63 -43.17 4.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.106 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -143.16 164.94 28.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.813 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.747 HG11 ' HB1' ' A' ' 76' ' ' ALA . 21.4 t -143.61 98.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.991 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 68.09 -66.89 0.21 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.126 0.488 . . . . 0.0 109.992 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -157.65 33.24 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.687 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.7 t -120.73 142.4 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.582 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.1 t0 -109.04 95.29 5.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.337 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 65' ' ' VAL . 27.4 m -80.28 58.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 0.0 111.48 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -85.22 -31.52 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.757 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.68 52.69 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 27.3 m -121.16 148.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.06 153.4 43.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 t-160 -49.44 -34.1 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.792 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.9 m -68.71 -34.09 75.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.785 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.35 -42.05 79.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.856 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.4 -46.91 84.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.661 0.743 . . . . 0.0 109.076 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.5 t -57.31 -50.39 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.231 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.82 -29.89 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.864 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.747 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.14 -50.22 74.09 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.305 0.574 . . . . 0.0 109.847 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -58.78 -36.31 74.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.955 179.115 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.61 -25.16 49.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.452 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.53 16.38 26.53 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.32 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.38 16.3 5.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.241 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.35 -98.32 0.82 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.063 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 8.5 p -136.4 -90.38 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 7' ' ' THR . 8.5 tp -83.37 88.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 109.875 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.2 p -104.14 139.6 24.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.87 103.06 15.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.744 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.2 mt -90.96 141.17 29.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.442 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.85 138.48 38.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 51' ' ' LEU . 13.0 m -138.92 167.86 20.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.439 ' HG3' HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -114.61 138.12 51.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.47 115.06 9.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.937 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 3.9 mtm . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.86 0.362 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.19 147.85 26.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.41 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 78.1 m-85 -110.98 148.09 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.892 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HG2' HG23 ' A' ' 88' ' ' VAL . 2.6 pt-20 -138.32 167.24 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 5.6 tt0 -121.18 144.64 48.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.991 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.13 109.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.866 0.365 . . . . 0.0 111.739 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -82.02 112.19 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.991 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -121.68 127.31 50.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.9 pt-20 -83.83 100.54 11.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.07 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.72 89.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.078 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.59 175.87 0.1 Allowed Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.556 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -54.94 -24.09 22.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 111.09 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.21 -24.82 15.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.111 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.66 -163.76 28.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.187 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.5 tp -66.77 -63.54 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.618 0.209 . . . . 0.0 110.731 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.28 22.05 1.01 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 119.745 -1.216 . . . . 0.0 114.809 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.875 ' CE2' HD23 ' A' ' 15' ' ' LEU . 10.5 p90 -161.4 136.51 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.035 0.918 . . . . 0.0 111.143 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.42 135.22 38.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.656 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.09 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.44 146.93 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.628 0.728 . . . . 0.0 111.367 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.83 124.07 34.41 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.706 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.85 -121.81 1.07 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.074 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 69.54 172.22 9.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.361 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 32' ' ' PRO . 4.3 p -77.85 -5.55 51.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.17 -23.14 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.516 ' O ' ' O ' ' A' ' 21' ' ' GLY . 2.6 t-20 -124.91 85.96 56.95 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.488 0.185 . . . . 0.0 110.57 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.153 1.902 . . . . 0.0 112.425 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.536 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 11.7 t-80 -53.8 -24.36 15.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.053 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.841 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.79 -153.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.337 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.682 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -65.35 -47.62 77.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.757 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.19 79.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 110.676 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -172.75 164.01 3.69 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.67 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.827 ' HB2' HG22 ' A' ' 23' ' ' THR . 96.0 Cg_endo -79.7 50.94 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.503 2.135 . . . . 0.0 112.174 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -99.28 116.65 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.873 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -89.99 112.49 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.459 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -137.31 146.76 45.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.125 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.103 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.05 155.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.169 -176.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.52 -30.36 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.04 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.12 131.04 0.48 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.031 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.98 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.88 132.8 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 115.26 59.32 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.123 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.3 Cg_exo -57.19 134.45 64.19 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.824 2.349 . . . . 0.0 112.201 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.25 4.02 59.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.642 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.55 179.39 22.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.801 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.66 -37.61 68.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.807 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.35 -57.45 6.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.56 -28.84 68.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.296 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.35 68.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 110.001 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.631 ' OD2' HD12 ' A' ' 8' ' ' LEU . 24.0 m-20 -82.86 -58.02 3.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.559 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 40.88 9.22 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.539 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER -115.6 6.98 14.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.94 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.103 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -135.24 154.76 51.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.993 0.425 . . . . 0.0 110.843 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.584 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.09 137.07 47.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.7 t -51.6 159.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.138 0.494 . . . . 0.0 111.716 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.4 m120 71.95 3.68 4.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.32 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.654 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.7 m-20 -74.63 128.37 35.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.85 105.25 16.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.564 0.697 . . . . 0.0 111.388 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.09 HD11 HG21 ' A' ' 19' ' ' ILE . 68.5 mt -51.09 141.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.602 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.41 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -121.61 -44.31 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.496 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -143.18 148.61 36.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.335 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.916 HG13 ' CD2' ' A' ' 86' ' ' LEU . 54.5 t -139.54 112.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.026 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.2 t30 50.81 35.8 13.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.129 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 80.23 33.94 0.16 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.501 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 60' ' ' VAL . 78.1 t -120.93 108.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 t0 -71.26 117.18 12.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.713 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 57' ' ' ILE . 33.8 m -101.89 23.45 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.301 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -62.84 -25.52 68.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -146.07 57.4 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.181 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.782 ' C ' HG23 ' A' ' 23' ' ' THR . 31.8 m -132.79 141.83 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.231 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.68 152.35 26.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.84 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 20.1 t-160 -47.99 -34.02 8.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.883 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -34.24 77.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.681 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.27 -40.62 77.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.873 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.0 -46.93 82.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.9 t -56.09 -50.86 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.391 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.681 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.76 -29.29 62.45 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.153 178.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.11 -56.72 18.18 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.359 0.6 . . . . 0.0 110.044 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 73' ' ' ALA . 2.0 mp -53.86 -36.4 62.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.34 -27.29 52.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.659 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.26 15.67 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.0 111.47 -178.411 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.991 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.81 16.32 4.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.316 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.03 -89.33 0.13 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.384 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -143.44 -88.87 0.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.763 HG13 HG22 ' A' ' 7' ' ' THR . 4.2 tp -84.4 91.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.991 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.4 p -107.06 135.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.1 ptt180 -86.81 102.96 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.916 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.8 mt -91.63 143.56 26.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.083 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CD1' ' HG3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -101.68 139.71 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.523 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG21 ' OD2' ' A' ' 55' ' ' ASP . 28.9 m -139.62 167.93 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.805 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 38.1 ttp -111.49 159.9 17.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.104 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 130.03 24.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.428 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.056 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttm . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.834 0.349 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -88.38 150.86 22.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.969 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.451 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 36.1 m-85 -105.83 150.07 25.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.795 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 133.31 21.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -97.17 144.61 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.076 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.0 109.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.863 0.364 . . . . 0.0 111.833 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.796 HG23 HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -79.83 114.55 18.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.076 HD13 HD11 ' A' ' 6' ' ' ILE . 5.6 tp -120.78 127.05 51.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.819 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.73 ' N ' HD12 ' A' ' 83' ' ' ILE . 3.8 pt-20 -80.59 99.92 8.36 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.558 ' NE ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -56.44 88.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.901 178.11 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.1 171.63 21.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.225 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 54.56 -89.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.64 0.257 . . . . 0.0 110.817 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.9 t -108.35 20.88 18.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.106 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 107.89 -138.77 14.77 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.086 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.982 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.5 tp -73.74 -63.7 1.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.003 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 126.6 25.19 1.3 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.849 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.843 ' CE2' HD23 ' A' ' 15' ' ' LEU . 4.5 p90 -161.82 134.75 6.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.854 0.827 . . . . 0.0 111.256 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.67 134.16 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.105 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.96 168.26 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.686 0.755 . . . . 0.0 111.677 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -165.43 132.2 2.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.319 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.4 0.54 1.16 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.545 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.562 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.015 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.777 HG22 ' CB ' ' A' ' 32' ' ' PRO . 16.6 p -74.42 -22.45 59.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -97.18 -23.76 16.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.693 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.32 87.7 53.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.365 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.84 63.16 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.339 2.026 . . . . 0.0 112.742 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.644 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.3 t-80 -47.53 -28.47 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.859 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.85 -155.1 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.239 179.46 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.47 -47.49 56.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.597 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.8 t0 177.23 76.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.37 165.26 7.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.861 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.777 ' CB ' HG22 ' A' ' 23' ' ' THR . 89.9 Cg_endo -81.12 6.68 5.42 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.657 2.238 . . . . 0.0 112.79 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.39 112.17 1.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.52 119.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.585 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.859 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.44 146.0 34.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.522 0.677 . . . . 0.0 110.668 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.049 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.79 155.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.415 -176.427 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.21 -30.46 4.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.347 -178.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.45 132.21 0.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.051 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.99 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.88 132.0 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.435 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.3 118.12 70.41 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.506 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.8 Cg_exo -58.01 135.29 67.72 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.363 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.1 3.02 62.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.845 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.77 178.49 23.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.057 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.58 -34.62 64.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.011 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.793 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -71.82 -56.92 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.679 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.19 -30.28 70.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.94 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 12.1 pt20 -72.06 -33.45 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -57.93 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.71 9.16 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.614 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.485 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.2 mtp85 -113.27 8.12 17.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.804 0.335 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.049 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -136.65 154.73 50.56 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.053 0.454 . . . . 0.0 110.816 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 tpm_? -131.76 136.3 47.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -51.58 157.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 111.564 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.2 t30 74.07 3.15 4.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.177 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.664 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -73.73 127.0 31.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.42 100.97 12.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.659 0.743 . . . . 0.0 111.296 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.105 HD11 HG21 ' A' ' 19' ' ' ILE . 62.5 mt -46.24 149.51 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.813 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -127.62 -45.71 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.387 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -143.03 157.78 44.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.081 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.85 HG11 ' HB1' ' A' ' 76' ' ' ALA . 41.7 t -132.55 95.73 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.873 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.9 t-20 68.85 -66.93 0.23 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.166 0.508 . . . . 0.0 109.896 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -155.59 32.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.654 179.171 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 86.4 t -120.7 142.2 37.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.512 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 24.5 t0 -107.86 112.15 24.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 23.8 m -94.18 36.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 111.513 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -65.07 -31.54 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.721 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.28 68.09 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.713 ' O ' HG23 ' A' ' 23' ' ' THR . 27.0 m -137.62 145.05 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.281 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.2 150.56 34.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.757 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.7 t-160 -48.1 -33.78 8.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.75 -34.1 76.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.027 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.67 -39.91 80.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.82 -46.92 76.81 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.646 0.736 . . . . 0.0 109.081 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 70' ' ' HIS . 97.2 t -57.2 -50.55 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.206 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.57 -30.48 60.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.953 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.63 -50.57 72.97 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.41 0.624 . . . . 0.0 110.018 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.064 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -58.55 -37.17 75.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.045 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -26.41 50.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.505 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.43 18.89 20.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 0.0 111.306 -178.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.77 16.25 6.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.531 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.31 -86.69 0.41 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.635 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' LEU . 38.1 m -147.67 -90.87 0.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.796 HD11 HG23 ' A' ' 7' ' ' THR . 8.4 tp -84.17 90.68 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.452 0.644 . . . . 0.0 109.743 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.949 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.8 p -105.92 135.06 45.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.294 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.6 ttt180 -85.21 102.89 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.565 HD12 ' HZ ' ' A' ' 17' ' ' PHE . 15.3 mt -92.05 140.9 29.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.969 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.55 141.18 34.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.713 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.664 HG21 ' OD2' ' A' ' 55' ' ' ASP . 25.1 m -135.6 167.03 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.581 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.445 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -115.55 145.31 42.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.929 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.82 134.63 32.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.983 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.907 0.384 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -107.87 120.23 41.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 4.6 m-30 -85.46 144.32 28.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -151.18 146.15 25.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.8 pt-20 -100.74 144.57 29.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.978 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.45 110.0 9.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.895 0.379 . . . . 0.0 111.521 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.909 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -76.92 121.48 23.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.03 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.4 tp -134.22 127.1 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 83' ' ' ILE . 4.1 pt-20 -85.89 100.88 12.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.344 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.634 ' CG ' HD23 ' A' ' 15' ' ' LEU . 8.0 mtp-105 -44.94 92.37 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.22 0.533 . . . . 0.0 110.897 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -60.64 73.36 0.01 OUTLIER Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.13 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER 64.15 -71.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.713 0.292 . . . . 0.0 111.586 179.539 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -74.97 -21.15 59.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.469 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . 150.87 -173.19 30.45 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.93 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.03 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.3 mt -58.31 -63.57 1.22 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.84 0.353 . . . . 0.0 110.793 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.77 39.17 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.086 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.9 p90 -162.51 132.38 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.345 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -92.48 137.29 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.134 0.492 . . . . 0.0 111.724 -179.046 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -120.3 142.11 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.661 0.744 . . . . 0.0 111.95 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -106.06 117.2 33.41 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.814 ' HA2' HG23 ' A' ' 34' ' ' ILE . . . -71.21 -158.72 3.09 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.44 -44.09 0.12 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.734 -0.746 . . . . 0.0 114.571 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.759 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -69.02 -58.9 3.47 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.672 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 4.0 m-20 -81.67 -34.2 30.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.09 0.471 . . . . 0.0 110.52 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' HIS . 11.1 t-20 -124.44 87.7 53.92 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.248 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.75 64.98 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.288 1.992 . . . . 0.0 112.538 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.572 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.2 t-80 -57.53 -21.82 40.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.724 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.764 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -96.61 -150.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.688 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -85.19 44.22 3.35 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.885 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 76.18 30.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.961 0.41 . . . . 0.0 110.738 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.47 146.92 38.56 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CB ' HG22 ' A' ' 23' ' ' THR . 74.4 Cg_endo -74.9 55.27 3.84 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.52 2.146 . . . . 0.0 112.508 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -121.01 108.88 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.964 HD11 ' O ' ' A' ' 68' ' ' VAL . 2.7 mp -79.49 131.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.764 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -142.89 152.82 42.5 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.213 0.53 . . . . 0.0 110.27 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.888 HD12 HD21 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -69.41 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.553 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.521 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.08 -26.12 4.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.978 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -176.53 131.73 0.21 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.868 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.8 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.49 130.37 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.36 114.16 53.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.1 Cg_exo -56.22 139.96 86.8 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.599 2.199 . . . . 0.0 112.205 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.2 15.24 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.522 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.55 174.69 16.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.986 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -30.64 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.251 . . . . 0.0 111.129 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.836 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -72.94 -57.52 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 111.823 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.66 -28.58 63.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.535 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -72.02 -30.84 65.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 110.382 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 8' ' ' LEU . 2.5 m-20 -80.53 -57.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.16 37.0 10.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.711 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -118.95 4.57 11.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.821 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 36' ' ' ILE . 16.3 tp -132.73 159.81 38.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.218 0.532 . . . . 0.0 111.173 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.595 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -139.44 152.77 47.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 38' ' ' LYS . 77.8 t -65.75 158.9 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.054 0.454 . . . . 0.0 111.271 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 53' ' ' VAL . 55.3 m-80 77.27 -6.35 2.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.714 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -64.44 125.86 25.99 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.87 104.39 16.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.611 0.719 . . . . 0.0 111.773 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.03 HG22 HG21 ' A' ' 65' ' ' VAL . 46.1 mt -48.2 138.89 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.794 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 89' ' ' MET . 1.1 mt -126.4 -37.75 2.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.471 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -147.17 156.67 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.917 HG13 ' CD2' ' A' ' 86' ' ' LEU . 47.8 t -141.21 102.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.232 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 66.95 -68.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.098 0.475 . . . . 0.0 110.247 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.86 31.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.929 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.8 t -120.79 142.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.281 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.8 p-10 -101.65 108.18 19.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.03 HG21 HG22 ' A' ' 57' ' ' ILE . 26.7 m -97.26 30.72 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.311 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.53 -37.45 75.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 110.725 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.25 56.32 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.505 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.964 ' O ' HD11 ' A' ' 34' ' ' ILE . 33.6 m -114.59 141.03 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.159 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.759 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 1.8 p -51.06 150.16 3.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.223 0.535 . . . . 0.0 112.0 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.803 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -47.09 -32.99 4.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.527 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 3.6 m -73.81 -33.31 64.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.387 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.66 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.79 -32.12 70.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.042 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.92 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.55 -46.89 58.2 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.0 t -60.29 -50.66 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.733 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.7 pt-20 -58.31 -31.48 67.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.497 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.786 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -58.39 -49.26 77.9 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.308 0.575 . . . . 0.0 109.795 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.814 ' CD1' HD12 ' A' ' 19' ' ' ILE . 1.5 mt -61.25 -34.67 75.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.186 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.14 -29.06 54.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.512 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.7 pt-20 -98.79 15.39 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.525 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.57 16.3 6.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.35 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.21 -114.76 6.57 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.078 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.9 OUTLIER -113.59 -88.87 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.894 HG13 HG22 ' A' ' 7' ' ' THR . 7.1 tp -86.72 100.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.122 0.487 . . . . 0.0 110.113 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -114.96 139.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.909 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.3 103.02 15.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.917 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.2 mt -91.84 137.22 32.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.511 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.87 131.56 48.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.5 m -139.72 152.45 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.134 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.746 ' HB3' HD21 ' A' ' 58' ' ' LEU . 25.5 ptt? -118.23 149.53 40.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.12 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -140.5 125.16 18.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.087 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -107.07 118.47 36.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.755 ' CE2' HD22 ' A' ' 58' ' ' LEU . 3.0 m-30 -96.6 107.45 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.575 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -115.16 165.02 13.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 111.251 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -120.0 145.01 47.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.836 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.15 110.98 14.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 111.931 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.924 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.35 117.15 20.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 5.1 tp -128.28 126.83 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.0 pt-20 -85.24 100.45 11.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.537 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.0 88.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.15 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.99 176.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.703 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -55.12 -24.03 23.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 111.099 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.7 p -97.06 -24.78 15.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.273 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.25 -163.25 28.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.164 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.005 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.2 tp -66.47 -63.39 1.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.698 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.77 21.95 0.97 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.65 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.866 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.8 p90 -161.42 137.46 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.736 0.768 . . . . 0.0 111.055 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.04 133.21 40.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.38 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.055 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.03 165.06 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.657 0.741 . . . . 0.0 111.76 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -162.64 132.11 4.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.262 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.84 0.66 0.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.42 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.15 -170.7 0.34 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.859 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.844 HG22 ' HB3' ' A' ' 32' ' ' PRO . 23.9 p -69.81 -32.62 71.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.79 -19.72 23.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.14 86.79 53.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.633 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.59 60.2 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.292 1.995 . . . . 0.0 112.547 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.636 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.4 t-80 -47.8 -28.71 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.145 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.844 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.23 -153.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.14 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.677 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -66.29 -47.83 68.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.413 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.32 46.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.349 . . . . 0.0 110.835 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.97 161.74 61.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.844 ' HB3' HG22 ' A' ' 23' ' ' THR . 7.5 Cg_exo -73.03 -2.78 12.54 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.864 2.376 . . . . 0.0 112.689 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -49.16 113.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.929 0.395 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.832 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -85.7 119.19 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.46 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.844 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.46 146.45 34.8 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.526 0.679 . . . . 0.0 110.794 178.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.075 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.92 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.954 -176.717 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.19 -28.68 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.337 -178.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.56 129.64 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.071 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.981 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.49 133.05 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.424 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 129.95 55.93 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 56.0 Cg_endo -70.0 130.24 18.71 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.784 2.323 . . . . 0.0 112.304 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 2.65 55.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.64 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.49 179.23 24.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.078 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.79 -35.48 68.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 111.065 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.859 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -71.9 -56.75 5.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.82 -31.89 72.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.93 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.1 pt20 -72.11 -33.73 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 110.159 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.43 -57.91 3.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.01 41.27 9.65 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.627 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.524 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -113.31 7.02 17.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.947 0.403 . . . . 0.0 110.795 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.075 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -135.97 154.16 51.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.37 135.54 48.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -49.7 157.95 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.556 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.4 t30 75.05 2.18 3.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -70.45 123.37 21.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.53 100.42 12.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.889 0.852 . . . . 0.0 111.54 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 19' ' ' ILE . 20.0 mt -49.18 142.79 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.392 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.755 HD22 ' CE2' ' A' ' 3' ' ' TYR . 1.4 mt -124.54 -37.84 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.069 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 m-85 -143.8 164.3 30.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.887 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.8 t -151.54 103.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.26 42.46 31.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.86 32.68 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.599 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 88.9 t -120.92 112.75 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.417 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 t0 -80.8 110.43 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 65' ' ' VAL . 33.4 m -83.09 55.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.8 105.67 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.12 48.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' THR . 11.8 m -116.1 142.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.977 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -61.29 152.01 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.867 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 t-160 -49.6 -33.76 16.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.211 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.761 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.64 -43.22 80.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.89 -46.88 82.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.0 t -57.48 -48.45 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.285 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.88 -31.74 63.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.764 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.652 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.8 -53.11 61.83 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.211 0.529 . . . . 0.0 109.797 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.037 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -52.49 -37.44 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.262 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.57 -27.8 51.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.082 178.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.2 mm-40 -84.08 -19.97 33.41 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 110.602 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -53.03 -18.81 2.24 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.628 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.78 -92.75 1.83 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.8 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -129.99 -92.34 0.44 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.924 HG13 HG22 ' A' ' 7' ' ' THR . 8.8 tp -86.59 100.97 10.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.178 0.513 . . . . 0.0 110.442 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.936 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.4 p -116.06 138.77 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.2 102.87 14.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.292 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.887 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.2 mt -93.37 135.59 34.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.57 135.46 43.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.743 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 57' ' ' ILE . 19.0 m -139.65 159.77 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.808 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.685 ' HG2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -121.51 137.69 54.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 111.033 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.76 134.92 34.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.955 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HB2' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.806 0.336 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -99.69 128.94 45.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.064 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.429 ' CE1' ' HG2' ' A' ' 89' ' ' MET . 11.2 m-30 -90.38 150.5 21.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.9 mm-40 -145.13 168.29 20.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 0.0 111.287 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -118.05 144.79 45.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.88 110.53 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 111.653 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.841 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.48 120.5 22.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 4.2 tp -132.58 127.45 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.433 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.636 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.0 pt-20 -86.56 100.88 12.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.588 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' CG ' HD23 ' A' ' 15' ' ' LEU . 2.6 mtp-105 -42.76 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.994 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.27 73.53 0.02 OUTLIER Glycine 0 C--N 1.318 -0.418 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.061 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.9 OUTLIER 63.2 -75.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 0.0 111.342 179.684 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 11' ' ' GLY . 29.0 t -70.05 -24.65 63.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.376 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 153.57 -172.63 32.37 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.801 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.005 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.5 mt -59.46 -63.59 1.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.645 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 135.34 39.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.598 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.785 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.4 p90 -161.69 133.85 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.483 . . . . 0.0 111.161 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.492 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.08 134.62 34.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.287 -179.489 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.107 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.93 162.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.675 0.75 . . . . 0.0 111.731 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -158.76 131.76 7.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.046 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.51 -1.3 0.98 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.504 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.14 -168.93 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.94 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.848 HG22 ' HB3' ' A' ' 32' ' ' PRO . 12.2 p -77.09 -23.49 51.86 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.206 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -94.87 -25.32 16.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.329 . . . . 0.0 111.557 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 27' ' ' HIS . 23.6 m-80 -124.65 82.82 59.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.6 64.24 0.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.912 2.408 . . . . 0.0 112.66 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.631 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.1 t-80 -50.68 -24.27 3.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.374 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.794 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.12 -154.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.762 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.633 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -80.1 52.48 4.27 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.733 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 74.76 30.53 0.99 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -117.08 147.76 40.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.848 ' HB3' HG22 ' A' ' 23' ' ' THR . 11.8 Cg_exo -70.76 -2.71 11.33 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.812 2.342 . . . . 0.0 112.88 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -53.99 116.55 2.62 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.035 0.445 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.865 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.84 120.19 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.375 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.794 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.52 144.93 33.17 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.456 0.646 . . . . 0.0 110.642 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.065 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.78 155.68 7.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.307 -176.529 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.67 -33.79 4.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.846 -178.905 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.52 142.49 2.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.517 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.005 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.19 132.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.321 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.96 125.17 73.54 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 46.2 Cg_endo -68.15 131.94 24.86 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.784 2.322 . . . . 0.0 112.413 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.04 27.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.27 178.96 16.37 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.203 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.35 -38.86 59.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.732 0.301 . . . . 0.0 111.461 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.793 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.98 -57.11 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.43 -30.32 65.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.7 OUTLIER -72.08 -30.59 65.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.948 0.404 . . . . 0.0 110.354 179.67 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.448 ' CG ' HE21 ' A' ' 47' ' ' GLN . 1.4 m-20 -81.95 -58.03 3.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.514 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.92 9.62 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.527 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 23.8 mtm180 -115.75 -3.99 12.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.808 0.304 . . . . 0.0 110.944 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.065 HD21 HD12 ' A' ' 36' ' ' ILE . 5.1 tp -122.57 153.94 38.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.883 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -131.8 135.86 47.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.865 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.41 158.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.307 0.575 . . . . 0.0 111.725 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.27 1.87 3.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.028 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -70.06 124.85 25.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.41 101.06 12.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.16 -178.694 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.107 HD11 HG21 ' A' ' 19' ' ' ILE . 55.8 mt -49.44 129.68 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.703 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.846 HD21 ' CG ' ' A' ' 89' ' ' MET . 7.9 mt -110.75 -31.7 7.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -151.05 166.42 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.3 t -148.91 100.45 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.219 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.649 ' OD1' HG23 ' A' ' 84' ' ' VAL . 14.0 t30 67.58 -67.31 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 110.065 -178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.0 mt-10 -157.92 32.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 49.5 t -119.57 142.21 36.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.529 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 30.1 t0 -111.65 84.96 2.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.362 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 65' ' ' VAL . 32.6 m -69.39 64.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.55 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -87.03 -28.09 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -151.31 59.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.688 ' O ' HG23 ' A' ' 23' ' ' THR . 34.5 m -127.78 145.38 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.261 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 150.66 27.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.822 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -48.29 -33.42 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -68.22 -34.04 75.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.072 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.11 -40.87 82.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.865 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.26 -46.84 81.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.021 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.0 t -57.74 -50.31 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.308 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -56.16 -34.31 66.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.647 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.618 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.58 -51.38 68.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.241 0.543 . . . . 0.0 110.109 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.021 HD11 HD12 ' A' ' 19' ' ' ILE . 2.9 mt -56.22 -36.43 68.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.416 179.065 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.2 mmmt -77.47 -24.62 50.18 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.33 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -95.81 -10.11 29.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 111.327 -178.858 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.91 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.81 -17.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.387 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.98 -109.76 3.74 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.8 m -118.84 -90.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.808 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.841 HG13 HG22 ' A' ' 7' ' ' THR . 7.9 tp -89.21 89.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.257 0.551 . . . . 0.0 109.735 178.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.91 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -103.54 140.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.497 ' HG3' HG23 ' A' ' 7' ' ' THR . 3.7 mtt180 -87.73 102.98 15.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.083 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.65 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.2 mt -91.89 137.67 32.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.109 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.68 134.39 44.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.091 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.6 m -139.7 167.94 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.154 -179.441 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.846 ' CG ' HD21 ' A' ' 58' ' ' LEU . 27.6 mtm -98.32 134.46 41.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.653 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.27 106.77 11.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.503 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.444 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.291 -0.862 . . . . 0.0 110.774 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.836 0.351 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.42 113.92 13.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.3 m-30 -82.11 121.15 26.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.954 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -132.65 160.61 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -107.37 144.67 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.044 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.04 109.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.91 0.386 . . . . 0.0 111.507 179.796 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.883 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.22 119.08 20.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.709 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.044 HD13 HD11 ' A' ' 6' ' ' ILE . 5.5 tp -130.81 127.33 38.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -86.68 99.41 11.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.647 179.443 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -54.49 92.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.868 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 13' ' ' SER . . . -65.6 59.89 0.12 Allowed Glycine 0 C--O 1.229 -0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 114.597 -177.151 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 64.04 -58.87 0.21 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.892 0.346 . . . . 0.0 111.777 178.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' GLY . 69.8 m -69.31 -25.04 64.03 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.923 -179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . 147.89 171.87 17.34 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.326 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.927 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.1 tp -65.6 -14.49 61.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.361 -0.419 . . . . 0.0 111.021 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 81.7 25.0 54.76 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.798 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -161.75 132.23 4.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.424 1.112 . . . . 0.0 111.857 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.53 138.75 32.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.83 -179.302 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.098 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.52 147.12 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.608 0.718 . . . . 0.0 111.939 179.756 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.673 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 134.4 31.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.183 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.9 -3.12 1.49 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.631 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.58 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.78 -176.19 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.045 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 68' ' ' VAL . 43.1 p -66.81 -30.33 70.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 9.6 t70 -93.56 -18.33 22.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -124.23 87.0 54.06 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.533 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.08 61.13 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.329 2.019 . . . . 0.0 112.606 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.673 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 9.4 t-80 -48.34 -28.32 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.04 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.851 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -85.47 -154.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.218 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.666 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.44 -49.82 48.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.439 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -178.44 47.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.383 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.66 160.89 64.8 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.142 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CB ' HG22 ' A' ' 23' ' ' THR . 94.5 Cg_endo -78.51 2.46 8.09 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 112.749 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -53.49 117.31 3.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.004 0.43 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.69 118.51 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.71 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.25 147.51 40.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.362 0.601 . . . . 0.0 110.599 178.453 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.077 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.06 155.5 7.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.8 -176.796 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.07 -33.71 3.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.528 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 142.29 2.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.063 0.458 . . . . 0.0 111.679 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.005 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.23 128.62 60.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.625 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.05 127.54 66.41 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 19.4 Cg_endo -60.2 137.99 78.61 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.759 2.306 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.65 -0.46 82.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.454 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.71 -179.99 38.82 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.084 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.26 -40.5 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.518 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.907 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -73.05 -54.99 7.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.468 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -63.94 -28.96 70.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.283 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -72.35 -36.54 68.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.005 0.431 . . . . 0.0 110.069 179.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -57.93 2.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.07 39.27 8.06 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.751 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' CB ' HG12 ' A' ' 6' ' ' ILE . 69.6 mtt-85 -112.98 8.5 18.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.906 0.353 . . . . 0.0 110.711 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.077 HD21 HD12 ' A' ' 36' ' ' ILE . 4.2 tp -133.02 153.72 51.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.1 137.75 49.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.836 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -51.65 157.88 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 111.732 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.475 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.5 t-20 76.92 -2.4 2.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.491 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -67.04 124.89 24.3 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.043 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 t -86.63 100.37 12.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.572 0.701 . . . . 0.0 111.129 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.098 HD11 HG21 ' A' ' 19' ' ' ILE . 59.9 mt -49.15 140.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.899 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' A' ' 89' ' ' MET . 2.6 mp -121.71 -32.36 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.552 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -150.86 164.23 36.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.791 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.665 HG21 ' CB ' ' A' ' 76' ' ' ALA . 25.9 t -141.92 97.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.758 ' OD1' HG23 ' A' ' 84' ' ' VAL . 10.4 t30 69.6 -65.84 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.111 0.482 . . . . 0.0 109.875 -178.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -159.41 32.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.709 179.2 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.5 t -120.78 142.25 37.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.579 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -103.97 110.8 23.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.26 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 20.2 m -94.43 34.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -25.63 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.877 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -146.21 60.68 1.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.036 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.796 ' O ' HG23 ' A' ' 23' ' ' THR . 26.8 m -133.48 150.06 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.182 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -69.18 154.51 41.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.341 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.6 t-160 -49.85 -34.49 20.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 t -70.32 -34.02 72.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.24 -41.58 80.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.62 -46.67 84.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 70' ' ' HIS . 95.7 t -57.54 -50.45 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.0 -29.86 60.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.966 178.55 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.665 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -61.94 -51.23 68.96 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.023 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -55.89 -37.59 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.452 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.39 -25.13 50.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.913 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -91.8 3.01 56.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.174 -179.019 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.14 16.55 7.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.04 -124.91 35.11 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.728 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 m -100.45 -88.4 0.36 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.883 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -83.06 111.52 19.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -130.21 137.7 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.812 ' HG3' HG23 ' A' ' 7' ' ' THR . 24.4 mtt180 -84.93 103.12 13.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.626 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.5 mt -91.91 141.2 28.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -101.67 128.13 48.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.648 179.985 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.3 m -139.78 158.68 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.909 ' HB3' HD11 ' A' ' 58' ' ' LEU . 15.3 ptp -121.45 132.81 54.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.875 0.369 . . . . 0.0 111.114 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -140.57 135.87 32.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.983 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.658 0.266 . . . . 0.0 111.229 . . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -122.07 141.9 50.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.369 . . . . 0.0 111.033 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD1' HD22 ' A' ' 58' ' ' LEU . 7.3 m-30 -106.73 121.29 44.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.682 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.43 151.8 37.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -102.84 144.71 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.972 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.69 109.36 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.405 179.873 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.968 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.68 121.23 23.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.133 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.052 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -131.24 127.23 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.468 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.669 ' N ' HD12 ' A' ' 83' ' ' ILE . 4.3 pt-20 -86.73 100.29 12.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.261 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.585 ' HG3' HD23 ' A' ' 15' ' ' LEU . 22.7 mtp85 -41.18 91.45 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.145 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -61.69 76.58 0.02 OUTLIER Glycine 0 C--N 1.317 -0.474 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.921 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 10' ' ' ARG . 1.4 m-80 63.29 -76.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.318 . . . . 0.0 111.168 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -70.09 -19.69 63.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.403 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.451 ' HA2' ' NH1' ' A' ' 10' ' ' ARG . . . 145.78 -173.4 26.15 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.95 -179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.052 ' HB3' HD23 ' A' ' 8' ' ' LEU . 17.9 mt -51.85 -63.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.983 0.421 . . . . 0.0 110.885 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 132.96 36.75 0.27 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.403 -0.904 . . . . 0.0 113.162 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -163.27 134.19 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.039 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.26 137.15 32.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.622 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.39 150.1 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.691 0.758 . . . . 0.0 112.02 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -143.64 132.85 23.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.971 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.96 0.88 0.74 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.871 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.492 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.74 -177.82 0.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.671 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.81 HG22 ' HB3' ' A' ' 32' ' ' PRO . 16.0 p -72.0 -21.55 61.54 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.01 -24.22 17.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.723 0.296 . . . . 0.0 111.501 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -124.36 87.3 54.13 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.59 65.03 0.54 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.292 1.994 . . . . 0.0 112.446 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.662 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 9.5 t-80 -48.44 -27.88 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.469 179.086 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.849 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.62 -154.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.449 179.597 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.21 -47.82 56.44 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.664 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 t70 179.97 47.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.41 157.29 76.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.81 ' HB3' HG22 ' A' ' 23' ' ' THR . 6.1 Cg_exo -77.77 0.6 9.67 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.833 2.355 . . . . 0.0 112.693 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -53.32 120.57 6.19 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.124 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.826 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.61 120.19 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.339 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.849 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.66 146.75 36.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.346 0.593 . . . . 0.0 110.681 178.89 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.061 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.96 155.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.977 -176.774 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.89 -34.38 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.617 -179.175 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.629 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.07 143.5 3.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.5 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.996 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.83 131.77 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.292 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 120.74 75.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.883 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 29.3 Cg_endo -63.01 137.09 60.17 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.667 2.244 . . . . 0.0 112.279 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.99 14.85 50.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.372 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.09 177.14 16.34 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.14 -31.2 61.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.798 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -73.14 -57.4 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.611 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.91 -28.92 64.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.396 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.04 -32.63 67.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.48 ' OD2' HD12 ' A' ' 8' ' ' LEU . 11.7 m-20 -81.53 -58.04 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.692 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.86 39.89 9.16 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.482 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.444 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.3 mmt180 -116.11 1.57 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.061 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -129.56 154.92 46.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.128 0.489 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.563 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.2 ttt180 -133.43 136.02 44.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.686 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.0 t -49.88 157.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.589 . . . . 0.0 111.747 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.2 t-20 75.65 -1.75 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -66.11 125.01 24.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.907 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.5 103.31 14.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.533 0.682 . . . . 0.0 111.305 -178.76 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.033 HD11 HG21 ' A' ' 19' ' ' ILE . 51.3 mt -53.13 134.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.213 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD22 ' CD1' ' A' ' 3' ' ' TYR . 1.5 pp -134.79 13.56 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.884 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 169.98 138.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.169 0.509 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.5 t -127.39 97.36 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.611 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.6 ' OD1' HG23 ' A' ' 84' ' ' VAL . 9.6 t30 70.95 -62.81 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -163.35 31.62 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.0 t -120.92 117.34 52.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -82.36 109.55 16.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.585 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -93.79 41.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.284 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -64.58 -35.52 81.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.835 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.11 71.67 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.739 ' C ' HG23 ' A' ' 23' ' ' THR . 9.3 m -136.49 142.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.44 156.23 10.7 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.313 0.578 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.9 p-80 -49.74 -34.1 18.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.635 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -69.76 -33.64 72.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.828 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -65.48 -45.05 85.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.29 0.567 . . . . 0.0 109.631 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.826 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.02 -45.67 91.23 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.219 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 70' ' ' HIS . 78.9 t -56.3 -50.36 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.033 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.614 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.52 -34.66 37.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.787 179.569 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.39 -57.37 5.99 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.323 -0.551 . . . . 0.0 112.074 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.861 HD12 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -60.32 -40.97 92.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.577 . . . . 0.0 110.237 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.614 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.75 -19.74 57.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.8 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -111.33 20.47 17.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.302 179.373 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.86 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -83.6 16.47 2.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.701 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.32 -101.87 0.87 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.4 m -123.7 -90.73 0.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.968 HG13 HG22 ' A' ' 7' ' ' THR . 6.2 tp -86.88 109.93 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.872 0.368 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.86 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.3 p -124.28 137.25 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.19 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.591 ' CG ' HG23 ' A' ' 7' ' ' THR . 11.6 mtt180 -85.94 103.58 14.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.909 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 17.4 mt -93.63 135.45 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.489 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.77 126.77 48.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.251 179.472 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 HD11 ' A' ' 51' ' ' LEU . 6.1 m -128.41 166.07 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.975 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.446 ' HG2' ' CE1' ' A' ' 3' ' ' TYR . 30.3 mtt -96.55 146.76 24.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.92 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -140.37 106.54 5.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.043 -179.729 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.814 0.34 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.86 117.73 22.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.745 ' CE2' HD13 ' A' ' 58' ' ' LEU . 3.5 m-30 -82.12 132.27 35.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -143.39 141.15 30.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 2.8 pt-20 -99.84 144.65 28.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.953 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.81 109.46 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.028 0.442 . . . . 0.0 111.362 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.877 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.23 119.46 22.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.858 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 6' ' ' ILE . 5.2 tp -127.63 126.79 42.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.6 pt-20 -84.97 100.57 11.73 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.306 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.86 88.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.226 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.01 177.76 0.05 OUTLIER Glycine 0 CA--C 1.517 0.218 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.659 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -55.47 -23.71 27.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.704 0.287 . . . . 0.0 111.165 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.95 -24.74 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.126 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.6 -163.24 28.24 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.09 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.927 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.2 tp -65.58 -63.34 1.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.561 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.88 19.36 1.15 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.572 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.86 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.6 p90 -162.04 134.52 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.816 0.808 . . . . 0.0 111.259 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.76 138.63 31.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.498 -179.336 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.062 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.25 147.25 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.672 0.748 . . . . 0.0 112.091 -179.923 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.12 132.3 26.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.062 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.24 -3.13 0.87 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.676 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.81 179.73 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.764 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.816 HG22 ' CB ' ' A' ' 32' ' ' PRO . 15.3 p -70.92 -20.06 62.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.84 -23.94 16.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.245 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -124.39 87.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.188 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 64.53 0.55 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.402 2.068 . . . . 0.0 112.649 -179.427 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.668 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 9.3 t-80 -49.93 -27.34 5.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.243 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.855 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.91 -154.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.369 179.597 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.68 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -66.77 -47.32 68.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.659 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 177.52 46.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.29 159.86 70.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.816 ' CB ' HG22 ' A' ' 23' ' ' THR . 86.6 Cg_endo -78.51 1.66 8.83 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.665 2.244 . . . . 0.0 112.8 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.65 118.25 4.04 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.008 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.858 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.83 121.03 36.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.476 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.855 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.23 147.68 38.68 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.334 0.588 . . . . 0.0 110.808 178.529 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.042 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.45 7.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.757 -176.892 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.454 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.49 -33.55 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.612 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.85 142.11 1.86 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.627 -179.743 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.976 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.86 132.2 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.209 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.93 114.23 52.78 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.647 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.0 Cg_exo -56.36 139.03 85.9 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.723 2.282 . . . . 0.0 112.241 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 8.53 64.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.433 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.31 176.23 17.7 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.79 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.31 -36.35 61.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 111.199 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.755 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.81 -57.49 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.576 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.19 -28.91 66.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.325 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.93 -33.14 68.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -82.1 -57.98 3.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.77 40.74 9.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.552 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.502 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.4 mtp180 -117.74 8.21 12.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.811 0.339 . . . . 0.0 110.843 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.042 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -133.49 155.35 49.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.058 0.456 . . . . 0.0 110.804 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.68 136.1 44.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.757 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.2 t -51.77 157.79 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.533 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.3 -2.03 2.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.361 179.775 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -67.66 124.91 24.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.56 101.68 13.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.574 0.702 . . . . 0.0 111.424 -178.608 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.062 HD11 HG21 ' A' ' 19' ' ' ILE . 50.1 mt -51.59 133.43 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.661 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.745 HD13 ' CE2' ' A' ' 3' ' ' TYR . 1.1 pp -123.5 -19.48 5.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.781 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -159.49 147.76 17.58 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 111.027 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.882 HG13 ' CD2' ' A' ' 86' ' ' LEU . 38.8 t -130.22 99.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.033 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.513 ' OD1' HG23 ' A' ' 84' ' ' VAL . 7.7 t30 67.65 -67.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.0 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.3 29.56 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.94 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 84.5 t -117.99 141.96 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.212 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.6 p30 -104.86 109.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.475 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 57' ' ' ILE . 33.0 m -96.7 32.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.52 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -62.42 -32.17 72.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.91 66.0 1.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.711 ' C ' HG23 ' A' ' 23' ' ' THR . 8.8 m -133.51 144.48 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.75 154.04 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.954 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.1 t-160 -49.61 -33.78 16.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.4 m -66.68 -33.92 76.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.65 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.603 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.0 -41.56 82.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.858 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.13 -46.22 81.86 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 70' ' ' HIS . 58.4 t -56.61 -50.42 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.022 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -52.12 -34.35 43.97 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.853 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.867 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.42 -57.53 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.927 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.882 HD12 HD12 ' A' ' 19' ' ' ILE . 1.5 mt -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.345 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.599 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.06 -20.32 55.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.048 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.5 pt-20 -110.43 21.36 16.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.905 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -83.93 16.57 2.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.778 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.8 0.28 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.862 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.499 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -137.87 -91.18 0.22 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.872 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.8 101.96 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.905 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -117.53 135.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.827 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.877 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.5 mtp180 -86.55 103.44 15.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.81 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.882 ' CD2' HG13 ' A' ' 60' ' ' VAL . 25.6 mt -94.06 133.59 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.295 -179.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.01 123.56 46.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.287 179.632 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.4 m -126.33 151.79 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.62 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.499 ' HB3' HD22 ' A' ' 58' ' ' LEU . 2.4 ptt? -122.73 135.31 54.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.829 0.347 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -128.0 120.6 27.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ttm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.75 0.309 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.69 160.0 21.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 26.5 m-85 -115.46 153.09 31.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -147.77 136.98 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.46 144.64 26.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.63 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.039 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.64 109.56 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.644 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.941 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 120.04 21.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.569 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.039 HD13 HD11 ' A' ' 6' ' ' ILE . 5.6 tp -130.82 126.86 37.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.006 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.589 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -84.49 99.73 10.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.039 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.62 87.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 179.155 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -55.23 179.61 0.29 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.65 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -53.73 -27.16 26.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.838 0.351 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.4 p -88.51 -24.88 22.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.04 -165.92 23.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.346 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.91 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.8 tp -69.12 -13.19 62.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.336 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 72.17 31.0 64.38 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.802 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 4.7 p90 -164.5 129.74 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.075 0.937 . . . . 0.0 111.574 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -96.1 140.2 31.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.937 -179.116 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.021 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -120.19 147.03 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.763 0.792 . . . . 0.0 112.221 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.599 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.77 133.43 30.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.044 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.75 3.29 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.724 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.68 -177.87 1.37 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.658 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.826 HG22 ' HB3' ' A' ' 32' ' ' PRO . 25.2 p -67.25 -28.87 68.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -92.74 -19.59 21.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.614 0.245 . . . . 0.0 111.369 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -124.15 87.0 53.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.8 61.7 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.385 2.057 . . . . 0.0 112.795 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.599 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 14.5 t-80 -49.78 -27.6 5.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.949 178.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.77 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.2 -152.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.355 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.24 52.54 4.53 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.733 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 74.6 32.07 0.92 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.927 0.394 . . . . 0.0 110.462 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -118.09 149.64 45.97 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.826 ' HB3' HG22 ' A' ' 23' ' ' THR . 9.8 Cg_exo -71.25 -4.47 15.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.753 2.302 . . . . 0.0 112.615 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.0 m -52.21 115.98 1.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 111.287 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.75 120.14 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.77 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.15 147.14 36.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.253 0.549 . . . . 0.0 110.692 178.994 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.054 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.07 155.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.841 -176.794 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.461 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.72 -30.26 4.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.176 -179.2 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.23 128.81 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.36 -179.524 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.76 126.64 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.691 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.26 119.19 72.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.684 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.1 Cg_exo -54.37 139.57 73.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.242 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.34 12.72 69.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.539 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.36 -157.59 21.72 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.97 -40.73 53.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.901 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -72.78 -54.44 8.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.13 -29.09 69.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -72.38 -39.17 68.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.119 0.485 . . . . 0.0 110.3 179.416 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 8' ' ' LEU . 2.4 m-20 -81.39 -57.87 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.848 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.23 37.0 10.22 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.561 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.474 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.82 -5.38 14.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.698 179.531 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.054 HD21 HD12 ' A' ' 36' ' ' ILE . 5.0 tp -119.93 154.06 34.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.547 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.31 137.18 47.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.901 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.4 t -51.98 157.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.264 0.554 . . . . 0.0 111.533 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.39 -1.28 3.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.359 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.7 m-20 -69.54 127.61 33.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.56 101.47 13.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.577 0.703 . . . . 0.0 111.428 -178.662 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.021 HD11 HG21 ' A' ' 19' ' ' ILE . 10.9 mt -48.07 139.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.84 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.845 HD21 ' SD ' ' A' ' 89' ' ' MET . 1.9 mm? -116.6 -44.62 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.092 179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.2 m-85 -142.57 174.69 10.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.925 HG13 ' CD2' ' A' ' 86' ' ' LEU . 31.0 t -151.98 98.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.923 179.35 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.635 ' OD1' HG23 ' A' ' 84' ' ' VAL . 7.1 t30 66.34 -68.23 0.14 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.226 0.536 . . . . 0.0 109.807 -178.676 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -155.2 31.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.8 t -117.77 142.41 32.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.596 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.5 p-10 -111.1 108.49 18.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 26.1 m -94.24 44.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.433 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -32.71 74.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.39 61.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.713 ' C ' HG23 ' A' ' 23' ' ' THR . 13.7 m -120.47 147.18 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -62.36 155.71 24.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 -179.071 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.917 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 p-80 -49.33 -34.28 15.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.787 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.7 p -70.19 -33.78 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.936 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.545 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.11 -45.73 80.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.265 0.555 . . . . 0.0 109.716 178.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.67 -45.5 92.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.153 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.1 t -56.47 -50.46 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.156 178.485 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.49 -34.36 35.44 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.924 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.697 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.84 -57.52 5.45 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.232 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.955 HD12 HD12 ' A' ' 19' ' ' ILE . 5.2 mt -61.51 -39.74 92.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.429 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.604 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.76 -19.84 57.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.544 179.608 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -110.61 17.75 20.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.129 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.861 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.8 16.54 1.4 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.702 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.55 -99.43 0.59 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.679 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.5 p -127.8 -91.59 0.49 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.941 HG13 HG22 ' A' ' 7' ' ' THR . 7.2 tp -84.27 106.19 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.061 0.457 . . . . 0.0 110.933 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.861 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.9 p -122.14 139.0 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.519 -178.364 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.928 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -85.95 103.76 14.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.916 178.812 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.925 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.0 mt -95.28 138.48 32.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.65 -178.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -102.07 141.56 34.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.462 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 51' ' ' LEU . 24.0 m -138.83 165.09 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.023 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.845 ' SD ' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -105.98 145.63 31.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.706 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -140.52 142.41 35.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.111 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.865 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.827 0.346 . . . . 0.0 111.165 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.35 160.25 15.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 20.9 m-85 -113.4 144.47 42.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.49 134.93 34.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.75 134.91 38.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.877 HG23 ' HB3' ' A' ' 50' ' ' ARG . 1.2 mt -129.36 109.29 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.263 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.998 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -76.95 123.07 25.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.841 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.97 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.2 tp -133.49 127.29 32.94 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.701 ' N ' HD12 ' A' ' 83' ' ' ILE . 1.4 pt-20 -85.37 103.39 14.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.819 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.627 ' CG ' HD23 ' A' ' 15' ' ' LEU . 10.1 mtp180 -47.58 92.96 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.319 0.581 . . . . 0.0 110.745 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.42 73.15 0.02 OUTLIER Glycine 0 C--N 1.316 -0.538 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.935 -179.472 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' ARG . 26.9 t-20 63.25 -75.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.732 0.301 . . . . 0.0 111.349 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 11' ' ' GLY . 2.6 p -70.08 -24.84 63.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.274 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 155.04 -173.45 33.34 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.923 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.97 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.9 mt -59.04 -63.94 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.683 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 136.85 40.99 0.11 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.29 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.785 ' HB3' HG23 ' A' ' 39' ' ' ILE . 34.7 p90 -163.96 136.35 5.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.004 0.431 . . . . 0.0 111.25 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.01 132.72 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.397 -179.507 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.092 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -109.86 167.43 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.768 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.696 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -166.17 132.99 2.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.339 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.42 -1.88 1.23 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.437 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.53 -172.06 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.93 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.726 HG23 ' C ' ' A' ' 68' ' ' VAL . 8.5 p -75.18 -22.17 58.21 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -94.82 -25.55 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.417 -179.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -124.35 87.32 54.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.222 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.79 62.95 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.411 2.074 . . . . 0.0 112.763 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.696 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 8.9 t-80 -48.01 -28.95 3.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.074 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.871 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.32 -155.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.143 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.32 -49.45 45.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.348 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -177.86 51.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.802 0.334 . . . . 0.0 111.175 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.21 159.91 64.4 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.076 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.685 ' CB ' HG22 ' A' ' 23' ' ' THR . 93.8 Cg_endo -80.48 5.49 6.06 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.711 2.274 . . . . 0.0 112.671 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -57.02 118.59 5.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.866 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.99 118.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.602 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.871 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.38 146.12 34.58 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.586 0.708 . . . . 0.0 110.79 178.824 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.79 156.01 7.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.294 -176.652 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.47 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.87 -30.24 4.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.395 -178.588 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.31 128.34 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.876 -179.368 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.808 ' CD1' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -96.84 132.18 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.619 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.483 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.3 113.82 50.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.959 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 54.3 Cg_exo -52.6 143.83 44.53 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.743 2.295 . . . . 0.0 112.482 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.51 83.03 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.85 176.68 20.77 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.111 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.49 -33.34 59.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.525 0.202 . . . . 0.0 111.389 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.839 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.29 -56.25 5.1 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.778 0.323 . . . . 0.0 111.488 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.83 -29.91 70.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.187 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -72.16 -31.81 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.934 0.397 . . . . 0.0 110.44 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -75.76 -57.87 3.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.063 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.62 32.11 19.74 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.422 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.877 ' HB3' HG23 ' A' ' 6' ' ' ILE . 51.9 mtt180 -115.23 -13.45 11.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.687 0.28 . . . . 0.0 110.96 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 36' ' ' ILE . 38.7 tp -112.57 162.4 15.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.183 0.516 . . . . 0.0 111.305 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.08 135.74 23.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.633 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.2 t -49.2 157.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 111.586 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER 74.24 2.39 4.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.255 -179.893 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.654 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.9 m-20 -72.12 127.11 31.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 10.4 p -86.61 100.02 12.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.552 0.691 . . . . 0.0 111.464 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.092 HD11 HG21 ' A' ' 19' ' ' ILE . 63.9 mt -45.25 149.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.055 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' SD ' ' A' ' 89' ' ' MET . 0.5 OUTLIER -128.91 -46.96 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.706 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -141.54 169.11 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.769 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 16.6 t -143.91 95.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.121 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.444 ' HB2' HG23 ' A' ' 84' ' ' VAL . 33.3 t30 68.34 -66.69 0.22 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -156.54 32.47 0.32 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.134 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 60.8 t -119.02 142.54 33.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.776 -178.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.1 p30 -112.06 113.14 25.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.122 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 35.3 m -86.41 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.89 100.94 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' C ' HG21 ' A' ' 23' ' ' THR . 0.5 OUTLIER 68.77 52.51 0.55 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.726 ' C ' HG23 ' A' ' 23' ' ' THR . 29.1 m -122.26 143.43 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 179.508 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.08 150.33 25.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.7 t-160 -49.09 -33.34 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.37 -38.49 81.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.788 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -68.03 -46.91 69.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.639 0.733 . . . . 0.0 109.168 178.184 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 70' ' ' HIS . 78.2 t -57.81 -48.03 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.214 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.74 -36.31 69.6 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.594 178.572 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -55.34 -51.2 67.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 0.0 110.105 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.02 HD11 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.06 -35.7 67.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.3 mmmt -77.29 -23.28 51.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.484 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -96.81 2.54 51.96 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 111.418 -179.016 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.891 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -82.54 16.32 2.18 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.709 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.79 -119.18 16.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.9 t -104.97 -87.73 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.998 HG13 HG22 ' A' ' 7' ' ' THR . 5.2 tp -87.7 109.18 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.682 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.891 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 2.8 p -122.67 138.53 52.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.296 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.846 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.2 mtt-85 -86.72 102.86 14.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 8.2 mt -91.29 142.6 27.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.33 -178.614 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.415 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.92 139.08 38.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.782 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG21 ' OD2' ' A' ' 55' ' ' ASP . 13.8 m -138.13 149.13 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.546 ' SD ' HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -96.88 138.67 34.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 0.0 110.975 -179.883 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.63 113.68 8.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.935 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.854 0.359 . . . . 0.0 111.069 . . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -152.19 174.76 13.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.337 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 52.2 m-85 -141.74 140.78 33.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.959 0.409 . . . . 0.0 111.183 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.53 151.42 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 4.9 pt-20 -110.12 144.71 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.998 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.36 109.46 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.482 179.841 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.48 120.29 23.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.047 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.998 HD13 HD11 ' A' ' 6' ' ' ILE . 4.0 tp -130.71 127.96 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.275 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 pt-20 -85.4 101.05 12.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.004 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.523 ' CG ' HD23 ' A' ' 15' ' ' LEU . 5.0 mtp-105 -47.84 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.132 178.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -45.38 -101.68 0.01 OUTLIER Glycine 0 C--N 1.319 -0.386 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.228 -179.22 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -114.22 -40.66 3.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 0.0 110.524 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 p -108.24 -6.65 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.374 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 154.81 -156.24 26.77 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.495 -179.717 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.952 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -78.12 -63.48 1.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.522 179.68 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.38 44.36 0.07 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.918 -1.134 . . . . 0.0 114.024 178.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.793 ' HB3' HG23 ' A' ' 39' ' ' ILE . 17.9 p90 -164.0 131.53 3.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.304 0.552 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -93.2 134.4 35.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.669 -179.089 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.038 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.19 172.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.795 179.957 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -168.96 132.29 1.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.288 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.34 1.08 0.94 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.652 179.593 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.55 -172.07 0.1 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.869 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.818 HG22 ' CB ' ' A' ' 32' ' ' PRO . 16.8 p -74.44 -21.72 59.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.448 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -97.0 -23.38 16.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 111.486 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.36 87.54 53.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.26 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.9 62.36 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.44 2.093 . . . . 0.0 112.738 -179.449 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.611 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.6 t-80 -48.34 -28.08 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.104 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.82 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.325 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.48 -50.44 62.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.608 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.937 0.399 . . . . 0.0 110.747 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.9 168.48 13.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' CB ' HG22 ' A' ' 23' ' ' THR . 83.0 Cg_endo -81.86 9.02 4.11 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.727 2.284 . . . . 0.0 112.893 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -61.03 114.15 2.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.867 0.365 . . . . 0.0 110.65 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.849 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -81.85 119.84 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.45 143.41 32.59 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.683 0.754 . . . . 0.0 110.819 178.936 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.024 HD12 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -68.89 155.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.102 -176.495 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.487 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.44 -26.96 4.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.376 -178.525 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.25 131.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.005 -179.645 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.023 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.43 132.73 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.681 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.4 123.75 74.47 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.853 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.0 Cg_endo -66.88 133.8 32.56 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.747 2.298 . . . . 0.0 112.267 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.62 17.2 31.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.315 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.48 178.31 16.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.169 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.97 -34.02 58.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.779 0.323 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.844 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -71.21 -57.48 4.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.897 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.59 -28.79 65.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.336 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -71.73 -29.95 65.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.391 . . . . 0.0 110.312 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.433 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -81.99 -58.08 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.941 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.06 37.85 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.569 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.45 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.6 mtt85 -112.71 -17.23 12.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.716 0.293 . . . . 0.0 110.962 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 36' ' ' ILE . 6.4 tp -110.21 155.25 22.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.073 0.463 . . . . 0.0 111.222 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.52 135.12 45.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.801 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 38' ' ' LYS . 65.5 t -51.86 158.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.31 0.576 . . . . 0.0 111.636 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.1 t30 73.19 5.58 5.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.001 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.4 m-20 -76.82 128.12 34.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.47 100.17 12.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.621 0.724 . . . . 0.0 111.317 -178.701 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 16.1 mt -48.08 136.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.67 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.2 mm? -116.11 -44.86 2.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.6 m-85 -137.76 170.14 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.158 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.789 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.9 t -149.59 96.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.965 179.359 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.458 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.7 t-20 67.09 -68.22 0.15 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 109.805 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mt-10 -154.44 32.32 0.42 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.603 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.2 t -118.71 142.42 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.478 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.0 p-10 -113.42 96.27 5.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.446 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 65' ' ' VAL . 26.9 m -81.81 57.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.303 -179.712 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -79.93 -30.13 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.73 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -151.61 62.86 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.777 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.724 ' O ' HG23 ' A' ' 23' ' ' THR . 35.1 m -128.85 146.09 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.207 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.48 151.1 33.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.3 t-160 -48.33 -33.72 9.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.722 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -67.25 -34.36 77.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.08 -42.66 80.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.7 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.849 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.81 -46.5 89.26 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 70' ' ' HIS . 90.8 t -56.51 -50.8 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.364 178.588 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.24 -30.37 64.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.371 178.887 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.2 -49.83 75.58 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.293 0.568 . . . . 0.0 110.179 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.853 HD23 ' CD1' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -60.44 -34.55 74.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.907 179.298 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.13 -26.23 52.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.191 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -103.07 14.73 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.302 -178.775 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.892 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.87 0.74 33.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.61 -112.62 3.79 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.009 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.461 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.25 -90.54 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.997 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.96 HG13 HG22 ' A' ' 7' ' ' THR . 7.6 tp -87.87 87.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.218 0.532 . . . . 0.0 109.691 178.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.892 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 p -98.87 138.42 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.399 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 4.7 ttp180 -89.34 103.15 15.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.198 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.853 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.1 mt -91.7 140.31 29.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.91 142.76 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.99 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 51' ' ' LEU . 29.7 m -133.03 167.91 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.646 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.401 ' N ' ' O ' ' A' ' 56' ' ' SER . 13.4 ttt -100.99 160.47 14.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.141 -179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -140.66 106.6 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.998 179.928 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.028 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.892 0.377 . . . . 0.0 111.186 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.82 162.98 16.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.035 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CG ' HD13 ' A' ' 58' ' ' LEU . 2.3 m-85 -119.86 130.47 54.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.78 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.27 152.28 43.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 3.6 tt0 -106.76 144.6 33.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.986 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.094 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.2 109.45 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.501 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.05 119.29 20.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.851 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.094 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -130.55 127.6 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.352 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 7.5 pt-20 -83.85 100.53 11.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.659 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -44.48 88.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.174 179.193 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -53.16 -170.17 0.03 OUTLIER Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.792 -179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -51.57 -35.2 40.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 111.366 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 p -108.06 4.4 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.585 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . 117.94 -167.08 12.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.051 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.061 ' HB3' HD23 ' A' ' 8' ' ' LEU . 17.3 mt -53.89 -44.23 70.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.017 0.437 . . . . 0.0 110.832 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 106.99 39.49 1.98 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.362 179.517 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.808 ' HB3' HG23 ' A' ' 39' ' ' ILE . 15.8 p90 -161.4 130.33 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.036 0.418 . . . . 0.0 111.424 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.27 134.77 34.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.66 -179.415 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -112.21 167.95 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 111.766 179.893 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -165.84 131.44 2.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.464 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.64 0.97 0.9 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.588 179.6 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.53 -168.55 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.987 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.836 HG22 ' HB3' ' A' ' 32' ' ' PRO . 11.2 p -76.25 -23.8 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -23.61 16.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.753 0.311 . . . . 0.0 111.669 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -124.22 87.41 53.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.03 63.08 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.388 2.058 . . . . 0.0 112.629 -179.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.644 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.2 t-80 -48.12 -27.86 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.308 179.027 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.83 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.71 -154.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.356 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.673 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -61.98 -49.01 79.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.588 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.31 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -125.17 163.46 37.83 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.836 ' HB3' HG22 ' A' ' 23' ' ' THR . 5.5 Cg_exo -79.14 3.41 7.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.978 2.452 . . . . 0.0 112.715 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.79 115.45 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 111.104 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.862 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.57 120.64 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.382 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.64 145.93 33.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.553 0.692 . . . . 0.0 110.567 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.051 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.86 155.8 7.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.275 -176.507 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.09 -30.72 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.253 -178.849 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.8 130.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.99 -179.419 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.021 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.03 131.56 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.518 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 126.32 69.88 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 28.8 Cg_endo -62.6 134.47 47.77 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.718 2.279 . . . . 0.0 112.415 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.13 4.74 61.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.7 -179.48 25.64 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.991 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -57.42 -34.87 69.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.518 0.199 . . . . 0.0 111.325 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.739 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.25 -55.63 5.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.84 -30.93 71.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.869 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.0 pt20 -72.13 -35.65 69.17 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.045 0.45 . . . . 0.0 110.1 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.46 -57.92 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.37 39.74 8.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.891 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.506 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -109.08 -4.65 16.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.578 179.476 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.051 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -123.7 154.67 39.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.693 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 4.4 tpt85 -132.63 136.39 46.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.835 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.44 157.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.482 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.1 t30 74.8 0.28 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.78 125.35 26.31 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.849 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.6 p -86.43 100.27 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.084 HD11 HG21 ' A' ' 19' ' ' ILE . 20.6 mt -50.76 136.01 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.911 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.489 HD13 ' CG ' ' A' ' 3' ' ' TYR . 7.8 mt -120.05 -28.13 5.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.705 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -153.4 156.14 37.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.034 0.445 . . . . 0.0 111.008 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.896 HG11 ' HB1' ' A' ' 76' ' ' ALA . 46.3 t -133.76 95.62 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.909 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.632 ' OD1' HG23 ' A' ' 84' ' ' VAL . 5.8 t30 67.78 -67.83 0.18 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.117 0.484 . . . . 0.0 110.031 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -153.4 31.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.739 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 65.7 t -119.44 142.19 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.355 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.1 p-10 -107.49 100.9 10.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' VAL . 22.9 m -86.87 53.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.493 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.84 -33.17 34.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.678 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.83 58.61 1.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.766 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.721 ' C ' HG23 ' A' ' 23' ' ' THR . 34.9 m -128.19 143.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.92 150.66 28.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.82 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.3 t-160 -48.29 -33.63 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.441 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.37 -34.06 75.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.96 179.633 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -38.57 81.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 109.453 178.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.67 -46.92 74.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.066 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 70' ' ' HIS . 92.5 t -57.55 -49.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.2 178.563 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.84 -34.04 67.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.688 178.65 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.74 -50.76 71.27 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.331 0.586 . . . . 0.0 109.906 179.332 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.15 -37.57 69.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.384 178.948 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER -77.33 -23.73 50.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.092 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.1 mm-40 -91.72 -17.05 26.01 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.971 0.415 . . . . 0.0 110.951 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.966 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.47 -19.87 10.85 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.295 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.99 -98.66 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.025 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 34.3 m -126.76 -91.38 0.51 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.76 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.2 tp -87.26 98.61 7.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.666 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.966 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 13.6 p -115.81 138.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.65 ' HG3' HG23 ' A' ' 7' ' ' THR . 7.2 mtt180 -85.83 103.14 14.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.274 177.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.6 HD11 ' CD1' ' A' ' 15' ' ' LEU . 14.3 mt -91.9 138.7 31.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.263 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.69 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.809 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 55' ' ' ASP . 21.5 m -139.56 162.25 26.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.683 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.489 ' CG ' HD21 ' A' ' 58' ' ' LEU . 1.6 ttp -96.85 147.68 23.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.94 135.13 47.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.897 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.46 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.051 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.811 0.338 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -132.2 123.13 26.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 10.3 m-85 -97.33 131.23 44.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.46 142.27 49.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.21 144.58 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.023 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.8 109.42 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.376 179.856 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.907 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.25 116.47 20.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.067 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.023 HD13 HD11 ' A' ' 6' ' ' ILE . 4.8 tp -124.14 126.74 46.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 pt-20 -87.46 100.27 12.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.564 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.87 87.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.229 179.283 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.03 -179.45 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.49 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -56.36 -21.82 27.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.699 0.285 . . . . 0.0 111.209 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -102.98 -12.79 17.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.689 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.459 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 132.1 -164.06 23.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.304 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.934 ' HG ' HD23 ' A' ' 8' ' ' LEU . 2.3 tp -64.66 -63.29 1.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.205 -0.198 . . . . 0.0 110.572 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.26 17.77 1.39 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.529 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.861 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.9 p90 -160.7 135.73 7.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.965 0.882 . . . . 0.0 111.196 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.9 139.3 32.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.376 -179.477 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.007 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.75 147.95 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.887 0.851 . . . . 0.0 112.359 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.11 133.2 27.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.055 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.14 2.92 0.68 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.798 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.09 -176.52 0.84 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.682 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.85 HG22 ' HB3' ' A' ' 32' ' ' PRO . 25.2 p -67.53 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.11 -21.05 21.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -124.38 87.02 54.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.671 0.272 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.81 62.62 0.91 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.332 2.021 . . . . 0.0 112.585 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.633 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.4 t-80 -47.45 -28.66 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.413 179.023 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.836 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.01 -154.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.281 179.531 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -61.31 -49.23 79.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.6 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.99 39.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.38 163.5 38.02 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.85 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.9 Cg_exo -76.73 1.47 8.5 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.984 2.456 . . . . 0.0 112.773 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.77 115.52 2.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.17 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.87 119.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.482 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.836 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.52 147.81 38.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.427 0.632 . . . . 0.0 110.869 178.776 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.997 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.953 -176.85 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.71 -31.37 4.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.217 -179.014 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.57 131.1 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.226 -179.42 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.984 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.96 130.89 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.594 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.457 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.13 114.03 51.86 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.874 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 42.4 Cg_exo -56.95 139.31 89.37 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.726 2.284 . . . . 0.0 112.378 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 12.75 59.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.431 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.69 179.36 16.87 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.919 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.7 -38.61 69.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.841 0.353 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.78 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -64.84 -57.65 8.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.577 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.47 -28.77 66.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.353 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.99 -33.06 67.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 110.162 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.28 -58.01 3.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.748 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.87 37.71 12.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.622 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CB ' HG12 ' A' ' 6' ' ' ILE . 18.2 mtm180 -118.96 9.05 11.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.728 0.299 . . . . 0.0 110.987 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.997 HD21 HD12 ' A' ' 36' ' ' ILE . 5.8 tp -135.24 154.4 51.59 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.01 0.433 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.563 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.94 134.42 42.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 179.996 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.631 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -49.15 159.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.13 0.491 . . . . 0.0 111.491 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 53' ' ' VAL . 3.0 m120 72.24 1.43 3.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.506 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.01 127.22 31.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.693 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 100.17 12.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 111.693 -178.437 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 19' ' ' ILE . 10.1 mt -46.76 132.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.76 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.827 HD23 ' HB3' ' A' ' 89' ' ' MET . 0.1 OUTLIER -112.97 -40.41 3.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.138 179.639 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -145.27 167.49 22.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.763 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.937 HG13 ' CD2' ' A' ' 86' ' ' LEU . 56.1 t -145.3 97.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.878 ' OD1' HG23 ' A' ' 84' ' ' VAL . 1.2 t30 66.25 -67.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 109.947 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' VAL . 10.2 mm-40 -154.14 32.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.921 179.145 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.7 t -119.64 142.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.412 -179.322 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.5 t0 -111.33 99.72 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.455 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 65' ' ' VAL . 24.5 m -85.3 55.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.294 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -32.51 59.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.851 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -152.67 62.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.667 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' THR . 13.2 m -124.6 144.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.88 155.06 20.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.973 0.416 . . . . 0.0 111.097 -179.117 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.945 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.2 p-80 -48.66 -34.09 11.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.859 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -33.88 73.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.139 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.558 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.18 -44.23 84.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.241 0.543 . . . . 0.0 109.674 178.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.92 -45.89 87.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.162 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 70' ' ' HIS . 59.4 t -57.06 -48.37 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.287 178.544 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.664 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -53.68 -33.82 56.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.33 179.134 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -64.66 -56.91 10.77 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.598 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.841 HD12 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -63.02 -42.93 99.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.879 -179.645 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.6 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.08 -20.59 55.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.748 -179.264 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.664 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 6.7 mm-40 -103.27 -8.8 20.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.088 0.471 . . . . 0.0 110.563 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.867 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.1 -20.49 0.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.791 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.79 -90.21 0.93 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.712 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -133.73 -92.42 0.34 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.871 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.907 HG13 HG22 ' A' ' 7' ' ' THR . 9.1 tp -88.05 102.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.116 0.484 . . . . 0.0 110.531 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.878 HG23 ' OD1' ' A' ' 61' ' ' ASN . 7.3 p -118.32 136.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.724 -178.13 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.857 ' HG2' HG23 ' A' ' 7' ' ' THR . 2.9 mtt85 -85.88 103.88 15.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.058 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.937 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.3 mt -95.49 137.8 34.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.576 -179.189 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.88 140.42 36.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.494 179.795 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 m -139.84 138.32 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.991 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.827 ' HB3' HD23 ' A' ' 58' ' ' LEU . 2.6 ptt? -107.01 135.37 48.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.65 146.59 38.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HG3' ' HE3' ' A' ' 89' ' ' MET . 1.3 pmm? . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.791 0.329 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.59 125.69 32.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.434 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 10.7 m-85 -91.06 144.71 25.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.815 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -131.6 151.04 51.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -109.96 143.89 39.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.78 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.034 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.32 109.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.975 0.416 . . . . 0.0 111.699 179.791 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.49 118.87 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.508 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.061 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -131.59 127.16 36.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 7.2 pt-20 -84.51 100.44 11.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.258 179.392 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.533 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.41 90.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.21 179.67 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -53.36 -168.71 0.02 OUTLIER Glycine 0 C--N 1.32 -0.337 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.88 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -51.71 -36.67 47.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.578 0.227 . . . . 0.0 111.471 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 t -108.05 4.54 25.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.817 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 120.06 -167.18 13.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.986 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.061 ' HB3' HD23 ' A' ' 8' ' ' LEU . 18.8 mt -52.17 -63.48 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.0 110.784 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.15 35.93 0.45 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.419 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.797 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.1 p90 -160.04 135.42 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.128 0.464 . . . . 0.0 111.242 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.33 137.63 33.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.427 -179.612 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.45 149.75 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.654 0.74 . . . . 0.0 111.954 -179.86 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.661 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.73 133.02 24.73 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.93 179.345 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.31 -7.65 1.16 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.462 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.558 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.6 -178.87 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.087 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 68' ' ' VAL . 29.9 p -65.06 -31.13 72.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.227 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.45 -20.46 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.237 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 0.4 OUTLIER -124.48 82.48 58.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.958 0.409 . . . . 0.0 110.131 179.77 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.25 62.67 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.886 2.391 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.661 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.5 t-80 -52.58 -22.35 4.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.386 178.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.781 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -95.21 -151.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.572 179.814 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.673 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.89 48.87 4.11 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.861 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.77 45.46 0.07 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.981 0.419 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 28' ' ' ILE . 8.2 m-20 -135.22 155.24 78.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 23' ' ' THR . 73.5 Cg_endo -75.57 -0.94 10.72 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.525 2.15 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.411 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 5.7 m -54.24 115.75 2.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.746 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.58 119.02 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.781 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.67 145.72 35.26 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.301 0.572 . . . . 0.0 110.527 178.53 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.053 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.98 155.48 7.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.094 -176.476 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.37 -33.44 4.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.766 -179.124 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.657 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.65 141.96 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.585 -179.749 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.962 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.7 132.31 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.266 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.1 125.16 73.26 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.685 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.1 Cg_endo -67.33 132.06 26.54 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.838 2.358 . . . . 0.0 112.381 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.68 14.39 32.17 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.474 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.87 178.07 16.42 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.0 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.37 -36.26 61.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 111.416 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.795 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.9 -57.43 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.833 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.478 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -33.92 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 110.174 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.15 -57.92 3.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.691 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.02 9.59 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.602 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.9 mmt180 -116.31 1.59 13.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.702 -0.293 . . . . 0.0 110.837 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.053 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -126.96 154.15 44.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 110.657 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.9 ttp85 -131.52 137.45 48.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -53.33 158.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 111.678 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER 74.53 0.19 3.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.184 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 3.1 m-20 -70.38 126.26 29.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.3 p -86.53 100.31 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 0.0 111.383 -178.607 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.036 HD11 HG21 ' A' ' 19' ' ' ILE . 69.1 mt -46.88 140.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.065 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD21 ' HG3' ' A' ' 89' ' ' MET . 1.5 mm? -118.76 -44.8 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.3 m-85 -139.86 169.43 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.793 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.749 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.5 t -151.4 100.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.584 ' OD1' HG23 ' A' ' 84' ' ' VAL . 11.3 t30 66.27 -67.86 0.14 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.131 0.491 . . . . 0.0 109.979 -178.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -156.67 32.05 0.31 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.495 179.124 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.6 t -117.8 142.51 31.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.55 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.7 p-10 -112.69 89.34 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 65' ' ' VAL . 27.4 m -75.77 61.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -82.38 -32.94 28.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.753 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -148.66 50.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.798 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.762 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -114.09 150.89 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.428 HG22 ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -66.95 153.66 43.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.029 -179.389 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.86 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.2 t-160 -49.68 -34.19 17.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.628 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -69.8 -34.04 73.19 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.653 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.04 -42.25 80.85 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.638 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.883 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.12 -46.75 85.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.555 0.693 . . . . 0.0 109.201 177.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.3 t -57.58 -50.18 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.15 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.653 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.01 -32.9 64.39 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.631 178.656 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.99 -52.63 64.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.228 0.537 . . . . 0.0 110.012 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 19' ' ' ILE . 2.5 mt -54.16 -36.47 63.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.283 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.19 -26.66 53.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.09 178.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -89.01 -16.65 31.16 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -178.998 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.41 -18.57 18.53 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.33 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.02 -108.02 3.6 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.164 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 1.3 p -118.78 -91.2 0.56 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 7' ' ' THR . 8.4 tp -86.92 95.09 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.079 0.466 . . . . 0.0 109.85 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.933 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.1 p -111.86 138.06 42.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.297 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.9 102.89 14.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.411 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.749 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.6 mt -90.18 141.15 28.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.72 141.38 34.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.771 -179.759 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.89 167.88 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.537 ' HG3' HD21 ' A' ' 58' ' ' LEU . 2.0 mtp -109.13 142.88 39.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.768 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -140.66 106.89 5.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.398 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.48 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.834 179.651 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.536 0.208 . . . . 0.0 111.01 . . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -161.7 138.81 8.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 111.077 179.838 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 65.7 m-85 -123.65 127.37 48.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.659 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -126.35 155.56 41.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 17.7 mt-10 -117.43 144.63 44.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.967 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.84 109.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.647 179.893 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.899 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 122.0 24.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.912 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.036 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.1 tp -134.14 127.31 31.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.149 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -86.37 100.76 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.632 179.551 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.55 ' CG ' HD23 ' A' ' 15' ' ' LEU . 12.0 mtp180 -42.45 91.93 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.064 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -61.65 72.64 0.02 OUTLIER Glycine 0 C--N 1.317 -0.477 0 CA-C-N 115.186 -0.916 . . . . 0.0 113.058 -179.538 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER 64.01 -73.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.743 0.306 . . . . 0.0 111.525 179.672 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER -72.7 -23.92 60.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.519 -179.59 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 155.15 -172.88 33.45 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.828 -179.672 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.036 ' HB3' HD23 ' A' ' 8' ' ' LEU . 8.3 mt -60.5 -63.64 1.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.024 0.412 . . . . 0.0 110.67 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 135.46 40.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.745 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.789 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -162.02 134.51 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.494 . . . . 0.0 110.971 178.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.51 135.16 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.459 -179.351 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.052 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.53 146.5 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.496 179.552 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.74 122.88 36.11 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.586 178.935 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 157.92 -132.0 3.03 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.605 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 75.76 167.36 22.75 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.263 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 68' ' ' VAL . 27.4 p -68.47 -6.68 26.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.074 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.7 m-20 -113.11 -24.34 9.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.5 t30 -124.62 87.18 54.86 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.478 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.91 64.69 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.39 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.549 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 12.6 t-80 -53.05 -24.12 9.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.31 179.221 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.866 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -92.64 -150.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 179.63 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.68 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.66 52.47 4.58 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.931 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 75.7 41.23 0.26 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.116 0.484 . . . . 0.0 110.488 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -132.3 161.46 62.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.909 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 97.3 Cg_endo -79.29 4.18 6.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.625 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -55.04 118.39 4.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.078 0.466 . . . . 0.0 111.258 -179.814 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.835 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.32 116.62 31.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.188 179.598 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.866 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.06 147.6 37.07 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.363 0.601 . . . . 0.0 110.573 179.256 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.089 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.26 155.74 7.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.834 -177.127 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.29 -33.02 3.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.677 -179.076 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.14 142.01 2.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 111.276 -179.78 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.958 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -105.32 132.32 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.48 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.446 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.01 114.48 54.53 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.674 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.1 Cg_exo -57.68 136.96 78.83 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.7 2.267 . . . . 0.0 112.365 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 16.97 39.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.562 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.54 178.76 16.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.175 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.84 -33.86 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.3 . . . . 0.0 111.402 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.829 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.81 -57.39 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.908 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.53 -28.67 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.525 -179.427 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.71 -30.43 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 110.335 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' OD2' HD12 ' A' ' 8' ' ' LEU . 6.0 m-20 -82.68 -57.77 3.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.708 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.78 37.0 12.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.572 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.449 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -111.28 -20.92 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.089 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -106.16 153.86 21.5 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.275 0.559 . . . . 0.0 111.361 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -131.78 135.4 46.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.57 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 38' ' ' LYS . 52.5 t -49.21 157.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.536 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER 75.15 0.26 3.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.223 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.639 ' HB3' HG11 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -68.24 124.71 24.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.991 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.5 p -86.63 99.78 11.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.564 0.697 . . . . 0.0 111.377 -178.46 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 11.0 mt -46.35 129.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.229 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.823 HD23 ' HB3' ' A' ' 89' ' ' MET . 0.3 OUTLIER -113.06 -41.44 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.005 179.653 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.4 m-85 -144.72 146.82 32.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.166 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.712 ' CG1' ' HB1' ' A' ' 76' ' ' ALA . 48.9 t -135.51 109.78 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.44 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 0.4 OUTLIER 52.78 35.93 19.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.843 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 80.72 32.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.445 -179.236 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 60' ' ' VAL . 74.7 t -121.01 112.75 37.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.699 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -72.05 116.83 12.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.711 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 57' ' ' ILE . 25.6 m -98.45 27.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.197 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -68.77 -27.76 66.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -138.52 52.67 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.082 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -127.63 146.08 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -67.83 155.61 38.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.384 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.5 p-80 -48.15 -35.44 11.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 -179.65 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.33 -33.67 65.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.115 179.716 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.628 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.68 -39.39 88.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.808 179.161 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.835 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.69 -46.88 74.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.584 0.707 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.5 t -58.07 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.362 178.556 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -58.22 -35.64 71.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.46 178.574 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -55.08 -49.39 71.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.237 0.542 . . . . 0.0 109.976 179.597 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.052 HD11 HD12 ' A' ' 19' ' ' ILE . 2.4 mt -57.84 -36.47 72.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 178.709 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.2 mmmt -77.33 -25.86 51.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.879 179.441 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -96.96 5.31 50.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -178.703 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.911 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.45 16.1 1.43 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.769 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.63 -110.5 3.43 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.294 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 35.8 m -118.96 -89.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.324 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.899 HG13 HG22 ' A' ' 7' ' ' THR . 7.5 tp -86.27 96.43 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.257 0.551 . . . . 0.0 110.263 179.019 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.911 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.6 p -111.1 138.4 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.807 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.57 102.8 14.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.388 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.711 ' CD2' HG13 ' A' ' 60' ' ' VAL . 10.9 mt -88.74 137.86 31.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.118 -178.79 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 145.95 28.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.923 -179.689 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 55' ' ' ASP . 35.4 m -139.62 144.54 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.139 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.823 ' HB3' HD23 ' A' ' 58' ' ' LEU . 7.0 ptt? -96.74 159.84 14.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.855 0.359 . . . . 0.0 111.132 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -139.5 106.86 5.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.899 -179.602 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.941 179.805 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.838 0.352 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -91.44 175.73 6.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 179.72 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -133.13 156.88 46.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.786 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -145.22 151.0 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.981 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -110.36 144.77 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.71 109.5 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.926 0.393 . . . . 0.0 111.545 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.845 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 112.46 17.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.959 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 6' ' ' ILE . 5.5 tp -122.87 126.81 48.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.269 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.62 100.46 10.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.059 179.09 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.51 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.169 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -54.86 167.96 2.17 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.539 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.63 -26.54 9.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.56 -24.73 18.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.944 179.736 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.57 -170.8 24.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.081 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.011 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.9 tp -62.15 -42.61 99.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.403 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 108.67 25.78 5.58 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.326 -0.94 . . . . 0.0 115.263 177.706 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 4.3 p90 -164.52 136.72 4.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.018 0.909 . . . . 0.0 111.072 178.779 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -98.68 133.44 43.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.636 -179.28 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.095 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.07 169.9 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.608 0.718 . . . . 0.0 111.501 179.729 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -167.33 131.5 1.87 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.424 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.45 2.09 0.71 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.436 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.13 -167.15 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.102 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.839 HG22 ' HB3' ' A' ' 32' ' ' PRO . 17.5 p -75.96 -28.16 57.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -95.31 -20.63 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.66 82.54 59.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.76 63.89 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -179.316 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.646 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.8 t-80 -50.09 -24.09 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.855 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.7 -155.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.367 179.716 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.66 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.9 -49.92 73.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.575 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.49 39.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.919 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -124.69 163.48 36.69 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.839 ' HB3' HG22 ' A' ' 23' ' ' THR . 5.9 Cg_exo -78.91 3.46 7.36 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.0 112.861 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.1 m -56.61 115.53 2.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 111.1 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.47 120.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.524 179.833 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.855 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.44 145.39 33.73 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.48 0.657 . . . . 0.0 110.704 178.842 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.046 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.84 155.83 7.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.473 -176.409 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.469 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.9 -28.36 4.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.509 -178.565 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.686 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.72 129.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.197 -179.486 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.997 HD11 HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -94.6 133.23 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.392 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 122.98 75.6 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.725 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 23.3 Cg_endo -61.59 137.41 68.96 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.642 2.228 . . . . 0.0 112.36 -179.661 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 -1.87 83.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.442 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.72 175.22 36.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.033 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.12 -34.38 60.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.814 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -74.43 -56.94 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.239 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.12 -28.87 70.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -71.67 -31.57 66.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 109.934 179.347 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.38 -57.91 2.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.552 179.87 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.04 40.83 8.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.491 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.9 mmt85 -117.03 6.58 12.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.71 0.29 . . . . 0.0 110.951 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -133.74 153.81 51.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.004 0.431 . . . . 0.0 110.819 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.13 140.1 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 179.96 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.5 t -56.69 158.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.242 0.544 . . . . 0.0 111.638 179.757 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.4 t-20 74.15 3.5 4.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.179 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.5 m-20 -75.06 127.1 32.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.978 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.49 103.03 14.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.517 0.675 . . . . 0.0 111.131 -178.853 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.095 HD11 HG21 ' A' ' 19' ' ' ILE . 62.5 mt -49.92 133.37 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.052 -179.775 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.938 HD21 ' HG3' ' A' ' 89' ' ' MET . 4.0 mm? -108.64 -42.6 4.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -147.33 140.58 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.301 179.987 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.77 HG11 ' HB1' ' A' ' 76' ' ' ALA . 58.3 t -123.72 97.29 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.754 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 t30 70.04 -62.84 0.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.05 0.453 . . . . 0.0 109.819 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -160.58 30.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.152 179.143 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 16.7 t -121.03 109.62 25.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.679 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 65' ' ' VAL . 18.9 t0 -63.08 -23.49 67.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.283 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 64' ' ' ASP . 13.4 m 46.07 28.96 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.639 -179.763 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -61.91 -37.76 85.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.77 61.93 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.708 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -127.83 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.315 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.405 ' HA ' ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -61.59 151.34 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -179.706 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.854 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 t-160 -48.11 -33.89 8.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.675 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -34.07 75.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.933 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.07 -42.38 80.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.643 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.75 -46.81 86.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.677 0.751 . . . . 0.0 109.047 177.939 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.5 t -57.31 -50.48 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.328 178.546 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.682 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -29.47 60.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.898 178.556 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.77 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.55 -51.57 68.03 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.273 0.559 . . . . 0.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.056 HD11 HD12 ' A' ' 19' ' ' ILE . 1.5 mt -55.78 -37.96 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.48 -23.28 50.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.034 178.978 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.72 7.94 45.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.397 -178.795 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.19 16.2 4.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.3 179.873 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.34 -99.62 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.575 179.849 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -129.18 -91.9 0.46 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.845 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -81.95 97.14 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.187 0.518 . . . . 0.0 110.405 179.336 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.936 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -114.21 137.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.733 . . . . 0.0 112.947 -178.2 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.812 ' HG3' HG23 ' A' ' 7' ' ' THR . 4.6 mtt180 -86.35 103.03 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.164 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.3 mt -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.165 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.62 142.88 32.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.552 -179.902 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.77 ' C ' HD23 ' A' ' 58' ' ' LEU . 14.3 m -139.48 168.17 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.639 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.938 ' HG3' HD21 ' A' ' 58' ' ' LEU . 2.0 mtm -96.52 150.85 20.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.56 106.86 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 -179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 179.837 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HG2' ' HB2' ' A' ' 89' ' ' MET . 4.2 tpp . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.785 0.326 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.93 128.28 49.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.107 -179.746 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.466 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 66.1 m-85 -100.89 146.19 27.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 179.746 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -155.48 152.45 28.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 pt-20 -105.68 144.75 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.019 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.25 109.17 12.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.956 0.408 . . . . 0.0 111.59 179.723 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.832 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.59 118.82 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.255 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.019 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -130.26 127.02 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.407 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.14 100.18 10.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.244 0.545 . . . . 0.0 112.239 179.812 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -53.55 89.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.137 178.448 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.62 176.63 18.49 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.325 -179.02 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m120 54.69 -92.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.508 0.194 . . . . 0.0 110.84 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -108.4 11.61 26.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.576 0.226 . . . . 0.0 111.104 179.663 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.92 -139.67 11.86 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.674 -179.516 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.997 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.7 tp -72.06 -63.44 1.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.377 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.24 27.43 0.91 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.091 177.951 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.766 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.3 p90 -164.15 134.91 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 118.013 0.906 . . . . 0.0 111.17 178.708 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.29 134.41 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.611 -179.2 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.06 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.51 146.98 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.327 179.299 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.598 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.45 123.17 33.02 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.649 179.098 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.58 -119.23 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.097 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 64.06 173.82 3.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.515 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.771 HG23 ' C ' ' A' ' 68' ' ' VAL . 4.6 p -76.89 -3.83 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.005 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.1 -25.15 9.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.7 t30 -125.05 86.1 57.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.453 0.168 . . . . 0.0 110.667 -179.824 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.63 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.0 1.8 . . . . 0.0 112.216 -179.767 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 25' ' ' ASN . 10.6 t-80 -53.52 -24.11 12.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.271 179.056 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -88.62 -153.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.423 179.438 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.663 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -63.22 -51.41 55.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.624 -179.22 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 3.3 p-10 -178.68 35.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.615 0.245 . . . . 0.0 111.519 -179.378 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -125.47 164.15 34.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -179.897 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.547 ' HB2' HG22 ' A' ' 23' ' ' THR . 79.0 Cg_endo -84.05 44.47 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.665 2.243 . . . . 0.0 112.337 179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -90.43 123.38 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.92 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.37 109.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.487 179.926 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -135.66 147.13 48.46 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.392 0.615 . . . . 0.0 110.287 178.842 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.17 155.6 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.751 -176.738 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.61 -32.69 3.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.606 -179.05 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.74 140.57 2.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.915 0.388 . . . . 0.0 111.406 -179.941 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.971 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -102.66 133.63 45.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.206 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.479 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 117.38 68.51 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.332 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.7 Cg_exo -57.69 135.19 67.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.833 2.355 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.32 1.51 64.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.672 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.19 179.84 28.54 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.076 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -57.68 -33.23 68.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.979 179.873 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.797 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -74.03 -56.43 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.729 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.39 -31.25 72.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -72.13 -32.63 67.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -58.07 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.676 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 41.47 9.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.552 179.681 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 13.9 mmt180 -108.98 -17.35 13.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.897 0.38 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -109.35 155.93 20.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 133.49 44.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 179.778 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.08 158.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.358 0.599 . . . . 0.0 111.989 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.8 t30 74.47 3.97 4.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.463 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -74.86 126.24 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.052 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 t -86.48 101.23 12.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.554 0.692 . . . . 0.0 111.269 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 19' ' ' ILE . 65.3 mt -47.13 131.56 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.815 179.833 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.3 mm? -110.37 -44.19 3.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.843 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.61 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -142.29 162.17 36.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.768 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.896 HG13 ' CD2' ' A' ' 86' ' ' LEU . 43.8 t -152.29 114.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.974 179.795 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 84' ' ' VAL . 26.7 t30 46.6 46.0 14.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 75.42 31.7 0.76 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 64.9 t -120.77 142.16 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 34.3 t0 -105.5 112.12 25.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.484 HG12 HG21 ' A' ' 68' ' ' VAL . 28.5 m -95.81 24.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.369 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -58.88 -28.92 66.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 60.58 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.771 ' C ' HG23 ' A' ' 23' ' ' THR . 28.3 m -132.89 142.76 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.352 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 152.47 28.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 -179.926 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.832 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.2 t-160 -48.15 -33.95 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.685 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -68.59 -34.1 75.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.173 179.812 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.661 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.94 -38.49 79.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.731 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.852 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.51 -46.83 74.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.5 t -57.62 -50.42 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 178.489 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.661 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.08 -29.81 58.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.786 178.44 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.696 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -61.37 -53.61 54.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.163 0.506 . . . . 0.0 109.785 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.06 HD11 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -51.75 -40.31 60.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.487 178.871 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -77.55 -25.56 50.22 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.454 179.314 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' GLU . 2.7 pt-20 -93.84 7.57 44.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 0.0 111.311 -178.615 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.942 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -84.99 16.3 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.508 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.82 -83.98 0.09 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.409 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -147.74 -90.09 0.08 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.439 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.832 HG13 HG22 ' A' ' 7' ' ' THR . 9.4 tp -82.32 96.72 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 109.938 179.134 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.942 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.1 p -116.04 136.9 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.507 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -86.06 102.79 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.491 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.896 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.3 mt -90.81 138.58 31.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.303 -178.71 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.66 137.34 40.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.423 179.818 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 55' ' ' ASP . 15.7 m -139.66 165.22 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.307 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.466 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.2 ptt? -133.32 145.2 50.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 111.201 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.59 133.07 28.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.196 -179.897 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.909 179.773 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.841 0.353 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 89' ' ' MET . 1.7 mt-10 -85.49 116.46 23.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.953 179.921 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.695 ' CD2' HD13 ' A' ' 58' ' ' LEU . 3.2 m-30 -82.12 126.78 32.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.554 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.91 139.76 36.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 111.253 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -97.87 144.9 26.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.787 ' CD1' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.26 109.38 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.086 0.47 . . . . 0.0 111.545 179.911 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.843 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.33 125.37 29.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.459 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.885 HD11 ' HA ' ' A' ' 45' ' ' ALA . 2.3 tp -135.01 126.91 29.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.669 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.17 100.18 10.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.371 179.262 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.23 89.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.166 178.798 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -131.82 178.0 18.23 Favored Glycine 0 C--N 1.322 -0.204 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.357 -179.09 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 55.43 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.511 0.196 . . . . 0.0 110.748 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -108.29 9.88 27.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.558 0.218 . . . . 0.0 110.924 179.448 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.39 -138.13 10.75 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.653 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.833 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.6 tp -73.1 -52.42 14.31 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.22 179.635 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 120.03 22.98 3.1 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.959 -1.115 . . . . 0.0 115.342 177.458 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -163.48 135.8 5.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.353 1.077 . . . . 0.0 111.502 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 134.55 35.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.276 -179.674 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.052 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.4 162.85 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.551 0.691 . . . . 0.0 111.655 179.938 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -158.82 132.79 7.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.354 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.14 1.68 1.27 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.501 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.21 -172.94 0.37 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.955 -179.763 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 68' ' ' VAL . 32.1 p -68.41 -27.53 66.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.225 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 10.6 m-20 -96.8 -18.78 19.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -124.27 87.21 53.99 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.27 59.86 1.01 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.28 1.987 . . . . 0.0 112.6 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.634 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.0 t-80 -47.63 -28.3 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 178.834 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.805 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -89.35 -154.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.332 179.315 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.05 -49.53 77.53 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.663 -179.692 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.83 39.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.08 166.27 21.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CB ' HG22 ' A' ' 23' ' ' THR . 91.6 Cg_endo -80.65 6.83 5.2 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.64 2.227 . . . . 0.0 112.802 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -58.56 115.41 3.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.775 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.878 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.03 120.13 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.706 -179.896 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.32 144.57 33.3 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.358 0.599 . . . . 0.0 110.386 178.501 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.077 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.74 155.72 7.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.321 -176.374 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.4 -34.69 3.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.777 -178.784 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.12 142.36 2.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.46 -179.566 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.968 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.95 133.17 49.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 178.345 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.86 114.95 57.35 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.606 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 52.2 Cg_exo -55.71 137.76 79.26 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.256 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.02 6.71 66.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.77 177.36 21.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.992 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.45 -31.26 55.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.885 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -73.91 -57.5 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.712 -179.712 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.1 -28.57 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.259 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.72 -31.16 66.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.001 0.429 . . . . 0.0 110.084 179.428 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.42 -57.82 2.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.43 40.32 9.15 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.672 179.589 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.8 mtt85 -111.77 -19.16 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.663 0.268 . . . . 0.0 110.815 179.796 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.077 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -107.81 155.23 20.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.154 0.502 . . . . 0.0 111.177 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.58 134.82 45.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.676 179.746 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.0 157.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.317 0.58 . . . . 0.0 111.72 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.89 1.57 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.235 179.837 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.95 124.47 24.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.059 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.37 12.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.604 0.716 . . . . 0.0 111.419 -178.615 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 19' ' ' ILE . 20.3 mt -51.72 130.7 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.791 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.695 HD13 ' CD2' ' A' ' 3' ' ' TYR . 1.4 pp -126.95 3.41 6.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.604 179.389 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.5 OUTLIER 179.07 140.54 0.1 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.207 0.527 . . . . 0.0 110.583 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.908 HG23 ' CD2' ' A' ' 86' ' ' LEU . 2.4 p -147.57 118.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' HB2' HG21 ' A' ' 84' ' ' VAL . 46.4 t30 51.78 33.44 11.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 110.076 -179.006 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 77.62 34.75 0.34 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.711 ' HB ' HG13 ' A' ' 60' ' ' VAL . 58.4 t -120.91 108.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.2 p-10 -73.19 106.43 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.485 179.271 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 29.5 m -93.78 40.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.363 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -22.01 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.163 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -146.99 59.8 1.18 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.148 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -134.52 148.86 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.527 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.37 153.11 43.59 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.034 -179.344 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.8 t-160 -49.85 -34.02 18.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -33.99 73.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.772 179.41 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.58 -40.56 80.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.675 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.878 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.94 -46.71 80.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.009 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.9 t -57.97 -50.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.2 178.612 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.6 OUTLIER -56.4 -35.24 67.54 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.739 178.537 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -55.34 -52.49 63.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 110.142 179.528 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.0 HD11 HD12 ' A' ' 19' ' ' ILE . 3.4 mt -53.88 -38.72 65.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.241 178.585 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -20.65 53.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.413 179.011 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.2 mt-10 -97.21 -12.67 22.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.288 -178.687 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.896 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.9 -15.46 8.74 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.393 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 -91.28 1.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.903 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.4 p -139.45 -91.59 0.18 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.894 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.843 HG13 HG22 ' A' ' 7' ' ' THR . 9.7 tp -84.22 93.97 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.235 0.54 . . . . 0.0 110.007 178.813 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.896 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -113.21 136.86 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 8.5 ptp180 -87.49 102.94 15.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.471 177.969 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.908 ' CD2' HG23 ' A' ' 60' ' ' VAL . 17.7 mt -91.13 132.75 35.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.136 -179.079 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.52 126.18 48.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.6 m -129.32 153.12 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.719 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 2.9 ptt? -121.77 133.65 54.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 111.251 -179.888 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 123.39 19.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.863 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.877 0.37 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.4 116.41 23.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.81 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.49 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 40.5 m-85 -83.22 128.77 34.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.102 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.4 mt-10 -129.93 170.57 13.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.32 144.59 49.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.973 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.015 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -140.36 109.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 111.801 179.968 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.751 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.6 118.72 20.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.392 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.039 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.1 tp -129.42 127.09 40.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.058 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 4.8 pt-20 -84.66 100.28 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.011 179.324 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.539 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.07 89.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.486 179.81 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -49.87 -178.27 0.02 OUTLIER Glycine 0 CA--C 1.52 0.357 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.812 179.835 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -45.02 -38.31 4.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.666 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -98.75 -24.74 14.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.356 . . . . 0.0 111.28 -179.807 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 149.34 -165.14 29.43 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.923 -179.821 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.039 ' HB3' HD23 ' A' ' 8' ' ' LEU . 22.7 mt -53.77 -63.39 1.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.937 0.399 . . . . 0.0 110.698 179.963 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 130.12 31.55 0.58 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.297 179.479 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.809 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.23 138.09 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.033 0.416 . . . . 0.0 110.561 179.096 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.98 135.03 40.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.425 -179.476 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.076 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.05 146.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.546 0.689 . . . . 0.0 111.388 179.596 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.66 123.86 34.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.736 179.0 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 159.47 -124.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.742 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 32' ' ' PRO . . . 70.09 174.06 13.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.794 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.766 HG22 ' HB2' ' A' ' 32' ' ' PRO . 12.2 p -76.93 -1.33 28.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.903 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.92 -23.06 8.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -124.85 86.83 55.83 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -179.89 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 65.72 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.051 1.834 . . . . 0.0 112.196 -179.812 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.508 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 13.2 t-80 -53.18 -23.69 9.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.262 179.286 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.87 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -91.34 -152.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.481 179.526 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.671 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.87 -46.89 63.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.8 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.56 77.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.2 170.28 5.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.65 179.91 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.766 ' HB2' HG22 ' A' ' 23' ' ' THR . 96.1 Cg_endo -84.47 16.54 1.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.548 2.165 . . . . 0.0 112.829 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.6 m -62.74 145.61 54.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.067 0.461 . . . . 0.0 111.047 -179.933 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.806 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -116.73 114.82 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 -179.914 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.87 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -139.9 148.11 41.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.393 0.616 . . . . 0.0 110.545 179.16 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.01 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.22 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.968 -176.894 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.78 -30.03 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.372 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.78 129.57 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.049 -179.366 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.93 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.06 130.08 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.586 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 115.3 59.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.588 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 39.1 Cg_exo -57.52 135.79 71.87 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.741 2.294 . . . . 0.0 112.212 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.36 14.62 40.88 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.65 177.47 16.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.997 179.693 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.32 -38.23 57.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.834 0.349 . . . . 0.0 111.224 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.833 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.16 -57.53 8.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.909 -179.608 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.26 -28.64 64.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.509 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -71.94 -32.79 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.008 0.432 . . . . 0.0 110.306 179.603 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -77.6 -58.02 3.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 36.0 16.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.564 179.562 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.508 ' CB ' HG12 ' A' ' 6' ' ' ILE . 59.0 mtt180 -118.29 5.26 11.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.01 HD21 HD12 ' A' ' 36' ' ' ILE . 10.9 tp -130.61 156.53 44.72 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.057 0.456 . . . . 0.0 110.932 179.644 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.612 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.54 135.18 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.684 179.846 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -48.98 157.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.305 0.574 . . . . 0.0 111.749 -179.746 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' HG12 ' A' ' 53' ' ' VAL . 41.1 t30 76.59 0.66 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.275 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.17 125.45 26.71 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.063 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.54 100.14 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 0.0 111.298 -178.958 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.076 HD11 HG21 ' A' ' 19' ' ' ILE . 61.2 mt -45.36 145.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.996 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -128.83 -44.61 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -140.66 146.41 37.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.063 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 40.0 t -140.4 111.41 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.703 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 50.46 37.42 15.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.398 . . . . 0.0 110.185 -179.125 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 79.55 34.24 0.19 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.493 -179.353 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 60' ' ' VAL . 97.3 t -120.95 108.44 22.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.424 -179.851 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.0 t0 -78.28 93.32 4.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.902 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG12 HG21 ' A' ' 68' ' ' VAL . 14.8 m -64.53 -122.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 65' ' ' VAL . 7.3 ttm180 70.16 -65.69 0.31 Allowed 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.03 0.443 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -93.61 40.22 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.725 179.585 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.592 ' C ' HG23 ' A' ' 23' ' ' THR . 34.7 m -137.92 142.34 36.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 179.88 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -58.36 155.06 12.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.234 0.54 . . . . 0.0 111.274 -179.558 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.7 p-80 -49.55 -33.78 15.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.873 179.646 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -72.05 -33.67 68.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.327 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.688 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.14 -44.13 85.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.247 0.546 . . . . 0.0 109.663 179.023 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.806 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.19 -46.88 88.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.609 0.719 . . . . 0.0 109.182 178.045 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.1 t -57.99 -50.43 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.416 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.93 -29.71 63.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.842 178.614 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -60.85 -51.09 70.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.818 179.493 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.037 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.59 -37.89 71.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.705 179.016 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.3 -22.8 51.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.143 179.059 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -102.23 13.17 35.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.328 -178.655 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.912 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.56 16.34 3.93 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.357 179.966 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.61 -93.69 0.56 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.303 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 19.3 m -139.79 -89.23 0.19 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.751 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.8 tp -85.44 91.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.113 0.482 . . . . 0.0 109.874 178.804 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.912 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.1 p -106.99 137.41 37.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.693 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.35 102.76 14.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.458 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.9 mt -90.64 140.65 29.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.41 -178.697 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -101.95 131.87 48.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.273 179.569 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.435 HG21 ' OD2' ' A' ' 55' ' ' ASP . 6.8 m -139.79 136.55 39.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 -179.654 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.49 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 3.0 ptt? -105.92 138.74 41.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.911 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.36 146.51 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.025 179.883 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -149.73 177.95 9.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.522 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 27.1 m-85 -143.56 150.15 38.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -137.6 146.53 44.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.0 pm0 -108.49 144.56 35.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.058 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.81 110.33 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.531 179.779 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.709 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.95 116.95 20.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.711 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.058 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -126.68 127.07 44.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.509 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pt-20 -85.52 100.41 11.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.327 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -48.52 88.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.254 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.41 177.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.554 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -55.39 -23.49 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.331 . . . . 0.0 111.139 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -98.76 -24.72 14.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.184 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.38 -163.94 28.41 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.182 -179.753 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.972 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.8 tp -64.99 -63.56 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.644 0.222 . . . . 0.0 110.695 179.99 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.4 21.37 1.05 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.89 -1.148 . . . . 0.0 114.726 178.537 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.855 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.2 p90 -161.6 135.96 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.935 0.868 . . . . 0.0 111.113 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.0 138.75 32.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.45 -179.459 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.038 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -119.66 148.81 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.727 0.775 . . . . 0.0 112.365 -179.642 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.15 134.21 27.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.281 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.68 -0.52 1.04 Allowed Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.807 179.491 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.88 -170.31 0.13 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.929 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 32' ' ' PRO . 18.1 p -74.9 -21.59 59.13 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.141 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.15 -25.14 15.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.719 0.295 . . . . 0.0 111.643 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.421 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 62.7 t30 -124.34 87.52 53.87 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.176 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.11 63.84 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.276 1.984 . . . . 0.0 112.576 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.61 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.2 t-80 -49.52 -26.23 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.43 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.386 179.543 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -55.96 -50.83 59.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.704 -179.644 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.03 39.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.7 170.02 10.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.769 ' HB3' HG22 ' A' ' 23' ' ' THR . 93.6 Cg_endo -80.35 6.59 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.653 2.235 . . . . 0.0 112.843 -179.872 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.97 113.41 1.5 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.931 0.396 . . . . 0.0 110.57 179.722 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.65 119.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.023 -179.633 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.67 146.96 36.76 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.646 178.485 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.034 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.97 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.194 -176.566 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.77 -31.31 4.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.154 -179.038 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.84 132.14 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.114 -179.363 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.35 132.9 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.549 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.17 126.72 69.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.655 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.2 Cg_endo -66.16 132.3 29.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.658 2.239 . . . . 0.0 112.355 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.02 1.72 58.34 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.476 -179.833 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.91 173.97 22.08 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.957 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.25 -35.57 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.837 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -71.03 -57.21 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.748 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.38 -35.21 80.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 -179.161 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.2 pp0? -72.08 -30.4 65.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.43 179.705 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.98 -58.13 3.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.647 179.929 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 41.43 10.09 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.579 179.451 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.2 mtt180 -116.44 7.95 13.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.034 HD21 HD12 ' A' ' 36' ' ' ILE . 5.1 tp -136.72 154.18 50.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.73 179.577 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.79 136.49 48.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.89 157.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.403 0.621 . . . . 0.0 111.513 179.839 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.52 -0.78 3.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.245 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.693 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -69.78 127.52 33.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.972 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.0 p -86.57 100.2 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.471 0.653 . . . . 0.0 111.605 -178.568 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.97 HD11 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -47.03 141.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.087 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.847 HD21 ' HG3' ' A' ' 89' ' ' MET . 1.6 mm? -118.58 -45.03 2.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.183 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 m-85 -140.33 169.93 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.81 HG13 ' CD2' ' A' ' 86' ' ' LEU . 18.4 t -149.46 96.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.058 179.355 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.3 -68.15 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.176 0.512 . . . . 0.0 109.936 -178.784 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.2 tt0 -154.47 30.75 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.683 179.244 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.3 t -117.28 142.18 32.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.386 -179.333 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 35.7 t0 -114.72 87.91 2.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.494 179.431 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 65' ' ' VAL . 31.7 m -70.53 63.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 111.355 -179.543 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -29.62 30.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -154.68 64.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.817 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.745 ' O ' HG23 ' A' ' 23' ' ' THR . 34.7 m -128.15 146.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.78 153.62 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.067 0.46 . . . . 0.0 110.811 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 74' ' ' VAL . 7.0 p-80 -49.6 -33.62 15.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.988 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -70.64 -33.82 71.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.416 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.657 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.78 -44.42 85.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 109.807 179.178 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.19 -46.84 87.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.569 0.7 . . . . 0.0 109.307 178.095 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.9 t -57.16 -49.33 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.281 178.647 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.657 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.72 -33.06 66.13 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.598 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.51 -51.42 69.51 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.522 . . . . 0.0 109.991 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.39 -37.54 67.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.472 178.927 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.53 -26.67 51.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.502 179.332 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -91.74 -12.62 33.42 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.928 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.97 -18.77 10.1 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.334 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.38 -100.34 2.32 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.142 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -126.9 -91.74 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.008 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.709 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.7 tp -87.78 94.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.205 0.526 . . . . 0.0 109.723 178.745 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.928 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.9 p -110.14 138.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.506 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.1 mtm105 -87.77 103.11 15.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.148 177.838 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.81 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.9 mt -92.5 139.04 30.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.175 -178.993 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.78 147.88 25.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.693 HG21 ' OD2' ' A' ' 55' ' ' ASP . 30.3 m -138.81 167.93 20.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.425 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.847 ' HG3' HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -101.49 156.88 17.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.336 . . . . 0.0 110.996 -179.932 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.62 106.71 5.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 -179.895 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.981 179.858 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' CE1' ' A' ' 3' ' ' TYR . 4.8 ttm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.799 0.333 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -78.47 141.43 38.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 58' ' ' LEU . 2.7 m-30 -105.09 146.37 29.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -140.82 148.88 41.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -103.48 141.64 35.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.904 HG23 ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt -130.66 109.33 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.19 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.982 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.85 112.14 15.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.708 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.969 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.5 tp -121.44 126.83 50.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.145 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.817 ' CG ' HD13 ' A' ' 83' ' ' ILE . 8.8 mt-10 -81.57 100.33 9.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.06 88.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.926 179.562 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -53.22 173.84 0.37 Allowed Glycine 0 N--CA 1.453 -0.221 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.66 -179.859 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -53.03 -25.82 13.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.713 0.292 . . . . 0.0 110.941 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 p -93.59 -24.73 17.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.161 179.896 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.72 -163.37 27.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.247 -179.965 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp -67.2 -63.56 1.03 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.433 0.159 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.14 20.16 0.84 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.599 178.675 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.847 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.6 p90 -162.76 134.53 5.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.986 0.893 . . . . 0.0 111.455 179.019 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.81 139.1 30.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.402 -179.566 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.054 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.69 147.37 23.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.68 0.752 . . . . 0.0 112.328 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.93 135.4 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.06 179.438 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.71 3.39 0.96 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.559 179.584 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.61 -168.36 0.29 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.874 -179.837 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.808 HG22 ' HB3' ' A' ' 32' ' ' PRO . 40.5 p -72.46 -30.01 64.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -96.09 -17.27 21.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.035 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.0 OUTLIER -124.84 82.66 60.32 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.248 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.36 62.32 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.777 2.318 . . . . 0.0 112.294 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.655 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.2 t-80 -50.17 -23.45 2.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.538 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.82 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.81 -154.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.325 179.693 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.66 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.64 -50.19 69.69 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.537 -179.681 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.55 39.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.736 0.303 . . . . 0.0 110.766 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.75 164.67 33.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.999 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.808 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.25 3.69 6.02 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.05 2.5 . . . . 0.0 112.826 -179.849 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 m -54.8 114.32 1.67 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.06 119.81 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.742 -179.898 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.82 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.17 148.5 38.35 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 178.722 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.093 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.22 155.59 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -176.73 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -34.06 3.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.595 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.588 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.56 141.61 2.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.552 -179.677 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.767 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -104.29 133.07 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.166 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 113.74 49.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -177.763 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 45.2 Cg_exo -56.74 140.53 91.11 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.756 2.304 . . . . 0.0 112.506 -179.828 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.37 13.01 64.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.421 -179.91 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.32 -176.91 19.08 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.038 179.751 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -59.62 -35.62 74.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.846 0.355 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.88 -57.26 4.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.886 -179.615 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.31 -33.32 75.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.765 -179.041 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.8 pt20 -72.34 -30.4 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 110.56 179.773 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.45 ' OD2' HD12 ' A' ' 8' ' ' LEU . 3.5 m-20 -76.31 -58.22 3.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.059 -179.552 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 41.29 8.99 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.384 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.904 ' HB3' HG23 ' A' ' 6' ' ' ILE . 8.6 mmt180 -120.44 -2.14 10.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.696 0.284 . . . . 0.0 110.935 179.667 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.093 HD21 HD12 ' A' ' 36' ' ' ILE . 36.0 tp -124.37 162.96 22.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.147 0.499 . . . . 0.0 111.402 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.63 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.37 134.38 25.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.241 179.302 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.6 t -49.18 156.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.842 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.473 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.4 OUTLIER 76.54 -1.43 2.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.332 179.885 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -67.18 126.82 30.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.966 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.6 102.74 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.545 0.688 . . . . 0.0 111.533 -178.747 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.054 HD11 HG21 ' A' ' 19' ' ' ILE . 69.3 mt -49.36 136.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.784 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.856 HD11 ' HG2' ' A' ' 89' ' ' MET . 48.4 mt -120.61 -30.08 4.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.618 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -152.94 158.36 41.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.952 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.893 HG13 ' CD2' ' A' ' 86' ' ' LEU . 43.0 t -152.41 109.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.77 47.92 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.84 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 73.13 31.4 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.823 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 73.6 t -120.2 142.06 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.832 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 8.9 p-10 -113.05 91.35 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.556 179.519 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.736 HG12 HG21 ' A' ' 68' ' ' VAL . 2.2 m -55.9 -102.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.17 -179.646 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.583 ' H ' HG23 ' A' ' 65' ' ' VAL . 5.1 mtp180 61.99 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.773 0.32 . . . . 0.0 111.24 179.74 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -88.25 51.92 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 -179.655 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 30.4 m -139.17 144.41 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.053 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.475 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.36 154.59 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.429 . . . . 0.0 111.038 -179.484 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.4 p-80 -48.15 -34.26 9.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.194 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -70.29 -33.89 72.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.393 179.921 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.77 -47.34 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.194 0.521 . . . . 0.0 109.624 179.079 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -59.31 -46.74 87.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.654 0.74 . . . . 0.0 109.36 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.1 t -56.86 -50.4 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.357 178.516 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.9 -28.59 57.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.991 178.649 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.98 -51.59 67.46 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.344 0.592 . . . . 0.0 109.691 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -56.75 -36.89 70.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.874 179.098 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.4 -30.52 53.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.852 179.712 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -97.85 19.76 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.42 -178.417 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.14 16.3 7.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 179.656 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.53 -93.44 0.81 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.225 -179.835 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.477 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.2 m -142.18 -90.6 0.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.982 HG13 HG22 ' A' ' 7' ' ' THR . 6.0 tp -83.11 89.22 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.561 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.895 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.8 p -105.75 137.6 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.644 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.852 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.17 102.92 14.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.659 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.893 ' CD2' HG13 ' A' ' 60' ' ' VAL . 9.3 mt -92.77 137.7 32.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.172 -178.906 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 138.5 38.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.587 179.877 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.61 167.94 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.856 ' HG2' HD11 ' A' ' 58' ' ' LEU . 22.0 mtm -100.95 152.51 20.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.884 0.374 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.44 110.36 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.964 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.955 179.886 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttm . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.751 0.31 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.93 155.72 40.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CG ' HD13 ' A' ' 58' ' ' LEU . 6.4 m-85 -107.02 147.77 29.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.46 146.18 31.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.887 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -102.53 144.66 30.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.896 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.016 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.75 109.23 9.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.446 179.679 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.884 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.2 119.86 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.095 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.019 HD23 ' HG ' ' A' ' 15' ' ' LEU . 5.3 tp -131.07 126.9 37.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.48 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 pt-20 -84.29 100.49 11.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 179.354 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.7 89.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.042 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.27 174.38 0.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.603 -179.912 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -54.51 -24.23 19.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.72 -23.65 16.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.52 -163.66 27.85 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.147 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.019 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.8 tp -68.13 -63.56 1.04 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.836 -0.214 . . . . 0.0 110.798 -179.96 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 132.22 22.11 0.92 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 119.693 -1.242 . . . . 0.0 114.914 178.38 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.862 ' CE2' HD23 ' A' ' 15' ' ' LEU . 10.4 p90 -161.17 135.96 7.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.073 0.936 . . . . 0.0 111.351 179.101 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.75 135.36 36.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.528 -179.571 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.2 146.83 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.418 179.638 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.14 123.59 34.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.446 178.956 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.48 -124.91 1.41 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.939 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 73.14 168.71 13.9 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.214 179.877 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 32' ' ' PRO . 6.3 p -75.53 -6.29 49.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -106.64 -26.92 11.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' HIS . 5.2 t-20 -124.91 86.97 55.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.579 -179.762 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.23 66.93 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.127 1.885 . . . . 0.0 112.455 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.56 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 11.2 t-80 -52.39 -24.91 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.252 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.852 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.1 -153.71 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.388 179.723 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -52.33 -51.62 41.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.85 -179.366 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 169.8 41.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 0.0 110.846 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.06 173.59 5.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.849 ' HB2' HG22 ' A' ' 23' ' ' THR . 80.9 Cg_endo -84.66 41.6 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.734 2.289 . . . . 0.0 112.438 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -90.41 119.49 30.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.003 0.43 . . . . 0.0 111.267 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.915 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.69 112.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.044 179.643 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.852 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -138.29 147.42 43.58 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.369 0.604 . . . . 0.0 110.283 179.249 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.045 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.15 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.111 -176.663 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.592 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.67 -33.55 4.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.574 -179.225 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.639 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.98 142.19 2.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.911 0.386 . . . . 0.0 111.457 -179.762 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.75 132.96 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.967 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 125.13 73.96 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.278 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 41.4 Cg_endo -67.05 129.92 21.73 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.936 2.424 . . . . 0.0 112.189 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.91 49.93 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.02 178.84 19.8 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.878 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.92 -38.81 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.749 0.309 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.784 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -66.62 -57.47 7.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.634 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.47 -28.89 67.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.487 -179.684 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -33.57 68.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.966 0.413 . . . . 0.0 110.175 179.594 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' OD2' HD12 ' A' ' 8' ' ' LEU . 4.3 m-20 -84.1 -57.99 2.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.66 -179.904 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 41.27 9.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.604 179.638 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.479 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -111.21 -10.24 14.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.885 0.374 . . . . 0.0 110.78 179.621 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.045 HD21 HD12 ' A' ' 36' ' ' ILE . 4.6 tp -117.14 153.45 32.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.93 137.8 51.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -52.24 158.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.828 -179.967 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 3.5 t30 75.93 -0.09 3.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.325 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -69.11 125.53 26.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.18 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.69 100.69 12.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.672 . . . . 0.0 111.366 -178.837 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.088 HD11 HG21 ' A' ' 19' ' ' ILE . 61.4 mt -47.11 129.15 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.911 179.927 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.766 HD21 ' SD ' ' A' ' 89' ' ' MET . 3.6 mt -114.95 -32.05 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.586 179.437 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -151.94 155.78 38.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.916 HG13 ' CD2' ' A' ' 86' ' ' LEU . 46.0 t -142.2 102.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.631 179.572 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.13 -68.13 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.088 0.47 . . . . 0.0 110.462 -179.508 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' VAL . 8.3 pt-20 -155.06 30.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.907 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.529 HG21 ' OE2' ' A' ' 79' ' ' GLU . 47.0 t -117.87 142.09 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.2 t0 -109.93 87.77 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.366 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 57' ' ' ILE . 29.9 m -63.37 -138.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.868 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HD3' HD23 ' A' ' 58' ' ' LEU . 0.0 OUTLIER 76.2 -59.73 0.5 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.092 -179.184 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -100.8 30.16 4.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.293 179.03 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.757 ' C ' HG23 ' A' ' 23' ' ' THR . 12.2 m -127.55 142.77 42.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.389 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.41 152.97 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.89 ' O ' HG23 ' A' ' 74' ' ' VAL . 22.7 t-160 -47.91 -33.96 8.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.881 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -65.25 -34.17 77.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.091 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.816 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -63.07 -46.93 85.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.908 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 70' ' ' HIS . 76.3 t -56.25 -50.91 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.287 178.601 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.58 -29.27 61.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.253 178.944 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.9 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.42 -56.83 16.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.962 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 73' ' ' ALA . 2.2 mp -53.4 -36.84 61.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.983 178.976 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.42 -27.4 52.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.642 179.521 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -99.44 14.64 29.07 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.435 -178.267 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.946 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.47 16.29 3.9 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.763 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.3 -86.71 0.05 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.191 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 13.3 p -144.14 -89.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.456 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.884 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.21 92.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.176 0.512 . . . . 0.0 110.077 179.127 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.946 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -108.1 137.92 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.898 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 11.0 ptp180 -88.29 102.7 15.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.188 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.916 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.2 mt -91.65 138.8 31.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.427 -178.52 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.49 137.36 39.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.138 179.584 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.468 HG21 ' OD2' ' A' ' 55' ' ' ASP . 11.6 m -139.63 168.12 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.213 -179.4 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.766 ' SD ' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.4 150.83 22.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.97 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.58 106.96 5.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HB2' ' HG3' ' A' ' 91' ' ' ARG . 2.8 ttp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.889 0.375 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.21 132.21 53.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.478 -179.426 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 1' ' ' MET . 3.2 m-85 -108.88 109.75 20.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.346 179.426 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.61 166.98 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 111.493 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -119.52 144.95 46.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.979 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.87 111.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.99 0.424 . . . . 0.0 111.856 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.5 120.15 23.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.972 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.98 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -129.83 126.8 38.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.613 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.6 pt-20 -86.68 100.74 12.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.233 179.312 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -47.86 88.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.325 179.531 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.14 177.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.781 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.14 -25.08 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.642 0.258 . . . . 0.0 111.06 -179.877 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t -97.64 -24.79 15.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.106 -179.909 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.7 -163.43 27.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.149 -179.791 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.98 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.1 tp -63.9 -63.45 1.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.485 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.96 22.14 1.16 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.909 -1.138 . . . . 0.0 114.632 178.446 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.829 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.1 p90 -162.89 134.79 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.76 0.78 . . . . 0.0 111.228 179.02 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.38 139.41 31.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.672 -179.287 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.029 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.74 147.18 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.661 0.743 . . . . 0.0 112.306 -179.92 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 132.62 29.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.876 179.202 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 149.76 -6.48 0.75 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.491 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.32 179.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.977 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 68' ' ' VAL . 19.1 p -65.03 -34.62 78.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.231 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.93 -17.58 29.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.557 -179.552 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -124.43 81.99 58.8 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.45 63.38 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.832 2.354 . . . . 0.0 112.522 -179.316 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.631 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.2 t-80 -53.16 -22.3 6.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.805 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.43 -152.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.448 179.73 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.674 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.97 50.37 4.39 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.643 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 78.04 47.34 0.05 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.028 0.442 . . . . 0.0 110.455 179.744 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.98 151.46 72.18 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CB ' HG22 ' A' ' 23' ' ' THR . 68.8 Cg_endo -74.45 -2.7 12.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.456 2.104 . . . . 0.0 112.576 179.976 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.402 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -52.16 119.25 4.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.537 179.695 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.823 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -86.55 120.34 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 -179.462 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.18 147.19 36.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.337 0.589 . . . . 0.0 110.564 178.479 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.992 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.943 -176.767 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.51 -30.95 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.783 -1.098 . . . . 0.0 112.215 -179.091 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.68 131.41 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.043 -179.408 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.0 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.84 132.14 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.492 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.44 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.32 124.22 74.08 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.719 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 34.9 Cg_endo -64.59 135.38 45.25 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.675 2.25 . . . . 0.0 112.242 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.94 7.13 60.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.486 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.09 174.51 17.65 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.904 179.804 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.64 -32.75 52.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.642 0.258 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.746 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -72.18 -57.42 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.547 -179.965 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.32 -28.91 67.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.446 -179.535 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -71.9 -31.58 66.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.197 179.596 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -83.83 -57.85 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.932 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.4 40.81 8.8 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.385 179.714 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.456 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.6 mtp85 -112.64 -9.23 13.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.017 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.0 HD23 HD11 ' A' ' 39' ' ' ILE . 6.3 tp -119.35 155.88 31.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.619 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.1 mpt_? -131.99 135.47 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.98 157.72 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.296 0.57 . . . . 0.0 111.721 179.889 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.3 OUTLIER 76.23 -1.27 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.715 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.3 m-20 -69.53 127.71 33.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.99 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.69 100.02 12.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.549 0.69 . . . . 0.0 111.281 -178.97 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 19' ' ' ILE . 10.6 mt -45.74 144.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.026 -179.927 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 89' ' ' MET . 0.2 OUTLIER -123.26 -44.36 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.205 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -140.97 165.78 26.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.818 HG13 ' CD2' ' A' ' 86' ' ' LEU . 42.0 t -150.75 103.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.523 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -71.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.108 0.48 . . . . 0.0 110.226 -179.24 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -151.14 28.56 0.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.816 179.3 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.833 HG12 ' H ' ' A' ' 65' ' ' VAL . 21.5 t -116.04 142.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.21 -179.485 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 38.4 p-10 -103.59 -0.96 28.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.422 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.833 ' H ' HG12 ' A' ' 63' ' ' VAL . 16.7 m 43.65 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.559 -179.645 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -51.92 99.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.765 179.91 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' O ' HG21 ' A' ' 23' ' ' THR . 11.3 pt-20 44.85 57.66 4.46 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 -179.58 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.741 ' C ' HG23 ' A' ' 23' ' ' THR . 4.9 m -108.51 145.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.25 156.84 14.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.337 -178.925 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.923 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.0 p-80 -48.9 -34.29 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.932 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -67.91 -33.86 75.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.568 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.29 -46.1 78.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.181 0.515 . . . . 0.0 109.649 178.898 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.823 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.37 -45.4 93.35 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 70' ' ' HIS . 66.9 t -56.52 -50.43 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.113 178.517 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.48 -34.65 36.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.862 179.534 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.793 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.49 -57.34 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.94 HD12 HD12 ' A' ' 19' ' ' ILE . 2.4 mt -59.98 -41.32 91.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.38 0.61 . . . . 0.0 110.231 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.604 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.92 -20.13 56.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.766 179.641 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -112.22 23.44 13.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 179.271 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.879 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -82.92 16.57 2.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.752 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.52 -91.24 0.48 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.676 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.0 m -138.29 -90.73 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.859 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 7' ' ' THR . 8.1 tp -86.55 100.23 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.526 179.361 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.879 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.3 p -114.11 139.95 37.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.793 -178.171 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.714 ' HG3' HG23 ' A' ' 7' ' ' THR . 11.7 mtt180 -88.12 103.51 15.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.603 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.818 ' CD2' HG13 ' A' ' 60' ' ' VAL . 17.7 mt -94.1 136.63 34.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -178.942 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 138.17 39.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.377 179.562 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.441 HG11 HD11 ' A' ' 51' ' ' LEU . 5.6 m -139.79 137.63 39.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.992 -179.679 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.61 ' HB3' HD23 ' A' ' 58' ' ' LEU . 8.7 ptt? -108.37 135.44 49.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.776 179.781 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.15 112.39 11.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.608 -179.491 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.535 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.289 -0.863 . . . . 0.0 110.914 179.818 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.856 0.36 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.92 133.56 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 71.1 m-85 -93.98 165.55 12.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.489 179.672 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -144.7 137.32 26.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.8 pt-20 -103.43 144.61 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.651 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.039 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.91 109.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 111.887 179.925 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.889 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.35 121.14 24.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.612 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.039 HD13 HD11 ' A' ' 6' ' ' ILE . 5.2 tp -130.44 127.2 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.233 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.1 mt-10 -77.78 99.72 6.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.201 179.59 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -62.57 90.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.235 178.455 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -136.74 179.59 17.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.996 -179.47 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 54.01 -91.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.578 0.228 . . . . 0.0 110.782 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m -108.38 14.65 24.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.652 0.263 . . . . 0.0 111.127 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 120.08 -138.54 13.13 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.868 -179.676 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.4 tp -75.25 -63.29 1.31 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.66 0.23 . . . . 0.0 110.591 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.519 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 133.61 19.12 0.96 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.942 -1.123 . . . . 0.0 114.775 178.596 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.865 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.7 p90 -161.31 137.05 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.755 0.778 . . . . 0.0 110.996 179.114 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.69 138.01 33.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.528 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.07 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.22 147.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.669 0.747 . . . . 0.0 112.302 -179.781 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.56 133.67 31.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.168 179.454 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.76 -7.48 1.08 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.531 179.57 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.54 -177.86 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.337 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 30.3 p -64.03 -33.72 76.39 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.914 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 12.2 t70 -89.78 -19.02 25.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.957 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.13 86.94 53.86 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.46 179.897 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.0 61.25 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.407 2.071 . . . . 0.0 112.4 -179.729 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.575 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 15.6 t-80 -49.83 -26.12 3.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.187 178.967 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.774 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.99 -151.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.525 179.616 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.69 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.25 49.87 4.31 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.828 -178.951 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.18 45.11 0.09 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.088 0.47 . . . . 0.0 110.511 179.558 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.13 78.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.913 179.912 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.502 ' HB3' HG22 ' A' ' 23' ' ' THR . 68.7 Cg_endo -74.77 -1.16 10.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.38 2.053 . . . . 0.0 112.546 179.847 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -51.99 115.91 1.92 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.91 0.386 . . . . 0.0 110.462 179.524 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.06 118.21 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.145 -179.346 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.774 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.94 146.96 38.06 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.372 0.606 . . . . 0.0 110.474 178.42 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.005 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.1 155.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.191 -176.52 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.17 -30.96 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.133 -178.846 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.86 132.93 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.113 -179.496 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.53 132.05 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.889 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.435 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.17 116.17 63.66 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.627 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.39 135.56 68.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.757 2.304 . . . . 0.0 112.273 179.742 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.55 9.49 57.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.655 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.71 179.76 18.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.033 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.38 -36.52 66.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.755 0.312 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.98 -57.35 5.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.029 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.77 -29.94 68.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.02 -178.964 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 11.4 pt20 -72.04 -33.42 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.45 -58.04 3.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 41.09 9.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.594 179.479 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.2 mtt-85 -115.38 9.05 15.5 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.751 179.584 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.005 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -136.19 154.58 50.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.627 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.15 135.59 46.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.85 179.841 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -51.4 157.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.437 0.637 . . . . 0.0 111.552 179.998 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.49 0.17 3.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.356 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.8 m-20 -71.35 127.73 33.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.0 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.4 p -86.49 100.41 12.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.576 0.703 . . . . 0.0 111.381 -178.597 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.07 HD11 HG21 ' A' ' 19' ' ' ILE . 68.1 mt -45.46 151.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.127 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -128.91 -46.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.278 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -141.15 163.98 31.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.835 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.4 t -148.67 101.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.603 179.573 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.72 -68.83 0.12 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.1 0.476 . . . . 0.0 110.389 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.8 mm-40 -154.13 30.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.799 179.29 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.832 HG12 ' H ' ' A' ' 65' ' ' VAL . 19.7 t -117.66 142.2 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.165 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 34.5 p-10 -105.54 1.35 27.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.389 179.77 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.832 ' H ' HG12 ' A' ' 63' ' ' VAL . 15.4 m 43.62 30.84 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.813 0.339 . . . . 0.0 111.319 -179.638 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 95.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.992 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 57.04 63.0 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.745 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 19.7 m -119.29 147.72 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.06 155.6 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.214 -179.17 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.1 p-80 -48.17 -34.93 10.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.181 -179.454 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 m -69.83 -33.79 72.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.381 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.87 -47.29 75.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.0 109.645 178.982 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.3 -46.77 88.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.551 0.691 . . . . 0.0 109.493 178.2 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.7 t -57.41 -48.45 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.296 178.606 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.96 -34.87 68.48 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.518 178.553 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.565 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.46 -51.3 67.39 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.258 0.551 . . . . 0.0 110.016 179.337 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.033 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.28 -37.19 66.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.307 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.47 -26.74 51.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -96.2 6.1 49.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 111.437 -178.647 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -79.14 16.19 1.0 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.65 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.91 -91.11 0.5 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.347 -179.954 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 10' ' ' ARG . 38.6 m -143.87 -91.15 0.11 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.198 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.889 HG13 HG22 ' A' ' 7' ' ' THR . 8.9 tp -81.68 92.69 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 109.726 178.693 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.913 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -110.89 137.05 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.262 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.8 ptt85 -87.04 103.09 15.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.196 177.676 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.835 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.5 mt -91.51 141.83 28.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.162 -178.983 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 144.32 30.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.624 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.73 167.52 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.435 179.714 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.451 ' HG3' HD21 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -104.29 139.82 38.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.998 -179.962 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.61 106.76 5.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.847 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.415 ' H ' ' HG3' ' A' ' 91' ' ' ARG . 1.8 ppt_? . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.94 179.823 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' CA ' ' A' ' 91' ' ' ARG . 2.2 ttt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.759 0.314 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.42 127.05 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.803 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.445 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 3.6 m-30 -93.39 169.15 10.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.021 -179.867 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -164.2 147.1 9.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -102.58 144.65 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.56 109.44 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.487 179.846 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.834 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.47 113.29 17.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.047 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -123.81 127.22 47.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.563 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 pt-20 -86.35 100.13 12.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.275 179.898 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.16 89.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.266 178.328 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -125.12 173.03 17.26 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.345 -178.983 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m120 53.97 -91.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.481 0.181 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -108.46 12.83 25.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.636 0.255 . . . . 0.0 111.178 179.673 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.2 -143.23 14.67 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.777 -179.696 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.908 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp -67.37 -63.39 1.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.44 -179.998 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.94 24.7 1.17 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.854 178.139 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.77 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.1 p90 -162.18 134.95 5.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.985 0.892 . . . . 0.0 111.498 178.923 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.31 134.78 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.173 -179.679 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.085 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.68 166.74 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.706 0.765 . . . . 0.0 111.655 179.936 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -163.62 131.93 3.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.296 179.997 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.46 0.53 1.15 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.456 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.966 -179.976 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.79 HG22 ' CB ' ' A' ' 32' ' ' PRO . 15.0 p -74.78 -20.03 59.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.18 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -98.39 -24.15 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 111.661 -179.376 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -124.53 87.89 53.9 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 179.814 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 63.07 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.317 2.011 . . . . 0.0 112.792 -179.368 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.627 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 11.8 t-80 -48.29 -27.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 178.859 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.814 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.39 -154.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.557 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.53 -50.41 63.11 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.582 -179.708 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.01 40.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.914 0.388 . . . . 0.0 110.711 -179.98 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.26 167.22 16.95 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.999 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.79 ' CB ' HG22 ' A' ' 23' ' ' THR . 89.0 Cg_endo -80.92 8.55 4.25 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.645 2.23 . . . . 0.0 112.83 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -60.49 113.76 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 110.772 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.876 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -81.34 119.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.446 179.962 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.814 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.42 145.0 33.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.37 0.605 . . . . 0.0 110.568 178.792 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.052 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.91 155.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.332 -176.333 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.11 -34.28 4.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.81 143.01 2.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 111.55 -179.602 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.011 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -105.77 132.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.097 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.427 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.02 125.91 71.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.475 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.1 Cg_endo -66.89 131.09 24.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 4.82 55.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.457 -179.649 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.78 177.67 21.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.726 179.685 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.19 -36.19 65.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.66 0.267 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.806 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -69.42 -57.53 5.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.517 -179.87 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.01 -28.92 67.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.12 -35.44 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.441 . . . . 0.0 110.0 179.318 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -83.59 -57.99 3.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.03 9.42 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' CB ' HG12 ' A' ' 6' ' ' ILE . 42.5 mtp180 -113.72 8.85 17.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.699 0.285 . . . . 0.0 110.662 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.052 HD21 HD12 ' A' ' 36' ' ' ILE . 4.6 tp -135.08 153.88 51.88 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.609 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.56 136.65 49.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.879 179.937 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.9 t -51.18 158.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.331 0.586 . . . . 0.0 111.676 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.29 2.17 4.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.023 179.911 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -71.02 126.03 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.988 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -86.48 101.95 13.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.652 0.739 . . . . 0.0 111.346 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.085 HD11 HG21 ' A' ' 19' ' ' ILE . 57.4 mt -49.74 136.27 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.491 HD11 ' HE3' ' A' ' 89' ' ' MET . 1.7 mt -115.38 -38.29 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.174 179.545 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -147.34 172.01 14.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.798 -179.73 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.858 HG13 ' CD2' ' A' ' 86' ' ' LEU . 36.7 t -150.27 96.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.996 179.351 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.764 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 68.44 -67.17 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.193 0.52 . . . . 0.0 109.775 -178.789 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -156.28 32.34 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.555 179.209 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.8 t -119.23 142.33 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.57 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.9 p-10 -111.07 106.77 15.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.214 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.454 HG12 HG21 ' A' ' 68' ' ' VAL . 31.4 m -91.88 43.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.52 -179.517 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.58 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.736 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.43 66.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 23' ' ' THR . 35.6 m -134.6 145.63 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 151.69 28.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.753 -179.884 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.8 t-160 -48.98 -33.67 11.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 t -67.15 -34.06 76.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.045 179.642 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.39 -40.39 81.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.829 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.876 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.55 -46.76 78.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.112 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 97.4 t -57.19 -50.29 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.143 178.563 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.25 -33.04 62.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.693 178.646 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.218 0.533 . . . . 0.0 110.124 179.453 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.048 HD11 HD12 ' A' ' 19' ' ' ILE . 1.4 mt -53.12 -37.57 61.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.212 178.857 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.47 -27.58 52.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.305 178.953 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -87.63 -17.65 31.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.021 0.438 . . . . 0.0 111.092 -178.825 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.973 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -52.32 -21.42 3.51 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.489 179.828 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.04 -91.31 1.44 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.045 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -134.49 -92.87 0.31 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.834 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -86.57 93.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.34 0.59 . . . . 0.0 109.983 178.961 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.973 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.7 p -110.17 139.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.232 -177.493 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.724 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.43 103.07 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.863 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.858 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.8 mt -93.81 135.73 34.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -101.73 139.92 36.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 -179.946 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 55' ' ' ASP . 25.9 m -139.8 167.88 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.992 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.491 ' HE3' HD11 ' A' ' 58' ' ' LEU . 8.9 mtp -118.14 146.26 44.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -140.65 106.91 5.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.608 ' HE3' ' HG2' ' A' ' 91' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.852 0.358 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.94 140.03 30.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.817 179.957 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' HE1' ' HE2' ' A' ' 89' ' ' MET . 9.9 m-30 -99.03 112.19 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.967 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.19 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.624 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.424 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 4.4 tt0 -130.36 141.65 50.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.683 0.278 . . . . 0.0 111.098 -179.822 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.023 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.1 112.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.026 0.441 . . . . 0.0 111.87 179.755 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.77 121.95 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.698 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.064 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.9 tp -131.14 127.14 37.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.368 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.4 pt-20 -82.96 100.36 10.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.208 179.276 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.03 88.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.107 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.75 174.02 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.61 -180.0 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -52.98 -25.51 12.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 0.0 111.028 179.997 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -96.01 -24.78 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.7 -164.1 27.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.368 -179.8 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.064 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.1 tp -63.95 -63.57 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.278 -0.169 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.02 28.15 0.88 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.922 178.33 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.7 p90 -162.9 132.92 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.879 0.84 . . . . 0.0 111.03 178.771 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.568 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -90.83 134.88 34.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.437 -179.2 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.03 163.63 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.703 0.763 . . . . 0.0 111.756 -179.944 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -159.06 130.67 6.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.931 179.452 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 146.91 -1.03 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.319 179.82 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.61 -172.08 0.25 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.91 -179.857 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.818 HG22 ' HB3' ' A' ' 32' ' ' PRO . 28.6 p -69.77 -34.38 73.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.308 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.43 -19.56 25.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -124.68 82.41 59.78 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 0.0 110.292 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.98 62.48 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.803 2.335 . . . . 0.0 112.224 -179.594 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.663 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 12.4 t-80 -50.73 -23.39 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.413 179.016 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.85 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -93.92 -154.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.308 179.582 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.57 -50.26 68.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.584 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.13 40.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -127.84 168.52 14.99 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.022 -179.913 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.18 3.2 6.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.01 2.473 . . . . 0.0 112.702 -179.81 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 2.7 m -53.96 112.17 0.9 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.863 0.363 . . . . 0.0 111.092 -179.917 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.867 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.34 119.64 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.388 179.914 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.85 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.58 144.48 32.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.505 0.669 . . . . 0.0 110.585 178.952 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.151 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.07 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.88 -176.593 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.463 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.57 -31.9 4.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.809 -178.842 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.47 142.12 2.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.384 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.952 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.89 133.82 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.26 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.476 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.94 119.28 73.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.18 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.8 Cg_exo -58.87 132.6 48.61 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.757 2.304 . . . . 0.0 112.137 179.748 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.82 -1.16 59.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.763 -179.976 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.36 177.39 28.47 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.873 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.78 -35.53 63.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.969 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.843 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.26 -57.39 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 -179.997 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.89 -28.97 68.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.318 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -71.81 -34.23 69.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.13 0.491 . . . . 0.0 109.889 179.509 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.08 -57.74 2.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.49 42.01 9.54 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.362 179.655 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtp180 -110.27 -18.64 13.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.688 179.765 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.151 HD21 HD12 ' A' ' 36' ' ' ILE . 4.8 tp -106.69 153.26 22.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.089 0.471 . . . . 0.0 110.666 179.371 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -127.85 135.89 50.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.919 179.825 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -50.29 160.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.495 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.2 m120 71.45 4.1 4.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.154 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.556 ' CG ' HG21 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -71.06 124.35 24.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.589 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.6 p -86.42 100.0 12.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.561 0.696 . . . . 0.0 111.709 -178.193 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.036 HD11 HG21 ' A' ' 19' ' ' ILE . 9.9 mt -53.12 129.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.861 179.792 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.4 pp -122.53 -18.61 6.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.521 178.974 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.524 ' HD1' HD12 ' A' ' 58' ' ' LEU . 1.9 m-85 -157.36 162.36 39.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.026 0.441 . . . . 0.0 110.652 -179.979 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.914 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.8 t -143.92 97.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.86 179.41 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.832 ' CG ' HG23 ' A' ' 84' ' ' VAL . 1.3 t-20 66.59 -69.02 0.13 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.159 0.504 . . . . 0.0 109.889 -178.572 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -152.89 29.66 0.51 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.866 179.174 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.5 t -115.98 141.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.359 -179.402 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.5 p-10 -113.47 97.18 6.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.492 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 65' ' ' VAL . 31.4 m -69.62 64.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.191 -179.781 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -91.31 101.02 13.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.547 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.41 51.01 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.019 -179.902 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.762 ' C ' HG23 ' A' ' 23' ' ' THR . 19.1 m -116.41 142.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 179.639 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.481 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.54 153.29 23.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.025 -179.129 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.881 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.1 p-80 -47.95 -33.82 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.963 -179.671 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -33.96 70.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.947 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.631 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.35 -44.56 82.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 109.724 179.321 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.867 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.01 -46.88 87.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.773 0.797 . . . . 0.0 109.161 178.095 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.911 HG22 HD11 ' A' ' 19' ' ' ILE . 90.0 t -56.22 -50.45 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.299 178.601 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.631 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.11 -29.84 61.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.379 179.071 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -61.94 -50.3 72.68 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.404 0.621 . . . . 0.0 109.986 179.57 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -59.05 -36.13 74.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.771 179.271 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -24.03 50.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.889 178.788 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -101.78 16.27 26.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.792 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.28 16.21 5.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.75 -93.97 0.75 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.316 -179.999 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.7 m -141.42 -89.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 7' ' ' THR . 6.8 tp -84.07 89.02 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.646 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.901 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.6 p -105.38 136.29 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.182 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.01 102.94 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.664 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.914 ' CD2' HG13 ' A' ' 60' ' ' VAL . 38.0 mt -89.12 137.34 32.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.389 -178.836 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.559 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.1 122.84 44.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.529 179.679 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 57' ' ' ILE . 17.0 m -128.89 151.49 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.565 -179.938 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.484 ' HE2' ' HE1' ' A' ' 3' ' ' TYR . 2.0 mtp -96.71 149.57 21.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.722 0.296 . . . . 0.0 110.874 -179.989 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.18 136.06 36.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.608 ' HG2' ' HE3' ' A' ' 1' ' ' MET . 2.6 ppt_? . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.781 0.324 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -134.16 124.37 25.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.68 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' HD11 ' A' ' 58' ' ' LEU . 6.4 m-85 -89.22 144.35 26.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.038 -179.775 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 11.2 pt-20 -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -118.73 144.71 46.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 -179.978 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.013 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.7 109.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 111.863 179.857 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.719 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.91 116.37 20.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.525 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.047 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.9 tp -126.06 127.36 45.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.249 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.8 pm0 -86.84 100.46 12.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.713 179.596 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.587 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 1.3 mtm180 -44.32 91.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.682 179.109 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.34 70.54 0.02 OUTLIER Glycine 0 C--N 1.32 -0.342 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.256 -179.19 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 10' ' ' ARG . 25.1 t-20 63.31 -72.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.815 0.34 . . . . 0.0 111.496 179.575 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 11' ' ' GLY . 74.7 m -69.98 -24.76 63.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.293 -179.692 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' CD ' ' A' ' 10' ' ' ARG . . . 153.11 -172.71 32.06 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.038 -179.776 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.047 ' HB3' HD23 ' A' ' 8' ' ' LEU . 16.4 mt -63.5 -63.59 1.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.493 179.9 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 137.0 34.62 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.71 179.318 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.7 p90 -159.64 138.08 10.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.137 0.469 . . . . 0.0 110.938 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.99 132.19 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.811 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.052 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -108.2 165.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.77 . . . . 0.0 111.803 -179.905 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -164.27 131.3 3.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.356 179.845 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.66 0.2 0.97 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.632 179.614 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.52 -170.96 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.977 -179.871 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.798 HG22 ' CB ' ' A' ' 32' ' ' PRO . 13.2 p -75.34 -20.79 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.187 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.85 -24.96 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 -179.347 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -124.39 87.66 53.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.208 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 63.12 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.418 2.079 . . . . 0.0 112.686 -179.484 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.64 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.2 t-80 -47.96 -27.9 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 178.887 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.874 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.59 -155.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.357 179.301 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.678 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.8 -46.78 59.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.562 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.2 m-20 176.71 73.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -165.67 165.69 10.85 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.798 ' CB ' HG22 ' A' ' 23' ' ' THR . 82.9 Cg_endo -81.21 5.7 6.07 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.674 2.249 . . . . 0.0 112.923 -179.947 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.405 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -56.0 112.87 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.948 179.953 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.846 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.51 119.16 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 -179.911 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.874 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.26 145.9 34.54 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.505 0.669 . . . . 0.0 110.847 178.653 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.05 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.73 155.97 7.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.008 -176.897 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.469 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.88 -27.47 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.622 -178.411 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.64 128.67 0.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.211 -179.444 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.031 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.98 130.51 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.662 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 114.74 56.63 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.569 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.5 Cg_exo -57.94 135.58 69.73 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.781 2.32 . . . . 0.0 112.217 179.918 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.12 15.27 39.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.97 179.58 16.09 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.037 179.773 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.33 -38.55 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.734 0.302 . . . . 0.0 111.343 -179.982 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.817 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.98 -57.65 7.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.012 -179.538 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.2 -28.76 64.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 -179.4 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -32.87 67.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.916 0.389 . . . . 0.0 110.264 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -79.63 -58.1 3.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.582 179.967 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.5 9.92 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.645 179.433 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.512 ' CB ' HG12 ' A' ' 6' ' ' ILE . 25.9 mtt180 -119.36 7.23 11.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.868 0.334 . . . . 0.0 110.941 179.68 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.05 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -134.3 154.8 51.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.917 179.555 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 135.1 43.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.863 179.995 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 38' ' ' LYS . 59.9 t -49.14 158.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.278 0.561 . . . . 0.0 111.55 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.3 t-20 73.69 4.19 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.992 -179.807 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.4 m-20 -73.27 124.23 25.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.46 101.77 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.693 0.759 . . . . 0.0 111.63 -178.395 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 19' ' ' ILE . 57.8 mt -49.46 137.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 89' ' ' MET . 3.9 mt -117.1 -34.03 4.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 179.246 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -149.55 169.24 21.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.734 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.8 t -146.56 97.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.278 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.903 ' OD1' HG23 ' A' ' 84' ' ' VAL . 4.3 t30 67.26 -68.1 0.16 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.256 0.55 . . . . 0.0 109.82 -178.655 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -155.68 32.87 0.36 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.527 179.106 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 57.3 t -119.38 142.27 35.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.523 -179.12 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -110.0 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.294 179.052 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.467 HG12 HG21 ' A' ' 68' ' ' VAL . 30.6 m -92.48 40.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.36 . . . . 0.0 111.414 -179.66 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.831 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -151.59 66.33 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 23' ' ' THR . 35.6 m -133.08 145.42 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.75 151.89 24.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 -179.808 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 t-160 -49.49 -33.61 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 t -67.12 -33.99 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.994 179.583 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -40.07 80.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.772 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.846 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.68 -46.88 77.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.014 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.8 t -57.32 -49.99 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.251 178.533 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.15 -34.33 66.04 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.669 178.633 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.699 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.66 -51.07 70.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.182 0.515 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.034 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.7 -36.35 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.476 178.955 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.26 -22.48 52.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.209 179.053 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -97.39 -11.99 23.3 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.38 -178.879 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.957 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.33 -18.99 19.64 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 179.944 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.07 -101.19 2.56 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.994 -179.825 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.587 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.9 p -127.67 -90.4 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.871 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.719 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.6 tp -87.19 91.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.589 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.957 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.3 p -107.16 137.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.296 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.2 ttt85 -86.71 103.1 14.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.131 177.762 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.734 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.4 mt -91.67 142.98 27.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.451 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 134.23 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.476 179.789 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.544 HG11 HD11 ' A' ' 51' ' ' LEU . 29.0 m -138.94 167.88 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 111.211 -179.724 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.8 ' CG ' HD21 ' A' ' 58' ' ' LEU . 9.3 mtt -100.8 151.64 21.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.012 -179.991 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.6 106.35 5.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.148 179.946 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.944 179.774 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG3' ' HA ' ' A' ' 91' ' ' ARG . 3.9 mtm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.848 0.356 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.67 177.95 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.995 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 53.0 m-85 -145.01 144.46 31.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.002 179.998 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -142.7 148.23 36.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.48 144.88 31.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.694 179.78 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.953 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.51 109.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.933 -179.779 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.899 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.42 123.41 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.774 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -133.69 126.78 31.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.089 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -85.19 99.83 11.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.926 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.91 86.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.362 179.188 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -55.52 177.32 0.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.56 -179.509 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -52.36 -26.61 12.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.34 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 p -88.06 -24.96 23.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.956 179.868 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 130.28 -170.05 21.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.357 179.915 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.922 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.8 tp -65.57 -15.8 63.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.828 0.346 . . . . 0.0 110.985 179.906 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 74.14 31.08 60.0 Favored Glycine 0 CA--C 1.519 0.281 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 177.829 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.806 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 6.5 p90 -164.52 131.38 3.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.282 1.041 . . . . 0.0 111.628 178.559 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -97.33 138.96 34.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.866 -179.083 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.027 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.7 148.93 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 112.01 179.864 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.676 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.62 133.19 25.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.937 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.14 -3.32 0.9 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.586 179.783 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.49 179.97 0.12 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' C ' ' A' ' 68' ' ' VAL . 26.5 p -65.24 -35.11 80.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.419 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.03 -17.14 29.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.628 0.251 . . . . 0.0 111.519 -179.486 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.56 82.05 59.45 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.043 0.449 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.14 62.87 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.853 2.368 . . . . 0.0 112.541 -179.291 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.676 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.4 t-80 -52.28 -22.71 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 178.78 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.853 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.71 -154.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.645 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.662 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.03 -49.8 74.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.551 -179.798 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.51 39.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.56 167.44 17.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.833 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.717 ' CB ' HG22 ' A' ' 23' ' ' THR . 98.6 Cg_endo -79.11 1.93 8.74 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.668 2.245 . . . . 0.0 112.755 179.995 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.78 115.27 1.73 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.821 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -86.5 121.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.566 -179.831 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.853 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.08 146.88 35.94 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.315 0.579 . . . . 0.0 110.59 178.824 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.017 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.98 155.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.69 -176.897 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.52 -30.72 4.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.174 -178.971 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.75 128.32 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.212 -0.595 . . . . 0.0 112.33 -179.362 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.98 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.47 127.03 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.69 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.24 119.39 73.14 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -177.814 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.5 Cg_exo -54.36 140.32 73.3 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.718 2.279 . . . . 0.0 112.297 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.75 12.98 70.77 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.537 -179.923 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.61 -158.68 21.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.978 179.779 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.96 -38.85 57.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.869 0.334 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.88 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.13 -54.46 7.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.586 -179.63 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -60.59 -32.48 71.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -72.36 -37.31 68.82 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.03 0.443 . . . . 0.0 110.308 179.514 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.62 -57.85 3.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.28 35.6 14.38 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.529 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.9 mmm180 -110.7 -12.56 14.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.701 179.584 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.017 HD21 HD12 ' A' ' 36' ' ' ILE . 6.2 tp -113.66 155.84 24.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.579 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.0 tpt180 -134.87 135.11 41.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.47 157.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.279 0.561 . . . . 0.0 111.638 179.935 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' HG12 ' A' ' 53' ' ' VAL . 4.9 t-20 75.7 -1.65 2.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.277 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.5 m-20 -68.48 126.6 30.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.936 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 p -86.57 100.14 12.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 111.471 -178.616 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -45.47 153.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.813 179.999 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -136.79 -46.23 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.64 -179.669 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -142.21 167.11 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.928 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.5 t -142.36 100.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.897 179.34 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.639 ' HB2' HG23 ' A' ' 84' ' ' VAL . 3.1 t-20 66.36 -68.04 0.14 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.199 0.523 . . . . 0.0 109.667 -178.517 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.2 mt-10 -156.65 31.28 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.38 178.974 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -116.36 142.52 29.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.452 -179.006 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 3.7 p-10 -108.29 120.18 41.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.505 179.176 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 19.1 m -93.79 37.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.15 -179.983 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -71.06 100.89 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.06 50.02 1.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.751 ' C ' HG23 ' A' ' 23' ' ' THR . 14.0 m -114.92 142.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.732 179.464 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.462 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.96 153.0 26.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.069 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.939 ' O ' HG23 ' A' ' 74' ' ' VAL . 11.0 t-160 -48.79 -33.98 11.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.516 -179.964 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -34.12 76.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.301 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.96 -42.69 80.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.478 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.821 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.81 -46.66 84.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.003 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 70' ' ' HIS . 58.0 t -57.17 -50.35 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.1 178.639 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.655 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.34 -32.55 38.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.772 179.222 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -68.38 -57.11 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.845 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.95 HD12 HD12 ' A' ' 19' ' ' ILE . 4.2 mt -64.1 -39.79 94.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.009 -179.436 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.596 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -77.1 -20.06 56.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.334 -179.73 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.655 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 4.4 mm-40 -104.1 -10.78 17.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.02 0.438 . . . . 0.0 110.873 178.894 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.87 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.17 -20.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.566 179.944 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.62 -104.33 2.99 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -117.8 -92.89 0.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.764 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.889 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -87.58 102.7 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.058 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.87 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -118.04 138.75 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.6 -178.6 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.899 ' HG2' HG23 ' A' ' 7' ' ' THR . 5.6 mtm180 -87.05 103.56 15.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.638 178.817 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.928 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.4 mt -93.58 139.17 31.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.018 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 137.99 39.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.763 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 29.0 m -125.9 168.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.422 179.837 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 56' ' ' SER . 3.0 ttt -129.31 144.35 51.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 111.027 -179.931 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -121.55 129.77 53.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.887 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.446 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 3.1 ppt_? . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.078 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.861 0.362 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.07 123.35 43.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.781 ' CD1' HD22 ' A' ' 58' ' ' LEU . 4.0 m-30 -101.38 110.68 22.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.7 mt-10 -109.55 125.43 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 12.2 pt-20 -94.7 144.62 25.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.984 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -142.26 109.51 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.715 179.935 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.792 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.45 122.01 24.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.031 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.043 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.3 tp -132.02 128.03 37.45 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.556 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.4 pt-20 -86.43 100.5 12.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.32 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.577 ' CG ' HD23 ' A' ' 15' ' ' LEU . 6.1 mtp-105 -42.74 91.56 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.105 179.592 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.09 75.75 0.02 OUTLIER Glycine 0 C--N 1.317 -0.521 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.878 -179.545 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 10' ' ' ARG . 2.8 m120 62.97 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.358 179.688 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.1 m -70.08 -22.15 63.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.581 -179.641 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 150.33 -172.16 30.16 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.937 -179.709 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.043 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.5 mt -57.08 -63.64 1.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.945 0.403 . . . . 0.0 110.776 -179.907 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.21 38.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.397 179.505 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.779 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -164.12 134.06 4.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.195 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.54 136.93 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.638 -179.34 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.31 148.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.643 0.735 . . . . 0.0 112.032 179.934 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.98 131.83 24.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.688 179.264 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.82 -3.72 0.84 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.787 179.644 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.04 179.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.675 179.91 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.851 HG22 ' CB ' ' A' ' 32' ' ' PRO . 17.5 p -70.34 -21.55 62.89 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.43 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -92.02 -26.58 18.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.792 0.33 . . . . 0.0 111.271 -179.679 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -124.48 87.52 54.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.33 64.94 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.362 2.042 . . . . 0.0 112.653 -179.432 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.625 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 10.0 t-80 -48.96 -27.43 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.404 178.998 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.848 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.54 -154.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.428 179.439 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.03 -49.45 78.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.691 -179.709 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.44 39.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.65 165.59 25.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 -179.929 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.851 ' CB ' HG22 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.03 1.98 8.69 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.656 2.237 . . . . 0.0 112.747 -179.822 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.57 116.66 2.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.829 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -86.32 120.05 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.592 -179.966 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.848 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.14 147.81 37.27 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.327 0.584 . . . . 0.0 110.726 178.762 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.994 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.828 -177.008 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.467 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -33.38 4.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.662 -179.173 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.26 142.84 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.0 111.41 -179.881 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.951 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.5 131.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.39 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.98 121.26 75.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.976 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.4 Cg_endo -63.89 136.95 55.5 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.836 2.358 . . . . 0.0 112.418 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 18.29 37.2 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.303 -179.894 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.63 179.42 16.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.233 179.886 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.09 -31.4 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.684 0.278 . . . . 0.0 111.384 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.792 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -74.18 -56.57 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.511 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.71 -30.31 65.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.066 -178.992 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 15.6 pt20 -71.96 -31.61 66.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.999 0.428 . . . . 0.0 110.331 179.534 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.38 -57.99 3.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.682 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.4 9.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.62 179.521 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.3 mtt-85 -114.87 -7.59 12.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.925 179.697 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.994 HD21 HD12 ' A' ' 36' ' ' ILE . 6.1 tp -119.93 155.73 32.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.085 0.469 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.594 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.6 tpt180 -134.05 135.08 43.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.6 t -49.91 157.43 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.368 0.604 . . . . 0.0 111.56 -179.95 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 7.5 t-20 75.0 -0.89 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.118 -179.98 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.78 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -68.15 124.95 24.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 178.851 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.55 100.32 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.649 . . . . 0.0 111.573 -178.386 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 19' ' ' ILE . 10.4 mt -47.86 131.28 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.875 179.865 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 3' ' ' TYR . 57.0 tp -114.3 -35.08 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.499 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -150.51 155.36 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.736 -179.817 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.946 HG11 ' HB1' ' A' ' 76' ' ' ALA . 27.8 t -130.82 96.51 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.974 179.288 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.777 ' CG ' HG23 ' A' ' 84' ' ' VAL . 4.9 t30 67.59 -67.9 0.17 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.173 0.511 . . . . 0.0 109.797 -178.777 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 60' ' ' VAL . 15.7 mt-10 -153.6 31.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.752 179.122 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.8 t -119.8 142.19 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.39 -179.277 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 27.8 t0 -107.96 107.33 17.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.538 179.211 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.24 42.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -65.61 -30.76 71.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.799 179.907 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -154.68 69.03 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.721 ' C ' HG23 ' A' ' 23' ' ' THR . 10.1 m -133.14 144.75 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.075 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.02 152.59 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.726 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.93 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.2 t-160 -48.17 -33.92 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.903 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -33.94 76.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 179.335 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.83 -43.45 79.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.606 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.829 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.85 -45.67 91.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.996 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 70' ' ' HIS . 56.8 t -57.89 -50.31 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.191 178.635 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.691 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.95 -30.36 34.2 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.353 178.882 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.946 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.59 -56.98 6.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.596 -179.587 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -65.19 -40.44 94.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.16 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.659 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -76.82 -20.23 56.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.701 -179.398 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.691 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.8 mm-40 -109.11 -5.49 15.97 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 179.179 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.849 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.21 -22.07 0.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.594 179.957 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.61 -101.62 1.97 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.599 -179.77 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -122.84 -91.45 0.55 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.626 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.792 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.3 tp -90.99 98.98 9.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.089 0.471 . . . . 0.0 110.265 179.108 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.849 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.3 p -113.07 138.18 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -177.792 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.0 ttt180 -86.93 103.86 15.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.143 178.933 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.78 HD13 HD22 ' A' ' 77' ' ' LEU . 16.7 mt -93.59 132.91 37.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.563 -179.253 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -101.99 151.5 22.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.539 179.691 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.78 HG21 ' OD2' ' A' ' 55' ' ' ASP . 18.5 m -139.68 119.61 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.343 -179.895 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.719 ' CG ' HD13 ' A' ' 58' ' ' LEU . 1.4 ptt? -96.76 111.85 23.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.928 0.394 . . . . 0.0 111.371 179.875 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -117.05 146.68 42.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.066 179.965 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.83 179.859 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 1.7 mtm . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.735 0.302 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -132.29 144.88 50.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 -179.912 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.461 ' CD1' HD11 ' A' ' 58' ' ' LEU . 8.4 m-30 -111.4 135.7 51.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.898 179.8 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.53 143.55 48.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.888 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.41 144.87 29.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.053 179.957 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.979 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.16 109.36 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.078 0.466 . . . . 0.0 111.411 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.925 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.26 120.98 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.319 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.979 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -129.71 126.69 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.634 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.567 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -86.66 100.88 12.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.185 179.178 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.65 88.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.211 179.599 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.5 178.02 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.608 -179.949 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -54.92 -25.32 28.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 111.125 -179.918 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -96.03 -24.62 16.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.207 -179.932 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.15 -162.3 27.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.059 -179.779 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.974 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp -66.16 -60.42 2.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.75 0.275 . . . . 0.0 110.441 179.94 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.22 19.4 1.55 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.021 -1.085 . . . . 0.0 114.513 178.404 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.858 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.6 p90 -162.09 137.33 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.844 0.822 . . . . 0.0 111.245 179.223 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.47 136.2 38.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.615 -179.426 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.54 156.62 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.736 0.779 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -152.22 132.38 13.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.75 -3.18 1.11 Allowed Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.669 179.639 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.36 178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.918 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 68' ' ' VAL . 29.1 p -65.98 -27.38 68.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.246 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -93.43 -19.95 20.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.672 0.273 . . . . 0.0 111.63 -179.647 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 70' ' ' HIS . 0.5 OUTLIER -124.24 86.86 54.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.392 179.897 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 62.4 0.84 Allowed 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.396 2.064 . . . . 0.0 112.705 -179.409 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.663 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 8.5 t-80 -48.1 -28.87 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.019 178.977 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.863 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.12 -155.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.121 179.277 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.2 -49.44 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.276 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -177.46 51.29 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.911 0.386 . . . . 0.0 111.153 -179.585 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 158.27 70.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 23' ' ' THR . 92.7 Cg_endo -78.53 0.86 9.57 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.677 2.251 . . . . 0.0 112.661 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.9 m -54.31 119.85 5.73 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.958 0.408 . . . . 0.0 111.291 -179.912 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.818 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.43 119.93 34.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 179.824 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.863 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.82 146.67 36.14 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.399 0.618 . . . . 0.0 110.762 178.749 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.054 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.76 155.84 7.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.055 -176.636 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.81 -30.38 4.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.307 -178.624 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.81 129.05 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.174 -179.321 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.91 131.68 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.569 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 113.88 51.11 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.825 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 49.7 Cg_exo -56.21 140.15 87.09 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.739 2.292 . . . . 0.0 112.392 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.82 10.37 64.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.483 -179.898 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.87 178.34 18.3 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.874 179.808 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.85 -35.38 66.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.796 0.331 . . . . 0.0 111.067 -179.995 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.756 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.87 -57.56 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.55 -28.73 67.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -71.88 -31.68 66.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.239 179.521 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 -57.78 3.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.96 35.77 14.87 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.439 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.3 mtt-85 -115.32 -2.06 12.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 111.227 179.874 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.054 HD21 HD12 ' A' ' 36' ' ' ILE . 5.9 tp -127.2 154.61 44.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.158 0.504 . . . . 0.0 111.34 179.98 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.71 135.29 43.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.543 179.93 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.47 157.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.496 179.934 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.8 0.43 3.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 -179.865 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.529 ' HB3' HG11 ' A' ' 88' ' ' VAL . 4.8 m-20 -69.67 126.08 28.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.931 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.2 p -86.49 100.39 12.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.467 0.651 . . . . 0.0 111.673 -178.322 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.033 HD11 HG21 ' A' ' 19' ' ' ILE . 61.7 mt -48.72 146.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.077 -179.961 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 89' ' ' MET . 12.4 mt -128.25 -38.96 1.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.424 179.615 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -145.72 155.31 42.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.899 -179.758 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.921 HG11 ' HB1' ' A' ' 76' ' ' ALA . 42.1 t -136.42 100.55 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.409 ' HB2' HG23 ' A' ' 84' ' ' VAL . 38.5 t30 67.53 -67.04 0.19 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.958 0.408 . . . . 0.0 110.046 -179.14 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.3 mt-10 -157.29 32.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.751 179.289 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -120.72 142.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.539 -179.23 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.3 t0 -106.04 107.93 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.293 179.208 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG12 HG21 ' A' ' 68' ' ' VAL . 21.8 m -93.81 35.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.522 -179.623 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.48 -37.25 80.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 110.78 179.974 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.42 54.59 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -179.897 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 23' ' ' THR . 32.9 m -116.12 148.95 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.896 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.439 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -64.8 154.69 36.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.033 -179.378 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.919 ' O ' HG23 ' A' ' 74' ' ' VAL . 19.1 t-160 -50.57 -33.94 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -34.03 75.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.133 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.62 -41.76 79.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 109.266 178.522 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.818 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.8 -46.12 83.37 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.1 t -57.4 -50.51 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.029 178.564 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -51.58 -34.16 35.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.694 179.417 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.921 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.81 -57.59 5.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.248 -179.508 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.929 HD12 HD12 ' A' ' 19' ' ' ILE . 2.1 mt -60.53 -40.85 93.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.244 -179.772 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.597 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.78 -20.06 56.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.768 179.669 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 4.1 pt-20 -112.24 22.3 14.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 111.24 179.579 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.926 ' HB1' ' HB ' ' A' ' 84' ' ' VAL . . . -83.19 16.64 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.829 -179.729 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.91 -85.59 0.21 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.83 -179.783 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 40.3 m -142.3 -89.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.925 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -86.37 105.64 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.869 0.366 . . . . 0.0 110.662 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.926 ' HB ' ' HB1' ' A' ' 80' ' ' ALA . 5.0 p -120.89 136.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.392 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.7 mtm105 -85.79 103.39 14.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.373 178.17 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.783 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.1 mt -93.98 134.8 35.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.394 -178.822 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.84 142.58 32.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.89 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 55' ' ' ASP . 24.9 m -138.53 167.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.819 ' HB2' HD21 ' A' ' 58' ' ' LEU . 35.4 ttm -117.16 142.16 47.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 -179.914 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -129.13 133.56 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.668 179.9 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.459 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.005 -179.809 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.809 0.338 . . . . 0.0 111.215 . . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -127.88 124.06 36.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CD1' HD11 ' A' ' 58' ' ' LEU . 15.9 m-30 -94.07 127.78 40.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.935 179.907 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -134.77 165.87 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.98 144.78 43.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 -179.837 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.089 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.83 109.51 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.402 179.876 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.41 119.68 21.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.65 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.089 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -130.75 128.08 40.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.403 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 4.6 pt-20 -86.71 100.21 12.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.354 179.685 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -42.87 90.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.364 179.496 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.9 -171.66 0.03 OUTLIER Glycine 0 C--N 1.318 -0.419 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.638 179.77 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.98 -35.76 35.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.593 0.235 . . . . 0.0 111.552 -179.839 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -108.24 4.86 25.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.574 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 120.99 -168.45 14.11 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.843 -179.752 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 1.008 ' HB3' HD23 ' A' ' 8' ' ' LEU . 18.4 mt -51.87 -63.54 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 129.42 33.02 0.54 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.515 179.458 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.815 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.86 137.41 12.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.977 0.389 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.88 136.71 37.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.302 -179.499 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.081 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.56 146.6 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.703 0.763 . . . . 0.0 112.264 -179.935 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.18 133.61 31.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.241 179.338 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.7 3.84 0.79 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.696 179.577 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.69 -169.26 0.5 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.902 -179.917 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.831 HG22 ' HB3' ' A' ' 32' ' ' PRO . 43.0 p -72.39 -27.86 62.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.104 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -93.75 -22.0 18.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.047 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 11.5 t-20 -124.39 87.52 53.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.579 0.228 . . . . 0.0 110.485 -179.991 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 62.51 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.271 1.981 . . . . 0.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.62 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.2 t-80 -47.16 -28.24 1.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.396 179.049 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.822 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.54 -154.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.362 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.5 -49.96 72.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.53 -179.697 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.03 40.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.6 164.06 36.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.831 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.9 Cg_exo -74.81 1.77 7.26 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.0 112.776 -179.88 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -52.75 113.43 1.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.978 0.418 . . . . 0.0 111.07 -179.814 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.43 117.85 30.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.999 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.822 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.13 147.46 40.23 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.276 0.56 . . . . 0.0 110.644 178.673 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.079 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.06 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.042 -176.771 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.43 -30.1 4.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.321 -178.846 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.648 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.09 130.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.065 -179.447 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.028 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.96 130.53 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.636 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.493 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 123.84 74.61 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.752 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.1 Cg_endo -66.14 132.0 28.53 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.798 2.332 . . . . 0.0 112.256 -179.879 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.66 16.74 23.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.331 -179.916 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.46 178.69 16.82 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.985 179.862 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.15 -38.78 63.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.803 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.44 -57.49 8.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.892 -179.502 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.83 -28.85 63.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -179.434 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -72.12 -34.15 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.543 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.12 -58.04 3.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.687 -179.936 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 38.08 13.93 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.624 179.452 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.513 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.9 mmt180 -117.9 7.05 12.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.776 0.322 . . . . 0.0 110.842 179.686 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.079 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -133.22 154.53 50.57 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 110.835 179.585 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.19 135.47 45.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.957 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.61 157.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 111.751 179.965 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.45 -0.55 3.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.27 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.67 126.37 29.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.035 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.57 103.31 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 111.316 -178.812 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.081 HD11 HG21 ' A' ' 19' ' ' ILE . 67.0 mt -51.21 134.21 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.723 -179.999 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 89' ' ' MET . 2.2 mt -116.19 -28.11 6.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.662 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -153.77 165.99 34.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.667 HG11 ' HB1' ' A' ' 76' ' ' ALA . 40.9 t -148.18 98.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.018 179.464 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' HG23 ' A' ' 84' ' ' VAL . 13.4 t30 67.79 -67.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 -178.844 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.48 32.47 0.27 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.621 179.218 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.2 t -119.34 142.24 35.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.597 -179.293 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.7 p-10 -111.19 88.04 2.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.331 179.258 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 65' ' ' VAL . 29.5 m -69.99 63.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.563 -179.522 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 66' ' ' ARG . 4.0 ptm85 -86.93 -32.77 19.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.688 179.643 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -145.47 59.02 1.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.8 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 23' ' ' THR . 35.9 m -124.55 147.72 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.46 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.36 154.65 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 -179.464 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 p-80 -48.59 -34.32 11.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.137 -179.573 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -33.69 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.67 -45.44 82.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.9 -46.77 89.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 178.069 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.3 t -57.6 -48.22 83.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.664 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.94 -33.07 68.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.583 178.717 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.55 -50.12 74.14 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.286 0.565 . . . . 0.0 109.817 179.317 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.04 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.99 -36.61 70.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.449 178.868 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.8 mmmt -77.15 -24.72 51.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.97 -12.9 27.73 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.067 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.914 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -56.74 -19.29 16.09 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 179.721 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.19 -108.18 3.39 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.034 -179.881 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.88 -90.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.03 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.838 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.2 tp -89.63 91.54 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.388 0.613 . . . . 0.0 109.674 178.719 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.914 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -105.81 139.88 25.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.357 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.64 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -87.45 103.18 15.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.647 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.4 mt -91.36 139.82 30.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.17 -178.985 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.77 134.1 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.618 179.893 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.48 HG11 HD11 ' A' ' 51' ' ' LEU . 22.1 m -139.69 167.96 18.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.188 179.846 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.722 ' HB3' HD21 ' A' ' 58' ' ' LEU . 4.1 ptt? -129.35 138.03 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.004 0.43 . . . . 0.0 111.158 179.896 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -112.14 141.23 46.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.814 179.911 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.052 -179.965 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.704 0.287 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -87.62 179.56 6.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 179.922 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.839 ' CD1' HD22 ' A' ' 58' ' ' LEU . 21.1 m-85 -136.26 111.98 9.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.971 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -105.01 170.75 7.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.722 179.647 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -131.83 144.77 51.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.91 111.07 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.909 0.385 . . . . 0.0 111.909 179.912 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.75 117.87 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.475 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -127.26 127.22 44.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.255 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.34 100.08 11.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.522 179.432 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.37 87.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.181 179.258 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.57 175.15 0.06 OUTLIER Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.605 -179.825 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.13 -24.68 18.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.726 0.298 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.6 m -97.36 -23.69 15.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.982 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.82 -164.03 27.54 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.136 -179.889 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.951 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.7 tp -65.54 -63.59 1.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.549 179.934 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.76 25.21 1.03 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 119.789 -1.196 . . . . 0.0 114.801 178.409 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.788 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -162.97 135.19 5.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.873 0.836 . . . . 0.0 111.066 178.887 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.87 137.89 33.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.506 -179.242 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.1 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.8 146.24 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 112.404 179.929 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.613 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.32 133.82 33.48 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.174 179.348 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.62 3.87 0.8 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.643 179.585 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.516 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.65 -168.85 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.893 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.834 HG22 ' HB3' ' A' ' 32' ' ' PRO . 41.5 p -72.14 -29.41 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.193 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.06 -20.76 20.22 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.162 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 35.7 t-20 -124.42 87.57 53.99 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.496 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.81 61.91 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.283 1.989 . . . . 0.0 112.388 -179.768 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.613 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 13.8 t-80 -47.16 -28.45 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.185 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.81 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.0 -154.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.183 179.386 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -57.7 -50.01 69.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.57 -179.815 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 171.87 40.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.36 166.69 21.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.834 ' HB3' HG22 ' A' ' 23' ' ' THR . 4.9 Cg_exo -75.04 2.33 6.77 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.037 2.491 . . . . 0.0 112.733 -179.734 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.24 111.67 0.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.842 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.16 118.27 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.675 179.987 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.81 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.77 147.91 39.84 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.303 0.573 . . . . 0.0 110.725 178.629 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.029 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.09 155.61 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.986 -176.829 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.446 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.58 -30.78 4.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.039 -178.98 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.625 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.47 132.29 0.6 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -179.53 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.995 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.56 132.26 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.739 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.25 130.12 55.48 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.486 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 50.9 Cg_endo -69.14 129.97 19.24 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 -179.996 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 2.08 55.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.495 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.65 174.37 21.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.751 179.676 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.7 -35.34 55.36 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.649 -0.324 . . . . 0.0 111.11 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.795 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -70.85 -57.39 4.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.601 -179.799 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.47 -29.07 68.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -72.19 -35.38 68.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.048 0.451 . . . . 0.0 109.969 179.346 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -84.69 -57.94 2.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.614 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.22 41.38 9.37 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.556 179.625 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.7 mtp85 -112.05 8.88 20.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.029 HD21 HD12 ' A' ' 36' ' ' ILE . 4.9 tp -136.16 154.06 51.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.687 179.641 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.99 135.21 48.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.824 179.869 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.47 157.82 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.31 0.576 . . . . 0.0 111.595 -180.0 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.6 t-20 77.33 -2.96 2.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.473 179.866 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.17 125.12 24.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.085 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.61 100.25 12.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.503 0.668 . . . . 0.0 111.504 -178.579 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.1 HD11 HG21 ' A' ' 19' ' ' ILE . 59.0 mt -49.97 134.92 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.433 179.507 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.839 HD22 ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -133.69 12.08 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.614 179.367 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 170.83 141.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.962 -179.894 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.865 HG13 ' CD2' ' A' ' 86' ' ' LEU . 25.3 t -131.56 99.7 4.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.879 179.274 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 84' ' ' VAL . 17.3 t30 69.76 -65.0 0.33 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 109.848 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -161.57 31.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.927 179.407 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.6 t -120.82 124.86 73.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.55 -179.337 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 21.0 p-10 -93.04 100.07 12.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.577 179.113 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 65' ' ' VAL . 33.7 m -80.69 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -179.755 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -29.25 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -148.88 60.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.753 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -126.5 146.43 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.991 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.481 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.76 153.94 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 111.076 -179.353 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.871 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 p-80 -48.34 -34.08 10.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.983 -179.515 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -33.83 69.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.181 179.757 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.68 -45.22 83.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 109.765 179.093 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.842 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.83 -46.69 88.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.536 0.684 . . . . 0.0 109.35 178.177 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.6 t -57.55 -48.06 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.369 178.586 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.62 -32.88 67.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.624 178.602 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -57.63 -50.39 73.31 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.837 179.241 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.005 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -56.61 -37.26 70.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.555 178.891 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -77.56 -26.06 50.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.395 179.327 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -92.84 -12.4 31.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.061 -178.843 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.926 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.17 -20.17 9.73 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.268 179.763 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -95.34 1.35 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.12 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 39.5 m -134.61 -92.17 0.32 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.096 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.763 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -85.72 89.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.28 0.562 . . . . 0.0 109.676 178.591 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.926 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.7 p -105.91 136.47 40.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.457 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 ttp180 -88.2 102.8 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.747 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.865 ' CD2' HG13 ' A' ' 60' ' ' VAL . 20.2 mt -90.59 136.24 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.813 -179.15 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' HD1' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.86 120.13 39.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.782 -179.889 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG21 ' CG ' ' A' ' 55' ' ' ASP . 29.3 m -123.22 142.95 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.829 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.441 ' HG2' ' CB ' ' A' ' 56' ' ' SER . 16.5 ptp -96.96 152.57 18.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 111.402 -179.676 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -140.57 145.0 36.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.014 179.904 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.939 179.799 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.28 143.73 42.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 -179.974 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 5.2 m-85 -109.31 147.45 32.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 179.814 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -146.7 154.0 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -105.31 144.78 31.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.972 -179.934 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.25 109.97 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 111.623 179.819 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.88 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 119.11 20.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.75 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -129.73 127.15 39.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.164 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.8 pt-20 -83.55 100.83 11.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.855 179.524 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.01 89.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.102 178.657 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -130.38 176.03 19.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.41 -179.115 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 m120 54.96 -92.41 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.498 0.19 . . . . 0.0 110.73 -179.853 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 p -108.27 11.38 27.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.62 0.247 . . . . 0.0 110.975 179.669 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 126.03 -140.12 11.91 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.641 -179.595 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.935 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp -70.57 -36.15 73.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.401 179.699 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 102.78 19.3 13.5 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.422 -0.894 . . . . 0.0 114.808 177.912 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.826 ' HB3' HG23 ' A' ' 39' ' ' ILE . 3.7 p90 -155.23 135.76 13.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.912 0.856 . . . . 0.0 110.89 179.126 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.68 135.98 37.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.404 -179.421 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.036 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.46 146.12 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.603 0.716 . . . . 0.0 111.928 179.79 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -124.81 118.65 26.85 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.51 177.988 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 146.08 165.61 11.56 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.575 -179.006 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 32' ' ' PRO . . . 140.93 173.53 13.57 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.244 -179.691 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.752 HG23 ' C ' ' A' ' 68' ' ' VAL . 18.4 p -67.14 -17.79 65.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.366 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -106.39 -27.28 11.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.686 0.279 . . . . 0.0 111.417 -179.67 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -124.32 87.0 54.29 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 42.7 Cg_endo -67.9 64.39 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.362 2.041 . . . . 0.0 112.607 -179.653 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.585 ' ND1' ' CZ ' ' A' ' 35' ' ' PHE . 10.8 t-80 -47.72 -28.92 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.525 179.207 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.945 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.65 -152.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.687 179.776 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.683 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.84 52.53 4.61 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.87 -178.761 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HA ' ' HB2' ' A' ' 26' ' ' PRO . 1.8 t0 76.59 44.9 0.11 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.494 179.575 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -137.14 157.31 74.68 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -179.941 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 23' ' ' THR . 7.8 Cg_exo -72.12 -2.2 11.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.699 2.266 . . . . 0.0 112.508 179.823 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.47 112.6 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.006 0.432 . . . . 0.0 111.561 -179.654 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.832 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.71 119.89 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.757 179.219 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.945 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.14 147.9 37.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.485 0.659 . . . . 0.0 110.844 179.369 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.045 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.32 156.04 7.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.565 -177.319 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.67 -28.78 4.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.134 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.25 129.14 0.36 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.17 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.987 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -93.3 125.02 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.79 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 132.73 46.59 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.783 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_exo -64.37 70.05 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.492 2.128 . . . . 0.0 110.887 178.9 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -104.82 -25.5 6.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.888 -179.076 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . 121.65 -30.59 5.29 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.397 -179.87 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -77.69 -70.32 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.152 179.707 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.844 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -75.92 -45.63 34.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.368 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.49 -42.22 95.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.741 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.781 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -72.15 -33.31 67.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -57.11 -58.36 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.08 0.467 . . . . 0.0 111.028 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.84 25.83 63.87 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.534 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtm-85 -108.11 -23.34 12.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.895 0.379 . . . . 0.0 110.303 179.553 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.045 HD21 HD12 ' A' ' 36' ' ' ILE . 6.3 tp -104.17 154.24 19.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.428 179.005 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 ttp85 -134.85 135.7 41.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -49.04 157.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.308 0.575 . . . . 0.0 111.539 179.994 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 73.32 3.03 4.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.084 -179.746 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -71.61 125.86 28.19 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.958 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.68 101.39 13.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.608 0.718 . . . . 0.0 111.74 -178.408 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.992 HD11 HG21 ' A' ' 19' ' ' ILE . 12.4 mt -49.33 131.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.923 179.84 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -114.74 -35.03 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.073 179.281 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -148.8 167.53 25.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.833 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 86' ' ' LEU . 41.1 t -147.74 98.43 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.034 179.471 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.804 ' OD1' HG23 ' A' ' 84' ' ' VAL . 5.5 t30 68.62 -66.61 0.23 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.071 0.462 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.16 32.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.741 179.312 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 62.1 t -120.88 142.21 37.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.523 -179.33 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -104.16 110.2 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.328 179.103 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.642 HG21 HG22 ' A' ' 57' ' ' ILE . 14.6 m -91.52 19.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.773 -179.523 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -59.55 -28.25 66.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.7 56.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.752 ' C ' HG23 ' A' ' 23' ' ' THR . 18.4 m -125.7 143.12 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 69' ' ' THR . 0.0 OUTLIER -62.32 151.74 35.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.692 -179.833 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.607 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -47.88 -34.32 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.658 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -71.45 -33.88 69.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.932 179.521 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.662 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.58 -40.47 84.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.93 -46.96 82.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.644 0.735 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.628 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 73.5 t -58.67 -50.66 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.198 178.676 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.35 -31.08 63.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.68 -50.45 73.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.367 0.603 . . . . 0.0 109.91 179.643 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -59.23 -36.83 76.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.084 179.291 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.61 -25.38 49.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.631 179.595 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -101.4 13.96 33.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.736 0.303 . . . . 0.0 111.647 -178.344 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.32 11.78 9.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.66 -90.16 0.85 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 179.735 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 10.1 p -144.63 -90.22 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.88 HG13 HG22 ' A' ' 7' ' ' THR . 9.1 tp -84.08 90.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.191 0.52 . . . . 0.0 109.714 178.67 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.913 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -107.54 139.3 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.361 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.546 ' CG ' HG23 ' A' ' 7' ' ' THR . 10.1 mtp180 -86.92 103.12 15.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.742 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.9 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.5 mt -92.95 138.28 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 -178.788 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -101.84 136.44 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.647 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.8 m -139.67 167.84 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.521 -179.89 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.442 ' HB2' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -115.55 150.48 36.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.348 . . . . 0.0 110.869 179.904 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -140.39 140.64 35.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 179.911 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 3.6 ttt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.89 0.376 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.18 -169.91 2.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.3 -179.462 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.442 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 29.2 m-85 -136.18 139.81 43.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.741 -179.988 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.45 146.85 40.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.946 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -103.28 144.38 31.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.966 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.984 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.36 109.13 8.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.924 0.392 . . . . 0.0 111.6 179.882 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.838 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.25 113.65 16.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.93 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.99 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.7 tp -124.87 126.94 46.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.9 pt-20 -85.82 100.77 12.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.073 179.29 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -46.97 89.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.323 179.893 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.41 177.72 0.04 OUTLIER Glycine 0 C--N 1.318 -0.456 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.639 -179.93 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -53.82 -26.72 25.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.145 -179.934 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.2 p -97.4 -22.93 16.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.154 179.998 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.93 -164.6 27.12 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.982 -179.774 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.99 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.3 tp -59.64 -63.29 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.737 -179.976 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.51 25.82 1.12 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.422 178.437 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.5 p90 -164.8 131.68 3.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.565 0.682 . . . . 0.0 110.849 178.86 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -91.67 138.36 31.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.653 -179.006 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.938 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -121.78 142.29 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 121.711 0.767 . . . . 0.0 112.222 179.78 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -105.64 117.85 35.09 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.695 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.795 ' HA2' HG23 ' A' ' 34' ' ' ILE . . . -73.21 -159.27 5.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -176.258 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.68 -42.93 0.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.783 -0.709 . . . . 0.0 114.15 -177.935 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.67 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -73.1 -54.06 9.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.039 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.492 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -81.25 -43.58 18.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.071 0.462 . . . . 0.0 111.004 -179.621 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.4 OUTLIER -124.83 83.45 59.41 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.479 179.462 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.95 69.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.638 2.225 . . . . 0.0 112.378 -179.104 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.72 ' HB2' ' HB1' ' A' ' 20' ' ' ALA . 4.2 t-80 -58.23 -18.24 24.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.254 179.31 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.824 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.26 -154.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.409 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.674 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -63.35 -49.5 69.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.57 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 167.98 41.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 179.995 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.22 155.6 75.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.403 ' CB ' HG22 ' A' ' 23' ' ' THR . 73.9 Cg_endo -75.64 55.76 4.39 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.941 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -117.12 107.12 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 179.697 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.961 HD11 ' O ' ' A' ' 68' ' ' VAL . 3.1 mt -79.01 130.63 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.994 -179.632 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.824 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.98 152.53 42.07 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.214 0.531 . . . . 0.0 110.389 179.495 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.03 HD12 HD21 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -69.42 155.57 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.489 -177.096 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.09 -28.43 4.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.974 -179.27 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.86 130.6 0.41 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.943 -179.625 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.995 HD11 HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -95.33 132.58 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.557 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 114.77 56.74 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.651 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 47.9 Cg_exo -56.36 137.79 81.43 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.733 2.289 . . . . 0.0 112.201 179.913 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.91 66.35 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.67 -179.994 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.98 -178.13 22.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -59.48 -33.55 71.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -179.955 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -72.95 -56.92 4.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.781 -179.885 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.45 -31.1 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.855 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 13.7 pt20 -72.15 -32.51 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.035 0.445 . . . . 0.0 110.138 179.615 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.536 ' OD2' HD12 ' A' ' 8' ' ' LEU . 11.9 m-20 -80.75 -57.96 3.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.553 179.94 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.54 9.3 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.715 179.564 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.6 mtt180 -114.96 7.46 15.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 179.544 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.03 HD21 HD12 ' A' ' 36' ' ' ILE . 5.9 tp -136.42 154.31 50.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.107 0.479 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.35 135.22 46.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.614 179.833 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 38' ' ' LYS . 60.6 t -49.06 157.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 0.0 111.815 -179.878 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.3 t30 78.22 -5.32 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.469 179.972 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -64.03 127.93 33.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.169 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.89 105.2 16.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -178.846 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.067 HG22 HG21 ' A' ' 65' ' ' VAL . 64.1 mt -48.92 134.87 6.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.522 179.792 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.534 ' C ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -120.17 -43.49 2.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.444 179.865 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -144.55 158.65 43.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.903 -179.893 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.889 HG13 HD21 ' A' ' 86' ' ' LEU . 60.3 t -140.03 98.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.894 ' OD1' HG23 ' A' ' 84' ' ' VAL . 2.1 t30 67.74 -67.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.46 . . . . 0.0 110.22 -178.973 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -155.12 31.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.927 179.361 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.4 t -120.81 142.39 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.403 -179.312 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.4 p-10 -103.28 108.84 20.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.473 179.402 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.067 HG21 HG22 ' A' ' 57' ' ' ILE . 29.2 m -97.32 29.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -38.01 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.413 . . . . 0.0 110.683 179.762 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -144.23 57.91 1.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.786 179.803 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.961 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -121.19 140.05 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.341 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 2.5 p -52.2 150.92 4.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.011 -178.425 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.83 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.9 t-160 -47.07 -33.36 4.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.368 179.552 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -71.54 -33.76 69.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 179.713 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.652 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.38 -31.7 67.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 109.753 178.827 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.924 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.44 -46.91 58.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.537 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.6 t -60.87 -50.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.728 178.735 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.8 pt-20 -57.45 -29.56 64.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.66 178.543 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.821 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -60.59 -51.4 69.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.795 179.456 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.861 ' CD1' HD12 ' A' ' 19' ' ' ILE . 1.2 mt -58.2 -35.12 71.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.178 179.191 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.15 -31.75 55.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.859 179.912 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.0 pt-20 -96.07 17.22 16.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.527 -178.523 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.916 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.54 16.34 7.88 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.323 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.01 -103.51 1.01 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.509 179.858 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -127.15 -89.41 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.466 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.838 HG13 HG22 ' A' ' 7' ' ' THR . 7.4 tp -84.68 94.73 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 109.878 178.909 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.916 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -111.06 136.43 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.444 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 10.4 ptt85 -85.58 102.87 13.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.889 HD21 HG13 ' A' ' 60' ' ' VAL . 15.9 mt -92.09 139.72 30.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.549 -178.499 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.64 135.47 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.963 179.39 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.594 HG11 HD11 ' A' ' 51' ' ' LEU . 6.6 m -137.69 168.07 21.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.758 -179.526 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -108.01 141.64 39.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.649 0.261 . . . . 0.0 110.733 -179.989 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.62 106.84 5.23 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.271 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.03 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.437 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.0 m-30 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -117.12 161.93 18.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.2 tt0 -115.92 144.63 43.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.085 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.84 111.69 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.773 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.5 115.63 20.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.085 HD13 HD11 ' A' ' 6' ' ' ILE . 4.8 tp -126.05 127.11 45.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -85.5 100.66 12.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.054 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.35 89.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.188 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.321 -0.287 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.496 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.992 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.81 -0.071 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.55 22.35 0.96 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 119.725 -1.226 . . . . 0.0 114.97 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.6 p90 -161.59 135.35 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.063 0.932 . . . . 0.0 111.224 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.495 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.55 135.47 34.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.98 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.16 147.7 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.541 0.686 . . . . 0.0 111.568 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.637 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.64 119.72 27.73 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.43 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 143.66 159.3 7.93 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.551 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 145.09 173.64 16.56 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.384 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 68' ' ' VAL . 24.3 p -63.67 -14.44 52.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.79 -25.79 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -124.25 86.77 54.29 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.486 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 64.13 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.306 2.004 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.778 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.0 t60 -49.05 -27.16 3.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.527 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.45 -152.29 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.693 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.79 52.65 4.62 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.941 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 76.54 43.36 0.14 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 158.78 74.15 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.929 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 72.9 Cg_endo -76.19 0.33 9.49 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.507 2.138 . . . . 0.0 112.569 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.1 114.92 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.23 119.62 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.984 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.41 147.65 36.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.119 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.34 155.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.655 -177.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.0 -32.86 4.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.753 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.33 142.11 2.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 111.424 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.51 133.35 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 122.69 76.2 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.4 Cg_endo -64.63 132.18 32.12 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.23 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.96 5.31 56.47 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.412 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.07 179.17 21.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.804 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.66 -39.08 70.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 111.121 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.825 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -66.4 -57.4 7.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.466 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.8 -28.82 67.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.382 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -72.25 -34.61 68.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.069 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.72 -57.97 3.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.16 41.23 9.53 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.474 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.4 mmp_? -113.14 -4.72 13.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.773 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.119 HD21 HD12 ' A' ' 36' ' ' ILE . 5.0 tp -121.44 153.66 37.58 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.019 0.438 . . . . 0.0 110.822 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.12 135.28 48.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.689 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.14 157.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 111.758 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.47 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 t30 75.41 0.99 3.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.17 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -68.55 125.18 25.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 102.23 13.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.625 . . . . 0.0 111.602 -178.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.98 HD11 HG21 ' A' ' 19' ' ' ILE . 16.4 mt -49.8 124.94 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.866 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 mt -109.76 -34.14 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.972 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.8 m-85 -150.27 161.22 42.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 76' ' ' ALA . 6.9 p -148.7 103.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.626 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 70.42 -66.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.289 0.566 . . . . 0.0 109.907 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.39 29.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' HG13 ' A' ' 60' ' ' VAL . 1.4 t -121.01 142.0 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.492 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.0 p-10 -101.07 111.45 23.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.859 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.689 HG21 HG22 ' A' ' 57' ' ' ILE . 21.3 m -89.68 24.1 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -67.85 -22.13 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 110.734 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -145.97 44.62 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 23' ' ' THR . 19.0 m -117.87 148.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.459 HG22 ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -67.52 151.99 46.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.54 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.798 ' O ' HG23 ' A' ' 74' ' ' VAL . 9.8 t-160 -49.55 -34.1 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.533 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 20.0 m -71.76 -33.66 68.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.495 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.49 -39.72 81.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -64.32 -46.88 81.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.616 0.722 . . . . 0.0 109.226 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.7 t -59.97 -50.63 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.333 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 2.2 pt-20 -57.75 -35.12 70.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.637 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -55.33 -51.92 65.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.269 0.557 . . . . 0.0 110.228 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 19' ' ' ILE . 6.2 mt -56.42 -36.64 69.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.533 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.32 -25.67 51.42 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.478 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.3 mt-10 -96.6 -6.96 35.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.294 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.921 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.62 -17.74 16.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.147 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.54 -100.74 2.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.9 m -130.45 -91.31 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 7' ' ' THR . 5.4 tp -87.03 86.27 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.254 0.55 . . . . 0.0 109.559 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.921 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.6 p -101.29 138.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HG2' HG23 ' A' ' 7' ' ' THR . 2.5 mtt180 -88.68 103.2 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.041 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.907 ' CD2' HG23 ' A' ' 60' ' ' VAL . 12.3 mt -92.6 138.04 31.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.722 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 133.53 46.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.7 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.144 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.8 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.762 0.315 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -139.83 160.2 40.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.2 mt-10 -117.08 144.9 44.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.835 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.074 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.82 111.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.886 0.374 . . . . 0.0 111.73 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.806 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.42 115.6 20.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.074 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -126.09 127.08 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.25 100.4 11.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.126 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.78 88.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.067 179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.628 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 110.725 -0.102 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.65 21.01 1.05 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.716 -1.23 . . . . 0.0 114.754 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.5 p90 -161.62 135.6 6.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.999 0.9 . . . . 0.0 111.12 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.47 138.55 32.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.455 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.096 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.14 146.5 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.691 0.757 . . . . 0.0 112.228 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.43 134.59 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.198 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.3 -5.32 1.4 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.573 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.57 -175.36 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.113 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 68' ' ' VAL . 16.1 p -71.43 -19.23 62.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.62 -24.91 15.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.591 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 2.2 t30 -124.41 87.91 53.66 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.099 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.96 63.07 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.463 2.109 . . . . 0.0 112.631 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.73 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 50.3 t60 -50.59 -25.74 4.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.165 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.774 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.73 -151.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.513 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.56 49.75 4.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.843 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 76.88 45.38 0.09 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.03 153.75 78.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.636 ' CB ' HG22 ' A' ' 23' ' ' THR . 74.2 Cg_endo -75.39 -0.17 9.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.468 2.112 . . . . 0.0 112.657 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.87 115.24 1.9 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.943 0.402 . . . . 0.0 110.495 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.08 119.8 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.092 -179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.774 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.05 147.41 36.78 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.348 0.594 . . . . 0.0 110.461 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.014 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.14 155.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.059 -176.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.05 -31.83 4.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.986 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.41 134.24 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.042 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.986 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.52 132.93 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.26 123.84 74.65 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 36.9 Cg_endo -65.18 132.68 32.56 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 112.289 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.2 5.5 57.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.48 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.84 178.56 20.93 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.928 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.65 -37.72 68.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.757 0.313 . . . . 0.0 111.179 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.819 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -67.78 -57.51 6.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.417 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.53 -28.87 68.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -72.13 -34.52 68.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.063 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.5 -58.07 2.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.6 41.02 9.25 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.481 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.514 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mtm180 -113.8 6.24 16.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.014 HD21 HD12 ' A' ' 36' ' ' ILE . 5.6 tp -132.8 154.6 50.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.071 0.462 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.606 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -130.86 136.1 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -51.74 157.78 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.315 0.578 . . . . 0.0 111.663 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.6 -2.01 2.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.352 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.652 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.4 m-20 -67.82 126.34 29.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.65 104.14 15.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.489 0.661 . . . . 0.0 111.259 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.096 HD11 HG21 ' A' ' 19' ' ' ILE . 67.8 mt -52.71 133.84 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.96 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 3' ' ' TYR . 14.2 mt -116.62 -28.56 6.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.661 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -156.29 149.54 24.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.826 HG13 ' CD2' ' A' ' 86' ' ' LEU . 39.8 t -139.44 105.94 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.168 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 t30 55.04 38.68 30.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 110.108 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 78.86 33.43 0.25 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.475 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 60' ' ' VAL . 92.7 t -120.99 107.82 21.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.596 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.5 t0 -74.01 111.6 9.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.744 0.307 . . . . 0.0 110.564 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 35.0 m -96.56 29.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -59.86 -22.71 62.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -150.8 76.27 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 111.106 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 23' ' ' THR . 35.4 m -149.81 145.75 17.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.19 155.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.212 0.529 . . . . 0.0 111.154 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.6 p-80 -50.89 -33.7 25.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.886 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.5 t -72.14 -33.96 68.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.686 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.32 -40.8 90.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.196 0.522 . . . . 0.0 109.874 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.48 -46.85 78.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.668 0.747 . . . . 0.0 109.168 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.2 t -56.9 -50.27 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.255 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.92 -29.24 59.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.917 178.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.619 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -62.32 -51.9 65.81 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 109.81 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.025 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.03 -37.52 66.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.558 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -27.41 52.13 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.244 179.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.28 14.72 25.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.313 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.924 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.77 16.42 4.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.517 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.27 -92.0 0.56 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.276 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.6 m -142.19 -90.25 0.14 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.806 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -84.67 90.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.283 0.563 . . . . 0.0 109.723 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.924 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -105.82 138.11 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.4 ttt180 -88.29 102.87 15.27 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.826 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.4 mt -91.45 138.49 31.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.239 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.65 134.51 44.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.652 HG21 ' OD2' ' A' ' 55' ' ' ASP . 6.2 m . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-85 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.732 0.301 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 8.6 mt-10 -118.84 153.01 35.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.15 144.91 31.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.481 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.028 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.19 110.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.443 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.821 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.73 117.61 20.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.028 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -127.6 127.0 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.4 pt-20 -83.96 100.45 11.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.296 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -51.4 88.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.322 -0.23 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.586 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.986 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.5 tp . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.283 0.087 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.81 21.28 1.01 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.707 -1.235 . . . . 0.0 114.614 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.86 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.3 p90 -161.31 134.7 6.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.874 0.837 . . . . 0.0 110.981 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.32 135.43 34.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.566 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.88 146.07 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.593 0.711 . . . . 0.0 111.385 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -125.34 122.69 37.55 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.457 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 140.01 157.77 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.787 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.71 176.09 22.55 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 68' ' ' VAL . 17.4 p -66.54 -18.37 65.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -107.06 -27.26 10.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.69 0.281 . . . . 0.0 111.635 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.42 87.38 54.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.494 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.27 64.53 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.405 2.07 . . . . 0.0 112.545 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.746 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.8 t60 -46.23 -29.76 1.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.545 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.979 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -83.13 -155.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.412 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.675 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.31 -52.63 51.5 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.698 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 4.1 p-10 -179.34 42.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.615 0.245 . . . . 0.0 111.322 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.47 174.08 5.13 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.992 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 88.6 Cg_endo -81.4 10.78 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.658 2.239 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 112.1 1.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.079 0.466 . . . . 0.0 111.316 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.872 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.11 119.87 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.9 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.979 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.63 149.75 39.35 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.38 0.61 . . . . 0.0 110.897 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.066 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.41 155.72 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.436 -177.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.72 -32.25 4.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.609 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 141.23 2.0 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.91 0.386 . . . . 0.0 111.337 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.959 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.38 132.98 48.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.0 124.59 74.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.2 Cg_endo -65.63 132.58 31.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.769 2.312 . . . . 0.0 112.1 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.51 5.15 56.98 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.473 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.86 176.1 19.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.797 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.43 -37.11 62.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 111.295 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.85 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.11 -57.41 6.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.527 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.31 -29.07 67.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.345 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -72.06 -36.08 69.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 109.979 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.35 -57.9 3.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.91 41.5 9.57 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.466 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 6' ' ' ILE . 74.7 mtp180 -113.2 8.23 18.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.848 0.356 . . . . 0.0 110.644 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.066 HD21 HD12 ' A' ' 36' ' ' ILE . 5.8 tp -133.48 155.48 49.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.77 134.89 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.619 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -49.08 157.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.627 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.03 -2.31 2.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.203 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -64.86 124.05 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.58 100.06 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.567 0.698 . . . . 0.0 111.867 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 19' ' ' ILE . 35.2 mt -47.82 126.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.616 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -122.08 -5.72 8.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.585 179.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -171.61 143.9 1.8 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.977 0.418 . . . . 0.0 110.728 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.876 HG13 ' CD2' ' A' ' 86' ' ' LEU . 25.3 t -141.97 109.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 84' ' ' VAL . 7.3 t30 52.85 38.59 27.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.161 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 78.73 32.29 0.3 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 60' ' ' VAL . 59.1 t -120.92 103.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.6 p-10 -66.68 113.43 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.532 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 57' ' ' ILE . 25.8 m -92.51 18.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.497 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -65.47 -21.29 66.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.981 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.56 45.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 23' ' ' THR . 17.2 m -127.35 142.74 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.059 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 153.47 31.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.011 0.434 . . . . 0.0 110.62 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.615 ' O ' HG23 ' A' ' 74' ' ' VAL . 8.0 t-160 -49.33 -33.88 14.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.591 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -33.7 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.834 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.872 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -71.42 -46.9 58.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.621 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 78.6 t -60.08 -50.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.334 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.668 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 9.2 pt-20 -57.9 -30.22 65.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.629 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.68 -51.12 71.15 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.329 0.585 . . . . 0.0 109.861 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.936 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -57.46 -37.55 73.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.891 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.28 -27.51 53.13 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.603 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 5.8 pt-20 -101.06 18.03 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.309 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.927 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.15 16.33 4.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.408 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.33 -92.4 0.66 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.27 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -142.84 -90.05 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.821 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -84.74 87.24 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.286 0.565 . . . . 0.0 109.745 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.927 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -102.29 137.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.683 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.4 mtt-85 -88.36 102.69 15.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.876 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.1 mt -91.61 132.53 36.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.597 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.46 115.11 29.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.075 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 57' ' ' ILE . 1.7 m . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.661 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.766 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.847 0.356 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 25.1 mt-10 -111.68 166.04 11.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.445 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 13.1 pt-20 -126.76 144.81 50.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.072 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.32 109.47 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.955 0.407 . . . . 0.0 112.016 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.842 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.89 121.55 25.0 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.072 HD13 HD11 ' A' ' 6' ' ' ILE . 4.3 tp -130.54 128.48 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 5.7 mt-10 -83.65 100.68 11.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.49 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CG ' HD23 ' A' ' 15' ' ' LEU . 11.8 mtp180 -44.76 92.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.984 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.405 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.896 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.985 ' HB3' HD23 ' A' ' 8' ' ' LEU . 4.5 mt . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.617 0.246 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 136.63 42.1 0.11 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.877 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.782 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.2 p90 -163.39 133.09 4.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.121 0.461 . . . . 0.0 110.895 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.453 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.32 136.64 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.548 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.02 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -117.73 148.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.669 0.747 . . . . 0.0 111.972 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.94 134.38 28.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.267 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 141.56 3.61 1.14 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.684 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.89 -175.75 1.49 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 68' ' ' VAL . 40.8 p -66.39 -26.9 67.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.5 -19.21 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.34 87.53 53.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.415 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.93 60.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.292 1.995 . . . . 0.0 112.562 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.728 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.3 t60 -48.16 -27.77 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.088 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.797 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.39 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.276 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.13 -50.22 68.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.679 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.8 40.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.87 168.18 15.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.7 ' HB3' HG22 ' A' ' 23' ' ' THR . 90.2 Cg_endo -79.0 5.34 5.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.546 2.164 . . . . 0.0 112.81 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -54.92 113.16 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.391 . . . . 0.0 110.757 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.859 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.19 119.49 33.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.845 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.797 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.82 145.93 35.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.328 0.585 . . . . 0.0 110.436 178.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.035 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.136 -176.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.437 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.82 -31.65 4.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.146 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -171.55 136.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.748 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.99 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -100.46 131.91 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 116.19 63.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.5 Cg_exo -58.98 136.49 73.78 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.785 2.324 . . . . 0.0 112.288 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.2 15.87 42.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.604 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.19 178.27 16.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.182 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.23 -36.18 51.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 111.397 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.826 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -70.28 -56.75 5.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.36 -30.47 66.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.4 pp0? -72.12 -29.93 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.265 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.65 -57.94 3.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.529 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 40.64 9.47 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.624 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -117.83 -3.71 11.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.035 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -123.3 153.11 40.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.956 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.38 135.88 47.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.17 157.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.337 0.589 . . . . 0.0 111.424 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.4 -3.02 2.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -64.86 125.3 24.39 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 14.2 p -86.72 100.24 12.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.5 0.667 . . . . 0.0 111.74 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.013 HD11 HG21 ' A' ' 19' ' ' ILE . 11.2 mt -52.99 127.41 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.698 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.766 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.8 OUTLIER -120.0 -10.98 9.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.579 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -167.02 143.29 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.06 0.457 . . . . 0.0 110.71 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.838 HG13 ' CD2' ' A' ' 86' ' ' LEU . 39.6 t -139.47 112.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.87 37.0 16.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 0.0 110.164 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 79.55 34.0 0.19 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.552 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 60' ' ' VAL . 88.9 t -120.97 107.84 21.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.479 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -71.59 110.33 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.606 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 34.7 m -95.97 40.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -24.96 59.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -143.87 61.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 23' ' ' THR . 26.9 m -135.62 146.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.023 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.66 155.62 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.055 0.455 . . . . 0.0 111.267 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.858 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 p-80 -48.23 -35.14 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.17 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -72.35 -33.85 67.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.153 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -42.87 88.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.813 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.859 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.06 -46.82 85.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.619 0.723 . . . . 0.0 109.169 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 70' ' ' HIS . 91.7 t -56.85 -50.29 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.194 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.21 -30.05 61.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.902 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -60.64 -50.14 74.7 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.327 0.584 . . . . 0.0 109.735 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.02 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -58.85 -36.53 74.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.825 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.5 -25.25 50.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.452 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -103.09 17.87 23.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 111.213 -178.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.881 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.82 16.31 5.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.83 -109.85 2.95 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -120.68 -89.38 0.6 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.842 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.0 OUTLIER -88.2 95.42 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 109.842 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.881 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -108.07 135.2 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.7 ptm180 -87.52 102.87 15.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.415 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.838 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.4 mt -89.78 132.94 34.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.58 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.77 120.01 39.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 57' ' ' ILE . 12.5 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.435 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 40.1 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.729 0.299 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -117.17 159.47 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.93 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 pt-20 -120.23 144.67 47.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.005 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.85 109.56 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.988 0.423 . . . . 0.0 111.768 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.807 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.18 112.2 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -122.91 127.19 48.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.4 pt-20 -83.92 100.29 10.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.287 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -47.83 88.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.254 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.323 -0.178 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.6 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.952 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.9 tp . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 110.659 -0.126 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.67 26.16 1.07 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 114.77 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.798 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.9 p90 -163.71 132.11 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.016 0.908 . . . . 0.0 111.266 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.7 139.62 30.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.707 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.047 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -121.37 146.57 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.46 135.43 35.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.353 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.91 -3.41 1.52 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.655 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.33 -174.78 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.06 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 68' ' ' VAL . 17.4 p -71.52 -21.27 61.93 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -22.29 16.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 111.48 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 1.5 t-20 -124.27 87.66 53.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.166 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.72 62.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.368 2.045 . . . . 0.0 112.71 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.739 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 46.6 t60 -50.98 -26.16 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.031 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.762 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.25 -151.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.477 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.89 49.01 4.14 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.858 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.23 45.88 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.475 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 154.14 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.98 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.666 ' CB ' HG22 ' A' ' 23' ' ' THR . 73.9 Cg_endo -75.71 0.26 9.39 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.497 2.131 . . . . 0.0 112.692 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.71 115.65 2.27 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.917 0.389 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.21 119.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.075 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.762 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.24 147.05 35.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.358 0.599 . . . . 0.0 110.492 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.99 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.339 -176.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.14 -31.77 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.52 134.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.051 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.971 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.83 132.51 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 125.37 72.83 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.6 Cg_endo -65.94 132.26 29.72 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.738 2.292 . . . . 0.0 112.226 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.01 56.66 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.486 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.68 177.07 20.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.944 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.95 -37.46 63.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.763 0.315 . . . . 0.0 111.173 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.836 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.7 -57.6 5.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.54 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.18 -34.74 68.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.226 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.81 -58.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.4 40.88 9.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.726 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.493 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mmt180 -111.13 -5.98 14.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.846 0.355 . . . . 0.0 110.759 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.99 HD21 HD12 ' A' ' 36' ' ' ILE . 6.4 tp -119.13 156.15 30.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.751 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.39 134.91 45.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.818 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -51.51 157.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 121.243 0.544 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER 75.29 -1.54 3.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.36 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 m-20 -69.76 129.35 39.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.76 104.03 15.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.646 0.736 . . . . 0.0 111.491 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.047 HD11 HG21 ' A' ' 19' ' ' ILE . 72.5 mt -50.71 138.65 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 2.1 mm? -116.67 -44.15 2.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.372 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -143.62 172.71 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.783 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.906 HG13 ' CD2' ' A' ' 86' ' ' LEU . 44.9 t -149.88 97.11 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.821 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.727 HD22 HG23 ' A' ' 84' ' ' VAL . 1.5 t-20 67.82 -67.56 0.18 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.138 0.494 . . . . 0.0 109.775 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mt-10 -156.41 32.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.479 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -118.58 142.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.559 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 16.1 p-10 -111.09 108.93 18.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.173 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.6 m -92.82 40.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 111.66 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.51 70.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.78 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -152.87 70.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.95 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 23' ' ' THR . 27.6 m -135.87 146.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.7 152.58 26.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 0.0 110.826 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.866 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.6 p-80 -48.55 -33.86 10.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.01 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.19 -33.82 70.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.542 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.4 -42.14 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.48 -46.89 81.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.582 0.706 . . . . 0.0 109.123 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 70' ' ' HIS . 83.9 t -56.57 -50.39 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.205 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.86 -30.11 60.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.053 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.3 -50.42 73.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 109.909 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -58.53 -36.05 73.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.861 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.5 -29.21 52.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.494 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -99.64 18.46 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -178.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.907 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.22 16.17 5.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.273 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.66 -94.11 0.66 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.18 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.0 p -140.49 -90.65 0.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.807 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -83.84 89.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.185 0.517 . . . . 0.0 109.718 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.907 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.5 p -105.17 137.01 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.96 103.0 15.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.906 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.5 mt -91.24 142.68 27.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.174 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.76 139.58 37.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.692 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 HD11 ' A' ' 51' ' ' LEU . 4.3 m . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.788 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.427 ' CG ' HD13 ' A' ' 58' ' ' LEU . 2.4 m-30 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.836 0.351 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.9 153.86 39.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.428 ' CG ' ' HB3' ' A' ' 85' ' ' ARG . 1.8 tt0 -108.01 138.36 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.645 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.805 HD13 HD13 ' A' ' 51' ' ' LEU . 1.1 mt -132.69 109.17 14.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.873 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.05 112.16 15.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.893 HD21 ' CA ' ' A' ' 45' ' ' ALA . 4.3 tp -121.91 126.84 49.58 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -87.81 99.54 12.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.021 178.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -57.79 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.573 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.255 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.889 -179.231 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.888 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.4 tp . . . . . 0 CA--C 1.533 0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 72.64 30.24 64.39 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.0 p90 -164.64 135.38 4.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.354 1.077 . . . . 0.0 111.745 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -100.91 137.63 39.03 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.659 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.035 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -116.74 150.84 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.723 0.773 . . . . 0.0 112.293 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -145.79 134.58 22.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.31 2.92 0.92 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.633 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.67 -173.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.005 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 33.2 p -70.57 -26.01 63.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 43.4 t0 -94.24 -24.05 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 4.0 m-20 -124.47 87.98 53.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 63.89 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.316 2.011 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.744 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 40.9 t60 -47.26 -28.32 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.315 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.818 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.06 -155.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.385 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.682 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.25 -50.91 59.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.691 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.89 39.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.18 166.08 23.78 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.838 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.659 ' CB ' HG22 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.76 7.28 4.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.52 2.147 . . . . 0.0 112.727 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -57.01 114.25 2.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.85 0.357 . . . . 0.0 110.779 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.39 118.07 29.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.795 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.818 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.48 147.21 37.49 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.187 0.518 . . . . 0.0 110.732 178.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.021 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.92 155.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.902 -176.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.457 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.49 -29.93 4.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.223 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.38 125.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.291 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.798 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.49 127.43 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.5 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.2 125.37 72.49 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_endo -60.9 138.39 78.67 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.716 2.278 . . . . 0.0 112.206 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 14.1 64.4 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.377 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . -107.05 -159.16 21.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.886 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.589 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.97 -38.72 57.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.832 0.316 . . . . 0.0 110.987 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.893 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.41 -54.19 8.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.893 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.95 -33.72 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.162 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 13.5 mm-40 -72.45 -32.39 66.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.5 ' HB2' HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -79.41 -57.98 3.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.63 38.34 8.91 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.701 ' CB ' HG23 ' A' ' 6' ' ' ILE . 22.0 mmt180 -120.29 1.92 10.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.021 HD21 HD12 ' A' ' 36' ' ' ILE . 29.5 tp -128.07 162.98 25.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.163 0.506 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.45 137.35 26.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.708 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.99 157.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.328 0.585 . . . . 0.0 111.629 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t-20 75.73 -0.52 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.328 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -69.34 126.75 30.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.66 101.99 13.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.585 0.707 . . . . 0.0 111.492 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.009 HD11 HG21 ' A' ' 19' ' ' ILE . 68.0 mt -48.81 137.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.581 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 5.2 mt -119.01 -32.9 4.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -150.13 160.13 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.577 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.849 HG13 ' CD2' ' A' ' 86' ' ' LEU . 28.3 t -152.42 110.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 t30 47.92 50.19 16.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 73.29 31.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 77.8 t -120.85 141.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.0 p-10 -109.47 109.57 20.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.664 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 32.5 m -94.01 43.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.247 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -30.17 68.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -149.87 67.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.768 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 35.5 m -135.02 148.1 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.438 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.04 154.35 39.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 74' ' ' VAL . 7.4 p-80 -49.17 -34.15 13.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.098 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -69.57 -33.93 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.642 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.37 -42.58 83.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 109.793 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.852 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.09 -46.62 83.42 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 70' ' ' HIS . 88.0 t -56.61 -50.4 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.21 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.29 -29.85 59.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.949 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -61.96 -50.77 70.81 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -57.01 -37.16 71.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.484 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.64 -23.62 49.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.957 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 5.0 pt-20 -93.6 3.21 55.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.032 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.931 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -90.28 16.3 8.92 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.46 -121.86 27.96 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.748 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -104.19 -87.12 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.873 HG13 HG22 ' A' ' 7' ' ' THR . 8.2 tp -82.59 107.82 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.931 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -127.05 137.72 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.72 ' HG2' HG23 ' A' ' 7' ' ' THR . 13.2 mtp180 -83.49 103.07 12.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.373 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.849 ' CD2' HG13 ' A' ' 60' ' ' VAL . 8.1 mt -94.92 142.12 27.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.017 0.436 . . . . 0.0 111.363 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.66 131.43 49.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.304 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.459 HG21 HD11 ' A' ' 6' ' ' ILE . 3.3 m . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.441 ' HB3' HD21 ' A' ' 58' ' ' LEU . 5.8 m-30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.822 0.344 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.19 141.93 51.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 17.0 pt-20 -99.46 144.66 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.132 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.43 109.42 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.372 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.898 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.81 118.39 20.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.132 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -128.51 127.18 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.1 pt-20 -84.06 100.63 11.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.195 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -51.63 89.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.111 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.339 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.613 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.004 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.9 tp . . . . . 0 CA--C 1.527 0.068 0 N-CA-C 110.637 -0.135 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 133.93 20.27 0.86 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.928 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.856 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.0 p90 -161.18 135.91 7.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.055 0.927 . . . . 0.0 111.381 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 135.82 34.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.019 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.27 148.03 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -130.46 124.85 32.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.71 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 158.3 -120.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.874 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 63.83 168.29 1.27 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.12 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 68' ' ' VAL . 25.1 p -70.18 -1.98 11.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 35.4 t70 -117.08 -22.52 8.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' HIS . 4.3 m-80 -124.72 85.89 56.41 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.61 65.74 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.008 1.805 . . . . 0.0 112.477 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.738 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 48.7 t60 -55.09 -23.62 21.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.173 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -94.75 -150.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.377 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.689 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.26 51.65 4.52 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.692 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 t0 76.25 43.53 0.15 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 110.414 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.53 156.77 79.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 95.9 Cg_endo -77.9 0.03 10.22 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.507 2.138 . . . . 0.0 112.599 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -55.2 120.09 6.5 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.108 0.48 . . . . 0.0 111.313 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.885 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.62 118.68 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.98 146.84 36.07 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.316 0.579 . . . . 0.0 110.463 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.23 155.78 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.042 -176.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.35 -33.51 4.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.772 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.82 142.04 2.37 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.483 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.962 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.92 133.58 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 115.0 57.79 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.6 Cg_exo -56.07 136.87 77.22 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.89 2.393 . . . . 0.0 112.405 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.91 2.57 66.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.1 176.39 22.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.111 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -38.41 59.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.87 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.18 -57.41 6.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.659 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.59 -35.35 80.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.081 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.1 pp0? -71.96 -30.07 64.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 0.0 110.471 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.678 ' OD2' HD12 ' A' ' 8' ' ' LEU . 49.1 m-20 -79.89 -58.07 3.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 41.39 9.81 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.593 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.513 ' CB ' HG12 ' A' ' 6' ' ' ILE . 5.5 mtm180 -117.09 -1.19 11.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -126.56 153.53 45.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.586 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.85 135.26 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.688 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.631 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.5 157.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.339 0.59 . . . . 0.0 111.619 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 75.79 -0.27 3.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.26 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -67.45 124.4 23.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.59 100.33 12.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 111.549 -178.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.019 HD11 HG21 ' A' ' 19' ' ' ILE . 12.1 mt -49.89 132.65 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.674 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.8 pp -130.04 -0.01 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.114 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 179.16 134.64 0.09 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.892 HG13 ' CD2' ' A' ' 86' ' ' LEU . 40.7 t -120.02 97.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.692 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.865 ' OD1' HG23 ' A' ' 84' ' ' VAL . 3.7 t30 71.32 -61.82 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -164.3 31.24 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.084 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.3 t -120.99 110.43 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.461 ' N ' ' CE1' ' A' ' 59' ' ' PHE . 6.7 t0 -72.47 112.37 8.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.79 0.328 . . . . 0.0 110.593 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.663 HG21 HG22 ' A' ' 57' ' ' ILE . 19.1 m -94.92 27.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.5 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -67.81 -25.54 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.44 51.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -126.19 148.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.006 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -68.42 154.53 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.848 ' O ' HG23 ' A' ' 74' ' ' VAL . 9.2 t-160 -48.29 -34.86 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.044 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 4.0 m -68.6 -33.76 74.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.244 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.6 -33.09 68.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.21 0.529 . . . . 0.0 109.598 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -71.59 -46.76 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 70' ' ' HIS . 67.9 t -60.58 -50.86 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.303 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -57.14 -29.32 63.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.69 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.788 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -61.16 -52.19 65.87 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.905 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.015 HD11 HD12 ' A' ' 19' ' ' ILE . 3.0 mt -56.6 -37.27 70.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.909 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.6 -28.33 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -97.37 15.93 21.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.295 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.924 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.11 16.28 6.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.39 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.54 -96.05 0.55 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.422 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -136.09 -90.2 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.898 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.5 93.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 109.879 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.924 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 p -109.81 136.39 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.2 ptt180 -87.01 103.05 14.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.273 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.892 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.1 mt -91.78 134.51 34.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.119 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.507 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.56 125.35 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.8 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.728 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.907 ' CD2' HD13 ' A' ' 58' ' ' LEU . 3.1 m-85 . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.66 0.267 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.451 ' HG2' HG23 ' A' ' 88' ' ' VAL . 4.3 pt-20 -129.0 164.62 22.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.978 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -121.45 144.77 48.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.94 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.03 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.59 112.12 13.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.638 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.717 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.12 115.36 20.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 6' ' ' ILE . 4.6 tp -125.44 128.76 48.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -89.48 100.84 13.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.698 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 5.1 mtp180 -45.6 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.342 0.591 . . . . 0.0 109.801 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.363 0 CA-C-N 114.835 -1.075 . . . . 0.0 114.168 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.975 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.1 tp . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.397 0.141 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.511 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.93 19.61 0.79 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.674 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.8 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.1 p90 -161.04 135.08 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.006 0.903 . . . . 0.0 111.19 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.37 138.86 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.466 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.65 147.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 112.037 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.98 134.98 32.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.283 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.4 1.23 0.92 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.409 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.34 -173.79 0.92 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.885 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 68' ' ' VAL . 28.7 p -66.83 -32.6 73.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -90.43 -20.7 22.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 20.7 t-20 -124.28 87.29 53.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.617 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.91 61.49 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.277 1.985 . . . . 0.0 112.387 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 49.2 t60 -47.9 -27.75 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.202 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.792 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.43 -153.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -57.2 -50.17 66.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.681 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.48 40.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.724 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 168.5 14.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' A' ' 23' ' ' THR . 87.0 Cg_endo -78.87 6.5 4.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.814 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 113.34 1.36 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.848 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.31 119.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.792 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.23 147.46 36.53 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.265 0.555 . . . . 0.0 110.456 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.053 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.02 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.121 -176.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.65 -34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.661 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.63 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.15 143.14 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.044 0.449 . . . . 0.0 111.737 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.46 132.79 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.449 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.2 124.54 73.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.0 Cg_endo -65.39 133.14 33.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 112.209 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.53 5.96 57.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.384 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.66 175.06 18.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.868 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.8 -36.15 57.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.721 0.296 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.846 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.89 -57.46 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.466 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.6 -29.04 67.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.401 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.02 -34.99 69.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.101 0.477 . . . . 0.0 110.005 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -84.75 -58.05 2.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.602 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 41.78 9.46 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.464 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.521 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.4 mmt85 -112.88 9.01 18.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.704 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.053 HD21 HD12 ' A' ' 36' ' ' ILE . 5.6 tp -134.34 155.1 50.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.635 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.607 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -132.09 133.52 44.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.881 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -49.4 157.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.79 -1.11 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.368 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.83 126.46 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.61 103.88 15.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.525 0.678 . . . . 0.0 111.361 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.088 HD11 HG21 ' A' ' 19' ' ' ILE . 64.2 mt -50.83 152.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.863 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.907 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -136.58 -39.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.474 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -142.58 159.52 42.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.888 HG13 ' CD2' ' A' ' 86' ' ' LEU . 35.9 t -152.5 113.78 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 49.84 44.87 25.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.773 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 72.86 32.62 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.595 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 68.6 t -120.37 142.19 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.7 p-10 -108.8 111.05 22.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.54 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 m -79.21 57.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.967 0.413 . . . . 0.0 110.948 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.62 103.02 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.85 53.81 1.41 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 23' ' ' THR . 16.7 m -119.85 142.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -62.99 154.21 31.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.075 0.465 . . . . 0.0 111.226 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.8 p-80 -48.09 -34.16 9.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -70.69 -33.98 71.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.94 -45.06 83.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 0.0 109.764 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.848 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.21 -46.92 86.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.299 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.9 t -56.55 -50.35 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.319 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.06 -29.35 57.31 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.971 178.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -61.78 -52.07 65.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.397 0.618 . . . . 0.0 109.759 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -56.61 -36.16 69.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.872 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.36 -30.53 53.84 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.674 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' OE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -98.29 19.82 13.63 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.406 -178.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.99 16.26 7.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.37 -101.4 1.15 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.237 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 18.1 t -130.28 -89.29 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.717 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.1 tp -88.41 91.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 109.919 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.887 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.9 p -105.11 137.18 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.72 102.63 14.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.888 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.9 mt -89.48 139.62 30.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.75 132.86 47.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.718 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.8 m . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.387 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.783 ' CD2' HD13 ' A' ' 58' ' ' LEU . 1.4 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.795 0.331 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -102.04 170.78 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.13 144.95 51.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.97 109.65 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.992 0.425 . . . . 0.0 111.966 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.861 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.27 119.53 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 6' ' ' ILE . 5.1 tp -132.03 127.15 35.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.3 pm0 -83.94 100.38 10.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.823 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.549 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.77 89.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.519 0.326 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.788 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.988 ' HB3' HD23 ' A' ' 8' ' ' LEU . 21.3 mt . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.98 0.419 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.85 32.82 0.54 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.436 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.783 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.8 p90 -158.86 135.97 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.068 0.434 . . . . 0.0 111.026 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.76 137.93 34.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.075 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.38 146.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.762 0.792 . . . . 0.0 112.377 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.77 133.59 30.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.096 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.36 -0.43 1.09 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.731 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.65 -173.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.919 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.865 HG22 ' HB3' ' A' ' 32' ' ' PRO . 37.2 p -69.09 -30.65 69.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.21 -20.86 21.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.35 87.23 54.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.425 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.63 61.79 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.349 2.033 . . . . 0.0 112.635 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 46.2 t60 -48.89 -27.55 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.78 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -91.23 -152.27 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.195 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.688 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.89 49.4 4.22 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.591 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.29 48.21 0.06 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 110.223 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.88 150.45 71.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.865 ' HB3' HG22 ' A' ' 23' ' ' THR . 12.1 Cg_exo -70.18 -5.23 15.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.674 2.249 . . . . 0.0 112.669 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.1 113.96 1.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.041 0.448 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.833 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.69 118.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.512 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.78 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.66 147.36 39.17 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.357 0.599 . . . . 0.0 110.69 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.044 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.05 155.71 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.017 -176.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.455 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.45 -29.6 4.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.252 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.76 130.57 0.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.176 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.003 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.61 129.75 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.27 116.87 67.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.7 134.47 60.89 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.67 2.247 . . . . 0.0 112.287 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.73 31.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.551 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.84 177.61 17.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.32 -34.77 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.425 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.787 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.77 -56.65 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.97 -31.1 65.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -72.0 -30.12 64.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.375 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.0 -57.96 3.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.97 9.57 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.615 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.523 ' CB ' HG12 ' A' ' 6' ' ' ILE . 44.1 mtt-85 -118.14 5.81 12.01 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.95 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.044 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -134.59 153.39 51.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.189 0.519 . . . . 0.0 111.026 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.576 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.58 137.35 49.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -52.19 157.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.344 0.592 . . . . 0.0 111.563 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.08 0.01 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.35 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.48 127.42 32.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 103.8 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.539 0.685 . . . . 0.0 111.339 -178.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 19' ' ' ILE . 69.6 mt -51.0 139.95 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.633 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.85 -37.08 3.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.5 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -148.68 165.41 31.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.76 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.685 HG11 ' HB1' ' A' ' 76' ' ' ALA . 39.4 t -142.07 97.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.73 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.7 t-20 68.53 -67.07 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.076 0.465 . . . . 0.0 109.771 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.4 mt-10 -157.37 33.36 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.582 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.4 t -120.59 142.36 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -107.19 108.38 19.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.393 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 65' ' ' VAL . 21.1 m -92.23 45.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.347 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -25.47 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -149.58 58.07 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.996 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.768 ' O ' HG23 ' A' ' 23' ' ' THR . 27.2 m -128.27 149.05 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.438 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.44 153.79 42.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 111.018 -179.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.2 t-160 -49.86 -34.14 19.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -69.62 -33.87 73.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.749 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.683 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.32 -42.68 79.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.833 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.79 -46.89 85.89 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.3 t -57.49 -50.41 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.259 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -30.03 61.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.889 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.76 -50.21 74.38 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.341 0.591 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.017 HD11 HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -59.53 -35.82 74.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.961 179.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.44 -25.79 50.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.348 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.439 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -102.58 16.78 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.36 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.908 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.9 16.27 4.26 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 -92.49 0.69 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.061 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 22.5 t -143.06 -89.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.861 HG13 HG22 ' A' ' 7' ' ' THR . 8.8 tp -84.47 88.23 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.217 0.532 . . . . 0.0 109.811 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.908 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.4 p -103.93 139.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.608 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.0 mtt-85 -88.15 102.82 15.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.61 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.9 mt -91.8 138.61 31.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.259 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.748 ' HB3' HD12 ' A' ' 58' ' ' LEU . 1.6 m-85 -101.66 138.66 38.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.773 ' O ' HD11 ' A' ' 58' ' ' LEU . 14.8 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.586 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.439 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 22.5 m-85 . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.778 0.323 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 142.36 18.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -106.24 144.63 32.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.993 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.03 109.41 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.925 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.39 121.22 24.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 6' ' ' ILE . 4.0 tp -132.05 127.38 36.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 pt-20 -85.57 101.07 12.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.853 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.566 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.2 mtp180 -47.79 94.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.384 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.317 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.97 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.17 44.14 0.07 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.978 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.774 ' HB3' HG23 ' A' ' 39' ' ' ILE . 12.5 p90 -164.55 134.16 3.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.149 0.474 . . . . 0.0 110.875 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.75 136.52 33.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.525 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.062 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.26 146.81 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.753 0.787 . . . . 0.0 112.247 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -140.0 132.86 29.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.13 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.5 3.61 0.71 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.707 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.75 -171.11 0.67 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.8 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.829 HG22 ' HB3' ' A' ' 32' ' ' PRO . 39.1 p -70.42 -29.14 65.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.97 -21.0 20.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.9 OUTLIER -124.38 87.32 54.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.524 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 62.2 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.266 1.977 . . . . 0.0 112.459 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.706 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.5 t60 -47.46 -28.12 2.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.327 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.822 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.49 -154.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.3 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.68 -50.09 70.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.604 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.37 40.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.48 165.84 25.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.829 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.5 Cg_exo -74.98 1.21 7.98 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.967 2.445 . . . . 0.0 112.815 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.46 112.3 0.79 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.034 0.445 . . . . 0.0 111.16 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.05 118.54 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.47 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.822 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.99 147.2 38.33 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.352 0.596 . . . . 0.0 110.841 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.011 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.11 155.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.911 -176.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.46 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.83 -29.02 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.189 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.4 131.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.998 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.969 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.59 132.29 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.32 114.23 53.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.8 Cg_exo -57.83 137.43 81.0 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.709 2.273 . . . . 0.0 112.326 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.77 54.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.568 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 179.5 16.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.113 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.69 -36.44 64.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.188 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.813 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.05 -57.68 5.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 0.0 111.87 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.75 -28.29 65.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.53 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.64 -30.21 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.362 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' OD2' HD12 ' A' ' 8' ' ' LEU . 1.7 m-20 -82.91 -57.87 3.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.14 37.74 10.91 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.574 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.6 mtt85 -112.44 -13.36 13.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.011 HD21 HD12 ' A' ' 36' ' ' ILE . 6.2 tp -114.69 154.82 27.76 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 111.408 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.592 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -133.11 135.71 45.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.691 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.84 157.41 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.195 0.521 . . . . 0.0 111.747 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.86 0.28 3.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.329 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.95 126.26 29.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.3 t -86.58 100.25 12.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.715 0.769 . . . . 0.0 111.316 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.062 HD11 HG21 ' A' ' 19' ' ' ILE . 69.9 mt -46.83 135.21 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.708 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.45 -42.29 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.052 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.2 m-85 -142.36 169.99 16.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.73 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.861 HG13 ' CD2' ' A' ' 86' ' ' LEU . 19.3 t -150.04 99.12 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.218 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 84' ' ' VAL . 8.6 t30 67.04 -67.61 0.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.167 0.508 . . . . 0.0 109.874 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -156.42 32.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.668 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.7 t -119.46 142.25 35.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.564 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.7 t0 -112.08 87.55 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 65' ' ' VAL . 24.9 m -70.22 63.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -29.9 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.691 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -149.03 58.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.76 ' O ' HG23 ' A' ' 23' ' ' THR . 34.8 m -123.91 146.67 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.246 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.458 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -65.81 154.94 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.868 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.5 p-80 -48.21 -34.65 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.1 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 p -71.58 -33.75 69.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.169 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.65 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.93 -45.49 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.86 -46.85 88.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.587 0.708 . . . . 0.0 109.162 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.8 t -57.12 -49.25 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.403 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.97 -30.15 63.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.957 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.77 -49.71 76.4 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.333 0.587 . . . . 0.0 109.679 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.986 HD11 HD12 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -59.94 -34.65 73.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.859 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.9 mmmt -77.36 -28.1 52.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.426 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.86 18.49 19.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 -178.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.48 16.29 6.71 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.39 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -111.03 3.42 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.155 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -119.68 -90.26 0.58 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.925 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -87.28 93.68 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.976 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.887 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -105.81 138.59 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.764 ' HG3' HG23 ' A' ' 7' ' ' THR . 49.1 mtp180 -88.67 102.96 15.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.861 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.0 mt -90.56 141.61 28.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.213 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 136.03 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.683 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.2 m-85 . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.625 0.25 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 1.6 mp0 -115.42 153.01 31.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 85' ' ' ARG . 1.9 pm0 -107.84 144.82 34.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.456 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.994 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.77 109.63 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 111.704 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.0 122.3 26.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.004 HD23 ' HG ' ' A' ' 15' ' ' LEU . 5.3 tp -131.54 126.85 35.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 12.8 mt-10 -80.31 99.99 8.17 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.279 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.28 88.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.085 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.441 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.004 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.8 tp . . . . . 0 N--CA 1.455 -0.214 0 CA-C-O 120.41 0.148 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.42 20.64 0.99 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.765 -1.207 . . . . 0.0 114.486 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.868 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.0 p90 -159.28 135.52 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.608 0.704 . . . . 0.0 110.847 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -95.27 135.2 37.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.89 146.6 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.543 0.687 . . . . 0.0 111.552 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.59 120.7 30.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.628 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 141.92 159.24 7.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.783 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.64 175.56 22.02 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 68' ' ' VAL . 26.6 p -65.87 -12.19 52.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -114.96 -26.35 7.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.53 87.37 54.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.466 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.94 66.06 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.365 2.043 . . . . 0.0 112.329 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.75 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 31.7 t60 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.656 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -85.96 -155.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.438 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.01 -50.1 69.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.746 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.03 76.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 110.701 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' CB ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -166.63 176.69 1.71 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 31' ' ' ASP . 94.1 Cg_endo -85.36 26.77 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.729 2.286 . . . . 0.0 112.543 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 m -77.21 112.29 13.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.903 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.59 118.85 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.009 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.34 148.15 37.47 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.259 0.552 . . . . 0.0 110.789 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.06 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.31 155.87 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.81 -177.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.64 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.31 -30.65 4.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.098 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.46 132.59 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.896 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.978 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.26 131.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 115.69 61.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.5 Cg_exo -57.72 134.79 65.23 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.731 2.288 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 8.12 56.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.43 179.75 18.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.903 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.08 -38.8 68.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 111.064 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.792 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -65.44 -57.46 8.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.25 -28.93 66.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.27 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.76 -57.94 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.632 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.06 9.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.602 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.1 mtt-85 -115.25 -6.18 12.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.06 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -121.23 154.06 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.162 0.506 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.46 135.45 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.552 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.21 157.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 0.0 111.538 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 77.06 -2.27 2.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -64.94 124.63 22.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.49 100.22 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.472 0.653 . . . . 0.0 111.615 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 19' ' ' ILE . 38.0 mt -48.51 125.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.565 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -117.42 -16.46 10.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.739 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -164.64 142.59 6.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.114 0.483 . . . . 0.0 110.94 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.913 HG13 ' CD2' ' A' ' 86' ' ' LEU . 38.6 t -136.98 112.18 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.393 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.606 HD22 HG23 ' A' ' 84' ' ' VAL . 3.4 t-20 50.69 39.29 21.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.918 0.389 . . . . 0.0 110.276 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.67 33.83 0.36 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.564 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 60' ' ' VAL . 88.7 t -120.9 103.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.307 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 10.3 t0 -65.99 108.05 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.616 HG21 HG22 ' A' ' 57' ' ' ILE . 25.3 m -87.39 8.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.638 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.64 -21.32 53.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.634 0.254 . . . . 0.0 111.051 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -139.21 42.04 2.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.185 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.758 ' O ' HG23 ' A' ' 23' ' ' THR . 8.3 m -124.42 144.71 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.418 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.48 153.92 41.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.93 0.395 . . . . 0.0 110.613 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.714 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.3 t-160 -48.76 -34.43 12.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 2.7 m -70.06 -33.68 72.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.04 -33.2 71.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.903 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -70.64 -46.79 62.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.8 t -59.57 -50.76 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.352 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 3.5 pt-20 -57.69 -31.82 66.75 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.605 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.11 -49.75 75.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.328 0.585 . . . . 0.0 110.022 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -59.8 -37.33 78.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.983 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.31 -25.74 51.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.699 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 6.4 pt-20 -103.26 17.75 23.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.191 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.94 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.73 16.15 4.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.16 -93.77 0.6 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.321 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 28.1 t -141.06 -90.63 0.15 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER -84.2 86.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.3 0.571 . . . . 0.0 109.706 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.94 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -100.27 137.57 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.114 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 6.0 ttt180 -89.4 102.65 15.32 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.913 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.0 mt -91.46 133.65 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.601 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.99 114.77 29.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.826 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.7 m . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.779 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.408 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 6.4 m-30 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.825 0.345 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -143.86 149.79 37.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.6 mt-10 -104.51 144.62 31.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.058 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.91 109.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.382 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.879 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 114.95 19.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.058 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -125.78 127.27 45.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.4 pt-20 -84.24 100.49 11.24 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.38 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.09 89.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.257 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.736 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.968 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.1 tp . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 110.505 -0.183 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.82 25.91 0.97 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.765 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -164.27 132.27 3.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.862 0.831 . . . . 0.0 111.363 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.39 137.13 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.331 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.038 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -116.22 161.76 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.767 0.794 . . . . 0.0 112.092 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -155.51 131.91 10.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.777 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 15.01 0.26 Allowed Glycine 0 C--O 1.229 -0.16 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.468 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.565 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -73.04 -174.14 26.45 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.712 HG23 ' C ' ' A' ' 68' ' ' VAL . 22.2 p -66.93 -32.71 74.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -85.09 -33.35 22.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.514 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -124.65 77.21 64.14 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 28' ' ' ILE . 3.6 Cg_endo -46.02 -24.25 2.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.736 2.29 . . . . 0.0 112.679 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.692 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.4 t60 58.94 -59.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.251 0.548 . . . . 0.0 111.497 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.837 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -66.28 -158.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.659 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.678 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.99 -49.45 78.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.484 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 179.39 75.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.56 156.99 14.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.2 5.73 4.38 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.857 2.371 . . . . 0.0 112.937 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -60.51 111.76 1.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.804 0.335 . . . . 0.0 110.707 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.853 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -79.76 121.45 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.263 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.837 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -142.23 147.2 36.13 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.419 0.628 . . . . 0.0 110.446 178.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.094 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.51 155.35 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.142 -0.935 . . . . 0.0 113.139 -176.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.98 -32.94 4.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.803 -179.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.13 143.67 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.616 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.02 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.27 132.27 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 116.78 66.43 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.8 Cg_exo -56.62 136.87 78.46 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.594 2.196 . . . . 0.0 112.305 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.61 1.98 67.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.689 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.55 174.83 24.06 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.864 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.84 -35.32 57.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.868 0.334 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.786 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.55 -57.44 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.485 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.0 -28.92 68.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.397 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -72.05 -35.36 69.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.049 0.452 . . . . 0.0 109.968 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.58 -57.77 3.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.523 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 40.88 9.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.599 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.49 9.55 19.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.794 0.33 . . . . 0.0 110.689 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.094 HD21 HD12 ' A' ' 36' ' ' ILE . 4.7 tp -136.3 153.8 51.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -131.2 134.37 46.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -48.98 157.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 111.83 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.5 t-20 76.56 -0.26 3.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.387 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.02 125.93 28.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.46 102.61 14.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.614 0.721 . . . . 0.0 111.199 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 61.6 mt -50.91 134.74 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.776 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.47 -30.54 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.576 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -152.47 163.69 39.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.773 HG13 ' CD2' ' A' ' 86' ' ' LEU . 19.3 t -144.05 97.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.029 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.873 ' OD1' HG23 ' A' ' 84' ' ' VAL . 4.7 t30 68.13 -67.36 0.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 6.2 pt-20 -156.54 32.41 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.691 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 59.0 t -119.78 142.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.496 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 p-10 -110.0 99.51 8.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.437 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.8 m -83.54 56.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.906 0.384 . . . . 0.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -29.09 26.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -147.36 56.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.712 ' C ' HG23 ' A' ' 23' ' ' THR . 31.7 m -126.22 144.39 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -62.14 151.77 34.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.4 t-160 -47.95 -33.98 8.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.717 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -33.99 75.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.977 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.18 -42.16 80.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.853 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.04 -46.65 86.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.631 0.729 . . . . 0.0 109.124 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.6 t -57.62 -50.56 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.193 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.34 -29.57 61.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.89 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.738 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.04 -50.66 72.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.318 0.58 . . . . 0.0 109.862 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.986 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -58.11 -37.14 73.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.836 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.51 -28.31 52.06 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.15 18.11 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 -178.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.904 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.04 16.38 5.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.246 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 -97.08 0.8 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.275 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.4 m -136.9 -90.44 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.879 HG13 HG22 ' A' ' 7' ' ' THR . 8.7 tp -84.86 89.97 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.23 0.538 . . . . 0.0 109.737 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.904 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.4 p -104.84 138.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.9 ttm-85 -87.95 103.12 15.39 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.773 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.6 mt -92.37 138.6 31.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.241 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.69 132.44 47.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.3 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.445 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 4.0 m-30 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.819 0.343 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -154.98 159.64 40.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 mt-10 -109.57 144.68 37.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.957 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.69 109.6 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 111.599 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.872 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.38 121.03 23.22 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.003 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -132.3 127.25 35.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.5 mt-10 -83.29 100.2 10.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.841 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.559 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -46.57 89.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.338 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.321 -0.301 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.747 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.003 ' HB3' HD23 ' A' ' 8' ' ' LEU . 20.1 mt . . . . . 0 N--CA 1.456 -0.157 0 CA-C-O 120.87 0.367 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 129.89 34.72 0.47 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.446 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.778 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.1 p90 -160.1 136.56 8.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.133 0.466 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.497 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.5 137.05 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.294 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.26 148.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.729 0.776 . . . . 0.0 112.355 -179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.75 133.8 27.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.065 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.474 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.41 4.77 0.88 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.725 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.545 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -61.49 -169.72 0.72 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.902 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.82 HG22 ' HB3' ' A' ' 32' ' ' PRO . 43.4 p -70.95 -29.89 66.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -93.54 -19.85 20.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 3.8 t-20 -124.46 87.43 54.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.91 61.24 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.32 2.013 . . . . 0.0 112.46 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.714 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.8 t60 -47.19 -28.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.814 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -88.79 -154.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.208 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.45 -49.9 73.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.51 40.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 0.0 110.799 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.85 165.59 27.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.82 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.4 Cg_exo -75.22 1.6 7.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.956 2.437 . . . . 0.0 112.754 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 t -52.62 112.07 0.76 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.978 0.418 . . . . 0.0 111.185 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.88 118.52 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.524 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.814 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.31 147.2 37.76 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.422 0.629 . . . . 0.0 110.622 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.076 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.94 155.72 7.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.064 -176.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.06 -30.4 4.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.165 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.25 130.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.995 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.007 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.19 130.86 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 126.06 70.67 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.4 Cg_endo -67.71 132.11 26.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.71 2.273 . . . . 0.0 112.34 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.39 26.89 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.333 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.24 177.54 16.9 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.022 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.49 -34.39 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.747 0.308 . . . . 0.0 111.487 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.62 -57.45 4.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.832 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.48 -28.82 64.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.603 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.74 -32.83 68.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 110.337 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.14 -57.89 3.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.685 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.57 9.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.717 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.7 mtm180 -113.93 -7.62 13.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.739 0.304 . . . . 0.0 110.821 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.076 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -121.2 154.02 36.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.079 0.466 . . . . 0.0 111.209 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -130.95 135.88 48.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.604 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -49.03 157.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.244 0.545 . . . . 0.0 111.454 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.9 t30 76.87 -2.02 2.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.111 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -65.47 124.54 22.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.1 p -86.5 100.76 12.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.52 0.676 . . . . 0.0 111.233 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 19' ' ' ILE . 65.8 mt -49.99 130.37 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.875 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.7 mt -112.91 -34.04 5.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.113 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -151.09 159.41 44.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.438 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.032 HG11 ' HB1' ' A' ' 76' ' ' ALA . 7.7 p -146.69 105.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 84' ' ' VAL . 18.7 t30 68.62 -67.18 0.21 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.137 0.494 . . . . 0.0 109.992 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.9 mm-40 -162.46 29.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.047 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 60' ' ' VAL . 1.4 t -121.01 142.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.279 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 18.0 t0 -106.36 90.75 3.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 m -70.54 63.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.429 . . . . 0.0 111.567 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -26.64 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -147.6 55.27 1.07 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 29.4 m -124.69 146.97 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.455 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.61 154.44 40.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.226 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.869 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.8 p-80 -48.12 -34.61 10.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.2 p -71.95 -33.75 68.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.197 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.691 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -45.39 80.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.61 -46.58 89.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.582 0.706 . . . . 0.0 109.203 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 70' ' ' HIS . 93.7 t -57.5 -50.47 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.245 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.691 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.86 -30.36 63.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.091 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 1.032 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.07 -49.79 75.9 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.28 0.562 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.976 HD11 HD12 ' A' ' 19' ' ' ILE . 4.0 mt -59.25 -35.54 73.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.739 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -77.31 -23.26 51.06 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.12 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -105.34 16.96 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.042 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.896 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.54 16.21 4.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.147 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -97.16 0.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.171 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 25.8 t -138.07 -89.09 0.24 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.872 ' CD1' HG22 ' A' ' 7' ' ' THR . 0.7 OUTLIER -85.98 87.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.264 0.554 . . . . 0.0 109.626 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.896 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.4 p -101.94 140.18 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.609 ' HG2' HG23 ' A' ' 7' ' ' THR . 56.5 mtm180 -87.97 103.18 15.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.802 ' CD2' HG23 ' A' ' 60' ' ' VAL . 11.8 mt -91.76 139.01 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.64 131.98 47.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.244 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 57' ' ' ILE . 14.2 m . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.855 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.665 ' CE2' HD13 ' A' ' 58' ' ' LEU . 3.7 m-30 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.703 0.287 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.1 144.57 38.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.085 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 43.9 mt-10 -102.33 144.69 30.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.982 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.19 109.39 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 111.563 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.836 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.33 121.53 23.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.012 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -132.27 128.2 37.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 5.7 pt-20 -86.96 100.9 12.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.57 ' CG ' HD23 ' A' ' 15' ' ' LEU . 6.6 mtp180 -43.72 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.935 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.433 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.042 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.012 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.2 mt . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.727 0.299 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 135.67 39.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.484 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.789 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.5 p90 -161.79 137.31 7.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.986 0.393 . . . . 0.0 110.708 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.8 134.33 40.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.624 -179.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.04 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.51 146.92 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.588 0.709 . . . . 0.0 111.684 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -127.37 121.57 31.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.464 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 140.69 159.62 8.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.007 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.455 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 148.86 175.59 21.47 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.359 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 68' ' ' VAL . 25.0 p -66.71 -11.69 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 23.7 t70 -114.62 -26.59 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.44 87.2 54.41 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.57 66.21 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.301 2.001 . . . . 0.0 112.579 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.753 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.8 t60 -48.43 -27.81 2.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.376 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.981 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -87.13 -155.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.437 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -52.83 -51.7 43.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.964 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.958 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.52 175.73 3.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.99 35.41 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.671 2.247 . . . . 0.0 112.445 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -84.84 114.77 22.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 110.903 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.926 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.69 118.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.066 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.981 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.15 148.03 37.61 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.344 0.593 . . . . 0.0 110.719 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.028 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.39 155.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.516 -177.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.13 -29.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.163 -178.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.34 130.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.785 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.983 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.62 132.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.466 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 125.56 71.71 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.1 Cg_endo -68.05 132.55 26.52 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 112.365 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.33 19.26 21.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.346 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.86 179.12 16.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.349 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.39 -33.31 59.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.653 0.263 . . . . 0.0 111.479 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.823 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -73.36 -56.0 5.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.45 -29.08 63.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.4 pt20 -72.19 -31.85 66.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.274 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.88 -57.94 3.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.4 11.9 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.592 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.67 -15.76 13.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.766 0.283 . . . . 0.0 110.863 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.028 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -113.9 153.37 29.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.21 0.529 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.99 136.28 48.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.574 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.2 t -49.08 157.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.363 0.601 . . . . 0.0 111.543 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER 76.82 -1.04 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.302 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -66.51 124.52 23.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.54 100.48 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.55 0.691 . . . . 0.0 111.432 -178.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 19' ' ' ILE . 27.4 mt -48.3 135.61 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.596 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' A' ' 3' ' ' TYR . 3.0 pp -139.92 12.79 2.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 170.82 134.74 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.317 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.799 HG21 ' CB ' ' A' ' 76' ' ' ALA . 37.5 t -123.91 95.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.299 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.626 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.6 t-20 73.26 -60.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 27.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.475 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 40.8 t -121.27 109.11 24.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.993 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -70.48 120.81 16.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.512 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.727 HG21 HG22 ' A' ' 57' ' ' ILE . 22.1 m -93.99 20.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -22.63 66.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.116 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.26 44.18 1.89 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.059 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 23' ' ' THR . 16.7 m -124.41 145.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.036 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.506 ' HG1' ' HG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -66.07 153.65 41.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.558 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.9 t-160 -49.14 -34.2 13.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.744 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.506 ' HG ' ' HG1' ' A' ' 69' ' ' THR . 0.1 OUTLIER -70.86 -33.76 70.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.7 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.676 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.05 -31.67 69.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.926 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -71.56 -46.96 57.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.636 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 81.8 t -60.48 -50.54 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.283 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -58.33 -34.89 71.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.39 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.799 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -55.22 -49.34 72.22 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.426 0.631 . . . . 0.0 110.09 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.918 HD11 HD12 ' A' ' 19' ' ' ILE . 1.8 mt -59.65 -36.01 75.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.591 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.36 -21.95 52.51 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mt-10 -102.05 -6.33 23.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.684 0.278 . . . . 0.0 111.383 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.921 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -59.71 -17.74 37.04 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.251 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.0 -117.04 5.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.921 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 m -110.68 -89.29 0.5 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.836 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.1 tp -90.92 90.91 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.296 0.569 . . . . 0.0 109.732 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.921 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -103.89 138.29 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.05 102.89 15.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.788 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.1 mt -89.78 134.7 34.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -101.91 116.52 32.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.271 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.5 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.644 0.259 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -113.2 163.87 14.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 111.065 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 68.8 mt-10 -114.16 144.6 42.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.78 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.948 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -132.39 109.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.501 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.938 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.26 120.67 23.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.043 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -132.29 127.22 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.6 pt-20 -85.9 100.84 12.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.192 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.588 ' CG ' HD23 ' A' ' 15' ' ' LEU . 9.7 mtp180 -42.77 91.85 0.0 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.35 0.595 . . . . 0.0 110.835 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.56 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.117 -179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.043 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.9 mt . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 120.781 0.324 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 131.97 38.25 0.26 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.594 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.801 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -160.44 135.36 7.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.006 0.403 . . . . 0.0 110.729 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.41 136.84 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.525 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.065 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.21 148.84 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.743 0.783 . . . . 0.0 112.337 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -143.25 133.22 24.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.12 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.89 -2.95 1.24 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.184 -1.007 . . . . 0.0 113.879 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.552 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.04 -173.16 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.951 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.802 HG22 ' CB ' ' A' ' 32' ' ' PRO . 19.9 p -73.09 -20.9 60.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -96.35 -24.61 16.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.585 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.36 87.52 53.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.211 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.73 63.17 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.384 2.056 . . . . 0.0 112.652 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.4 t60 -49.78 -26.58 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.842 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.15 -154.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.323 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.91 -50.04 71.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.615 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.72 40.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.09 169.19 12.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.802 ' CB ' HG22 ' A' ' 23' ' ' THR . 98.0 Cg_endo -79.35 3.5 7.42 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.566 2.178 . . . . 0.0 112.74 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -53.61 111.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.883 0.373 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.838 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.55 119.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.838 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.842 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.23 147.22 36.15 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 121.361 0.601 . . . . 0.0 110.779 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.96 155.6 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.803 -177.011 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.451 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.6 -29.53 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.286 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.99 130.19 0.49 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.001 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.003 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.5 131.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.481 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 124.33 74.25 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.0 Cg_endo -66.2 132.58 30.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.348 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.81 17.46 25.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.437 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 177.39 17.27 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.042 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.68 -32.76 52.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 111.444 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.812 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -71.55 -57.3 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.799 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.15 -29.02 63.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.477 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -71.95 -33.32 68.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.148 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -79.37 -58.05 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.38 39.97 10.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.592 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.468 ' CB ' HG12 ' A' ' 6' ' ' ILE . 19.2 mmt180 -115.88 -4.75 12.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 110.814 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 6.1 tp -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.589 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 134.55 42.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.487 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.09 157.5 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.319 0.58 . . . . 0.0 111.681 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER 77.01 -1.61 2.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.174 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.17 125.55 26.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.653 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.26 12.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.753 0.787 . . . . 0.0 111.435 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.065 HD11 HG21 ' A' ' 19' ' ' ILE . 65.8 mt -47.35 138.35 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.887 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.508 HD11 HH21 ' A' ' 66' ' ' ARG . 0.2 OUTLIER -117.31 -44.42 2.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.073 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -142.52 167.14 22.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.771 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 86' ' ' LEU . 23.4 t -142.22 97.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.788 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.501 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.8 t-20 67.57 -67.99 0.17 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.093 0.473 . . . . 0.0 109.775 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.2 tt0 -155.71 33.71 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.481 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.1 t -120.73 142.49 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.636 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.7 p-10 -106.95 111.23 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.29 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HB ' HD12 ' A' ' 34' ' ' ILE . 18.2 m -95.32 31.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.801 0.334 . . . . 0.0 111.54 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.508 HH21 HD11 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -63.33 -29.16 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.766 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.85 65.91 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.729 ' O ' HG23 ' A' ' 23' ' ' THR . 27.2 m -136.19 147.12 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.274 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.54 153.01 33.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.0 t-160 -50.51 -33.75 22.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -34.02 73.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.756 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.29 -39.96 81.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.838 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.11 -46.99 78.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.6 t -57.02 -50.34 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.253 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.38 -30.69 63.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.026 178.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.672 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -60.44 -49.78 76.2 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.405 0.622 . . . . 0.0 109.908 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.996 HD11 HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -60.27 -34.76 74.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.48 -26.77 51.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.361 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.84 15.54 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.383 -178.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.22 16.28 6.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.172 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.98 -114.01 5.57 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.989 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.4 m -114.99 -89.36 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.938 HG13 HG22 ' A' ' 7' ' ' THR . 7.1 tp -86.77 97.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.993 0.425 . . . . 0.0 110.222 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.901 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -111.37 138.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.573 ' HG2' HG23 ' A' ' 7' ' ' THR . 7.2 mtt85 -88.16 103.24 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.8 mt -91.12 142.97 27.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.74 136.07 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.768 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 51' ' ' LEU . 17.2 m . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.42 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 20.6 m-85 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.778 0.323 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -144.42 147.46 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.968 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 39.6 mt-10 -104.63 144.74 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.963 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.23 109.26 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.033 0.444 . . . . 0.0 111.439 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.25 122.96 25.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.016 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.6 tp -134.23 127.05 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -82.4 100.43 10.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.542 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -50.33 92.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.514 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.286 -179.173 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.016 ' HB3' HD23 ' A' ' 8' ' ' LEU . 8.4 mt . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 120.733 0.302 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 138.2 39.12 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.632 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.795 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.8 p90 -160.17 134.29 7.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.093 0.446 . . . . 0.0 110.764 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.68 133.43 37.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.071 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.67 162.98 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.711 0.767 . . . . 0.0 111.632 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.687 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -160.36 132.61 6.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.357 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 -2.8 1.47 Allowed Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.464 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.74 -175.57 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.138 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 32.2 p -67.97 -29.1 68.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.78 -20.49 20.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -124.17 87.02 53.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.71 61.74 0.86 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.354 2.036 . . . . 0.0 112.645 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 28.8 t60 -47.57 -29.09 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.033 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.847 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.74 -155.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.194 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.67 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.88 -49.52 47.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.46 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -178.17 49.01 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.897 0.379 . . . . 0.0 111.231 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.08 159.16 70.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CB ' HG22 ' A' ' 23' ' ' THR . 96.6 Cg_endo -79.1 3.41 7.45 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.647 2.232 . . . . 0.0 112.691 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.43 119.43 5.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.976 0.417 . . . . 0.0 110.931 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.856 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.71 119.19 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.567 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.24 144.71 33.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.48 0.657 . . . . 0.0 110.783 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.056 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.74 155.94 7.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.311 -176.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.455 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.12 -29.82 4.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.343 -178.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.646 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.97 131.57 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.931 -179.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.955 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.471 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.37 115.3 59.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.5 Cg_exo -58.11 136.48 75.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.697 2.265 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 19.96 27.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.48 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.48 179.54 16.83 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.175 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.65 -36.55 57.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.859 0.361 . . . . 0.0 111.531 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -68.86 -57.41 5.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.2 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.55 -28.39 62.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.781 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -29.91 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.257 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.498 ' OD2' HD12 ' A' ' 8' ' ' LEU . 5.2 m-20 -82.49 -57.86 3.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.88 37.19 11.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.602 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.443 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtt180 -112.33 -14.43 13.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.713 0.292 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.056 HD21 HD12 ' A' ' 36' ' ' ILE . 7.1 tp -113.75 156.82 23.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.267 0.556 . . . . 0.0 111.374 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.616 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -135.09 134.66 40.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.413 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 38' ' ' LYS . 52.9 t -49.04 157.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.248 0.547 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.485 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 75.15 2.51 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.091 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.62 127.07 31.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.48 102.5 14.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 111.306 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.071 HD11 HG21 ' A' ' 19' ' ' ILE . 57.3 mt -49.7 131.2 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.814 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 3.4 mm? -109.63 -43.17 4.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.106 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -143.16 164.94 28.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.813 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.747 HG11 ' HB1' ' A' ' 76' ' ' ALA . 21.4 t -143.61 98.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.991 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 68.09 -66.89 0.21 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.126 0.488 . . . . 0.0 109.992 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -157.65 33.24 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.687 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.7 t -120.73 142.4 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.582 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.1 t0 -109.04 95.29 5.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.337 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 65' ' ' VAL . 27.4 m -80.28 58.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 0.0 111.48 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -85.22 -31.52 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.757 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.68 52.69 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 27.3 m -121.16 148.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.06 153.4 43.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 t-160 -49.44 -34.1 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.792 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.9 m -68.71 -34.09 75.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.785 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.35 -42.05 79.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.856 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.4 -46.91 84.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.661 0.743 . . . . 0.0 109.076 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.5 t -57.31 -50.39 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.231 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.82 -29.89 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.864 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.747 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.14 -50.22 74.09 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.305 0.574 . . . . 0.0 109.847 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -58.78 -36.31 74.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.955 179.115 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.61 -25.16 49.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.452 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.53 16.38 26.53 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.32 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.38 16.3 5.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.241 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.35 -98.32 0.82 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.063 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 8.5 p -136.4 -90.38 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 7' ' ' THR . 8.5 tp -83.37 88.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 109.875 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.2 p -104.14 139.6 24.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.87 103.06 15.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.744 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.2 mt -90.96 141.17 29.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.442 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.85 138.48 38.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 51' ' ' LEU . 13.0 m . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.41 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 78.1 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.791 0.329 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HG2' HG23 ' A' ' 88' ' ' VAL . 2.6 pt-20 -138.32 167.24 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 5.6 tt0 -121.18 144.64 48.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.991 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.13 109.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.866 0.365 . . . . 0.0 111.739 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -82.02 112.19 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.991 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -121.68 127.31 50.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.9 pt-20 -83.83 100.54 11.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.07 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.72 89.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.078 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.238 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.556 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.5 tp . . . . . 0 N--CA 1.457 -0.09 0 N-CA-C 110.731 -0.1 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.28 22.05 1.01 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 119.745 -1.216 . . . . 0.0 114.809 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.875 ' CE2' HD23 ' A' ' 15' ' ' LEU . 10.5 p90 -161.4 136.51 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.035 0.918 . . . . 0.0 111.143 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.42 135.22 38.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.656 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.09 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.44 146.93 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.628 0.728 . . . . 0.0 111.367 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.83 124.07 34.41 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.706 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.85 -121.81 1.07 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.074 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 69.54 172.22 9.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.361 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 32' ' ' PRO . 4.3 p -77.85 -5.55 51.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.17 -23.14 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.516 ' O ' ' O ' ' A' ' 21' ' ' GLY . 2.6 t-20 -124.91 85.96 56.95 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.488 0.185 . . . . 0.0 110.57 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.153 1.902 . . . . 0.0 112.425 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.733 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.1 t60 -53.8 -24.36 15.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.053 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.841 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.79 -153.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.337 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.682 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -65.35 -47.62 77.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.757 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.19 79.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 110.676 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -172.75 164.01 3.69 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.67 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.827 ' HB2' HG22 ' A' ' 23' ' ' THR . 96.0 Cg_endo -79.7 50.94 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.503 2.135 . . . . 0.0 112.174 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -99.28 116.65 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.873 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -89.99 112.49 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.459 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -137.31 146.76 45.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.125 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.103 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.05 155.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.169 -176.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.52 -30.36 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.04 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.12 131.04 0.48 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.031 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.98 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.88 132.8 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 115.26 59.32 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.3 Cg_exo -57.19 134.45 64.19 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.824 2.349 . . . . 0.0 112.201 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.25 4.02 59.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.642 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.55 179.39 22.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.801 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.66 -37.61 68.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.807 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.35 -57.45 6.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.56 -28.84 68.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.296 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.35 68.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 110.001 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.631 ' OD2' HD12 ' A' ' 8' ' ' LEU . 24.0 m-20 -82.86 -58.02 3.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.559 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 40.88 9.22 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.539 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER -115.6 6.98 14.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.94 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.103 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -135.24 154.76 51.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.993 0.425 . . . . 0.0 110.843 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.584 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.09 137.07 47.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.7 t -51.6 159.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.138 0.494 . . . . 0.0 111.716 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.4 m120 71.95 3.68 4.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.32 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.654 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.7 m-20 -74.63 128.37 35.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.85 105.25 16.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.564 0.697 . . . . 0.0 111.388 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.09 HD11 HG21 ' A' ' 19' ' ' ILE . 68.5 mt -51.09 141.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.602 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.41 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -121.61 -44.31 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.496 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -143.18 148.61 36.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.335 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.916 HG13 ' CD2' ' A' ' 86' ' ' LEU . 54.5 t -139.54 112.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.026 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 50.81 35.8 13.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.129 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 80.23 33.94 0.16 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.501 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 60' ' ' VAL . 78.1 t -120.93 108.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 t0 -71.26 117.18 12.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.713 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 57' ' ' ILE . 33.8 m -101.89 23.45 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.301 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -62.84 -25.52 68.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -146.07 57.4 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.181 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.782 ' C ' HG23 ' A' ' 23' ' ' THR . 31.8 m -132.79 141.83 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.231 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.68 152.35 26.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.84 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 20.1 t-160 -47.99 -34.02 8.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.883 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -34.24 77.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.681 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.27 -40.62 77.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.873 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.0 -46.93 82.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.9 t -56.09 -50.86 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.391 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.681 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.76 -29.29 62.45 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.153 178.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.11 -56.72 18.18 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.359 0.6 . . . . 0.0 110.044 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 73' ' ' ALA . 2.0 mp -53.86 -36.4 62.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.34 -27.29 52.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.659 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.26 15.67 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.0 111.47 -178.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.991 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.81 16.32 4.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.316 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.03 -89.33 0.13 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.384 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -143.44 -88.87 0.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.763 HG13 HG22 ' A' ' 7' ' ' THR . 4.2 tp -84.4 91.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.991 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.4 p -107.06 135.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.1 ptt180 -86.81 102.96 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.916 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.8 mt -91.63 143.56 26.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.083 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CD1' ' HG3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -101.68 139.71 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.523 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG21 ' OD2' ' A' ' 55' ' ' ASP . 28.9 m . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.805 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.451 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 36.1 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.769 0.318 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 133.31 21.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -97.17 144.61 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.076 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.0 109.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.863 0.364 . . . . 0.0 111.833 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.796 HG23 HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -79.83 114.55 18.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.076 HD13 HD11 ' A' ' 6' ' ' ILE . 5.6 tp -120.78 127.05 51.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.819 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.73 ' N ' HD12 ' A' ' 83' ' ' ILE . 3.8 pt-20 -80.59 99.92 8.36 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -56.44 88.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.901 178.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.248 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.225 -179.012 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.982 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.5 tp . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.306 0.098 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 126.6 25.19 1.3 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.849 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.843 ' CE2' HD23 ' A' ' 15' ' ' LEU . 4.5 p90 -161.82 134.75 6.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.854 0.827 . . . . 0.0 111.256 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.67 134.16 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.105 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.96 168.26 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.686 0.755 . . . . 0.0 111.677 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -165.43 132.2 2.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.319 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.4 0.54 1.16 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.545 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.562 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.015 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.777 HG22 ' CB ' ' A' ' 32' ' ' PRO . 16.6 p -74.42 -22.45 59.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -97.18 -23.76 16.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.693 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.32 87.7 53.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.365 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.84 63.16 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.339 2.026 . . . . 0.0 112.742 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.718 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.0 t60 -47.53 -28.47 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.859 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.85 -155.1 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.239 179.46 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.47 -47.49 56.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.597 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.8 t0 177.23 76.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.37 165.26 7.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.861 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.777 ' CB ' HG22 ' A' ' 23' ' ' THR . 89.9 Cg_endo -81.12 6.68 5.42 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.657 2.238 . . . . 0.0 112.79 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.39 112.17 1.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.52 119.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.585 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.859 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.44 146.0 34.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.522 0.677 . . . . 0.0 110.668 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.049 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.79 155.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.415 -176.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.21 -30.46 4.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.347 -178.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.45 132.21 0.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.051 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.99 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.88 132.0 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.435 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.3 118.12 70.41 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.506 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.8 Cg_exo -58.01 135.29 67.72 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.363 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.1 3.02 62.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.845 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.77 178.49 23.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.057 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.58 -34.62 64.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.011 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.793 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -71.82 -56.92 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.679 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.19 -30.28 70.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.94 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 3.0 pt20 -72.06 -33.45 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -57.93 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.71 9.16 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.614 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.485 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.2 mtp85 -113.27 8.12 17.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.804 0.335 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.049 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -136.65 154.73 50.56 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.053 0.454 . . . . 0.0 110.816 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 tpm_? -131.76 136.3 47.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -51.58 157.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 111.564 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.2 t30 74.07 3.15 4.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.177 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.664 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -73.73 127.0 31.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.42 100.97 12.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.659 0.743 . . . . 0.0 111.296 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.105 HD11 HG21 ' A' ' 19' ' ' ILE . 62.5 mt -46.24 149.51 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.813 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -127.62 -45.71 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.387 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -143.03 157.78 44.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.081 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.85 HG11 ' HB1' ' A' ' 76' ' ' ALA . 41.7 t -132.55 95.73 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.873 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.9 t-20 68.85 -66.93 0.23 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.166 0.508 . . . . 0.0 109.896 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -155.59 32.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.654 179.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 86.4 t -120.7 142.2 37.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.512 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 24.5 t0 -107.86 112.15 24.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 23.8 m -94.18 36.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 111.513 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -65.07 -31.54 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.721 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.28 68.09 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.713 ' O ' HG23 ' A' ' 23' ' ' THR . 27.0 m -137.62 145.05 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.281 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.2 150.56 34.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.757 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.7 t-160 -48.1 -33.78 8.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.75 -34.1 76.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.027 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.67 -39.91 80.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.82 -46.92 76.81 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.646 0.736 . . . . 0.0 109.081 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 70' ' ' HIS . 97.2 t -57.2 -50.55 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.206 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.57 -30.48 60.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.953 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.63 -50.57 72.97 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.41 0.624 . . . . 0.0 110.018 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.064 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -58.55 -37.17 75.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.045 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -26.41 50.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.505 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.43 18.89 20.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 0.0 111.306 -178.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.77 16.25 6.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.531 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.31 -86.69 0.41 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.635 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' LEU . 38.1 m -147.67 -90.87 0.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.796 HD11 HG23 ' A' ' 7' ' ' THR . 8.4 tp -84.17 90.68 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.452 0.644 . . . . 0.0 109.743 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.949 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.8 p -105.92 135.06 45.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.294 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.6 ttt180 -85.21 102.89 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.565 HD12 ' HZ ' ' A' ' 17' ' ' PHE . 15.3 mt -92.05 140.9 29.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.969 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.55 141.18 34.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.713 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.664 HG21 ' OD2' ' A' ' 55' ' ' ASP . 25.1 m . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.581 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 4.6 m-30 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.828 0.347 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -151.18 146.15 25.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.8 pt-20 -100.74 144.57 29.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.978 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.45 110.0 9.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.895 0.379 . . . . 0.0 111.521 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.909 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -76.92 121.48 23.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.03 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.4 tp -134.22 127.1 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 83' ' ' ILE . 4.1 pt-20 -85.89 100.88 12.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.344 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.634 ' CG ' HD23 ' A' ' 15' ' ' LEU . 8.0 mtp-105 -44.94 92.37 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.22 0.533 . . . . 0.0 110.897 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.315 -0.608 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.13 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.03 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.3 mt . . . . . 0 N--CA 1.455 -0.221 0 CA-C-O 120.84 0.353 . . . . 0.0 110.793 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.77 39.17 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.086 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.9 p90 -162.51 132.38 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.345 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -92.48 137.29 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.134 0.492 . . . . 0.0 111.724 -179.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -120.3 142.11 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.661 0.744 . . . . 0.0 111.95 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.583 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -106.06 117.2 33.41 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.814 ' HA2' HG23 ' A' ' 34' ' ' ILE . . . -71.21 -158.72 3.09 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.44 -44.09 0.12 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.734 -0.746 . . . . 0.0 114.571 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.759 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -69.02 -58.9 3.47 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 4.0 m-20 -81.67 -34.2 30.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.09 0.471 . . . . 0.0 110.52 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' HIS . 11.1 t-20 -124.44 87.7 53.92 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.248 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.75 64.98 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.288 1.992 . . . . 0.0 112.538 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.76 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.3 t60 -57.53 -21.82 40.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.724 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.764 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -96.61 -150.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.688 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -85.19 44.22 3.35 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.885 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 76.18 30.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.961 0.41 . . . . 0.0 110.738 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.47 146.92 38.56 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CB ' HG22 ' A' ' 23' ' ' THR . 74.4 Cg_endo -74.9 55.27 3.84 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.52 2.146 . . . . 0.0 112.508 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -121.01 108.88 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.964 HD11 ' O ' ' A' ' 68' ' ' VAL . 2.7 mp -79.49 131.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.764 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -142.89 152.82 42.5 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.213 0.53 . . . . 0.0 110.27 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.888 HD12 HD21 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -69.41 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.553 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.521 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.08 -26.12 4.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.978 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -176.53 131.73 0.21 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.868 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.8 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.49 130.37 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.36 114.16 53.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.1 Cg_exo -56.22 139.96 86.8 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.599 2.199 . . . . 0.0 112.205 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.2 15.24 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.522 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.55 174.69 16.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.986 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -30.64 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.251 . . . . 0.0 111.129 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.836 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -72.94 -57.52 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 111.823 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.66 -28.58 63.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.535 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -72.02 -30.84 65.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 110.382 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 8' ' ' LEU . 2.5 m-20 -80.53 -57.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.16 37.0 10.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.711 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -118.95 4.57 11.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.821 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 36' ' ' ILE . 16.3 tp -132.73 159.81 38.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.218 0.532 . . . . 0.0 111.173 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.595 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -139.44 152.77 47.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 38' ' ' LYS . 77.8 t -65.75 158.9 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.054 0.454 . . . . 0.0 111.271 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 53' ' ' VAL . 55.3 m-80 77.27 -6.35 2.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.714 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -64.44 125.86 25.99 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.87 104.39 16.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.611 0.719 . . . . 0.0 111.773 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.03 HG22 HG21 ' A' ' 65' ' ' VAL . 46.1 mt -48.2 138.89 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.794 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.667 ' C ' HG22 ' A' ' 65' ' ' VAL . 1.1 mt -126.4 -37.75 2.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.471 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -147.17 156.67 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.917 HG13 ' CD2' ' A' ' 86' ' ' LEU . 47.8 t -141.21 102.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.232 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.443 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 66.95 -68.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.098 0.475 . . . . 0.0 110.247 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.86 31.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.929 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.8 t -120.79 142.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.281 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.8 p-10 -101.65 108.18 19.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.03 HG21 HG22 ' A' ' 57' ' ' ILE . 26.7 m -97.26 30.72 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.311 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.53 -37.45 75.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 110.725 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.25 56.32 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.505 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.964 ' O ' HD11 ' A' ' 34' ' ' ILE . 33.6 m -114.59 141.03 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.159 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.759 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 1.8 p -51.06 150.16 3.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.223 0.535 . . . . 0.0 112.0 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.803 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -47.09 -32.99 4.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.527 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 3.6 m -73.81 -33.31 64.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.387 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.66 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.79 -32.12 70.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.042 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.92 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.55 -46.89 58.2 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.0 t -60.29 -50.66 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.733 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.7 pt-20 -58.31 -31.48 67.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.497 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.786 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -58.39 -49.26 77.9 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.308 0.575 . . . . 0.0 109.795 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.814 ' CD1' HD12 ' A' ' 19' ' ' ILE . 1.5 mt -61.25 -34.67 75.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.186 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.14 -29.06 54.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.512 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.7 pt-20 -98.79 15.39 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.525 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.57 16.3 6.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.35 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.21 -114.76 6.57 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.078 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.9 OUTLIER -113.59 -88.87 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.894 HG13 HG22 ' A' ' 7' ' ' THR . 7.1 tp -86.72 100.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.122 0.487 . . . . 0.0 110.113 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -114.96 139.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.909 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.3 103.02 15.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.917 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.2 mt -91.84 137.22 32.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.511 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.87 131.56 48.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.5 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.134 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.755 ' CE2' HD22 ' A' ' 58' ' ' LEU . 3.0 m-30 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.751 0.31 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -115.16 165.02 13.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 111.251 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -120.0 145.01 47.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.836 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.15 110.98 14.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 111.931 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.924 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.35 117.15 20.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 5.1 tp -128.28 126.83 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.0 pt-20 -85.24 100.45 11.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.537 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.0 88.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.15 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.703 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.005 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.2 tp . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.361 0.124 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.77 21.95 0.97 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.65 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.866 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.8 p90 -161.42 137.46 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.736 0.768 . . . . 0.0 111.055 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.04 133.21 40.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.38 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.055 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.03 165.06 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.657 0.741 . . . . 0.0 111.76 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -162.64 132.11 4.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.262 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.84 0.66 0.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.42 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.15 -170.7 0.34 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.859 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.844 HG22 ' HB3' ' A' ' 32' ' ' PRO . 23.9 p -69.81 -32.62 71.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.79 -19.72 23.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.14 86.79 53.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.633 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.59 60.2 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.292 1.995 . . . . 0.0 112.547 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.675 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.8 t60 -47.8 -28.71 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.145 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.844 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.23 -153.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.14 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.677 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -66.29 -47.83 68.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.413 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.32 46.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.349 . . . . 0.0 110.835 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.97 161.74 61.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.844 ' HB3' HG22 ' A' ' 23' ' ' THR . 7.5 Cg_exo -73.03 -2.78 12.54 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.864 2.376 . . . . 0.0 112.689 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -49.16 113.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.929 0.395 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.832 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -85.7 119.19 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.46 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.844 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.46 146.45 34.8 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.526 0.679 . . . . 0.0 110.794 178.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.075 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.92 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.954 -176.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.19 -28.68 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.337 -178.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.56 129.64 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.071 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.981 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.49 133.05 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.424 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 129.95 55.93 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 56.0 Cg_endo -70.0 130.24 18.71 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.784 2.323 . . . . 0.0 112.304 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 2.65 55.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.64 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.49 179.23 24.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.078 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.79 -35.48 68.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 111.065 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.859 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -71.9 -56.75 5.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.82 -31.89 72.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.93 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.1 pt20 -72.11 -33.73 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 110.159 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.43 -57.91 3.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.01 41.27 9.65 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.627 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.524 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -113.31 7.02 17.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.947 0.403 . . . . 0.0 110.795 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.075 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -135.97 154.16 51.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.37 135.54 48.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -49.7 157.95 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.556 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.4 t30 75.05 2.18 3.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -70.45 123.37 21.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.53 100.42 12.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.889 0.852 . . . . 0.0 111.54 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 19' ' ' ILE . 20.0 mt -49.18 142.79 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.392 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.755 HD22 ' CE2' ' A' ' 3' ' ' TYR . 1.4 mt -124.54 -37.84 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.069 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 m-85 -143.8 164.3 30.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.887 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.8 t -151.54 103.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.26 42.46 31.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.86 32.68 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.599 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 88.9 t -120.92 112.75 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.417 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 t0 -80.8 110.43 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 65' ' ' VAL . 33.4 m -83.09 55.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.8 105.67 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.12 48.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' THR . 11.8 m -116.1 142.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.977 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -61.29 152.01 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.867 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 t-160 -49.6 -33.76 16.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.211 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.761 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.64 -43.22 80.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.89 -46.88 82.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.0 t -57.48 -48.45 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.285 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.88 -31.74 63.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.764 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.652 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.8 -53.11 61.83 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.211 0.529 . . . . 0.0 109.797 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.037 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -52.49 -37.44 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.262 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.57 -27.8 51.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.082 178.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.2 mm-40 -84.08 -19.97 33.41 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 110.602 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -53.03 -18.81 2.24 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.628 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.78 -92.75 1.83 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.8 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -129.99 -92.34 0.44 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.924 HG13 HG22 ' A' ' 7' ' ' THR . 8.8 tp -86.59 100.97 10.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.178 0.513 . . . . 0.0 110.442 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.936 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.4 p -116.06 138.77 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.2 102.87 14.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.887 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.2 mt -93.37 135.59 34.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.57 135.46 43.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.743 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 57' ' ' ILE . 19.0 m . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.808 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.408 ' CD1' HD11 ' A' ' 58' ' ' LEU . 11.2 m-30 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.746 0.308 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.9 mm-40 -145.13 168.29 20.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 0.0 111.287 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -118.05 144.79 45.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.88 110.53 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 111.653 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.841 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.48 120.5 22.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 4.2 tp -132.58 127.45 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.636 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.0 pt-20 -86.56 100.88 12.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.588 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.517 ' CG ' HD23 ' A' ' 15' ' ' LEU . 2.6 mtp-105 -42.76 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.994 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.418 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.061 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.005 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.5 mt . . . . . 0 N--CA 1.454 -0.239 0 CA-C-O 120.799 0.333 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 135.34 39.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.598 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.785 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.4 p90 -161.69 133.85 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.483 . . . . 0.0 111.161 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.492 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.08 134.62 34.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.287 -179.489 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.107 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.93 162.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.675 0.75 . . . . 0.0 111.731 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -158.76 131.76 7.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.046 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.51 -1.3 0.98 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.504 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.14 -168.93 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.94 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.848 HG22 ' HB3' ' A' ' 32' ' ' PRO . 12.2 p -77.09 -23.49 51.86 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -94.87 -25.32 16.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.329 . . . . 0.0 111.557 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 27' ' ' HIS . 23.6 m-80 -124.65 82.82 59.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.6 64.24 0.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.912 2.408 . . . . 0.0 112.66 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.746 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.4 t60 -50.68 -24.27 3.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.374 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.794 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.12 -154.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.633 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -80.1 52.48 4.27 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.733 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 74.76 30.53 0.99 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -117.08 147.76 40.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.848 ' HB3' HG22 ' A' ' 23' ' ' THR . 11.8 Cg_exo -70.76 -2.71 11.33 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.812 2.342 . . . . 0.0 112.88 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -53.99 116.55 2.62 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.035 0.445 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.865 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.84 120.19 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.375 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.794 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.52 144.93 33.17 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.456 0.646 . . . . 0.0 110.642 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.065 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.78 155.68 7.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.307 -176.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.67 -33.79 4.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.846 -178.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.52 142.49 2.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.517 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.005 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.19 132.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.321 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.96 125.17 73.54 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 46.2 Cg_endo -68.15 131.94 24.86 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.784 2.322 . . . . 0.0 112.413 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.04 27.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.27 178.96 16.37 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.203 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.35 -38.86 59.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.732 0.301 . . . . 0.0 111.461 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.793 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.98 -57.11 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.43 -30.32 65.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -72.08 -30.59 65.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.948 0.404 . . . . 0.0 110.354 179.67 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 -58.03 3.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.514 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.92 9.62 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.527 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 23.8 mtm180 -115.75 -3.99 12.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.808 0.304 . . . . 0.0 110.944 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.065 HD21 HD12 ' A' ' 36' ' ' ILE . 5.1 tp -122.57 153.94 38.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.883 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -131.8 135.86 47.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.865 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.41 158.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.307 0.575 . . . . 0.0 111.725 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.27 1.87 3.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.028 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -70.06 124.85 25.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.41 101.06 12.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.16 -178.694 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.107 HD11 HG21 ' A' ' 19' ' ' ILE . 55.8 mt -49.44 129.68 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.703 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 87' ' ' TYR . 7.9 mt -110.75 -31.7 7.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -151.05 166.42 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.3 t -148.91 100.45 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.219 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.649 ' OD1' HG23 ' A' ' 84' ' ' VAL . 14.0 t30 67.58 -67.31 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 110.065 -178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.0 mt-10 -157.92 32.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 49.5 t -119.57 142.21 36.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.529 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 30.1 t0 -111.65 84.96 2.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.362 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 65' ' ' VAL . 32.6 m -69.39 64.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.55 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -87.03 -28.09 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -151.31 59.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.688 ' O ' HG23 ' A' ' 23' ' ' THR . 34.5 m -127.78 145.38 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.261 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 150.66 27.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.822 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -48.29 -33.42 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -68.22 -34.04 75.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.072 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.11 -40.87 82.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.865 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.26 -46.84 81.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.0 t -57.74 -50.31 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.308 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -56.16 -34.31 66.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.647 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.618 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.58 -51.38 68.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.241 0.543 . . . . 0.0 110.109 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.021 HD11 HD12 ' A' ' 19' ' ' ILE . 2.9 mt -56.22 -36.43 68.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.416 179.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.2 mmmt -77.47 -24.62 50.18 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.33 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -95.81 -10.11 29.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 111.327 -178.858 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.91 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.81 -17.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.387 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.98 -109.76 3.74 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.8 m -118.84 -90.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.841 HG13 HG22 ' A' ' 7' ' ' THR . 7.9 tp -89.21 89.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.257 0.551 . . . . 0.0 109.735 178.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.91 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -103.54 140.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.497 ' HG3' HG23 ' A' ' 7' ' ' THR . 3.7 mtt180 -87.73 102.98 15.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.083 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.65 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.2 mt -91.89 137.67 32.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.109 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.68 134.39 44.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.091 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.6 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.154 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.469 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.3 m-30 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.771 0.319 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -132.65 160.61 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -107.37 144.67 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.044 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.04 109.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.91 0.386 . . . . 0.0 111.507 179.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.883 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.22 119.08 20.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.044 HD13 HD11 ' A' ' 6' ' ' ILE . 5.5 tp -130.81 127.33 38.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -86.68 99.41 11.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.647 179.443 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -54.49 92.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.868 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--O 1.229 -0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 114.597 -177.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.927 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 120.706 0.289 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 81.7 25.0 54.76 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.798 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -161.75 132.23 4.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.424 1.112 . . . . 0.0 111.857 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.53 138.75 32.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.83 -179.302 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.098 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.52 147.12 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.608 0.718 . . . . 0.0 111.939 179.756 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.673 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 134.4 31.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.183 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.9 -3.12 1.49 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.631 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.58 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.78 -176.19 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.045 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 68' ' ' VAL . 43.1 p -66.81 -30.33 70.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 9.6 t70 -93.56 -18.33 22.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 87.0 54.06 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.08 61.13 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.329 2.019 . . . . 0.0 112.606 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 30.7 t60 -48.34 -28.32 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.04 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.851 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -85.47 -154.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.218 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.666 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.44 -49.82 48.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.439 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -178.44 47.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.383 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.66 160.89 64.8 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.142 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CB ' HG22 ' A' ' 23' ' ' THR . 94.5 Cg_endo -78.51 2.46 8.09 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 112.749 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -53.49 117.31 3.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.004 0.43 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.69 118.51 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.71 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.25 147.51 40.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.362 0.601 . . . . 0.0 110.599 178.453 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.077 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.06 155.5 7.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.8 -176.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.07 -33.71 3.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.528 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 142.29 2.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.063 0.458 . . . . 0.0 111.679 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.005 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.23 128.62 60.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.05 127.54 66.41 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 19.4 Cg_endo -60.2 137.99 78.61 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.759 2.306 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.65 -0.46 82.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.454 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.44 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.71 -179.99 38.82 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.084 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.26 -40.5 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.518 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.907 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -73.05 -54.99 7.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.468 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -63.94 -28.96 70.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.283 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -72.35 -36.54 68.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.005 0.431 . . . . 0.0 110.069 179.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -57.93 2.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.07 39.27 8.06 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.751 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' CB ' HG12 ' A' ' 6' ' ' ILE . 69.6 mtt-85 -112.98 8.5 18.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.906 0.353 . . . . 0.0 110.711 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.077 HD21 HD12 ' A' ' 36' ' ' ILE . 4.2 tp -133.02 153.72 51.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.553 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.1 137.75 49.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.836 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -51.65 157.88 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 111.732 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.475 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.5 t-20 76.92 -2.4 2.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.491 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -67.04 124.89 24.3 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.043 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 t -86.63 100.37 12.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.572 0.701 . . . . 0.0 111.129 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.098 HD11 HG21 ' A' ' 19' ' ' ILE . 59.9 mt -49.15 140.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.899 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 88' ' ' VAL . 2.6 mp -121.71 -32.36 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.552 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -150.86 164.23 36.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.791 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.665 HG21 ' CB ' ' A' ' 76' ' ' ALA . 25.9 t -141.92 97.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.758 ' OD1' HG23 ' A' ' 84' ' ' VAL . 10.4 t30 69.6 -65.84 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.111 0.482 . . . . 0.0 109.875 -178.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -159.41 32.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.709 179.2 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.5 t -120.78 142.25 37.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.579 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -103.97 110.8 23.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.26 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 20.2 m -94.43 34.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -25.63 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.877 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -146.21 60.68 1.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.036 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.796 ' O ' HG23 ' A' ' 23' ' ' THR . 26.8 m -133.48 150.06 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.182 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -69.18 154.51 41.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.341 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.6 t-160 -49.85 -34.49 20.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 t -70.32 -34.02 72.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.24 -41.58 80.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.62 -46.67 84.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 70' ' ' HIS . 95.7 t -57.54 -50.45 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.0 -29.86 60.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.966 178.55 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.665 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -61.94 -51.23 68.96 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.023 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -55.89 -37.59 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.452 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.39 -25.13 50.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.913 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -91.8 3.01 56.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.174 -179.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.14 16.55 7.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.04 -124.91 35.11 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.728 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 m -100.45 -88.4 0.36 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.883 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -83.06 111.52 19.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -130.21 137.7 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.812 ' HG3' HG23 ' A' ' 7' ' ' THR . 24.4 mtt180 -84.93 103.12 13.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.626 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.5 mt -91.91 141.2 28.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -101.67 128.13 48.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.648 179.985 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.3 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD1' HD22 ' A' ' 58' ' ' LEU . 7.3 m-30 . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.856 0.36 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.43 151.8 37.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -102.84 144.71 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.972 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.69 109.36 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.405 179.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.968 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.68 121.23 23.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.133 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.052 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -131.24 127.23 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.669 ' N ' HD12 ' A' ' 83' ' ' ILE . 4.3 pt-20 -86.73 100.29 12.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.261 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.585 ' HG3' HD23 ' A' ' 15' ' ' LEU . 22.7 mtp85 -41.18 91.45 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.145 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.474 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.921 -179.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.052 ' HB3' HD23 ' A' ' 8' ' ' LEU . 17.9 mt . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.983 0.421 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 132.96 36.75 0.27 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.403 -0.904 . . . . 0.0 113.162 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -163.27 134.19 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.039 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.26 137.15 32.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.622 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.39 150.1 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.691 0.758 . . . . 0.0 112.02 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -143.64 132.85 23.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.971 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.96 0.88 0.74 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.871 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.492 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.74 -177.82 0.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.671 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.81 HG22 ' HB3' ' A' ' 32' ' ' PRO . 16.0 p -72.0 -21.55 61.54 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.01 -24.22 17.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.723 0.296 . . . . 0.0 111.501 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -124.36 87.3 54.13 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.59 65.03 0.54 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.292 1.994 . . . . 0.0 112.446 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.728 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 31.1 t60 -48.44 -27.88 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.469 179.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.849 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.62 -154.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.449 179.597 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.21 -47.82 56.44 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.664 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 t70 179.97 47.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.41 157.29 76.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.81 ' HB3' HG22 ' A' ' 23' ' ' THR . 6.1 Cg_exo -77.77 0.6 9.67 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.833 2.355 . . . . 0.0 112.693 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -53.32 120.57 6.19 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.124 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.826 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.61 120.19 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.339 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.849 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.66 146.75 36.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.346 0.593 . . . . 0.0 110.681 178.89 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.061 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.96 155.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.977 -176.774 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.89 -34.38 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.617 -179.175 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.629 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.07 143.5 3.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.5 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.996 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.83 131.77 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.292 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 120.74 75.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.883 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 29.3 Cg_endo -63.01 137.09 60.17 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.667 2.244 . . . . 0.0 112.279 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.99 14.85 50.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.372 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.09 177.14 16.34 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.14 -31.2 61.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.798 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -73.14 -57.4 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.611 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.91 -28.92 64.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.396 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.04 -32.63 67.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.48 ' OD2' HD12 ' A' ' 8' ' ' LEU . 11.7 m-20 -81.53 -58.04 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.692 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.86 39.89 9.16 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.482 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.444 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.3 mmt180 -116.11 1.57 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.061 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -129.56 154.92 46.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.128 0.489 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.563 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.2 ttt180 -133.43 136.02 44.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.686 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.0 t -49.88 157.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.589 . . . . 0.0 111.747 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.2 t-20 75.65 -1.75 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -66.11 125.01 24.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.5 103.31 14.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.533 0.682 . . . . 0.0 111.305 -178.76 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.033 HD11 HG21 ' A' ' 19' ' ' ILE . 51.3 mt -53.13 134.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.213 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD22 ' CD1' ' A' ' 3' ' ' TYR . 1.5 pp -134.79 13.56 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.884 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 169.98 138.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.169 0.509 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.5 t -127.39 97.36 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.611 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.752 ' ND2' HG23 ' A' ' 84' ' ' VAL . 1.7 t-20 70.95 -62.81 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -163.35 31.62 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.0 t -120.92 117.34 52.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -82.36 109.55 16.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.585 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -93.79 41.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.284 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -64.58 -35.52 81.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.835 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.11 71.67 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.739 ' C ' HG23 ' A' ' 23' ' ' THR . 9.3 m -136.49 142.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.44 156.23 10.7 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.313 0.578 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.9 p-80 -49.74 -34.1 18.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.635 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -69.76 -33.64 72.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.828 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -65.48 -45.05 85.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.29 0.567 . . . . 0.0 109.631 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.826 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.02 -45.67 91.23 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 70' ' ' HIS . 78.9 t -56.3 -50.36 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.033 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.614 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.52 -34.66 37.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.787 179.569 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.39 -57.37 5.99 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.323 -0.551 . . . . 0.0 112.074 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.861 HD12 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -60.32 -40.97 92.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.577 . . . . 0.0 110.237 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.614 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.75 -19.74 57.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.8 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -111.33 20.47 17.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.302 179.373 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.86 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -83.6 16.47 2.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.701 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.32 -101.87 0.87 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.4 m -123.7 -90.73 0.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.968 HG13 HG22 ' A' ' 7' ' ' THR . 6.2 tp -86.88 109.93 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.872 0.368 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.86 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.3 p -124.28 137.25 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.591 ' CG ' HG23 ' A' ' 7' ' ' THR . 11.6 mtt180 -85.94 103.58 14.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.909 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 17.4 mt -93.63 135.45 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.489 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.77 126.77 48.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.251 179.472 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 HD11 ' A' ' 51' ' ' LEU . 6.1 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.975 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.745 ' CE2' HD13 ' A' ' 58' ' ' LEU . 3.5 m-30 . . . . . 0 CA--C 1.527 0.076 0 CA-C-O 120.782 0.325 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -143.39 141.15 30.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 2.8 pt-20 -99.84 144.65 28.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.953 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.81 109.46 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.028 0.442 . . . . 0.0 111.362 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.877 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.23 119.46 22.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.858 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 6' ' ' ILE . 5.2 tp -127.63 126.79 42.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.6 pt-20 -84.97 100.57 11.73 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.306 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.86 88.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.226 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.517 0.218 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.659 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.927 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.2 tp . . . . . 0 N--CA 1.457 -0.112 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.88 19.36 1.15 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.572 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.86 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.6 p90 -162.04 134.52 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.816 0.808 . . . . 0.0 111.259 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.76 138.63 31.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.498 -179.336 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.062 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.25 147.25 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.672 0.748 . . . . 0.0 112.091 -179.923 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.12 132.3 26.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.062 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.24 -3.13 0.87 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.676 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.81 179.73 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.764 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.816 HG22 ' CB ' ' A' ' 32' ' ' PRO . 15.3 p -70.92 -20.06 62.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.84 -23.94 16.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.245 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -124.39 87.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.188 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 64.53 0.55 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.402 2.068 . . . . 0.0 112.649 -179.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 30.0 t60 -49.93 -27.34 5.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.243 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.855 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.91 -154.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.369 179.597 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.68 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -66.77 -47.32 68.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.659 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 177.52 46.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.29 159.86 70.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.816 ' CB ' HG22 ' A' ' 23' ' ' THR . 86.6 Cg_endo -78.51 1.66 8.83 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.665 2.244 . . . . 0.0 112.8 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.65 118.25 4.04 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.008 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.858 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.83 121.03 36.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.476 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.855 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.23 147.68 38.68 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.334 0.588 . . . . 0.0 110.808 178.529 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.042 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.45 7.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.757 -176.892 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.454 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.49 -33.55 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.612 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.85 142.11 1.86 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.627 -179.743 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.976 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.86 132.2 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.209 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.93 114.23 52.78 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.647 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.0 Cg_exo -56.36 139.03 85.9 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.723 2.282 . . . . 0.0 112.241 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 8.53 64.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.433 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.31 176.23 17.7 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.79 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.31 -36.35 61.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 111.199 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.755 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.81 -57.49 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.576 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.19 -28.91 66.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.325 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.93 -33.14 68.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -82.1 -57.98 3.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.77 40.74 9.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.552 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.502 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.4 mtp180 -117.74 8.21 12.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.811 0.339 . . . . 0.0 110.843 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.042 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -133.49 155.35 49.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.058 0.456 . . . . 0.0 110.804 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.68 136.1 44.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.757 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.2 t -51.77 157.79 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.533 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.3 -2.03 2.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.361 179.775 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -67.66 124.91 24.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.56 101.68 13.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.574 0.702 . . . . 0.0 111.424 -178.608 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.062 HD11 HG21 ' A' ' 19' ' ' ILE . 50.1 mt -51.59 133.43 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.661 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.745 HD13 ' CE2' ' A' ' 3' ' ' TYR . 1.1 pp -123.5 -19.48 5.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.781 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -159.49 147.76 17.58 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 111.027 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.882 HG13 ' CD2' ' A' ' 86' ' ' LEU . 38.8 t -130.22 99.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.033 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.663 ' ND2' HG23 ' A' ' 84' ' ' VAL . 1.5 t-20 67.65 -67.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.0 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.3 29.56 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.94 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 84.5 t -117.99 141.96 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.212 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.6 p30 -104.86 109.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.475 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 57' ' ' ILE . 33.0 m -96.7 32.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.52 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -62.42 -32.17 72.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.91 66.0 1.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.711 ' C ' HG23 ' A' ' 23' ' ' THR . 8.8 m -133.51 144.48 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.75 154.04 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.954 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.1 t-160 -49.61 -33.78 16.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.4 m -66.68 -33.92 76.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.65 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.603 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.0 -41.56 82.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.858 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.13 -46.22 81.86 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 70' ' ' HIS . 58.4 t -56.61 -50.42 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.022 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -52.12 -34.35 43.97 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.853 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.867 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.42 -57.53 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.927 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.882 HD12 HD12 ' A' ' 19' ' ' ILE . 1.5 mt -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.345 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.599 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.06 -20.32 55.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.048 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.5 pt-20 -110.43 21.36 16.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.905 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -83.93 16.57 2.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.778 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.8 0.28 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.862 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.499 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -137.87 -91.18 0.22 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.872 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.8 101.96 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.905 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -117.53 135.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.827 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.877 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.5 mtp180 -86.55 103.44 15.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.81 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.882 ' CD2' HG13 ' A' ' 60' ' ' VAL . 25.6 mt -94.06 133.59 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.295 -179.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.01 123.56 46.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.287 179.632 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.4 m . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.62 -179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 26.5 m-85 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.813 0.339 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -147.77 136.98 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.46 144.64 26.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.63 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.039 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.64 109.56 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.644 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.941 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 120.04 21.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.569 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.039 HD13 HD11 ' A' ' 6' ' ' ILE . 5.6 tp -130.82 126.86 37.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.589 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -84.49 99.73 10.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.039 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.62 87.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 179.155 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.196 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.65 -179.554 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.91 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.8 tp . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.805 0.336 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 72.17 31.0 64.38 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.802 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 4.7 p90 -164.5 129.74 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.075 0.937 . . . . 0.0 111.574 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -96.1 140.2 31.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.937 -179.116 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.021 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -120.19 147.03 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.763 0.792 . . . . 0.0 112.221 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.599 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.77 133.43 30.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.044 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.75 3.29 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.724 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.68 -177.87 1.37 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.658 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.826 HG22 ' HB3' ' A' ' 32' ' ' PRO . 25.2 p -67.25 -28.87 68.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -92.74 -19.59 21.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.614 0.245 . . . . 0.0 111.369 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -124.15 87.0 53.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.8 61.7 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.385 2.057 . . . . 0.0 112.795 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.729 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 50.4 t60 -49.78 -27.6 5.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.949 178.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.77 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.2 -152.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.355 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.24 52.54 4.53 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.733 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 74.6 32.07 0.92 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.927 0.394 . . . . 0.0 110.462 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -118.09 149.64 45.97 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.826 ' HB3' HG22 ' A' ' 23' ' ' THR . 9.8 Cg_exo -71.25 -4.47 15.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.753 2.302 . . . . 0.0 112.615 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.0 m -52.21 115.98 1.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 111.287 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.75 120.14 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.77 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.15 147.14 36.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.253 0.549 . . . . 0.0 110.692 178.994 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.054 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.07 155.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.841 -176.794 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.461 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.72 -30.26 4.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.176 -179.2 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.23 128.81 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.36 -179.524 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.76 126.64 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.691 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.26 119.19 72.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.684 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.1 Cg_exo -54.37 139.57 73.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.242 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.34 12.72 69.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.539 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.36 -157.59 21.72 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.97 -40.73 53.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.901 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -72.78 -54.44 8.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.13 -29.09 69.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -72.38 -39.17 68.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.119 0.485 . . . . 0.0 110.3 179.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 8' ' ' LEU . 2.4 m-20 -81.39 -57.87 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.848 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.23 37.0 10.22 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.561 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.474 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.82 -5.38 14.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.698 179.531 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.054 HD21 HD12 ' A' ' 36' ' ' ILE . 5.0 tp -119.93 154.06 34.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.547 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.31 137.18 47.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.901 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.4 t -51.98 157.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.264 0.554 . . . . 0.0 111.533 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.39 -1.28 3.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.359 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.7 m-20 -69.54 127.61 33.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.56 101.47 13.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.577 0.703 . . . . 0.0 111.428 -178.662 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.021 HD11 HG21 ' A' ' 19' ' ' ILE . 10.9 mt -48.07 139.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.84 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.9 mm? -116.6 -44.62 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.092 179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.2 m-85 -142.57 174.69 10.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.925 HG13 ' CD2' ' A' ' 86' ' ' LEU . 31.0 t -151.98 98.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.923 179.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.785 ' ND2' HG23 ' A' ' 84' ' ' VAL . 1.2 t-20 66.34 -68.23 0.14 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.226 0.536 . . . . 0.0 109.807 -178.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -155.2 31.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.8 t -117.77 142.41 32.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.596 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.5 p-10 -111.1 108.49 18.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 26.1 m -94.24 44.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.433 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -32.71 74.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.39 61.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.713 ' C ' HG23 ' A' ' 23' ' ' THR . 13.7 m -120.47 147.18 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -62.36 155.71 24.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 -179.071 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.917 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 p-80 -49.33 -34.28 15.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.787 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.7 p -70.19 -33.78 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.936 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.545 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.11 -45.73 80.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.265 0.555 . . . . 0.0 109.716 178.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.67 -45.5 92.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.1 t -56.47 -50.46 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.156 178.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.49 -34.36 35.44 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.924 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.697 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.84 -57.52 5.45 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.232 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.955 HD12 HD12 ' A' ' 19' ' ' ILE . 5.2 mt -61.51 -39.74 92.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.429 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.604 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.76 -19.84 57.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.544 179.608 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -110.61 17.75 20.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.129 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.861 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.8 16.54 1.4 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.702 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.55 -99.43 0.59 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.679 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.5 p -127.8 -91.59 0.49 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.941 HG13 HG22 ' A' ' 7' ' ' THR . 7.2 tp -84.27 106.19 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.061 0.457 . . . . 0.0 110.933 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.861 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.9 p -122.14 139.0 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.519 -178.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.928 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -85.95 103.76 14.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.916 178.812 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.925 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.0 mt -95.28 138.48 32.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.65 -178.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -102.07 141.56 34.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.462 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 51' ' ' LEU . 24.0 m . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.023 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.445 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 20.9 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.799 0.333 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.49 134.93 34.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.75 134.91 38.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.877 HG23 ' HB3' ' A' ' 50' ' ' ARG . 1.2 mt -129.36 109.29 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.263 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.998 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -76.95 123.07 25.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.841 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.97 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.2 tp -133.49 127.29 32.94 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.701 ' N ' HD12 ' A' ' 83' ' ' ILE . 1.4 pt-20 -85.37 103.39 14.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.819 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.627 ' CG ' HD23 ' A' ' 15' ' ' LEU . 10.1 mtp180 -47.58 92.96 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.319 0.581 . . . . 0.0 110.745 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.316 -0.538 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.935 -179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.97 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.9 mt . . . . . 0 N--CA 1.455 -0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 136.85 40.99 0.11 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.29 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.785 ' HB3' HG23 ' A' ' 39' ' ' ILE . 34.7 p90 -163.96 136.35 5.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.004 0.431 . . . . 0.0 111.25 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.01 132.72 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.397 -179.507 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.092 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -109.86 167.43 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.768 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.696 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -166.17 132.99 2.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.339 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.42 -1.88 1.23 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.437 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.53 -172.06 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.93 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.726 HG23 ' C ' ' A' ' 68' ' ' VAL . 8.5 p -75.18 -22.17 58.21 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -94.82 -25.55 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.417 -179.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -124.35 87.32 54.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.222 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.79 62.95 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.411 2.074 . . . . 0.0 112.763 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.699 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 28.4 t60 -48.01 -28.95 3.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.074 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.871 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.32 -155.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.143 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.32 -49.45 45.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.348 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -177.86 51.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.802 0.334 . . . . 0.0 111.175 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.21 159.91 64.4 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.076 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.685 ' CB ' HG22 ' A' ' 23' ' ' THR . 93.8 Cg_endo -80.48 5.49 6.06 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.711 2.274 . . . . 0.0 112.671 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -57.02 118.59 5.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.866 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.99 118.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.602 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.871 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.38 146.12 34.58 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.586 0.708 . . . . 0.0 110.79 178.824 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.79 156.01 7.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.294 -176.652 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.47 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.87 -30.24 4.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.395 -178.588 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.31 128.34 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.876 -179.368 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.808 ' CD1' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -96.84 132.18 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.619 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.483 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.3 113.82 50.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 54.3 Cg_exo -52.6 143.83 44.53 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.743 2.295 . . . . 0.0 112.482 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.51 83.03 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.85 176.68 20.77 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.111 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.49 -33.34 59.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.525 0.202 . . . . 0.0 111.389 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.839 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.29 -56.25 5.1 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.778 0.323 . . . . 0.0 111.488 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.83 -29.91 70.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.187 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -72.16 -31.81 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.934 0.397 . . . . 0.0 110.44 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -75.76 -57.87 3.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.063 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.62 32.11 19.74 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.422 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.877 ' HB3' HG23 ' A' ' 6' ' ' ILE . 51.9 mtt180 -115.23 -13.45 11.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.687 0.28 . . . . 0.0 110.96 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 36' ' ' ILE . 38.7 tp -112.57 162.4 15.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.183 0.516 . . . . 0.0 111.305 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.08 135.74 23.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.633 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.2 t -49.2 157.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 111.586 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER 74.24 2.39 4.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.255 -179.893 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.654 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.9 m-20 -72.12 127.11 31.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 10.4 p -86.61 100.02 12.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.552 0.691 . . . . 0.0 111.464 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.092 HD11 HG21 ' A' ' 19' ' ' ILE . 63.9 mt -45.25 149.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.055 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.445 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -128.91 -46.96 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.706 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -141.54 169.11 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.769 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 16.6 t -143.91 95.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.121 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.444 ' HB2' HG23 ' A' ' 84' ' ' VAL . 5.4 t-20 68.34 -66.69 0.22 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -156.54 32.47 0.32 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.134 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 60.8 t -119.02 142.54 33.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.776 -178.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.1 p30 -112.06 113.14 25.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.122 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 35.3 m -86.41 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.89 100.94 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' C ' HG21 ' A' ' 23' ' ' THR . 0.5 OUTLIER 68.77 52.51 0.55 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.726 ' C ' HG23 ' A' ' 23' ' ' THR . 29.1 m -122.26 143.43 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 179.508 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.08 150.33 25.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.7 t-160 -49.09 -33.34 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.37 -38.49 81.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -68.03 -46.91 69.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.639 0.733 . . . . 0.0 109.168 178.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 70' ' ' HIS . 78.2 t -57.81 -48.03 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.214 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.74 -36.31 69.6 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.594 178.572 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -55.34 -51.2 67.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 0.0 110.105 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.02 HD11 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.06 -35.7 67.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.3 mmmt -77.29 -23.28 51.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.484 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -96.81 2.54 51.96 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 111.418 -179.016 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.891 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -82.54 16.32 2.18 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.709 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.79 -119.18 16.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.9 t -104.97 -87.73 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.998 HG13 HG22 ' A' ' 7' ' ' THR . 5.2 tp -87.7 109.18 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.682 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.891 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 2.8 p -122.67 138.53 52.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.296 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.846 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.2 mtt-85 -86.72 102.86 14.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 8.2 mt -91.29 142.6 27.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.33 -178.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.415 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.92 139.08 38.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.782 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.654 HG21 ' OD2' ' A' ' 55' ' ' ASP . 13.8 m . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.724 179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 52.2 m-85 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.959 0.409 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.53 151.42 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 4.9 pt-20 -110.12 144.71 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.998 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.36 109.46 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.482 179.841 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.48 120.29 23.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.047 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.998 HD13 HD11 ' A' ' 6' ' ' ILE . 4.0 tp -130.71 127.96 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 pt-20 -85.4 101.05 12.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.004 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.523 ' CG ' HD23 ' A' ' 15' ' ' LEU . 5.0 mtp-105 -47.84 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.132 178.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.319 -0.386 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.228 -179.22 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.952 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.38 44.36 0.07 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.918 -1.134 . . . . 0.0 114.024 178.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.793 ' HB3' HG23 ' A' ' 39' ' ' ILE . 17.9 p90 -164.0 131.53 3.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.304 0.552 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -93.2 134.4 35.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.669 -179.089 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.038 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.19 172.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.795 179.957 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -168.96 132.29 1.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.288 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.34 1.08 0.94 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.652 179.593 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.55 -172.07 0.1 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.869 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.818 HG22 ' CB ' ' A' ' 32' ' ' PRO . 16.8 p -74.44 -21.72 59.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.448 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -97.0 -23.38 16.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 111.486 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.36 87.54 53.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.26 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.9 62.36 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.44 2.093 . . . . 0.0 112.738 -179.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.745 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.7 t60 -48.34 -28.08 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.104 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.82 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.325 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.48 -50.44 62.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.608 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.937 0.399 . . . . 0.0 110.747 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.9 168.48 13.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.818 ' CB ' HG22 ' A' ' 23' ' ' THR . 83.0 Cg_endo -81.86 9.02 4.11 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.727 2.284 . . . . 0.0 112.893 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -61.03 114.15 2.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.867 0.365 . . . . 0.0 110.65 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.849 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -81.85 119.84 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.45 143.41 32.59 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.683 0.754 . . . . 0.0 110.819 178.936 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.024 HD12 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -68.89 155.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.102 -176.495 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.487 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.44 -26.96 4.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.376 -178.525 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.25 131.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.005 -179.645 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.023 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.43 132.73 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.681 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.4 123.75 74.47 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.853 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.0 Cg_endo -66.88 133.8 32.56 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.747 2.298 . . . . 0.0 112.267 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.62 17.2 31.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.315 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.48 178.31 16.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.169 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.97 -34.02 58.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.779 0.323 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.844 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -71.21 -57.48 4.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.897 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.59 -28.79 65.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.336 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -71.73 -29.95 65.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.391 . . . . 0.0 110.312 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.433 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -81.99 -58.08 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.941 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.06 37.85 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.569 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.45 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.6 mtt85 -112.71 -17.23 12.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.716 0.293 . . . . 0.0 110.962 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 36' ' ' ILE . 6.4 tp -110.21 155.25 22.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.073 0.463 . . . . 0.0 111.222 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.52 135.12 45.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.801 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 38' ' ' LYS . 65.5 t -51.86 158.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.31 0.576 . . . . 0.0 111.636 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.1 t30 73.19 5.58 5.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.001 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.4 m-20 -76.82 128.12 34.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.47 100.17 12.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.621 0.724 . . . . 0.0 111.317 -178.701 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 16.1 mt -48.08 136.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.67 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.2 mm? -116.11 -44.86 2.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.6 m-85 -137.76 170.14 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.158 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.789 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.9 t -149.59 96.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.965 179.359 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.458 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.7 t-20 67.09 -68.22 0.15 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 109.805 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mt-10 -154.44 32.32 0.42 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.603 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.2 t -118.71 142.42 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.478 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.0 p-10 -113.42 96.27 5.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.446 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 65' ' ' VAL . 26.9 m -81.81 57.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.303 -179.712 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -79.93 -30.13 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.73 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -151.61 62.86 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.777 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.724 ' O ' HG23 ' A' ' 23' ' ' THR . 35.1 m -128.85 146.09 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.207 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.48 151.1 33.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.3 t-160 -48.33 -33.72 9.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.722 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -67.25 -34.36 77.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.08 -42.66 80.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.849 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.81 -46.5 89.26 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 70' ' ' HIS . 90.8 t -56.51 -50.8 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.364 178.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.24 -30.37 64.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.371 178.887 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.2 -49.83 75.58 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.293 0.568 . . . . 0.0 110.179 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.853 HD23 ' CD1' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -60.44 -34.55 74.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.907 179.298 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.13 -26.23 52.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.191 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -103.07 14.73 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.302 -178.775 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.892 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.87 0.74 33.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.61 -112.62 3.79 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.009 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.461 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.25 -90.54 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.997 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.96 HG13 HG22 ' A' ' 7' ' ' THR . 7.6 tp -87.87 87.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.218 0.532 . . . . 0.0 109.691 178.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.892 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 p -98.87 138.42 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 4.7 ttp180 -89.34 103.15 15.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.198 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.853 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.1 mt -91.7 140.31 29.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.91 142.76 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.99 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 51' ' ' LEU . 29.7 m . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.646 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CG ' HD13 ' A' ' 58' ' ' LEU . 2.3 m-85 . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.792 0.329 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.27 152.28 43.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 3.6 tt0 -106.76 144.6 33.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.986 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.094 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.2 109.45 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.501 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.05 119.29 20.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.851 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.094 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -130.55 127.6 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 7.5 pt-20 -83.85 100.53 11.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.659 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -44.48 88.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.174 179.193 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.52 0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.792 -179.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.061 ' HB3' HD23 ' A' ' 8' ' ' LEU . 17.3 mt . . . . . 0 C--O 1.225 -0.236 0 CA-C-O 121.017 0.437 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 106.99 39.49 1.98 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.362 179.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.808 ' HB3' HG23 ' A' ' 39' ' ' ILE . 15.8 p90 -161.4 130.33 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.036 0.418 . . . . 0.0 111.424 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.27 134.77 34.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.66 -179.415 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -112.21 167.95 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 111.766 179.893 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -165.84 131.44 2.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.464 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.64 0.97 0.9 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.588 179.6 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.53 -168.55 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.987 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.836 HG22 ' HB3' ' A' ' 32' ' ' PRO . 11.2 p -76.25 -23.8 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -23.61 16.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.753 0.311 . . . . 0.0 111.669 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.22 87.41 53.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.03 63.08 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.388 2.058 . . . . 0.0 112.629 -179.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.716 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 37.9 t60 -48.12 -27.86 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.308 179.027 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.83 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.71 -154.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.356 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.673 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -61.98 -49.01 79.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.588 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.31 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -125.17 163.46 37.83 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.836 ' HB3' HG22 ' A' ' 23' ' ' THR . 5.5 Cg_exo -79.14 3.41 7.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.978 2.452 . . . . 0.0 112.715 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.79 115.45 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 111.104 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.862 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.57 120.64 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.382 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.64 145.93 33.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.553 0.692 . . . . 0.0 110.567 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.051 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.86 155.8 7.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.275 -176.507 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.09 -30.72 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.253 -178.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.8 130.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.99 -179.419 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.021 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.03 131.56 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.518 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 126.32 69.88 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 28.8 Cg_endo -62.6 134.47 47.77 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.718 2.279 . . . . 0.0 112.415 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.13 4.74 61.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.7 -179.48 25.64 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.991 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -57.42 -34.87 69.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.518 0.199 . . . . 0.0 111.325 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.739 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.25 -55.63 5.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.84 -30.93 71.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.869 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.0 pt20 -72.13 -35.65 69.17 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.045 0.45 . . . . 0.0 110.1 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.46 -57.92 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.37 39.74 8.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.891 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.506 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -109.08 -4.65 16.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.578 179.476 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.051 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -123.7 154.67 39.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.693 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 4.4 tpt85 -132.63 136.39 46.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.835 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.44 157.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.482 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.1 t30 74.8 0.28 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.78 125.35 26.31 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.6 p -86.43 100.27 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.084 HD11 HG21 ' A' ' 19' ' ' ILE . 20.6 mt -50.76 136.01 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.911 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.489 HD13 ' CG ' ' A' ' 3' ' ' TYR . 7.8 mt -120.05 -28.13 5.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.705 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -153.4 156.14 37.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.034 0.445 . . . . 0.0 111.008 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.896 HG11 ' HB1' ' A' ' 76' ' ' ALA . 46.3 t -133.76 95.62 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.909 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.632 ' OD1' HG23 ' A' ' 84' ' ' VAL . 5.8 t30 67.78 -67.83 0.18 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.117 0.484 . . . . 0.0 110.031 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -153.4 31.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.739 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 65.7 t -119.44 142.19 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.355 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.1 p-10 -107.49 100.9 10.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 65' ' ' VAL . 22.9 m -86.87 53.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.493 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.84 -33.17 34.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.83 58.61 1.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.766 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.721 ' C ' HG23 ' A' ' 23' ' ' THR . 34.9 m -128.19 143.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.92 150.66 28.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.82 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.3 t-160 -48.29 -33.63 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.441 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.37 -34.06 75.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.96 179.633 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -38.57 81.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 109.453 178.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.67 -46.92 74.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.066 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 70' ' ' HIS . 92.5 t -57.55 -49.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.2 178.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.84 -34.04 67.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.688 178.65 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.74 -50.76 71.27 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.331 0.586 . . . . 0.0 109.906 179.332 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.15 -37.57 69.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.384 178.948 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER -77.33 -23.73 50.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.092 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.1 mm-40 -91.72 -17.05 26.01 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.971 0.415 . . . . 0.0 110.951 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.966 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.47 -19.87 10.85 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.295 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.99 -98.66 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.025 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 34.3 m -126.76 -91.38 0.51 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.76 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.2 tp -87.26 98.61 7.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.666 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.966 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 13.6 p -115.81 138.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.65 ' HG3' HG23 ' A' ' 7' ' ' THR . 7.2 mtt180 -85.83 103.14 14.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.274 177.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.6 HD11 ' CD1' ' A' ' 15' ' ' LEU . 14.3 mt -91.9 138.7 31.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.263 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.69 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.809 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 55' ' ' ASP . 21.5 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.683 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.447 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 10.3 m-85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.837 0.351 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.46 142.27 49.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.21 144.58 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.023 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.8 109.42 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.376 179.856 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.907 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.25 116.47 20.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.067 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.023 HD13 HD11 ' A' ' 6' ' ' ILE . 4.8 tp -124.14 126.74 46.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 pt-20 -87.46 100.27 12.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.564 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.87 87.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.229 179.283 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.215 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.49 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.934 ' HG ' HD23 ' A' ' 8' ' ' LEU . 2.3 tp . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.26 17.77 1.39 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.529 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.861 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.9 p90 -160.7 135.73 7.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.965 0.882 . . . . 0.0 111.196 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.9 139.3 32.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.376 -179.477 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.007 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.75 147.95 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.887 0.851 . . . . 0.0 112.359 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.11 133.2 27.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.055 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.14 2.92 0.68 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.798 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.09 -176.52 0.84 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.682 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.85 HG22 ' HB3' ' A' ' 32' ' ' PRO . 25.2 p -67.53 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.11 -21.05 21.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -124.38 87.02 54.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.671 0.272 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.81 62.62 0.91 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.332 2.021 . . . . 0.0 112.585 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 38.5 t60 -47.45 -28.66 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.413 179.023 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.836 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.01 -154.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.281 179.531 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -61.31 -49.23 79.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.6 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.99 39.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.38 163.5 38.02 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.85 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.9 Cg_exo -76.73 1.47 8.5 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.984 2.456 . . . . 0.0 112.773 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.77 115.52 2.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.17 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.87 119.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.482 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.836 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.52 147.81 38.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.427 0.632 . . . . 0.0 110.869 178.776 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.997 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.953 -176.85 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.71 -31.37 4.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.217 -179.014 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.57 131.1 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.226 -179.42 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.984 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.96 130.89 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.594 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.457 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.13 114.03 51.86 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 42.4 Cg_exo -56.95 139.31 89.37 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.726 2.284 . . . . 0.0 112.378 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 12.75 59.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.431 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.69 179.36 16.87 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.919 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.7 -38.61 69.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.841 0.353 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.78 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -64.84 -57.65 8.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.577 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.47 -28.77 66.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.353 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.99 -33.06 67.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 110.162 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.28 -58.01 3.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.748 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.87 37.71 12.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.622 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CB ' HG12 ' A' ' 6' ' ' ILE . 18.2 mtm180 -118.96 9.05 11.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.728 0.299 . . . . 0.0 110.987 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.997 HD21 HD12 ' A' ' 36' ' ' ILE . 5.8 tp -135.24 154.4 51.59 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.01 0.433 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.563 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.94 134.42 42.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 179.996 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.631 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -49.15 159.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.13 0.491 . . . . 0.0 111.491 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 53' ' ' VAL . 3.0 m120 72.24 1.43 3.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.506 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.01 127.22 31.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.693 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 100.17 12.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 111.693 -178.437 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 19' ' ' ILE . 10.1 mt -46.76 132.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.76 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.97 -40.41 3.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.138 179.639 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -145.27 167.49 22.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.763 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.937 HG13 ' CD2' ' A' ' 86' ' ' LEU . 56.1 t -145.3 97.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.878 ' OD1' HG23 ' A' ' 84' ' ' VAL . 1.2 t30 66.25 -67.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 109.947 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' VAL . 10.2 mm-40 -154.14 32.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.921 179.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.7 t -119.64 142.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.412 -179.322 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.5 t0 -111.33 99.72 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.455 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 65' ' ' VAL . 24.5 m -85.3 55.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.294 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -32.51 59.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.851 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -152.67 62.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.667 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' THR . 13.2 m -124.6 144.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.88 155.06 20.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.973 0.416 . . . . 0.0 111.097 -179.117 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.945 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.2 p-80 -48.66 -34.09 11.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.859 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -33.88 73.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.139 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.558 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.18 -44.23 84.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.241 0.543 . . . . 0.0 109.674 178.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.92 -45.89 87.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.162 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 70' ' ' HIS . 59.4 t -57.06 -48.37 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.287 178.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.664 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -53.68 -33.82 56.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.33 179.134 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -64.66 -56.91 10.77 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.598 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.841 HD12 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -63.02 -42.93 99.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.879 -179.645 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.6 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.08 -20.59 55.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.748 -179.264 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.664 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 6.7 mm-40 -103.27 -8.8 20.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.088 0.471 . . . . 0.0 110.563 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.867 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.1 -20.49 0.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.791 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.79 -90.21 0.93 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.712 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -133.73 -92.42 0.34 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.907 HG13 HG22 ' A' ' 7' ' ' THR . 9.1 tp -88.05 102.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.116 0.484 . . . . 0.0 110.531 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.878 HG23 ' OD1' ' A' ' 61' ' ' ASN . 7.3 p -118.32 136.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.724 -178.13 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.857 ' HG2' HG23 ' A' ' 7' ' ' THR . 2.9 mtt85 -85.88 103.88 15.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.058 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.937 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.3 mt -95.49 137.8 34.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.576 -179.189 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.88 140.42 36.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.494 179.795 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 m . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.991 179.886 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.434 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 10.7 m-85 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.749 0.309 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -131.6 151.04 51.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -109.96 143.89 39.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.78 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.034 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.32 109.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.975 0.416 . . . . 0.0 111.699 179.791 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.49 118.87 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.508 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.061 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -131.59 127.16 36.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 7.2 pt-20 -84.51 100.44 11.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.258 179.392 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.533 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.41 90.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.21 179.67 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.337 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.88 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.061 ' HB3' HD23 ' A' ' 8' ' ' LEU . 18.8 mt . . . . . 0 C--O 1.227 -0.108 0 CA-C-O 120.938 0.399 . . . . 0.0 110.784 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.15 35.93 0.45 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.419 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.797 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.1 p90 -160.04 135.42 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.128 0.464 . . . . 0.0 111.242 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.33 137.63 33.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.427 -179.612 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.45 149.75 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.654 0.74 . . . . 0.0 111.954 -179.86 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.661 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.73 133.02 24.73 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.93 179.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.31 -7.65 1.16 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.462 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.558 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.6 -178.87 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.087 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 68' ' ' VAL . 29.9 p -65.06 -31.13 72.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.45 -20.46 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 0.4 OUTLIER -124.48 82.48 58.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.958 0.409 . . . . 0.0 110.131 179.77 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.25 62.67 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.886 2.391 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.748 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.6 t60 -52.58 -22.35 4.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.386 178.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.781 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -95.21 -151.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.572 179.814 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.673 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.89 48.87 4.11 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.861 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.77 45.46 0.07 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.981 0.419 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 28' ' ' ILE . 8.2 m-20 -135.22 155.24 78.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 23' ' ' THR . 73.5 Cg_endo -75.57 -0.94 10.72 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.525 2.15 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.411 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 5.7 m -54.24 115.75 2.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.746 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.58 119.02 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.781 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.67 145.72 35.26 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.301 0.572 . . . . 0.0 110.527 178.53 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.053 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.98 155.48 7.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.094 -176.476 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.37 -33.44 4.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.766 -179.124 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.657 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.65 141.96 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.585 -179.749 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.962 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.7 132.31 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.266 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.1 125.16 73.26 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.685 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.1 Cg_endo -67.33 132.06 26.54 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.838 2.358 . . . . 0.0 112.381 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.68 14.39 32.17 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.474 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.87 178.07 16.42 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.0 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.37 -36.26 61.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 111.416 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.795 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.9 -57.43 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.833 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.478 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -33.92 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 110.174 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.15 -57.92 3.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.691 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.02 9.59 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.602 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.9 mmt180 -116.31 1.59 13.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.702 -0.293 . . . . 0.0 110.837 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.053 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -126.96 154.15 44.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 110.657 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.9 ttp85 -131.52 137.45 48.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -53.33 158.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 111.678 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER 74.53 0.19 3.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.184 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 3.1 m-20 -70.38 126.26 29.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.3 p -86.53 100.31 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 0.0 111.383 -178.607 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.036 HD11 HG21 ' A' ' 19' ' ' ILE . 69.1 mt -46.88 140.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.065 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.434 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.5 mm? -118.76 -44.8 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.3 m-85 -139.86 169.43 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.793 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.749 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.5 t -151.4 100.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.584 ' OD1' HG23 ' A' ' 84' ' ' VAL . 11.3 t30 66.27 -67.86 0.14 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.131 0.491 . . . . 0.0 109.979 -178.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -156.67 32.05 0.31 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.495 179.124 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.6 t -117.8 142.51 31.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.55 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.7 p-10 -112.69 89.34 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 65' ' ' VAL . 27.4 m -75.77 61.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -82.38 -32.94 28.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.753 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -148.66 50.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.798 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.762 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -114.09 150.89 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.428 HG22 ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -66.95 153.66 43.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.029 -179.389 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.86 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.2 t-160 -49.68 -34.19 17.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.628 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -69.8 -34.04 73.19 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.653 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.04 -42.25 80.85 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.883 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.12 -46.75 85.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.555 0.693 . . . . 0.0 109.201 177.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.3 t -57.58 -50.18 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.15 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.653 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.01 -32.9 64.39 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.631 178.656 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.99 -52.63 64.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.228 0.537 . . . . 0.0 110.012 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 19' ' ' ILE . 2.5 mt -54.16 -36.47 63.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.283 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.19 -26.66 53.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.09 178.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -89.01 -16.65 31.16 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -178.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.41 -18.57 18.53 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.33 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.02 -108.02 3.6 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.164 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 1.3 p -118.78 -91.2 0.56 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 7' ' ' THR . 8.4 tp -86.92 95.09 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.079 0.466 . . . . 0.0 109.85 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.933 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.1 p -111.86 138.06 42.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.297 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.9 102.89 14.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.411 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.749 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.6 mt -90.18 141.15 28.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.72 141.38 34.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.771 -179.759 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.852 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 65.7 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.732 0.301 . . . . 0.0 110.659 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -126.35 155.56 41.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 17.7 mt-10 -117.43 144.63 44.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.967 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.84 109.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.647 179.893 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.899 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 122.0 24.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.912 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.036 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.1 tp -134.14 127.31 31.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.149 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -86.37 100.76 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.632 179.551 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.55 ' CG ' HD23 ' A' ' 15' ' ' LEU . 12.0 mtp180 -42.45 91.93 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.064 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.477 0 CA-C-N 115.186 -0.916 . . . . 0.0 113.058 -179.538 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.036 ' HB3' HD23 ' A' ' 8' ' ' LEU . 8.3 mt . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.7 0.286 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 135.46 40.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.745 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.789 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -162.02 134.51 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.494 . . . . 0.0 110.971 178.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.51 135.16 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.459 -179.351 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.052 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.53 146.5 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.496 179.552 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.74 122.88 36.11 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.586 178.935 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 157.92 -132.0 3.03 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.605 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 75.76 167.36 22.75 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.263 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 68' ' ' VAL . 27.4 p -68.47 -6.68 26.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.074 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.7 m-20 -113.11 -24.34 9.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.5 t30 -124.62 87.18 54.86 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.478 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.91 64.69 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.39 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.736 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.0 t60 -53.05 -24.12 9.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.31 179.221 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.866 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -92.64 -150.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 179.63 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.68 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.66 52.47 4.58 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.931 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 75.7 41.23 0.26 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.116 0.484 . . . . 0.0 110.488 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -132.3 161.46 62.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.909 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 97.3 Cg_endo -79.29 4.18 6.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.625 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -55.04 118.39 4.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.078 0.466 . . . . 0.0 111.258 -179.814 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.835 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.32 116.62 31.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.188 179.598 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.866 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.06 147.6 37.07 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.363 0.601 . . . . 0.0 110.573 179.256 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.089 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.26 155.74 7.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.834 -177.127 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.29 -33.02 3.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.677 -179.076 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.14 142.01 2.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 111.276 -179.78 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.958 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -105.32 132.32 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.48 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.446 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.01 114.48 54.53 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.674 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.1 Cg_exo -57.68 136.96 78.83 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.7 2.267 . . . . 0.0 112.365 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 16.97 39.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.562 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.54 178.76 16.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.175 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.84 -33.86 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.3 . . . . 0.0 111.402 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.829 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.81 -57.39 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.908 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.53 -28.67 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.525 -179.427 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.71 -30.43 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 110.335 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' OD2' HD12 ' A' ' 8' ' ' LEU . 6.0 m-20 -82.68 -57.77 3.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.708 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.78 37.0 12.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.572 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.449 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -111.28 -20.92 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.089 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -106.16 153.86 21.5 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.275 0.559 . . . . 0.0 111.361 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.578 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -131.78 135.4 46.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.57 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 38' ' ' LYS . 52.5 t -49.21 157.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.536 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER 75.15 0.26 3.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.223 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.639 ' HB3' HG11 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -68.24 124.71 24.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.991 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.5 p -86.63 99.78 11.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.564 0.697 . . . . 0.0 111.377 -178.46 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 11.0 mt -46.35 129.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.229 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.49 HD22 ' HA ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -113.06 -41.44 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.005 179.653 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.4 m-85 -144.72 146.82 32.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.166 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.712 ' CG1' ' HB1' ' A' ' 76' ' ' ALA . 48.9 t -135.51 109.78 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 52.78 35.93 19.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.843 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 80.72 32.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.445 -179.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 60' ' ' VAL . 74.7 t -121.01 112.75 37.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.699 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -72.05 116.83 12.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.711 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 57' ' ' ILE . 25.6 m -98.45 27.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.197 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -68.77 -27.76 66.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -138.52 52.67 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.082 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -127.63 146.08 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -67.83 155.61 38.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.384 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.5 p-80 -48.15 -35.44 11.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 -179.65 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.33 -33.67 65.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.115 179.716 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.628 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.68 -39.39 88.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.808 179.161 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.835 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.69 -46.88 74.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.584 0.707 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.5 t -58.07 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.362 178.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -58.22 -35.64 71.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.46 178.574 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -55.08 -49.39 71.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.237 0.542 . . . . 0.0 109.976 179.597 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.052 HD11 HD12 ' A' ' 19' ' ' ILE . 2.4 mt -57.84 -36.47 72.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 178.709 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.2 mmmt -77.33 -25.86 51.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.879 179.441 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -96.96 5.31 50.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -178.703 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.911 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.45 16.1 1.43 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.769 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.63 -110.5 3.43 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.294 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 35.8 m -118.96 -89.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.324 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.899 HG13 HG22 ' A' ' 7' ' ' THR . 7.5 tp -86.27 96.43 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.257 0.551 . . . . 0.0 110.263 179.019 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.911 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.6 p -111.1 138.4 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.57 102.8 14.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.388 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.711 ' CD2' HG13 ' A' ' 60' ' ' VAL . 10.9 mt -88.74 137.86 31.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.118 -178.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 145.95 28.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.923 -179.689 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 55' ' ' ASP . 35.4 m . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.139 179.748 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.72 0.295 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -145.22 151.0 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.981 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -110.36 144.77 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.71 109.5 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.926 0.393 . . . . 0.0 111.545 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.845 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 112.46 17.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.959 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 6' ' ' ILE . 5.5 tp -122.87 126.81 48.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.269 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.62 100.46 10.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.059 179.09 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.51 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.169 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.337 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.539 -179.807 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.011 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.9 tp . . . . . 0 N--CA 1.456 -0.148 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 108.67 25.78 5.58 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.326 -0.94 . . . . 0.0 115.263 177.706 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 4.3 p90 -164.52 136.72 4.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.018 0.909 . . . . 0.0 111.072 178.779 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -98.68 133.44 43.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.636 -179.28 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.095 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.07 169.9 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.608 0.718 . . . . 0.0 111.501 179.729 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -167.33 131.5 1.87 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.424 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.45 2.09 0.71 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.436 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.13 -167.15 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.102 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.839 HG22 ' HB3' ' A' ' 32' ' ' PRO . 17.5 p -75.96 -28.16 57.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -95.31 -20.63 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.66 82.54 59.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.76 63.89 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -179.316 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.713 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.3 t60 -50.09 -24.09 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.855 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.7 -155.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.367 179.716 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.66 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.9 -49.92 73.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.575 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.49 39.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.919 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -124.69 163.48 36.69 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.839 ' HB3' HG22 ' A' ' 23' ' ' THR . 5.9 Cg_exo -78.91 3.46 7.36 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.0 112.861 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.1 m -56.61 115.53 2.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 111.1 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.47 120.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.524 179.833 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.855 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.44 145.39 33.73 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.48 0.657 . . . . 0.0 110.704 178.842 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.046 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.84 155.83 7.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.473 -176.409 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.469 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.9 -28.36 4.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.509 -178.565 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.686 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.72 129.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.197 -179.486 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.997 HD11 HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -94.6 133.23 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.392 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 122.98 75.6 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.725 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 23.3 Cg_endo -61.59 137.41 68.96 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.642 2.228 . . . . 0.0 112.36 -179.661 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 -1.87 83.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.442 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.72 175.22 36.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.033 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.12 -34.38 60.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.814 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -74.43 -56.94 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.239 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.12 -28.87 70.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -71.67 -31.57 66.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 109.934 179.347 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.38 -57.91 2.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.552 179.87 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.04 40.83 8.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.491 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.9 mmt85 -117.03 6.58 12.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.71 0.29 . . . . 0.0 110.951 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -133.74 153.81 51.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.004 0.431 . . . . 0.0 110.819 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.13 140.1 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 179.96 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.5 t -56.69 158.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.242 0.544 . . . . 0.0 111.638 179.757 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.4 t-20 74.15 3.5 4.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.179 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.5 m-20 -75.06 127.1 32.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.49 103.03 14.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.517 0.675 . . . . 0.0 111.131 -178.853 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.095 HD11 HG21 ' A' ' 19' ' ' ILE . 62.5 mt -49.92 133.37 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.052 -179.775 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.77 HD23 ' C ' ' A' ' 88' ' ' VAL . 4.0 mm? -108.64 -42.6 4.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -147.33 140.58 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.301 179.987 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.77 HG11 ' HB1' ' A' ' 76' ' ' ALA . 58.3 t -123.72 97.29 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.754 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 t30 70.04 -62.84 0.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.05 0.453 . . . . 0.0 109.819 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -160.58 30.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.152 179.143 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 16.7 t -121.03 109.62 25.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.679 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 65' ' ' VAL . 18.9 t0 -63.08 -23.49 67.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.283 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 64' ' ' ASP . 13.4 m 46.07 28.96 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.639 -179.763 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -61.91 -37.76 85.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.77 61.93 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.708 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -127.83 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.315 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.405 ' HA ' ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -61.59 151.34 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -179.706 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.854 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 t-160 -48.11 -33.89 8.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.675 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -34.07 75.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.933 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.07 -42.38 80.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.75 -46.81 86.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.677 0.751 . . . . 0.0 109.047 177.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.5 t -57.31 -50.48 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.328 178.546 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.682 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -29.47 60.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.898 178.556 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.77 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.55 -51.57 68.03 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.273 0.559 . . . . 0.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.056 HD11 HD12 ' A' ' 19' ' ' ILE . 1.5 mt -55.78 -37.96 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.48 -23.28 50.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.034 178.978 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.72 7.94 45.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.397 -178.795 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.19 16.2 4.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.3 179.873 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.34 -99.62 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.575 179.849 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -129.18 -91.9 0.46 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.845 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -81.95 97.14 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.187 0.518 . . . . 0.0 110.405 179.336 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.936 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -114.21 137.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.733 . . . . 0.0 112.947 -178.2 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.812 ' HG3' HG23 ' A' ' 7' ' ' THR . 4.6 mtt180 -86.35 103.03 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.164 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.3 mt -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.165 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.62 142.88 32.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.552 -179.902 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.77 ' C ' HD23 ' A' ' 58' ' ' LEU . 14.3 m . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.466 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 66.1 m-85 . . . . . 0 CA--C 1.527 0.078 0 CA-C-O 120.795 0.331 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -155.48 152.45 28.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 pt-20 -105.68 144.75 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.019 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.25 109.17 12.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.956 0.408 . . . . 0.0 111.59 179.723 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.832 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.59 118.82 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.255 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.019 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -130.26 127.02 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.407 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.14 100.18 10.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.244 0.545 . . . . 0.0 112.239 179.812 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -53.55 89.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.137 178.448 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.199 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.325 -179.02 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.997 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.7 tp . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.24 27.43 0.91 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.091 177.951 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.766 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.3 p90 -164.15 134.91 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 118.013 0.906 . . . . 0.0 111.17 178.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.29 134.41 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.611 -179.2 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.06 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.51 146.98 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.327 179.299 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.598 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.45 123.17 33.02 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.649 179.098 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.58 -119.23 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.097 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 64.06 173.82 3.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.515 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.771 HG23 ' C ' ' A' ' 68' ' ' VAL . 4.6 p -76.89 -3.83 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.005 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.1 -25.15 9.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.7 t30 -125.05 86.1 57.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.453 0.168 . . . . 0.0 110.667 -179.824 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.63 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.0 1.8 . . . . 0.0 112.216 -179.767 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.712 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 35.5 t60 -53.52 -24.11 12.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.271 179.056 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -88.62 -153.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.423 179.438 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.663 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -63.22 -51.41 55.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.624 -179.22 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 3.3 p-10 -178.68 35.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.615 0.245 . . . . 0.0 111.519 -179.378 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -125.47 164.15 34.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -179.897 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.547 ' HB2' HG22 ' A' ' 23' ' ' THR . 79.0 Cg_endo -84.05 44.47 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.665 2.243 . . . . 0.0 112.337 179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -90.43 123.38 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.92 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.37 109.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.487 179.926 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -135.66 147.13 48.46 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.392 0.615 . . . . 0.0 110.287 178.842 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.17 155.6 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.751 -176.738 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.61 -32.69 3.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.606 -179.05 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.74 140.57 2.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.915 0.388 . . . . 0.0 111.406 -179.941 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.971 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -102.66 133.63 45.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.206 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.479 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 117.38 68.51 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.332 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.7 Cg_exo -57.69 135.19 67.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.833 2.355 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.32 1.51 64.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.672 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.19 179.84 28.54 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.076 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -57.68 -33.23 68.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.979 179.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.797 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -74.03 -56.43 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.729 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.39 -31.25 72.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -72.13 -32.63 67.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -58.07 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.676 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 41.47 9.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.552 179.681 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 13.9 mmt180 -108.98 -17.35 13.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.897 0.38 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -109.35 155.93 20.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 133.49 44.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 179.778 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.08 158.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.358 0.599 . . . . 0.0 111.989 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.8 t30 74.47 3.97 4.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.463 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -74.86 126.24 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.052 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 t -86.48 101.23 12.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.554 0.692 . . . . 0.0 111.269 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 19' ' ' ILE . 65.3 mt -47.13 131.56 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.815 179.833 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.3 mm? -110.37 -44.19 3.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.843 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.61 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -142.29 162.17 36.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.768 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.896 HG13 ' CD2' ' A' ' 86' ' ' LEU . 43.8 t -152.29 114.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.974 179.795 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 84' ' ' VAL . 26.7 t30 46.6 46.0 14.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 75.42 31.7 0.76 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 64.9 t -120.77 142.16 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 34.3 t0 -105.5 112.12 25.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.484 HG12 HG21 ' A' ' 68' ' ' VAL . 28.5 m -95.81 24.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.369 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -58.88 -28.92 66.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 60.58 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.771 ' C ' HG23 ' A' ' 23' ' ' THR . 28.3 m -132.89 142.76 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.352 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 152.47 28.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 -179.926 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.832 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.2 t-160 -48.15 -33.95 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.685 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -68.59 -34.1 75.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.173 179.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.661 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.94 -38.49 79.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.731 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.852 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.51 -46.83 74.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.5 t -57.62 -50.42 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 178.489 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.661 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.08 -29.81 58.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.786 178.44 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.696 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -61.37 -53.61 54.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.163 0.506 . . . . 0.0 109.785 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.06 HD11 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -51.75 -40.31 60.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.487 178.871 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -77.55 -25.56 50.22 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.454 179.314 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' GLU . 2.7 pt-20 -93.84 7.57 44.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 0.0 111.311 -178.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.942 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -84.99 16.3 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.508 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.82 -83.98 0.09 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.409 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -147.74 -90.09 0.08 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.439 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.832 HG13 HG22 ' A' ' 7' ' ' THR . 9.4 tp -82.32 96.72 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 109.938 179.134 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.942 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.1 p -116.04 136.9 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.507 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -86.06 102.79 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.491 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.896 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.3 mt -90.81 138.58 31.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.303 -178.71 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.66 137.34 40.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.423 179.818 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 55' ' ' ASP . 15.7 m . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.307 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.695 ' CD2' HD13 ' A' ' 58' ' ' LEU . 3.2 m-30 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.608 0.242 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.91 139.76 36.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 111.253 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -97.87 144.9 26.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.787 ' CD1' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.26 109.38 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.086 0.47 . . . . 0.0 111.545 179.911 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.843 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.33 125.37 29.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.459 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.885 HD11 ' HA ' ' A' ' 45' ' ' ALA . 2.3 tp -135.01 126.91 29.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.669 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.17 100.18 10.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.371 179.262 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.23 89.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.166 178.798 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.322 -0.204 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.357 -179.09 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.833 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.6 tp . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 120.03 22.98 3.1 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.959 -1.115 . . . . 0.0 115.342 177.458 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -163.48 135.8 5.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.353 1.077 . . . . 0.0 111.502 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 134.55 35.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.276 -179.674 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.052 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.4 162.85 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.551 0.691 . . . . 0.0 111.655 179.938 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -158.82 132.79 7.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.354 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.14 1.68 1.27 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.501 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.21 -172.94 0.37 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.955 -179.763 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 68' ' ' VAL . 32.1 p -68.41 -27.53 66.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.225 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 10.6 m-20 -96.8 -18.78 19.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -124.27 87.21 53.99 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.27 59.86 1.01 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.28 1.987 . . . . 0.0 112.6 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.732 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 40.3 t60 -47.63 -28.3 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 178.834 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.805 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -89.35 -154.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.332 179.315 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.05 -49.53 77.53 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.663 -179.692 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.83 39.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.08 166.27 21.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CB ' HG22 ' A' ' 23' ' ' THR . 91.6 Cg_endo -80.65 6.83 5.2 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.64 2.227 . . . . 0.0 112.802 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -58.56 115.41 3.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.775 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.878 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.03 120.13 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.706 -179.896 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.32 144.57 33.3 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.358 0.599 . . . . 0.0 110.386 178.501 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.077 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.74 155.72 7.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.321 -176.374 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.4 -34.69 3.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.777 -178.784 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.12 142.36 2.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.46 -179.566 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.968 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.95 133.17 49.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 178.345 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.86 114.95 57.35 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.606 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 52.2 Cg_exo -55.71 137.76 79.26 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.256 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.02 6.71 66.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.77 177.36 21.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.992 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.45 -31.26 55.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.885 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -73.91 -57.5 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.712 -179.712 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.1 -28.57 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.259 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.72 -31.16 66.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.001 0.429 . . . . 0.0 110.084 179.428 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.42 -57.82 2.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.43 40.32 9.15 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.672 179.589 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.8 mtt85 -111.77 -19.16 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.663 0.268 . . . . 0.0 110.815 179.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.077 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -107.81 155.23 20.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.154 0.502 . . . . 0.0 111.177 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.58 134.82 45.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.676 179.746 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.0 157.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.317 0.58 . . . . 0.0 111.72 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.89 1.57 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.235 179.837 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.95 124.47 24.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.059 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.37 12.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.604 0.716 . . . . 0.0 111.419 -178.615 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 19' ' ' ILE . 20.3 mt -51.72 130.7 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.791 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.695 HD13 ' CD2' ' A' ' 3' ' ' TYR . 1.4 pp -126.95 3.41 6.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.604 179.389 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.5 OUTLIER 179.07 140.54 0.1 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.207 0.527 . . . . 0.0 110.583 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.908 HG23 ' CD2' ' A' ' 86' ' ' LEU . 2.4 p -147.57 118.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.402 ' HB2' HG21 ' A' ' 84' ' ' VAL . 7.9 t-20 51.78 33.44 11.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 110.076 -179.006 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 77.62 34.75 0.34 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.711 ' HB ' HG13 ' A' ' 60' ' ' VAL . 58.4 t -120.91 108.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.2 p-10 -73.19 106.43 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.485 179.271 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 29.5 m -93.78 40.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.363 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -22.01 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.163 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -146.99 59.8 1.18 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.148 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -134.52 148.86 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.527 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.37 153.11 43.59 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.034 -179.344 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.8 t-160 -49.85 -34.02 18.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -33.99 73.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.772 179.41 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.58 -40.56 80.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.675 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.878 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.94 -46.71 80.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.009 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.9 t -57.97 -50.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.2 178.612 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.6 OUTLIER -56.4 -35.24 67.54 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.739 178.537 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -55.34 -52.49 63.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 110.142 179.528 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.0 HD11 HD12 ' A' ' 19' ' ' ILE . 3.4 mt -53.88 -38.72 65.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.241 178.585 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -20.65 53.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.413 179.011 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.2 mt-10 -97.21 -12.67 22.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.288 -178.687 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.896 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.9 -15.46 8.74 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.393 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 -91.28 1.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.903 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.4 p -139.45 -91.59 0.18 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.843 HG13 HG22 ' A' ' 7' ' ' THR . 9.7 tp -84.22 93.97 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.235 0.54 . . . . 0.0 110.007 178.813 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.896 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -113.21 136.86 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 8.5 ptp180 -87.49 102.94 15.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.471 177.969 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.908 ' CD2' HG23 ' A' ' 60' ' ' VAL . 17.7 mt -91.13 132.75 35.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.136 -179.079 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.459 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.52 126.18 48.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.6 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.719 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.458 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 40.5 m-85 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.93 0.395 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.4 mt-10 -129.93 170.57 13.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.32 144.59 49.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.973 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.015 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -140.36 109.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 111.801 179.968 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.751 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.6 118.72 20.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.392 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.039 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.1 tp -129.42 127.09 40.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.058 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 4.8 pt-20 -84.66 100.28 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.011 179.324 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.539 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.07 89.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.486 179.81 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.52 0.357 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.812 179.835 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.039 ' HB3' HD23 ' A' ' 8' ' ' LEU . 22.7 mt . . . . . 0 C--O 1.227 -0.092 0 CA-C-O 120.937 0.399 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 130.12 31.55 0.58 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.297 179.479 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.809 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.23 138.09 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.033 0.416 . . . . 0.0 110.561 179.096 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.98 135.03 40.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.425 -179.476 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.076 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.05 146.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.546 0.689 . . . . 0.0 111.388 179.596 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.66 123.86 34.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.736 179.0 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 159.47 -124.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.742 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 32' ' ' PRO . . . 70.09 174.06 13.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.794 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.766 HG22 ' HB2' ' A' ' 32' ' ' PRO . 12.2 p -76.93 -1.33 28.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.92 -23.06 8.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -124.85 86.83 55.83 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -179.89 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 65.72 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.051 1.834 . . . . 0.0 112.196 -179.812 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.701 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.2 t60 -53.18 -23.69 9.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.262 179.286 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.87 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -91.34 -152.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.481 179.526 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.671 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.87 -46.89 63.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.8 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.56 77.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.2 170.28 5.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.65 179.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.766 ' HB2' HG22 ' A' ' 23' ' ' THR . 96.1 Cg_endo -84.47 16.54 1.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.548 2.165 . . . . 0.0 112.829 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.6 m -62.74 145.61 54.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.067 0.461 . . . . 0.0 111.047 -179.933 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.806 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -116.73 114.82 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 -179.914 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.87 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -139.9 148.11 41.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.393 0.616 . . . . 0.0 110.545 179.16 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.01 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.22 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.968 -176.894 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.78 -30.03 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.372 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.78 129.57 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.049 -179.366 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.93 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.06 130.08 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.586 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 115.3 59.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.588 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 39.1 Cg_exo -57.52 135.79 71.87 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.741 2.294 . . . . 0.0 112.212 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.36 14.62 40.88 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.65 177.47 16.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.997 179.693 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.32 -38.23 57.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.834 0.349 . . . . 0.0 111.224 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.833 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.16 -57.53 8.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.909 -179.608 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.26 -28.64 64.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.509 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -71.94 -32.79 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.008 0.432 . . . . 0.0 110.306 179.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -77.6 -58.02 3.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 36.0 16.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.564 179.562 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.508 ' CB ' HG12 ' A' ' 6' ' ' ILE . 59.0 mtt180 -118.29 5.26 11.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.01 HD21 HD12 ' A' ' 36' ' ' ILE . 10.9 tp -130.61 156.53 44.72 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.057 0.456 . . . . 0.0 110.932 179.644 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.612 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.54 135.18 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.684 179.846 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -48.98 157.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.305 0.574 . . . . 0.0 111.749 -179.746 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' HG12 ' A' ' 53' ' ' VAL . 7.8 t-20 76.59 0.66 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.275 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.17 125.45 26.71 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.063 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.54 100.14 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 0.0 111.298 -178.958 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.076 HD11 HG21 ' A' ' 19' ' ' ILE . 61.2 mt -45.36 145.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.996 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -128.83 -44.61 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -140.66 146.41 37.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.063 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 40.0 t -140.4 111.41 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.703 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 50.46 37.42 15.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.398 . . . . 0.0 110.185 -179.125 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 79.55 34.24 0.19 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.493 -179.353 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 60' ' ' VAL . 97.3 t -120.95 108.44 22.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.424 -179.851 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.0 t0 -78.28 93.32 4.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.902 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.525 HG12 HG21 ' A' ' 68' ' ' VAL . 14.8 m -64.53 -122.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 65' ' ' VAL . 7.3 ttm180 70.16 -65.69 0.31 Allowed 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.03 0.443 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -93.61 40.22 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.725 179.585 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.592 ' C ' HG23 ' A' ' 23' ' ' THR . 34.7 m -137.92 142.34 36.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 179.88 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -58.36 155.06 12.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.234 0.54 . . . . 0.0 111.274 -179.558 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.7 p-80 -49.55 -33.78 15.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.873 179.646 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -72.05 -33.67 68.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.327 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.688 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.14 -44.13 85.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.247 0.546 . . . . 0.0 109.663 179.023 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.806 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.19 -46.88 88.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.609 0.719 . . . . 0.0 109.182 178.045 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.1 t -57.99 -50.43 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.416 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.93 -29.71 63.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.842 178.614 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -60.85 -51.09 70.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.818 179.493 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.037 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.59 -37.89 71.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.705 179.016 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.3 -22.8 51.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.143 179.059 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -102.23 13.17 35.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.328 -178.655 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.912 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.56 16.34 3.93 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.357 179.966 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.61 -93.69 0.56 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.303 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 19.3 m -139.79 -89.23 0.19 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.751 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.8 tp -85.44 91.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.113 0.482 . . . . 0.0 109.874 178.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.912 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.1 p -106.99 137.41 37.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.693 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.35 102.76 14.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.458 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.9 mt -90.64 140.65 29.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.41 -178.697 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -101.95 131.87 48.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.273 179.569 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.435 HG21 ' OD2' ' A' ' 55' ' ' ASP . 6.8 m . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 -179.654 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.443 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 27.1 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.912 0.387 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -137.6 146.53 44.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.0 pm0 -108.49 144.56 35.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.058 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.81 110.33 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.531 179.779 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.709 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.95 116.95 20.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.711 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.058 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -126.68 127.07 44.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.509 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pt-20 -85.52 100.41 11.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.327 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -48.52 88.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.254 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.284 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.554 -179.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.972 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.8 tp . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.391 0.138 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.4 21.37 1.05 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.89 -1.148 . . . . 0.0 114.726 178.537 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.855 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.2 p90 -161.6 135.96 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.935 0.868 . . . . 0.0 111.113 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.0 138.75 32.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.45 -179.459 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.038 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -119.66 148.81 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.727 0.775 . . . . 0.0 112.365 -179.642 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.15 134.21 27.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.281 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.68 -0.52 1.04 Allowed Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.807 179.491 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.88 -170.31 0.13 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.929 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 32' ' ' PRO . 18.1 p -74.9 -21.59 59.13 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.141 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.15 -25.14 15.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.719 0.295 . . . . 0.0 111.643 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.421 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 62.7 t30 -124.34 87.52 53.87 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.176 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.11 63.84 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.276 1.984 . . . . 0.0 112.576 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.726 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.3 t60 -49.52 -26.23 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.43 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.386 179.543 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -55.96 -50.83 59.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.704 -179.644 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.03 39.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.7 170.02 10.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.769 ' HB3' HG22 ' A' ' 23' ' ' THR . 93.6 Cg_endo -80.35 6.59 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.653 2.235 . . . . 0.0 112.843 -179.872 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.97 113.41 1.5 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.931 0.396 . . . . 0.0 110.57 179.722 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.65 119.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.023 -179.633 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.67 146.96 36.76 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.646 178.485 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.034 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.97 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.194 -176.566 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.77 -31.31 4.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.154 -179.038 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.84 132.14 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.114 -179.363 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.35 132.9 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.549 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.17 126.72 69.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.655 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.2 Cg_endo -66.16 132.3 29.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.658 2.239 . . . . 0.0 112.355 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.02 1.72 58.34 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.476 -179.833 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.91 173.97 22.08 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.957 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.25 -35.57 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.837 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -71.03 -57.21 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.748 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.38 -35.21 80.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 -179.161 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -72.08 -30.4 65.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.43 179.705 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.98 -58.13 3.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.647 179.929 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 41.43 10.09 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.579 179.451 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.2 mtt180 -116.44 7.95 13.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.034 HD21 HD12 ' A' ' 36' ' ' ILE . 5.1 tp -136.72 154.18 50.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.73 179.577 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.79 136.49 48.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.89 157.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.403 0.621 . . . . 0.0 111.513 179.839 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.52 -0.78 3.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.245 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.693 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -69.78 127.52 33.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.972 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.0 p -86.57 100.2 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.471 0.653 . . . . 0.0 111.605 -178.568 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.97 HD11 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -47.03 141.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.087 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.6 mm? -118.58 -45.03 2.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.183 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 m-85 -140.33 169.93 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.81 HG13 ' CD2' ' A' ' 86' ' ' LEU . 18.4 t -149.46 96.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.058 179.355 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.3 -68.15 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.176 0.512 . . . . 0.0 109.936 -178.784 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.2 tt0 -154.47 30.75 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.683 179.244 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.3 t -117.28 142.18 32.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.386 -179.333 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 35.7 t0 -114.72 87.91 2.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.494 179.431 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 65' ' ' VAL . 31.7 m -70.53 63.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 111.355 -179.543 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -29.62 30.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -154.68 64.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.817 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.745 ' O ' HG23 ' A' ' 23' ' ' THR . 34.7 m -128.15 146.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.78 153.62 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.067 0.46 . . . . 0.0 110.811 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 74' ' ' VAL . 7.0 p-80 -49.6 -33.62 15.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.988 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -70.64 -33.82 71.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.416 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.657 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.78 -44.42 85.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 109.807 179.178 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.19 -46.84 87.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.569 0.7 . . . . 0.0 109.307 178.095 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.9 t -57.16 -49.33 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.281 178.647 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.657 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.72 -33.06 66.13 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.598 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.51 -51.42 69.51 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.522 . . . . 0.0 109.991 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.39 -37.54 67.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.472 178.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.53 -26.67 51.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.502 179.332 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -91.74 -12.62 33.42 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.928 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.97 -18.77 10.1 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.334 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.38 -100.34 2.32 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.142 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -126.9 -91.74 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.008 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.709 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.7 tp -87.78 94.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.205 0.526 . . . . 0.0 109.723 178.745 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.928 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.9 p -110.14 138.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.506 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.1 mtm105 -87.77 103.11 15.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.148 177.838 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.81 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.9 mt -92.5 139.04 30.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.175 -178.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.78 147.88 25.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.693 HG21 ' OD2' ' A' ' 55' ' ' ASP . 30.3 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.425 179.857 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 58' ' ' LEU . 2.7 m-30 . . . . . 0 C--O 1.229 0.023 0 CA-C-O 120.9 0.381 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -140.82 148.88 41.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -103.48 141.64 35.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.904 HG23 ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt -130.66 109.33 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.19 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.982 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.85 112.14 15.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.708 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.969 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.5 tp -121.44 126.83 50.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.145 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.817 ' CG ' HD13 ' A' ' 83' ' ' ILE . 8.8 mt-10 -81.57 100.33 9.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.06 88.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.926 179.562 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.221 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.66 -179.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.433 0.159 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.14 20.16 0.84 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.599 178.675 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.847 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.6 p90 -162.76 134.53 5.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.986 0.893 . . . . 0.0 111.455 179.019 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.81 139.1 30.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.402 -179.566 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.054 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.69 147.37 23.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.68 0.752 . . . . 0.0 112.328 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.93 135.4 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.06 179.438 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.71 3.39 0.96 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.559 179.584 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.61 -168.36 0.29 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.874 -179.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.808 HG22 ' HB3' ' A' ' 32' ' ' PRO . 40.5 p -72.46 -30.01 64.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -96.09 -17.27 21.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.035 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.0 OUTLIER -124.84 82.66 60.32 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.248 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.36 62.32 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.777 2.318 . . . . 0.0 112.294 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.723 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.4 t60 -50.17 -23.45 2.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.538 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.82 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.81 -154.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.325 179.693 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.66 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.64 -50.19 69.69 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.537 -179.681 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.55 39.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.736 0.303 . . . . 0.0 110.766 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.75 164.67 33.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.999 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.808 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.25 3.69 6.02 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.05 2.5 . . . . 0.0 112.826 -179.849 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 m -54.8 114.32 1.67 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.06 119.81 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.742 -179.898 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.82 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.17 148.5 38.35 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 178.722 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.093 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.22 155.59 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -176.73 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -34.06 3.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.595 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.56 141.61 2.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.552 -179.677 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.767 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -104.29 133.07 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.166 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 113.74 49.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -177.763 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 45.2 Cg_exo -56.74 140.53 91.11 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.756 2.304 . . . . 0.0 112.506 -179.828 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.37 13.01 64.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.421 -179.91 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.32 -176.91 19.08 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.038 179.751 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -59.62 -35.62 74.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.846 0.355 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.88 -57.26 4.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.886 -179.615 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.31 -33.32 75.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.765 -179.041 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.8 pt20 -72.34 -30.4 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 110.56 179.773 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.45 ' OD2' HD12 ' A' ' 8' ' ' LEU . 3.5 m-20 -76.31 -58.22 3.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.059 -179.552 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 41.29 8.99 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.384 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.904 ' HB3' HG23 ' A' ' 6' ' ' ILE . 8.6 mmt180 -120.44 -2.14 10.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.696 0.284 . . . . 0.0 110.935 179.667 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.093 HD21 HD12 ' A' ' 36' ' ' ILE . 36.0 tp -124.37 162.96 22.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.147 0.499 . . . . 0.0 111.402 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.63 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.37 134.38 25.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.241 179.302 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.6 t -49.18 156.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.842 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.473 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.4 OUTLIER 76.54 -1.43 2.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.332 179.885 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -67.18 126.82 30.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.966 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.6 102.74 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.545 0.688 . . . . 0.0 111.533 -178.747 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.054 HD11 HG21 ' A' ' 19' ' ' ILE . 69.3 mt -49.36 136.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.784 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.552 HD11 ' CD1' ' A' ' 3' ' ' TYR . 48.4 mt -120.61 -30.08 4.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.618 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -152.94 158.36 41.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.952 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.893 HG13 ' CD2' ' A' ' 86' ' ' LEU . 43.0 t -152.41 109.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.77 47.92 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.84 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 73.13 31.4 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.823 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 73.6 t -120.2 142.06 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.832 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 8.9 p-10 -113.05 91.35 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.556 179.519 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.736 HG12 HG21 ' A' ' 68' ' ' VAL . 2.2 m -55.9 -102.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.17 -179.646 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.583 ' H ' HG23 ' A' ' 65' ' ' VAL . 5.1 mtp180 61.99 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.773 0.32 . . . . 0.0 111.24 179.74 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -88.25 51.92 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 -179.655 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 30.4 m -139.17 144.41 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.053 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.475 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.36 154.59 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.429 . . . . 0.0 111.038 -179.484 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.4 p-80 -48.15 -34.26 9.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.194 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -70.29 -33.89 72.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.393 179.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.77 -47.34 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.194 0.521 . . . . 0.0 109.624 179.079 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -59.31 -46.74 87.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.654 0.74 . . . . 0.0 109.36 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.1 t -56.86 -50.4 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.357 178.516 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.9 -28.59 57.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.991 178.649 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.98 -51.59 67.46 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.344 0.592 . . . . 0.0 109.691 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -56.75 -36.89 70.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.874 179.098 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.4 -30.52 53.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.852 179.712 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -97.85 19.76 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.42 -178.417 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.14 16.3 7.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 179.656 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.53 -93.44 0.81 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.225 -179.835 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.477 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.2 m -142.18 -90.6 0.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.982 HG13 HG22 ' A' ' 7' ' ' THR . 6.0 tp -83.11 89.22 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.561 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.895 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.8 p -105.75 137.6 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.644 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.852 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.17 102.92 14.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.659 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.893 ' CD2' HG13 ' A' ' 60' ' ' VAL . 9.3 mt -92.77 137.7 32.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.172 -178.906 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 138.5 38.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.587 179.877 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.8 m . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.996 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CG ' HD13 ' A' ' 58' ' ' LEU . 6.4 m-85 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.826 0.346 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.46 146.18 31.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.887 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -102.53 144.66 30.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.896 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.016 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.75 109.23 9.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.446 179.679 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.884 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.2 119.86 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.095 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.019 HD23 ' HG ' ' A' ' 15' ' ' LEU . 5.3 tp -131.07 126.9 37.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.48 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 pt-20 -84.29 100.49 11.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 179.354 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.7 89.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.042 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.603 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.019 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.8 tp . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.29 0.091 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 132.22 22.11 0.92 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 119.693 -1.242 . . . . 0.0 114.914 178.38 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.862 ' CE2' HD23 ' A' ' 15' ' ' LEU . 10.4 p90 -161.17 135.96 7.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.073 0.936 . . . . 0.0 111.351 179.101 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.75 135.36 36.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.528 -179.571 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.2 146.83 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.418 179.638 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.14 123.59 34.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.446 178.956 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.48 -124.91 1.41 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.939 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 73.14 168.71 13.9 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.214 179.877 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 32' ' ' PRO . 6.3 p -75.53 -6.29 49.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -106.64 -26.92 11.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' HIS . 5.2 t-20 -124.91 86.97 55.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.579 -179.762 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.23 66.93 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.127 1.885 . . . . 0.0 112.455 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.748 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 37.4 t60 -52.39 -24.91 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.252 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.852 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.1 -153.71 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.388 179.723 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -52.33 -51.62 41.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.85 -179.366 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 169.8 41.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 0.0 110.846 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.06 173.59 5.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.849 ' HB2' HG22 ' A' ' 23' ' ' THR . 80.9 Cg_endo -84.66 41.6 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.734 2.289 . . . . 0.0 112.438 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -90.41 119.49 30.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.003 0.43 . . . . 0.0 111.267 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.915 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.69 112.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.044 179.643 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.852 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -138.29 147.42 43.58 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.369 0.604 . . . . 0.0 110.283 179.249 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.045 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.15 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.111 -176.663 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.592 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.67 -33.55 4.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.574 -179.225 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.639 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.98 142.19 2.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.911 0.386 . . . . 0.0 111.457 -179.762 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.75 132.96 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.967 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 125.13 73.96 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.278 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 41.4 Cg_endo -67.05 129.92 21.73 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.936 2.424 . . . . 0.0 112.189 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.91 49.93 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.02 178.84 19.8 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.878 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.92 -38.81 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.749 0.309 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.784 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -66.62 -57.47 7.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.634 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.47 -28.89 67.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.487 -179.684 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -33.57 68.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.966 0.413 . . . . 0.0 110.175 179.594 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' OD2' HD12 ' A' ' 8' ' ' LEU . 4.3 m-20 -84.1 -57.99 2.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.66 -179.904 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 41.27 9.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.604 179.638 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.479 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -111.21 -10.24 14.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.885 0.374 . . . . 0.0 110.78 179.621 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.045 HD21 HD12 ' A' ' 36' ' ' ILE . 4.6 tp -117.14 153.45 32.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.93 137.8 51.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -52.24 158.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.828 -179.967 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 3.5 t30 75.93 -0.09 3.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.325 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -69.11 125.53 26.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.18 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.69 100.69 12.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.672 . . . . 0.0 111.366 -178.837 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.088 HD11 HG21 ' A' ' 19' ' ' ILE . 61.4 mt -47.11 129.15 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.911 179.927 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.619 HD23 ' HD3' ' A' ' 66' ' ' ARG . 3.6 mt -114.95 -32.05 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.586 179.437 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -151.94 155.78 38.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.916 HG13 ' CD2' ' A' ' 86' ' ' LEU . 46.0 t -142.2 102.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.631 179.572 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.13 -68.13 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.088 0.47 . . . . 0.0 110.462 -179.508 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' VAL . 8.3 pt-20 -155.06 30.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.907 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.529 HG21 ' OE2' ' A' ' 79' ' ' GLU . 47.0 t -117.87 142.09 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.2 t0 -109.93 87.77 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.366 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 57' ' ' ILE . 29.9 m -63.37 -138.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.868 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HD3' HD23 ' A' ' 58' ' ' LEU . 0.0 OUTLIER 76.2 -59.73 0.5 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.092 -179.184 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -100.8 30.16 4.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.293 179.03 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.757 ' C ' HG23 ' A' ' 23' ' ' THR . 12.2 m -127.55 142.77 42.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.389 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.41 152.97 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.89 ' O ' HG23 ' A' ' 74' ' ' VAL . 22.7 t-160 -47.91 -33.96 8.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.881 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -65.25 -34.17 77.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.091 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.816 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -63.07 -46.93 85.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.908 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 70' ' ' HIS . 76.3 t -56.25 -50.91 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.287 178.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.58 -29.27 61.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.253 178.944 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.9 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.42 -56.83 16.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.962 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 73' ' ' ALA . 2.2 mp -53.4 -36.84 61.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.983 178.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.42 -27.4 52.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.642 179.521 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -99.44 14.64 29.07 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.435 -178.267 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.946 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.47 16.29 3.9 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.3 -86.71 0.05 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.191 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 13.3 p -144.14 -89.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.456 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.884 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.21 92.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.176 0.512 . . . . 0.0 110.077 179.127 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.946 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -108.1 137.92 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.898 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 11.0 ptp180 -88.29 102.7 15.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.188 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.916 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.2 mt -91.65 138.8 31.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.427 -178.52 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.49 137.36 39.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.138 179.584 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.468 HG21 ' OD2' ' A' ' 55' ' ' ASP . 11.6 m . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.213 -179.4 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CD2' ' HG ' ' A' ' 58' ' ' LEU . 3.2 m-85 . . . . . 0 C--O 1.231 0.092 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.61 166.98 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 111.493 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -119.52 144.95 46.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.979 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.87 111.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.99 0.424 . . . . 0.0 111.856 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.5 120.15 23.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.972 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.98 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -129.83 126.8 38.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.613 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.6 pt-20 -86.68 100.74 12.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.233 179.312 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -47.86 88.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.325 179.531 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.237 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.781 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.98 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.1 tp . . . . . 0 N--CA 1.456 -0.156 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.96 22.14 1.16 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.909 -1.138 . . . . 0.0 114.632 178.446 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.829 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.1 p90 -162.89 134.79 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.76 0.78 . . . . 0.0 111.228 179.02 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.38 139.41 31.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.672 -179.287 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.029 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.74 147.18 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.661 0.743 . . . . 0.0 112.306 -179.92 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 132.62 29.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.876 179.202 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 149.76 -6.48 0.75 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.491 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.32 179.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.977 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 68' ' ' VAL . 19.1 p -65.03 -34.62 78.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.231 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.93 -17.58 29.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.557 -179.552 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -124.43 81.99 58.8 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.45 63.38 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.832 2.354 . . . . 0.0 112.522 -179.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.717 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 t60 -53.16 -22.3 6.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.805 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.43 -152.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.448 179.73 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.674 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.97 50.37 4.39 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.643 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 78.04 47.34 0.05 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.028 0.442 . . . . 0.0 110.455 179.744 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.98 151.46 72.18 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CB ' HG22 ' A' ' 23' ' ' THR . 68.8 Cg_endo -74.45 -2.7 12.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.456 2.104 . . . . 0.0 112.576 179.976 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.402 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -52.16 119.25 4.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.537 179.695 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.823 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -86.55 120.34 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 -179.462 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.18 147.19 36.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.337 0.589 . . . . 0.0 110.564 178.479 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.992 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.943 -176.767 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.51 -30.95 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.783 -1.098 . . . . 0.0 112.215 -179.091 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.68 131.41 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.043 -179.408 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.0 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.84 132.14 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.492 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.44 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.32 124.22 74.08 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.719 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 34.9 Cg_endo -64.59 135.38 45.25 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.675 2.25 . . . . 0.0 112.242 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.94 7.13 60.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.486 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.09 174.51 17.65 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.904 179.804 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.64 -32.75 52.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.642 0.258 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.746 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -72.18 -57.42 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.547 -179.965 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.32 -28.91 67.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.446 -179.535 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -71.9 -31.58 66.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.197 179.596 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -83.83 -57.85 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.932 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.4 40.81 8.8 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.385 179.714 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.456 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.6 mtp85 -112.64 -9.23 13.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.017 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.0 HD23 HD11 ' A' ' 39' ' ' ILE . 6.3 tp -119.35 155.88 31.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.619 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.1 mpt_? -131.99 135.47 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.98 157.72 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.296 0.57 . . . . 0.0 111.721 179.889 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.3 OUTLIER 76.23 -1.27 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.715 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.3 m-20 -69.53 127.71 33.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.69 100.02 12.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.549 0.69 . . . . 0.0 111.281 -178.97 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 19' ' ' ILE . 10.6 mt -45.74 144.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.026 -179.927 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.455 ' HG ' ' CD2' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -123.26 -44.36 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.205 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -140.97 165.78 26.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.818 HG13 ' CD2' ' A' ' 86' ' ' LEU . 42.0 t -150.75 103.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.523 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -71.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.108 0.48 . . . . 0.0 110.226 -179.24 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -151.14 28.56 0.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.816 179.3 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.833 HG12 ' H ' ' A' ' 65' ' ' VAL . 21.5 t -116.04 142.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.21 -179.485 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 38.4 p-10 -103.59 -0.96 28.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.422 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.833 ' H ' HG12 ' A' ' 63' ' ' VAL . 16.7 m 43.65 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.559 -179.645 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -51.92 99.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.765 179.91 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' O ' HG21 ' A' ' 23' ' ' THR . 11.3 pt-20 44.85 57.66 4.46 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 -179.58 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.741 ' C ' HG23 ' A' ' 23' ' ' THR . 4.9 m -108.51 145.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.25 156.84 14.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.337 -178.925 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.923 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.0 p-80 -48.9 -34.29 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.932 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -67.91 -33.86 75.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.568 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.29 -46.1 78.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.181 0.515 . . . . 0.0 109.649 178.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.823 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.37 -45.4 93.35 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 70' ' ' HIS . 66.9 t -56.52 -50.43 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.113 178.517 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.48 -34.65 36.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.862 179.534 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.793 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.49 -57.34 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.94 HD12 HD12 ' A' ' 19' ' ' ILE . 2.4 mt -59.98 -41.32 91.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.38 0.61 . . . . 0.0 110.231 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.604 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.92 -20.13 56.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.766 179.641 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -112.22 23.44 13.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 179.271 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.879 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -82.92 16.57 2.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.752 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.52 -91.24 0.48 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.676 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.0 m -138.29 -90.73 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.859 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 7' ' ' THR . 8.1 tp -86.55 100.23 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.526 179.361 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.879 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.3 p -114.11 139.95 37.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.793 -178.171 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.714 ' HG3' HG23 ' A' ' 7' ' ' THR . 11.7 mtt180 -88.12 103.51 15.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.603 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.818 ' CD2' HG13 ' A' ' 60' ' ' VAL . 17.7 mt -94.1 136.63 34.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -178.942 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 138.17 39.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.377 179.562 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.441 HG11 HD11 ' A' ' 51' ' ' LEU . 5.6 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.992 -179.679 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 71.1 m-85 . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.721 0.296 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -144.7 137.32 26.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.8 pt-20 -103.43 144.61 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.651 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.039 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.91 109.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 111.887 179.925 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.889 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.35 121.14 24.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.612 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.039 HD13 HD11 ' A' ' 6' ' ' ILE . 5.2 tp -130.44 127.2 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.233 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.1 mt-10 -77.78 99.72 6.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.201 179.59 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -62.57 90.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.235 178.455 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.996 -179.47 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.4 tp . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 110.591 -0.152 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.519 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 133.61 19.12 0.96 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.942 -1.123 . . . . 0.0 114.775 178.596 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.865 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.7 p90 -161.31 137.05 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.755 0.778 . . . . 0.0 110.996 179.114 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.69 138.01 33.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.528 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.07 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.22 147.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.669 0.747 . . . . 0.0 112.302 -179.781 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.56 133.67 31.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.168 179.454 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.76 -7.48 1.08 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.531 179.57 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.54 -177.86 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.337 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 30.3 p -64.03 -33.72 76.39 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.914 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 12.2 t70 -89.78 -19.02 25.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.957 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.13 86.94 53.86 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.46 179.897 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.0 61.25 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.407 2.071 . . . . 0.0 112.4 -179.729 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.722 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 54.8 t60 -49.83 -26.12 3.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.187 178.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.774 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.99 -151.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.525 179.616 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.69 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.25 49.87 4.31 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.828 -178.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.18 45.11 0.09 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.088 0.47 . . . . 0.0 110.511 179.558 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.13 78.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.913 179.912 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.502 ' HB3' HG22 ' A' ' 23' ' ' THR . 68.7 Cg_endo -74.77 -1.16 10.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.38 2.053 . . . . 0.0 112.546 179.847 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -51.99 115.91 1.92 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.91 0.386 . . . . 0.0 110.462 179.524 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.06 118.21 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.145 -179.346 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.774 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.94 146.96 38.06 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.372 0.606 . . . . 0.0 110.474 178.42 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.005 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.1 155.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.191 -176.52 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.17 -30.96 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.133 -178.846 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.86 132.93 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.113 -179.496 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.53 132.05 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.889 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.435 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.17 116.17 63.66 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.627 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.39 135.56 68.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.757 2.304 . . . . 0.0 112.273 179.742 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.55 9.49 57.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.655 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.71 179.76 18.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.033 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.38 -36.52 66.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.755 0.312 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.98 -57.35 5.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.029 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.77 -29.94 68.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.02 -178.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.6 pt20 -72.04 -33.42 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.45 -58.04 3.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 41.09 9.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.594 179.479 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.2 mtt-85 -115.38 9.05 15.5 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.751 179.584 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.005 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -136.19 154.58 50.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.627 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.15 135.59 46.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.85 179.841 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -51.4 157.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.437 0.637 . . . . 0.0 111.552 179.998 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.49 0.17 3.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.356 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.8 m-20 -71.35 127.73 33.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.0 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.4 p -86.49 100.41 12.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.576 0.703 . . . . 0.0 111.381 -178.597 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.07 HD11 HG21 ' A' ' 19' ' ' ILE . 68.1 mt -45.46 151.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.127 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -128.91 -46.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.278 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -141.15 163.98 31.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.835 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.4 t -148.67 101.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.603 179.573 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.72 -68.83 0.12 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.1 0.476 . . . . 0.0 110.389 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.8 mm-40 -154.13 30.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.799 179.29 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.832 HG12 ' H ' ' A' ' 65' ' ' VAL . 19.7 t -117.66 142.2 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.165 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 34.5 p-10 -105.54 1.35 27.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.389 179.77 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.832 ' H ' HG12 ' A' ' 63' ' ' VAL . 15.4 m 43.62 30.84 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.813 0.339 . . . . 0.0 111.319 -179.638 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 95.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.992 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 57.04 63.0 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.745 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 19.7 m -119.29 147.72 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.06 155.6 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.214 -179.17 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.1 p-80 -48.17 -34.93 10.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.181 -179.454 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 m -69.83 -33.79 72.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.381 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.87 -47.29 75.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.0 109.645 178.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.3 -46.77 88.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.551 0.691 . . . . 0.0 109.493 178.2 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.7 t -57.41 -48.45 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.296 178.606 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.96 -34.87 68.48 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.518 178.553 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.565 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.46 -51.3 67.39 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.258 0.551 . . . . 0.0 110.016 179.337 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.033 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.28 -37.19 66.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.307 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.47 -26.74 51.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -96.2 6.1 49.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 111.437 -178.647 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -79.14 16.19 1.0 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.65 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.91 -91.11 0.5 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.347 -179.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 10' ' ' ARG . 38.6 m -143.87 -91.15 0.11 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.198 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.889 HG13 HG22 ' A' ' 7' ' ' THR . 8.9 tp -81.68 92.69 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 109.726 178.693 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.913 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -110.89 137.05 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.262 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.8 ptt85 -87.04 103.09 15.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.196 177.676 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.835 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.5 mt -91.51 141.83 28.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.162 -178.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 144.32 30.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.624 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.435 179.714 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.445 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 3.6 m-30 . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.856 0.36 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -164.2 147.1 9.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -102.58 144.65 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.56 109.44 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.487 179.846 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.834 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.47 113.29 17.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.047 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -123.81 127.22 47.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.563 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 pt-20 -86.35 100.13 12.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.275 179.898 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.16 89.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.266 178.328 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.186 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.345 -178.983 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.908 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.94 24.7 1.17 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.854 178.139 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.77 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.1 p90 -162.18 134.95 5.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.985 0.892 . . . . 0.0 111.498 178.923 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.31 134.78 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.173 -179.679 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.085 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.68 166.74 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.706 0.765 . . . . 0.0 111.655 179.936 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -163.62 131.93 3.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.296 179.997 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.46 0.53 1.15 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.456 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.966 -179.976 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.79 HG22 ' CB ' ' A' ' 32' ' ' PRO . 15.0 p -74.78 -20.03 59.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.18 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -98.39 -24.15 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 111.661 -179.376 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -124.53 87.89 53.9 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 179.814 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 63.07 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.317 2.011 . . . . 0.0 112.792 -179.368 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.75 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 38.9 t60 -48.29 -27.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 178.859 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.814 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.39 -154.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.557 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.53 -50.41 63.11 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.582 -179.708 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.01 40.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.914 0.388 . . . . 0.0 110.711 -179.98 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.26 167.22 16.95 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.999 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.79 ' CB ' HG22 ' A' ' 23' ' ' THR . 89.0 Cg_endo -80.92 8.55 4.25 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.645 2.23 . . . . 0.0 112.83 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -60.49 113.76 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 110.772 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.876 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -81.34 119.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.446 179.962 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.814 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.42 145.0 33.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.37 0.605 . . . . 0.0 110.568 178.792 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.052 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.91 155.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.332 -176.333 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.11 -34.28 4.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.81 143.01 2.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 111.55 -179.602 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.011 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -105.77 132.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.097 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.427 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.02 125.91 71.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.475 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.1 Cg_endo -66.89 131.09 24.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 4.82 55.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.457 -179.649 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.78 177.67 21.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.726 179.685 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.19 -36.19 65.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.66 0.267 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.806 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -69.42 -57.53 5.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.517 -179.87 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.01 -28.92 67.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.12 -35.44 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.441 . . . . 0.0 110.0 179.318 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -83.59 -57.99 3.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.03 9.42 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' CB ' HG12 ' A' ' 6' ' ' ILE . 42.5 mtp180 -113.72 8.85 17.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.699 0.285 . . . . 0.0 110.662 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.052 HD21 HD12 ' A' ' 36' ' ' ILE . 4.6 tp -135.08 153.88 51.88 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.609 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.56 136.65 49.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.879 179.937 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.9 t -51.18 158.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.331 0.586 . . . . 0.0 111.676 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.29 2.17 4.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.023 179.911 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -71.02 126.03 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.988 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -86.48 101.95 13.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.652 0.739 . . . . 0.0 111.346 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.085 HD11 HG21 ' A' ' 19' ' ' ILE . 57.4 mt -49.74 136.27 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.38 -38.29 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.174 179.545 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -147.34 172.01 14.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.798 -179.73 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.858 HG13 ' CD2' ' A' ' 86' ' ' LEU . 36.7 t -150.27 96.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.996 179.351 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.764 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 68.44 -67.17 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.193 0.52 . . . . 0.0 109.775 -178.789 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -156.28 32.34 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.555 179.209 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.8 t -119.23 142.33 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.57 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.9 p-10 -111.07 106.77 15.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.214 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.454 HG12 HG21 ' A' ' 68' ' ' VAL . 31.4 m -91.88 43.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.52 -179.517 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.58 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.736 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.43 66.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 23' ' ' THR . 35.6 m -134.6 145.63 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 151.69 28.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.753 -179.884 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.8 t-160 -48.98 -33.67 11.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 t -67.15 -34.06 76.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.045 179.642 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.39 -40.39 81.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.829 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.876 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.55 -46.76 78.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.112 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 97.4 t -57.19 -50.29 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.143 178.563 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.25 -33.04 62.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.693 178.646 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.218 0.533 . . . . 0.0 110.124 179.453 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.048 HD11 HD12 ' A' ' 19' ' ' ILE . 1.4 mt -53.12 -37.57 61.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.212 178.857 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.47 -27.58 52.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.305 178.953 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -87.63 -17.65 31.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.021 0.438 . . . . 0.0 111.092 -178.825 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.973 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -52.32 -21.42 3.51 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.489 179.828 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.04 -91.31 1.44 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.045 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -134.49 -92.87 0.31 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.834 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -86.57 93.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.34 0.59 . . . . 0.0 109.983 178.961 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.973 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.7 p -110.17 139.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.232 -177.493 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.724 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.43 103.07 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.863 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.858 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.8 mt -93.81 135.73 34.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -101.73 139.92 36.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 -179.946 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 55' ' ' ASP . 25.9 m . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.992 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CG ' HD22 ' A' ' 58' ' ' LEU . 9.9 m-30 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.893 0.378 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.19 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.624 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.424 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 4.4 tt0 -130.36 141.65 50.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.683 0.278 . . . . 0.0 111.098 -179.822 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.023 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.1 112.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.026 0.441 . . . . 0.0 111.87 179.755 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.77 121.95 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.698 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.064 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.9 tp -131.14 127.14 37.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.368 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.4 pt-20 -82.96 100.36 10.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.208 179.276 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.03 88.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.107 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.451 -0.315 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.61 -180.0 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.064 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.244 0.068 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.02 28.15 0.88 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.922 178.33 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.7 p90 -162.9 132.92 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.879 0.84 . . . . 0.0 111.03 178.771 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.568 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -90.83 134.88 34.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.437 -179.2 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.03 163.63 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.703 0.763 . . . . 0.0 111.756 -179.944 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -159.06 130.67 6.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.931 179.452 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 146.91 -1.03 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.319 179.82 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.61 -172.08 0.25 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.91 -179.857 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.818 HG22 ' HB3' ' A' ' 32' ' ' PRO . 28.6 p -69.77 -34.38 73.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.308 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.43 -19.56 25.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.424 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -124.68 82.41 59.78 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 0.0 110.292 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.98 62.48 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.803 2.335 . . . . 0.0 112.224 -179.594 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.5 t60 -50.73 -23.39 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.413 179.016 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.85 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -93.92 -154.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.308 179.582 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.57 -50.26 68.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.584 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.13 40.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -127.84 168.52 14.99 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.022 -179.913 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.18 3.2 6.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.01 2.473 . . . . 0.0 112.702 -179.81 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 2.7 m -53.96 112.17 0.9 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.863 0.363 . . . . 0.0 111.092 -179.917 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.867 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.34 119.64 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.388 179.914 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.85 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.58 144.48 32.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.505 0.669 . . . . 0.0 110.585 178.952 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.151 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.07 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.88 -176.593 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.463 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.57 -31.9 4.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.809 -178.842 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.47 142.12 2.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.384 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.952 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.89 133.82 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.26 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.476 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.94 119.28 73.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.18 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.8 Cg_exo -58.87 132.6 48.61 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.757 2.304 . . . . 0.0 112.137 179.748 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.82 -1.16 59.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.763 -179.976 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.36 177.39 28.47 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.873 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.78 -35.53 63.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.969 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.843 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.26 -57.39 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 -179.997 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.89 -28.97 68.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.318 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -71.81 -34.23 69.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.13 0.491 . . . . 0.0 109.889 179.509 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.08 -57.74 2.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.49 42.01 9.54 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.362 179.655 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtp180 -110.27 -18.64 13.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.688 179.765 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.151 HD21 HD12 ' A' ' 36' ' ' ILE . 4.8 tp -106.69 153.26 22.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.089 0.471 . . . . 0.0 110.666 179.371 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -127.85 135.89 50.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.919 179.825 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -50.29 160.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.495 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.2 m120 71.45 4.1 4.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.154 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.556 ' CG ' HG21 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -71.06 124.35 24.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.589 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.6 p -86.42 100.0 12.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.561 0.696 . . . . 0.0 111.709 -178.193 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.036 HD11 HG21 ' A' ' 19' ' ' ILE . 9.9 mt -53.12 129.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.861 179.792 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.4 pp -122.53 -18.61 6.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.521 178.974 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.524 ' HD1' HD12 ' A' ' 58' ' ' LEU . 1.9 m-85 -157.36 162.36 39.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.026 0.441 . . . . 0.0 110.652 -179.979 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.914 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.8 t -143.92 97.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.86 179.41 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.832 ' CG ' HG23 ' A' ' 84' ' ' VAL . 1.3 t-20 66.59 -69.02 0.13 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.159 0.504 . . . . 0.0 109.889 -178.572 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -152.89 29.66 0.51 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.866 179.174 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.5 t -115.98 141.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.359 -179.402 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.5 p-10 -113.47 97.18 6.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.492 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 65' ' ' VAL . 31.4 m -69.62 64.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.191 -179.781 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -91.31 101.02 13.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.547 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.41 51.01 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.019 -179.902 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.762 ' C ' HG23 ' A' ' 23' ' ' THR . 19.1 m -116.41 142.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 179.639 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.481 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.54 153.29 23.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.025 -179.129 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.881 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.1 p-80 -47.95 -33.82 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.963 -179.671 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -33.96 70.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.947 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.631 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.35 -44.56 82.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 109.724 179.321 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.867 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.01 -46.88 87.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.773 0.797 . . . . 0.0 109.161 178.095 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.911 HG22 HD11 ' A' ' 19' ' ' ILE . 90.0 t -56.22 -50.45 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.299 178.601 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.631 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.11 -29.84 61.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.379 179.071 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -61.94 -50.3 72.68 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.404 0.621 . . . . 0.0 109.986 179.57 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -59.05 -36.13 74.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.771 179.271 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -24.03 50.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.889 178.788 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -101.78 16.27 26.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.792 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.28 16.21 5.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.75 -93.97 0.75 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.316 -179.999 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.7 m -141.42 -89.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 7' ' ' THR . 6.8 tp -84.07 89.02 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.646 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.901 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.6 p -105.38 136.29 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.182 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.01 102.94 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.664 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.914 ' CD2' HG13 ' A' ' 60' ' ' VAL . 38.0 mt -89.12 137.34 32.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.389 -178.836 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.559 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.1 122.84 44.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.529 179.679 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 57' ' ' ILE . 17.0 m . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.565 -179.938 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' HD11 ' A' ' 58' ' ' LEU . 6.4 m-85 . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.849 0.357 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 11.2 pt-20 -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -118.73 144.71 46.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 -179.978 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.013 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.7 109.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 111.863 179.857 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.719 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.91 116.37 20.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.525 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.047 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.9 tp -126.06 127.36 45.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.249 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.8 pm0 -86.84 100.46 12.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.713 179.596 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.587 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 1.3 mtm180 -44.32 91.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.682 179.109 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.32 -0.342 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.256 -179.19 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.047 ' HB3' HD23 ' A' ' 8' ' ' LEU . 16.4 mt . . . . . 0 N--CA 1.455 -0.218 0 CA-C-O 120.776 0.322 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 137.0 34.62 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.71 179.318 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.7 p90 -159.64 138.08 10.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.137 0.469 . . . . 0.0 110.938 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.99 132.19 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.811 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.052 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -108.2 165.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.77 . . . . 0.0 111.803 -179.905 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -164.27 131.3 3.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.356 179.845 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.66 0.2 0.97 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.632 179.614 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.52 -170.96 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.977 -179.871 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.798 HG22 ' CB ' ' A' ' 32' ' ' PRO . 13.2 p -75.34 -20.79 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.187 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.85 -24.96 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 -179.347 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -124.39 87.66 53.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.208 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 63.12 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.418 2.079 . . . . 0.0 112.686 -179.484 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.69 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.0 t60 -47.96 -27.9 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 178.887 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.874 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.59 -155.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.357 179.301 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.678 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.8 -46.78 59.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.562 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.2 m-20 176.71 73.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -165.67 165.69 10.85 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.798 ' CB ' HG22 ' A' ' 23' ' ' THR . 82.9 Cg_endo -81.21 5.7 6.07 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.674 2.249 . . . . 0.0 112.923 -179.947 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.405 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -56.0 112.87 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.948 179.953 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.846 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.51 119.16 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 -179.911 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.874 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.26 145.9 34.54 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.505 0.669 . . . . 0.0 110.847 178.653 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.05 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.73 155.97 7.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.008 -176.897 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.469 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.88 -27.47 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.622 -178.411 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.64 128.67 0.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.211 -179.444 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.031 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.98 130.51 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.662 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 114.74 56.63 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.569 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.5 Cg_exo -57.94 135.58 69.73 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.781 2.32 . . . . 0.0 112.217 179.918 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.12 15.27 39.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.97 179.58 16.09 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.037 179.773 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.33 -38.55 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.734 0.302 . . . . 0.0 111.343 -179.982 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.817 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.98 -57.65 7.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.012 -179.538 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.2 -28.76 64.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 -179.4 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -32.87 67.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.916 0.389 . . . . 0.0 110.264 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -79.63 -58.1 3.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.582 179.967 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.5 9.92 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.645 179.433 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.512 ' CB ' HG12 ' A' ' 6' ' ' ILE . 25.9 mtt180 -119.36 7.23 11.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.868 0.334 . . . . 0.0 110.941 179.68 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.05 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -134.3 154.8 51.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.917 179.555 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 135.1 43.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.863 179.995 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 38' ' ' LYS . 59.9 t -49.14 158.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.278 0.561 . . . . 0.0 111.55 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.3 t-20 73.69 4.19 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.992 -179.807 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.4 m-20 -73.27 124.23 25.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.46 101.77 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.693 0.759 . . . . 0.0 111.63 -178.395 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 19' ' ' ILE . 57.8 mt -49.46 137.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.547 HD11 ' CD1' ' A' ' 3' ' ' TYR . 3.9 mt -117.1 -34.03 4.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 179.246 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -149.55 169.24 21.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.734 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.8 t -146.56 97.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.278 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.903 ' OD1' HG23 ' A' ' 84' ' ' VAL . 4.3 t30 67.26 -68.1 0.16 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.256 0.55 . . . . 0.0 109.82 -178.655 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -155.68 32.87 0.36 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.527 179.106 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 57.3 t -119.38 142.27 35.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.523 -179.12 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -110.0 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.294 179.052 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.467 HG12 HG21 ' A' ' 68' ' ' VAL . 30.6 m -92.48 40.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.36 . . . . 0.0 111.414 -179.66 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.831 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -151.59 66.33 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 23' ' ' THR . 35.6 m -133.08 145.42 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.75 151.89 24.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 -179.808 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 t-160 -49.49 -33.61 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 t -67.12 -33.99 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.994 179.583 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -40.07 80.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.772 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.846 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.68 -46.88 77.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.014 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.8 t -57.32 -49.99 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.251 178.533 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.15 -34.33 66.04 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.669 178.633 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.699 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.66 -51.07 70.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.182 0.515 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.034 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.7 -36.35 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.476 178.955 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.26 -22.48 52.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.209 179.053 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -97.39 -11.99 23.3 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.38 -178.879 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.957 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.33 -18.99 19.64 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 179.944 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.07 -101.19 2.56 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.994 -179.825 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.587 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.9 p -127.67 -90.4 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.871 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.719 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.6 tp -87.19 91.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.589 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.957 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.3 p -107.16 137.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.296 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.2 ttt85 -86.71 103.1 14.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.131 177.762 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.734 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.4 mt -91.67 142.98 27.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.451 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 134.23 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.476 179.789 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.544 HG11 HD11 ' A' ' 51' ' ' LEU . 29.0 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 111.211 -179.724 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 53.0 m-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.77 0.319 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -142.7 148.23 36.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.48 144.88 31.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.694 179.78 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.953 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.51 109.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.933 -179.779 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.899 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.42 123.41 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.774 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -133.69 126.78 31.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.089 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -85.19 99.83 11.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.926 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.91 86.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.362 179.188 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.271 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.56 -179.509 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.922 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.8 tp . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.828 0.346 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 74.14 31.08 60.0 Favored Glycine 0 CA--C 1.519 0.281 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 177.829 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.806 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 6.5 p90 -164.52 131.38 3.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.282 1.041 . . . . 0.0 111.628 178.559 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -97.33 138.96 34.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.866 -179.083 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.027 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.7 148.93 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 112.01 179.864 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.676 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.62 133.19 25.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.937 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.14 -3.32 0.9 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.586 179.783 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.49 179.97 0.12 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' C ' ' A' ' 68' ' ' VAL . 26.5 p -65.24 -35.11 80.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.419 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.03 -17.14 29.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.628 0.251 . . . . 0.0 111.519 -179.486 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.56 82.05 59.45 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.043 0.449 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.14 62.87 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.853 2.368 . . . . 0.0 112.541 -179.291 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.713 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.5 t60 -52.28 -22.71 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 178.78 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.853 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.71 -154.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.645 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.662 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.03 -49.8 74.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.551 -179.798 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.51 39.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.56 167.44 17.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.833 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.717 ' CB ' HG22 ' A' ' 23' ' ' THR . 98.6 Cg_endo -79.11 1.93 8.74 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.668 2.245 . . . . 0.0 112.755 179.995 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.78 115.27 1.73 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.821 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -86.5 121.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.566 -179.831 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.853 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.08 146.88 35.94 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.315 0.579 . . . . 0.0 110.59 178.824 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.017 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.98 155.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.69 -176.897 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.52 -30.72 4.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.174 -178.971 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.75 128.32 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.212 -0.595 . . . . 0.0 112.33 -179.362 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.98 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.47 127.03 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.69 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.24 119.39 73.14 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -177.814 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.5 Cg_exo -54.36 140.32 73.3 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.718 2.279 . . . . 0.0 112.297 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.75 12.98 70.77 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.537 -179.923 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.61 -158.68 21.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.978 179.779 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.96 -38.85 57.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.869 0.334 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.88 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.13 -54.46 7.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.586 -179.63 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -60.59 -32.48 71.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -72.36 -37.31 68.82 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.03 0.443 . . . . 0.0 110.308 179.514 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.62 -57.85 3.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.28 35.6 14.38 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.529 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.9 mmm180 -110.7 -12.56 14.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.701 179.584 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.017 HD21 HD12 ' A' ' 36' ' ' ILE . 6.2 tp -113.66 155.84 24.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.579 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.0 tpt180 -134.87 135.11 41.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.47 157.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.279 0.561 . . . . 0.0 111.638 179.935 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' HG12 ' A' ' 53' ' ' VAL . 4.9 t-20 75.7 -1.65 2.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.277 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.5 m-20 -68.48 126.6 30.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.936 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 p -86.57 100.14 12.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 111.471 -178.616 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -45.47 153.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.813 179.999 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -136.79 -46.23 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.64 -179.669 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -142.21 167.11 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.928 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.5 t -142.36 100.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.897 179.34 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.639 ' HB2' HG23 ' A' ' 84' ' ' VAL . 3.1 t-20 66.36 -68.04 0.14 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.199 0.523 . . . . 0.0 109.667 -178.517 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.2 mt-10 -156.65 31.28 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.38 178.974 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -116.36 142.52 29.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.452 -179.006 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 3.7 p-10 -108.29 120.18 41.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.505 179.176 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 19.1 m -93.79 37.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.15 -179.983 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -71.06 100.89 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.06 50.02 1.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.751 ' C ' HG23 ' A' ' 23' ' ' THR . 14.0 m -114.92 142.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.732 179.464 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.462 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.96 153.0 26.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.069 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.939 ' O ' HG23 ' A' ' 74' ' ' VAL . 11.0 t-160 -48.79 -33.98 11.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.516 -179.964 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -34.12 76.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.301 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.96 -42.69 80.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.478 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.821 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.81 -46.66 84.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.003 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 70' ' ' HIS . 58.0 t -57.17 -50.35 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.1 178.639 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.655 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.34 -32.55 38.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.772 179.222 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -68.38 -57.11 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.845 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.95 HD12 HD12 ' A' ' 19' ' ' ILE . 4.2 mt -64.1 -39.79 94.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.009 -179.436 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.596 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -77.1 -20.06 56.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.334 -179.73 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.655 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 4.4 mm-40 -104.1 -10.78 17.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.02 0.438 . . . . 0.0 110.873 178.894 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.87 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.17 -20.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.566 179.944 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.62 -104.33 2.99 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -117.8 -92.89 0.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.764 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.889 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -87.58 102.7 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.058 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.87 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -118.04 138.75 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.6 -178.6 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.899 ' HG2' HG23 ' A' ' 7' ' ' THR . 5.6 mtm180 -87.05 103.56 15.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.638 178.817 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.928 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.4 mt -93.58 139.17 31.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.018 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 137.99 39.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.763 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 29.0 m . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.422 179.837 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.781 ' CD1' HD22 ' A' ' 58' ' ' LEU . 4.0 m-30 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.834 0.35 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.477 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.7 mt-10 -109.55 125.43 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 12.2 pt-20 -94.7 144.62 25.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.984 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -142.26 109.51 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.715 179.935 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.792 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.45 122.01 24.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.031 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.043 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.3 tp -132.02 128.03 37.45 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.556 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.4 pt-20 -86.43 100.5 12.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.32 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.577 ' CG ' HD23 ' A' ' 15' ' ' LEU . 6.1 mtp-105 -42.74 91.56 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.105 179.592 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.317 -0.521 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.878 -179.545 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.043 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.5 mt . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.945 0.403 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.21 38.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.397 179.505 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.779 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -164.12 134.06 4.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.195 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.54 136.93 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.638 -179.34 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.31 148.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.643 0.735 . . . . 0.0 112.032 179.934 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.98 131.83 24.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.688 179.264 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.82 -3.72 0.84 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.787 179.644 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.04 179.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.675 179.91 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.851 HG22 ' CB ' ' A' ' 32' ' ' PRO . 17.5 p -70.34 -21.55 62.89 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.43 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -92.02 -26.58 18.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.792 0.33 . . . . 0.0 111.271 -179.679 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -124.48 87.52 54.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.33 64.94 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.362 2.042 . . . . 0.0 112.653 -179.432 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.716 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.0 t60 -48.96 -27.43 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.404 178.998 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.848 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.54 -154.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.428 179.439 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.03 -49.45 78.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.691 -179.709 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.44 39.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.65 165.59 25.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 -179.929 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.851 ' CB ' HG22 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.03 1.98 8.69 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.656 2.237 . . . . 0.0 112.747 -179.822 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.57 116.66 2.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.829 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -86.32 120.05 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.592 -179.966 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.848 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.14 147.81 37.27 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.327 0.584 . . . . 0.0 110.726 178.762 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.994 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.828 -177.008 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.467 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -33.38 4.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.662 -179.173 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.26 142.84 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.0 111.41 -179.881 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.951 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.5 131.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.39 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.98 121.26 75.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.976 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.4 Cg_endo -63.89 136.95 55.5 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.836 2.358 . . . . 0.0 112.418 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 18.29 37.2 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.303 -179.894 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.63 179.42 16.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.233 179.886 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.09 -31.4 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.684 0.278 . . . . 0.0 111.384 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.792 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -74.18 -56.57 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.511 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.71 -30.31 65.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.066 -178.992 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 15.6 pt20 -71.96 -31.61 66.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.999 0.428 . . . . 0.0 110.331 179.534 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.38 -57.99 3.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.682 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.4 9.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.62 179.521 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.463 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.3 mtt-85 -114.87 -7.59 12.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.925 179.697 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.994 HD21 HD12 ' A' ' 36' ' ' ILE . 6.1 tp -119.93 155.73 32.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.085 0.469 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.594 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.6 tpt180 -134.05 135.08 43.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.6 t -49.91 157.43 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.368 0.604 . . . . 0.0 111.56 -179.95 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 7.5 t-20 75.0 -0.89 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.118 -179.98 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.78 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -68.15 124.95 24.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 178.851 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.55 100.32 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.649 . . . . 0.0 111.573 -178.386 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 19' ' ' ILE . 10.4 mt -47.86 131.28 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.875 179.865 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 3' ' ' TYR . 57.0 tp -114.3 -35.08 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.499 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -150.51 155.36 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.736 -179.817 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.946 HG11 ' HB1' ' A' ' 76' ' ' ALA . 27.8 t -130.82 96.51 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.974 179.288 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.777 ' CG ' HG23 ' A' ' 84' ' ' VAL . 4.9 t30 67.59 -67.9 0.17 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.173 0.511 . . . . 0.0 109.797 -178.777 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 60' ' ' VAL . 15.7 mt-10 -153.6 31.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.752 179.122 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.8 t -119.8 142.19 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.39 -179.277 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 27.8 t0 -107.96 107.33 17.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.538 179.211 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.24 42.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -65.61 -30.76 71.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.799 179.907 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -154.68 69.03 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.721 ' C ' HG23 ' A' ' 23' ' ' THR . 10.1 m -133.14 144.75 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.075 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.02 152.59 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.726 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.93 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.2 t-160 -48.17 -33.92 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.903 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -33.94 76.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 179.335 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.83 -43.45 79.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.606 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.829 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.85 -45.67 91.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.996 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 70' ' ' HIS . 56.8 t -57.89 -50.31 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.191 178.635 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.691 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.95 -30.36 34.2 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.353 178.882 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.946 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.59 -56.98 6.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.596 -179.587 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -65.19 -40.44 94.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.16 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.659 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -76.82 -20.23 56.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.701 -179.398 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.691 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.8 mm-40 -109.11 -5.49 15.97 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 179.179 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.849 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.21 -22.07 0.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.594 179.957 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.61 -101.62 1.97 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.599 -179.77 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -122.84 -91.45 0.55 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.626 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.792 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.3 tp -90.99 98.98 9.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.089 0.471 . . . . 0.0 110.265 179.108 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.849 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.3 p -113.07 138.18 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -177.792 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.0 ttt180 -86.93 103.86 15.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.143 178.933 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.78 HD13 HD22 ' A' ' 77' ' ' LEU . 16.7 mt -93.59 132.91 37.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.563 -179.253 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -101.99 151.5 22.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.539 179.691 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.78 HG21 ' OD2' ' A' ' 55' ' ' ASP . 18.5 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.343 -179.895 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.461 ' CD1' HD11 ' A' ' 58' ' ' LEU . 8.4 m-30 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.81 0.338 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.53 143.55 48.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.888 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.41 144.87 29.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.053 179.957 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.979 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.16 109.36 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.078 0.466 . . . . 0.0 111.411 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.925 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.26 120.98 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.319 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.979 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -129.71 126.69 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.634 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.567 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -86.66 100.88 12.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.185 179.178 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.65 88.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.211 179.599 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.247 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.608 -179.949 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.974 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.22 19.4 1.55 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.021 -1.085 . . . . 0.0 114.513 178.404 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.858 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.6 p90 -162.09 137.33 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.844 0.822 . . . . 0.0 111.245 179.223 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.47 136.2 38.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.615 -179.426 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.54 156.62 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.736 0.779 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -152.22 132.38 13.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.75 -3.18 1.11 Allowed Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.669 179.639 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.36 178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.918 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 68' ' ' VAL . 29.1 p -65.98 -27.38 68.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.246 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -93.43 -19.95 20.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.672 0.273 . . . . 0.0 111.63 -179.647 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 70' ' ' HIS . 0.5 OUTLIER -124.24 86.86 54.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.392 179.897 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 62.4 0.84 Allowed 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.396 2.064 . . . . 0.0 112.705 -179.409 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.701 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 26.4 t60 -48.1 -28.87 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.019 178.977 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.863 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.12 -155.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.121 179.277 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.2 -49.44 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.276 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -177.46 51.29 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.911 0.386 . . . . 0.0 111.153 -179.585 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 158.27 70.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 23' ' ' THR . 92.7 Cg_endo -78.53 0.86 9.57 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.677 2.251 . . . . 0.0 112.661 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.9 m -54.31 119.85 5.73 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.958 0.408 . . . . 0.0 111.291 -179.912 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.818 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.43 119.93 34.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 179.824 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.863 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.82 146.67 36.14 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.399 0.618 . . . . 0.0 110.762 178.749 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.054 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.76 155.84 7.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.055 -176.636 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.81 -30.38 4.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.307 -178.624 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.81 129.05 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.174 -179.321 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.91 131.68 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.569 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 113.88 51.11 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.825 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 49.7 Cg_exo -56.21 140.15 87.09 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.739 2.292 . . . . 0.0 112.392 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.82 10.37 64.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.483 -179.898 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.87 178.34 18.3 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.874 179.808 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.85 -35.38 66.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.796 0.331 . . . . 0.0 111.067 -179.995 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.756 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.87 -57.56 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.55 -28.73 67.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -71.88 -31.68 66.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.239 179.521 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 -57.78 3.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.96 35.77 14.87 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.439 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.3 mtt-85 -115.32 -2.06 12.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 111.227 179.874 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.054 HD21 HD12 ' A' ' 36' ' ' ILE . 5.9 tp -127.2 154.61 44.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.158 0.504 . . . . 0.0 111.34 179.98 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.71 135.29 43.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.543 179.93 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.47 157.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.496 179.934 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.8 0.43 3.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 -179.865 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.529 ' HB3' HG11 ' A' ' 88' ' ' VAL . 4.8 m-20 -69.67 126.08 28.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.931 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.2 p -86.49 100.39 12.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.467 0.651 . . . . 0.0 111.673 -178.322 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.033 HD11 HG21 ' A' ' 19' ' ' ILE . 61.7 mt -48.72 146.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.077 -179.961 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.461 HD11 ' CD1' ' A' ' 3' ' ' TYR . 12.4 mt -128.25 -38.96 1.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.424 179.615 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -145.72 155.31 42.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.899 -179.758 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.921 HG11 ' HB1' ' A' ' 76' ' ' ALA . 42.1 t -136.42 100.55 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.409 ' HB2' HG23 ' A' ' 84' ' ' VAL . 6.2 t-20 67.53 -67.04 0.19 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.958 0.408 . . . . 0.0 110.046 -179.14 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.3 mt-10 -157.29 32.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.751 179.289 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -120.72 142.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.539 -179.23 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.3 t0 -106.04 107.93 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.293 179.208 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.521 HG12 HG21 ' A' ' 68' ' ' VAL . 21.8 m -93.81 35.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.522 -179.623 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.48 -37.25 80.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 110.78 179.974 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.42 54.59 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -179.897 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 23' ' ' THR . 32.9 m -116.12 148.95 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.896 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.439 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -64.8 154.69 36.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.033 -179.378 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.919 ' O ' HG23 ' A' ' 74' ' ' VAL . 19.1 t-160 -50.57 -33.94 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -34.03 75.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.133 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.62 -41.76 79.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 109.266 178.522 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.818 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.8 -46.12 83.37 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.1 t -57.4 -50.51 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.029 178.564 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -51.58 -34.16 35.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.694 179.417 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.921 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.81 -57.59 5.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.248 -179.508 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.929 HD12 HD12 ' A' ' 19' ' ' ILE . 2.1 mt -60.53 -40.85 93.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.244 -179.772 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.597 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.78 -20.06 56.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.768 179.669 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 4.1 pt-20 -112.24 22.3 14.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 111.24 179.579 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.926 ' HB1' ' HB ' ' A' ' 84' ' ' VAL . . . -83.19 16.64 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.829 -179.729 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.91 -85.59 0.21 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.83 -179.783 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 40.3 m -142.3 -89.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.925 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -86.37 105.64 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.869 0.366 . . . . 0.0 110.662 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.926 ' HB ' ' HB1' ' A' ' 80' ' ' ALA . 5.0 p -120.89 136.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.392 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.7 mtm105 -85.79 103.39 14.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.373 178.17 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.783 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.1 mt -93.98 134.8 35.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.394 -178.822 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.84 142.58 32.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.89 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 55' ' ' ASP . 24.9 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.951 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CD1' HD11 ' A' ' 58' ' ' LEU . 15.9 m-30 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.909 0.385 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -134.77 165.87 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.98 144.78 43.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 -179.837 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.089 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.83 109.51 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.402 179.876 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.41 119.68 21.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.65 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.089 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -130.75 128.08 40.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.403 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 4.6 pt-20 -86.71 100.21 12.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.354 179.685 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -42.87 90.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.364 179.496 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.419 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.638 179.77 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 1.008 ' HB3' HD23 ' A' ' 8' ' ' LEU . 18.4 mt . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 129.42 33.02 0.54 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.515 179.458 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.815 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.86 137.41 12.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.977 0.389 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.88 136.71 37.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.302 -179.499 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.081 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.56 146.6 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.703 0.763 . . . . 0.0 112.264 -179.935 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.18 133.61 31.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.241 179.338 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.7 3.84 0.79 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.696 179.577 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.69 -169.26 0.5 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.902 -179.917 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.831 HG22 ' HB3' ' A' ' 32' ' ' PRO . 43.0 p -72.39 -27.86 62.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.104 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -93.75 -22.0 18.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.047 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 11.5 t-20 -124.39 87.52 53.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.579 0.228 . . . . 0.0 110.485 -179.991 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 62.51 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.271 1.981 . . . . 0.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.8 t60 -47.16 -28.24 1.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.396 179.049 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.822 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.54 -154.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.362 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.5 -49.96 72.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.53 -179.697 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.03 40.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.6 164.06 36.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.831 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.9 Cg_exo -74.81 1.77 7.26 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.0 112.776 -179.88 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -52.75 113.43 1.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.978 0.418 . . . . 0.0 111.07 -179.814 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.43 117.85 30.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.999 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.822 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.13 147.46 40.23 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.276 0.56 . . . . 0.0 110.644 178.673 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.079 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.06 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.042 -176.771 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.43 -30.1 4.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.321 -178.846 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.648 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.09 130.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.065 -179.447 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.028 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.96 130.53 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.636 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.493 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 123.84 74.61 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.752 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.1 Cg_endo -66.14 132.0 28.53 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.798 2.332 . . . . 0.0 112.256 -179.879 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.66 16.74 23.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.331 -179.916 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.46 178.69 16.82 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.985 179.862 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.15 -38.78 63.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.803 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.44 -57.49 8.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.892 -179.502 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.83 -28.85 63.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -179.434 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -72.12 -34.15 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.543 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.12 -58.04 3.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.687 -179.936 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 38.08 13.93 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.624 179.452 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.513 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.9 mmt180 -117.9 7.05 12.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.776 0.322 . . . . 0.0 110.842 179.686 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.079 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -133.22 154.53 50.57 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 110.835 179.585 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.19 135.47 45.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.957 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.61 157.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 111.751 179.965 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.45 -0.55 3.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.27 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.67 126.37 29.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.035 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.57 103.31 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 111.316 -178.812 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.081 HD11 HG21 ' A' ' 19' ' ' ILE . 67.0 mt -51.21 134.21 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.723 -179.999 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' A' ' 3' ' ' TYR . 2.2 mt -116.19 -28.11 6.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.662 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -153.77 165.99 34.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.667 HG11 ' HB1' ' A' ' 76' ' ' ALA . 40.9 t -148.18 98.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.018 179.464 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' HG23 ' A' ' 84' ' ' VAL . 13.4 t30 67.79 -67.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 -178.844 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.48 32.47 0.27 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.621 179.218 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.2 t -119.34 142.24 35.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.597 -179.293 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.7 p-10 -111.19 88.04 2.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.331 179.258 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 65' ' ' VAL . 29.5 m -69.99 63.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.563 -179.522 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 66' ' ' ARG . 4.0 ptm85 -86.93 -32.77 19.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.688 179.643 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -145.47 59.02 1.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.8 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 23' ' ' THR . 35.9 m -124.55 147.72 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.46 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.36 154.65 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 -179.464 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 p-80 -48.59 -34.32 11.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.137 -179.573 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -33.69 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.67 -45.44 82.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.9 -46.77 89.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 178.069 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.3 t -57.6 -48.22 83.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.664 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.94 -33.07 68.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.583 178.717 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.55 -50.12 74.14 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.286 0.565 . . . . 0.0 109.817 179.317 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.04 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.99 -36.61 70.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.449 178.868 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.8 mmmt -77.15 -24.72 51.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.97 -12.9 27.73 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.067 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.914 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -56.74 -19.29 16.09 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 179.721 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.19 -108.18 3.39 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.034 -179.881 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.88 -90.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.03 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.838 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.2 tp -89.63 91.54 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.388 0.613 . . . . 0.0 109.674 178.719 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.914 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -105.81 139.88 25.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.357 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.64 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -87.45 103.18 15.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.647 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.4 mt -91.36 139.82 30.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.17 -178.985 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.77 134.1 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.618 179.893 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.48 HG11 HD11 ' A' ' 51' ' ' LEU . 22.1 m . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.188 179.846 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.839 ' CD1' HD22 ' A' ' 58' ' ' LEU . 21.1 m-85 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.934 0.397 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -105.01 170.75 7.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.722 179.647 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -131.83 144.77 51.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.91 111.07 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.909 0.385 . . . . 0.0 111.909 179.912 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.75 117.87 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.475 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -127.26 127.22 44.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.255 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.34 100.08 11.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.522 179.432 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.37 87.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.181 179.258 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 CA--C 1.518 0.249 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.605 -179.825 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.951 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.7 tp . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.76 25.21 1.03 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 119.789 -1.196 . . . . 0.0 114.801 178.409 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.788 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -162.97 135.19 5.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.873 0.836 . . . . 0.0 111.066 178.887 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.87 137.89 33.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.506 -179.242 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.1 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.8 146.24 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 112.404 179.929 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.613 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.32 133.82 33.48 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.174 179.348 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.62 3.87 0.8 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.643 179.585 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.516 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.65 -168.85 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.893 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.834 HG22 ' HB3' ' A' ' 32' ' ' PRO . 41.5 p -72.14 -29.41 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.193 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.06 -20.76 20.22 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.162 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 35.7 t-20 -124.42 87.57 53.99 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.496 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.81 61.91 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.283 1.989 . . . . 0.0 112.388 -179.768 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.707 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 47.5 t60 -47.16 -28.45 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.185 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.81 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.0 -154.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.183 179.386 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -57.7 -50.01 69.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.57 -179.815 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 171.87 40.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.36 166.69 21.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.834 ' HB3' HG22 ' A' ' 23' ' ' THR . 4.9 Cg_exo -75.04 2.33 6.77 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.037 2.491 . . . . 0.0 112.733 -179.734 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.24 111.67 0.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.842 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.16 118.27 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.675 179.987 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.81 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.77 147.91 39.84 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.303 0.573 . . . . 0.0 110.725 178.629 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.029 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.09 155.61 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.986 -176.829 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.446 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.58 -30.78 4.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.039 -178.98 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.625 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.47 132.29 0.6 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -179.53 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.995 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.56 132.26 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.739 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.25 130.12 55.48 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.486 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 50.9 Cg_endo -69.14 129.97 19.24 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 -179.996 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 2.08 55.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.495 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.65 174.37 21.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.751 179.676 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.7 -35.34 55.36 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.649 -0.324 . . . . 0.0 111.11 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.795 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -70.85 -57.39 4.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.601 -179.799 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.468 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.47 -29.07 68.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -72.19 -35.38 68.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.048 0.451 . . . . 0.0 109.969 179.346 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -84.69 -57.94 2.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.614 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.22 41.38 9.37 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.556 179.625 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.7 mtp85 -112.05 8.88 20.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.029 HD21 HD12 ' A' ' 36' ' ' ILE . 4.9 tp -136.16 154.06 51.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.687 179.641 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.99 135.21 48.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.824 179.869 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.47 157.82 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.31 0.576 . . . . 0.0 111.595 -180.0 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.6 t-20 77.33 -2.96 2.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.473 179.866 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.17 125.12 24.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.085 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.61 100.25 12.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.503 0.668 . . . . 0.0 111.504 -178.579 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.1 HD11 HG21 ' A' ' 19' ' ' ILE . 59.0 mt -49.97 134.92 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.433 179.507 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.839 HD22 ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -133.69 12.08 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.614 179.367 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 170.83 141.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.962 -179.894 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.865 HG13 ' CD2' ' A' ' 86' ' ' LEU . 25.3 t -131.56 99.7 4.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.879 179.274 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.742 HD22 HG23 ' A' ' 84' ' ' VAL . 2.9 t-20 69.76 -65.0 0.33 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 109.848 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -161.57 31.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.927 179.407 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.6 t -120.82 124.86 73.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.55 -179.337 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 21.0 p-10 -93.04 100.07 12.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.577 179.113 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 65' ' ' VAL . 33.7 m -80.69 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -179.755 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -29.25 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -148.88 60.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.753 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -126.5 146.43 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.991 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.481 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.76 153.94 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 111.076 -179.353 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.871 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 p-80 -48.34 -34.08 10.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.983 -179.515 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -33.83 69.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.181 179.757 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.68 -45.22 83.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 109.765 179.093 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.842 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.83 -46.69 88.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.536 0.684 . . . . 0.0 109.35 178.177 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.6 t -57.55 -48.06 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.369 178.586 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.62 -32.88 67.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.624 178.602 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -57.63 -50.39 73.31 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.837 179.241 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.005 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -56.61 -37.26 70.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.555 178.891 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -77.56 -26.06 50.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.395 179.327 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -92.84 -12.4 31.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.061 -178.843 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.926 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.17 -20.17 9.73 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.268 179.763 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -95.34 1.35 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.12 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 39.5 m -134.61 -92.17 0.32 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.096 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.763 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -85.72 89.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.28 0.562 . . . . 0.0 109.676 178.591 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.926 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.7 p -105.91 136.47 40.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.457 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 ttp180 -88.2 102.8 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.747 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.865 ' CD2' HG13 ' A' ' 60' ' ' VAL . 20.2 mt -90.59 136.24 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.813 -179.15 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.586 ' HD1' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.86 120.13 39.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.782 -179.889 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG21 ' CG ' ' A' ' 55' ' ' ASP . 29.3 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.829 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 5.2 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.791 0.329 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -146.7 154.0 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -105.31 144.78 31.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.972 -179.934 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.25 109.97 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 111.623 179.819 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.88 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 119.11 20.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.75 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -129.73 127.15 39.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.164 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.8 pt-20 -83.55 100.83 11.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.855 179.524 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.01 89.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.102 178.657 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.41 -179.115 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.935 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 102.78 19.3 13.5 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.422 -0.894 . . . . 0.0 114.808 177.912 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.826 ' HB3' HG23 ' A' ' 39' ' ' ILE . 3.7 p90 -155.23 135.76 13.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.912 0.856 . . . . 0.0 110.89 179.126 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.68 135.98 37.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.404 -179.421 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.036 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.46 146.12 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.603 0.716 . . . . 0.0 111.928 179.79 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -124.81 118.65 26.85 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.51 177.988 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 146.08 165.61 11.56 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.575 -179.006 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 32' ' ' PRO . . . 140.93 173.53 13.57 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.244 -179.691 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.752 HG23 ' C ' ' A' ' 68' ' ' VAL . 18.4 p -67.14 -17.79 65.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.366 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -106.39 -27.28 11.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.686 0.279 . . . . 0.0 111.417 -179.67 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -124.32 87.0 54.29 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 42.7 Cg_endo -67.9 64.39 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.362 2.041 . . . . 0.0 112.607 -179.653 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.785 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.2 t60 -47.72 -28.92 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.525 179.207 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.945 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.65 -152.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.687 179.776 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.683 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.84 52.53 4.61 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.87 -178.761 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HA ' ' HB2' ' A' ' 26' ' ' PRO . 1.8 t0 76.59 44.9 0.11 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.494 179.575 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -137.14 157.31 74.68 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -179.941 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 23' ' ' THR . 7.8 Cg_exo -72.12 -2.2 11.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.699 2.266 . . . . 0.0 112.508 179.823 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.47 112.6 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.006 0.432 . . . . 0.0 111.561 -179.654 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.832 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.71 119.89 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.757 179.219 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.945 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.14 147.9 37.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.485 0.659 . . . . 0.0 110.844 179.369 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.045 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.32 156.04 7.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.565 -177.319 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.67 -28.78 4.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.134 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.25 129.14 0.36 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.17 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.987 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -93.3 125.02 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.79 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 132.73 46.59 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.783 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_exo -64.37 70.05 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.492 2.128 . . . . 0.0 110.887 178.9 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -104.82 -25.5 6.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.888 -179.076 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . 121.65 -30.59 5.29 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.397 -179.87 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -77.69 -70.32 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.152 179.707 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.844 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -75.92 -45.63 34.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.368 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.49 -42.22 95.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.741 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.781 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -72.15 -33.31 67.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -57.11 -58.36 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.08 0.467 . . . . 0.0 111.028 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.84 25.83 63.87 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.534 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtm-85 -108.11 -23.34 12.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.895 0.379 . . . . 0.0 110.303 179.553 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.045 HD21 HD12 ' A' ' 36' ' ' ILE . 6.3 tp -104.17 154.24 19.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.428 179.005 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.578 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 ttp85 -134.85 135.7 41.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -49.04 157.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.308 0.575 . . . . 0.0 111.539 179.994 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 73.32 3.03 4.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.084 -179.746 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -71.61 125.86 28.19 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.958 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.68 101.39 13.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.608 0.718 . . . . 0.0 111.74 -178.408 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.992 HD11 HG21 ' A' ' 19' ' ' ILE . 12.4 mt -49.33 131.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.923 179.84 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -114.74 -35.03 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.073 179.281 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -148.8 167.53 25.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.833 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 86' ' ' LEU . 41.1 t -147.74 98.43 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.034 179.471 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.804 ' OD1' HG23 ' A' ' 84' ' ' VAL . 5.5 t30 68.62 -66.61 0.23 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.071 0.462 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.16 32.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.741 179.312 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 62.1 t -120.88 142.21 37.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.523 -179.33 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -104.16 110.2 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.328 179.103 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.642 HG21 HG22 ' A' ' 57' ' ' ILE . 14.6 m -91.52 19.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.773 -179.523 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -59.55 -28.25 66.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.7 56.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.752 ' C ' HG23 ' A' ' 23' ' ' THR . 18.4 m -125.7 143.12 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 69' ' ' THR . 0.0 OUTLIER -62.32 151.74 35.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.692 -179.833 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.607 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -47.88 -34.32 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.658 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -71.45 -33.88 69.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.932 179.521 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.662 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.58 -40.47 84.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.93 -46.96 82.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.644 0.735 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.628 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 73.5 t -58.67 -50.66 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.198 178.676 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.35 -31.08 63.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.68 -50.45 73.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.367 0.603 . . . . 0.0 109.91 179.643 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -59.23 -36.83 76.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.084 179.291 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.61 -25.38 49.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.631 179.595 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -101.4 13.96 33.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.736 0.303 . . . . 0.0 111.647 -178.344 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.32 11.78 9.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.66 -90.16 0.85 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 179.735 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 10.1 p -144.63 -90.22 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.88 HG13 HG22 ' A' ' 7' ' ' THR . 9.1 tp -84.08 90.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.191 0.52 . . . . 0.0 109.714 178.67 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.913 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -107.54 139.3 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.361 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.546 ' CG ' HG23 ' A' ' 7' ' ' THR . 10.1 mtp180 -86.92 103.12 15.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.742 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.9 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.5 mt -92.95 138.28 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 -178.788 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -101.84 136.44 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.647 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.8 m . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.521 -179.89 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.442 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 29.2 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.811 0.338 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.45 146.85 40.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.946 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -103.28 144.38 31.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.966 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.984 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.36 109.13 8.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.924 0.392 . . . . 0.0 111.6 179.882 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.838 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.25 113.65 16.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.93 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.99 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.7 tp -124.87 126.94 46.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.9 pt-20 -85.82 100.77 12.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.073 179.29 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -46.97 89.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.323 179.893 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . . . . . . 0 C--N 1.318 -0.456 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.639 -179.93 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.99 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.3 tp . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.361 0.124 . . . . 0.0 110.737 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.51 25.82 1.12 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.422 178.437 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.5 p90 -164.8 131.68 3.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.565 0.682 . . . . 0.0 110.849 178.86 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -91.67 138.36 31.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.653 -179.006 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.938 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -121.78 142.29 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 121.711 0.767 . . . . 0.0 112.222 179.78 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -105.64 117.85 35.09 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.695 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.795 ' HA2' HG23 ' A' ' 34' ' ' ILE . . . -73.21 -159.27 5.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -176.258 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.68 -42.93 0.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.783 -0.709 . . . . 0.0 114.15 -177.935 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.67 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -73.1 -54.06 9.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.039 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.492 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -81.25 -43.58 18.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.071 0.462 . . . . 0.0 111.004 -179.621 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.4 OUTLIER -124.83 83.45 59.41 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.479 179.462 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.95 69.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.638 2.225 . . . . 0.0 112.378 -179.104 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.799 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 12.5 t60 -58.23 -18.24 24.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.254 179.31 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.824 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.26 -154.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.409 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.674 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -63.35 -49.5 69.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.57 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 167.98 41.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 179.995 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.22 155.6 75.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.403 ' CB ' HG22 ' A' ' 23' ' ' THR . 73.9 Cg_endo -75.64 55.76 4.39 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.941 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -117.12 107.12 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 179.697 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.961 HD11 ' O ' ' A' ' 68' ' ' VAL . 3.1 mt -79.01 130.63 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.994 -179.632 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.824 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.98 152.53 42.07 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.214 0.531 . . . . 0.0 110.389 179.495 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.03 HD12 HD21 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -69.42 155.57 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.489 -177.096 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.09 -28.43 4.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.974 -179.27 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.86 130.6 0.41 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.943 -179.625 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.995 HD11 HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -95.33 132.58 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.557 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 114.77 56.74 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.651 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 47.9 Cg_exo -56.36 137.79 81.43 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.733 2.289 . . . . 0.0 112.201 179.913 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.91 66.35 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.67 -179.994 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.98 -178.13 22.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -59.48 -33.55 71.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -179.955 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -72.95 -56.92 4.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.781 -179.885 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.45 -31.1 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.855 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 13.7 pt20 -72.15 -32.51 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.035 0.445 . . . . 0.0 110.138 179.615 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.536 ' OD2' HD12 ' A' ' 8' ' ' LEU . 11.9 m-20 -80.75 -57.96 3.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.553 179.94 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.54 9.3 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.715 179.564 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.6 mtt180 -114.96 7.46 15.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 179.544 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.03 HD21 HD12 ' A' ' 36' ' ' ILE . 5.9 tp -136.42 154.31 50.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.107 0.479 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.35 135.22 46.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.614 179.833 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 38' ' ' LYS . 60.6 t -49.06 157.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 0.0 111.815 -179.878 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.3 t30 78.22 -5.32 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.469 179.972 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -64.03 127.93 33.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.169 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.89 105.2 16.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -178.846 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.067 HG22 HG21 ' A' ' 65' ' ' VAL . 64.1 mt -48.92 134.87 6.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.522 179.792 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.534 ' C ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -120.17 -43.49 2.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.444 179.865 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -144.55 158.65 43.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.903 -179.893 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.889 HG13 HD21 ' A' ' 86' ' ' LEU . 60.3 t -140.03 98.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.894 ' OD1' HG23 ' A' ' 84' ' ' VAL . 2.1 t30 67.74 -67.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.46 . . . . 0.0 110.22 -178.973 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -155.12 31.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.927 179.361 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.4 t -120.81 142.39 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.403 -179.312 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.4 p-10 -103.28 108.84 20.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.473 179.402 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.067 HG21 HG22 ' A' ' 57' ' ' ILE . 29.2 m -97.32 29.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -38.01 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.413 . . . . 0.0 110.683 179.762 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -144.23 57.91 1.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.786 179.803 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.961 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -121.19 140.05 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.341 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 2.5 p -52.2 150.92 4.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.011 -178.425 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.83 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.9 t-160 -47.07 -33.36 4.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.368 179.552 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -71.54 -33.76 69.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 179.713 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.652 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.38 -31.7 67.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 109.753 178.827 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.924 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.44 -46.91 58.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.537 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.6 t -60.87 -50.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.728 178.735 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.8 pt-20 -57.45 -29.56 64.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.66 178.543 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.821 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -60.59 -51.4 69.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.795 179.456 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.861 ' CD1' HD12 ' A' ' 19' ' ' ILE . 1.2 mt -58.2 -35.12 71.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.178 179.191 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.15 -31.75 55.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.859 179.912 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.0 pt-20 -96.07 17.22 16.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.527 -178.523 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.916 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.54 16.34 7.88 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.323 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.01 -103.51 1.01 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.509 179.858 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -127.15 -89.41 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.466 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.838 HG13 HG22 ' A' ' 7' ' ' THR . 7.4 tp -84.68 94.73 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 109.878 178.909 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.916 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -111.06 136.43 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.444 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 10.4 ptt85 -85.58 102.87 13.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.889 HD21 HG13 ' A' ' 60' ' ' VAL . 15.9 mt -92.09 139.72 30.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.549 -178.499 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.64 135.47 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.963 179.39 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.594 HG11 HD11 ' A' ' 51' ' ' LEU . 6.6 m . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.758 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.808 0.337 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.77 137.74 46.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.727 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.437 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.0 m-30 -94.48 119.1 32.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' HG3' HG23 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -117.12 161.93 18.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.2 tt0 -115.92 144.63 43.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.085 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.84 111.69 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.985 0.421 . . . . 0.0 111.773 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.5 115.63 20.9 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.085 HD13 HD11 ' A' ' 6' ' ' ILE . 4.8 tp -126.05 127.11 45.33 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -85.5 100.66 12.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.054 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.35 89.25 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.188 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.09 176.02 0.07 OUTLIER Glycine 0 C--N 1.321 -0.287 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.496 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -54.87 -24.05 21.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.739 0.305 . . . . 0.0 111.115 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -97.36 -24.82 15.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.2 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.86 -163.53 28.28 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.196 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.992 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp -66.12 -63.6 1.04 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.68 0.24 . . . . 0.0 110.81 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.55 22.35 0.96 Allowed Glycine 0 CA--C 1.52 0.374 0 C-N-CA 119.725 -1.226 . . . . 0.0 114.97 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.6 p90 -161.59 135.35 6.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.063 0.932 . . . . 0.0 111.224 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.495 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.55 135.47 34.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.368 -179.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.98 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.16 147.7 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-O 121.541 0.686 . . . . 0.0 111.568 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.637 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.64 119.72 27.73 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.43 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 143.66 159.3 7.93 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.551 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 145.09 173.64 16.56 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.384 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 68' ' ' VAL . 24.3 p -63.67 -14.44 52.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -112.79 -25.79 8.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -124.25 86.77 54.29 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.486 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 64.13 0.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.306 2.004 . . . . 0.0 112.549 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.778 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.0 t60 -49.05 -27.16 3.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.527 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.45 -152.29 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.693 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.79 52.65 4.62 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.941 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 t0 76.54 43.36 0.14 Allowed 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.119 0.485 . . . . 0.0 110.489 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 158.78 74.15 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.929 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 72.9 Cg_endo -76.19 0.33 9.49 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.507 2.138 . . . . 0.0 112.569 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.1 114.92 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.1 0.476 . . . . 0.0 111.141 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.23 119.62 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.984 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.41 147.65 36.53 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 121.289 0.566 . . . . 0.0 110.579 179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.119 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.34 155.83 7.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.655 -177.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.637 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.0 -32.86 4.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.753 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.617 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.33 142.11 2.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.92 0.39 . . . . 0.0 111.424 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.51 133.35 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 122.69 76.2 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.4 Cg_endo -64.63 132.18 32.12 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.826 2.351 . . . . 0.0 112.23 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.96 5.31 56.47 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.412 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.07 179.17 21.02 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.804 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.801 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.66 -39.08 70.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 111.121 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.825 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -66.4 -57.4 7.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.466 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.8 -28.82 67.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.382 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -72.25 -34.61 68.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.893 0.377 . . . . 0.0 110.069 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -82.72 -57.97 3.09 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.16 41.23 9.53 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.474 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.4 mmp_? -113.14 -4.72 13.75 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.773 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.119 HD21 HD12 ' A' ' 36' ' ' ILE . 5.0 tp -121.44 153.66 37.58 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.019 0.438 . . . . 0.0 110.822 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.12 135.28 48.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.689 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.14 157.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 111.758 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.47 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.4 t30 75.41 0.99 3.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.17 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -68.55 125.18 25.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.065 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 102.23 13.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.625 . . . . 0.0 111.602 -178.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.98 HD11 HG21 ' A' ' 19' ' ' ILE . 16.4 mt -49.8 124.94 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.866 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.82 HD21 ' CG ' ' A' ' 89' ' ' MET . 3.6 mt -109.76 -34.14 6.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.972 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.486 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.8 m-85 -150.27 161.22 42.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 76' ' ' ALA . 6.9 p -148.7 103.97 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.626 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 70.42 -66.83 0.27 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.289 0.566 . . . . 0.0 109.907 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.39 29.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' HG13 ' A' ' 60' ' ' VAL . 1.4 t -121.01 142.0 39.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.492 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.0 p-10 -101.07 111.45 23.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.859 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.689 HG21 HG22 ' A' ' 57' ' ' ILE . 21.3 m -89.68 24.1 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.4 ttp180 -67.85 -22.13 65.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 110.734 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -145.97 44.62 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 23' ' ' THR . 19.0 m -117.87 148.31 20.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.864 0.364 . . . . 0.0 111.004 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.459 HG22 ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -67.52 151.99 46.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.54 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.798 ' O ' HG23 ' A' ' 74' ' ' VAL . 9.8 t-160 -49.55 -34.1 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.533 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 20.0 m -71.76 -33.66 68.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.495 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.49 -39.72 81.2 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -64.32 -46.88 81.61 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.616 0.722 . . . . 0.0 109.226 177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.7 t -59.97 -50.63 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.333 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 2.2 pt-20 -57.75 -35.12 70.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.637 178.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -55.33 -51.92 65.16 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.269 0.557 . . . . 0.0 110.228 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.907 HD11 HD12 ' A' ' 19' ' ' ILE . 6.2 mt -56.42 -36.64 69.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.533 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.32 -25.67 51.42 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.478 179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.3 mt-10 -96.6 -6.96 35.55 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.294 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.921 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.62 -17.74 16.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.147 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.54 -100.74 2.11 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.038 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.9 m -130.45 -91.31 0.44 Allowed 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 7' ' ' THR . 5.4 tp -87.03 86.27 2.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.254 0.55 . . . . 0.0 109.559 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.921 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.6 p -101.29 138.83 24.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HG2' HG23 ' A' ' 7' ' ' THR . 2.5 mtt180 -88.68 103.2 15.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.041 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.907 ' CD2' HG23 ' A' ' 60' ' ' VAL . 12.3 mt -92.6 138.04 31.84 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.722 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 133.53 46.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.873 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.7 m -139.72 167.9 18.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.144 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.82 ' CG ' HD21 ' A' ' 58' ' ' LEU . 92.7 mtp -103.18 151.18 22.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.701 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -140.54 115.72 9.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.244 -0.884 . . . . 0.0 111.022 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.761 0.315 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -99.95 112.6 24.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.843 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.8 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-30 -82.19 129.29 34.8 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.663 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -139.83 160.2 40.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.846 0.355 . . . . 0.0 111.115 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.2 mt-10 -117.08 144.9 44.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.835 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.074 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.82 111.74 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.886 0.374 . . . . 0.0 111.73 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.806 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.42 115.6 20.84 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.074 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -126.09 127.08 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.25 100.4 11.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.126 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.78 88.89 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.067 179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.41 176.07 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.628 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -55.21 -23.81 24.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.776 0.322 . . . . 0.0 111.058 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.7 p -96.8 -24.87 15.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.144 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.47 -162.89 28.24 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.23 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp -67.89 -63.49 1.05 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.174 -0.211 . . . . 0.0 110.725 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.65 21.01 1.05 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.716 -1.23 . . . . 0.0 114.754 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.5 p90 -161.62 135.6 6.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.999 0.9 . . . . 0.0 111.12 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.47 138.55 32.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.455 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.096 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.14 146.5 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.691 0.757 . . . . 0.0 112.228 -179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.43 134.59 34.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.519 -1.218 . . . . 0.0 111.198 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.3 -5.32 1.4 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.13 -1.033 . . . . 0.0 113.573 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.57 -175.36 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.113 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 68' ' ' VAL . 16.1 p -71.43 -19.23 62.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.62 -24.91 15.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.822 0.344 . . . . 0.0 111.591 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 2.2 t30 -124.41 87.91 53.66 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.099 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.96 63.07 0.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.463 2.109 . . . . 0.0 112.631 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.73 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 50.3 t60 -50.59 -25.74 4.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.165 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.774 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.73 -151.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.513 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.56 49.75 4.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.843 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t0 76.88 45.38 0.09 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.073 0.463 . . . . 0.0 110.486 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.03 153.75 78.67 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.909 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.636 ' CB ' HG22 ' A' ' 23' ' ' THR . 74.2 Cg_endo -75.39 -0.17 9.77 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.468 2.112 . . . . 0.0 112.657 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.87 115.24 1.9 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.943 0.402 . . . . 0.0 110.495 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.08 119.8 33.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.092 -179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.774 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.05 147.41 36.78 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.348 0.594 . . . . 0.0 110.461 178.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.014 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.14 155.7 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.059 -176.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.05 -31.83 4.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.986 -179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.41 134.24 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.042 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.986 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.52 132.93 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.26 123.84 74.65 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 36.9 Cg_endo -65.18 132.68 32.56 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.769 2.313 . . . . 0.0 112.289 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.2 5.5 57.14 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.48 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.84 178.56 20.93 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.928 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.65 -37.72 68.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.757 0.313 . . . . 0.0 111.179 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.819 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -67.78 -57.51 6.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.417 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.53 -28.87 68.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.328 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -72.13 -34.52 68.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 0.0 110.063 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -83.5 -58.07 2.98 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.64 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.6 41.02 9.25 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.481 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.514 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mtm180 -113.8 6.24 16.66 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.828 0.347 . . . . 0.0 110.854 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.014 HD21 HD12 ' A' ' 36' ' ' ILE . 5.6 tp -132.8 154.6 50.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.071 0.462 . . . . 0.0 110.732 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.606 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -130.86 136.1 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.801 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -51.74 157.78 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.315 0.578 . . . . 0.0 111.663 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.6 -2.01 2.78 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.352 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.652 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.4 m-20 -67.82 126.34 29.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.65 104.14 15.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.489 0.661 . . . . 0.0 111.259 -178.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.096 HD11 HG21 ' A' ' 19' ' ' ILE . 67.8 mt -52.71 133.84 14.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.96 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.881 HD11 ' HB3' ' A' ' 89' ' ' MET . 14.2 mt -116.62 -28.56 6.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.661 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -156.29 149.54 24.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.911 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.826 HG13 ' CD2' ' A' ' 86' ' ' LEU . 39.8 t -139.44 105.94 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.168 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 t30 55.04 38.68 30.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 110.108 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 78.86 33.43 0.25 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.475 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 60' ' ' VAL . 92.7 t -120.99 107.82 21.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.596 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.5 t0 -74.01 111.6 9.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.744 0.307 . . . . 0.0 110.564 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 35.0 m -96.56 29.88 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -59.86 -22.71 62.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -150.8 76.27 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.82 0.343 . . . . 0.0 111.106 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.71 ' O ' HG23 ' A' ' 23' ' ' THR . 35.4 m -149.81 145.75 17.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.06 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.19 155.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.212 0.529 . . . . 0.0 111.154 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.6 p-80 -50.89 -33.7 25.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.886 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.5 t -72.14 -33.96 68.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.686 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.32 -40.8 90.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.196 0.522 . . . . 0.0 109.874 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.48 -46.85 78.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.668 0.747 . . . . 0.0 109.168 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.2 t -56.9 -50.27 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.255 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.686 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.92 -29.24 59.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.917 178.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.619 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -62.32 -51.9 65.81 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.321 0.581 . . . . 0.0 109.81 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.025 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.03 -37.52 66.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.558 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -27.41 52.13 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.244 179.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.28 14.72 25.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.313 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.924 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.77 16.42 4.81 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.517 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.27 -92.0 0.56 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.276 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.6 m -142.19 -90.25 0.14 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.806 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -84.67 90.12 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.283 0.563 . . . . 0.0 109.723 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.924 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -105.82 138.11 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.4 ttt180 -88.29 102.87 15.27 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.826 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.4 mt -91.45 138.49 31.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.239 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.65 134.51 44.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.495 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.652 HG21 ' OD2' ' A' ' 55' ' ' ASP . 6.2 m -139.74 166.47 20.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.674 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.881 ' HB3' HD11 ' A' ' 58' ' ' LEU . 2.4 ptt? -137.07 138.57 40.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 111.159 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.89 120.69 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.024 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.813 0.34 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -98.67 114.14 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.967 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-85 -91.4 115.02 27.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.693 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 8.6 mt-10 -118.84 153.01 35.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.908 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.15 144.91 31.3 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.481 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.028 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.19 110.83 8.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.443 179.593 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.821 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.73 117.61 20.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.028 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -127.6 127.0 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 7.4 pt-20 -83.96 100.45 11.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.296 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -51.4 88.92 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.183 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.03 175.41 0.14 Allowed Glycine 0 C--N 1.322 -0.23 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.586 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -54.44 -24.45 20.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.33 . . . . 0.0 111.066 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -96.24 -24.75 16.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.36 -163.67 28.12 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.156 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.986 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.5 tp -66.55 -63.52 1.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.141 -0.224 . . . . 0.0 110.789 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.81 21.28 1.01 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.707 -1.235 . . . . 0.0 114.614 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.86 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.3 p90 -161.31 134.7 6.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.874 0.837 . . . . 0.0 110.981 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.476 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -93.32 135.43 34.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.566 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.88 146.07 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.593 0.711 . . . . 0.0 111.385 179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -125.34 122.69 37.55 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.457 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 140.01 157.77 7.37 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.787 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.71 176.09 22.55 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.16 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 68' ' ' VAL . 17.4 p -66.54 -18.37 65.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -107.06 -27.26 10.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.69 0.281 . . . . 0.0 111.635 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.42 87.38 54.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.494 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.27 64.53 0.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.405 2.07 . . . . 0.0 112.545 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.746 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.8 t60 -46.23 -29.76 1.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.545 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.979 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -83.13 -155.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.412 179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.675 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.31 -52.63 51.5 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.698 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 4.1 p-10 -179.34 42.12 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.615 0.245 . . . . 0.0 111.322 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.47 174.08 5.13 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.992 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 88.6 Cg_endo -81.4 10.78 3.29 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.658 2.239 . . . . 0.0 112.72 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.71 112.1 1.69 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.079 0.466 . . . . 0.0 111.316 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.872 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.11 119.87 37.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.9 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.979 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.63 149.75 39.35 Favored 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 121.38 0.61 . . . . 0.0 110.897 179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.066 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.41 155.72 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.436 -177.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.647 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.72 -32.25 4.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.609 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 141.23 2.0 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.91 0.386 . . . . 0.0 111.337 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.959 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.38 132.98 48.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.0 124.59 74.34 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.2 Cg_endo -65.63 132.58 31.32 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.769 2.312 . . . . 0.0 112.1 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.51 5.15 56.98 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.473 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.86 176.1 19.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.797 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.781 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.43 -37.11 62.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.744 0.307 . . . . 0.0 111.295 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.85 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.11 -57.41 6.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.527 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.31 -29.07 67.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.345 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -72.06 -36.08 69.47 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 121.08 0.467 . . . . 0.0 109.979 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -83.35 -57.9 3.06 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.631 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.91 41.5 9.57 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.466 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 6' ' ' ILE . 74.7 mtp180 -113.2 8.23 18.12 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 120.848 0.356 . . . . 0.0 110.644 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.066 HD21 HD12 ' A' ' 36' ' ' ILE . 5.8 tp -133.48 155.48 49.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.721 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.61 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.77 134.89 46.33 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.619 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.8 t -49.08 157.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.255 0.55 . . . . 0.0 111.627 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.03 -2.31 2.68 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.203 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -64.86 124.05 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.58 100.06 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.567 0.698 . . . . 0.0 111.867 -178.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 19' ' ' ILE . 35.2 mt -47.82 126.2 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.616 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -122.08 -5.72 8.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.585 179.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.8 OUTLIER -171.61 143.9 1.8 Allowed 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.977 0.418 . . . . 0.0 110.728 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.876 HG13 ' CD2' ' A' ' 86' ' ' LEU . 25.3 t -141.97 109.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 84' ' ' VAL . 7.3 t30 52.85 38.59 27.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.933 0.397 . . . . 0.0 110.161 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 78.73 32.29 0.3 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.549 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 60' ' ' VAL . 59.1 t -120.92 103.77 14.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.507 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.6 p-10 -66.68 113.43 4.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.532 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.618 HG21 HG22 ' A' ' 57' ' ' ILE . 25.8 m -92.51 18.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.497 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -65.47 -21.29 66.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.981 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -140.56 45.38 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.183 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.706 ' O ' HG23 ' A' ' 23' ' ' THR . 17.2 m -127.35 142.74 42.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.059 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 153.47 31.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.011 0.434 . . . . 0.0 110.62 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.615 ' O ' HG23 ' A' ' 74' ' ' VAL . 8.0 t-160 -49.33 -33.88 14.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.591 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.33 -33.7 71.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.834 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.21 -31.77 69.36 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.872 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -71.42 -46.9 58.98 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.621 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 78.6 t -60.08 -50.83 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.334 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.668 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 9.2 pt-20 -57.9 -30.22 65.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.629 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.68 -51.12 71.15 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.329 0.585 . . . . 0.0 109.861 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.936 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -57.46 -37.55 73.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.891 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.28 -27.51 53.13 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.603 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 5.8 pt-20 -101.06 18.03 20.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.309 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.927 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.15 16.33 4.41 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.408 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.33 -92.4 0.66 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.27 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -142.84 -90.05 0.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.821 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -84.74 87.24 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.286 0.565 . . . . 0.0 109.745 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.927 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -102.29 137.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.683 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.4 mtt-85 -88.36 102.69 15.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.876 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.1 mt -91.61 132.53 36.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.597 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.46 115.11 29.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.075 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' A' ' 57' ' ' ILE . 1.7 m -119.7 138.06 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.661 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' TYR . 2.5 ptt? -96.65 158.76 15.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.018 0.437 . . . . 0.0 111.271 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.79 114.85 9.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.828 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.572 ' NH2' HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.035 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.801 0.334 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.49 124.77 30.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.766 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.0 m-30 -91.38 111.4 22.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.699 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 25.1 mt-10 -111.68 166.04 11.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.818 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.445 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 13.1 pt-20 -126.76 144.81 50.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.072 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.32 109.47 5.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.955 0.407 . . . . 0.0 112.016 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.842 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.89 121.55 25.0 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.072 HD13 HD11 ' A' ' 6' ' ' ILE . 4.3 tp -130.54 128.48 41.22 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 5.7 mt-10 -83.65 100.68 11.0 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.49 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' CG ' HD23 ' A' ' 15' ' ' LEU . 11.8 mtp180 -44.76 92.13 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.984 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -63.08 70.3 0.03 OUTLIER Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.896 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 10' ' ' ARG . 61.1 t-20 64.65 -74.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.688 0.28 . . . . 0.0 111.37 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.63 -24.24 62.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.519 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 155.17 -170.2 33.27 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.637 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.985 ' HB3' HD23 ' A' ' 8' ' ' LEU . 4.5 mt -66.33 -63.59 1.04 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.616 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 136.63 42.1 0.11 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.029 -1.081 . . . . 0.0 113.877 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.782 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.2 p90 -163.39 133.09 4.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.121 0.461 . . . . 0.0 110.895 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.453 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.32 136.64 32.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.548 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.02 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -117.73 148.8 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.669 0.747 . . . . 0.0 111.972 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.94 134.38 28.07 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.267 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 141.56 3.61 1.14 Allowed Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.684 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.89 -175.75 1.49 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.887 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 68' ' ' VAL . 40.8 p -66.39 -26.9 67.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.5 -19.21 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.34 87.53 53.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.415 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.93 60.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.292 1.995 . . . . 0.0 112.562 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.728 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.3 t60 -48.16 -27.77 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.088 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.797 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.39 -154.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.276 179.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.13 -50.22 68.24 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.679 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 172.8 40.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.87 168.18 15.35 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.7 ' HB3' HG22 ' A' ' 23' ' ' THR . 90.2 Cg_endo -79.0 5.34 5.79 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.546 2.164 . . . . 0.0 112.81 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -54.92 113.16 1.23 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.92 0.391 . . . . 0.0 110.757 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.859 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.19 119.49 33.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.845 -179.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.797 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.82 145.93 35.28 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-O 121.328 0.585 . . . . 0.0 110.436 178.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.035 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.2 -0.909 . . . . 0.0 113.136 -176.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.437 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.82 -31.65 4.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.686 -1.143 . . . . 0.0 112.146 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -171.55 136.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.748 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.99 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -100.46 131.91 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 116.19 63.76 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -177.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.5 Cg_exo -58.98 136.49 73.78 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.785 2.324 . . . . 0.0 112.288 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.2 15.87 42.94 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.604 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.19 178.27 16.5 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.182 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.23 -36.18 51.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.836 0.35 . . . . 0.0 111.397 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.826 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -70.28 -56.75 5.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.36 -30.47 66.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.4 pp0? -72.12 -29.93 64.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.874 0.369 . . . . 0.0 110.265 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.65 -57.94 3.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.529 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.73 40.64 9.47 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.624 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -117.83 -3.71 11.19 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.061 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.035 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -123.3 153.11 40.69 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.181 0.515 . . . . 0.0 110.956 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.38 135.88 47.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.652 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.17 157.57 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.337 0.589 . . . . 0.0 111.424 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 77.4 -3.02 2.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.288 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -64.86 125.3 24.39 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.006 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 14.2 p -86.72 100.24 12.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.5 0.667 . . . . 0.0 111.74 -178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.013 HD11 HG21 ' A' ' 19' ' ' ILE . 11.2 mt -52.99 127.41 10.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.698 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.82 HD22 ' HG2' ' A' ' 89' ' ' MET . 0.8 OUTLIER -120.0 -10.98 9.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.579 179.329 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.491 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -167.02 143.29 4.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.06 0.457 . . . . 0.0 110.71 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.838 HG13 ' CD2' ' A' ' 86' ' ' LEU . 39.6 t -139.47 112.18 5.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.233 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.87 37.0 16.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.898 0.38 . . . . 0.0 110.164 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 79.55 34.0 0.19 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.552 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 60' ' ' VAL . 88.9 t -120.97 107.84 21.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.479 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -71.59 110.33 6.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.606 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 34.7 m -95.97 40.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.956 0.408 . . . . 0.0 111.218 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -24.96 59.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -143.87 61.82 1.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 23' ' ' THR . 26.9 m -135.62 146.95 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.023 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.66 155.62 38.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.055 0.455 . . . . 0.0 111.267 -179.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.858 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 p-80 -48.23 -35.14 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.17 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.3 m -72.35 -33.85 67.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.153 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -42.87 88.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.137 0.494 . . . . 0.0 109.813 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.859 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.06 -46.82 85.7 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.619 0.723 . . . . 0.0 109.169 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.858 HG23 ' O ' ' A' ' 70' ' ' HIS . 91.7 t -56.85 -50.29 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.194 178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.21 -30.05 61.79 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.902 178.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -60.64 -50.14 74.7 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.327 0.584 . . . . 0.0 109.735 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.02 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -58.85 -36.53 74.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.825 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.606 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.5 -25.25 50.18 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.452 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -103.09 17.87 23.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 111.213 -178.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.881 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.82 16.31 5.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.256 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.83 -109.85 2.95 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.146 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -120.68 -89.38 0.6 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.842 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.0 OUTLIER -88.2 95.42 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.049 0.452 . . . . 0.0 109.842 178.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.881 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -108.07 135.2 47.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.7 ptm180 -87.52 102.87 15.0 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.415 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.838 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.4 mt -89.78 132.94 34.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.854 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.58 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.77 120.01 39.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.553 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' A' ' 57' ' ' ILE . 12.5 m -125.04 153.38 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.699 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.82 ' HG2' HD22 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -106.77 154.84 20.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.893 0.377 . . . . 0.0 110.863 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -140.5 106.98 5.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.914 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.935 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ttm . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.906 0.384 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.79 166.7 13.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.025 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CE1' ' HG3' ' A' ' 89' ' ' MET . 40.1 m-85 -118.87 125.55 49.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.791 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -117.17 159.47 22.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.93 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.3 pt-20 -120.23 144.67 47.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.005 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.85 109.56 7.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.988 0.423 . . . . 0.0 111.768 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.807 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.18 112.2 18.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.005 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -122.91 127.19 48.61 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.4 pt-20 -83.92 100.29 10.91 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.287 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -47.83 88.2 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.254 179.379 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.06 174.03 0.11 Allowed Glycine 0 C--N 1.323 -0.178 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.6 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -25.87 12.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.859 0.361 . . . . 0.0 111.031 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.1 t -96.01 -24.81 16.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.48 -163.8 27.81 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.165 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.952 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.9 tp -65.11 -63.55 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.113 -0.235 . . . . 0.0 110.659 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.67 26.16 1.07 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 119.821 -1.18 . . . . 0.0 114.77 178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.798 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.9 p90 -163.71 132.11 3.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 118.016 0.908 . . . . 0.0 111.266 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.7 139.62 30.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.707 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.047 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -121.37 146.57 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.242 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.46 135.43 35.18 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.394 -1.276 . . . . 0.0 111.353 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.91 -3.41 1.52 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.655 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.33 -174.78 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.453 -0.88 . . . . 0.0 113.06 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 68' ' ' VAL . 17.4 p -71.52 -21.27 61.93 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -22.29 16.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 111.48 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB2' ' CG ' ' A' ' 70' ' ' HIS . 1.5 t-20 -124.27 87.66 53.6 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.166 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.72 62.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.368 2.045 . . . . 0.0 112.71 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.739 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 46.6 t60 -50.98 -26.16 5.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.031 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.762 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.25 -151.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.477 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.684 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.89 49.01 4.14 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.858 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 77.23 45.88 0.08 Allowed 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.028 0.442 . . . . 0.0 110.475 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.04 154.14 78.91 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.98 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.666 ' CB ' HG22 ' A' ' 23' ' ' THR . 73.9 Cg_endo -75.71 0.26 9.39 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.497 2.131 . . . . 0.0 112.692 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.71 115.65 2.27 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.917 0.389 . . . . 0.0 110.524 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.21 119.63 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.075 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.762 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.24 147.05 35.84 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.358 0.599 . . . . 0.0 110.492 178.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.99 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.115 -0.948 . . . . 0.0 113.339 -176.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.14 -31.77 4.06 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -179.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.52 134.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.363 -0.535 . . . . 0.0 112.051 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.971 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.83 132.51 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 125.37 72.83 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.6 Cg_endo -65.94 132.26 29.72 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.738 2.292 . . . . 0.0 112.226 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.88 5.01 56.66 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.486 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.68 177.07 20.41 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.944 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.95 -37.46 63.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.763 0.315 . . . . 0.0 111.173 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.836 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.7 -57.6 5.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.54 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -72.18 -34.74 68.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.226 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.81 -58.15 2.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.803 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.4 40.88 9.58 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.726 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.493 ' CB ' HG12 ' A' ' 6' ' ' ILE . 8.8 mmt180 -111.13 -5.98 14.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.846 0.355 . . . . 0.0 110.759 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.99 HD21 HD12 ' A' ' 36' ' ' ILE . 6.4 tp -119.13 156.15 30.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.751 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.39 134.91 45.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.818 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -51.51 157.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 121.243 0.544 . . . . 0.0 111.728 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.1 OUTLIER 75.29 -1.54 3.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.36 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 m-20 -69.76 129.35 39.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.76 104.03 15.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.646 0.736 . . . . 0.0 111.491 -178.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.047 HD11 HG21 ' A' ' 19' ' ' ILE . 72.5 mt -50.71 138.65 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.553 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 2.1 mm? -116.67 -44.15 2.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.372 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -143.62 172.71 12.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.783 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.906 HG13 ' CD2' ' A' ' 86' ' ' LEU . 44.9 t -149.88 97.11 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.821 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.727 HD22 HG23 ' A' ' 84' ' ' VAL . 1.5 t-20 67.82 -67.56 0.18 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.138 0.494 . . . . 0.0 109.775 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mt-10 -156.41 32.27 0.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.479 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.9 t -118.58 142.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.559 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 16.1 p-10 -111.09 108.93 18.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.173 179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 27.6 m -92.82 40.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.904 0.383 . . . . 0.0 111.66 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -29.51 70.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.78 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -152.87 70.64 0.89 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.95 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.72 ' O ' HG23 ' A' ' 23' ' ' THR . 27.6 m -135.87 146.87 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.179 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.7 152.58 26.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.031 0.443 . . . . 0.0 110.826 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.866 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.6 p-80 -48.55 -33.86 10.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.01 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.19 -33.82 70.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.542 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.673 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.4 -42.14 88.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 109.82 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.48 -46.89 81.08 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.582 0.706 . . . . 0.0 109.123 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 70' ' ' HIS . 83.9 t -56.57 -50.39 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.205 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.86 -30.11 60.96 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.053 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.3 -50.42 73.06 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.403 0.621 . . . . 0.0 109.909 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -58.53 -36.05 73.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.861 179.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.5 -29.21 52.43 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.494 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -99.64 18.46 17.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.487 -178.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.907 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.22 16.17 5.48 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.273 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.66 -94.11 0.66 Allowed Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.18 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.508 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.0 p -140.49 -90.65 0.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.807 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -83.84 89.34 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.185 0.517 . . . . 0.0 109.718 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.907 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.5 p -105.17 137.01 36.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.96 103.0 15.28 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.906 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.5 mt -91.24 142.68 27.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.174 -178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.76 139.58 37.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.692 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 HD11 ' A' ' 51' ' ' LEU . 4.3 m -139.22 167.91 19.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.459 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 2.7 ttt -115.29 142.33 46.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.057 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.15 141.16 47.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.907 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.981 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -112.65 145.45 40.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.471 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 2.4 m-30 -103.37 155.86 18.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -147.9 153.86 39.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.131 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.428 ' CG ' ' HB3' ' A' ' 85' ' ' ARG . 1.8 tt0 -108.01 138.36 44.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.645 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.805 HD13 HD13 ' A' ' 51' ' ' LEU . 1.1 mt -132.69 109.17 14.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.873 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.05 112.16 15.98 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.893 HD21 ' CA ' ' A' ' 45' ' ' ALA . 4.3 tp -121.91 126.84 49.58 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -87.81 99.54 12.19 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.021 178.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HG3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -57.79 90.13 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.573 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.04 173.56 17.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.889 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 58.45 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.622 0.248 . . . . 0.0 111.057 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.3 -2.2 19.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.583 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.485 ' HA2' ' HG3' ' A' ' 10' ' ' ARG . . . 132.03 -148.02 18.94 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.951 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.888 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.4 tp -70.31 -12.87 61.88 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.908 0.385 . . . . 0.0 110.689 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 72.64 30.24 64.39 Favored Glycine 0 CA--C 1.521 0.414 0 N-CA-C 115.502 0.961 . . . . 0.0 115.502 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.0 p90 -164.64 135.38 4.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.354 1.077 . . . . 0.0 111.745 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -100.91 137.63 39.03 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.659 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.035 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -116.74 150.84 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 121.723 0.773 . . . . 0.0 112.293 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.601 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -145.79 134.58 22.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.31 2.92 0.92 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.633 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.67 -173.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.005 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 33.2 p -70.57 -26.01 63.34 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 43.4 t0 -94.24 -24.05 17.63 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 4.0 m-20 -124.47 87.98 53.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.49 63.89 0.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.316 2.011 . . . . 0.0 112.672 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.744 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 40.9 t60 -47.26 -28.32 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.315 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.818 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.06 -155.16 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.385 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.682 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.25 -50.91 59.3 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.691 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.89 39.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.18 166.08 23.78 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.838 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.659 ' CB ' HG22 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.76 7.28 4.66 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.52 2.147 . . . . 0.0 112.727 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -57.01 114.25 2.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.85 0.357 . . . . 0.0 110.779 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.39 118.07 29.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.795 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.818 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.48 147.21 37.49 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.187 0.518 . . . . 0.0 110.732 178.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.021 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.92 155.7 7.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.902 -176.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.457 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.49 -29.93 4.33 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.223 -178.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.38 125.8 0.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.211 -0.596 . . . . 0.0 112.291 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.798 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.49 127.43 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.5 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.2 125.37 72.49 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_endo -60.9 138.39 78.67 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.716 2.278 . . . . 0.0 112.206 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.42 14.1 64.4 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.377 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . -107.05 -159.16 21.38 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.886 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.589 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.97 -38.72 57.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.832 0.316 . . . . 0.0 110.987 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.893 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.41 -54.19 8.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.893 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.95 -33.72 74.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.162 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 13.5 mm-40 -72.45 -32.39 66.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.877 0.37 . . . . 0.0 110.741 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.5 ' HB2' HD11 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -79.41 -57.98 3.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.296 -179.363 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.63 38.34 8.91 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.424 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.701 ' CB ' HG23 ' A' ' 6' ' ' ILE . 22.0 mmt180 -120.29 1.92 10.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.584 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.021 HD21 HD12 ' A' ' 36' ' ' ILE . 29.5 tp -128.07 162.98 25.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.163 0.506 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.45 137.35 26.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.708 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.99 157.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.328 0.585 . . . . 0.0 111.629 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.474 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.3 t-20 75.73 -0.52 3.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.201 -0.908 . . . . 0.0 111.328 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -69.34 126.75 30.72 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.66 101.99 13.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.585 0.707 . . . . 0.0 111.492 -178.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.009 HD11 HG21 ' A' ' 19' ' ' ILE . 68.0 mt -48.81 137.54 4.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.581 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.498 HD21 ' SD ' ' A' ' 89' ' ' MET . 5.2 mt -119.01 -32.9 4.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.591 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -150.13 160.13 43.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.577 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.849 HG13 ' CD2' ' A' ' 86' ' ' LEU . 28.3 t -152.42 110.12 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.232 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.2 t30 47.92 50.19 16.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.868 0.366 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 73.29 31.03 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 77.8 t -120.85 141.96 39.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.0 p-10 -109.47 109.57 20.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.664 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 32.5 m -94.01 43.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.247 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -30.17 68.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -149.87 67.96 1.0 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.768 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 35.5 m -135.02 148.1 29.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.001 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.438 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.04 154.35 39.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.884 -179.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 74' ' ' VAL . 7.4 p-80 -49.17 -34.15 13.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.098 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -69.57 -33.93 73.43 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.157 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.642 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.37 -42.58 83.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.076 0.465 . . . . 0.0 109.793 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.852 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.09 -46.62 83.42 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 70' ' ' HIS . 88.0 t -56.61 -50.4 73.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.571 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.21 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.29 -29.85 59.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.949 178.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -61.96 -50.77 70.81 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.333 0.587 . . . . 0.0 110.011 179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -57.01 -37.16 71.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.484 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.64 -23.62 49.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.957 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 76' ' ' ALA . 5.0 pt-20 -93.6 3.21 55.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.032 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.931 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -90.28 16.3 8.92 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.191 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.46 -121.86 27.96 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.748 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.3 m -104.19 -87.12 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.873 HG13 HG22 ' A' ' 7' ' ' THR . 8.2 tp -82.59 107.82 14.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.974 0.416 . . . . 0.0 110.791 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.931 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -127.05 137.72 57.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.72 ' HG2' HG23 ' A' ' 7' ' ' THR . 13.2 mtp180 -83.49 103.07 12.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.373 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.849 ' CD2' HG13 ' A' ' 60' ' ' VAL . 8.1 mt -94.92 142.12 27.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.017 0.436 . . . . 0.0 111.363 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.432 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.66 131.43 49.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.304 179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.459 HG21 HD11 ' A' ' 6' ' ' ILE . 3.3 m -131.8 167.93 25.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.498 ' SD ' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -106.81 158.74 16.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -140.51 124.04 17.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.783 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.422 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.279 -0.867 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.854 0.359 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.32 138.77 35.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.954 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.441 ' CD1' ' HG2' ' A' ' 89' ' ' MET . 5.8 m-30 -96.83 127.82 43.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.816 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.19 141.93 51.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.694 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 17.0 pt-20 -99.46 144.66 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.183 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.132 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.43 109.42 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.372 179.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.898 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.81 118.39 20.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.132 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -128.51 127.18 41.91 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 10.1 pt-20 -84.06 100.63 11.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.195 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -51.63 89.74 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.111 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.65 175.62 0.17 Allowed Glycine 0 C--N 1.32 -0.339 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.613 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -55.08 -24.1 23.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.735 0.303 . . . . 0.0 111.126 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.5 p -96.56 -24.65 15.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.205 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.94 -163.12 28.35 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.203 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.004 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.9 tp -67.51 -63.56 1.03 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.844 -0.21 . . . . 0.0 110.637 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 133.93 20.27 0.86 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.928 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.856 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.0 p90 -161.18 135.91 7.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.055 0.927 . . . . 0.0 111.381 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 135.82 34.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.314 -179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.019 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.27 148.03 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.645 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -130.46 124.85 32.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.71 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 158.3 -120.06 0.94 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.874 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 63.83 168.29 1.27 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.12 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 68' ' ' VAL . 25.1 p -70.18 -1.98 11.76 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 35.4 t70 -117.08 -22.52 8.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' HIS . 4.3 m-80 -124.72 85.89 56.41 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.61 65.74 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.008 1.805 . . . . 0.0 112.477 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.738 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 48.7 t60 -55.09 -23.62 21.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.173 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -94.75 -150.69 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.377 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.689 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.26 51.65 4.52 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.692 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 t0 76.25 43.53 0.15 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.026 0.441 . . . . 0.0 110.414 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -131.53 156.77 79.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 95.9 Cg_endo -77.9 0.03 10.22 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.507 2.138 . . . . 0.0 112.599 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.8 m -55.2 120.09 6.5 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.108 0.48 . . . . 0.0 111.313 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.885 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.62 118.68 34.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.141 179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.98 146.84 36.07 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.316 0.579 . . . . 0.0 110.463 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.23 155.78 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.042 -176.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.582 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.35 -33.51 4.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.772 -179.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.82 142.04 2.37 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.483 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.962 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.92 133.58 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.429 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 115.0 57.79 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.6 Cg_exo -56.07 136.87 77.22 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.89 2.393 . . . . 0.0 112.405 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.91 2.57 66.6 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.611 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.1 176.39 22.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.111 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -38.41 59.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.898 0.38 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.87 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.18 -57.41 6.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.659 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.59 -35.35 80.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.081 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 1.1 pp0? -71.96 -30.07 64.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.951 0.405 . . . . 0.0 110.471 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.678 ' OD2' HD12 ' A' ' 8' ' ' LEU . 49.1 m-20 -79.89 -58.07 3.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.598 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 41.39 9.81 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.593 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.513 ' CB ' HG12 ' A' ' 6' ' ' ILE . 5.5 mtm180 -117.09 -1.19 11.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -126.56 153.53 45.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.004 0.431 . . . . 0.0 110.975 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.586 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.85 135.26 47.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.688 179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.631 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.5 157.73 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.339 0.59 . . . . 0.0 111.619 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 75.79 -0.27 3.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.26 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -67.45 124.4 23.09 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.59 100.33 12.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 111.549 -178.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.019 HD11 HG21 ' A' ' 19' ' ' ILE . 12.1 mt -49.89 132.65 9.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.674 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.8 pp -130.04 -0.01 4.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.114 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.509 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 179.16 134.64 0.09 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.079 0.466 . . . . 0.0 111.245 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.892 HG13 ' CD2' ' A' ' 86' ' ' LEU . 40.7 t -120.02 97.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.692 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.865 ' OD1' HG23 ' A' ' 84' ' ' VAL . 3.7 t30 71.32 -61.82 0.47 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -164.3 31.24 0.07 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.084 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.3 t -120.99 110.43 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.905 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.461 ' N ' ' CE1' ' A' ' 59' ' ' PHE . 6.7 t0 -72.47 112.37 8.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.79 0.328 . . . . 0.0 110.593 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.663 HG21 HG22 ' A' ' 57' ' ' ILE . 19.1 m -94.92 27.13 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.5 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -67.81 -25.54 65.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.975 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -143.44 51.9 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 0.0 111.102 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.767 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -126.19 148.62 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.006 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -68.42 154.53 41.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.723 -179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.848 ' O ' HG23 ' A' ' 74' ' ' VAL . 9.2 t-160 -48.29 -34.86 11.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.044 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 4.0 m -68.6 -33.76 74.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.244 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.6 -33.09 68.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.21 0.529 . . . . 0.0 109.598 178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -71.59 -46.76 58.37 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 70' ' ' HIS . 67.9 t -60.58 -50.86 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.303 178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -57.14 -29.32 63.5 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.69 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.788 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -61.16 -52.19 65.87 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.206 0.527 . . . . 0.0 109.905 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.015 HD11 HD12 ' A' ' 19' ' ' ILE . 3.0 mt -56.6 -37.27 70.41 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.909 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.6 -28.33 51.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.624 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -97.37 15.93 21.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.903 0.382 . . . . 0.0 111.295 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.924 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.11 16.28 6.33 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.39 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.54 -96.05 0.55 Allowed Glycine 0 C--N 1.335 0.513 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.422 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -136.09 -90.2 0.29 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.403 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.898 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.5 93.74 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 109.879 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.924 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 p -109.81 136.39 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.2 ptt180 -87.01 103.05 14.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.273 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.892 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.1 mt -91.78 134.51 34.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.119 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.507 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.56 125.35 48.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.562 179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.617 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.8 m -129.48 157.04 42.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.728 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.506 ' HG2' HD22 ' A' ' 58' ' ' LEU . 26.7 mtt -96.84 148.18 23.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 110.963 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -140.54 113.55 8.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.853 0.358 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -75.53 117.8 17.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.028 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.907 ' CD2' HD13 ' A' ' 58' ' ' LEU . 3.1 m-85 -82.23 121.35 26.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.819 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.451 ' HG2' HG23 ' A' ' 88' ' ' VAL . 4.3 pt-20 -129.0 164.62 22.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.978 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.9 OUTLIER -121.45 144.77 48.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.94 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.03 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.59 112.12 13.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.638 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.717 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.12 115.36 20.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 6' ' ' ILE . 4.6 tp -125.44 128.76 48.57 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.5 pt-20 -89.48 100.84 13.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.698 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' ASN . 5.1 mtp180 -45.6 93.41 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.342 0.591 . . . . 0.0 109.801 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' SER . . . -63.35 63.1 0.04 OUTLIER Glycine 0 C--N 1.319 -0.363 0 CA-C-N 114.835 -1.075 . . . . 0.0 114.168 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 10' ' ' ARG . 4.6 m120 61.78 -65.9 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.748 0.309 . . . . 0.0 111.503 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' GLY . 36.4 m -69.62 -24.86 63.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.994 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.9 -177.74 32.83 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.883 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.975 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.1 tp -64.06 -63.49 1.14 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.859 -0.171 . . . . 0.0 110.808 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.511 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.93 19.61 0.79 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.81 -1.186 . . . . 0.0 114.674 178.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.8 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.1 p90 -161.04 135.08 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.006 0.903 . . . . 0.0 111.19 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.37 138.86 31.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.466 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.65 147.5 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.59 0.71 . . . . 0.0 112.037 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.624 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.98 134.98 32.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.283 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.4 1.23 0.92 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.409 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.34 -173.79 0.92 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.885 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 68' ' ' VAL . 28.7 p -66.83 -32.6 73.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -90.43 -20.7 22.47 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 20.7 t-20 -124.28 87.29 53.93 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.617 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.91 61.49 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 122.277 1.985 . . . . 0.0 112.387 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 49.2 t60 -47.9 -27.75 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.202 179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.792 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.43 -153.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 179.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -57.2 -50.17 66.58 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.681 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 171.48 40.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.923 0.392 . . . . 0.0 110.724 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.57 168.5 14.88 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.689 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' A' ' 23' ' ' THR . 87.0 Cg_endo -78.87 6.5 4.9 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.528 2.152 . . . . 0.0 112.814 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 113.34 1.36 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.852 0.358 . . . . 0.0 110.446 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.848 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.31 119.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.048 -179.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.792 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.23 147.46 36.53 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.265 0.555 . . . . 0.0 110.456 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.053 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.02 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.151 -0.931 . . . . 0.0 113.121 -176.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.65 -34.07 3.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.661 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.63 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.15 143.14 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.044 0.449 . . . . 0.0 111.737 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.46 132.79 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.449 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.2 124.54 73.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -177.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.0 Cg_endo -65.39 133.14 33.7 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.755 2.303 . . . . 0.0 112.209 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.53 5.96 57.62 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.384 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.66 175.06 18.5 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.868 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.8 -36.15 57.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.721 0.296 . . . . 0.0 111.24 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.846 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.89 -57.46 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.466 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.6 -29.04 67.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.401 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -72.02 -34.99 69.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.101 0.477 . . . . 0.0 110.005 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -84.75 -58.05 2.87 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.602 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 41.78 9.46 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.464 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.521 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.4 mmt85 -112.88 9.01 18.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.929 0.395 . . . . 0.0 110.704 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.053 HD21 HD12 ' A' ' 36' ' ' ILE . 5.6 tp -134.34 155.1 50.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.635 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.607 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -132.09 133.52 44.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.881 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -49.4 157.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 111.889 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.79 -1.11 3.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.368 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.83 126.46 29.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.61 103.88 15.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.525 0.678 . . . . 0.0 111.361 -178.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.088 HD11 HG21 ' A' ' 19' ' ' ILE . 64.2 mt -50.83 152.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.863 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.907 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.5 OUTLIER -136.58 -39.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.474 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -142.58 159.52 42.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.888 HG13 ' CD2' ' A' ' 86' ' ' LEU . 35.9 t -152.5 113.78 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.836 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 49.84 44.87 25.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.885 0.374 . . . . 0.0 110.773 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 72.86 32.62 1.37 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.595 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 68.6 t -120.37 142.19 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.063 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.7 p-10 -108.8 111.05 22.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.54 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 m -79.21 57.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.967 0.413 . . . . 0.0 110.948 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.62 103.02 13.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.588 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.85 53.81 1.41 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 23' ' ' THR . 16.7 m -119.85 142.47 35.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.92 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -62.99 154.21 31.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.075 0.465 . . . . 0.0 111.226 -179.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.8 p-80 -48.09 -34.16 9.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.008 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -70.69 -33.98 71.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.393 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.94 -45.06 83.19 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 0.0 109.764 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.848 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.21 -46.92 86.73 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.574 0.702 . . . . 0.0 109.299 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.9 t -56.55 -50.35 73.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.319 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.06 -29.35 57.31 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.971 178.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -61.78 -52.07 65.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.397 0.618 . . . . 0.0 109.759 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -56.61 -36.16 69.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.872 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.616 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.36 -30.53 53.84 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.674 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' OE2' HG21 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -98.29 19.82 13.63 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.406 -178.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.99 16.26 7.3 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.203 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.37 -101.4 1.15 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.237 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 18.1 t -130.28 -89.29 0.48 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.717 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.1 tp -88.41 91.82 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.196 0.522 . . . . 0.0 109.919 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.887 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.9 p -105.11 137.18 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.72 102.63 14.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.888 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.9 mt -89.48 139.62 30.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.047 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.423 ' O ' ' N ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.75 132.86 47.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.718 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.8 m -138.82 165.34 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.387 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.754 ' CG ' HD21 ' A' ' 58' ' ' LEU . 12.2 ptt? -138.34 131.8 30.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.979 0.419 . . . . 0.0 111.185 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 111.74 7.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.879 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.978 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.799 0.333 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.42 147.64 23.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.783 ' CD2' HD13 ' A' ' 58' ' ' LEU . 1.4 m-85 -104.25 106.17 16.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.608 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -102.04 170.78 7.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.12 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.13 144.95 51.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.694 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.97 109.65 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.992 0.425 . . . . 0.0 111.966 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.861 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.27 119.53 21.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 6' ' ' ILE . 5.1 tp -132.03 127.15 35.57 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 1.3 pm0 -83.94 100.38 10.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.823 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.549 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -46.77 89.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.428 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -49.48 -179.36 0.02 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.788 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -45.25 -36.95 4.28 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 p -99.31 -24.76 14.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.194 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.431 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 148.37 -164.65 29.02 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.956 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.988 ' HB3' HD23 ' A' ' 8' ' ' LEU . 21.3 mt -56.08 -63.48 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.98 0.419 . . . . 0.0 110.548 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.85 32.82 0.54 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.436 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.783 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.8 p90 -158.86 135.97 9.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.068 0.434 . . . . 0.0 111.026 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.76 137.93 34.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.254 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.075 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.38 146.64 22.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.762 0.792 . . . . 0.0 112.377 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.77 133.59 30.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.096 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.488 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.36 -0.43 1.09 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.254 -0.975 . . . . 0.0 113.731 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.569 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.65 -173.42 0.31 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.919 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.865 HG22 ' HB3' ' A' ' 32' ' ' PRO . 37.2 p -69.09 -30.65 69.0 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -91.21 -20.86 21.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -124.35 87.23 54.16 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.649 -0.25 . . . . 0.0 110.425 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.63 61.79 0.84 Allowed 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.349 2.033 . . . . 0.0 112.635 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 46.2 t60 -48.89 -27.55 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.185 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.78 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -91.23 -152.27 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.195 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.688 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.89 49.4 4.22 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.591 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.29 48.21 0.06 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 121.033 0.444 . . . . 0.0 110.223 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -135.88 150.45 71.59 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.117 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.865 ' HB3' HG22 ' A' ' 23' ' ' THR . 12.1 Cg_exo -70.18 -5.23 15.98 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.674 2.249 . . . . 0.0 112.669 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.1 113.96 1.18 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.041 0.448 . . . . 0.0 111.23 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.833 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.69 118.69 31.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.512 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.78 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.66 147.36 39.17 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.357 0.599 . . . . 0.0 110.69 178.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.044 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.05 155.71 7.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.086 -0.961 . . . . 0.0 113.017 -176.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.455 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.45 -29.6 4.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.252 -178.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.76 130.57 0.42 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.176 -179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.003 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.61 129.75 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.27 116.87 67.01 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.7 134.47 60.89 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.67 2.247 . . . . 0.0 112.287 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.33 16.73 31.35 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.551 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.84 177.61 17.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.132 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.32 -34.77 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 111.425 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.787 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.77 -56.65 5.88 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.97 -31.1 65.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -72.0 -30.12 64.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.931 0.396 . . . . 0.0 110.375 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.0 -57.96 3.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.469 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.97 9.57 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.615 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.523 ' CB ' HG12 ' A' ' 6' ' ' ILE . 44.1 mtt-85 -118.14 5.81 12.01 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.95 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.044 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -134.59 153.39 51.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.189 0.519 . . . . 0.0 111.026 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.576 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.58 137.35 49.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.834 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -52.19 157.88 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.344 0.592 . . . . 0.0 111.563 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.08 0.01 3.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.35 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.48 127.42 32.66 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 103.8 15.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.539 0.685 . . . . 0.0 111.339 -178.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.075 HD11 HG21 ' A' ' 19' ' ' ILE . 69.6 mt -51.0 139.95 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.633 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.783 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -119.85 -37.08 3.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.5 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -148.68 165.41 31.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.76 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.685 HG11 ' HB1' ' A' ' 76' ' ' ALA . 39.4 t -142.07 97.59 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.73 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.49 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.7 t-20 68.53 -67.07 0.21 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.076 0.465 . . . . 0.0 109.771 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.4 mt-10 -157.37 33.36 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.582 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.4 t -120.59 142.36 36.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.578 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -107.19 108.38 19.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.393 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 65' ' ' VAL . 21.1 m -92.23 45.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.347 . . . . 0.0 111.444 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -25.47 53.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.949 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -149.58 58.07 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.996 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.768 ' O ' HG23 ' A' ' 23' ' ' THR . 27.2 m -128.27 149.05 32.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.04 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.438 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.44 153.79 42.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.958 0.408 . . . . 0.0 111.018 -179.443 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.2 t-160 -49.86 -34.14 19.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.598 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.1 t -69.62 -33.87 73.26 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.749 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.683 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.32 -42.68 79.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.833 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.79 -46.89 85.89 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.3 t -57.49 -50.41 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.259 178.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.683 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -30.03 61.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.889 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.76 -50.21 74.38 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.341 0.591 . . . . 0.0 109.856 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.017 HD11 HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -59.53 -35.82 74.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.961 179.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.44 -25.79 50.95 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.348 179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -102.58 16.78 25.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.36 -178.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.908 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.9 16.27 4.26 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.172 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.55 -92.49 0.69 Allowed Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.061 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 22.5 t -143.06 -89.39 0.13 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.861 HG13 HG22 ' A' ' 7' ' ' THR . 8.8 tp -84.47 88.23 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.217 0.532 . . . . 0.0 109.811 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.908 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.4 p -103.93 139.33 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.608 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.0 mtt-85 -88.15 102.82 15.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.61 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.9 mt -91.8 138.61 31.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.259 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.748 ' HB3' HD12 ' A' ' 58' ' ' LEU . 1.6 m-85 -101.66 138.66 38.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.733 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.773 ' O ' HD11 ' A' ' 58' ' ' LEU . 14.8 m -139.52 168.01 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.586 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.452 ' N ' HD21 ' A' ' 58' ' ' LEU . 2.3 ttm -110.79 148.06 33.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.34 . . . . 0.0 110.865 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.52 132.46 27.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.78 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.964 179.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.938 0.399 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -99.44 133.67 43.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.993 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 22.5 m-85 -94.3 156.38 16.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.3 142.36 18.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -106.24 144.63 32.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 -179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.993 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.03 109.41 7.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.058 0.456 . . . . 0.0 111.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.925 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.39 121.22 24.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.993 HD13 HD11 ' A' ' 6' ' ' ILE . 4.0 tp -132.05 127.38 36.02 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.6 pt-20 -85.57 101.07 12.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.853 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.566 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.2 mtp180 -47.79 94.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.256 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -46.38 -104.28 0.01 OUTLIER Glycine 0 C--N 1.319 -0.384 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.317 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -109.94 -41.44 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.505 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.0 m -108.14 -5.06 17.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.553 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 151.76 -157.04 27.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.466 -0.874 . . . . 0.0 111.518 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.97 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -74.68 -63.47 1.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.427 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.559 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.17 44.14 0.07 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.978 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.774 ' HB3' HG23 ' A' ' 39' ' ' ILE . 12.5 p90 -164.55 134.16 3.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 117.149 0.474 . . . . 0.0 110.875 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.467 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.75 136.52 33.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.525 -179.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.062 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.26 146.81 22.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.753 0.787 . . . . 0.0 112.247 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -140.0 132.86 29.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.13 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.5 3.61 0.71 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.707 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.541 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.75 -171.11 0.67 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.8 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.829 HG22 ' HB3' ' A' ' 32' ' ' PRO . 39.1 p -70.42 -29.14 65.66 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.97 -21.0 20.04 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.9 OUTLIER -124.38 87.32 54.14 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.524 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.89 62.2 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.266 1.977 . . . . 0.0 112.459 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.706 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.5 t60 -47.46 -28.12 2.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.327 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.822 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.49 -154.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.3 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.68 -50.09 70.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.604 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.37 40.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 110.752 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.48 165.84 25.61 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.829 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.5 Cg_exo -74.98 1.21 7.98 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.967 2.445 . . . . 0.0 112.815 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.46 112.3 0.79 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.034 0.445 . . . . 0.0 111.16 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.05 118.54 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.47 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.822 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.99 147.2 38.33 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.352 0.596 . . . . 0.0 110.841 178.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.011 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.11 155.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.928 -1.033 . . . . 0.0 112.911 -176.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.46 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.83 -29.02 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.189 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.4 131.27 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.998 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.969 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.59 132.29 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.32 114.23 53.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 35.8 Cg_exo -57.83 137.43 81.0 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.709 2.273 . . . . 0.0 112.326 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 13.77 54.06 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.568 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.75 179.5 16.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.113 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.731 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.69 -36.44 64.67 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.712 0.291 . . . . 0.0 111.188 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.813 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.05 -57.68 5.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.904 0.383 . . . . 0.0 111.87 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.75 -28.29 65.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.53 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -71.64 -30.21 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 0.0 110.362 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' OD2' HD12 ' A' ' 8' ' ' LEU . 1.7 m-20 -82.91 -57.87 3.11 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.14 37.74 10.91 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.574 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' CB ' HG12 ' A' ' 6' ' ' ILE . 6.6 mtt85 -112.44 -13.36 13.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.765 0.317 . . . . 0.0 110.875 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.011 HD21 HD12 ' A' ' 36' ' ' ILE . 6.2 tp -114.69 154.82 27.76 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 111.408 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.592 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -133.11 135.71 45.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.691 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -50.84 157.41 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.195 0.521 . . . . 0.0 111.747 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.86 0.28 3.31 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.329 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.95 126.26 29.09 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.3 t -86.58 100.25 12.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.715 0.769 . . . . 0.0 111.316 -178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.062 HD11 HG21 ' A' ' 19' ' ' ILE . 69.9 mt -46.83 135.21 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.708 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD23 ' HB3' ' A' ' 89' ' ' MET . 0.1 OUTLIER -113.45 -42.29 3.5 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.052 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.2 m-85 -142.36 169.99 16.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.73 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.861 HG13 ' CD2' ' A' ' 86' ' ' LEU . 19.3 t -150.04 99.12 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.218 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 84' ' ' VAL . 8.6 t30 67.04 -67.61 0.16 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.167 0.508 . . . . 0.0 109.874 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -156.42 32.64 0.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.668 179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.7 t -119.46 142.25 35.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.564 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.7 t0 -112.08 87.55 2.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.362 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 65' ' ' VAL . 24.9 m -70.22 63.73 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.041 0.448 . . . . 0.0 111.543 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -29.9 21.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.691 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -149.03 58.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.607 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.76 ' O ' HG23 ' A' ' 23' ' ' THR . 34.8 m -123.91 146.67 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.246 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.458 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -65.81 154.94 37.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.868 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.5 p-80 -48.21 -34.65 10.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.1 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.4 p -71.58 -33.75 69.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.169 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.65 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.93 -45.49 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.86 -46.85 88.98 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.587 0.708 . . . . 0.0 109.162 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.8 t -57.12 -49.25 80.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.403 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.97 -30.15 63.84 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.957 178.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.77 -49.71 76.4 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.333 0.587 . . . . 0.0 109.679 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.986 HD11 HD12 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -59.94 -34.65 73.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.118 -0.947 . . . . 0.0 109.859 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.656 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.9 mmmt -77.36 -28.1 52.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.426 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.86 18.49 19.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.205 -178.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.887 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.48 16.29 6.71 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.39 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.09 -111.03 3.42 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.155 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -119.68 -90.26 0.58 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.925 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -87.28 93.68 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.19 0.519 . . . . 0.0 109.976 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.887 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -105.81 138.59 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.764 ' HG3' HG23 ' A' ' 7' ' ' THR . 49.1 mtp180 -88.67 102.96 15.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.861 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.0 mt -90.56 141.61 28.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.213 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 136.03 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.683 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 m -139.81 136.76 39.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.749 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.639 ' HB3' HD23 ' A' ' 58' ' ' LEU . 2.2 ptt? -104.33 146.89 28.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.349 . . . . 0.0 110.936 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -140.57 116.71 10.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.016 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.829 0.347 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.76 110.97 23.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.955 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 58' ' ' LEU . 4.2 m-85 -82.23 113.48 20.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 1.6 mp0 -115.42 153.01 31.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.668 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HB2' ' HG2' ' A' ' 85' ' ' ARG . 1.9 pm0 -107.84 144.82 34.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.456 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.994 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.77 109.63 3.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.918 0.39 . . . . 0.0 111.704 179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.845 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.0 122.3 26.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.004 HD23 ' HG ' ' A' ' 15' ' ' LEU . 5.3 tp -131.54 126.85 35.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 12.8 mt-10 -80.31 99.99 8.17 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.279 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.28 88.42 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.085 179.356 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -53.6 171.31 0.77 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.441 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -52.8 -25.0 10.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.817 0.342 . . . . 0.0 110.991 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 m -94.09 -22.74 18.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.38 -164.47 26.95 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.315 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.004 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.8 tp -68.73 -63.48 1.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.41 0.148 . . . . 0.0 110.898 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.42 20.64 0.99 Allowed Glycine 0 CA--C 1.52 0.381 0 C-N-CA 119.765 -1.207 . . . . 0.0 114.486 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.868 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.0 p90 -159.28 135.52 9.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.608 0.704 . . . . 0.0 110.847 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -95.27 135.2 37.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.554 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.984 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.89 146.6 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 CA-C-O 121.543 0.687 . . . . 0.0 111.552 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.59 120.7 30.23 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.628 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 141.92 159.24 7.85 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.783 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 149.64 175.56 22.02 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 68' ' ' VAL . 26.6 p -65.87 -12.19 52.57 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -114.96 -26.35 7.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.53 87.37 54.45 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.466 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.94 66.06 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.365 2.043 . . . . 0.0 112.329 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.75 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 31.7 t60 -46.89 -28.8 1.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.656 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -85.96 -155.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.438 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.01 -50.1 69.07 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.746 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.03 76.25 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.876 0.37 . . . . 0.0 110.701 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' CB ' ' CD ' ' A' ' 32' ' ' PRO . 0.2 OUTLIER -166.63 176.69 1.71 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 -179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 31' ' ' ASP . 94.1 Cg_endo -85.36 26.77 0.63 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.729 2.286 . . . . 0.0 112.543 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 m -77.21 112.29 13.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.138 0.494 . . . . 0.0 110.992 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.903 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.59 118.85 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.009 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.34 148.15 37.47 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.259 0.552 . . . . 0.0 110.789 179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.06 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.31 155.87 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.81 -177.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.64 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.31 -30.65 4.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.098 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.613 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.46 132.59 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.444 -0.503 . . . . 0.0 111.896 -179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.978 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.26 131.52 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 115.69 61.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.5 Cg_exo -57.72 134.79 65.23 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.731 2.288 . . . . 0.0 112.162 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.22 8.12 56.75 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.598 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.43 179.75 18.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.903 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.08 -38.8 68.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.825 0.345 . . . . 0.0 111.064 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.792 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -65.44 -57.46 8.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.668 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.25 -28.93 66.76 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.349 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.27 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.875 0.369 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.76 -57.94 3.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.632 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.06 9.56 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.602 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.1 mtt-85 -115.25 -6.18 12.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.787 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.06 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -121.23 154.06 36.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.162 0.506 . . . . 0.0 111.197 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.597 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -130.46 135.45 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.552 179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.613 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.21 157.54 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.197 0.523 . . . . 0.0 111.538 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 77.06 -2.27 2.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.185 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -64.94 124.63 22.53 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.49 100.22 12.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.472 0.653 . . . . 0.0 111.615 -178.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.984 HD11 HG21 ' A' ' 19' ' ' ILE . 38.0 mt -48.51 125.66 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.565 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -117.42 -16.46 10.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.739 179.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -164.64 142.59 6.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.114 0.483 . . . . 0.0 110.94 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.913 HG13 ' CD2' ' A' ' 86' ' ' LEU . 38.6 t -136.98 112.18 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.393 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.606 HD22 HG23 ' A' ' 84' ' ' VAL . 3.4 t-20 50.69 39.29 21.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.918 0.389 . . . . 0.0 110.276 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 77.67 33.83 0.36 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.564 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 60' ' ' VAL . 88.7 t -120.9 103.76 14.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.307 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 10.3 t0 -65.99 108.05 2.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.582 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.616 HG21 HG22 ' A' ' 57' ' ' ILE . 25.3 m -87.39 8.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.638 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.64 -21.32 53.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.634 0.254 . . . . 0.0 111.051 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -139.21 42.04 2.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.185 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.758 ' O ' HG23 ' A' ' 23' ' ' THR . 8.3 m -124.42 144.71 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.418 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.48 153.92 41.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.93 0.395 . . . . 0.0 110.613 -179.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.714 ' O ' HG23 ' A' ' 74' ' ' VAL . 13.3 t-160 -48.76 -34.43 12.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.867 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 2.7 m -70.06 -33.68 72.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.843 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.638 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.04 -33.2 71.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.903 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -70.64 -46.79 62.64 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.8 t -59.57 -50.76 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.352 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 3.5 pt-20 -57.69 -31.82 66.75 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.605 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.655 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.11 -49.75 75.87 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.328 0.585 . . . . 0.0 110.022 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.944 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -59.8 -37.33 78.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.983 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.31 -25.74 51.55 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.699 179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 6.4 pt-20 -103.26 17.75 23.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.191 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.94 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.73 16.15 4.21 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.16 -93.77 0.6 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.321 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 28.1 t -141.06 -90.63 0.15 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.845 ' CD1' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER -84.2 86.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.3 0.571 . . . . 0.0 109.706 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.94 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -100.27 137.57 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.29 -0.868 . . . . 0.0 113.114 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 6.0 ttt180 -89.4 102.65 15.32 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.913 ' CD2' HG13 ' A' ' 60' ' ' VAL . 19.0 mt -91.46 133.65 35.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.005 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.601 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.99 114.77 29.18 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.826 179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.676 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.7 m -120.34 129.31 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.779 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.461 ' HB3' ' CD2' ' A' ' 3' ' ' TYR . 25.8 ptt? -96.77 133.73 40.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.139 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -114.22 146.51 40.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.822 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.978 179.904 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' HE3' ' HD3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.792 0.329 . . . . 0.0 111.217 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.55 119.69 35.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.805 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 6.4 m-30 -82.15 136.16 35.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -143.86 149.79 37.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 1.6 mt-10 -104.51 144.62 31.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.058 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.91 109.44 9.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.997 0.427 . . . . 0.0 111.382 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.879 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 114.95 19.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.058 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -125.78 127.27 45.87 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.4 pt-20 -84.24 100.49 11.24 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.38 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.09 89.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.257 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.25 174.69 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.736 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -53.33 -25.54 15.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.81 0.338 . . . . 0.0 111.078 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -97.75 -24.74 15.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.57 -165.57 27.92 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.244 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.968 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.1 tp -61.9 -63.52 1.23 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.638 0.219 . . . . 0.0 110.505 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.82 25.91 0.97 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.82 -1.181 . . . . 0.0 114.765 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.775 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -164.27 132.27 3.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.862 0.831 . . . . 0.0 111.363 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.486 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -91.39 137.13 32.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.331 -179.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.038 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -116.22 161.76 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-O 121.767 0.794 . . . . 0.0 112.092 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 35' ' ' PHE . . . -155.51 131.91 10.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.777 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 15.01 0.26 Allowed Glycine 0 C--O 1.229 -0.16 0 C-N-CA 120.159 -1.02 . . . . 0.0 113.468 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.565 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -73.04 -174.14 26.45 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.769 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.712 HG23 ' C ' ' A' ' 68' ' ' VAL . 22.2 p -66.93 -32.71 74.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -85.09 -33.35 22.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.032 0.444 . . . . 0.0 110.514 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -124.65 77.21 64.14 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 28' ' ' ILE . 3.6 Cg_endo -46.02 -24.25 2.18 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.736 2.29 . . . . 0.0 112.679 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.692 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.4 t60 58.94 -59.26 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.251 0.548 . . . . 0.0 111.497 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.837 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -66.28 -158.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.659 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.678 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.99 -49.45 78.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.484 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 179.39 75.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.795 0.331 . . . . 0.0 110.959 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -164.56 156.99 14.38 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.882 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.563 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.2 5.73 4.38 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.857 2.371 . . . . 0.0 112.937 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -60.51 111.76 1.71 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.804 0.335 . . . . 0.0 110.707 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.853 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -79.76 121.45 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.263 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.837 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -142.23 147.2 36.13 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.419 0.628 . . . . 0.0 110.446 178.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.094 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.51 155.35 7.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.142 -0.935 . . . . 0.0 113.139 -176.388 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.98 -32.94 4.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.803 -179.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.13 143.67 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.616 -179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.02 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.27 132.27 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.92 116.78 66.43 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.8 Cg_exo -56.62 136.87 78.46 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.594 2.196 . . . . 0.0 112.305 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.61 1.98 67.92 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.689 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -102.55 174.83 24.06 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.864 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.84 -35.32 57.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.868 0.334 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.786 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.55 -57.44 4.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.485 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.0 -28.92 68.65 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.397 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -72.05 -35.36 69.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.049 0.452 . . . . 0.0 109.968 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.58 -57.77 3.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.523 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 40.88 9.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.599 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -112.49 9.55 19.6 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.794 0.33 . . . . 0.0 110.689 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.094 HD21 HD12 ' A' ' 36' ' ' ILE . 4.7 tp -136.3 153.8 51.06 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -131.2 134.37 46.41 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.705 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -48.98 157.57 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 111.83 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.5 t-20 76.56 -0.26 3.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.387 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.02 125.93 28.22 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.047 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.46 102.61 14.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.614 0.721 . . . . 0.0 111.199 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 61.6 mt -50.91 134.74 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.776 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 89' ' ' MET . 0.9 OUTLIER -117.47 -30.54 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.576 179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -152.47 163.69 39.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.773 HG13 ' CD2' ' A' ' 86' ' ' LEU . 19.3 t -144.05 97.65 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.029 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.873 ' OD1' HG23 ' A' ' 84' ' ' VAL . 4.7 t30 68.13 -67.36 0.2 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.202 0.525 . . . . 0.0 109.917 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 6.2 pt-20 -156.54 32.41 0.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.691 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 59.0 t -119.78 142.27 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.496 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 p-10 -110.0 99.51 8.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.437 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.8 m -83.54 56.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.906 0.384 . . . . 0.0 111.462 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.46 -29.09 26.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.727 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -147.36 56.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.688 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.712 ' C ' HG23 ' A' ' 23' ' ' THR . 31.7 m -126.22 144.39 36.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.155 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -62.14 151.77 34.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.063 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.4 t-160 -47.95 -33.98 8.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.717 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -33.99 75.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.977 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.692 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.18 -42.16 80.37 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.853 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.04 -46.65 86.51 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.631 0.729 . . . . 0.0 109.124 177.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.6 t -57.62 -50.56 76.94 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.193 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.692 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.34 -29.57 61.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.89 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.738 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.04 -50.66 72.44 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.318 0.58 . . . . 0.0 109.862 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.986 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -58.11 -37.14 73.99 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.836 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.51 -28.31 52.06 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.15 18.11 19.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 -178.316 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.904 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.04 16.38 5.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.246 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.94 -97.08 0.8 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.275 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.496 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 37.4 m -136.9 -90.44 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.879 HG13 HG22 ' A' ' 7' ' ' THR . 8.7 tp -84.86 89.97 2.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.23 0.538 . . . . 0.0 109.737 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.904 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.4 p -104.84 138.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 5.9 ttm-85 -87.95 103.12 15.39 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.773 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.6 mt -92.37 138.6 31.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.241 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.69 132.44 47.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.516 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.3 m -139.77 153.62 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.627 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.686 ' HB3' HD21 ' A' ' 58' ' ' LEU . 8.6 ptt? -121.39 131.24 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 111.013 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.53 121.76 14.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.819 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.46 ' HD3' ' HE3' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.034 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HE2' ' HE2' ' A' ' 89' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.795 0.331 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -87.19 132.61 33.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.445 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 4.0 m-30 -99.12 153.37 18.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.98 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -154.98 159.64 40.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.993 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 2.0 mt-10 -109.57 144.68 37.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.957 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.69 109.6 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 111.599 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.872 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.38 121.03 23.22 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.003 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -132.3 127.25 35.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.5 mt-10 -83.29 100.2 10.48 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.841 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.559 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -46.57 89.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.338 179.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.85 -174.4 0.03 OUTLIER Glycine 0 C--N 1.321 -0.301 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.747 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -45.98 -45.04 15.48 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.745 0.307 . . . . 0.0 111.581 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.4 t -92.82 -22.84 19.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.171 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.443 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 145.58 -162.6 28.25 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.928 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.003 ' HB3' HD23 ' A' ' 8' ' ' LEU . 20.1 mt -54.39 -63.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.036 0.418 . . . . 0.0 110.712 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 129.89 34.72 0.47 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.446 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.778 ' HB3' HG23 ' A' ' 39' ' ' ILE . 10.1 p90 -160.1 136.56 8.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 117.133 0.466 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.497 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.5 137.05 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.294 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.26 148.74 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.729 0.776 . . . . 0.0 112.355 -179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.75 133.8 27.57 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.409 -1.269 . . . . 0.0 111.065 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.474 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.41 4.77 0.88 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.725 179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.545 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -61.49 -169.72 0.72 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.902 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.82 HG22 ' HB3' ' A' ' 32' ' ' PRO . 43.4 p -70.95 -29.89 66.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -93.54 -19.85 20.81 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 3.8 t-20 -124.46 87.43 54.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.548 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.91 61.24 0.93 Allowed 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.32 2.013 . . . . 0.0 112.46 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.714 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.8 t60 -47.19 -28.67 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.814 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -88.79 -154.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.208 179.386 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.45 -49.9 73.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.597 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.51 40.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.847 0.356 . . . . 0.0 110.799 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.85 165.59 27.69 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.941 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.82 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.4 Cg_exo -75.22 1.6 7.66 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.956 2.437 . . . . 0.0 112.754 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.8 t -52.62 112.07 0.76 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.978 0.418 . . . . 0.0 111.185 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.88 118.52 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.524 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.814 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.31 147.2 37.76 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.422 0.629 . . . . 0.0 110.622 178.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.076 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.94 155.72 7.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.005 . . . . 0.0 113.064 -176.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.06 -30.4 4.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.165 -178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.25 130.24 0.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.995 -179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.007 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.19 130.86 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 126.06 70.67 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.4 Cg_endo -67.71 132.11 26.02 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.71 2.273 . . . . 0.0 112.34 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.57 16.39 26.89 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.333 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.24 177.54 16.9 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.022 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.49 -34.39 57.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.747 0.308 . . . . 0.0 111.487 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.789 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.62 -57.45 4.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.832 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.48 -28.82 64.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.603 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -71.74 -32.83 68.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 110.337 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -81.14 -57.89 3.31 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.685 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.12 39.57 9.94 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.717 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.7 mtm180 -113.93 -7.62 13.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.739 0.304 . . . . 0.0 110.821 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.076 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -121.2 154.02 36.81 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.079 0.466 . . . . 0.0 111.209 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -130.95 135.88 48.05 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.604 179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.6 t -49.03 157.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.244 0.545 . . . . 0.0 111.454 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.9 t30 76.87 -2.02 2.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.111 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -65.47 124.54 22.57 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.1 p -86.5 100.76 12.61 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.52 0.676 . . . . 0.0 111.233 -178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 19' ' ' ILE . 65.8 mt -49.99 130.37 8.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.875 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' HG ' ' CG ' ' A' ' 89' ' ' MET . 3.7 mt -112.91 -34.04 5.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.113 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -151.09 159.41 44.51 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.438 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.032 HG11 ' HB1' ' A' ' 76' ' ' ALA . 7.7 p -146.69 105.48 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.52 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.493 ' OD1' HG23 ' A' ' 84' ' ' VAL . 18.7 t30 68.62 -67.18 0.21 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.137 0.494 . . . . 0.0 109.992 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.9 mm-40 -162.46 29.99 0.11 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.047 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HB ' HG13 ' A' ' 60' ' ' VAL . 1.4 t -121.01 142.01 39.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.279 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 18.0 t0 -106.36 90.75 3.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.3 m -70.54 63.32 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.002 0.429 . . . . 0.0 111.567 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.88 -26.64 19.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.804 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -147.6 55.27 1.07 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.815 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 29.4 m -124.69 146.97 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.455 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.61 154.44 40.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.226 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.869 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.8 p-80 -48.12 -34.61 10.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 87.2 p -71.95 -33.75 68.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.197 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.691 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.24 -45.39 80.78 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.61 -46.58 89.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.582 0.706 . . . . 0.0 109.203 178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 70' ' ' HIS . 93.7 t -57.5 -50.47 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.245 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.691 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.86 -30.36 63.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.091 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 1.032 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.07 -49.79 75.9 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 121.28 0.562 . . . . 0.0 109.945 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.976 HD11 HD12 ' A' ' 19' ' ' ILE . 4.0 mt -59.25 -35.54 73.87 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.739 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -77.31 -23.26 51.06 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.12 179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -105.34 16.96 24.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.042 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.896 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.54 16.21 4.01 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.147 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -97.16 0.99 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.171 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 25.8 t -138.07 -89.09 0.24 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.872 ' CD1' HG22 ' A' ' 7' ' ' THR . 0.7 OUTLIER -85.98 87.91 2.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.264 0.554 . . . . 0.0 109.626 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.896 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.4 p -101.94 140.18 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.609 ' HG2' HG23 ' A' ' 7' ' ' THR . 56.5 mtm180 -87.97 103.18 15.45 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.802 ' CD2' HG23 ' A' ' 60' ' ' VAL . 11.8 mt -91.76 139.01 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.64 131.98 47.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.244 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 57' ' ' ILE . 14.2 m -139.87 158.68 26.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.855 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.496 ' HB2' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -113.12 150.08 32.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.83 0.348 . . . . 0.0 110.747 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 120.99 14.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.946 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.431 HH22 HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.907 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.903 0.382 . . . . 0.0 111.143 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.38 119.16 17.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.009 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.665 ' CE2' HD13 ' A' ' 58' ' ' LEU . 3.7 m-30 -82.88 130.85 35.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.684 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.1 144.57 38.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.085 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.44 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 43.9 mt-10 -102.33 144.69 30.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.02 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.982 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.19 109.39 5.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 111.563 179.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.836 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.33 121.53 23.87 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.069 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.012 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.0 tp -132.27 128.2 37.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 5.7 pt-20 -86.96 100.9 12.94 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.57 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.57 ' CG ' HD23 ' A' ' 15' ' ' LEU . 6.6 mtp180 -43.72 91.62 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.935 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.71 74.42 0.03 OUTLIER Glycine 0 C--N 1.318 -0.433 0 CA-C-N 115.03 -0.986 . . . . 0.0 113.042 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 10' ' ' ARG . 8.4 m-20 63.08 -76.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.802 0.334 . . . . 0.0 111.24 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.2 t -69.98 -24.68 63.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.39 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 154.15 -172.2 32.76 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.038 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.012 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.2 mt -59.74 -63.7 1.21 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.827 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 135.67 39.22 0.17 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.189 -1.005 . . . . 0.0 113.484 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.789 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.5 p90 -161.79 137.31 7.56 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.986 0.393 . . . . 0.0 110.708 179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.8 134.33 40.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.624 -179.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.04 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.51 146.92 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-O 121.588 0.709 . . . . 0.0 111.684 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -127.37 121.57 31.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.464 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' ILE . . . 140.69 159.62 8.0 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.007 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.455 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 148.86 175.59 21.47 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.359 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 68' ' ' VAL . 25.0 p -66.71 -11.69 55.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.417 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 23.7 t70 -114.62 -26.59 7.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.676 0.274 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -124.44 87.2 54.41 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.394 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.57 66.21 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.301 2.001 . . . . 0.0 112.579 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.753 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.8 t60 -48.43 -27.81 2.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.376 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.981 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -87.13 -155.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.437 179.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -52.83 -51.7 43.47 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.964 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 172.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.862 0.363 . . . . 0.0 110.958 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.52 175.73 3.28 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.99 35.41 0.53 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.671 2.247 . . . . 0.0 112.445 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -84.84 114.77 22.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.108 0.48 . . . . 0.0 110.903 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.926 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.69 118.18 35.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.066 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.981 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.15 148.03 37.61 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.344 0.593 . . . . 0.0 110.719 179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.028 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.39 155.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.516 -177.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.13 -29.82 4.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.163 -178.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.628 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.34 130.37 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.785 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.983 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.62 132.13 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.466 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 125.56 71.71 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -177.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 44.1 Cg_endo -68.05 132.55 26.52 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.694 2.263 . . . . 0.0 112.365 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.33 19.26 21.47 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.346 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.86 179.12 16.67 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.349 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.739 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.39 -33.31 59.01 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.653 0.263 . . . . 0.0 111.479 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.823 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -73.36 -56.0 5.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.45 -29.08 63.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.4 pt20 -72.19 -31.85 66.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.274 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.88 -57.94 3.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.75 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.69 37.4 11.9 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.592 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -111.67 -15.76 13.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.766 0.283 . . . . 0.0 110.863 179.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.028 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -113.9 153.37 29.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.21 0.529 . . . . 0.0 111.412 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.557 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.99 136.28 48.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.574 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.2 t -49.08 157.3 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.363 0.601 . . . . 0.0 111.543 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER 76.82 -1.04 2.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.302 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -66.51 124.52 23.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.54 100.48 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.55 0.691 . . . . 0.0 111.432 -178.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.04 HD11 HG21 ' A' ' 19' ' ' ILE . 27.4 mt -48.3 135.61 4.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.596 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.665 HD13 ' CE2' ' A' ' 3' ' ' TYR . 3.0 pp -139.92 12.79 2.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.868 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 170.82 134.74 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.184 0.516 . . . . 0.0 111.317 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.799 HG21 ' CB ' ' A' ' 76' ' ' ALA . 37.5 t -123.91 95.92 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.299 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.626 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.6 t-20 73.26 -60.49 0.53 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 27.28 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.475 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 40.8 t -121.27 109.11 24.06 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.993 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -70.48 120.81 16.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.512 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.727 HG21 HG22 ' A' ' 57' ' ' ILE . 22.1 m -93.99 20.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.43 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -22.63 66.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.116 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.26 44.18 1.89 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.059 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 23' ' ' THR . 16.7 m -124.41 145.84 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.036 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.513 ' HG1' ' HG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -66.07 153.65 41.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.558 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.629 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.9 t-160 -49.14 -34.2 13.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.744 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.513 ' HG ' ' HG1' ' A' ' 69' ' ' THR . 0.1 OUTLIER -70.86 -33.76 70.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.7 179.269 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.676 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -70.05 -31.67 69.41 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.926 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -71.56 -46.96 57.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.636 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 81.8 t -60.48 -50.54 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.283 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 6.4 pt-20 -58.33 -34.89 71.12 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.39 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.799 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -55.22 -49.34 72.22 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.426 0.631 . . . . 0.0 110.09 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.918 HD11 HD12 ' A' ' 19' ' ' ILE . 1.8 mt -59.65 -36.01 75.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.591 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.36 -21.95 52.51 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.491 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mt-10 -102.05 -6.33 23.49 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.684 0.278 . . . . 0.0 111.383 -178.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.921 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -59.71 -17.74 37.04 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.251 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.0 -117.04 5.75 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.921 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 m -110.68 -89.29 0.5 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.836 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.1 tp -90.92 90.91 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.296 0.569 . . . . 0.0 109.732 178.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.921 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.8 p -103.89 138.29 29.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.493 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.05 102.89 15.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.788 ' CD2' HG13 ' A' ' 60' ' ' VAL . 14.1 mt -89.78 134.7 34.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.223 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -101.91 116.52 32.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.271 179.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.5 m -122.83 150.97 26.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.455 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.485 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 1.2 ptt? -118.58 144.54 46.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.935 0.397 . . . . 0.0 111.234 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -138.11 120.06 15.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.793 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.565 HH22 HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.245 -0.883 . . . . 0.0 111.003 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 2.6 ttt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.969 0.414 . . . . 0.0 111.15 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.82 136.39 38.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.353 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 56.2 m-85 -111.74 109.83 19.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.438 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -113.2 163.87 14.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 111.065 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 68.8 mt-10 -114.16 144.6 42.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.78 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.948 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -132.39 109.47 14.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.067 0.461 . . . . 0.0 111.501 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.938 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.26 120.67 23.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.043 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -132.29 127.22 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.6 pt-20 -85.9 100.84 12.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.192 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.588 ' CG ' HD23 ' A' ' 15' ' ' LEU . 9.7 mtp180 -42.77 91.85 0.0 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 121.35 0.595 . . . . 0.0 110.835 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -61.86 75.72 0.02 OUTLIER Glycine 0 C--N 1.316 -0.56 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.117 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 10' ' ' ARG . 3.3 m120 62.29 -76.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.865 0.364 . . . . 0.0 111.25 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.9 m -70.13 -23.77 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.261 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 152.08 -172.07 31.39 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.419 -0.895 . . . . 0.0 112.026 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.043 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.9 mt -57.86 -63.64 1.18 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.781 0.324 . . . . 0.0 110.924 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 131.97 38.25 0.26 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.594 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.801 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -160.44 135.36 7.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.006 0.403 . . . . 0.0 110.729 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.41 136.84 34.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.525 -179.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.065 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.21 148.84 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.743 0.783 . . . . 0.0 112.337 -179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -143.25 133.22 24.16 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.12 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.89 -2.95 1.24 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.184 -1.007 . . . . 0.0 113.879 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.552 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.04 -173.16 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.951 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.802 HG22 ' CB ' ' A' ' 32' ' ' PRO . 19.9 p -73.09 -20.9 60.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -96.35 -24.61 16.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.776 0.322 . . . . 0.0 111.585 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.36 87.52 53.92 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.211 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.73 63.17 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.384 2.056 . . . . 0.0 112.652 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.4 t60 -49.78 -26.58 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.076 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.842 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.15 -154.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.323 179.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.91 -50.04 71.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.615 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.72 40.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 110.94 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -127.09 169.19 12.68 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.802 ' CB ' HG22 ' A' ' 23' ' ' THR . 98.0 Cg_endo -79.35 3.5 7.42 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.566 2.178 . . . . 0.0 112.74 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -53.61 111.91 0.81 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.883 0.373 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.838 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -83.55 119.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.838 -179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.842 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.23 147.22 36.15 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 121.361 0.601 . . . . 0.0 110.779 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.96 155.6 7.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.803 -177.011 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.451 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.6 -29.53 4.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.286 -178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.99 130.19 0.49 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.001 -179.553 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.003 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.5 131.09 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.481 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.18 124.33 74.25 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.0 Cg_endo -66.2 132.58 30.16 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.742 2.295 . . . . 0.0 112.348 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.81 17.46 25.63 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.437 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 177.39 17.27 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.042 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.68 -32.76 52.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.736 0.303 . . . . 0.0 111.444 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.812 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -71.55 -57.3 4.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.799 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.15 -29.02 63.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.477 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -71.95 -33.32 68.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.148 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -79.37 -58.05 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.38 39.97 10.52 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.592 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.468 ' CB ' HG12 ' A' ' 6' ' ' ILE . 19.2 mmt180 -115.88 -4.75 12.06 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.758 0.313 . . . . 0.0 110.814 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 6.1 tp -123.69 155.85 37.04 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.072 0.463 . . . . 0.0 111.092 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.589 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 134.55 42.96 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.487 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.09 157.5 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.319 0.58 . . . . 0.0 111.681 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.5 OUTLIER 77.01 -1.61 2.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.174 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -68.17 125.55 26.73 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.653 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.26 12.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.753 0.787 . . . . 0.0 111.435 -178.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.065 HD11 HG21 ' A' ' 19' ' ' ILE . 65.8 mt -47.35 138.35 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.887 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.508 HD11 HH21 ' A' ' 66' ' ' ARG . 0.2 OUTLIER -117.31 -44.42 2.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.073 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -142.52 167.14 22.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.771 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 86' ' ' LEU . 23.4 t -142.22 97.55 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.788 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.501 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.8 t-20 67.57 -67.99 0.17 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.093 0.473 . . . . 0.0 109.775 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.2 tt0 -155.71 33.71 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.481 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 58.1 t -120.73 142.49 36.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.636 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.7 p-10 -106.95 111.23 23.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.29 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.426 ' HB ' HD12 ' A' ' 34' ' ' ILE . 18.2 m -95.32 31.02 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.801 0.334 . . . . 0.0 111.54 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.508 HH21 HD11 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -63.33 -29.16 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.766 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.85 65.91 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.045 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.729 ' O ' HG23 ' A' ' 23' ' ' THR . 27.2 m -136.19 147.12 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.274 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.54 153.01 33.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.013 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.0 t-160 -50.51 -33.75 22.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.333 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.83 -34.02 73.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.756 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.29 -39.96 81.95 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.838 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.11 -46.99 78.79 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.6 t -57.02 -50.34 76.59 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.253 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.38 -30.69 63.03 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.026 178.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.672 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -60.44 -49.78 76.2 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.405 0.622 . . . . 0.0 109.908 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.996 HD11 HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -60.27 -34.76 74.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.832 179.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.5 mmmt -77.48 -26.77 51.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.361 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.84 15.54 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.383 -178.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.22 16.28 6.44 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.172 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.98 -114.01 5.57 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.989 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.4 m -114.99 -89.36 0.55 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.938 HG13 HG22 ' A' ' 7' ' ' THR . 7.1 tp -86.77 97.93 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-O 120.993 0.425 . . . . 0.0 110.222 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.901 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -111.37 138.64 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.573 ' HG2' HG23 ' A' ' 7' ' ' THR . 7.2 mtt85 -88.16 103.24 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.8 mt -91.12 142.97 27.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.437 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.446 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -101.74 136.07 42.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.768 -179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.535 HG11 HD11 ' A' ' 51' ' ' LEU . 17.2 m -139.87 143.93 29.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.469 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 9.1 ptt? -108.11 136.87 47.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.61 0.243 . . . . 0.0 110.758 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 106.89 5.16 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.942 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HE2' ' HE3' ' A' ' 89' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.776 0.322 . . . . 0.0 111.223 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -112.54 134.44 54.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 89' ' ' MET . 20.6 m-85 -91.79 146.09 24.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -144.42 147.46 33.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.968 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 39.6 mt-10 -104.63 144.74 31.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.963 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.23 109.26 8.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.033 0.444 . . . . 0.0 111.439 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.902 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.25 122.96 25.8 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.016 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.6 tp -134.23 127.05 31.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -82.4 100.43 10.0 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.845 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.542 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -50.33 92.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.514 179.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 13' ' ' SER . . . -63.29 68.22 0.03 OUTLIER Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.286 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER 63.97 -71.33 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.785 0.326 . . . . 0.0 111.584 179.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' GLY . 4.4 t -70.05 -24.73 63.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.29 -170.32 32.77 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.771 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.016 ' HB3' HD23 ' A' ' 8' ' ' LEU . 8.4 mt -69.87 -63.61 1.04 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.501 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 138.2 39.12 0.12 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.632 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.795 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.8 p90 -160.17 134.29 7.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.093 0.446 . . . . 0.0 110.764 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.68 133.43 37.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.071 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.67 162.98 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-O 121.711 0.767 . . . . 0.0 111.632 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.687 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -160.36 132.61 6.22 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.357 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.84 -2.8 1.47 Allowed Glycine 0 C--N 1.329 0.167 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.464 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.56 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.74 -175.57 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.138 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 32.2 p -67.97 -29.1 68.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -93.78 -20.49 20.06 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -124.17 87.02 53.88 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.71 61.74 0.86 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.354 2.036 . . . . 0.0 112.645 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.72 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 28.8 t60 -47.57 -29.09 2.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.033 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.847 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.74 -155.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.194 179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.67 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.88 -49.52 47.87 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.46 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -178.17 49.01 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.897 0.379 . . . . 0.0 111.231 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -137.08 159.16 70.99 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.576 ' CB ' HG22 ' A' ' 23' ' ' THR . 96.6 Cg_endo -79.1 3.41 7.45 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.647 2.232 . . . . 0.0 112.691 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.43 119.43 5.6 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.976 0.417 . . . . 0.0 110.931 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.856 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.71 119.19 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.567 -179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.847 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.24 144.71 33.46 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-O 121.48 0.657 . . . . 0.0 110.783 178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.056 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.74 155.94 7.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.98 -1.009 . . . . 0.0 113.311 -176.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.455 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.12 -29.82 4.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.343 -178.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.646 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.97 131.57 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.931 -179.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.955 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.42 130.94 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.471 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.37 115.3 59.72 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -177.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.5 Cg_exo -58.11 136.48 75.14 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.697 2.265 . . . . 0.0 112.389 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.72 19.96 27.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.48 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -130.48 179.54 16.83 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.175 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.65 -36.55 57.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.859 0.361 . . . . 0.0 111.531 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -68.86 -57.41 5.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.2 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -72.55 -28.39 62.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.781 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.66 -29.91 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.257 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.498 ' OD2' HD12 ' A' ' 8' ' ' LEU . 5.2 m-20 -82.49 -57.86 3.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.689 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.88 37.19 11.89 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.602 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.443 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtt180 -112.33 -14.43 13.31 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.713 0.292 . . . . 0.0 110.894 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.056 HD21 HD12 ' A' ' 36' ' ' ILE . 7.1 tp -113.75 156.82 23.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.267 0.556 . . . . 0.0 111.374 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.616 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -135.09 134.66 40.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.413 179.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' A' ' 38' ' ' LYS . 52.9 t -49.04 157.64 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.248 0.547 . . . . 0.0 111.708 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.485 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 75.15 2.51 3.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.091 179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -72.62 127.07 31.46 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.48 102.5 14.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 111.306 -178.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.071 HD11 HG21 ' A' ' 19' ' ' ILE . 57.3 mt -49.7 131.2 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.814 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD21 ' HG3' ' A' ' 89' ' ' MET . 3.4 mm? -109.63 -43.17 4.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.106 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -143.16 164.94 28.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.813 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.747 HG11 ' HB1' ' A' ' 76' ' ' ALA . 21.4 t -143.61 98.79 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.991 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 68.09 -66.89 0.21 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.126 0.488 . . . . 0.0 109.992 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -157.65 33.24 0.27 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.687 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.7 t -120.73 142.4 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.582 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.1 t0 -109.04 95.29 5.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.337 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 65' ' ' VAL . 27.4 m -80.28 58.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 0.0 111.48 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp85 -85.22 -31.52 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.757 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -144.68 52.69 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 27.3 m -121.16 148.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -67.06 153.4 43.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.92 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.853 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 t-160 -49.44 -34.1 15.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.792 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.9 m -68.71 -34.09 75.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.785 179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.35 -42.05 79.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.856 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.4 -46.91 84.25 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.661 0.743 . . . . 0.0 109.076 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.5 t -57.31 -50.39 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.231 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.82 -29.89 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.864 178.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.747 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.14 -50.22 74.09 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.305 0.574 . . . . 0.0 109.847 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -58.78 -36.31 74.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.955 179.115 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.61 -25.16 49.59 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.452 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.53 16.38 26.53 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.32 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.38 16.3 5.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.241 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.35 -98.32 0.82 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.063 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 8.5 p -136.4 -90.38 0.28 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.902 HG13 HG22 ' A' ' 7' ' ' THR . 8.5 tp -83.37 88.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 109.875 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.2 p -104.14 139.6 24.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.87 103.06 15.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.744 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.2 mt -90.96 141.17 29.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.442 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.85 138.48 38.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 51' ' ' LEU . 13.0 m -138.92 167.86 20.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.97 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.439 ' HG3' HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -114.61 138.12 51.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.874 0.369 . . . . 0.0 110.899 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.47 115.06 9.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.937 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 3.9 mtm . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.86 0.362 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.19 147.85 26.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.41 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 78.1 m-85 -110.98 148.09 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.892 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HG2' HG23 ' A' ' 88' ' ' VAL . 2.6 pt-20 -138.32 167.24 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.971 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 5.6 tt0 -121.18 144.64 48.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.767 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.991 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.13 109.41 11.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.866 0.365 . . . . 0.0 111.739 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -82.02 112.19 18.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.991 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -121.68 127.31 50.63 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.9 pt-20 -83.83 100.54 11.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.07 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.519 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.72 89.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.078 179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.59 175.87 0.1 Allowed Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.556 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -54.94 -24.09 22.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 111.09 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.21 -24.82 15.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.111 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.66 -163.76 28.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.187 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.5 tp -66.77 -63.54 1.04 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.618 0.209 . . . . 0.0 110.731 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.28 22.05 1.01 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 119.745 -1.216 . . . . 0.0 114.809 178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.875 ' CE2' HD23 ' A' ' 15' ' ' LEU . 10.5 p90 -161.4 136.51 7.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.035 0.918 . . . . 0.0 111.143 179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.42 135.22 38.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.656 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.09 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.44 146.93 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.628 0.728 . . . . 0.0 111.367 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.83 124.07 34.41 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.706 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.85 -121.81 1.07 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.074 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.462 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 69.54 172.22 9.0 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.361 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.827 HG22 ' HB2' ' A' ' 32' ' ' PRO . 4.3 p -77.85 -5.55 51.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.17 -23.14 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.516 ' O ' ' O ' ' A' ' 21' ' ' GLY . 2.6 t-20 -124.91 85.96 56.95 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-O 120.488 0.185 . . . . 0.0 110.57 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.83 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.153 1.902 . . . . 0.0 112.425 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.733 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.1 t60 -53.8 -24.36 15.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.053 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.841 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -91.79 -153.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.337 179.533 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.682 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -65.35 -47.62 77.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.757 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 171.19 79.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.934 0.397 . . . . 0.0 110.676 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -172.75 164.01 3.69 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.67 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.827 ' HB2' HG22 ' A' ' 23' ' ' THR . 96.0 Cg_endo -79.7 50.94 3.68 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.503 2.135 . . . . 0.0 112.174 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -99.28 116.65 31.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.848 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.873 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -89.99 112.49 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.459 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -137.31 146.76 45.03 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.276 0.56 . . . . 0.0 110.125 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.103 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.05 155.8 7.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.169 -176.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.609 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.52 -30.36 4.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.04 -178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.12 131.04 0.48 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.447 -0.501 . . . . 0.0 112.031 -179.442 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.98 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.88 132.8 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 177.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.2 115.26 59.32 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.3 Cg_exo -57.19 134.45 64.19 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.824 2.349 . . . . 0.0 112.201 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.25 4.02 59.92 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.642 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.55 179.39 22.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.801 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.66 -37.61 68.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 0.0 111.043 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.807 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.35 -57.45 6.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.518 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.56 -28.84 68.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.296 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -33.35 68.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.978 0.418 . . . . 0.0 110.001 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.631 ' OD2' HD12 ' A' ' 8' ' ' LEU . 24.0 m-20 -82.86 -58.02 3.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.559 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.76 40.88 9.22 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.539 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER -115.6 6.98 14.7 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.94 179.676 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.103 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -135.24 154.76 51.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.993 0.425 . . . . 0.0 110.843 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.584 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.09 137.07 47.61 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.7 t -51.6 159.87 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.138 0.494 . . . . 0.0 111.716 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.4 m120 71.95 3.68 4.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.32 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.654 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.7 m-20 -74.63 128.37 35.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.562 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.85 105.25 16.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.564 0.697 . . . . 0.0 111.388 -178.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.09 HD11 HG21 ' A' ' 19' ' ' ILE . 68.5 mt -51.09 141.11 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.602 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.41 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -121.61 -44.31 2.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.496 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -143.18 148.61 36.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.335 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.916 HG13 ' CD2' ' A' ' 86' ' ' LEU . 54.5 t -139.54 112.93 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.026 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 50.81 35.8 13.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.129 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 80.23 33.94 0.16 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.501 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 60' ' ' VAL . 78.1 t -120.93 108.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 t0 -71.26 117.18 12.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.713 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 57' ' ' ILE . 33.8 m -101.89 23.45 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.301 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -62.84 -25.52 68.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -146.07 57.4 1.21 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.181 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.782 ' C ' HG23 ' A' ' 23' ' ' THR . 31.8 m -132.79 141.83 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.231 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.68 152.35 26.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.84 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 20.1 t-160 -47.99 -34.02 8.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.883 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -34.24 77.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.018 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.681 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.27 -40.62 77.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.873 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.0 -46.93 82.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.9 t -56.09 -50.86 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.391 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.681 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.76 -29.29 62.45 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.153 178.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.846 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.11 -56.72 18.18 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.359 0.6 . . . . 0.0 110.044 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 73' ' ' ALA . 2.0 mp -53.86 -36.4 62.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.34 -27.29 52.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.659 179.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -100.26 15.67 26.84 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.0 111.47 -178.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.991 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.81 16.32 4.95 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.316 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.03 -89.33 0.13 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.384 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.519 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -143.44 -88.87 0.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.763 HG13 HG22 ' A' ' 7' ' ' THR . 4.2 tp -84.4 91.03 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.991 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.4 p -107.06 135.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.1 ptt180 -86.81 102.96 14.78 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.916 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.8 mt -91.63 143.56 26.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.083 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CD1' ' HG3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -101.68 139.71 36.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.523 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG21 ' OD2' ' A' ' 55' ' ' ASP . 28.9 m -139.62 167.93 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.805 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.404 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 38.1 ttp -111.49 159.9 17.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.104 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 130.03 24.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.428 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.056 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttm . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.834 0.349 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -88.38 150.86 22.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.969 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.451 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 36.1 m-85 -105.83 150.07 25.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.795 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 133.31 21.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -97.17 144.61 26.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.959 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.076 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.0 109.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 120.863 0.364 . . . . 0.0 111.833 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.796 HG23 HD11 ' A' ' 83' ' ' ILE . 0.6 OUTLIER -79.83 114.55 18.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.076 HD13 HD11 ' A' ' 6' ' ' ILE . 5.6 tp -120.78 127.05 51.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.819 -178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.73 ' N ' HD12 ' A' ' 83' ' ' ILE . 3.8 pt-20 -80.59 99.92 8.36 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.558 ' NE ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -56.44 88.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.901 178.11 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -132.1 171.63 21.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.225 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 54.56 -89.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.64 0.257 . . . . 0.0 110.817 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.9 t -108.35 20.88 18.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.106 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 107.89 -138.77 14.77 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.086 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.982 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.5 tp -73.74 -63.7 1.15 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 121.198 -0.201 . . . . 0.0 111.003 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 126.6 25.19 1.3 Allowed Glycine 0 CA--C 1.52 0.371 0 C-N-CA 119.661 -1.257 . . . . 0.0 114.849 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.843 ' CE2' HD23 ' A' ' 15' ' ' LEU . 4.5 p90 -161.82 134.75 6.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 117.854 0.827 . . . . 0.0 111.256 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.67 134.16 38.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.386 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.105 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.96 168.26 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 121.686 0.755 . . . . 0.0 111.677 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -165.43 132.2 2.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.319 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.4 0.54 1.16 Allowed Glycine 0 C--N 1.329 0.192 0 C-N-CA 120.321 -0.942 . . . . 0.0 113.545 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.562 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.02 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.015 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.777 HG22 ' CB ' ' A' ' 32' ' ' PRO . 16.6 p -74.42 -22.45 59.14 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -97.18 -23.76 16.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.693 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -124.32 87.7 53.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.365 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.84 63.16 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.339 2.026 . . . . 0.0 112.742 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.718 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.0 t60 -47.53 -28.47 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.181 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.859 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.85 -155.1 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.239 179.46 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.47 -47.49 56.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.597 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.408 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.8 t0 177.23 76.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.37 165.26 7.7 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.861 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.777 ' CB ' HG22 ' A' ' 23' ' ' THR . 89.9 Cg_endo -81.12 6.68 5.42 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.657 2.238 . . . . 0.0 112.79 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.39 112.17 1.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.84 0.353 . . . . 0.0 110.897 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.52 119.46 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.585 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.859 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.44 146.0 34.37 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 121.522 0.677 . . . . 0.0 110.668 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.049 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.79 155.77 7.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.415 -176.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.21 -30.46 4.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.347 -178.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.45 132.21 0.47 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.425 -0.51 . . . . 0.0 112.051 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.99 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.88 132.0 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.435 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.3 118.12 70.41 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.506 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.8 Cg_exo -58.01 135.29 67.72 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.722 2.281 . . . . 0.0 112.363 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.1 3.02 62.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.845 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.77 178.49 23.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.057 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.58 -34.62 64.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 111.011 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.793 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -71.82 -56.92 4.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.679 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.19 -30.28 70.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.94 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 3.0 pt20 -72.06 -33.45 67.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.976 0.417 . . . . 0.0 110.077 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.89 -57.93 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.71 9.16 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.614 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.485 ' CB ' HG12 ' A' ' 6' ' ' ILE . 2.2 mtp85 -113.27 8.12 17.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.804 0.335 . . . . 0.0 110.785 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.049 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -136.65 154.73 50.56 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.053 0.454 . . . . 0.0 110.816 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.7 tpm_? -131.76 136.3 47.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.944 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -51.58 157.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.333 0.587 . . . . 0.0 111.564 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.2 t30 74.07 3.15 4.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.177 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.664 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -73.73 127.0 31.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.42 100.97 12.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.659 0.743 . . . . 0.0 111.296 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.105 HD11 HG21 ' A' ' 19' ' ' ILE . 62.5 mt -46.24 149.51 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.813 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -127.62 -45.71 1.47 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.387 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -143.03 157.78 44.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.081 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.85 HG11 ' HB1' ' A' ' 76' ' ' ALA . 41.7 t -132.55 95.73 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.873 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.457 ' CG ' HG23 ' A' ' 84' ' ' VAL . 2.9 t-20 68.85 -66.93 0.23 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.166 0.508 . . . . 0.0 109.896 -178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -155.59 32.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.654 179.171 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 86.4 t -120.7 142.2 37.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.512 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 24.5 t0 -107.86 112.15 24.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.158 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 23.8 m -94.18 36.8 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.726 0.298 . . . . 0.0 111.513 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -65.07 -31.54 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.721 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.28 68.09 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.713 ' O ' HG23 ' A' ' 23' ' ' THR . 27.0 m -137.62 145.05 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.281 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.2 150.56 34.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.757 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.7 t-160 -48.1 -33.78 8.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.695 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.75 -34.1 76.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.027 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.67 -39.91 80.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.82 -46.92 76.81 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.646 0.736 . . . . 0.0 109.081 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 70' ' ' HIS . 97.2 t -57.2 -50.55 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.206 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.57 -30.48 60.89 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.953 178.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.63 -50.57 72.97 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.41 0.624 . . . . 0.0 110.018 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.064 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -58.55 -37.17 75.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.045 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -26.41 50.87 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.505 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.431 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -102.43 18.89 20.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.795 0.331 . . . . 0.0 111.306 -178.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.949 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.77 16.25 6.0 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.531 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.31 -86.69 0.41 Allowed Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.635 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' LEU . 38.1 m -147.67 -90.87 0.08 Allowed 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.796 HD11 HG23 ' A' ' 7' ' ' THR . 8.4 tp -84.17 90.68 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.452 0.644 . . . . 0.0 109.743 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.949 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.8 p -105.92 135.06 45.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.318 -0.855 . . . . 0.0 113.294 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.6 ttt180 -85.21 102.89 13.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.565 HD12 ' HZ ' ' A' ' 17' ' ' PHE . 15.3 mt -92.05 140.9 29.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.969 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.55 141.18 34.81 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.713 -179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.664 HG21 ' OD2' ' A' ' 55' ' ' ASP . 25.1 m -135.6 167.03 26.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.581 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.445 ' HG3' ' CE1' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -115.55 145.31 42.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.929 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.82 134.63 32.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.983 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.907 0.384 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -107.87 120.23 41.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 4.6 m-30 -85.46 144.32 28.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -151.18 146.15 25.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.8 pt-20 -100.74 144.57 29.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.001 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.978 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.45 110.0 9.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.895 0.379 . . . . 0.0 111.521 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.909 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -76.92 121.48 23.5 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.03 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.4 tp -134.22 127.1 31.23 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 83' ' ' ILE . 4.1 pt-20 -85.89 100.88 12.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.344 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.634 ' CG ' HD23 ' A' ' 15' ' ' LEU . 8.0 mtp-105 -44.94 92.37 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.22 0.533 . . . . 0.0 110.897 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -60.64 73.36 0.01 OUTLIER Glycine 0 C--N 1.315 -0.608 0 CA-C-N 115.045 -0.979 . . . . 0.0 113.13 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER 64.15 -71.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.713 0.292 . . . . 0.0 111.586 179.539 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -74.97 -21.15 59.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.469 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . 150.87 -173.19 30.45 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.93 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.03 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.3 mt -58.31 -63.57 1.22 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.84 0.353 . . . . 0.0 110.793 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.529 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 132.77 39.17 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.086 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.9 p90 -162.51 132.38 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.789 0.328 . . . . 0.0 110.345 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -92.48 137.29 32.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.134 0.492 . . . . 0.0 111.724 -179.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -120.3 142.11 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 CA-C-O 121.661 0.744 . . . . 0.0 111.95 179.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.583 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . . . -106.06 117.2 33.41 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.814 ' HA2' HG23 ' A' ' 34' ' ' ILE . . . -71.21 -158.72 3.09 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.44 -44.09 0.12 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 120.734 -0.746 . . . . 0.0 114.571 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.759 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.0 OUTLIER -69.02 -58.9 3.47 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 4.0 m-20 -81.67 -34.2 30.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.09 0.471 . . . . 0.0 110.52 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' HIS . 11.1 t-20 -124.44 87.7 53.92 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.248 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.75 64.98 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.288 1.992 . . . . 0.0 112.538 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.76 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.3 t60 -57.53 -21.82 40.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.724 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.764 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -96.61 -150.15 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.372 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.688 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -85.19 44.22 3.35 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.875 -0.678 . . . . 0.0 113.885 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 t0 76.18 30.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.961 0.41 . . . . 0.0 110.738 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -116.47 146.92 38.56 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.712 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.409 ' CB ' HG22 ' A' ' 23' ' ' THR . 74.4 Cg_endo -74.9 55.27 3.84 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.52 2.146 . . . . 0.0 112.508 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.0 m -121.01 108.88 14.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.4 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.964 HD11 ' O ' ' A' ' 68' ' ' VAL . 2.7 mp -79.49 131.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.083 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.764 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -142.89 152.82 42.5 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 121.213 0.53 . . . . 0.0 110.27 179.294 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.888 HD12 HD21 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -69.41 155.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.988 -1.006 . . . . 0.0 112.553 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.521 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.08 -26.12 4.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.978 -179.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -176.53 131.73 0.21 Allowed 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.868 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.8 HG23 ' HB3' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -97.49 130.37 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.36 114.16 53.12 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -177.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.1 Cg_exo -56.22 139.96 86.8 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.599 2.199 . . . . 0.0 112.205 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.2 15.24 56.2 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.522 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.55 174.69 16.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.986 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.47 -30.64 30.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.628 0.251 . . . . 0.0 111.129 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.836 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -72.94 -57.52 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.343 . . . . 0.0 111.823 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.66 -28.58 63.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.535 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -72.02 -30.84 65.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.923 0.392 . . . . 0.0 110.382 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 8' ' ' LEU . 2.5 m-20 -80.53 -57.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.16 37.0 10.28 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.711 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.426 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -118.95 4.57 11.42 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.821 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.888 HD21 HD12 ' A' ' 36' ' ' ILE . 16.3 tp -132.73 159.81 38.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.218 0.532 . . . . 0.0 111.173 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.595 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -139.44 152.77 47.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.604 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 38' ' ' LYS . 77.8 t -65.75 158.9 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 121.054 0.454 . . . . 0.0 111.271 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 53' ' ' VAL . 55.3 m-80 77.27 -6.35 2.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.714 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -64.44 125.86 25.99 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.87 104.39 16.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.611 0.719 . . . . 0.0 111.773 -178.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.03 HG22 HG21 ' A' ' 65' ' ' VAL . 46.1 mt -48.2 138.89 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.794 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 89' ' ' MET . 1.1 mt -126.4 -37.75 2.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.471 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -147.17 156.67 43.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.941 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.917 HG13 ' CD2' ' A' ' 86' ' ' LEU . 47.8 t -141.21 102.38 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.232 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.443 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 66.95 -68.57 0.14 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.098 0.475 . . . . 0.0 110.247 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.86 31.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.929 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.8 t -120.79 142.33 37.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.281 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.8 p-10 -101.65 108.18 19.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.492 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.03 HG21 HG22 ' A' ' 57' ' ' ILE . 26.7 m -97.26 30.72 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.311 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -58.53 -37.45 75.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.003 0.43 . . . . 0.0 110.725 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.25 56.32 1.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.505 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.964 ' O ' HD11 ' A' ' 34' ' ' ILE . 33.6 m -114.59 141.03 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.159 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.759 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 1.8 p -51.06 150.16 3.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.223 0.535 . . . . 0.0 112.0 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.803 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.4 OUTLIER -47.09 -32.99 4.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.527 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 3.6 m -73.81 -33.31 64.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.387 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.66 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -69.79 -32.12 70.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.973 0.416 . . . . 0.0 110.042 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.92 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.55 -46.89 58.2 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.803 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.0 t -60.29 -50.66 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.733 178.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.7 pt-20 -58.31 -31.48 67.56 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.497 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.786 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -58.39 -49.26 77.9 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.308 0.575 . . . . 0.0 109.795 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.814 ' CD1' HD12 ' A' ' 19' ' ' ILE . 1.5 mt -61.25 -34.67 75.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.186 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.1 mmmt -77.14 -29.06 54.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.512 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.7 pt-20 -98.79 15.39 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.525 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -88.57 16.3 6.79 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.35 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 67.21 -114.76 6.57 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.078 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.9 OUTLIER -113.59 -88.87 0.54 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.894 HG13 HG22 ' A' ' 7' ' ' THR . 7.1 tp -86.72 100.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 121.122 0.487 . . . . 0.0 110.113 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.7 p -114.96 139.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.909 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.3 103.02 15.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.917 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.2 mt -91.84 137.22 32.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.511 -178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.87 131.56 48.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.42 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 57' ' ' ILE . 2.5 m -139.72 152.45 22.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.134 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.746 ' HB3' HD21 ' A' ' 58' ' ' LEU . 25.5 ptt? -118.23 149.53 40.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 0.0 111.12 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 ptp85 -140.5 125.16 18.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.883 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.087 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.783 0.325 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -107.07 118.47 36.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.755 ' CE2' HD22 ' A' ' 58' ' ' LEU . 3.0 m-30 -96.6 107.45 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.575 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -115.16 165.02 13.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.841 0.353 . . . . 0.0 111.251 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -120.0 145.01 47.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.836 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.15 110.98 14.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 111.931 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.924 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.35 117.15 20.07 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.697 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 5.1 tp -128.28 126.83 41.61 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.0 pt-20 -85.24 100.45 11.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.537 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.0 88.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.15 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.99 176.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.703 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -55.12 -24.03 23.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 0.0 111.099 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.7 p -97.06 -24.78 15.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.273 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.25 -163.25 28.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.164 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.005 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.2 tp -66.47 -63.39 1.08 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.698 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.526 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.77 21.95 0.97 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.65 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.866 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.8 p90 -161.42 137.46 8.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.736 0.768 . . . . 0.0 111.055 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.546 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.04 133.21 40.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.38 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.055 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.03 165.06 5.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.657 0.741 . . . . 0.0 111.76 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -162.64 132.11 4.34 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.504 -1.226 . . . . 0.0 111.262 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.84 0.66 0.9 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.42 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.15 -170.7 0.34 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.859 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.844 HG22 ' HB3' ' A' ' 32' ' ' PRO . 23.9 p -69.81 -32.62 71.16 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.79 -19.72 23.15 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.14 86.79 53.98 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.633 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.59 60.2 1.13 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.292 1.995 . . . . 0.0 112.547 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.675 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.8 t60 -47.8 -28.71 2.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.145 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.844 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.23 -153.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.14 179.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.677 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -66.29 -47.83 68.54 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.413 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.32 46.5 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.834 0.349 . . . . 0.0 110.835 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.97 161.74 61.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.06 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.844 ' HB3' HG22 ' A' ' 23' ' ' THR . 7.5 Cg_exo -73.03 -2.78 12.54 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.864 2.376 . . . . 0.0 112.689 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -49.16 113.87 0.89 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.929 0.395 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.832 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -85.7 119.19 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.46 179.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.844 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.46 146.45 34.8 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.526 0.679 . . . . 0.0 110.794 178.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.075 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.92 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.954 -176.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.19 -28.68 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.337 -178.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.56 129.64 0.43 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.547 -0.461 . . . . 0.0 112.071 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.981 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.49 133.05 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.424 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 129.95 55.93 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 56.0 Cg_endo -70.0 130.24 18.71 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.784 2.323 . . . . 0.0 112.304 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 2.65 55.43 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.64 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.49 179.23 24.51 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.078 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.79 -35.48 68.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 111.065 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.859 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -71.9 -56.75 5.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.625 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.82 -31.89 72.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.93 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.1 pt20 -72.11 -33.73 68.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.026 0.441 . . . . 0.0 110.159 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -81.43 -57.91 3.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.01 41.27 9.65 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.627 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.524 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -113.31 7.02 17.58 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.947 0.403 . . . . 0.0 110.795 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.075 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -135.97 154.16 51.17 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.37 135.54 48.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.911 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.1 t -49.7 157.95 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.277 0.56 . . . . 0.0 111.556 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.486 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.4 t30 75.05 2.18 3.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.008 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.51 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -70.45 123.37 21.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.614 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.53 100.42 12.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.889 0.852 . . . . 0.0 111.54 -178.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 19' ' ' ILE . 20.0 mt -49.18 142.79 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.392 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.755 HD22 ' CE2' ' A' ' 3' ' ' TYR . 1.4 mt -124.54 -37.84 2.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.069 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.4 m-85 -143.8 164.3 30.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.81 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.887 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.8 t -151.54 103.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.264 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 54.26 42.46 31.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 110.342 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.86 32.68 0.49 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.599 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 88.9 t -120.92 112.75 37.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.417 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.9 t0 -80.8 110.43 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.703 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 65' ' ' VAL . 33.4 m -83.09 55.59 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.917 0.389 . . . . 0.0 110.83 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.8 105.67 14.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.12 48.27 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.288 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' THR . 11.8 m -116.1 142.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.866 0.365 . . . . 0.0 110.977 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.467 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -61.29 152.01 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.832 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.867 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 t-160 -49.6 -33.76 16.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.211 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.64 -34.06 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.761 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.64 -43.22 80.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.89 -46.88 82.89 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.0 t -57.48 -48.45 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.285 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.88 -31.74 63.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.764 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.652 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.8 -53.11 61.83 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.211 0.529 . . . . 0.0 109.797 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.037 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -52.49 -37.44 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.262 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.57 -27.8 51.55 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.082 178.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.2 mm-40 -84.08 -19.97 33.41 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 110.602 -179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -53.03 -18.81 2.24 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.628 179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.78 -92.75 1.83 Allowed Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.8 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.6 OUTLIER -129.99 -92.34 0.44 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.924 HG13 HG22 ' A' ' 7' ' ' THR . 8.8 tp -86.59 100.97 10.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.178 0.513 . . . . 0.0 110.442 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.936 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.4 p -116.06 138.77 45.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.2 102.87 14.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.887 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.2 mt -93.37 135.59 34.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.57 135.46 43.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.743 -179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.559 HG12 ' HA ' ' A' ' 57' ' ' ILE . 19.0 m -139.65 159.77 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.808 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.685 ' HG2' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -121.51 137.69 54.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 111.033 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.76 134.92 34.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.955 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.173 -0.918 . . . . 0.0 110.888 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HB2' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.806 0.336 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -99.69 128.94 45.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.064 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.429 ' CE1' ' HG2' ' A' ' 89' ' ' MET . 11.2 m-30 -90.38 150.5 21.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.442 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.401 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 2.9 mm-40 -145.13 168.29 20.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 0.0 111.287 -179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -118.05 144.79 45.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.69 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.88 110.53 14.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.905 0.383 . . . . 0.0 111.653 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.841 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.48 120.5 22.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 4.2 tp -132.58 127.45 35.05 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.636 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.0 pt-20 -86.56 100.88 12.72 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.588 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.517 ' CG ' HD23 ' A' ' 15' ' ' LEU . 2.6 mtp-105 -42.76 91.29 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.119 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.994 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.27 73.53 0.02 OUTLIER Glycine 0 C--N 1.318 -0.418 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.061 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.9 OUTLIER 63.2 -75.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.81 0.338 . . . . 0.0 111.342 179.684 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 11' ' ' GLY . 29.0 t -70.05 -24.65 63.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.376 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 153.57 -172.63 32.37 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.801 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.005 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.5 mt -59.46 -63.59 1.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.645 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 135.34 39.38 0.17 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.598 179.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.785 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.4 p90 -161.69 133.85 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.113 0.483 . . . . 0.0 111.161 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.492 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.08 134.62 34.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.287 -179.489 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.107 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.93 162.59 10.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.675 0.75 . . . . 0.0 111.731 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -158.76 131.76 7.16 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.046 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.51 -1.3 0.98 Allowed Glycine 0 CA--C 1.517 0.194 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.504 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.14 -168.93 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.94 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.848 HG22 ' HB3' ' A' ' 32' ' ' PRO . 12.2 p -77.09 -23.49 51.86 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -94.87 -25.32 16.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.329 . . . . 0.0 111.557 -179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 27' ' ' HIS . 23.6 m-80 -124.65 82.82 59.16 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -64.6 64.24 0.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.912 2.408 . . . . 0.0 112.66 -179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.746 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.4 t60 -50.68 -24.27 3.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.374 178.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.794 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.12 -154.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.586 179.762 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.633 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -80.1 52.48 4.27 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.733 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 74.76 30.53 0.99 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.446 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -117.08 147.76 40.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.848 ' HB3' HG22 ' A' ' 23' ' ' THR . 11.8 Cg_exo -70.76 -2.71 11.33 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.812 2.342 . . . . 0.0 112.88 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -53.99 116.55 2.62 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.035 0.445 . . . . 0.0 111.078 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.865 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.84 120.19 33.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.375 179.77 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.794 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.52 144.93 33.17 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.456 0.646 . . . . 0.0 110.642 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.065 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.78 155.68 7.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.109 -0.951 . . . . 0.0 113.307 -176.529 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.67 -33.79 4.16 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.846 -178.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.52 142.49 2.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.517 -179.561 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.005 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.19 132.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.321 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.96 125.17 73.54 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.621 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 46.2 Cg_endo -68.15 131.94 24.86 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.784 2.322 . . . . 0.0 112.413 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.79 16.04 27.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.27 178.96 16.37 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.203 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.35 -38.86 59.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.732 0.301 . . . . 0.0 111.461 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.793 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.98 -57.11 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.456 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.43 -30.32 65.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -72.08 -30.59 65.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.948 0.404 . . . . 0.0 110.354 179.67 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.95 -58.03 3.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.514 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 40.92 9.62 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.527 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 23.8 mtm180 -115.75 -3.99 12.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.808 0.304 . . . . 0.0 110.944 179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.065 HD21 HD12 ' A' ' 36' ' ' ILE . 5.1 tp -122.57 153.94 38.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.883 179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -131.8 135.86 47.08 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.865 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -49.41 158.4 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.307 0.575 . . . . 0.0 111.725 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.27 1.87 3.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.028 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -70.06 124.85 25.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.929 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.41 101.06 12.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.593 0.711 . . . . 0.0 111.16 -178.694 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.107 HD11 HG21 ' A' ' 19' ' ' ILE . 55.8 mt -49.44 129.68 6.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.703 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.846 HD21 ' CG ' ' A' ' 89' ' ' MET . 7.9 mt -110.75 -31.7 7.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.256 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -151.05 166.42 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.722 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.3 t -148.91 100.45 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.219 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.649 ' OD1' HG23 ' A' ' 84' ' ' VAL . 14.0 t30 67.58 -67.31 0.18 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.154 0.502 . . . . 0.0 110.065 -178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.0 mt-10 -157.92 32.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.711 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 49.5 t -119.57 142.21 36.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.529 -179.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 30.1 t0 -111.65 84.96 2.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.362 179.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 65' ' ' VAL . 32.6 m -69.39 64.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.55 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -87.03 -28.09 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.748 179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -151.31 59.82 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.768 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.688 ' O ' HG23 ' A' ' 23' ' ' THR . 34.5 m -127.78 145.38 35.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.261 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 150.66 27.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.77 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.822 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.4 t-160 -48.29 -33.42 8.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.523 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -68.22 -34.04 75.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.072 179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.11 -40.87 82.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.865 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.26 -46.84 81.94 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.0 t -57.74 -50.31 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.308 178.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.4 OUTLIER -56.16 -34.31 66.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.647 178.481 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.618 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.58 -51.38 68.84 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.241 0.543 . . . . 0.0 110.109 179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.021 HD11 HD12 ' A' ' 19' ' ' ILE . 2.9 mt -56.22 -36.43 68.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.416 179.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.2 mmmt -77.47 -24.62 50.18 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.33 179.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.426 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -95.81 -10.11 29.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 120.842 0.353 . . . . 0.0 111.327 -178.858 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.91 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.81 -17.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.387 179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.98 -109.76 3.74 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.908 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.417 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.8 m -118.84 -90.93 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.808 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.841 HG13 HG22 ' A' ' 7' ' ' THR . 7.9 tp -89.21 89.78 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.257 0.551 . . . . 0.0 109.735 178.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.91 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -103.54 140.42 21.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -177.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.497 ' HG3' HG23 ' A' ' 7' ' ' THR . 3.7 mtt180 -87.73 102.98 15.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.083 177.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.65 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.2 mt -91.89 137.67 32.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.423 -179.109 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.426 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.68 134.39 44.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.091 179.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 57' ' ' ILE . 4.6 m -139.7 167.94 18.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.154 -179.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.846 ' CG ' HD21 ' A' ' 58' ' ' LEU . 27.6 mtm -98.32 134.46 41.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.653 179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.27 106.77 11.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.503 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.444 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.291 -0.862 . . . . 0.0 110.774 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.836 0.351 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -133.42 113.92 13.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.96 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 4.3 m-30 -82.11 121.15 26.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.954 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -132.65 160.61 36.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -107.37 144.67 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.891 -179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.044 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.04 109.31 11.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.91 0.386 . . . . 0.0 111.507 179.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.883 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.22 119.08 20.39 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.044 HD13 HD11 ' A' ' 6' ' ' ILE . 5.5 tp -130.81 127.33 38.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -177.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.58 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -86.68 99.41 11.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.647 179.443 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.439 ' CZ ' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -54.49 92.99 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.868 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 13' ' ' SER . . . -65.6 59.89 0.12 Allowed Glycine 0 C--O 1.229 -0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 114.597 -177.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 64.04 -58.87 0.21 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.892 0.346 . . . . 0.0 111.777 178.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' GLY . 69.8 m -69.31 -25.04 64.03 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.923 -179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.439 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . 147.89 171.87 17.34 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.627 -1.273 . . . . 0.0 113.326 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.927 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.1 tp -65.6 -14.49 61.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.361 -0.419 . . . . 0.0 111.021 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 81.7 25.0 54.76 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 115.456 0.942 . . . . 0.0 115.456 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.798 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -161.75 132.23 4.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 118.424 1.112 . . . . 0.0 111.857 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.53 138.75 32.77 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.83 -179.302 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.098 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.52 147.12 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.608 0.718 . . . . 0.0 111.939 179.756 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.673 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 134.4 31.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.183 179.455 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.9 -3.12 1.49 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.631 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.58 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.78 -176.19 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.045 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 68' ' ' VAL . 43.1 p -66.81 -30.33 70.5 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 9.6 t70 -93.56 -18.33 22.36 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.865 0.321 . . . . 0.0 111.865 -179.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.23 87.0 54.06 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.08 61.13 0.98 Allowed 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.329 2.019 . . . . 0.0 112.606 -179.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 30.7 t60 -48.34 -28.32 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.04 178.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.851 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -85.47 -154.76 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.218 179.248 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.666 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.44 -49.82 48.5 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.439 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -178.44 47.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.383 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.66 160.89 64.8 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.142 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.575 ' CB ' HG22 ' A' ' 23' ' ' THR . 94.5 Cg_endo -78.51 2.46 8.09 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.637 2.225 . . . . 0.0 112.749 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -53.49 117.31 3.0 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.004 0.43 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.864 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.69 118.51 31.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.71 -179.825 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.851 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.25 147.51 40.1 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.362 0.601 . . . . 0.0 110.599 178.453 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.077 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.06 155.5 7.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.8 -176.796 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.07 -33.71 3.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.528 -179.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.29 142.29 2.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.063 0.458 . . . . 0.0 111.679 -179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.005 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.23 128.62 60.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 178.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.05 127.54 66.41 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 -177.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 19.4 Cg_endo -60.2 137.99 78.61 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.759 2.306 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.65 -0.46 82.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.454 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.44 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -93.71 -179.99 38.82 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.084 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.26 -40.5 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.681 0.277 . . . . 0.0 111.518 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.907 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -73.05 -54.99 7.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 0.0 111.468 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -63.94 -28.96 70.18 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.283 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -72.35 -36.54 68.82 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.005 0.431 . . . . 0.0 110.069 179.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -57.93 2.77 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.899 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.07 39.27 8.06 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.751 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' CB ' HG12 ' A' ' 6' ' ' ILE . 69.6 mtt-85 -112.98 8.5 18.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.906 0.353 . . . . 0.0 110.711 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.077 HD21 HD12 ' A' ' 36' ' ' ILE . 4.2 tp -133.02 153.72 51.22 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.008 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -131.1 137.75 49.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.836 179.973 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -51.65 157.88 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.321 0.581 . . . . 0.0 111.732 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.475 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.5 t-20 76.92 -2.4 2.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.491 179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -67.04 124.89 24.3 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.043 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 t -86.63 100.37 12.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.572 0.701 . . . . 0.0 111.129 -178.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.098 HD11 HG21 ' A' ' 19' ' ' ILE . 59.9 mt -49.15 140.22 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.899 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.909 HD11 ' HB3' ' A' ' 89' ' ' MET . 2.6 mp -121.71 -32.36 3.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.552 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -150.86 164.23 36.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.791 -179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.665 HG21 ' CB ' ' A' ' 76' ' ' ALA . 25.9 t -141.92 97.79 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.914 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.758 ' OD1' HG23 ' A' ' 84' ' ' VAL . 10.4 t30 69.6 -65.84 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.111 0.482 . . . . 0.0 109.875 -178.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -159.41 32.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.709 179.2 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.5 t -120.78 142.25 37.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.579 -179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -103.97 110.8 23.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.26 179.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 20.2 m -94.43 34.58 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.777 0.322 . . . . 0.0 111.542 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -25.63 63.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.877 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -146.21 60.68 1.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.036 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.796 ' O ' HG23 ' A' ' 23' ' ' THR . 26.8 m -133.48 150.06 31.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.182 179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -69.18 154.51 41.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.341 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.6 t-160 -49.85 -34.49 20.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 29.7 t -70.32 -34.02 72.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.68 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.24 -41.58 80.97 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.864 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.62 -46.67 84.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 70' ' ' HIS . 95.7 t -57.54 -50.45 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.203 178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -56.0 -29.86 60.96 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.966 178.55 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.665 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -61.94 -51.23 68.96 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.023 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 19' ' ' ILE . 1.3 mt -55.89 -37.59 69.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.452 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.39 -25.13 50.57 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.913 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -91.8 3.01 56.11 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.174 -179.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.903 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.14 16.55 7.03 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.09 179.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.04 -124.91 35.11 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.728 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 34.5 m -100.45 -88.4 0.36 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.883 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -83.06 111.52 19.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.881 0.372 . . . . 0.0 110.931 179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.903 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -130.21 137.7 55.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -178.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.812 ' HG3' HG23 ' A' ' 7' ' ' THR . 24.4 mtt180 -84.93 103.12 13.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.626 ' CD2' HG13 ' A' ' 60' ' ' VAL . 12.5 mt -91.91 141.2 28.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.171 -178.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -101.67 128.13 48.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.648 179.985 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.3 m -139.78 158.68 27.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.909 ' HB3' HD11 ' A' ' 58' ' ' LEU . 15.3 ptp -121.45 132.81 54.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.875 0.369 . . . . 0.0 111.114 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -140.57 135.87 32.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.983 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.658 0.266 . . . . 0.0 111.229 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -122.07 141.9 50.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.876 0.369 . . . . 0.0 111.033 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CD1' HD22 ' A' ' 58' ' ' LEU . 7.3 m-30 -106.73 121.29 44.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.682 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.43 151.8 37.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -102.84 144.71 30.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.911 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.972 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.69 109.36 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.405 179.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.968 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.68 121.23 23.71 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.133 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.052 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.5 tp -131.24 127.23 37.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.669 ' N ' HD12 ' A' ' 83' ' ' ILE . 4.3 pt-20 -86.73 100.29 12.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.261 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.585 ' HG3' HD23 ' A' ' 15' ' ' LEU . 22.7 mtp85 -41.18 91.45 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.206 0.527 . . . . 0.0 111.145 179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -61.69 76.58 0.02 OUTLIER Glycine 0 C--N 1.317 -0.474 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.921 -179.515 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 10' ' ' ARG . 1.4 m-80 63.29 -76.32 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.767 0.318 . . . . 0.0 111.168 179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.3 OUTLIER -70.09 -19.69 63.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.403 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.451 ' HA2' ' NH1' ' A' ' 10' ' ' ARG . . . 145.78 -173.4 26.15 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.95 -179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.052 ' HB3' HD23 ' A' ' 8' ' ' LEU . 17.9 mt -51.85 -63.61 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.983 0.421 . . . . 0.0 110.885 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.504 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 132.96 36.75 0.27 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.403 -0.904 . . . . 0.0 113.162 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -163.27 134.19 4.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.92 0.391 . . . . 0.0 111.039 179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.26 137.15 32.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.622 -179.468 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.39 150.1 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.691 0.758 . . . . 0.0 112.02 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.662 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -143.64 132.85 23.11 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.971 179.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.96 0.88 0.74 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.871 179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.492 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.74 -177.82 0.15 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.671 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.81 HG22 ' HB3' ' A' ' 32' ' ' PRO . 16.0 p -72.0 -21.55 61.54 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.443 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.01 -24.22 17.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.723 0.296 . . . . 0.0 111.501 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -124.36 87.3 54.13 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.359 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.59 65.03 0.54 Allowed 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.292 1.994 . . . . 0.0 112.446 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.728 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 31.1 t60 -48.44 -27.88 2.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.469 179.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.849 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.62 -154.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.449 179.597 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.681 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.21 -47.82 56.44 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.664 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.6 t70 179.97 47.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.928 0.394 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.41 157.29 76.85 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.81 ' HB3' HG22 ' A' ' 23' ' ' THR . 6.1 Cg_exo -77.77 0.6 9.67 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.833 2.355 . . . . 0.0 112.693 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -53.32 120.57 6.19 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.913 0.387 . . . . 0.0 111.124 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.826 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.61 120.19 35.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.339 179.787 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.849 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.66 146.75 36.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.346 0.593 . . . . 0.0 110.681 178.89 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.061 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.96 155.64 7.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.977 -176.774 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -118.89 -34.38 3.94 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.617 -179.175 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.629 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.07 143.5 3.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.013 0.435 . . . . 0.0 111.5 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.996 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.83 131.77 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.292 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.95 120.74 75.35 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.883 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 29.3 Cg_endo -63.01 137.09 60.17 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.667 2.244 . . . . 0.0 112.279 -179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.99 14.85 50.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.372 -179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -120.09 177.14 16.34 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.967 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.14 -31.2 61.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.701 0.286 . . . . 0.0 111.356 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.798 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -73.14 -57.4 4.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.902 0.382 . . . . 0.0 111.611 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.91 -28.92 64.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.396 -179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -72.04 -32.63 67.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.48 ' OD2' HD12 ' A' ' 8' ' ' LEU . 11.7 m-20 -81.53 -58.04 3.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.692 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.86 39.89 9.16 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.482 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.444 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.3 mmt180 -116.11 1.57 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.731 0.301 . . . . 0.0 110.991 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.061 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -129.56 154.92 46.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.128 0.489 . . . . 0.0 111.275 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.563 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 5.2 ttt180 -133.43 136.02 44.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.686 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.0 t -49.88 157.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.338 0.589 . . . . 0.0 111.747 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 2.2 t-20 75.65 -1.75 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.148 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -66.11 125.01 24.15 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.907 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.5 103.31 14.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.533 0.682 . . . . 0.0 111.305 -178.76 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.033 HD11 HG21 ' A' ' 19' ' ' ILE . 51.3 mt -53.13 134.46 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.213 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD22 ' CD1' ' A' ' 3' ' ' TYR . 1.5 pp -134.79 13.56 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.884 179.52 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.581 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER 169.98 138.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.169 0.509 . . . . 0.0 111.001 179.946 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.5 t -127.39 97.36 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.611 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.752 ' ND2' HG23 ' A' ' 84' ' ' VAL . 1.7 t-20 70.95 -62.81 0.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -163.35 31.62 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.999 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 41.0 t -120.92 117.34 52.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.834 -179.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -82.36 109.55 16.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.585 179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -93.79 41.81 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.284 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 52.0 ttm-85 -64.58 -35.52 81.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.835 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.11 71.67 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.982 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.739 ' C ' HG23 ' A' ' 23' ' ' THR . 9.3 m -136.49 142.98 36.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.061 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.44 156.23 10.7 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.313 0.578 . . . . 0.0 111.425 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.9 p-80 -49.74 -34.1 18.07 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.635 179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -69.76 -33.64 72.69 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.828 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -65.48 -45.05 85.16 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.29 0.567 . . . . 0.0 109.631 178.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.826 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.02 -45.67 91.23 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 70' ' ' HIS . 78.9 t -56.3 -50.36 72.01 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.033 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.614 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.52 -34.66 37.19 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.787 179.569 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.758 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.39 -57.37 5.99 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 120.323 -0.551 . . . . 0.0 112.074 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.861 HD12 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -60.32 -40.97 92.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.313 0.577 . . . . 0.0 110.237 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.614 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.75 -19.74 57.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.8 179.794 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.519 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -111.33 20.47 17.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.302 179.373 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.86 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -83.6 16.47 2.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.701 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.32 -101.87 0.87 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.539 -179.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.4 m -123.7 -90.73 0.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.968 HG13 HG22 ' A' ' 7' ' ' THR . 6.2 tp -86.88 109.93 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.872 0.368 . . . . 0.0 110.629 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.86 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.3 p -124.28 137.25 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -178.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.591 ' CG ' HG23 ' A' ' 7' ' ' THR . 11.6 mtt180 -85.94 103.58 14.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.909 178.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 17.4 mt -93.63 135.45 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.489 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HB3' ' CD1' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.77 126.77 48.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.251 179.472 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 HD11 ' A' ' 51' ' ' LEU . 6.1 m -128.41 166.07 26.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.975 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.446 ' HG2' ' CE1' ' A' ' 3' ' ' TYR . 30.3 mtt -96.55 146.76 24.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.92 -179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -140.37 106.54 5.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.043 -179.729 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.814 0.34 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.86 117.73 22.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.745 ' CE2' HD13 ' A' ' 58' ' ' LEU . 3.5 m-30 -82.12 132.27 35.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.794 -179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -143.39 141.15 30.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 2.8 pt-20 -99.84 144.65 28.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.953 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.81 109.46 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.028 0.442 . . . . 0.0 111.362 179.576 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.877 HG23 ' HG3' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -79.23 119.46 22.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.858 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 6' ' ' ILE . 5.2 tp -127.63 126.79 42.66 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.6 pt-20 -84.97 100.57 11.73 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.306 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.86 88.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.226 179.497 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.01 177.76 0.05 OUTLIER Glycine 0 CA--C 1.517 0.218 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.659 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -55.47 -23.71 27.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.704 0.287 . . . . 0.0 111.165 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.95 -24.74 15.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.126 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 145.6 -163.24 28.24 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.09 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.927 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.2 tp -65.58 -63.34 1.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.031 -0.268 . . . . 0.0 110.561 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.88 19.36 1.15 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 119.896 -1.145 . . . . 0.0 114.572 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.86 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.6 p90 -162.04 134.52 5.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 117.816 0.808 . . . . 0.0 111.259 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.448 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.76 138.63 31.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.498 -179.336 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.062 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.25 147.25 22.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 CA-C-O 121.672 0.748 . . . . 0.0 112.091 -179.923 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.668 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.12 132.3 26.43 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.482 -1.235 . . . . 0.0 111.062 179.409 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.24 -3.13 0.87 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.676 179.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.81 179.73 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.764 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.816 HG22 ' CB ' ' A' ' 32' ' ' PRO . 15.3 p -70.92 -20.06 62.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -95.84 -23.94 16.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.767 0.318 . . . . 0.0 111.245 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -124.39 87.43 54.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.188 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 64.53 0.55 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.402 2.068 . . . . 0.0 112.649 -179.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 30.0 t60 -49.93 -27.34 5.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.243 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.855 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.91 -154.09 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.369 179.597 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.68 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -66.77 -47.32 68.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.659 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t0 177.52 46.19 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.29 159.86 70.92 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.816 ' CB ' HG22 ' A' ' 23' ' ' THR . 86.6 Cg_endo -78.51 1.66 8.83 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.665 2.244 . . . . 0.0 112.8 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.65 118.25 4.04 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.949 0.404 . . . . 0.0 111.008 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.858 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.83 121.03 36.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.476 179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.855 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.23 147.68 38.68 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.334 0.588 . . . . 0.0 110.808 178.529 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.042 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.45 7.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.757 -176.892 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.454 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.49 -33.55 4.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.612 -179.188 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.85 142.11 1.86 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.627 -179.743 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.976 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.86 132.2 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.209 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.422 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.93 114.23 52.78 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.647 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 48.0 Cg_exo -56.36 139.03 85.9 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.723 2.282 . . . . 0.0 112.241 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.14 8.53 64.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.433 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.31 176.23 17.7 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.79 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.31 -36.35 61.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.827 0.346 . . . . 0.0 111.199 -179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.755 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -67.81 -57.49 6.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.576 -179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.19 -28.91 66.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.325 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -71.93 -33.14 68.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.029 0.442 . . . . 0.0 110.206 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -82.1 -57.98 3.16 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.618 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.77 40.74 9.33 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.552 179.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.502 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.4 mtp180 -117.74 8.21 12.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.811 0.339 . . . . 0.0 110.843 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.042 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -133.49 155.35 49.72 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.058 0.456 . . . . 0.0 110.804 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.68 136.1 44.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.757 179.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.2 t -51.77 157.79 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.22 0.533 . . . . 0.0 111.718 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.0 OUTLIER 76.3 -2.03 2.8 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.361 179.775 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -67.66 124.91 24.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.033 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.56 101.68 13.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.574 0.702 . . . . 0.0 111.424 -178.608 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.062 HD11 HG21 ' A' ' 19' ' ' ILE . 50.1 mt -51.59 133.43 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.661 179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.745 HD13 ' CE2' ' A' ' 3' ' ' TYR . 1.1 pp -123.5 -19.48 5.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.781 179.241 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.3 m-85 -159.49 147.76 17.58 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.019 0.437 . . . . 0.0 111.027 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.882 HG13 ' CD2' ' A' ' 86' ' ' LEU . 38.8 t -130.22 99.2 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.033 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.663 ' ND2' HG23 ' A' ' 84' ' ' VAL . 1.5 t-20 67.65 -67.81 0.17 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.159 0.504 . . . . 0.0 110.0 -178.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -155.3 29.56 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.94 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 84.5 t -117.99 141.96 34.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.212 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.6 p30 -104.86 109.79 21.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.475 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 57' ' ' ILE . 33.0 m -96.7 32.53 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.52 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 -62.42 -32.17 72.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.77 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.91 66.0 1.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.711 ' C ' HG23 ' A' ' 23' ' ' THR . 8.8 m -133.51 144.48 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.16 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.75 154.04 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.883 0.373 . . . . 0.0 110.954 -179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.898 ' O ' HG23 ' A' ' 74' ' ' VAL . 12.1 t-160 -49.61 -33.78 16.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.572 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.4 m -66.68 -33.92 76.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.65 179.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.603 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.0 -41.56 82.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.858 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.13 -46.22 81.86 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 70' ' ' HIS . 58.4 t -56.61 -50.42 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.022 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -52.12 -34.35 43.97 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.853 179.46 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.867 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.42 -57.53 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.229 -0.588 . . . . 0.0 111.927 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.882 HD12 HD12 ' A' ' 19' ' ' ILE . 1.5 mt -60.4 -41.47 93.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.251 0.548 . . . . 0.0 110.345 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.599 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.06 -20.32 55.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.048 179.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.571 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 3.5 pt-20 -110.43 21.36 16.75 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.753 0.311 . . . . 0.0 110.824 179.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.905 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -83.93 16.57 2.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.778 -179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.25 -90.8 0.28 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.862 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.499 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 2.1 m -137.87 -91.18 0.22 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.132 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.872 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.8 101.96 10.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.999 0.428 . . . . 0.0 110.464 179.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.905 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -117.53 135.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.827 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.877 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.5 mtp180 -86.55 103.44 15.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.81 178.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.882 ' CD2' HG13 ' A' ' 60' ' ' VAL . 25.6 mt -94.06 133.59 37.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.295 -179.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.485 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.01 123.56 46.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.287 179.632 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 57' ' ' ILE . 3.4 m -126.33 151.79 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.62 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.499 ' HB3' HD22 ' A' ' 58' ' ' LEU . 2.4 ptt? -122.73 135.31 54.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.829 0.347 . . . . 0.0 111.149 -179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -128.0 120.6 27.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ttm . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.75 0.309 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -83.69 160.0 21.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.848 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 26.5 m-85 -115.46 153.09 31.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -147.77 136.98 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.012 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.46 144.64 26.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.63 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.039 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -137.64 109.56 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.644 179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.941 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 120.04 21.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.569 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.039 HD13 HD11 ' A' ' 6' ' ' ILE . 5.6 tp -130.82 126.86 37.37 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.006 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.589 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.4 OUTLIER -84.49 99.73 10.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.039 179.025 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.463 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.62 87.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.127 179.155 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -55.23 179.61 0.29 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.65 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -53.73 -27.16 26.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.838 0.351 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.4 p -88.51 -24.88 22.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.04 -165.92 23.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.346 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.91 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.8 tp -69.12 -13.19 62.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.805 0.336 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 72.17 31.0 64.38 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 177.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.802 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 4.7 p90 -164.5 129.74 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.075 0.937 . . . . 0.0 111.574 178.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -96.1 140.2 31.17 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.937 -179.116 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.021 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -120.19 147.03 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.763 0.792 . . . . 0.0 112.221 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.599 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.77 133.43 30.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.044 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.75 3.29 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.724 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.68 -177.87 1.37 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.658 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.826 HG22 ' HB3' ' A' ' 32' ' ' PRO . 25.2 p -67.25 -28.87 68.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -92.74 -19.59 21.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.614 0.245 . . . . 0.0 111.369 -179.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -124.15 87.0 53.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.213 179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.8 61.7 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.385 2.057 . . . . 0.0 112.795 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.729 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 50.4 t60 -49.78 -27.6 5.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.949 178.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.77 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -93.2 -152.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.355 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.24 52.54 4.53 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.733 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 t0 74.6 32.07 0.92 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.927 0.394 . . . . 0.0 110.462 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB3' HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -118.09 149.64 45.97 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.029 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.826 ' HB3' HG22 ' A' ' 23' ' ' THR . 9.8 Cg_exo -71.25 -4.47 15.0 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.753 2.302 . . . . 0.0 112.615 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.0 m -52.21 115.98 1.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 111.287 -179.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.75 120.14 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.305 179.772 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.77 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.15 147.14 36.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.253 0.549 . . . . 0.0 110.692 178.994 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.054 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.07 155.65 7.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.841 -176.794 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.461 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -121.72 -30.26 4.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.176 -179.2 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.23 128.81 0.45 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.36 -179.524 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.76 126.64 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.691 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.26 119.19 72.86 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -177.684 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.1 Cg_exo -54.37 139.57 73.81 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.242 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.34 12.72 69.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.539 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.36 -157.59 21.72 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.942 179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.97 -40.73 53.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.81 0.338 . . . . 0.0 111.12 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.901 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -72.78 -54.44 8.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.676 -179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -61.13 -29.09 69.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.785 -179.337 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -72.38 -39.17 68.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.119 0.485 . . . . 0.0 110.3 179.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 8' ' ' LEU . 2.4 m-20 -81.39 -57.87 3.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.848 -179.755 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.23 37.0 10.22 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.561 179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.474 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -110.82 -5.38 14.94 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.794 0.33 . . . . 0.0 110.698 179.531 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.054 HD21 HD12 ' A' ' 36' ' ' ILE . 5.0 tp -119.93 154.06 34.98 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 179.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.547 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.31 137.18 47.35 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.901 -179.919 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.4 t -51.98 157.7 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 121.264 0.554 . . . . 0.0 111.533 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.39 -1.28 3.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.359 179.91 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.7 m-20 -69.54 127.61 33.61 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.56 101.47 13.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.577 0.703 . . . . 0.0 111.428 -178.662 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.021 HD11 HG21 ' A' ' 19' ' ' ILE . 10.9 mt -48.07 139.07 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.84 179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.845 HD21 ' SD ' ' A' ' 89' ' ' MET . 1.9 mm? -116.6 -44.62 2.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.092 179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.2 m-85 -142.57 174.69 10.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.606 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.925 HG13 ' CD2' ' A' ' 86' ' ' LEU . 31.0 t -151.98 98.47 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.923 179.35 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.785 ' ND2' HG23 ' A' ' 84' ' ' VAL . 1.2 t-20 66.34 -68.23 0.14 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.226 0.536 . . . . 0.0 109.807 -178.676 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.8 OUTLIER -155.2 31.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.489 179.192 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 48.8 t -117.77 142.41 32.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.596 -179.122 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.518 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.5 p-10 -111.1 108.49 18.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.392 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 26.1 m -94.24 44.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.433 -179.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -32.71 74.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -155.39 61.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.713 ' C ' HG23 ' A' ' 23' ' ' THR . 13.7 m -120.47 147.18 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -62.36 155.71 24.43 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.193 -179.071 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.917 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 p-80 -49.33 -34.28 15.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.787 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.7 p -70.19 -33.78 72.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.936 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.545 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.11 -45.73 80.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.265 0.555 . . . . 0.0 109.716 178.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.67 -45.5 92.5 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.917 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.1 t -56.47 -50.46 72.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.156 178.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.49 -34.36 35.44 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.924 179.514 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.697 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.84 -57.52 5.45 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.218 -0.593 . . . . 0.0 112.232 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.955 HD12 HD12 ' A' ' 19' ' ' ILE . 5.2 mt -61.51 -39.74 92.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.429 -179.523 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.604 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.76 -19.84 57.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.544 179.608 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 6.1 pt-20 -110.61 17.75 20.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.129 179.359 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.861 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.8 16.54 1.4 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.702 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.55 -99.43 0.59 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.679 -179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.5 p -127.8 -91.59 0.49 Allowed 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.941 HG13 HG22 ' A' ' 7' ' ' THR . 7.2 tp -84.27 106.19 14.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.061 0.457 . . . . 0.0 110.933 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.861 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.9 p -122.14 139.0 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.519 -178.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.928 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -85.95 103.76 14.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.916 178.812 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.925 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.0 mt -95.28 138.48 32.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.65 -178.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.45 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -102.07 141.56 34.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.462 179.584 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG11 HD11 ' A' ' 51' ' ' LEU . 24.0 m -138.83 165.09 24.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.023 -179.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.845 ' SD ' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -105.98 145.63 31.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.706 179.886 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -140.52 142.41 35.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.111 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.865 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.827 0.346 . . . . 0.0 111.165 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.35 160.25 15.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CD1' ' HG3' ' A' ' 89' ' ' MET . 20.9 m-85 -113.4 144.47 42.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.852 179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.49 134.93 34.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.842 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.75 134.91 38.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.877 HG23 ' HB3' ' A' ' 50' ' ' ARG . 1.2 mt -129.36 109.29 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.263 179.92 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.998 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -76.95 123.07 25.76 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.841 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.97 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.2 tp -133.49 127.29 32.94 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.701 ' N ' HD12 ' A' ' 83' ' ' ILE . 1.4 pt-20 -85.37 103.39 14.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.819 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.627 ' CG ' HD23 ' A' ' 15' ' ' LEU . 10.1 mtp180 -47.58 92.96 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.319 0.581 . . . . 0.0 110.745 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.42 73.15 0.02 OUTLIER Glycine 0 C--N 1.316 -0.538 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.935 -179.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 10' ' ' ARG . 26.9 t-20 63.25 -75.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.732 0.301 . . . . 0.0 111.349 179.724 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 11' ' ' GLY . 2.6 p -70.08 -24.84 63.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.274 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 155.04 -173.45 33.34 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.497 -0.858 . . . . 0.0 111.923 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.97 ' HB3' HD23 ' A' ' 8' ' ' LEU . 10.9 mt -59.04 -63.94 1.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.683 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 136.85 40.99 0.11 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.157 -1.021 . . . . 0.0 113.29 179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.785 ' HB3' HG23 ' A' ' 39' ' ' ILE . 34.7 p90 -163.96 136.35 5.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.004 0.431 . . . . 0.0 111.25 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.01 132.72 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.397 -179.507 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.092 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -109.86 167.43 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 CA-C-O 121.594 0.711 . . . . 0.0 111.768 179.77 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.696 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -166.17 132.99 2.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.339 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.42 -1.88 1.23 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.437 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.528 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -54.53 -172.06 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.93 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.726 HG23 ' C ' ' A' ' 68' ' ' VAL . 8.5 p -75.18 -22.17 58.21 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.369 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -94.82 -25.55 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.323 . . . . 0.0 111.417 -179.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -124.35 87.32 54.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.222 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.79 62.95 0.58 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.411 2.074 . . . . 0.0 112.763 -179.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.699 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 28.4 t60 -48.01 -28.95 3.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.074 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.871 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.32 -155.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.143 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.32 -49.45 45.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.348 -179.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -177.86 51.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.802 0.334 . . . . 0.0 111.175 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.21 159.91 64.4 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.076 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.685 ' CB ' HG22 ' A' ' 23' ' ' THR . 93.8 Cg_endo -80.48 5.49 6.06 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.711 2.274 . . . . 0.0 112.671 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -57.02 118.59 5.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.866 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.99 118.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.602 -179.879 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.871 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.38 146.12 34.58 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.586 0.708 . . . . 0.0 110.79 178.824 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.79 156.01 7.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.981 -1.009 . . . . 0.0 113.294 -176.652 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.47 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.87 -30.24 4.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.395 -178.588 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.31 128.34 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.876 -179.368 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.808 ' CD1' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -96.84 132.18 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.619 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.483 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.3 113.82 50.87 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 54.3 Cg_exo -52.6 143.83 44.53 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.743 2.295 . . . . 0.0 112.482 -179.765 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.51 83.03 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.43 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.85 176.68 20.77 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.111 179.795 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.49 -33.34 59.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.525 0.202 . . . . 0.0 111.389 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.839 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.29 -56.25 5.1 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.778 0.323 . . . . 0.0 111.488 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.83 -29.91 70.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.187 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -72.16 -31.81 66.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.934 0.397 . . . . 0.0 110.44 179.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -75.76 -57.87 3.62 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.063 -179.51 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.62 32.11 19.74 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.422 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.877 ' HB3' HG23 ' A' ' 6' ' ' ILE . 51.9 mtt180 -115.23 -13.45 11.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.687 0.28 . . . . 0.0 110.96 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 36' ' ' ILE . 38.7 tp -112.57 162.4 15.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.183 0.516 . . . . 0.0 111.305 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.617 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.08 135.74 23.23 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.633 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.2 t -49.2 157.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.354 0.597 . . . . 0.0 111.586 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.481 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.8 OUTLIER 74.24 2.39 4.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.255 -179.893 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.654 ' OD2' HG21 ' A' ' 88' ' ' VAL . 1.9 m-20 -72.12 127.11 31.52 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 10.4 p -86.61 100.02 12.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.552 0.691 . . . . 0.0 111.464 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.092 HD11 HG21 ' A' ' 19' ' ' ILE . 63.9 mt -45.25 149.41 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.055 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD21 ' SD ' ' A' ' 89' ' ' MET . 0.5 OUTLIER -128.91 -46.96 1.24 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.706 179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -141.54 169.11 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.769 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 16.6 t -143.91 95.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.121 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.444 ' HB2' HG23 ' A' ' 84' ' ' VAL . 5.4 t-20 68.34 -66.69 0.22 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.5 OUTLIER -156.54 32.47 0.32 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.134 179.044 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 60.8 t -119.02 142.54 33.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.776 -178.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.1 p30 -112.06 113.14 25.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.122 179.029 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.452 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 35.3 m -86.41 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 111.246 -179.684 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.89 100.94 7.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.463 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' C ' HG21 ' A' ' 23' ' ' THR . 0.5 OUTLIER 68.77 52.51 0.55 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.96 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.726 ' C ' HG23 ' A' ' 23' ' ' THR . 29.1 m -122.26 143.43 34.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 179.508 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.08 150.33 25.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.818 -179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.7 t-160 -49.09 -33.34 11.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.29 179.682 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.1 m -67.61 -34.18 76.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.002 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.37 -38.49 81.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.866 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -68.03 -46.91 69.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.639 0.733 . . . . 0.0 109.168 178.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 70' ' ' HIS . 78.2 t -57.81 -48.03 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.214 178.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.74 -36.31 69.6 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.594 178.572 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -55.34 -51.2 67.52 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.248 0.547 . . . . 0.0 110.105 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.02 HD11 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.06 -35.7 67.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.333 178.889 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.3 mmmt -77.29 -23.28 51.1 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.484 179.236 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -96.81 2.54 51.96 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 120.944 0.402 . . . . 0.0 111.418 -179.016 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.891 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -82.54 16.32 2.18 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.709 -179.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.79 -119.18 16.45 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.224 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 15.9 t -104.97 -87.73 0.44 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.998 HG13 HG22 ' A' ' 7' ' ' THR . 5.2 tp -87.7 109.18 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-O 120.894 0.378 . . . . 0.0 110.682 179.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.891 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 2.8 p -122.67 138.53 52.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.296 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.846 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.2 mtt-85 -86.72 102.86 14.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 8.2 mt -91.29 142.6 27.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.33 -178.614 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.415 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.92 139.08 38.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.782 -179.84 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.654 HG21 ' OD2' ' A' ' 55' ' ' ASP . 13.8 m -138.13 149.13 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.724 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.546 ' SD ' HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -96.88 138.67 34.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.33 . . . . 0.0 110.975 -179.883 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.63 113.68 8.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.935 179.836 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.854 0.359 . . . . 0.0 111.069 . . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -152.19 174.76 13.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.337 179.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 52.2 m-85 -141.74 140.78 33.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.959 0.409 . . . . 0.0 111.183 -179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -131.53 151.42 51.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.879 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 4.9 pt-20 -110.12 144.71 38.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.812 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.998 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.36 109.46 8.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.482 179.841 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.96 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.48 120.29 23.67 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.047 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.998 HD13 HD11 ' A' ' 6' ' ' ILE . 4.0 tp -130.71 127.96 39.89 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.275 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.0 pt-20 -85.4 101.05 12.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.004 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.523 ' CG ' HD23 ' A' ' 15' ' ' LEU . 5.0 mtp-105 -47.84 94.69 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.132 178.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -45.38 -101.68 0.01 OUTLIER Glycine 0 C--N 1.319 -0.386 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.228 -179.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.22 -40.66 3.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.026 0.441 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.7 p -108.24 -6.65 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.374 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 154.81 -156.24 26.77 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.495 -179.717 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.952 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -78.12 -63.48 1.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.522 179.68 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 139.38 44.36 0.07 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 119.918 -1.134 . . . . 0.0 114.024 178.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.793 ' HB3' HG23 ' A' ' 39' ' ' ILE . 17.9 p90 -164.0 131.53 3.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.304 0.552 . . . . 0.0 110.784 178.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -93.2 134.4 35.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.669 -179.089 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.038 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.19 172.41 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.795 179.957 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -168.96 132.29 1.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.382 -1.281 . . . . 0.0 111.288 179.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.467 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.34 1.08 0.94 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.347 -0.93 . . . . 0.0 113.652 179.593 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.55 -172.07 0.1 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.869 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.818 HG22 ' CB ' ' A' ' 32' ' ' PRO . 16.8 p -74.44 -21.72 59.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -179.448 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -97.0 -23.38 16.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.665 0.269 . . . . 0.0 111.486 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -124.36 87.54 53.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.26 179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.9 62.36 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.44 2.093 . . . . 0.0 112.738 -179.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.745 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.7 t60 -48.34 -28.08 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.104 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.82 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.325 179.574 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.676 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.48 -50.44 62.74 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.608 -179.624 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 171.58 40.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.937 0.399 . . . . 0.0 110.747 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.9 168.48 13.24 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.836 -179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' CB ' HG22 ' A' ' 23' ' ' THR . 83.0 Cg_endo -81.86 9.02 4.11 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.727 2.284 . . . . 0.0 112.893 -179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -61.03 114.15 2.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.867 0.365 . . . . 0.0 110.65 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.849 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -81.85 119.84 32.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.316 -179.946 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.45 143.41 32.59 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.683 0.754 . . . . 0.0 110.819 178.936 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.024 HD12 HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -68.89 155.81 7.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.102 -176.495 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.487 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.44 -26.96 4.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.376 -178.525 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.656 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.25 131.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.342 -0.543 . . . . 0.0 112.005 -179.645 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.023 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.43 132.73 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.681 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.4 123.75 74.47 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -177.853 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.0 Cg_endo -66.88 133.8 32.56 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.747 2.298 . . . . 0.0 112.267 -179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.62 17.2 31.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.315 -179.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.48 178.31 16.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.169 179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.97 -34.02 58.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.779 0.323 . . . . 0.0 111.431 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.844 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -71.21 -57.48 4.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.897 -179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -70.59 -28.79 65.14 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.336 -179.409 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -71.73 -29.95 65.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.391 . . . . 0.0 110.312 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.433 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -81.99 -58.08 3.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.941 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.06 37.85 12.13 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.569 179.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.45 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.6 mtt85 -112.71 -17.23 12.62 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.716 0.293 . . . . 0.0 110.962 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.024 HD21 HD12 ' A' ' 36' ' ' ILE . 6.4 tp -110.21 155.25 22.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.073 0.463 . . . . 0.0 111.222 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.587 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.52 135.12 45.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.801 179.828 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.656 HG21 ' HA ' ' A' ' 38' ' ' LYS . 65.5 t -51.86 158.62 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.31 0.576 . . . . 0.0 111.636 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.1 t30 73.19 5.58 5.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.001 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.4 m-20 -76.82 128.12 34.01 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.596 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.47 100.17 12.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.621 0.724 . . . . 0.0 111.317 -178.701 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 16.1 mt -48.08 136.28 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.67 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.436 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.2 mm? -116.11 -44.86 2.88 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.231 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.6 m-85 -137.76 170.14 16.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.158 -179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.789 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.9 t -149.59 96.38 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.965 179.359 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.458 ' CG ' HG23 ' A' ' 84' ' ' VAL . 3.7 t-20 67.09 -68.22 0.15 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.161 0.505 . . . . 0.0 109.805 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 60' ' ' VAL . 1.3 mt-10 -154.44 32.32 0.42 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.603 179.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.2 t -118.71 142.42 33.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.478 -179.254 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.0 p-10 -113.42 96.27 5.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.446 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.573 ' O ' HG23 ' A' ' 65' ' ' VAL . 26.9 m -81.81 57.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 111.303 -179.712 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -79.93 -30.13 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.73 179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -151.61 62.86 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.777 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.724 ' O ' HG23 ' A' ' 23' ' ' THR . 35.1 m -128.85 146.09 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.207 -179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.48 151.1 33.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.876 ' O ' HG23 ' A' ' 74' ' ' VAL . 16.3 t-160 -48.33 -33.72 9.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.722 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -67.25 -34.36 77.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.997 179.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.08 -42.66 80.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.849 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.81 -46.5 89.26 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.876 HG23 ' O ' ' A' ' 70' ' ' HIS . 90.8 t -56.51 -50.8 71.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.364 178.588 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.67 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.24 -30.37 64.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.371 178.887 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.2 -49.83 75.58 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.293 0.568 . . . . 0.0 110.179 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.853 HD23 ' CD1' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -60.44 -34.55 74.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.907 179.298 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.66 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.13 -26.23 52.94 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.191 179.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -103.07 14.73 31.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.302 -178.775 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.892 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.87 0.74 33.8 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.253 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.61 -112.62 3.79 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.009 -179.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.461 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.25 -90.54 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 178.997 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.96 HG13 HG22 ' A' ' 7' ' ' THR . 7.6 tp -87.87 87.26 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.218 0.532 . . . . 0.0 109.691 178.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.892 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.1 p -98.87 138.42 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 4.7 ttp180 -89.34 103.15 15.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.198 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.853 ' CD1' HD23 ' A' ' 77' ' ' LEU . 14.1 mt -91.7 140.31 29.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.293 -178.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.91 142.76 32.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.99 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 51' ' ' LEU . 29.7 m -133.03 167.91 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.646 179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.401 ' N ' ' O ' ' A' ' 56' ' ' SER . 13.4 ttt -100.99 160.47 14.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.141 -179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -140.66 106.6 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.998 179.928 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.228 -0.891 . . . . 0.0 111.028 179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.892 0.377 . . . . 0.0 111.186 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.82 162.98 16.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.035 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' CG ' HD13 ' A' ' 58' ' ' LEU . 2.3 m-85 -119.86 130.47 54.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.78 179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.27 152.28 43.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 3.6 tt0 -106.76 144.6 33.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.986 -179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.094 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.2 109.45 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.879 0.371 . . . . 0.0 111.501 179.831 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.05 119.29 20.56 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.851 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.094 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -130.55 127.6 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 7.5 pt-20 -83.85 100.53 11.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.659 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.7 OUTLIER -44.48 88.96 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.174 179.193 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -53.16 -170.17 0.03 OUTLIER Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.792 -179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -51.57 -35.2 40.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.757 0.313 . . . . 0.0 111.366 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.1 p -108.06 4.4 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.585 -179.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 10' ' ' ARG . . . 117.94 -167.08 12.78 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.051 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.061 ' HB3' HD23 ' A' ' 8' ' ' LEU . 17.3 mt -53.89 -44.23 70.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.017 0.437 . . . . 0.0 110.832 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.422 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 106.99 39.49 1.98 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.362 179.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.808 ' HB3' HG23 ' A' ' 39' ' ' ILE . 15.8 p90 -161.4 130.33 4.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.036 0.418 . . . . 0.0 111.424 178.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.27 134.77 34.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.66 -179.415 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.11 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -112.21 167.95 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.63 0.729 . . . . 0.0 111.766 179.893 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.644 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -165.84 131.44 2.49 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.464 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.64 0.97 0.9 Allowed Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.588 179.6 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.53 -168.55 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.987 -179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.836 HG22 ' HB3' ' A' ' 32' ' ' PRO . 11.2 p -76.25 -23.8 54.5 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.67 -23.61 16.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.753 0.311 . . . . 0.0 111.669 -179.234 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -124.22 87.41 53.71 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.03 63.08 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.388 2.058 . . . . 0.0 112.629 -179.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.716 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 37.9 t60 -48.12 -27.86 2.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.308 179.027 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.83 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.71 -154.4 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.356 179.502 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.673 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -61.98 -49.01 79.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.588 -179.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.31 40.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.815 0.34 . . . . 0.0 110.927 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -125.17 163.46 37.83 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.787 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.836 ' HB3' HG22 ' A' ' 23' ' ' THR . 5.5 Cg_exo -79.14 3.41 7.46 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.978 2.452 . . . . 0.0 112.715 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.79 115.45 2.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 111.104 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.862 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.57 120.64 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.382 179.787 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.83 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.64 145.93 33.96 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.553 0.692 . . . . 0.0 110.567 178.699 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.051 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.86 155.8 7.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.275 -176.507 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.09 -30.72 4.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.253 -178.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.8 130.34 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.99 -179.419 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.021 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -97.03 131.56 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.518 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 126.32 69.88 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -177.593 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 28.8 Cg_endo -62.6 134.47 47.77 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.718 2.279 . . . . 0.0 112.415 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.13 4.74 61.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.463 -179.6 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.7 -179.48 25.64 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.991 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.727 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -57.42 -34.87 69.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.518 0.199 . . . . 0.0 111.325 -179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.739 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.25 -55.63 5.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 -179.821 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.84 -30.93 71.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.869 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 16.0 pt20 -72.13 -35.65 69.17 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.045 0.45 . . . . 0.0 110.1 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.46 -57.92 2.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.603 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.37 39.74 8.89 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.891 179.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.506 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -109.08 -4.65 16.45 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.96 0.409 . . . . 0.0 110.578 179.476 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.051 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -123.7 154.67 39.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.693 179.438 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 4.4 tpt85 -132.63 136.39 46.48 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.835 -179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.44 157.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.267 0.556 . . . . 0.0 111.482 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.1 t30 74.8 0.28 3.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.091 -179.827 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -68.78 125.35 26.31 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.6 p -86.43 100.27 12.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.578 0.704 . . . . 0.0 111.549 -178.407 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.084 HD11 HG21 ' A' ' 19' ' ' ILE . 20.6 mt -50.76 136.01 9.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.911 179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.489 HD13 ' CG ' ' A' ' 3' ' ' TYR . 7.8 mt -120.05 -28.13 5.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.705 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -153.4 156.14 37.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.034 0.445 . . . . 0.0 111.008 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.896 HG11 ' HB1' ' A' ' 76' ' ' ALA . 46.3 t -133.76 95.62 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.909 179.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.632 ' OD1' HG23 ' A' ' 84' ' ' VAL . 5.8 t30 67.78 -67.83 0.18 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.117 0.484 . . . . 0.0 110.031 -178.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -153.4 31.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.739 179.259 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 65.7 t -119.44 142.19 35.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.355 -179.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 10.1 p-10 -107.49 100.9 10.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.44 179.231 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.563 ' O ' HG23 ' A' ' 65' ' ' VAL . 22.9 m -86.87 53.23 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.493 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.84 -33.17 34.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.544 179.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -142.83 58.61 1.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.766 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.721 ' C ' HG23 ' A' ' 23' ' ' THR . 34.9 m -128.19 143.7 40.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.169 -179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.92 150.66 28.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.82 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.3 t-160 -48.29 -33.63 9.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.441 179.74 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.37 -34.06 75.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.96 179.633 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -38.57 81.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.328 0.585 . . . . 0.0 109.453 178.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.862 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.67 -46.92 74.13 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 178.066 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 70' ' ' HIS . 92.5 t -57.55 -49.3 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.2 178.563 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -56.84 -34.04 67.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.688 178.65 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.74 -50.76 71.27 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.331 0.586 . . . . 0.0 109.906 179.332 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.11 HD11 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -56.15 -37.57 69.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.384 178.948 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER -77.33 -23.73 50.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.092 178.968 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 75' ' ' GLU . 1.1 mm-40 -91.72 -17.05 26.01 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.971 0.415 . . . . 0.0 110.951 -178.99 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.966 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.47 -19.87 10.85 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.295 179.825 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.99 -98.66 2.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.025 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 34.3 m -126.76 -91.38 0.51 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.76 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.2 tp -87.26 98.61 7.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.666 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.966 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 13.6 p -115.81 138.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -177.164 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.65 ' HG3' HG23 ' A' ' 7' ' ' THR . 7.2 mtt180 -85.83 103.14 14.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.274 177.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.6 HD11 ' CD1' ' A' ' 15' ' ' LEU . 14.3 mt -91.9 138.7 31.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.263 -178.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.69 139.02 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.809 -179.868 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 55' ' ' ASP . 21.5 m -139.56 162.25 26.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.683 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.489 ' CG ' HD21 ' A' ' 58' ' ' LEU . 1.6 ttp -96.85 147.68 23.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.94 135.13 47.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.897 -179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.46 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.051 -179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.811 0.338 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -132.2 123.13 26.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.447 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 10.3 m-85 -97.33 131.23 44.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -132.46 142.27 49.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.21 144.58 29.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.023 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.8 109.42 4.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.97 0.414 . . . . 0.0 111.376 179.856 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.907 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.25 116.47 20.36 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.067 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.023 HD13 HD11 ' A' ' 6' ' ' ILE . 4.8 tp -124.14 126.74 46.68 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.2 pt-20 -87.46 100.27 12.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.564 179.101 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.87 87.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.229 179.283 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.03 -179.45 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.49 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -56.36 -21.82 27.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.699 0.285 . . . . 0.0 111.209 179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 p -102.98 -12.79 17.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.689 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.459 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 132.1 -164.06 23.81 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.304 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.934 ' HG ' HD23 ' A' ' 8' ' ' LEU . 2.3 tp -64.66 -63.29 1.16 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.205 -0.198 . . . . 0.0 110.572 -179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.26 17.77 1.39 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 119.837 -1.173 . . . . 0.0 114.529 178.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.861 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.9 p90 -160.7 135.73 7.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.965 0.882 . . . . 0.0 111.196 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.9 139.3 32.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.376 -179.477 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.007 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.75 147.95 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.887 0.851 . . . . 0.0 112.359 -179.83 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.11 133.2 27.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.206 -1.361 . . . . 0.0 111.055 179.457 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.14 2.92 0.68 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.798 179.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.09 -176.52 0.84 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.682 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.85 HG22 ' HB3' ' A' ' 32' ' ' PRO . 25.2 p -67.53 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.11 -21.05 21.39 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -124.38 87.02 54.42 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.671 0.272 . . . . 0.0 110.543 179.925 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.81 62.62 0.91 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.332 2.021 . . . . 0.0 112.585 -179.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.715 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 38.5 t60 -47.45 -28.66 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.413 179.023 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.836 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -88.01 -154.44 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.281 179.531 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.685 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -61.31 -49.23 79.83 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.6 -179.72 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 174.99 39.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 0.0 110.846 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.38 163.5 38.02 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.85 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.9 Cg_exo -76.73 1.47 8.5 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.984 2.456 . . . . 0.0 112.773 -179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.77 115.52 2.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.01 0.433 . . . . 0.0 111.17 -179.826 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.87 119.61 33.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.482 179.764 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.836 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.52 147.81 38.37 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 121.427 0.632 . . . . 0.0 110.869 178.776 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.997 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.01 155.76 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.996 -1.002 . . . . 0.0 112.953 -176.85 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.71 -31.37 4.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.217 -179.014 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.631 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.57 131.1 0.56 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.226 -179.42 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.984 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.96 130.89 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.594 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.457 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.13 114.03 51.86 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.874 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 42.4 Cg_exo -56.95 139.31 89.37 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.726 2.284 . . . . 0.0 112.378 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 12.75 59.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.431 -179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -118.69 179.36 16.87 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.919 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.7 -38.61 69.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.841 0.353 . . . . 0.0 110.987 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.78 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -64.84 -57.65 8.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.577 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.47 -28.77 66.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.353 -179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -71.99 -33.06 67.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.967 0.413 . . . . 0.0 110.162 179.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.28 -58.01 3.48 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.748 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.87 37.71 12.77 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.622 179.542 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' CB ' HG12 ' A' ' 6' ' ' ILE . 18.2 mtm180 -118.96 9.05 11.78 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.728 0.299 . . . . 0.0 110.987 179.717 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.997 HD21 HD12 ' A' ' 36' ' ' ILE . 5.8 tp -135.24 154.4 51.59 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 121.01 0.433 . . . . 0.0 111.07 179.599 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.563 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.94 134.42 42.56 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 179.996 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.631 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.9 t -49.15 159.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.13 0.491 . . . . 0.0 111.491 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.497 ' N ' HG12 ' A' ' 53' ' ' VAL . 3.0 m120 72.24 1.43 3.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.506 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -71.01 127.22 31.83 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.693 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.604 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.6 100.17 12.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.47 0.652 . . . . 0.0 111.693 -178.437 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 19' ' ' ILE . 10.1 mt -46.76 132.69 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.76 179.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.827 HD23 ' HB3' ' A' ' 89' ' ' MET . 0.1 OUTLIER -112.97 -40.41 3.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.138 179.639 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -145.27 167.49 22.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.763 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.937 HG13 ' CD2' ' A' ' 86' ' ' LEU . 56.1 t -145.3 97.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.899 179.497 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.878 ' OD1' HG23 ' A' ' 84' ' ' VAL . 1.2 t30 66.25 -67.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.141 0.496 . . . . 0.0 109.947 -178.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 60' ' ' VAL . 10.2 mm-40 -154.14 32.4 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.921 179.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.7 t -119.64 142.24 35.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.412 -179.322 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.5 t0 -111.33 99.72 8.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 179.455 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 65' ' ' VAL . 24.5 m -85.3 55.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.294 -179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -32.51 59.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.851 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -152.67 62.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.667 179.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.737 ' C ' HG23 ' A' ' 23' ' ' THR . 13.2 m -124.6 144.94 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.043 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.452 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.88 155.06 20.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.973 0.416 . . . . 0.0 111.097 -179.117 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.945 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.2 p-80 -48.66 -34.09 11.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.859 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -33.88 73.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.139 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.558 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.18 -44.23 84.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.241 0.543 . . . . 0.0 109.674 178.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.92 -45.89 87.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.162 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.945 HG23 ' O ' ' A' ' 70' ' ' HIS . 59.4 t -57.06 -48.37 82.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.287 178.544 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.664 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -53.68 -33.82 56.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.33 179.134 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.896 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -64.66 -56.91 10.77 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.376 -0.53 . . . . 0.0 111.598 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.841 HD12 HD12 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -63.02 -42.93 99.93 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.879 -179.645 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.6 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -77.08 -20.59 55.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.748 -179.264 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.664 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 6.7 mm-40 -103.27 -8.8 20.06 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.088 0.471 . . . . 0.0 110.563 178.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.867 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.1 -20.49 0.36 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.791 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.79 -90.21 0.93 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.712 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.7 OUTLIER -133.73 -92.42 0.34 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.871 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.907 HG13 HG22 ' A' ' 7' ' ' THR . 9.1 tp -88.05 102.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.116 0.484 . . . . 0.0 110.531 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.878 HG23 ' OD1' ' A' ' 61' ' ' ASN . 7.3 p -118.32 136.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.724 -178.13 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.857 ' HG2' HG23 ' A' ' 7' ' ' THR . 2.9 mtt85 -85.88 103.88 15.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.058 179.121 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.937 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.3 mt -95.49 137.8 34.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.576 -179.189 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.447 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -101.88 140.42 36.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.494 179.795 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 m -139.84 138.32 38.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.991 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.827 ' HB3' HD23 ' A' ' 58' ' ' LEU . 2.6 ptt? -107.01 135.37 48.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.65 146.59 38.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.85 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.935 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HG3' ' HE3' ' A' ' 89' ' ' MET . 1.3 pmm? . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.791 0.329 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.59 125.69 32.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.765 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.434 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 10.7 m-85 -91.06 144.71 25.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.815 179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -131.6 151.04 51.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -109.96 143.89 39.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.78 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.034 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.32 109.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.975 0.416 . . . . 0.0 111.699 179.791 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.49 118.87 20.34 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.508 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.061 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.0 tp -131.59 127.16 36.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 7.2 pt-20 -84.51 100.44 11.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.258 179.392 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.533 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.41 90.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.21 179.67 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -53.36 -168.71 0.02 OUTLIER Glycine 0 C--N 1.32 -0.337 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.88 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -51.71 -36.67 47.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.578 0.227 . . . . 0.0 111.471 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 t -108.05 4.54 25.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.817 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 120.06 -167.18 13.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.986 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.061 ' HB3' HD23 ' A' ' 8' ' ' LEU . 18.8 mt -52.17 -63.48 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.0 110.784 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.15 35.93 0.45 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.419 179.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.797 ' HB3' HG23 ' A' ' 39' ' ' ILE . 9.1 p90 -160.04 135.42 8.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.128 0.464 . . . . 0.0 111.242 179.047 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.449 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.33 137.63 33.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.427 -179.612 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.45 149.75 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.654 0.74 . . . . 0.0 111.954 -179.86 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.661 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.73 133.02 24.73 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.93 179.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 147.31 -7.65 1.16 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.462 179.768 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.558 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.6 -178.87 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.087 -179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 68' ' ' VAL . 29.9 p -65.06 -31.13 72.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -91.45 -20.46 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.237 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 70' ' ' HIS . 0.4 OUTLIER -124.48 82.48 58.64 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.958 0.409 . . . . 0.0 110.131 179.77 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.25 62.67 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.886 2.391 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.748 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.6 t60 -52.58 -22.35 4.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.386 178.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.781 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -95.21 -151.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.572 179.814 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.673 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -82.89 48.87 4.11 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 113.861 -178.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.4 t0 77.77 45.46 0.07 Allowed 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 120.981 0.419 . . . . 0.0 110.653 179.577 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 28' ' ' ILE . 8.2 m-20 -135.22 155.24 78.99 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.855 179.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.639 ' HB3' HG22 ' A' ' 23' ' ' THR . 73.5 Cg_endo -75.57 -0.94 10.72 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.525 2.15 . . . . 0.0 112.776 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.411 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 5.7 m -54.24 115.75 2.24 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.746 179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.58 119.02 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.781 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.67 145.72 35.26 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.301 0.572 . . . . 0.0 110.527 178.53 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.053 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.98 155.48 7.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.207 -0.906 . . . . 0.0 113.094 -176.476 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.37 -33.44 4.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.766 -179.124 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.657 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.65 141.96 1.94 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.585 -179.749 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.962 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.7 132.31 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.266 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.1 125.16 73.26 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -177.685 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 43.1 Cg_endo -67.33 132.06 26.54 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.838 2.358 . . . . 0.0 112.381 -179.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.68 14.39 32.17 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.474 -179.829 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -122.87 178.07 16.42 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.0 179.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.37 -36.26 61.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.776 0.322 . . . . 0.0 111.416 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.795 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.9 -57.43 5.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.833 -179.454 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.22 -28.83 64.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.478 -179.417 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -33.92 68.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.968 0.413 . . . . 0.0 110.174 179.464 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -82.15 -57.92 3.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.691 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.25 41.02 9.59 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.602 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 20.9 mmt180 -116.31 1.59 13.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.702 -0.293 . . . . 0.0 110.837 179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.053 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -126.96 154.15 44.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.977 0.418 . . . . 0.0 110.657 179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.582 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.9 ttp85 -131.52 137.45 48.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.043 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -53.33 158.23 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.305 0.574 . . . . 0.0 111.678 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.484 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER 74.53 0.19 3.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.184 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 3.1 m-20 -70.38 126.26 29.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.616 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.3 p -86.53 100.31 12.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.656 0.741 . . . . 0.0 111.383 -178.607 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.036 HD11 HG21 ' A' ' 19' ' ' ILE . 69.1 mt -46.88 140.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.065 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD21 ' HG3' ' A' ' 89' ' ' MET . 1.5 mm? -118.76 -44.8 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.091 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.3 m-85 -139.86 169.43 17.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.793 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.749 HG13 ' CD2' ' A' ' 86' ' ' LEU . 26.5 t -151.4 100.14 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.217 179.472 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.584 ' OD1' HG23 ' A' ' 84' ' ' VAL . 11.3 t30 66.27 -67.86 0.14 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.131 0.491 . . . . 0.0 109.979 -178.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.4 OUTLIER -156.67 32.05 0.31 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.495 179.124 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 45.6 t -117.8 142.51 31.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.55 -179.165 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.7 p-10 -112.69 89.34 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.36 179.41 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 65' ' ' VAL . 27.4 m -75.77 61.02 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.535 -179.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -82.38 -32.94 28.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.753 179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -148.66 50.84 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.798 -179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.762 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -114.09 150.89 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.218 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.428 HG22 ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -66.95 153.66 43.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.029 -179.389 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.86 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.2 t-160 -49.68 -34.19 17.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.628 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -69.8 -34.04 73.19 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.653 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.04 -42.25 80.85 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.638 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.883 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.12 -46.75 85.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.555 0.693 . . . . 0.0 109.201 177.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.3 t -57.58 -50.18 78.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.15 178.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.653 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.01 -32.9 64.39 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.631 178.656 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.567 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.99 -52.63 64.71 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.228 0.537 . . . . 0.0 110.012 179.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.035 HD11 HD12 ' A' ' 19' ' ' ILE . 2.5 mt -54.16 -36.47 63.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.283 178.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.19 -26.66 53.06 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.09 178.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -89.01 -16.65 31.16 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.126 -178.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.41 -18.57 18.53 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.33 179.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.02 -108.02 3.6 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.164 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.457 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 1.3 p -118.78 -91.2 0.56 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.056 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 7' ' ' THR . 8.4 tp -86.92 95.09 4.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.079 0.466 . . . . 0.0 109.85 178.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.933 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.1 p -111.86 138.06 42.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -177.297 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.9 102.89 14.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 177.411 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.749 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.6 mt -90.18 141.15 28.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.327 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.427 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.72 141.38 34.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.771 -179.759 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.89 167.88 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.537 ' HG3' HD21 ' A' ' 58' ' ' LEU . 2.0 mtp -109.13 142.88 39.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.768 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -140.66 106.89 5.23 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.398 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.48 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.834 179.651 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.536 0.208 . . . . 0.0 111.01 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -161.7 138.81 8.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 111.077 179.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 65.7 m-85 -123.65 127.37 48.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.659 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -126.35 155.56 41.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.932 -179.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HG2' ' CD2' ' A' ' 87' ' ' TYR . 17.7 mt-10 -117.43 144.63 44.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.967 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.84 109.59 11.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.963 0.411 . . . . 0.0 111.647 179.893 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.899 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 122.0 24.45 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.912 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.036 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.1 tp -134.14 127.31 31.8 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.149 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -86.37 100.76 12.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.632 179.551 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.55 ' CG ' HD23 ' A' ' 15' ' ' LEU . 12.0 mtp180 -42.45 91.93 0.0 OUTLIER 'General case' 0 CA--C 1.522 -0.097 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.064 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -61.65 72.64 0.02 OUTLIER Glycine 0 C--N 1.317 -0.477 0 CA-C-N 115.186 -0.916 . . . . 0.0 113.058 -179.538 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 10' ' ' ARG . 0.5 OUTLIER 64.01 -73.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.743 0.306 . . . . 0.0 111.525 179.672 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.4 OUTLIER -72.7 -23.92 60.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.519 -179.59 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 155.15 -172.88 33.45 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.828 -179.672 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.036 ' HB3' HD23 ' A' ' 8' ' ' LEU . 8.3 mt -60.5 -63.64 1.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.024 0.412 . . . . 0.0 110.67 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 135.46 40.47 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.121 -1.037 . . . . 0.0 113.745 179.229 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.789 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.1 p90 -162.02 134.51 5.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.136 0.494 . . . . 0.0 110.971 178.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.51 135.16 34.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.459 -179.351 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.052 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.53 146.5 18.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.496 179.552 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.641 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -126.74 122.88 36.11 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.586 178.935 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 157.92 -132.0 3.03 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.605 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 75.76 167.36 22.75 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.263 179.118 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 68' ' ' VAL . 27.4 p -68.47 -6.68 26.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.074 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 11.7 m-20 -113.11 -24.34 9.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.5 t30 -124.62 87.18 54.86 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.478 -179.859 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.91 64.69 0.29 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.39 -179.692 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.736 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 43.0 t60 -53.05 -24.12 9.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.31 179.221 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.866 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -92.64 -150.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.604 179.63 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.68 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.66 52.47 4.58 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.931 -178.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t0 75.7 41.23 0.26 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.116 0.484 . . . . 0.0 110.488 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -132.3 161.46 62.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.909 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 97.3 Cg_endo -79.29 4.18 6.82 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.561 2.174 . . . . 0.0 112.625 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -55.04 118.39 4.28 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.078 0.466 . . . . 0.0 111.258 -179.814 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.835 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.32 116.62 31.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.188 179.598 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.866 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.06 147.6 37.07 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.363 0.601 . . . . 0.0 110.573 179.256 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.089 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.26 155.74 7.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.834 -177.127 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.641 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.29 -33.02 3.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.677 -179.076 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.14 142.01 2.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 111.276 -179.78 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.958 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -105.32 132.32 52.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.48 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.446 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.01 114.48 54.53 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -177.674 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 37.1 Cg_exo -57.68 136.96 78.83 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.7 2.267 . . . . 0.0 112.365 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.85 16.97 39.77 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.562 -179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.54 178.76 16.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.175 179.76 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.84 -33.86 57.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.731 0.3 . . . . 0.0 111.402 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.829 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -70.81 -57.39 4.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.908 -179.55 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.53 -28.67 64.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.525 -179.427 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -71.71 -30.43 65.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 110.335 179.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' OD2' HD12 ' A' ' 8' ' ' LEU . 6.0 m-20 -82.68 -57.77 3.18 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.708 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.78 37.0 12.26 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.572 179.597 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.449 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.7 mmt180 -111.28 -20.92 12.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 0.0 110.784 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.089 HD21 HD12 ' A' ' 36' ' ' ILE . 5.4 tp -106.16 153.86 21.5 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.275 0.559 . . . . 0.0 111.361 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.3 mpp_? -131.78 135.4 46.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.57 179.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 38' ' ' LYS . 52.5 t -49.21 157.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.325 0.583 . . . . 0.0 111.536 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.8 OUTLIER 75.15 0.26 3.47 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.223 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.639 ' HB3' HG11 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -68.24 124.71 24.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 178.991 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.5 p -86.63 99.78 11.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.564 0.697 . . . . 0.0 111.377 -178.46 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.038 HD11 HG21 ' A' ' 19' ' ' ILE . 11.0 mt -46.35 129.9 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.229 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.823 HD23 ' HB3' ' A' ' 89' ' ' MET . 0.3 OUTLIER -113.06 -41.44 3.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.005 179.653 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 1.4 m-85 -144.72 146.82 32.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.166 -179.92 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.712 ' CG1' ' HB1' ' A' ' 76' ' ' ALA . 48.9 t -135.51 109.78 10.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.84 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 52.78 35.93 19.99 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.843 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 80.72 32.96 0.14 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.445 -179.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 60' ' ' VAL . 74.7 t -121.01 112.75 37.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.699 -179.666 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 4.9 p-10 -72.05 116.83 12.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.711 179.213 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 57' ' ' ILE . 25.6 m -98.45 27.44 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.197 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 mtp180 -68.77 -27.76 66.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.026 -179.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -138.52 52.67 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.082 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -127.63 146.08 33.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.792 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -67.83 155.61 38.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.121 -179.384 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.5 p-80 -48.15 -35.44 11.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.131 -179.65 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.33 -33.67 65.26 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.115 179.716 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.628 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.68 -39.39 88.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.15 0.5 . . . . 0.0 109.808 179.161 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.835 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.69 -46.88 74.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.584 0.707 . . . . 0.0 109.168 178.17 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.5 t -58.07 -48.52 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.362 178.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.7 OUTLIER -58.22 -35.64 71.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.46 178.574 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.712 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -55.08 -49.39 71.79 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.237 0.542 . . . . 0.0 109.976 179.597 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.052 HD11 HD12 ' A' ' 19' ' ' ILE . 2.4 mt -57.84 -36.47 72.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.414 178.709 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 2.2 mmmt -77.33 -25.86 51.56 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.879 179.441 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -96.96 5.31 50.7 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.824 0.345 . . . . 0.0 111.549 -178.703 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.911 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -80.45 16.1 1.43 Allowed 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.769 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.63 -110.5 3.43 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.294 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 35.8 m -118.96 -89.46 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.324 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.899 HG13 HG22 ' A' ' 7' ' ' THR . 7.5 tp -86.27 96.43 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-O 121.257 0.551 . . . . 0.0 110.263 179.019 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.911 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.6 p -111.1 138.4 39.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -177.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.57 102.8 14.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.388 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.711 ' CD2' HG13 ' A' ' 60' ' ' VAL . 10.9 mt -88.74 137.86 31.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.118 -178.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 145.95 28.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.923 -179.689 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.639 HG11 ' HB3' ' A' ' 55' ' ' ASP . 35.4 m -139.62 144.54 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.139 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.823 ' HB3' HD23 ' A' ' 58' ' ' LEU . 7.0 ptt? -96.74 159.84 14.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.855 0.359 . . . . 0.0 111.132 -179.77 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.41 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -139.5 106.86 5.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.899 -179.602 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.941 179.805 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.838 0.352 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -91.44 175.73 6.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 179.72 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -133.13 156.88 46.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.786 179.883 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -145.22 151.0 37.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.981 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -110.36 144.77 38.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.71 109.5 11.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.926 0.393 . . . . 0.0 111.545 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.845 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.72 112.46 17.01 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.959 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 6' ' ' ILE . 5.5 tp -122.87 126.81 48.04 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.269 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.62 100.46 10.84 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.059 179.09 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.445 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -46.51 89.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.169 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 44' ' ' ALA . . . -54.86 167.96 2.17 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.539 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.63 -26.54 9.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.56 -24.73 18.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.944 179.736 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.57 -170.8 24.99 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.081 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.011 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.9 tp -62.15 -42.61 99.43 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.064 -0.255 . . . . 0.0 110.403 179.986 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 108.67 25.78 5.58 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.326 -0.94 . . . . 0.0 115.263 177.706 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.786 ' HB3' HG23 ' A' ' 39' ' ' ILE . 4.3 p90 -164.52 136.72 4.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.018 0.909 . . . . 0.0 111.072 178.779 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -98.68 133.44 43.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.636 -179.28 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.095 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -110.07 169.9 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.608 0.718 . . . . 0.0 111.501 179.729 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.646 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -167.33 131.5 1.87 Allowed 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.424 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.45 2.09 0.71 Allowed Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.436 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.13 -167.15 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.102 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.839 HG22 ' HB3' ' A' ' 32' ' ' PRO . 17.5 p -75.96 -28.16 57.8 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.034 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -95.31 -20.63 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.061 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.66 82.54 59.52 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.953 0.406 . . . . 0.0 109.974 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.76 63.89 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -179.316 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.713 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 39.3 t60 -50.09 -24.09 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.435 178.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.855 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.7 -155.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.367 179.716 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.66 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.9 -49.92 73.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.575 -179.754 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 175.49 39.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.751 0.31 . . . . 0.0 110.919 -179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -124.69 163.48 36.69 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.815 179.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.839 ' HB3' HG22 ' A' ' 23' ' ' THR . 5.9 Cg_exo -78.91 3.46 7.36 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.921 2.414 . . . . 0.0 112.861 -179.799 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.1 m -56.61 115.53 2.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.388 . . . . 0.0 111.1 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -82.47 120.69 34.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.524 179.833 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.855 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.44 145.39 33.73 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 121.48 0.657 . . . . 0.0 110.704 178.842 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.046 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.84 155.83 7.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.473 -176.409 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.469 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.9 -28.36 4.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.633 -1.167 . . . . 0.0 112.509 -178.565 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.686 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -175.72 129.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.272 -0.571 . . . . 0.0 112.197 -179.486 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.997 HD11 HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -94.6 133.23 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.392 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.427 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 122.98 75.6 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.725 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 23.3 Cg_endo -61.59 137.41 68.96 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.642 2.228 . . . . 0.0 112.36 -179.661 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 -1.87 83.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.442 -179.64 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.72 175.22 36.89 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.033 179.671 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.12 -34.38 60.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.883 0.373 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.814 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -74.43 -56.94 4.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.239 179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.12 -28.87 70.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 -179.67 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -71.67 -31.57 66.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 109.934 179.347 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -84.38 -57.91 2.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.552 179.87 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.04 40.83 8.99 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.491 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.9 mmt85 -117.03 6.58 12.95 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.71 0.29 . . . . 0.0 110.951 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.046 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -133.74 153.81 51.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.004 0.431 . . . . 0.0 110.819 179.569 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -130.13 140.1 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.034 179.96 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 38' ' ' LYS . 56.5 t -56.69 158.91 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-O 121.242 0.544 . . . . 0.0 111.638 179.757 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.4 t-20 74.15 3.5 4.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.179 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.5 m-20 -75.06 127.1 32.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.613 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.49 103.03 14.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.517 0.675 . . . . 0.0 111.131 -178.853 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.095 HD11 HG21 ' A' ' 19' ' ' ILE . 62.5 mt -49.92 133.37 9.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.052 -179.775 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.938 HD21 ' HG3' ' A' ' 89' ' ' MET . 4.0 mm? -108.64 -42.6 4.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.793 179.107 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -147.33 140.58 25.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.301 179.987 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.77 HG11 ' HB1' ' A' ' 76' ' ' ALA . 58.3 t -123.72 97.29 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.754 179.285 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.3 t30 70.04 -62.84 0.41 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.05 0.453 . . . . 0.0 109.819 -178.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -160.58 30.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.152 179.143 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 16.7 t -121.03 109.62 25.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.679 -179.421 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 65' ' ' VAL . 18.9 t0 -63.08 -23.49 67.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.283 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 64' ' ' ASP . 13.4 m 46.07 28.96 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.639 -179.763 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -61.91 -37.76 85.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 110.754 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.77 61.93 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.87 179.833 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.708 ' O ' HG23 ' A' ' 23' ' ' THR . 34.4 m -127.83 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.315 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.405 ' HA ' ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -61.59 151.34 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.961 -179.706 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.854 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.6 t-160 -48.11 -33.89 8.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.675 179.819 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -34.07 75.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.933 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.07 -42.38 80.53 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.643 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.75 -46.81 86.31 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 121.677 0.751 . . . . 0.0 109.047 177.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 70' ' ' HIS . 96.5 t -57.31 -50.48 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.328 178.546 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.682 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.1 -29.47 60.67 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.898 178.556 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.77 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.55 -51.57 68.03 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.273 0.559 . . . . 0.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.056 HD11 HD12 ' A' ' 19' ' ' ILE . 1.5 mt -55.78 -37.96 69.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.471 178.931 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.582 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.48 -23.28 50.37 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.034 178.978 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -97.72 7.94 45.55 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.397 -178.795 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.936 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -86.19 16.2 4.55 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.3 179.873 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.34 -99.62 0.4 Allowed Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.575 179.849 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.3 OUTLIER -129.18 -91.9 0.46 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.479 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.845 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -81.95 97.14 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.187 0.518 . . . . 0.0 110.405 179.336 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.936 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.6 p -114.21 137.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.586 -0.733 . . . . 0.0 112.947 -178.2 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.812 ' HG3' HG23 ' A' ' 7' ' ' THR . 4.6 mtt180 -86.35 103.03 14.55 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.164 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.3 mt -92.97 136.4 33.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.165 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.62 142.88 32.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.552 -179.902 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.77 ' C ' HD23 ' A' ' 58' ' ' LEU . 14.3 m -139.48 168.17 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.083 -179.639 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.938 ' HG3' HD21 ' A' ' 58' ' ' LEU . 2.0 mtm -96.52 150.85 20.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.56 106.86 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.05 -179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.855 179.837 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.466 ' HG2' ' HB2' ' A' ' 89' ' ' MET . 4.2 tpp . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.785 0.326 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.93 128.28 49.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.107 -179.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.466 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 66.1 m-85 -100.89 146.19 27.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.715 179.746 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -155.48 152.45 28.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.955 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 8.9 pt-20 -105.68 144.75 31.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.974 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.019 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -134.25 109.17 12.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-O 120.956 0.408 . . . . 0.0 111.59 179.723 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.832 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.59 118.82 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.255 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.019 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -130.26 127.02 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.407 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.14 100.18 10.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.244 0.545 . . . . 0.0 112.239 179.812 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -53.55 89.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.137 178.448 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -129.62 176.63 18.49 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.325 -179.02 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m120 54.69 -92.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.508 0.194 . . . . 0.0 110.84 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -108.4 11.61 26.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.576 0.226 . . . . 0.0 111.104 179.663 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.92 -139.67 11.86 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.674 -179.516 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.997 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.7 tp -72.06 -63.44 1.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.377 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.24 27.43 0.91 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 119.623 -1.275 . . . . 0.0 115.091 177.951 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.766 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.3 p90 -164.15 134.91 4.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 118.013 0.906 . . . . 0.0 111.17 178.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.29 134.41 35.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.611 -179.2 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.06 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.51 146.98 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.327 179.299 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.598 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.45 123.17 33.02 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.649 179.098 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.58 -119.23 0.88 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.097 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 64.06 173.82 3.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.515 179.834 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.771 HG23 ' C ' ' A' ' 68' ' ' VAL . 4.6 p -76.89 -3.83 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.005 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -111.1 -25.15 9.91 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.267 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' HIS . 2.7 t30 -125.05 86.1 57.15 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.453 0.168 . . . . 0.0 110.667 -179.824 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.63 66.17 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.0 1.8 . . . . 0.0 112.216 -179.767 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.712 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 35.5 t60 -53.52 -24.11 12.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.271 179.056 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.93 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -88.62 -153.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.423 179.438 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.663 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -63.22 -51.41 55.18 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.624 -179.22 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 3.3 p-10 -178.68 35.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.615 0.245 . . . . 0.0 111.519 -179.378 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -125.47 164.15 34.16 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 110.731 -179.897 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.547 ' HB2' HG22 ' A' ' 23' ' ' THR . 79.0 Cg_endo -84.05 44.47 1.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.665 2.243 . . . . 0.0 112.337 179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -90.43 123.38 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 0.0 110.92 -179.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.852 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.37 109.59 20.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.487 179.926 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.93 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -135.66 147.13 48.46 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.392 0.615 . . . . 0.0 110.287 178.842 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.043 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.17 155.6 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.751 -176.738 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.598 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -120.61 -32.69 3.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.606 -179.05 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.74 140.57 2.16 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.915 0.388 . . . . 0.0 111.406 -179.941 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.971 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -102.66 133.63 45.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.206 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.479 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 117.38 68.51 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -177.332 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.52 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.7 Cg_exo -57.69 135.19 67.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.833 2.355 . . . . 0.0 112.273 179.859 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.32 1.51 64.48 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.672 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -101.19 179.84 28.54 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.076 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -57.68 -33.23 68.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.854 0.359 . . . . 0.0 110.979 179.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.797 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -74.03 -56.43 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.729 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.39 -31.25 72.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.801 -179.312 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -72.13 -32.63 67.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.973 0.416 . . . . 0.0 110.131 179.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.43 -58.07 2.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.676 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.83 41.47 9.66 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.552 179.681 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.48 ' CB ' HG12 ' A' ' 6' ' ' ILE . 13.9 mmt180 -108.98 -17.35 13.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.897 0.38 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.043 HD21 HD12 ' A' ' 36' ' ' ILE . 5.7 tp -109.35 155.93 20.61 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.603 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.38 133.49 44.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 179.778 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.626 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.8 t -49.08 158.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.358 0.599 . . . . 0.0 111.989 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.8 t30 74.47 3.97 4.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.463 179.628 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -74.86 126.24 30.52 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.052 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.586 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 4.8 t -86.48 101.23 12.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.554 0.692 . . . . 0.0 111.269 -178.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.055 HD11 HG21 ' A' ' 19' ' ' ILE . 65.3 mt -47.13 131.56 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.815 179.833 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.466 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 1.3 mm? -110.37 -44.19 3.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.843 179.514 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.61 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.9 m-85 -142.29 162.17 36.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.768 179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.896 HG13 ' CD2' ' A' ' 86' ' ' LEU . 43.8 t -152.29 114.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.974 179.795 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 84' ' ' VAL . 26.7 t30 46.6 46.0 14.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.122 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 75.42 31.7 0.76 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.828 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 64.9 t -120.77 142.16 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.94 179.766 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 34.3 t0 -105.5 112.12 25.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.484 HG12 HG21 ' A' ' 68' ' ' VAL . 28.5 m -95.81 24.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.369 179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 20.5 tpt85 -58.88 -28.92 66.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.85 179.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 60.58 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.771 ' C ' HG23 ' A' ' 23' ' ' THR . 28.3 m -132.89 142.76 41.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.352 179.699 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.1 152.47 28.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 -179.926 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.832 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.2 t-160 -48.15 -33.95 9.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.685 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.7 t -68.59 -34.1 75.21 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.173 179.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.661 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.94 -38.49 79.51 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.731 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.852 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -66.51 -46.83 74.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.032 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.5 t -57.62 -50.42 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.196 178.489 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.661 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.08 -29.81 58.35 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.786 178.44 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.696 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -61.37 -53.61 54.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.163 0.506 . . . . 0.0 109.785 179.443 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.06 HD11 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -51.75 -40.31 60.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.487 178.871 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -77.55 -25.56 50.22 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.454 179.314 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' GLU . 2.7 pt-20 -93.84 7.57 44.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.791 0.329 . . . . 0.0 111.311 -178.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.942 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -84.99 16.3 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.508 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.82 -83.98 0.09 OUTLIER Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.409 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -147.74 -90.09 0.08 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.439 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.832 HG13 HG22 ' A' ' 7' ' ' THR . 9.4 tp -82.32 96.72 3.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.208 0.527 . . . . 0.0 109.938 179.134 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.942 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.1 p -116.04 136.9 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -177.507 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -86.06 102.79 14.14 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.491 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.896 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.3 mt -90.81 138.58 31.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.303 -178.71 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.66 137.34 40.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.423 179.818 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 55' ' ' ASP . 15.7 m -139.66 165.22 22.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.307 179.999 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.466 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 2.2 ptt? -133.32 145.2 50.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 111.201 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.59 133.07 28.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.196 -179.897 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.909 179.773 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.841 0.353 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 89' ' ' MET . 1.7 mt-10 -85.49 116.46 23.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.953 179.921 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.695 ' CD2' HD13 ' A' ' 58' ' ' LEU . 3.2 m-30 -82.12 126.78 32.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.554 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -139.91 139.76 36.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.853 0.359 . . . . 0.0 111.253 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.434 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 0.7 OUTLIER -97.87 144.9 26.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.904 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.787 ' CD1' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.26 109.38 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.086 0.47 . . . . 0.0 111.545 179.911 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.843 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.33 125.37 29.22 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.459 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.885 HD11 ' HA ' ' A' ' 45' ' ' ALA . 2.3 tp -135.01 126.91 29.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.669 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -83.17 100.18 10.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.371 179.262 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.454 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.4 OUTLIER -53.23 89.01 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.166 178.798 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -131.82 178.0 18.23 Favored Glycine 0 C--N 1.322 -0.204 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.357 -179.09 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 55.43 -91.61 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.511 0.196 . . . . 0.0 110.748 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.4 m -108.29 9.88 27.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.558 0.218 . . . . 0.0 110.924 179.448 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 125.39 -138.13 10.75 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.653 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.833 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 2.6 tp -73.1 -52.42 14.31 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.22 179.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 120.03 22.98 3.1 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 119.959 -1.115 . . . . 0.0 115.342 177.458 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.769 ' HB3' HG23 ' A' ' 39' ' ' ILE . 8.0 p90 -163.48 135.8 5.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.353 1.077 . . . . 0.0 111.502 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -93.6 134.55 35.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.276 -179.674 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.052 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -112.4 162.85 10.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.551 0.691 . . . . 0.0 111.655 179.938 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.634 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -158.82 132.79 7.67 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.354 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.14 1.68 1.27 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.331 -0.937 . . . . 0.0 113.501 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.544 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -58.21 -172.94 0.37 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.955 -179.763 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 68' ' ' VAL . 32.1 p -68.41 -27.53 66.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.225 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.433 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 10.6 m-20 -96.8 -18.78 19.36 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -124.27 87.21 53.99 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.475 -179.813 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.27 59.86 1.01 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.28 1.987 . . . . 0.0 112.6 -179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.732 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 40.3 t60 -47.63 -28.3 2.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.056 178.834 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.805 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -89.35 -154.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.332 179.315 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.05 -49.53 77.53 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.663 -179.692 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 173.83 39.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.996 -179.97 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.08 166.27 21.35 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.862 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.573 ' CB ' HG22 ' A' ' 23' ' ' THR . 91.6 Cg_endo -80.65 6.83 5.2 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.64 2.227 . . . . 0.0 112.802 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 m -58.56 115.41 3.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.775 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.878 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -83.03 120.13 33.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.706 -179.896 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.32 144.57 33.3 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.358 0.599 . . . . 0.0 110.386 178.501 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.077 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.74 155.72 7.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.321 -176.374 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.4 -34.69 3.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.369 -1.287 . . . . 0.0 111.777 -178.784 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.61 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.12 142.36 2.78 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.46 -179.566 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.968 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.95 133.17 49.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 178.345 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.86 114.95 57.35 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.606 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 52.2 Cg_exo -55.71 137.76 79.26 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.797 2.332 . . . . 0.0 112.256 -179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.02 6.71 66.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.951 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.77 177.36 21.16 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.992 179.695 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.45 -31.26 55.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.747 0.308 . . . . 0.0 111.026 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.885 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -73.91 -57.5 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.712 -179.712 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -69.1 -28.57 66.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.259 -179.499 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -71.72 -31.16 66.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.001 0.429 . . . . 0.0 110.084 179.428 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -85.42 -57.82 2.92 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.712 179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.43 40.32 9.15 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.672 179.589 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.8 mtt85 -111.77 -19.16 12.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.663 0.268 . . . . 0.0 110.815 179.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.077 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -107.81 155.23 20.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.154 0.502 . . . . 0.0 111.177 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.58 134.82 45.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.676 179.746 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.61 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.0 t -49.0 157.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.317 0.58 . . . . 0.0 111.72 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.89 1.57 3.81 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.235 179.837 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.95 124.47 24.13 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.059 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.599 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.55 100.37 12.36 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.604 0.716 . . . . 0.0 111.419 -178.615 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 19' ' ' ILE . 20.3 mt -51.72 130.7 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.791 179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.695 HD13 ' CD2' ' A' ' 3' ' ' TYR . 1.4 pp -126.95 3.41 6.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.604 179.389 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 0.5 OUTLIER 179.07 140.54 0.1 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.207 0.527 . . . . 0.0 110.583 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.908 HG23 ' CD2' ' A' ' 86' ' ' LEU . 2.4 p -147.57 118.88 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.001 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.402 ' HB2' HG21 ' A' ' 84' ' ' VAL . 7.9 t-20 51.78 33.44 11.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.938 0.399 . . . . 0.0 110.076 -179.006 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 77.62 34.75 0.34 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.424 -179.124 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.711 ' HB ' HG13 ' A' ' 60' ' ' VAL . 58.4 t -120.91 108.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.624 -179.531 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 9.2 p-10 -73.19 106.43 5.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.485 179.271 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 34' ' ' ILE . 29.5 m -93.78 40.56 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.363 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.08 -22.01 59.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.163 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -146.99 59.8 1.18 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.148 -179.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -134.52 148.86 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.977 179.527 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.37 153.11 43.59 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.034 -179.344 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 74' ' ' VAL . 3.8 t-160 -49.85 -34.02 18.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 -179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -33.99 73.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.053 -0.522 . . . . 0.0 109.772 179.41 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.62 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.58 -40.56 80.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.675 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.878 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.94 -46.71 80.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.009 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.9 t -57.97 -50.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.2 178.612 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.62 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.6 OUTLIER -56.4 -35.24 67.54 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.739 178.537 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.903 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -55.34 -52.49 63.31 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.268 0.556 . . . . 0.0 110.142 179.528 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.0 HD11 HD12 ' A' ' 19' ' ' ILE . 3.4 mt -53.88 -38.72 65.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.241 178.585 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.56 -20.65 53.76 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.413 179.011 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.2 mt-10 -97.21 -12.67 22.73 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.288 -178.687 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.896 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.9 -15.46 8.74 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.393 179.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.18 -91.28 1.2 Allowed Glycine 0 C--N 1.336 0.533 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.903 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' LEU . 10.4 p -139.45 -91.59 0.18 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.843 HG13 HG22 ' A' ' 7' ' ' THR . 9.7 tp -84.22 93.97 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.235 0.54 . . . . 0.0 110.007 178.813 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.896 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 9.7 p -113.21 136.86 48.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.624 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 8.5 ptp180 -87.49 102.94 15.05 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.471 177.969 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.908 ' CD2' HG23 ' A' ' 60' ' ' VAL . 17.7 mt -91.13 132.75 35.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.136 -179.079 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -101.52 126.18 48.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.55 179.915 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.635 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.6 m -129.32 153.12 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.489 -179.719 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.479 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 2.9 ptt? -121.77 133.65 54.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.874 0.369 . . . . 0.0 111.251 -179.888 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 123.39 19.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.863 179.924 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.877 0.37 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.4 116.41 23.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.81 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.49 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 40.5 m-85 -83.22 128.77 34.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.102 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 13.4 mt-10 -129.93 170.57 13.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.32 144.59 49.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.973 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.015 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -140.36 109.18 3.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.811 0.338 . . . . 0.0 111.801 179.968 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.751 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.6 118.72 20.98 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.392 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.039 HD23 ' HB3' ' A' ' 15' ' ' LEU . 5.1 tp -129.42 127.09 40.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.058 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 4.8 pt-20 -84.66 100.28 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.011 179.324 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.539 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -46.07 89.25 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.486 179.81 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -49.87 -178.27 0.02 OUTLIER Glycine 0 CA--C 1.52 0.357 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.812 179.835 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -45.02 -38.31 4.72 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -98.75 -24.74 14.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.849 0.356 . . . . 0.0 111.28 -179.807 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 149.34 -165.14 29.43 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.923 -179.821 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.039 ' HB3' HD23 ' A' ' 8' ' ' LEU . 22.7 mt -53.77 -63.39 1.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.937 0.399 . . . . 0.0 110.698 179.963 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 130.12 31.55 0.58 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.291 -0.956 . . . . 0.0 113.297 179.479 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.809 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.23 138.09 13.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.033 0.416 . . . . 0.0 110.561 179.096 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.98 135.03 40.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.425 -179.476 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.076 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.05 146.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.546 0.689 . . . . 0.0 111.388 179.596 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.653 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.66 123.86 34.26 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.736 179.0 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 70' ' ' HIS . . . 159.47 -124.28 1.34 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.742 -179.735 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 32' ' ' PRO . . . 70.09 174.06 13.41 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.794 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.766 HG22 ' HB2' ' A' ' 32' ' ' PRO . 12.2 p -76.93 -1.33 28.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -116.92 -23.06 8.2 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.271 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.1 OUTLIER -124.85 86.83 55.83 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.44 -0.208 . . . . 0.0 110.44 -179.89 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.87 65.72 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.051 1.834 . . . . 0.0 112.196 -179.812 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.701 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.2 t60 -53.18 -23.69 9.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.262 179.286 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.87 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -91.34 -152.92 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.481 179.526 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.671 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -67.87 -46.89 63.91 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.8 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.56 77.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.916 0.389 . . . . 0.0 110.858 -179.772 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.2 170.28 5.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.65 179.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.766 ' HB2' HG22 ' A' ' 23' ' ' THR . 96.1 Cg_endo -84.47 16.54 1.92 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.548 2.165 . . . . 0.0 112.829 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.6 m -62.74 145.61 54.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.067 0.461 . . . . 0.0 111.047 -179.933 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.806 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -116.73 114.82 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.23 -179.914 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.87 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -139.9 148.11 41.56 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.393 0.616 . . . . 0.0 110.545 179.16 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.01 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.22 155.91 7.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.968 -176.894 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.653 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.78 -30.03 4.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.372 -178.57 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.65 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.78 129.57 0.51 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.482 -0.487 . . . . 0.0 112.049 -179.366 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.93 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.06 130.08 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.586 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.33 115.3 59.68 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.588 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 39.1 Cg_exo -57.52 135.79 71.87 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.741 2.294 . . . . 0.0 112.212 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.36 14.62 40.88 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.431 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.65 177.47 16.81 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.997 179.693 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.32 -38.23 57.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.834 0.349 . . . . 0.0 111.224 -179.985 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.833 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.16 -57.53 8.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.909 -179.608 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.26 -28.64 64.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.509 -179.453 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -71.94 -32.79 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.008 0.432 . . . . 0.0 110.306 179.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -77.6 -58.02 3.5 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.708 -179.821 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.9 36.0 16.99 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.564 179.562 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.508 ' CB ' HG12 ' A' ' 6' ' ' ILE . 59.0 mtt180 -118.29 5.26 11.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.016 179.736 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.01 HD21 HD12 ' A' ' 36' ' ' ILE . 10.9 tp -130.61 156.53 44.72 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 121.057 0.456 . . . . 0.0 110.932 179.644 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.612 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -136.54 135.18 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.684 179.846 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.65 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.5 t -48.98 157.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.305 0.574 . . . . 0.0 111.749 -179.746 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' HG12 ' A' ' 53' ' ' VAL . 7.8 t-20 76.59 0.66 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.275 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -69.17 125.45 26.71 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.063 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -86.54 100.14 12.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 0.0 111.298 -178.958 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.076 HD11 HG21 ' A' ' 19' ' ' ILE . 61.2 mt -45.36 145.07 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.996 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -128.83 -44.61 1.32 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.135 179.799 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -140.66 146.41 37.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.063 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.874 HG13 ' CD2' ' A' ' 86' ' ' LEU . 40.0 t -140.4 111.41 4.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.248 179.703 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 50.46 37.42 15.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.937 0.398 . . . . 0.0 110.185 -179.125 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 79.55 34.24 0.19 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.493 -179.353 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 60' ' ' VAL . 97.3 t -120.95 108.44 22.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.424 -179.851 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 7.0 t0 -78.28 93.32 4.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.902 179.592 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.525 HG12 HG21 ' A' ' 68' ' ' VAL . 14.8 m -64.53 -122.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.372 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.427 ' N ' HG23 ' A' ' 65' ' ' VAL . 7.3 ttm180 70.16 -65.69 0.31 Allowed 'General case' 0 CA--C 1.522 -0.132 0 CA-C-O 121.03 0.443 . . . . 0.0 110.662 -179.938 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -93.61 40.22 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.725 179.585 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.592 ' C ' HG23 ' A' ' 23' ' ' THR . 34.7 m -137.92 142.34 36.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.224 179.88 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -58.36 155.06 12.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.234 0.54 . . . . 0.0 111.274 -179.558 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.7 p-80 -49.55 -33.78 15.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.873 179.646 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 m -72.05 -33.67 68.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.327 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.688 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.14 -44.13 85.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.247 0.546 . . . . 0.0 109.663 179.023 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.806 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.19 -46.88 88.67 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.609 0.719 . . . . 0.0 109.182 178.045 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.1 t -57.99 -50.43 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.416 178.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.688 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.93 -29.71 63.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.842 178.614 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -60.85 -51.09 70.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.322 0.582 . . . . 0.0 109.818 179.493 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.037 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.59 -37.89 71.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.705 179.016 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.3 -22.8 51.44 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.143 179.059 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -102.23 13.17 35.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.328 -178.655 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.912 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.56 16.34 3.93 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.357 179.966 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.61 -93.69 0.56 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.303 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 19.3 m -139.79 -89.23 0.19 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.751 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.8 tp -85.44 91.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.113 0.482 . . . . 0.0 109.874 178.804 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.912 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.1 p -106.99 137.41 37.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -177.693 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -86.35 102.76 14.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.458 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.874 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.9 mt -90.64 140.65 29.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.41 -178.697 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.486 ' HA ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -101.95 131.87 48.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.273 179.569 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.435 HG21 ' OD2' ' A' ' 55' ' ' ASP . 6.8 m -139.79 136.55 39.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.874 -179.654 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.49 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 3.0 ptt? -105.92 138.74 41.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.911 179.726 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.36 146.51 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.078 -179.934 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.025 179.883 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -149.73 177.95 9.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.522 179.698 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 27.1 m-85 -143.56 150.15 38.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 111.116 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -137.6 146.53 44.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.852 179.959 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 7.0 pm0 -108.49 144.56 35.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.058 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.81 110.33 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.531 179.779 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.709 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.95 116.95 20.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.711 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.058 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -126.68 127.07 44.57 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.509 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.579 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 4.0 pt-20 -85.52 100.41 11.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.327 179.391 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -48.52 88.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.254 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.41 177.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.554 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -55.39 -23.49 24.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.796 0.331 . . . . 0.0 111.139 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.5 t -98.76 -24.72 14.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.184 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.38 -163.94 28.41 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.182 -179.753 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.972 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.8 tp -64.99 -63.56 1.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.644 0.222 . . . . 0.0 110.695 179.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 131.4 21.37 1.05 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 119.89 -1.148 . . . . 0.0 114.726 178.537 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.855 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.2 p90 -161.6 135.96 6.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.935 0.868 . . . . 0.0 111.113 179.049 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.0 138.75 32.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.45 -179.459 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.038 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -119.66 148.81 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.727 0.775 . . . . 0.0 112.365 -179.642 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.15 134.21 27.44 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.281 179.475 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.68 -0.52 1.04 Allowed Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.199 -1.0 . . . . 0.0 113.807 179.491 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -56.88 -170.31 0.13 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.929 -179.837 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 32' ' ' PRO . 18.1 p -74.9 -21.59 59.13 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.141 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -96.15 -25.14 15.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.719 0.295 . . . . 0.0 111.643 -179.117 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.421 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 62.7 t30 -124.34 87.52 53.87 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.176 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.11 63.84 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.276 1.984 . . . . 0.0 112.576 -179.513 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.726 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.3 t60 -49.52 -26.23 3.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.154 179.059 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.802 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.43 -154.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.386 179.543 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -55.96 -50.83 59.23 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.704 -179.644 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.03 39.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.835 0.35 . . . . 0.0 110.826 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -126.7 170.02 10.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.769 ' HB3' HG22 ' A' ' 23' ' ' THR . 93.6 Cg_endo -80.35 6.59 5.28 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.653 2.235 . . . . 0.0 112.843 -179.872 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.97 113.41 1.5 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.931 0.396 . . . . 0.0 110.57 179.722 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.65 119.16 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.023 -179.633 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.802 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.67 146.96 36.76 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 121.296 0.57 . . . . 0.0 110.646 178.485 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.034 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.97 155.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.156 -0.929 . . . . 0.0 113.194 -176.566 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.77 -31.31 4.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.845 -1.07 . . . . 0.0 112.154 -179.038 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.84 132.14 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.114 -179.363 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.35 132.9 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.549 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.17 126.72 69.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.655 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.2 Cg_endo -66.16 132.3 29.4 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.658 2.239 . . . . 0.0 112.355 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.02 1.72 58.34 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.476 -179.833 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -103.91 173.97 22.08 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.957 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.792 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.25 -35.57 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.75 0.31 . . . . 0.0 111.186 -179.998 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.837 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -71.03 -57.21 4.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.748 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.38 -35.21 80.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.83 -179.161 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -72.08 -30.4 65.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.839 0.352 . . . . 0.0 110.43 179.705 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.98 -58.13 3.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.647 179.929 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.38 41.43 10.09 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.579 179.451 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' CB ' HG12 ' A' ' 6' ' ' ILE . 14.2 mtt180 -116.44 7.95 13.95 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.865 0.364 . . . . 0.0 110.679 179.574 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.034 HD21 HD12 ' A' ' 36' ' ' ILE . 5.1 tp -136.72 154.18 50.66 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.73 179.577 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.79 136.49 48.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.89 -179.991 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.89 157.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.403 0.621 . . . . 0.0 111.513 179.839 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 75.52 -0.78 3.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.245 179.81 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.693 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.3 OUTLIER -69.78 127.52 33.21 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.972 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.615 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 6.0 p -86.57 100.2 12.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.471 0.653 . . . . 0.0 111.605 -178.568 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.97 HD11 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -47.03 141.23 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.087 -179.892 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.847 HD21 ' HG3' ' A' ' 89' ' ' MET . 1.6 mm? -118.58 -45.03 2.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.183 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.3 m-85 -140.33 169.93 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.898 -179.894 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.81 HG13 ' CD2' ' A' ' 86' ' ' LEU . 18.4 t -149.46 96.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.058 179.355 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.3 -68.15 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.176 0.512 . . . . 0.0 109.936 -178.784 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 60' ' ' VAL . 3.2 tt0 -154.47 30.75 0.43 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.683 179.244 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.3 t -117.28 142.18 32.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.386 -179.333 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 35.7 t0 -114.72 87.91 2.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.494 179.431 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 65' ' ' VAL . 31.7 m -70.53 63.14 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 111.355 -179.543 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -29.62 30.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.688 179.715 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -154.68 64.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.817 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.745 ' O ' HG23 ' A' ' 23' ' ' THR . 34.7 m -128.15 146.73 33.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.284 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.78 153.62 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.067 0.46 . . . . 0.0 110.811 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 74' ' ' VAL . 7.0 p-80 -49.6 -33.62 15.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.988 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -70.64 -33.82 71.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.416 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.657 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.78 -44.42 85.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 0.0 109.807 179.178 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.19 -46.84 87.15 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.569 0.7 . . . . 0.0 109.307 178.095 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 70' ' ' HIS . 89.9 t -57.16 -49.33 80.01 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.281 178.647 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.657 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.72 -33.06 66.13 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.598 178.608 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.687 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.51 -51.42 69.51 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.197 0.522 . . . . 0.0 109.991 179.325 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.39 -37.54 67.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.472 178.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.5 OUTLIER -77.53 -26.67 51.24 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.502 179.332 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -91.74 -12.62 33.42 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 120.894 0.378 . . . . 0.0 111.216 -178.796 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.928 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.97 -18.77 10.1 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.334 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.38 -100.34 2.32 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.142 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -126.9 -91.74 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.008 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.709 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.7 tp -87.78 94.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.205 0.526 . . . . 0.0 109.723 178.745 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.928 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.9 p -110.14 138.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -177.506 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 2.1 mtm105 -87.77 103.11 15.31 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.148 177.838 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.81 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.9 mt -92.5 139.04 30.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.175 -178.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.78 147.88 25.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.693 HG21 ' OD2' ' A' ' 55' ' ' ASP . 30.3 m -138.81 167.93 20.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.425 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.847 ' HG3' HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -101.49 156.88 17.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.807 0.336 . . . . 0.0 110.996 -179.932 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.62 106.71 5.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.113 -179.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.981 179.858 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' ' CE1' ' A' ' 3' ' ' TYR . 4.8 ttm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.799 0.333 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -78.47 141.43 38.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.959 179.859 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.552 ' CD1' HD11 ' A' ' 58' ' ' LEU . 2.7 m-30 -105.09 146.37 29.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -140.82 148.88 41.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -103.48 141.64 35.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.904 HG23 ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt -130.66 109.33 16.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.19 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.982 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.85 112.14 15.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.708 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.969 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.5 tp -121.44 126.83 50.25 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.145 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.817 ' CG ' HD13 ' A' ' 83' ' ' ILE . 8.8 mt-10 -81.57 100.33 9.33 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.07 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.06 88.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.926 179.562 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -53.22 173.84 0.37 Allowed Glycine 0 N--CA 1.453 -0.221 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.66 -179.859 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -53.03 -25.82 13.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.713 0.292 . . . . 0.0 110.941 179.909 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.5 p -93.59 -24.73 17.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.161 179.896 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.72 -163.37 27.62 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.247 -179.965 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.969 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp -67.2 -63.56 1.03 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.433 0.159 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.14 20.16 0.84 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 119.791 -1.195 . . . . 0.0 114.599 178.675 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.847 ' CE2' HD23 ' A' ' 15' ' ' LEU . 8.6 p90 -162.76 134.53 5.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 117.986 0.893 . . . . 0.0 111.455 179.019 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.81 139.1 30.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.402 -179.566 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.054 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.69 147.37 23.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.68 0.752 . . . . 0.0 112.328 -179.69 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.93 135.4 32.78 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.06 179.438 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 142.71 3.39 0.96 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.559 179.584 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -59.61 -168.36 0.29 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.874 -179.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.808 HG22 ' HB3' ' A' ' 32' ' ' PRO . 40.5 p -72.46 -30.01 64.18 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.126 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -96.09 -17.27 21.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.035 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.431 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.0 OUTLIER -124.84 82.66 60.32 Favored Pre-proline 0 N--CA 1.452 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.248 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -66.36 62.32 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.777 2.318 . . . . 0.0 112.294 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.723 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 41.4 t60 -50.17 -23.45 2.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.538 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.82 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.81 -154.77 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.325 179.693 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.66 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.64 -50.19 69.69 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.537 -179.681 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.55 39.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.736 0.303 . . . . 0.0 110.766 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.75 164.67 33.28 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.999 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.808 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.25 3.69 6.02 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 123.05 2.5 . . . . 0.0 112.826 -179.849 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 m -54.8 114.32 1.67 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 -179.944 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -84.06 119.81 33.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.742 -179.898 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.82 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.17 148.5 38.35 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-O 121.284 0.564 . . . . 0.0 110.647 178.722 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.093 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.22 155.59 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.162 -0.926 . . . . 0.0 113.012 -176.73 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -34.06 3.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.595 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.588 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.56 141.61 2.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.001 0.429 . . . . 0.0 111.552 -179.677 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.767 HG23 ' HB3' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -104.29 133.07 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.166 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.05 113.74 49.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.86 0.362 . . . . 0.0 111.943 -177.763 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 45.2 Cg_exo -56.74 140.53 91.11 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.756 2.304 . . . . 0.0 112.506 -179.828 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.37 13.01 64.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.421 -179.91 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.32 -176.91 19.08 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.038 179.751 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.826 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -59.62 -35.62 74.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.846 0.355 . . . . 0.0 111.08 179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.88 -57.26 4.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.886 -179.615 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.44 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.31 -33.32 75.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.765 -179.041 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.8 pt20 -72.34 -30.4 64.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.897 0.379 . . . . 0.0 110.56 179.773 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.45 ' OD2' HD12 ' A' ' 8' ' ' LEU . 3.5 m-20 -76.31 -58.22 3.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.059 -179.552 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.71 41.29 8.99 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.384 179.86 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.904 ' HB3' HG23 ' A' ' 6' ' ' ILE . 8.6 mmt180 -120.44 -2.14 10.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.696 0.284 . . . . 0.0 110.935 179.667 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.093 HD21 HD12 ' A' ' 36' ' ' ILE . 36.0 tp -124.37 162.96 22.73 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.147 0.499 . . . . 0.0 111.402 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.63 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.37 134.38 25.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.241 179.302 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.588 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 54.6 t -49.18 156.9 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.842 -179.604 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.473 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.4 OUTLIER 76.54 -1.43 2.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.332 179.885 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -67.18 126.82 30.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.966 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.6 102.74 14.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.545 0.688 . . . . 0.0 111.533 -178.747 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.054 HD11 HG21 ' A' ' 19' ' ' ILE . 69.3 mt -49.36 136.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.784 179.825 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.856 HD11 ' HG2' ' A' ' 89' ' ' MET . 48.4 mt -120.61 -30.08 4.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.795 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.618 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -152.94 158.36 41.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.8 179.952 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.893 HG13 ' CD2' ' A' ' 86' ' ' LEU . 43.0 t -152.41 109.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.955 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 49.77 47.92 22.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.84 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 73.13 31.4 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.823 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 73.6 t -120.2 142.06 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.832 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 8.9 p-10 -113.05 91.35 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.556 179.519 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.736 HG12 HG21 ' A' ' 68' ' ' VAL . 2.2 m -55.9 -102.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.17 -179.646 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.583 ' H ' HG23 ' A' ' 65' ' ' VAL . 5.1 mtp180 61.99 -82.88 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.773 0.32 . . . . 0.0 111.24 179.74 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -88.25 51.92 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 -179.655 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.763 ' O ' HG23 ' A' ' 23' ' ' THR . 30.4 m -139.17 144.41 29.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.053 179.81 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.475 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.36 154.59 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.429 . . . . 0.0 111.038 -179.484 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.882 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.4 p-80 -48.15 -34.26 9.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.194 -179.487 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.0 m -70.29 -33.89 72.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.393 179.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.629 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.77 -47.34 75.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.194 0.521 . . . . 0.0 109.624 179.079 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.834 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -59.31 -46.74 87.76 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.654 0.74 . . . . 0.0 109.36 178.118 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.882 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.1 t -56.86 -50.4 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.357 178.516 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.9 -28.59 57.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.991 178.649 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -61.98 -51.59 67.46 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.344 0.592 . . . . 0.0 109.691 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -56.75 -36.89 70.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.874 179.098 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.4 -30.52 53.62 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.852 179.712 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.3 OUTLIER -97.85 19.76 13.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.42 -178.417 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.14 16.3 7.44 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 179.656 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.53 -93.44 0.81 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.225 -179.835 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.477 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.2 m -142.18 -90.6 0.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.121 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.982 HG13 HG22 ' A' ' 7' ' ' THR . 6.0 tp -83.11 89.22 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.561 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.895 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.8 p -105.75 137.6 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.644 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.852 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.17 102.92 14.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.659 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.893 ' CD2' HG13 ' A' ' 60' ' ' VAL . 9.3 mt -92.77 137.7 32.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.172 -178.906 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.88 138.5 38.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.587 179.877 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.61 167.94 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.793 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.856 ' HG2' HD11 ' A' ' 58' ' ' LEU . 22.0 mtm -100.95 152.51 20.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.884 0.374 . . . . 0.0 110.959 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.44 110.36 6.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.964 179.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.955 179.886 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ttm . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.751 0.31 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.93 155.72 40.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' CG ' HD13 ' A' ' 58' ' ' LEU . 6.4 m-85 -107.02 147.77 29.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.46 146.18 31.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.885 179.887 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -102.53 144.66 30.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.977 -179.896 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.016 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.75 109.23 9.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.075 0.464 . . . . 0.0 111.446 179.679 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.884 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.2 119.86 22.18 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.095 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.019 HD23 ' HG ' ' A' ' 15' ' ' LEU . 5.3 tp -131.07 126.9 37.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.48 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.4 pt-20 -84.29 100.49 11.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.26 179.354 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.47 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -50.7 89.15 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.042 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.27 174.38 0.2 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.603 -179.912 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -54.51 -24.23 19.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.753 0.311 . . . . 0.0 111.019 -179.946 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.72 -23.65 16.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.52 -163.66 27.85 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.147 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.019 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.8 tp -68.13 -63.56 1.04 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.836 -0.214 . . . . 0.0 110.798 -179.96 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 132.22 22.11 0.92 Allowed Glycine 0 CA--C 1.521 0.442 0 C-N-CA 119.693 -1.242 . . . . 0.0 114.914 178.38 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.862 ' CE2' HD23 ' A' ' 15' ' ' LEU . 10.4 p90 -161.17 135.96 7.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.073 0.936 . . . . 0.0 111.351 179.101 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.75 135.36 36.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.528 -179.571 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.088 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -115.2 146.83 19.13 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.418 179.638 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.592 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -128.14 123.59 34.78 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.446 178.956 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 70' ' ' HIS . . . 159.48 -124.91 1.41 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.939 -179.708 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . 73.14 168.71 13.9 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.214 179.877 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.849 HG22 ' HB2' ' A' ' 32' ' ' PRO . 6.3 p -75.53 -6.29 49.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.16 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -106.64 -26.92 11.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -179.65 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' HIS . 5.2 t-20 -124.91 86.97 55.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.579 -179.762 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.23 66.93 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.127 1.885 . . . . 0.0 112.455 -179.608 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.748 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 37.4 t60 -52.39 -24.91 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.252 179.151 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.852 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -92.1 -153.71 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.388 179.723 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -52.33 -51.62 41.29 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.85 -179.366 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 169.8 41.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 0.0 110.846 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.06 173.59 5.33 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.777 179.936 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.849 ' HB2' HG22 ' A' ' 23' ' ' THR . 80.9 Cg_endo -84.66 41.6 1.01 Allowed 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.734 2.289 . . . . 0.0 112.438 179.891 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 t -90.41 119.49 30.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.003 0.43 . . . . 0.0 111.267 -179.707 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.915 HD12 ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -90.69 112.66 25.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.044 179.643 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.852 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -138.29 147.42 43.58 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 121.369 0.604 . . . . 0.0 110.283 179.249 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.045 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.15 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.794 -1.094 . . . . 0.0 113.111 -176.663 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.592 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.67 -33.55 4.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.574 -179.225 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.639 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -169.98 142.19 2.31 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.911 0.386 . . . . 0.0 111.457 -179.762 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.97 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -104.75 132.96 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.967 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.412 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.81 125.13 73.96 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -177.278 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 41.4 Cg_endo -67.05 129.92 21.73 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.936 2.424 . . . . 0.0 112.189 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.91 49.93 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.02 178.84 19.8 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.878 179.645 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.92 -38.81 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.749 0.309 . . . . 0.0 111.151 179.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.784 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -66.62 -57.47 7.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.634 -179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.47 -28.89 67.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.487 -179.684 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -33.57 68.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.966 0.413 . . . . 0.0 110.175 179.594 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' OD2' HD12 ' A' ' 8' ' ' LEU . 4.3 m-20 -84.1 -57.99 2.95 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.66 -179.904 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 41.27 9.51 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.604 179.638 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.479 ' CB ' HG12 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -111.21 -10.24 14.29 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.885 0.374 . . . . 0.0 110.78 179.621 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.045 HD21 HD12 ' A' ' 36' ' ' ILE . 4.6 tp -117.14 153.45 32.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.127 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.581 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -128.93 137.8 51.61 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.844 179.852 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.639 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.5 t -52.24 158.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.356 0.598 . . . . 0.0 111.828 -179.967 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 3.5 t30 75.93 -0.09 3.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.325 179.797 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -69.11 125.53 26.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.18 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.69 100.69 12.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.512 0.672 . . . . 0.0 111.366 -178.837 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.088 HD11 HG21 ' A' ' 19' ' ' ILE . 61.4 mt -47.11 129.15 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.911 179.927 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.766 HD21 ' SD ' ' A' ' 89' ' ' MET . 3.6 mt -114.95 -32.05 5.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.586 179.437 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.6 m-85 -151.94 155.78 38.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.843 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.916 HG13 ' CD2' ' A' ' 86' ' ' LEU . 46.0 t -142.2 102.06 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.631 179.572 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 66.13 -68.13 0.14 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.088 0.47 . . . . 0.0 110.462 -179.508 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 60' ' ' VAL . 8.3 pt-20 -155.06 30.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.907 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.529 HG21 ' OE2' ' A' ' 79' ' ' GLU . 47.0 t -117.87 142.09 33.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.315 -179.456 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 41.2 t0 -109.93 87.77 2.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.366 179.408 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 57' ' ' ILE . 29.9 m -63.37 -138.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.868 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HD3' HD23 ' A' ' 58' ' ' LEU . 0.0 OUTLIER 76.2 -59.73 0.5 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.021 0.439 . . . . 0.0 110.092 -179.184 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -100.8 30.16 4.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.293 179.03 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.757 ' C ' HG23 ' A' ' 23' ' ' THR . 12.2 m -127.55 142.77 42.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.389 -180.0 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.41 152.97 24.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.653 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.89 ' O ' HG23 ' A' ' 74' ' ' VAL . 22.7 t-160 -47.91 -33.96 8.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.023 -179.881 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.6 m -65.25 -34.17 77.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.091 179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.687 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.816 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.915 ' HB2' HD12 ' A' ' 34' ' ' ILE . . . -63.07 -46.93 85.12 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.908 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.89 HG23 ' O ' ' A' ' 70' ' ' HIS . 76.3 t -56.25 -50.91 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.287 178.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.687 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.58 -29.27 61.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.253 178.944 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.9 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -60.42 -56.83 16.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.962 179.619 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.735 HD12 ' O ' ' A' ' 73' ' ' ALA . 2.2 mp -53.4 -36.84 61.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.983 178.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.42 -27.4 52.27 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.642 179.521 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' OE2' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -99.44 14.64 29.07 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.435 -178.267 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.946 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.47 16.29 3.9 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.322 179.763 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.3 -86.71 0.05 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.191 -179.904 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 13.3 p -144.14 -89.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.456 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.884 HG13 HG22 ' A' ' 7' ' ' THR . 9.0 tp -84.21 92.83 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.176 0.512 . . . . 0.0 110.077 179.127 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.946 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.1 p -108.1 137.92 37.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.898 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 11.0 ptp180 -88.29 102.7 15.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.188 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.916 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.2 mt -91.65 138.8 31.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.427 -178.52 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.49 137.36 39.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.138 179.584 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.468 HG21 ' OD2' ' A' ' 55' ' ' ASP . 11.6 m -139.63 168.12 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.213 -179.4 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.766 ' SD ' HD21 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.4 150.83 22.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.97 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.58 106.96 5.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.98 179.97 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.535 ' HB2' ' HG3' ' A' ' 91' ' ' ARG . 2.8 ttp . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.889 0.375 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.21 132.21 53.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.478 -179.426 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.458 ' CE1' ' HG2' ' A' ' 1' ' ' MET . 3.2 m-85 -108.88 109.75 20.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.346 179.426 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -118.61 166.98 12.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.401 . . . . 0.0 111.493 -179.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -119.52 144.95 46.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.979 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.87 111.39 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.99 0.424 . . . . 0.0 111.856 -179.79 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.5 120.15 23.48 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.972 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.98 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.8 tp -129.83 126.8 38.92 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.613 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 3.6 pt-20 -86.68 100.74 12.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.233 179.312 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -47.86 88.54 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.325 179.531 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.14 177.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.781 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -54.14 -25.08 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.642 0.258 . . . . 0.0 111.06 -179.877 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 t -97.64 -24.79 15.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.106 -179.909 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.7 -163.43 27.94 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.149 -179.791 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.98 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.1 tp -63.9 -63.45 1.16 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.104 -0.238 . . . . 0.0 110.485 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.96 22.14 1.16 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 119.909 -1.138 . . . . 0.0 114.632 178.446 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.829 ' CE2' HD23 ' A' ' 15' ' ' LEU . 7.1 p90 -162.89 134.79 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.76 0.78 . . . . 0.0 111.228 179.02 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.38 139.41 31.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.672 -179.287 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.029 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -119.74 147.18 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.661 0.743 . . . . 0.0 112.306 -179.92 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.86 132.62 29.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.44 -1.255 . . . . 0.0 110.876 179.202 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 149.76 -6.48 0.75 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.18 -1.009 . . . . 0.0 113.491 179.639 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.32 179.04 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.977 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.741 HG23 ' C ' ' A' ' 68' ' ' VAL . 19.1 p -65.03 -34.62 78.87 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.231 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -88.93 -17.58 29.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.557 -179.552 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -124.43 81.99 58.8 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.45 63.38 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.832 2.354 . . . . 0.0 112.522 -179.316 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.717 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 45.5 t60 -53.16 -22.3 6.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 178.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.805 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -95.43 -152.46 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.448 179.73 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.674 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.97 50.37 4.39 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.643 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 78.04 47.34 0.05 Allowed 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.028 0.442 . . . . 0.0 110.455 179.744 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.98 151.46 72.18 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.917 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.584 ' CB ' HG22 ' A' ' 23' ' ' THR . 68.8 Cg_endo -74.45 -2.7 12.76 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.456 2.104 . . . . 0.0 112.576 179.976 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.402 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.3 OUTLIER -52.16 119.25 4.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.537 179.695 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.823 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -86.55 120.34 36.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 -179.462 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.805 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.18 147.19 36.19 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.337 0.589 . . . . 0.0 110.564 178.479 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.992 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.943 -176.767 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.456 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.51 -30.95 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.783 -1.098 . . . . 0.0 112.215 -179.091 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.651 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.68 131.41 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.341 -0.544 . . . . 0.0 112.043 -179.408 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.0 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.84 132.14 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.492 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.44 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.32 124.22 74.08 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -177.719 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.447 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 34.9 Cg_endo -64.59 135.38 45.25 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.675 2.25 . . . . 0.0 112.242 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.94 7.13 60.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.486 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.09 174.51 17.65 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.904 179.804 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.64 -32.75 52.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.642 0.258 . . . . 0.0 111.209 -179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.746 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -72.18 -57.42 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.547 -179.965 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.32 -28.91 67.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.446 -179.535 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -71.9 -31.58 66.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.909 0.385 . . . . 0.0 110.197 179.596 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -83.83 -57.85 3.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.714 -179.932 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.4 40.81 8.8 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.385 179.714 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.456 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.6 mtp85 -112.64 -9.23 13.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.017 179.736 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.0 HD23 HD11 ' A' ' 39' ' ' ILE . 6.3 tp -119.35 155.88 31.09 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.619 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.1 mpt_? -131.99 135.47 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.651 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -51.98 157.72 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.296 0.57 . . . . 0.0 111.721 179.889 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.3 OUTLIER 76.23 -1.27 2.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.38 179.715 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.3 m-20 -69.53 127.71 33.95 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.611 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.69 100.02 12.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.549 0.69 . . . . 0.0 111.281 -178.97 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.029 HD11 HG21 ' A' ' 19' ' ' ILE . 10.6 mt -45.74 144.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.026 -179.927 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 89' ' ' MET . 0.2 OUTLIER -123.26 -44.36 2.15 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.205 179.736 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -140.97 165.78 26.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.818 HG13 ' CD2' ' A' ' 86' ' ' LEU . 42.0 t -150.75 103.13 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.523 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.51 -71.24 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.108 0.48 . . . . 0.0 110.226 -179.24 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' VAL . 4.4 mm-40 -151.14 28.56 0.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.816 179.3 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.833 HG12 ' H ' ' A' ' 65' ' ' VAL . 21.5 t -116.04 142.17 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.21 -179.485 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 38.4 p-10 -103.59 -0.96 28.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.422 179.831 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.833 ' H ' HG12 ' A' ' 63' ' ' VAL . 16.7 m 43.65 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.559 -179.645 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -51.92 99.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.765 179.91 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' O ' HG21 ' A' ' 23' ' ' THR . 11.3 pt-20 44.85 57.66 4.46 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.111 -179.58 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.741 ' C ' HG23 ' A' ' 23' ' ' THR . 4.9 m -108.51 145.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.15 179.952 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.456 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.25 156.84 14.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.337 -178.925 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.923 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.0 p-80 -48.9 -34.29 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.932 -179.757 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.3 m -67.91 -33.86 75.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.967 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.568 ' CB ' ' HB ' ' A' ' 68' ' ' VAL . . . -66.29 -46.1 78.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.181 0.515 . . . . 0.0 109.649 178.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.823 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.37 -45.4 93.35 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 70' ' ' HIS . 66.9 t -56.52 -50.43 73.11 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.113 178.517 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.604 ' HA ' ' CG ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -51.48 -34.65 36.65 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.862 179.534 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.793 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.49 -57.34 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.305 -0.558 . . . . 0.0 112.059 -179.478 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.94 HD12 HD12 ' A' ' 19' ' ' ILE . 2.4 mt -59.98 -41.32 91.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.38 0.61 . . . . 0.0 110.231 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.604 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.92 -20.13 56.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.766 179.641 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -112.22 23.44 13.67 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 111.005 179.271 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.879 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -82.92 16.57 2.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.752 -179.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.52 -91.24 0.48 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.676 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 38.0 m -138.29 -90.73 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.859 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.905 HG13 HG22 ' A' ' 7' ' ' THR . 8.1 tp -86.55 100.23 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.162 0.506 . . . . 0.0 110.526 179.361 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.879 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.3 p -114.11 139.95 37.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.793 -178.171 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.714 ' HG3' HG23 ' A' ' 7' ' ' THR . 11.7 mtt180 -88.12 103.51 15.81 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.603 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.818 ' CD2' HG13 ' A' ' 60' ' ' VAL . 17.7 mt -94.1 136.63 34.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.621 -178.942 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.83 138.17 39.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.377 179.562 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.441 HG11 HD11 ' A' ' 51' ' ' LEU . 5.6 m -139.79 137.63 39.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.992 -179.679 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.61 ' HB3' HD23 ' A' ' 58' ' ' LEU . 8.7 ptt? -108.37 135.44 49.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.776 179.781 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.15 112.39 11.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.608 -179.491 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.535 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.289 -0.863 . . . . 0.0 110.914 179.818 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.856 0.36 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.92 133.56 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.931 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 71.1 m-85 -93.98 165.55 12.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.489 179.672 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -144.7 137.32 26.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.359 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 11.8 pt-20 -103.43 144.61 31.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.651 179.769 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.039 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.91 109.37 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.984 0.421 . . . . 0.0 111.887 179.925 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.889 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.35 121.14 24.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.612 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.039 HD13 HD11 ' A' ' 6' ' ' ILE . 5.2 tp -130.44 127.2 38.79 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.233 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.1 mt-10 -77.78 99.72 6.01 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.201 179.59 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -62.57 90.23 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.235 178.455 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -136.74 179.59 17.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.996 -179.47 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 54.01 -91.48 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.578 0.228 . . . . 0.0 110.782 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m -108.38 14.65 24.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.652 0.263 . . . . 0.0 111.127 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 120.08 -138.54 13.13 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.868 -179.676 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.94 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.4 tp -75.25 -63.29 1.31 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.66 0.23 . . . . 0.0 110.591 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.519 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 133.61 19.12 0.96 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.942 -1.123 . . . . 0.0 114.775 178.596 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.865 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.7 p90 -161.31 137.05 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.755 0.778 . . . . 0.0 110.996 179.114 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -95.69 138.01 33.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.223 -179.528 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.07 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.22 147.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.669 0.747 . . . . 0.0 112.302 -179.781 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.575 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.56 133.67 31.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.168 179.454 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.76 -7.48 1.08 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.218 -0.992 . . . . 0.0 113.531 179.57 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.54 -177.86 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.545 -0.836 . . . . 0.0 113.337 -179.753 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.778 HG23 ' O ' ' A' ' 68' ' ' VAL . 30.3 p -64.03 -33.72 76.39 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.914 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' CB ' ' HB ' ' A' ' 69' ' ' THR . 12.2 t70 -89.78 -19.02 25.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -178.957 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 1.2 t-20 -124.13 86.94 53.86 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.46 179.897 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.0 61.25 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.407 2.071 . . . . 0.0 112.4 -179.729 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.722 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 54.8 t60 -49.83 -26.12 3.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.187 178.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.774 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -93.99 -151.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.525 179.616 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.69 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -83.25 49.87 4.31 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.828 -178.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 77.18 45.11 0.09 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.088 0.47 . . . . 0.0 110.511 179.558 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.13 78.5 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.913 179.912 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.502 ' HB3' HG22 ' A' ' 23' ' ' THR . 68.7 Cg_endo -74.77 -1.16 10.77 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.38 2.053 . . . . 0.0 112.546 179.847 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -51.99 115.91 1.92 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-O 120.91 0.386 . . . . 0.0 110.462 179.524 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -84.06 118.21 31.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.145 -179.346 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.774 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.94 146.96 38.06 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-O 121.372 0.606 . . . . 0.0 110.474 178.42 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.005 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.1 155.79 7.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.977 -1.011 . . . . 0.0 113.191 -176.52 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.449 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.17 -30.96 4.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.781 -1.1 . . . . 0.0 112.133 -178.846 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.86 132.93 0.55 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.113 -179.496 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.994 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.53 132.05 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.889 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.435 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.17 116.17 63.66 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.627 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.2 Cg_exo -58.39 135.56 68.7 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.757 2.304 . . . . 0.0 112.273 179.742 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.55 9.49 57.64 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.655 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.71 179.76 18.51 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.033 179.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.38 -36.52 66.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.755 0.312 . . . . 0.0 111.033 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.848 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -68.98 -57.35 5.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.029 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.77 -29.94 68.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.02 -178.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 2.6 pt20 -72.04 -33.42 67.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 0.0 110.123 179.666 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.45 -58.04 3.21 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.32 41.09 9.48 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.594 179.479 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 22.2 mtt-85 -115.38 9.05 15.5 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.751 179.584 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.005 HD21 HD12 ' A' ' 36' ' ' ILE . 5.3 tp -136.19 154.58 50.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.627 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.575 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -132.15 135.59 46.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.85 179.841 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.4 t -51.4 157.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.437 0.637 . . . . 0.0 111.552 179.998 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 1.9 t30 75.49 0.17 3.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.356 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.8 m-20 -71.35 127.73 33.53 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.0 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 3.4 p -86.49 100.41 12.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.576 0.703 . . . . 0.0 111.381 -178.597 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.07 HD11 HG21 ' A' ' 19' ' ' ILE . 68.1 mt -45.46 151.0 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.127 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -128.91 -46.26 1.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.278 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -141.15 163.98 31.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.973 -179.966 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.835 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.4 t -148.67 101.99 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.603 179.573 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.4 t30 65.72 -68.83 0.12 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.1 0.476 . . . . 0.0 110.389 -179.371 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.8 mm-40 -154.13 30.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.799 179.29 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.832 HG12 ' H ' ' A' ' 65' ' ' VAL . 19.7 t -117.66 142.2 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.165 -179.57 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 34.5 p-10 -105.54 1.35 27.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.389 179.77 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.832 ' H ' HG12 ' A' ' 63' ' ' VAL . 15.4 m 43.62 30.84 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 120.813 0.339 . . . . 0.0 111.319 -179.638 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.16 95.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.992 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 57.04 63.0 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.745 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 23' ' ' THR . 19.7 m -119.29 147.72 22.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.453 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -66.06 155.6 36.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.214 -179.17 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.875 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.1 p-80 -48.17 -34.93 10.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.181 -179.454 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 m -69.83 -33.79 72.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.381 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.87 -47.29 75.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.267 0.556 . . . . 0.0 109.645 178.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.3 -46.77 88.72 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.551 0.691 . . . . 0.0 109.493 178.2 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 70' ' ' HIS . 87.7 t -57.41 -48.45 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.296 178.606 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.96 -34.87 68.48 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.518 178.553 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.565 ' N ' ' HG3' ' A' ' 75' ' ' GLU . . . -55.46 -51.3 67.39 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.258 0.551 . . . . 0.0 110.016 179.337 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.033 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -55.28 -37.19 66.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.307 178.722 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.47 -26.74 51.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.973 179.56 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -96.2 6.1 49.56 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.03 0.443 . . . . 0.0 111.437 -178.647 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -79.14 16.19 1.0 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.65 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.91 -91.11 0.5 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.347 -179.954 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.509 ' C ' ' H ' ' A' ' 10' ' ' ARG . 38.6 m -143.87 -91.15 0.11 Allowed 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.198 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.889 HG13 HG22 ' A' ' 7' ' ' THR . 8.9 tp -81.68 92.69 2.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.175 0.512 . . . . 0.0 109.726 178.693 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.913 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -110.89 137.05 44.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.262 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.8 ptt85 -87.04 103.09 15.04 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.196 177.676 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.835 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.5 mt -91.51 141.83 28.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.162 -178.983 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.8 144.32 30.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.858 -179.624 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.73 167.52 25.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.435 179.714 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.451 ' HG3' HD21 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -104.29 139.82 38.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.762 0.315 . . . . 0.0 110.998 -179.962 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.61 106.76 5.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.847 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.415 ' H ' ' HG3' ' A' ' 91' ' ' ARG . 1.8 ppt_? . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.94 179.823 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG3' ' CA ' ' A' ' 91' ' ' ARG . 2.2 ttt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.759 0.314 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.42 127.05 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.803 179.921 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.445 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 3.6 m-30 -93.39 169.15 10.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.021 -179.867 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -164.2 147.1 9.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -102.58 144.65 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 -179.976 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.56 109.44 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 111.487 179.846 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.834 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.47 113.29 17.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.047 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -123.81 127.22 47.77 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.563 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.3 pt-20 -86.35 100.13 12.09 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.275 179.898 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -49.16 89.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.266 178.328 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -125.12 173.03 17.26 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.345 -178.983 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.2 m120 53.97 -91.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.481 0.181 . . . . 0.0 110.887 -179.911 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -108.46 12.83 25.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.636 0.255 . . . . 0.0 111.178 179.673 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.2 -143.23 14.67 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.777 -179.696 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.908 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp -67.37 -63.39 1.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.44 -179.998 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.94 24.7 1.17 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 119.809 -1.186 . . . . 0.0 114.854 178.139 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.77 ' HB3' HG23 ' A' ' 39' ' ' ILE . 6.1 p90 -162.18 134.95 5.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.985 0.892 . . . . 0.0 111.498 178.923 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.494 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.31 134.78 36.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.173 -179.679 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.085 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.68 166.74 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.706 0.765 . . . . 0.0 111.655 179.936 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.627 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -163.62 131.93 3.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.296 179.997 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.473 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.46 0.53 1.15 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.456 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.539 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.41 -171.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.966 -179.976 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.79 HG22 ' CB ' ' A' ' 32' ' ' PRO . 15.0 p -74.78 -20.03 59.96 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.18 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -98.39 -24.15 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.706 0.289 . . . . 0.0 111.661 -179.376 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -124.53 87.89 53.9 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.223 179.814 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.51 63.07 0.53 Allowed 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.317 2.011 . . . . 0.0 112.792 -179.368 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.75 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 38.9 t60 -48.29 -27.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.151 178.859 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.814 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -90.39 -154.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.434 179.557 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.668 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -56.53 -50.41 63.11 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.582 -179.708 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 172.01 40.7 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.914 0.388 . . . . 0.0 110.711 -179.98 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.26 167.22 16.95 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.999 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.79 ' CB ' HG22 ' A' ' 23' ' ' THR . 89.0 Cg_endo -80.92 8.55 4.25 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.645 2.23 . . . . 0.0 112.83 -179.995 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m -60.49 113.76 2.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.869 0.366 . . . . 0.0 110.772 179.961 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.876 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -81.34 119.54 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.446 179.962 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.814 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.42 145.0 33.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.37 0.605 . . . . 0.0 110.568 178.792 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.052 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.91 155.68 7.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.068 -0.969 . . . . 0.0 113.332 -176.333 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.11 -34.28 4.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.821 -178.908 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.638 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.81 143.01 2.55 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 111.55 -179.602 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.011 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -105.77 132.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.097 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.427 ' CG2' ' HE2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -84.02 125.91 71.5 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -177.475 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 40.1 Cg_endo -66.89 131.09 24.64 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.93 4.82 55.41 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.457 -179.649 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.78 177.67 21.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.726 179.685 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.19 -36.19 65.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.66 0.267 . . . . 0.0 111.074 -179.941 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.806 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -69.42 -57.53 5.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.517 -179.87 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.01 -28.92 67.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.206 -179.623 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -72.12 -35.44 69.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.025 0.441 . . . . 0.0 110.0 179.318 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -83.59 -57.99 3.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.61 179.99 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.42 41.03 9.42 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.572 179.468 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' CB ' HG12 ' A' ' 6' ' ' ILE . 42.5 mtp180 -113.72 8.85 17.62 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.699 0.285 . . . . 0.0 110.662 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.052 HD21 HD12 ' A' ' 36' ' ' ILE . 4.6 tp -135.08 153.88 51.88 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.78 179.609 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.566 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -130.56 136.65 49.12 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.879 179.937 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.9 t -51.18 158.06 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.331 0.586 . . . . 0.0 111.676 179.899 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.48 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 0.7 OUTLIER 74.29 2.17 4.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.023 179.911 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -71.02 126.03 28.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.988 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -86.48 101.95 13.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.652 0.739 . . . . 0.0 111.346 -178.581 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.085 HD11 HG21 ' A' ' 19' ' ' ILE . 57.4 mt -49.74 136.27 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.989 -179.712 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.491 HD11 ' HE3' ' A' ' 89' ' ' MET . 1.7 mt -115.38 -38.29 3.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.174 179.545 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.1 m-85 -147.34 172.01 14.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.798 -179.73 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.858 HG13 ' CD2' ' A' ' 86' ' ' LEU . 36.7 t -150.27 96.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.996 179.351 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.764 ' CG ' HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER 68.44 -67.17 0.21 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.193 0.52 . . . . 0.0 109.775 -178.789 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -156.28 32.34 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.555 179.209 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 51.8 t -119.23 142.33 34.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.57 -179.082 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 6.9 p-10 -111.07 106.77 15.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.301 179.214 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.454 HG12 HG21 ' A' ' 68' ' ' VAL . 31.4 m -91.88 43.32 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 111.52 -179.517 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.58 68.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.736 179.794 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -150.43 66.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 23' ' ' THR . 35.6 m -134.6 145.63 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.72 151.69 28.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.753 -179.884 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 4.8 t-160 -48.98 -33.67 11.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.558 179.977 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.3 t -67.15 -34.06 76.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.045 179.642 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.39 -40.39 81.35 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.829 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.876 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.55 -46.76 78.27 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 178.112 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 97.4 t -57.19 -50.29 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.143 178.563 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -55.25 -33.04 62.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.693 178.646 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.7 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -58.69 -52.62 64.93 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.218 0.533 . . . . 0.0 110.124 179.453 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.048 HD11 HD12 ' A' ' 19' ' ' ILE . 1.4 mt -53.12 -37.57 61.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.212 178.857 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.47 -27.58 52.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.305 178.953 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 1.7 mm-40 -87.63 -17.65 31.39 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.021 0.438 . . . . 0.0 111.092 -178.825 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.973 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -52.32 -21.42 3.51 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.489 179.828 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.04 -91.31 1.44 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.045 -179.95 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 17.7 t -134.49 -92.87 0.31 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.09 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.834 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -86.57 93.67 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.34 0.59 . . . . 0.0 109.983 178.961 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.973 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.7 p -110.17 139.1 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.287 -0.869 . . . . 0.0 113.232 -177.493 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.724 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.6 OUTLIER -87.43 103.07 15.15 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.863 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.858 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.8 mt -93.81 135.73 34.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.152 -179.013 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -101.73 139.92 36.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.716 -179.946 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 55' ' ' ASP . 25.9 m -139.8 167.88 18.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.646 179.992 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.491 ' HE3' HD11 ' A' ' 58' ' ' LEU . 8.9 mtp -118.14 146.26 44.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 110.897 179.694 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -140.65 106.91 5.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' CA ' ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.366 -0.826 . . . . 0.0 110.874 179.978 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.608 ' HE3' ' HG2' ' A' ' 91' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.852 0.358 . . . . 0.0 111.141 . . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -91.94 140.03 30.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.817 179.957 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' HE1' ' HE2' ' A' ' 89' ' ' MET . 9.9 m-30 -99.03 112.19 24.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 179.967 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -101.19 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.396 179.624 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.424 ' HG3' ' CD2' ' A' ' 87' ' ' TYR . 4.4 tt0 -130.36 141.65 50.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.683 0.278 . . . . 0.0 111.098 -179.822 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.023 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.1 112.0 8.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 121.026 0.441 . . . . 0.0 111.87 179.755 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.76 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -80.77 121.95 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.698 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.064 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.9 tp -131.14 127.14 37.44 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.368 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 6.4 pt-20 -82.96 100.36 10.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.208 179.276 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -50.03 88.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.107 179.632 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.75 174.02 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.61 -180.0 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -52.98 -25.51 12.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 0.0 111.028 179.997 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -96.01 -24.78 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.073 -179.971 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.7 -164.1 27.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.368 -179.8 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.064 ' HG ' HD23 ' A' ' 8' ' ' LEU . 6.1 tp -63.95 -63.57 1.12 Allowed 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.278 -0.169 . . . . 0.0 110.831 179.9 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.02 28.15 0.88 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 119.832 -1.175 . . . . 0.0 114.922 178.33 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.853 ' CE2' HD23 ' A' ' 15' ' ' LEU . 5.7 p90 -162.9 132.92 4.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.879 0.84 . . . . 0.0 111.03 178.771 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.568 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -90.83 134.88 34.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.437 -179.2 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.036 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -113.03 163.63 9.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.703 0.763 . . . . 0.0 111.756 -179.944 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -159.06 130.67 6.37 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.931 179.452 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 146.91 -1.03 0.76 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.319 179.82 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -57.61 -172.08 0.25 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.91 -179.857 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.818 HG22 ' HB3' ' A' ' 32' ' ' PRO . 28.6 p -69.77 -34.38 73.69 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.308 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.43 -19.56 25.0 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.253 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.424 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 0.1 OUTLIER -124.68 82.41 59.78 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.905 0.383 . . . . 0.0 110.292 179.773 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.98 62.48 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.803 2.335 . . . . 0.0 112.224 -179.594 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.725 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 42.5 t60 -50.73 -23.39 2.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.413 179.016 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.85 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -93.92 -154.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.308 179.582 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -58.57 -50.26 68.82 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.584 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 172.13 40.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -127.84 168.52 14.99 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.022 -179.913 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 Cg_exo -76.18 3.2 6.42 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.01 2.473 . . . . 0.0 112.702 -179.81 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.4 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 2.7 m -53.96 112.17 0.9 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.863 0.363 . . . . 0.0 111.092 -179.917 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.867 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.34 119.64 34.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.388 179.914 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.85 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.58 144.48 32.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-O 121.505 0.669 . . . . 0.0 110.585 178.952 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.151 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.07 155.69 7.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.88 -176.593 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.463 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.57 -31.9 4.45 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.809 -178.842 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -170.47 142.12 2.06 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.384 -179.823 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.952 ' CD1' HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -103.89 133.82 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 178.26 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.476 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.94 119.28 73.23 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.18 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 31.8 Cg_exo -58.87 132.6 48.61 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.757 2.304 . . . . 0.0 112.137 179.748 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.82 -1.16 59.56 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.763 -179.976 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.36 177.39 28.47 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.873 179.688 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.797 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -54.78 -35.53 63.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.805 0.336 . . . . 0.0 110.961 -179.969 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.843 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -70.26 -57.39 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.357 -179.997 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -66.89 -28.97 68.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.318 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -71.81 -34.23 69.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.13 0.491 . . . . 0.0 109.889 179.509 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.08 -57.74 2.97 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.462 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.49 42.01 9.54 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.362 179.655 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtp180 -110.27 -18.64 13.23 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 120.812 0.339 . . . . 0.0 110.688 179.765 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.151 HD21 HD12 ' A' ' 36' ' ' ILE . 4.8 tp -106.69 153.26 22.66 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.089 0.471 . . . . 0.0 110.666 179.371 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.604 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -127.85 135.89 50.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.919 179.825 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -50.29 160.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.026 0.441 . . . . 0.0 111.437 179.742 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.495 ' N ' HG12 ' A' ' 53' ' ' VAL . 2.2 m120 71.45 4.1 4.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.154 -179.78 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.556 ' CG ' HG21 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -71.06 124.35 24.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.589 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.6 p -86.42 100.0 12.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.561 0.696 . . . . 0.0 111.709 -178.193 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.036 HD11 HG21 ' A' ' 19' ' ' ILE . 9.9 mt -53.12 129.51 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 114.911 -1.041 . . . . 0.0 111.861 179.792 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' ' HB3' ' A' ' 87' ' ' TYR . 1.4 pp -122.53 -18.61 6.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.521 178.974 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.524 ' HD1' HD12 ' A' ' 58' ' ' LEU . 1.9 m-85 -157.36 162.36 39.07 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 121.026 0.441 . . . . 0.0 110.652 -179.979 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.914 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.8 t -143.92 97.09 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.86 179.41 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.832 ' CG ' HG23 ' A' ' 84' ' ' VAL . 1.3 t-20 66.59 -69.02 0.13 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.159 0.504 . . . . 0.0 109.889 -178.572 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -152.89 29.66 0.51 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.866 179.174 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.5 t -115.98 141.99 31.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.359 -179.402 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.5 p-10 -113.47 97.18 6.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.492 179.338 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 65' ' ' VAL . 31.4 m -69.62 64.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.898 0.38 . . . . 0.0 111.191 -179.781 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -91.31 101.02 13.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.547 179.881 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 67.41 51.01 0.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.019 -179.902 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.762 ' C ' HG23 ' A' ' 23' ' ' THR . 19.1 m -116.41 142.3 30.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.966 179.639 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.481 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.54 153.29 23.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.106 0.479 . . . . 0.0 111.025 -179.129 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.881 ' O ' HG23 ' A' ' 74' ' ' VAL . 6.1 p-80 -47.95 -33.82 8.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.963 -179.671 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.99 -33.96 70.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.468 -179.947 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.631 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -66.35 -44.56 82.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.138 0.494 . . . . 0.0 109.724 179.321 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.867 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.01 -46.88 87.24 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.773 0.797 . . . . 0.0 109.161 178.095 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.911 HG22 HD11 ' A' ' 19' ' ' ILE . 90.0 t -56.22 -50.45 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.299 178.601 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.631 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -56.11 -29.84 61.22 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.379 179.071 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -61.94 -50.3 72.68 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.404 0.621 . . . . 0.0 109.986 179.57 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 74' ' ' VAL . 0.6 OUTLIER -59.05 -36.13 74.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.771 179.271 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.638 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.4 OUTLIER -77.45 -24.03 50.35 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.889 178.788 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -101.78 16.27 26.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.792 -179.018 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.901 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -87.28 16.21 5.5 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 179.979 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 73.75 -93.97 0.75 Allowed Glycine 0 C--N 1.334 0.421 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.316 -179.999 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 36.7 m -141.42 -89.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.376 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.76 HG13 HG22 ' A' ' 7' ' ' THR . 6.8 tp -84.07 89.02 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.646 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.901 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 11.6 p -105.38 136.29 39.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 -177.182 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -88.01 102.94 15.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.664 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.914 ' CD2' HG13 ' A' ' 60' ' ' VAL . 38.0 mt -89.12 137.34 32.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.389 -178.836 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.559 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -102.1 122.84 44.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.529 179.679 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 57' ' ' ILE . 17.0 m -128.89 151.49 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.565 -179.938 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.484 ' HE2' ' HE1' ' A' ' 3' ' ' TYR . 2.0 mtp -96.71 149.57 21.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.722 0.296 . . . . 0.0 110.874 -179.989 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.18 136.06 36.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.939 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.608 ' HG2' ' HE3' ' A' ' 1' ' ' MET . 2.6 ppt_? . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.781 0.324 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -134.16 124.37 25.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.68 179.919 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CD1' HD11 ' A' ' 58' ' ' LEU . 6.4 m-85 -89.22 144.35 26.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.038 -179.775 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.403 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 11.2 pt-20 -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.944 179.937 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -118.73 144.71 46.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 -179.978 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.013 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.7 109.44 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 111.863 179.857 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.719 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -79.91 116.37 20.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.525 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.047 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.9 tp -126.06 127.36 45.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.249 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 5.8 pm0 -86.84 100.46 12.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.713 179.596 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.587 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 1.3 mtm180 -44.32 91.82 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.682 179.109 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.34 70.54 0.02 OUTLIER Glycine 0 C--N 1.32 -0.342 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.256 -179.19 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 10' ' ' ARG . 4.4 t30 63.31 -72.18 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.815 0.34 . . . . 0.0 111.496 179.575 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 11' ' ' GLY . 74.7 m -69.98 -24.76 63.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.293 -179.692 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.413 ' HA2' ' CD ' ' A' ' 10' ' ' ARG . . . 153.11 -172.71 32.06 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.038 -179.776 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.047 ' HB3' HD23 ' A' ' 8' ' ' LEU . 16.4 mt -63.5 -63.59 1.14 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.493 179.9 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 137.0 34.62 0.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.71 179.318 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.748 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.7 p90 -159.64 138.08 10.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.137 0.469 . . . . 0.0 110.938 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.535 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.99 132.19 43.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.039 -179.811 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.052 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -108.2 165.74 4.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.718 0.77 . . . . 0.0 111.803 -179.905 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -164.27 131.3 3.19 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.474 -1.239 . . . . 0.0 111.356 179.845 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 144.66 0.2 0.97 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.316 -0.945 . . . . 0.0 113.632 179.614 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.535 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -55.52 -170.96 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.977 -179.871 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.798 HG22 ' CB ' ' A' ' 32' ' ' PRO . 13.2 p -75.34 -20.79 58.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.187 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -96.85 -24.96 15.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.692 0.282 . . . . 0.0 111.623 -179.347 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -124.39 87.66 53.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.208 179.93 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.62 63.12 0.55 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.418 2.079 . . . . 0.0 112.686 -179.484 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.69 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.0 t60 -47.96 -27.9 2.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.282 178.887 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.874 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -86.59 -155.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.357 179.301 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.678 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.8 -46.78 59.16 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.562 -179.893 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.2 m-20 176.71 73.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -165.67 165.69 10.85 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.798 ' CB ' HG22 ' A' ' 23' ' ' THR . 82.9 Cg_endo -81.21 5.7 6.07 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.674 2.249 . . . . 0.0 112.923 -179.947 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.405 ' O ' ' HA3' ' A' ' 21' ' ' GLY . 0.9 OUTLIER -56.0 112.87 1.31 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.948 179.953 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.846 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -83.51 119.16 32.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.81 -179.911 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.874 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.26 145.9 34.54 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.505 0.669 . . . . 0.0 110.847 178.653 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.05 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.73 155.97 7.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 114.833 -1.076 . . . . 0.0 113.008 -176.897 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.469 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.88 -27.47 5.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.738 -1.119 . . . . 0.0 112.622 -178.411 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.64 128.67 0.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.211 -179.444 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.031 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.98 130.51 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.662 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 114.74 56.63 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.569 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 33.5 Cg_exo -57.94 135.58 69.73 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.781 2.32 . . . . 0.0 112.217 179.918 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.12 15.27 39.3 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.537 179.986 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.97 179.58 16.09 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.037 179.773 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.33 -38.55 63.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.734 0.302 . . . . 0.0 111.343 -179.982 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.817 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.98 -57.65 7.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.012 -179.538 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.2 -28.76 64.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.471 -179.4 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -32.87 67.88 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.916 0.389 . . . . 0.0 110.264 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -79.63 -58.1 3.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.582 179.967 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.5 9.92 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.645 179.433 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.512 ' CB ' HG12 ' A' ' 6' ' ' ILE . 25.9 mtt180 -119.36 7.23 11.19 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.868 0.334 . . . . 0.0 110.941 179.68 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.05 HD21 HD12 ' A' ' 36' ' ' ILE . 5.5 tp -134.3 154.8 51.1 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 110.917 179.555 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.82 135.1 43.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.863 179.995 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.645 HG21 ' HA ' ' A' ' 38' ' ' LYS . 59.9 t -49.14 158.15 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.278 0.561 . . . . 0.0 111.55 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.3 t-20 73.69 4.19 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.992 -179.807 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.4 m-20 -73.27 124.23 25.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.86 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -86.46 101.77 13.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.693 0.759 . . . . 0.0 111.63 -178.395 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.052 HD11 HG21 ' A' ' 19' ' ' ILE . 57.8 mt -49.46 137.3 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.402 -1.272 . . . . 0.0 112.023 179.979 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.8 HD21 ' CG ' ' A' ' 89' ' ' MET . 3.9 mt -117.1 -34.03 4.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.43 179.246 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -149.55 169.24 21.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.566 -179.815 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.734 HG13 ' CD2' ' A' ' 86' ' ' LEU . 21.8 t -146.56 97.86 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.917 179.278 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.903 ' OD1' HG23 ' A' ' 84' ' ' VAL . 4.3 t30 67.26 -68.1 0.16 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.256 0.55 . . . . 0.0 109.82 -178.655 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.3 OUTLIER -155.68 32.87 0.36 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.527 179.106 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 57.3 t -119.38 142.27 35.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.523 -179.12 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.1 p-10 -110.0 107.83 17.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.294 179.052 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.467 HG12 HG21 ' A' ' 68' ' ' VAL . 30.6 m -92.48 40.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.36 . . . . 0.0 111.414 -179.66 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.96 179.831 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -151.59 66.33 0.88 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 23' ' ' THR . 35.6 m -133.08 145.42 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.154 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.75 151.89 24.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.738 -179.808 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.851 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.2 t-160 -49.49 -33.61 14.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.448 179.699 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 33.4 t -67.12 -33.99 76.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.994 179.583 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.626 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.52 -40.07 80.95 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.772 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.846 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -65.68 -46.88 77.41 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.014 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 70' ' ' HIS . 85.8 t -57.32 -49.99 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.251 178.533 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.15 -34.33 66.04 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.669 178.633 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.699 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -56.66 -51.07 70.15 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.182 0.515 . . . . 0.0 109.988 179.466 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.034 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.7 -36.35 69.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.476 178.955 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.4 mmmt -77.26 -22.48 52.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.209 179.053 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -97.39 -11.99 23.3 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.38 -178.879 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.957 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -57.33 -18.99 19.64 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.37 179.944 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.07 -101.19 2.56 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.994 -179.825 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.587 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 9.9 p -127.67 -90.4 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.871 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.719 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.6 tp -87.19 91.3 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.589 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.957 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.3 p -107.16 137.09 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.296 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 22.2 ttt85 -86.71 103.1 14.84 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.131 177.762 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.734 ' CD2' HG13 ' A' ' 60' ' ' VAL . 11.4 mt -91.67 142.98 27.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.451 -178.801 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.409 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 134.23 45.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.476 179.789 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.544 HG11 HD11 ' A' ' 51' ' ' LEU . 29.0 m -138.94 167.88 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 111.211 -179.724 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.8 ' CG ' HD21 ' A' ' 58' ' ' LEU . 9.3 mtt -100.8 151.64 21.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.012 -179.991 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.6 106.35 5.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.148 179.946 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.944 179.774 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG3' ' HA ' ' A' ' 91' ' ' ARG . 3.9 mtm . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.848 0.356 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.67 177.95 7.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.995 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.448 ' HB3' ' CE1' ' A' ' 87' ' ' TYR . 53.0 m-85 -145.01 144.46 31.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.002 179.998 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -142.7 148.23 36.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.48 144.88 31.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.694 179.78 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.953 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -139.51 109.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.034 0.445 . . . . 0.0 111.933 -179.779 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.899 HG23 ' HG2' ' A' ' 85' ' ' ARG . 0.2 OUTLIER -77.42 123.41 26.5 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.774 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.953 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -133.69 126.78 31.51 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.089 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.564 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -85.19 99.83 11.35 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.926 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 10' ' ' ARG . 0.0 OUTLIER -55.91 86.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.362 179.188 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -55.52 177.32 0.55 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.56 -179.509 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -52.36 -26.61 12.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.813 0.34 . . . . 0.0 110.89 179.934 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.0 p -88.06 -24.96 23.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.956 179.868 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 130.28 -170.05 21.0 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.357 179.915 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.922 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.8 tp -65.57 -15.8 63.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.828 0.346 . . . . 0.0 110.985 179.906 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 74.14 31.08 60.0 Favored Glycine 0 CA--C 1.519 0.281 0 N-CA-C 115.205 0.842 . . . . 0.0 115.205 177.829 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.806 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 6.5 p90 -164.52 131.38 3.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.282 1.041 . . . . 0.0 111.628 178.559 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.459 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -97.33 138.96 34.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.866 -179.083 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.027 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.7 148.93 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.0 112.01 179.864 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.676 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -142.62 133.19 25.15 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.937 179.415 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.14 -3.32 0.9 Allowed Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.586 179.783 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.534 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -53.49 179.97 0.12 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.843 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.751 HG23 ' C ' ' A' ' 68' ' ' VAL . 26.5 p -65.24 -35.11 80.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.419 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -89.03 -17.14 29.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.628 0.251 . . . . 0.0 111.519 -179.486 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.56 82.05 59.45 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.043 0.449 . . . . 0.0 110.089 179.781 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.14 62.87 0.66 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.853 2.368 . . . . 0.0 112.541 -179.291 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.713 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 34.5 t60 -52.28 -22.71 4.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.236 178.78 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.853 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.5 OUTLIER -92.71 -154.85 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.29 179.645 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.662 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.03 -49.8 74.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.551 -179.798 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.51 39.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.909 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.56 167.44 17.3 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.833 179.992 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.717 ' CB ' HG22 ' A' ' 23' ' ' THR . 98.6 Cg_endo -79.11 1.93 8.74 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.668 2.245 . . . . 0.0 112.755 179.995 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -52.78 115.27 1.73 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.832 0.349 . . . . 0.0 111.016 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.821 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -86.5 121.0 37.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.566 -179.831 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.853 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.08 146.88 35.94 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-O 121.315 0.579 . . . . 0.0 110.59 178.824 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.017 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.98 155.74 7.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.69 -176.897 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.459 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.52 -30.72 4.17 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.9 -1.045 . . . . 0.0 112.174 -178.971 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.635 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.75 128.32 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.212 -0.595 . . . . 0.0 112.33 -179.362 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.98 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.47 127.03 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.69 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.24 119.39 73.14 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -177.814 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 51.5 Cg_exo -54.36 140.32 73.3 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.718 2.279 . . . . 0.0 112.297 179.907 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.75 12.98 70.77 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.537 -179.923 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' HA3' ' HA3' ' A' ' 16' ' ' GLY . . . -106.61 -158.68 21.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.978 179.779 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 15' ' ' LEU . . . -75.96 -38.85 57.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.869 0.334 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.88 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -74.13 -54.46 7.75 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.586 -179.63 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -60.59 -32.48 71.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.717 -179.294 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -72.36 -37.31 68.82 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.03 0.443 . . . . 0.0 110.308 179.514 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.62 -57.85 3.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.933 -179.772 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.28 35.6 14.38 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.529 179.646 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 3.9 mmm180 -110.7 -12.56 14.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.749 0.309 . . . . 0.0 110.701 179.584 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.017 HD21 HD12 ' A' ' 36' ' ' ILE . 6.2 tp -113.66 155.84 24.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.084 179.991 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.579 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.0 tpt180 -134.87 135.11 41.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.737 -179.994 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.635 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.0 t -49.47 157.16 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.279 0.561 . . . . 0.0 111.638 179.935 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' HG12 ' A' ' 53' ' ' VAL . 4.9 t-20 75.7 -1.65 2.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.277 179.957 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.5 m-20 -68.48 126.6 30.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.936 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 5.4 p -86.57 100.14 12.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.44 0.638 . . . . 0.0 111.471 -178.616 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.027 HD11 HG21 ' A' ' 19' ' ' ILE . 11.6 mt -45.47 153.46 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.813 179.999 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.433 ' HG ' ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -136.79 -46.23 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.64 -179.669 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 64' ' ' ASP . 2.0 m-85 -142.21 167.11 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.748 -179.668 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.928 HG13 ' CD2' ' A' ' 86' ' ' LEU . 24.5 t -142.36 100.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.897 179.34 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.639 ' HB2' HG23 ' A' ' 84' ' ' VAL . 3.1 t-20 66.36 -68.04 0.14 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.199 0.523 . . . . 0.0 109.667 -178.517 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 60' ' ' VAL . 2.2 mt-10 -156.65 31.28 0.32 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.38 178.974 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -116.36 142.52 29.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.452 -179.006 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 3.7 p-10 -108.29 120.18 41.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.505 179.176 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' CG2' ' A' ' 68' ' ' VAL . 19.1 m -93.79 37.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.15 -179.983 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -71.06 100.89 2.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.92 -179.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 66.06 50.02 1.49 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.293 179.786 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.751 ' C ' HG23 ' A' ' 23' ' ' THR . 14.0 m -114.92 142.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.732 179.464 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.462 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.7 OUTLIER -60.96 153.0 26.2 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.105 -179.069 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.939 ' O ' HG23 ' A' ' 74' ' ' VAL . 11.0 t-160 -48.79 -33.98 11.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.516 -179.964 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -34.12 76.42 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.301 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.96 -42.69 80.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.478 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.821 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.81 -46.66 84.12 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.003 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.939 HG23 ' O ' ' A' ' 70' ' ' HIS . 58.0 t -57.17 -50.35 76.83 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.1 178.639 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.655 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.34 -32.55 38.65 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.772 179.222 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.85 ' HB1' HG21 ' A' ' 60' ' ' VAL . . . -68.38 -57.11 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.845 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.95 HD12 HD12 ' A' ' 19' ' ' ILE . 4.2 mt -64.1 -39.79 94.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.009 -179.436 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.596 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -77.1 -20.06 56.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.334 -179.73 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.655 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 4.4 mm-40 -104.1 -10.78 17.74 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.02 0.438 . . . . 0.0 110.873 178.894 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.87 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.17 -20.98 0.41 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.566 179.944 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.62 -104.33 2.99 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -117.8 -92.89 0.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.764 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.889 HG13 HG22 ' A' ' 7' ' ' THR . 7.3 tp -87.58 102.7 12.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.146 0.498 . . . . 0.0 111.058 179.63 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.87 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.4 p -118.04 138.75 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.6 -178.6 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.899 ' HG2' HG23 ' A' ' 7' ' ' THR . 5.6 mtm180 -87.05 103.56 15.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.638 178.817 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.928 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.4 mt -93.58 139.17 31.08 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.594 -179.018 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.481 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -102.04 137.99 39.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.763 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 3' ' ' TYR . 29.0 m -125.9 168.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.422 179.837 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 56' ' ' SER . 3.0 ttt -129.31 144.35 51.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 111.027 -179.931 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.1 mtp85 -121.55 129.77 53.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.887 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.446 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 3.1 ppt_? . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.078 179.876 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 ttm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.861 0.362 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -120.07 123.35 43.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.821 179.959 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.781 ' CD1' HD22 ' A' ' 58' ' ' LEU . 4.0 m-30 -101.38 110.68 22.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.924 179.999 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.477 ' O ' HG22 ' A' ' 88' ' ' VAL . 2.7 mt-10 -109.55 125.43 52.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.922 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 12.2 pt-20 -94.7 144.62 25.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.942 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.984 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -142.26 109.51 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.865 0.364 . . . . 0.0 111.715 179.935 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.792 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.45 122.01 24.6 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.031 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.043 HD23 ' HB3' ' A' ' 15' ' ' LEU . 4.3 tp -132.02 128.03 37.45 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.556 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 3.4 pt-20 -86.43 100.5 12.39 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.32 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.577 ' CG ' HD23 ' A' ' 15' ' ' LEU . 6.1 mtp-105 -42.74 91.56 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.105 179.592 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -62.09 75.75 0.02 OUTLIER Glycine 0 C--N 1.317 -0.521 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.878 -179.545 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 10' ' ' ARG . 2.8 m120 62.97 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.801 0.334 . . . . 0.0 111.358 179.688 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 11' ' ' GLY . 1.1 m -70.08 -22.15 63.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.581 -179.641 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 150.33 -172.16 30.16 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.937 -179.709 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.043 ' HB3' HD23 ' A' ' 8' ' ' LEU . 11.5 mt -57.08 -63.64 1.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.945 0.403 . . . . 0.0 110.776 -179.907 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 134.21 38.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.397 179.505 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.779 ' HB3' HG23 ' A' ' 39' ' ' ILE . 11.8 p90 -164.12 134.06 4.07 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.195 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -92.54 136.93 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.638 -179.34 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.031 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.31 148.88 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 CA-C-O 121.643 0.735 . . . . 0.0 112.032 179.934 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.625 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -141.98 131.83 24.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.688 179.264 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 27' ' ' HIS . . . 147.82 -3.72 0.84 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.787 179.644 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -52.04 179.09 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.675 179.91 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.851 HG22 ' CB ' ' A' ' 32' ' ' PRO . 17.5 p -70.34 -21.55 62.89 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.43 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -92.02 -26.58 18.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.792 0.33 . . . . 0.0 111.271 -179.679 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -124.48 87.52 54.18 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.296 179.955 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.33 64.94 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.362 2.042 . . . . 0.0 112.653 -179.432 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.716 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 33.0 t60 -48.96 -27.43 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.404 178.998 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.848 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -87.54 -154.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.428 179.439 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -60.03 -49.45 78.4 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.691 -179.709 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 175.44 39.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.016 0.436 . . . . 0.0 110.895 -179.876 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -125.65 165.59 25.92 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.754 -179.929 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.851 ' CB ' HG22 ' A' ' 23' ' ' THR . 97.4 Cg_endo -79.03 1.98 8.69 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.656 2.237 . . . . 0.0 112.747 -179.822 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.57 116.66 2.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.829 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -86.32 120.05 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.592 -179.966 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.848 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.14 147.81 37.27 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.327 0.584 . . . . 0.0 110.726 178.762 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.994 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.12 155.66 7.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.828 -177.008 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.467 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -119.6 -33.38 4.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.662 -179.173 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.619 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -169.26 142.84 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.923 0.392 . . . . 0.0 111.41 -179.881 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.951 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -106.5 131.95 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.39 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -83.98 121.26 75.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -177.976 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 32.4 Cg_endo -63.89 136.95 55.5 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.836 2.358 . . . . 0.0 112.418 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 18.29 37.2 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.303 -179.894 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.63 179.42 16.15 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.233 179.886 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -56.09 -31.4 63.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.684 0.278 . . . . 0.0 111.384 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.792 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -74.18 -56.57 4.74 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.511 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.71 -30.31 65.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.167 -0.469 . . . . 0.0 112.066 -178.992 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 15.6 pt20 -71.96 -31.61 66.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.999 0.428 . . . . 0.0 110.331 179.534 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -80.38 -57.99 3.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.682 -179.931 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.4 9.22 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.62 179.521 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' CB ' HG12 ' A' ' 6' ' ' ILE . 1.3 mtt-85 -114.87 -7.59 12.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.717 0.294 . . . . 0.0 110.925 179.697 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.994 HD21 HD12 ' A' ' 36' ' ' ILE . 6.1 tp -119.93 155.73 32.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.085 0.469 . . . . 0.0 111.191 -179.946 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.594 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 3.6 tpt180 -134.05 135.08 43.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.67 179.88 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 38' ' ' LYS . 55.6 t -49.91 157.43 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.368 0.604 . . . . 0.0 111.56 -179.95 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.476 ' N ' ' CG1' ' A' ' 53' ' ' VAL . 7.5 t-20 75.0 -0.89 3.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.118 -179.98 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.78 ' OD2' HG21 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -68.15 124.95 24.85 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 178.851 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.55 100.32 12.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.462 0.649 . . . . 0.0 111.573 -178.386 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.031 HD11 HG21 ' A' ' 19' ' ' ILE . 10.4 mt -47.86 131.28 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.875 179.865 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.781 HD22 ' CD1' ' A' ' 3' ' ' TYR . 57.0 tp -114.3 -35.08 5.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.499 179.809 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.5 m-85 -150.51 155.36 39.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.736 -179.817 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.946 HG11 ' HB1' ' A' ' 76' ' ' ALA . 27.8 t -130.82 96.51 2.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.974 179.288 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.777 ' CG ' HG23 ' A' ' 84' ' ' VAL . 4.9 t30 67.59 -67.9 0.17 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.173 0.511 . . . . 0.0 109.797 -178.777 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 60' ' ' VAL . 15.7 mt-10 -153.6 31.92 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.752 179.122 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.8 t -119.8 142.19 36.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.39 -179.277 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 27.8 t0 -107.96 107.33 17.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.538 179.211 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.5 m -94.24 42.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.22 -179.783 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -65.61 -30.76 71.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.799 179.907 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -154.68 69.03 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.721 ' C ' HG23 ' A' ' 23' ' ' THR . 10.1 m -133.14 144.75 35.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.075 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.02 152.59 19.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.842 -179.726 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.93 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.2 t-160 -48.17 -33.92 9.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.903 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m -65.9 -33.94 76.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.794 179.335 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.83 -43.45 79.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.606 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.829 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -62.85 -45.67 91.5 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.996 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.93 HG23 ' O ' ' A' ' 70' ' ' HIS . 56.8 t -57.89 -50.31 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.191 178.635 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.691 ' O ' ' CG ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -52.95 -30.36 34.2 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.353 178.882 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.946 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.59 -56.98 6.45 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.596 -179.587 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.793 HD12 HD12 ' A' ' 19' ' ' ILE . 1.6 mt -65.19 -40.44 94.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.16 -179.437 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.659 ' CD ' ' HG2' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -76.82 -20.23 56.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.701 -179.398 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.691 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 2.8 mm-40 -109.11 -5.49 15.97 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 179.179 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.849 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -48.21 -22.07 0.6 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.594 179.957 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.61 -101.62 1.97 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.599 -179.77 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -122.84 -91.45 0.55 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.626 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.792 ' CD1' HG22 ' A' ' 7' ' ' THR . 2.3 tp -90.99 98.98 9.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.089 0.471 . . . . 0.0 110.265 179.108 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.849 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.3 p -113.07 138.18 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -177.792 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.0 ttt180 -86.93 103.86 15.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.143 178.933 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.78 HD13 HD22 ' A' ' 77' ' ' LEU . 16.7 mt -93.59 132.91 37.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.563 -179.253 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -101.99 151.5 22.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.539 179.691 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.78 HG21 ' OD2' ' A' ' 55' ' ' ASP . 18.5 m -139.68 119.61 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.343 -179.895 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.719 ' CG ' HD13 ' A' ' 58' ' ' LEU . 1.4 ptt? -96.76 111.85 23.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.928 0.394 . . . . 0.0 111.371 179.875 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -117.05 146.68 42.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.066 179.965 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.83 179.859 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 1.7 mtm . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.735 0.302 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -132.29 144.88 50.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 -179.912 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.461 ' CD1' HD11 ' A' ' 58' ' ' LEU . 8.4 m-30 -111.4 135.7 51.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.898 179.8 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -133.53 143.55 48.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.973 -179.888 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.41 144.87 29.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.053 179.957 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.979 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.16 109.36 8.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.078 0.466 . . . . 0.0 111.411 179.784 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.925 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.26 120.98 23.06 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.319 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.979 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -129.71 126.69 38.86 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.634 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.567 ' N ' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -86.66 100.88 12.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.185 179.178 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -49.65 88.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.211 179.599 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -51.5 178.02 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.608 -179.949 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -54.92 -25.32 28.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 111.125 -179.918 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -96.03 -24.62 16.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.207 -179.932 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 144.15 -162.3 27.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.059 -179.779 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.974 ' HG ' HD23 ' A' ' 8' ' ' LEU . 3.7 tp -66.16 -60.42 2.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.75 0.275 . . . . 0.0 110.441 179.94 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 129.22 19.4 1.55 Allowed Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.021 -1.085 . . . . 0.0 114.513 178.404 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.858 ' CE2' HD23 ' A' ' 15' ' ' LEU . 6.6 p90 -162.09 137.33 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.844 0.822 . . . . 0.0 111.245 179.223 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.496 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -97.47 136.2 38.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.615 -179.426 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.033 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -114.54 156.62 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-O 121.736 0.779 . . . . 0.0 112.073 179.907 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -152.22 132.38 13.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.989 179.624 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 145.75 -3.18 1.11 Allowed Glycine 0 CA--C 1.517 0.207 0 C-N-CA 120.276 -0.964 . . . . 0.0 113.669 179.639 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.546 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -51.36 178.08 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.918 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.747 HG23 ' O ' ' A' ' 68' ' ' VAL . 29.1 p -65.98 -27.38 68.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.246 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -93.43 -19.95 20.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.672 0.273 . . . . 0.0 111.63 -179.647 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 70' ' ' HIS . 0.5 OUTLIER -124.24 86.86 54.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.392 179.897 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.64 62.4 0.84 Allowed 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.396 2.064 . . . . 0.0 112.705 -179.409 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.701 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 26.4 t60 -48.1 -28.87 3.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.019 178.977 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.863 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -84.12 -155.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.121 179.277 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.687 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -68.2 -49.44 46.31 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.276 -179.947 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -177.46 51.29 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.911 0.386 . . . . 0.0 111.153 -179.585 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.54 158.27 70.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.054 -179.92 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.736 ' HB2' HG22 ' A' ' 23' ' ' THR . 92.7 Cg_endo -78.53 0.86 9.57 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.677 2.251 . . . . 0.0 112.661 179.978 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.9 m -54.31 119.85 5.73 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.958 0.408 . . . . 0.0 111.291 -179.912 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.818 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -85.43 119.93 34.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.46 179.824 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.863 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -141.82 146.67 36.14 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.399 0.618 . . . . 0.0 110.762 178.749 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.054 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -68.76 155.84 7.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.041 -0.982 . . . . 0.0 113.055 -176.636 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.464 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -120.81 -30.38 4.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.307 -178.624 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.81 129.05 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.174 -179.321 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.998 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -94.91 131.68 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.569 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.23 113.88 51.11 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -177.825 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 49.7 Cg_exo -56.21 140.15 87.09 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.739 2.292 . . . . 0.0 112.392 -179.938 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.82 10.37 64.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.483 -179.898 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.87 178.34 18.3 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.874 179.808 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.815 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -55.85 -35.38 66.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.796 0.331 . . . . 0.0 111.067 -179.995 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.756 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -68.87 -57.56 5.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.563 -179.932 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -68.55 -28.73 67.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.345 -179.644 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.3 mm100 -71.88 -31.68 66.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.239 179.521 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.45 -57.78 3.59 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.96 35.77 14.87 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.439 179.751 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' CB ' HG12 ' A' ' 6' ' ' ILE . 4.3 mtt-85 -115.32 -2.06 12.74 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.7 0.286 . . . . 0.0 111.227 179.874 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.054 HD21 HD12 ' A' ' 36' ' ' ILE . 5.9 tp -127.2 154.61 44.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.158 0.504 . . . . 0.0 111.34 179.98 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.558 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.71 135.29 43.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.543 179.93 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.47 157.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.496 179.934 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER 74.8 0.43 3.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 -179.865 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.529 ' HB3' HG11 ' A' ' 88' ' ' VAL . 4.8 m-20 -69.67 126.08 28.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.931 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 2.2 p -86.49 100.39 12.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.467 0.651 . . . . 0.0 111.673 -178.322 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.033 HD11 HG21 ' A' ' 19' ' ' ILE . 61.7 mt -48.72 146.05 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.077 -179.961 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 89' ' ' MET . 12.4 mt -128.25 -38.96 1.74 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.424 179.615 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.551 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -145.72 155.31 42.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.899 -179.758 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.921 HG11 ' HB1' ' A' ' 76' ' ' ALA . 42.1 t -136.42 100.55 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.247 179.533 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.409 ' HB2' HG23 ' A' ' 84' ' ' VAL . 6.2 t-20 67.53 -67.04 0.19 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.958 0.408 . . . . 0.0 110.046 -179.14 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 5.3 mt-10 -157.29 32.3 0.28 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.751 179.289 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.4 t -120.72 142.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.539 -179.23 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 39.3 t0 -106.04 107.93 19.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.293 179.208 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.521 HG12 HG21 ' A' ' 68' ' ' VAL . 21.8 m -93.81 35.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.522 -179.623 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.48 -37.25 80.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.379 . . . . 0.0 110.78 179.974 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -147.42 54.59 1.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.189 -179.897 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.747 ' O ' HG23 ' A' ' 23' ' ' THR . 32.9 m -116.12 148.95 18.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.034 179.896 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.439 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -64.8 154.69 36.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.033 -179.378 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.919 ' O ' HG23 ' A' ' 74' ' ' VAL . 19.1 t-160 -50.57 -33.94 23.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.71 -179.84 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -34.03 75.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.133 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -68.62 -41.76 79.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.464 0.649 . . . . 0.0 109.266 178.522 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.818 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -64.8 -46.12 83.37 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.919 HG23 ' O ' ' A' ' 70' ' ' HIS . 73.1 t -57.4 -50.51 76.72 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.029 178.564 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.607 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -51.58 -34.16 35.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.694 179.417 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.921 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -68.81 -57.59 5.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.173 -0.611 . . . . 0.0 112.248 -179.508 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.929 HD12 HD12 ' A' ' 19' ' ' ILE . 2.1 mt -60.53 -40.85 93.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.244 -179.772 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.597 ' CG ' ' HA ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -76.78 -20.06 56.88 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.768 179.669 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 75' ' ' GLU . 4.1 pt-20 -112.24 22.3 14.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.851 0.358 . . . . 0.0 111.24 179.579 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.926 ' HB1' ' HB ' ' A' ' 84' ' ' VAL . . . -83.19 16.64 2.33 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.829 -179.729 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.91 -85.59 0.21 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.83 -179.783 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 40.3 m -142.3 -89.85 0.14 Allowed 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.172 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.925 HG13 HG22 ' A' ' 7' ' ' THR . 7.7 tp -86.37 105.64 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.869 0.366 . . . . 0.0 110.662 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.926 ' HB ' ' HB1' ' A' ' 80' ' ' ALA . 5.0 p -120.89 136.83 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -178.392 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 1.7 mtm105 -85.79 103.39 14.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.373 178.17 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.783 ' CD2' HG13 ' A' ' 60' ' ' VAL . 18.1 mt -93.98 134.8 35.99 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.394 -178.822 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.417 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.84 142.58 32.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.668 179.89 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.529 HG11 ' HB3' ' A' ' 55' ' ' ASP . 24.9 m -138.53 167.6 21.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.689 179.951 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.819 ' HB2' HD21 ' A' ' 58' ' ' LEU . 35.4 ttm -117.16 142.16 47.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 -179.914 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -129.13 133.56 47.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.668 179.9 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.459 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.005 -179.809 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' CG ' ' HB3' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.809 0.338 . . . . 0.0 111.215 . . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -127.88 124.06 36.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.463 ' CD1' HD11 ' A' ' 58' ' ' LEU . 15.9 m-30 -94.07 127.78 40.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.935 179.907 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -134.77 165.87 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 179.906 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -115.98 144.78 43.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.944 -179.837 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.089 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -133.83 109.51 13.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.402 179.876 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.838 HG22 ' CD1' ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.41 119.68 21.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.65 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.089 HD13 HD11 ' A' ' 6' ' ' ILE . 4.9 tp -130.75 128.08 40.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -178.403 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 4.6 pt-20 -86.71 100.21 12.31 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.354 179.685 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' CG ' HD23 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -42.87 90.39 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.364 179.496 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -52.9 -171.66 0.03 OUTLIER Glycine 0 C--N 1.318 -0.419 0 CA-C-N 115.505 -0.771 . . . . 0.0 112.638 179.77 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.98 -35.76 35.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.593 0.235 . . . . 0.0 111.552 -179.839 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 t -108.24 4.86 25.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.574 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 120.99 -168.45 14.11 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.843 -179.752 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 1.008 ' HB3' HD23 ' A' ' 8' ' ' LEU . 18.4 mt -51.87 -63.54 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.967 0.413 . . . . 0.0 110.901 -179.881 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 129.42 33.02 0.54 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.515 179.458 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.815 ' HB3' HG23 ' A' ' 39' ' ' ILE . 7.0 p90 -157.86 137.41 12.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.977 0.389 . . . . 0.0 110.613 179.114 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.88 136.71 37.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.302 -179.499 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.081 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -117.56 146.6 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.703 0.763 . . . . 0.0 112.264 -179.935 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -139.18 133.61 31.63 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.241 179.338 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.7 3.84 0.79 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.696 179.577 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.69 -169.26 0.5 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.47 -0.872 . . . . 0.0 112.902 -179.917 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.831 HG22 ' HB3' ' A' ' 32' ' ' PRO . 43.0 p -72.39 -27.86 62.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.104 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -93.75 -22.0 18.97 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.047 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 11.5 t-20 -124.39 87.52 53.99 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.579 0.228 . . . . 0.0 110.485 -179.991 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.36 62.51 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.271 1.981 . . . . 0.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.711 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 44.8 t60 -47.16 -28.24 1.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.396 179.049 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.822 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -89.54 -154.68 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.311 179.362 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.665 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -59.5 -49.96 72.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.53 -179.697 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.03 40.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 110.87 -179.909 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.6 164.06 36.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.831 ' HB3' HG22 ' A' ' 23' ' ' THR . 3.9 Cg_exo -74.81 1.77 7.26 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.013 2.475 . . . . 0.0 112.776 -179.88 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 m -52.75 113.43 1.08 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.978 0.418 . . . . 0.0 111.07 -179.814 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.841 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.43 117.85 30.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.999 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.822 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.13 147.46 40.23 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 121.276 0.56 . . . . 0.0 110.644 178.673 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.079 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.06 155.63 7.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.042 -176.771 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.45 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.43 -30.1 4.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.321 -178.846 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.648 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.09 130.26 0.48 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.065 -179.447 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.028 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -95.96 130.53 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.636 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.493 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.28 123.84 74.61 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -177.752 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 38.1 Cg_endo -66.14 132.0 28.53 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.798 2.332 . . . . 0.0 112.256 -179.879 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.66 16.74 23.44 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.331 -179.916 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -127.46 178.69 16.82 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.985 179.862 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -53.15 -38.78 63.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.797 0.332 . . . . 0.0 111.44 179.979 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.803 ' HA ' HD21 ' A' ' 8' ' ' LEU . . . -65.44 -57.49 8.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.892 -179.502 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -71.83 -28.85 63.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.48 -179.434 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -72.12 -34.15 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.957 0.408 . . . . 0.0 110.227 179.543 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -78.12 -58.04 3.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.687 -179.936 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.15 38.08 13.93 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.624 179.452 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.513 ' CB ' HG12 ' A' ' 6' ' ' ILE . 7.9 mmt180 -117.9 7.05 12.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.776 0.322 . . . . 0.0 110.842 179.686 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.079 HD21 HD12 ' A' ' 36' ' ' ILE . 5.2 tp -133.22 154.53 50.57 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.018 0.437 . . . . 0.0 110.835 179.585 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.19 135.47 45.09 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.957 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.648 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.3 t -49.61 157.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 111.751 179.965 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 76.45 -0.55 3.04 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.27 179.799 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -69.67 126.37 29.54 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.035 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.57 103.31 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.627 0.727 . . . . 0.0 111.316 -178.812 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.081 HD11 HG21 ' A' ' 19' ' ' ILE . 67.0 mt -51.21 134.21 12.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.723 -179.999 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 89' ' ' MET . 2.2 mt -116.19 -28.11 6.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.662 179.652 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 m-85 -153.77 165.99 34.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.637 -179.78 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.667 HG11 ' HB1' ' A' ' 76' ' ' ALA . 40.9 t -148.18 98.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.018 179.464 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.67 ' OD1' HG23 ' A' ' 84' ' ' VAL . 13.4 t30 67.79 -67.26 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.177 0.513 . . . . 0.0 109.993 -178.844 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.48 32.47 0.27 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.621 179.218 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 61.2 t -119.34 142.24 35.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.597 -179.293 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 11.7 p-10 -111.19 88.04 2.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.331 179.258 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 65' ' ' VAL . 29.5 m -69.99 63.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.991 0.424 . . . . 0.0 111.563 -179.522 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 66' ' ' ARG . 4.0 ptm85 -86.93 -32.77 19.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.688 179.643 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -145.47 59.02 1.27 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.857 179.8 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 23' ' ' THR . 35.9 m -124.55 147.72 29.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 -179.857 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.46 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -66.36 154.65 39.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.127 -179.464 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.857 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 p-80 -48.59 -34.32 11.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.137 -179.573 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.31 -33.69 67.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.126 179.63 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.67 -45.44 82.89 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.841 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -60.9 -46.77 89.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 178.069 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 70' ' ' HIS . 86.3 t -57.6 -48.22 83.65 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.403 178.659 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.664 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.94 -33.07 68.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.583 178.717 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.667 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -57.55 -50.12 74.14 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.286 0.565 . . . . 0.0 109.817 179.317 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.04 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -56.99 -36.61 70.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.449 178.868 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.8 mmmt -77.15 -24.72 51.52 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 179.171 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -93.97 -12.9 27.73 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.105 -179.067 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.914 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -56.74 -19.29 16.09 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.272 179.721 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.19 -108.18 3.39 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.034 -179.881 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER -119.88 -90.39 0.58 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.03 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.838 ' CD1' HG22 ' A' ' 7' ' ' THR . 1.2 tp -89.63 91.54 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 121.388 0.613 . . . . 0.0 109.674 178.719 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.914 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 12.0 p -105.81 139.88 25.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.357 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.64 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.4 OUTLIER -87.45 103.18 15.27 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.647 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.612 ' CD2' HG13 ' A' ' 60' ' ' VAL . 13.4 mt -91.36 139.82 30.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.17 -178.985 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -101.77 134.1 45.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.618 179.893 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.48 HG11 HD11 ' A' ' 51' ' ' LEU . 22.1 m -139.69 167.96 18.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.188 179.846 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.722 ' HB3' HD21 ' A' ' 58' ' ' LEU . 4.1 ptt? -129.35 138.03 51.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.004 0.43 . . . . 0.0 111.158 179.896 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -112.14 141.23 46.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.814 179.911 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.435 ' HB3' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.052 -179.965 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.704 0.287 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -87.62 179.56 6.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 179.922 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.839 ' CD1' HD22 ' A' ' 58' ' ' LEU . 21.1 m-85 -136.26 111.98 9.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.971 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 87' ' ' TYR . 0.3 OUTLIER -105.01 170.75 7.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.722 179.647 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -131.83 144.77 51.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.146 -179.894 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.042 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -138.91 111.07 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.909 0.385 . . . . 0.0 111.909 179.912 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -81.75 117.87 22.4 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.475 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.042 HD13 HD11 ' A' ' 6' ' ' ILE . 5.0 tp -127.26 127.22 44.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.255 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.34 100.08 11.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.522 179.432 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -47.37 87.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.181 179.258 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.57 175.15 0.06 OUTLIER Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.605 -179.825 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -54.13 -24.68 18.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.726 0.298 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.6 m -97.36 -23.69 15.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.982 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.82 -164.03 27.54 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.136 -179.889 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.951 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.7 tp -65.54 -63.59 1.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.549 179.934 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 128.76 25.21 1.03 Allowed Glycine 0 C--N 1.332 0.359 0 C-N-CA 119.789 -1.196 . . . . 0.0 114.801 178.409 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.788 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.7 p90 -162.97 135.19 5.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.873 0.836 . . . . 0.0 111.066 178.887 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -94.87 137.89 33.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.506 -179.242 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.1 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -118.8 146.24 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.611 0.72 . . . . 0.0 112.404 179.929 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.613 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -138.32 133.82 33.48 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.174 179.348 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' A' ' 27' ' ' HIS . . . 143.62 3.87 0.8 Allowed Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.643 179.585 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.516 ' HA3' ' N ' ' A' ' 70' ' ' HIS . . . -60.65 -168.85 0.46 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.893 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.834 HG22 ' HB3' ' A' ' 32' ' ' PRO . 41.5 p -72.14 -29.41 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.193 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -93.06 -20.76 20.22 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.162 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' HB2' ' ND1' ' A' ' 70' ' ' HIS . 35.7 t-20 -124.42 87.57 53.99 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.587 0.232 . . . . 0.0 110.496 179.979 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.81 61.91 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.283 1.989 . . . . 0.0 112.388 -179.768 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.707 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 47.5 t60 -47.16 -28.45 1.83 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.284 179.185 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.81 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.7 OUTLIER -90.0 -154.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.183 179.386 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.667 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -57.7 -50.01 69.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.57 -179.815 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 171.87 40.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.965 0.412 . . . . 0.0 110.722 -179.943 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.36 166.69 21.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.936 -179.947 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.834 ' HB3' HG22 ' A' ' 23' ' ' THR . 4.9 Cg_exo -75.04 2.33 6.77 Favored 'Trans proline' 0 CA--C 1.53 0.32 0 C-N-CA 123.037 2.491 . . . . 0.0 112.733 -179.734 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.24 111.67 0.73 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.842 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -84.16 118.27 31.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.675 179.987 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.81 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -140.77 147.91 39.84 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.303 0.573 . . . . 0.0 110.725 178.629 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.029 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.09 155.61 7.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.986 -176.829 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.446 ' C ' HG13 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -121.58 -30.78 4.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.039 -178.98 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.625 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -172.47 132.29 0.6 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.99 -179.53 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.995 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -96.56 132.26 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.739 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.452 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.25 130.12 55.48 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -177.486 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 50.9 Cg_endo -69.14 129.97 19.24 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.725 2.283 . . . . 0.0 112.126 -179.996 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.96 2.08 55.01 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.495 -179.718 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.65 174.37 21.75 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.751 179.676 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -52.7 -35.34 55.36 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.649 -0.324 . . . . 0.0 111.11 -179.835 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.795 ' CA ' HD21 ' A' ' 8' ' ' LEU . . . -70.85 -57.39 4.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.601 -179.799 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -67.47 -29.07 68.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -72.19 -35.38 68.94 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.048 0.451 . . . . 0.0 109.969 179.346 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -84.69 -57.94 2.92 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.614 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.22 41.38 9.37 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.556 179.625 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' CB ' HG12 ' A' ' 6' ' ' ILE . 11.7 mtp85 -112.05 8.88 20.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.652 179.655 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.029 HD21 HD12 ' A' ' 36' ' ' ILE . 4.9 tp -136.16 154.06 51.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.687 179.641 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.568 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -129.99 135.21 48.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.824 179.869 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 38' ' ' LYS . 53.7 t -49.47 157.82 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.31 0.576 . . . . 0.0 111.595 -180.0 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.6 t-20 77.33 -2.96 2.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.473 179.866 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -66.17 125.12 24.53 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.085 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -86.61 100.25 12.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.503 0.668 . . . . 0.0 111.504 -178.579 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.1 HD11 HG21 ' A' ' 19' ' ' ILE . 59.0 mt -49.97 134.92 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.433 179.507 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.839 HD22 ' CD1' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -133.69 12.08 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.614 179.367 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 170.83 141.04 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.962 -179.894 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.865 HG13 ' CD2' ' A' ' 86' ' ' LEU . 25.3 t -131.56 99.7 4.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.879 179.274 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.742 HD22 HG23 ' A' ' 84' ' ' VAL . 2.9 t-20 69.76 -65.0 0.33 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.027 0.441 . . . . 0.0 109.848 -178.741 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -161.57 31.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.927 179.407 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 63.6 t -120.82 124.86 73.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.55 -179.337 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 21.0 p-10 -93.04 100.07 12.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 0.0 110.577 179.113 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 65' ' ' VAL . 33.7 m -80.69 58.13 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.323 -179.755 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -29.25 37.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 179.954 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -148.88 60.69 1.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.753 ' O ' HG23 ' A' ' 23' ' ' THR . 32.8 m -126.5 146.43 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.991 179.833 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.481 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER -64.76 153.94 38.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.015 0.436 . . . . 0.0 111.076 -179.353 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.871 ' O ' HG23 ' A' ' 74' ' ' VAL . 5.4 p-80 -48.34 -34.08 10.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.983 -179.515 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -33.83 69.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.181 179.757 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -65.68 -45.22 83.7 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.276 0.56 . . . . 0.0 109.765 179.093 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.842 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -61.83 -46.69 88.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.536 0.684 . . . . 0.0 109.35 178.177 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 70' ' ' HIS . 84.6 t -57.55 -48.06 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.369 178.586 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -57.62 -32.88 67.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.624 178.602 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 73' ' ' ALA . . . -57.63 -50.39 73.31 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.221 0.534 . . . . 0.0 109.837 179.241 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.005 HD11 HD12 ' A' ' 19' ' ' ILE . 1.1 mt -56.61 -37.26 70.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.555 178.891 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER -77.56 -26.06 50.6 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.395 179.327 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -92.84 -12.4 31.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.061 -178.843 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.926 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -55.17 -20.17 9.73 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.268 179.763 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.41 -95.34 1.35 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.12 179.934 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 39.5 m -134.61 -92.17 0.32 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.096 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.763 HG13 HG22 ' A' ' 7' ' ' THR . 7.0 tp -85.72 89.14 2.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.28 0.562 . . . . 0.0 109.676 178.591 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.926 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 10.7 p -105.91 136.47 40.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -177.457 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 7.2 ttp180 -88.2 102.8 15.16 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.747 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.865 ' CD2' HG13 ' A' ' 60' ' ' VAL . 20.2 mt -90.59 136.24 33.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.813 -179.15 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.586 ' HD1' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -101.86 120.13 39.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.782 -179.889 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG21 ' CG ' ' A' ' 55' ' ' ASP . 29.3 m -123.22 142.95 37.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.564 179.829 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.441 ' HG2' ' CB ' ' A' ' 56' ' ' SER . 16.5 ptp -96.96 152.57 18.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 111.402 -179.676 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -140.57 145.0 36.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.014 179.904 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.939 179.799 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.803 0.335 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.28 143.73 42.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.836 -179.974 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.441 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 5.2 m-85 -109.31 147.45 32.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.025 179.814 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -146.7 154.0 40.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -105.31 144.78 31.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.972 -179.934 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.045 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -135.25 109.97 11.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.891 0.377 . . . . 0.0 111.623 179.819 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.88 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -77.24 119.11 20.45 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.75 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.045 HD13 HD11 ' A' ' 6' ' ' ILE . 5.4 tp -129.73 127.15 39.86 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.164 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.8 pt-20 -83.55 100.83 11.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.855 179.524 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.0 OUTLIER -54.01 89.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.102 178.657 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 14' ' ' GLY . . . -130.38 176.03 19.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.41 -179.115 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.7 m120 54.96 -92.41 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.498 0.19 . . . . 0.0 110.73 -179.853 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 p -108.27 11.38 27.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.62 0.247 . . . . 0.0 110.975 179.669 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' GLY . . . 126.03 -140.12 11.91 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.641 -179.595 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.935 ' HG ' HD23 ' A' ' 8' ' ' LEU . 4.3 tp -70.57 -36.15 73.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.401 179.699 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 45' ' ' ALA . . . 102.78 19.3 13.5 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.422 -0.894 . . . . 0.0 114.808 177.912 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.826 ' HB3' HG23 ' A' ' 39' ' ' ILE . 3.7 p90 -155.23 135.76 13.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.912 0.856 . . . . 0.0 110.89 179.126 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -96.68 135.98 37.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.404 -179.421 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.036 HD12 HD11 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -114.46 146.12 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 CA-C-O 121.603 0.716 . . . . 0.0 111.928 179.79 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.633 ' HB2' HG21 ' A' ' 37' ' ' THR . . . -124.81 118.65 26.85 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.502 -1.227 . . . . 0.0 109.51 177.988 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 70' ' ' HIS . . . 146.08 165.61 11.56 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.575 -179.006 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 32' ' ' PRO . . . 140.93 173.53 13.57 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.244 -179.691 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.752 HG23 ' C ' ' A' ' 68' ' ' VAL . 18.4 p -67.14 -17.79 65.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.366 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -106.39 -27.28 11.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.686 0.279 . . . . 0.0 111.417 -179.67 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -124.32 87.0 54.29 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 42.7 Cg_endo -67.9 64.39 0.94 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.362 2.041 . . . . 0.0 112.607 -179.653 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.785 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 36.2 t60 -47.72 -28.92 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.525 179.207 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.945 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -86.65 -152.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.687 179.776 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.683 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -81.84 52.53 4.61 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.87 -178.761 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.416 ' HA ' ' HB2' ' A' ' 26' ' ' PRO . 1.8 t0 76.59 44.9 0.11 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.039 0.447 . . . . 0.0 110.494 179.575 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -137.14 157.31 74.68 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -179.941 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HB3' HG22 ' A' ' 23' ' ' THR . 7.8 Cg_exo -72.12 -2.2 11.23 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.699 2.266 . . . . 0.0 112.508 179.823 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.47 112.6 0.85 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.006 0.432 . . . . 0.0 111.561 -179.654 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.832 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -88.71 119.89 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.757 179.219 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.945 ' CZ ' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.14 147.9 37.42 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.485 0.659 . . . . 0.0 110.844 179.369 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.045 HD12 HD21 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -69.32 156.04 7.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.565 -177.319 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.633 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -121.67 -28.78 4.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.134 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.614 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -174.25 129.14 0.36 Allowed 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.17 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.987 HD11 HD23 ' A' ' 51' ' ' LEU . 0.9 OUTLIER -93.3 125.02 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.79 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -84.31 132.73 46.59 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.783 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 21.4 Cg_exo -64.37 70.05 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.492 2.128 . . . . 0.0 110.887 178.9 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' ILE . . . -104.82 -25.5 6.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.888 -179.076 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.781 ' O ' ' HB2' ' A' ' 47' ' ' GLN . . . 121.65 -30.59 5.29 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.354 -0.927 . . . . 0.0 112.397 -179.87 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -77.69 -70.32 0.48 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.152 179.707 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.844 ' CB ' HD21 ' A' ' 8' ' ' LEU . . . -75.92 -45.63 34.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.368 -179.832 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -64.49 -42.22 95.99 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.741 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.781 ' HB2' ' O ' ' A' ' 43' ' ' GLY . 0.8 OUTLIER -72.15 -33.31 67.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.78 0.324 . . . . 0.0 111.476 -179.526 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' HB2' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -57.11 -58.36 8.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.08 0.467 . . . . 0.0 111.028 -179.015 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.84 25.83 63.87 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.352 179.616 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.534 ' CB ' HG12 ' A' ' 6' ' ' ILE . 10.0 mtm-85 -108.11 -23.34 12.02 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.895 0.379 . . . . 0.0 110.303 179.553 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.045 HD21 HD12 ' A' ' 36' ' ' ILE . 6.3 tp -104.17 154.24 19.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.428 179.005 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 1.6 ttp85 -134.85 135.7 41.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.688 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 38' ' ' LYS . 54.3 t -49.04 157.01 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.308 0.575 . . . . 0.0 111.539 179.994 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.468 ' N ' HG12 ' A' ' 53' ' ' VAL . 0.6 OUTLIER 73.32 3.03 4.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.084 -179.746 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 1.2 m-20 -71.61 125.86 28.19 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.958 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -86.68 101.39 13.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.608 0.718 . . . . 0.0 111.74 -178.408 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.992 HD11 HG21 ' A' ' 19' ' ' ILE . 12.4 mt -49.33 131.58 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.923 179.84 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 mt -114.74 -35.03 4.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.073 179.281 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 2.0 m-85 -148.8 167.53 25.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.833 -179.919 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.9 HG13 ' CD2' ' A' ' 86' ' ' LEU . 41.1 t -147.74 98.43 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.034 179.471 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.804 ' OD1' HG23 ' A' ' 84' ' ' VAL . 5.5 t30 68.62 -66.61 0.23 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.071 0.462 . . . . 0.0 110.024 -178.769 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.16 32.46 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.741 179.312 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 62.1 t -120.88 142.21 37.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.523 -179.33 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 5.9 p-10 -104.16 110.2 22.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.328 179.103 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.642 HG21 HG22 ' A' ' 57' ' ' ILE . 14.6 m -91.52 19.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.773 -179.523 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -59.55 -28.25 66.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.7 56.24 1.21 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.832 179.977 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.752 ' C ' HG23 ' A' ' 23' ' ' THR . 18.4 m -125.7 143.12 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.924 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 69' ' ' THR . 0.0 OUTLIER -62.32 151.74 35.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 110.692 -179.833 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.607 ' O ' HG23 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -47.88 -34.32 8.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.421 179.658 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.8 t -71.45 -33.88 69.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.932 179.521 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.662 ' HA ' ' HG2' ' A' ' 75' ' ' GLU . . . -67.58 -40.47 84.82 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.553 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CD1' ' A' ' 34' ' ' ILE . . . -63.93 -46.96 82.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.644 0.735 . . . . 0.0 109.399 178.1 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.628 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 73.5 t -58.67 -50.66 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.198 178.676 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 0.2 OUTLIER -56.35 -31.08 63.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.003 178.785 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.578 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.68 -50.45 73.81 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.367 0.603 . . . . 0.0 109.91 179.643 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 19' ' ' ILE . 1.2 mt -59.23 -36.83 76.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.084 179.291 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.628 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 0.3 OUTLIER -77.61 -25.38 49.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.631 179.595 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -101.4 13.96 33.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.736 0.303 . . . . 0.0 111.647 -178.344 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -85.32 11.78 9.5 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.66 -90.16 0.85 Allowed Glycine 0 C--N 1.337 0.608 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.63 179.735 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 10.1 p -144.63 -90.22 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.533 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.88 HG13 HG22 ' A' ' 7' ' ' THR . 9.1 tp -84.08 90.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.191 0.52 . . . . 0.0 109.714 178.67 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.913 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 8.7 p -107.54 139.3 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.361 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.546 ' CG ' HG23 ' A' ' 7' ' ' THR . 10.1 mtp180 -86.92 103.12 15.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.742 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.9 ' CD2' HG13 ' A' ' 60' ' ' VAL . 15.5 mt -92.95 138.28 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.595 -178.788 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -101.84 136.44 41.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.554 179.647 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 57' ' ' ILE . 6.8 m -139.67 167.84 18.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.521 -179.89 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.442 ' HB2' ' OG ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -115.55 150.48 36.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.348 . . . . 0.0 110.869 179.904 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -140.39 140.64 35.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.844 179.911 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.93 -179.991 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HA ' ' HA ' ' A' ' 91' ' ' ARG . 3.6 ttt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.89 0.376 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.18 -169.91 2.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.3 -179.462 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.442 ' CD1' ' HG ' ' A' ' 58' ' ' LEU . 29.2 m-85 -136.18 139.81 43.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.741 -179.988 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -139.45 146.85 40.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.971 179.946 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -103.28 144.38 31.42 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.966 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.984 HD11 HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.36 109.13 8.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.924 0.392 . . . . 0.0 111.6 179.882 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.838 HG22 HG13 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -78.25 113.65 16.4 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.93 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.99 HD23 ' HG ' ' A' ' 15' ' ' LEU . 4.7 tp -124.87 126.94 46.34 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.579 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 2.9 pt-20 -85.82 100.77 12.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.073 179.29 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HB2' ' HA ' ' A' ' 82' ' ' SER . 0.5 OUTLIER -46.97 89.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.323 179.893 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 9' ' ' GLU . . . -50.41 177.72 0.04 OUTLIER Glycine 0 C--N 1.318 -0.456 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.639 -179.93 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -53.82 -26.72 25.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.314 . . . . 0.0 111.145 -179.934 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.2 p -97.4 -22.93 16.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.154 179.998 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.93 -164.6 27.12 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.982 -179.774 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.99 ' HG ' HD23 ' A' ' 8' ' ' LEU . 5.3 tp -59.64 -63.29 1.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.737 -179.976 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 127.51 25.82 1.12 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.422 178.437 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.8 ' HB3' HG23 ' A' ' 39' ' ' ILE . 5.5 p90 -164.8 131.68 3.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.565 0.682 . . . . 0.0 110.849 178.86 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -91.67 138.36 31.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.653 -179.006 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.938 HG21 HD11 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -121.78 142.29 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 CA-C-O 121.711 0.767 . . . . 0.0 112.222 179.78 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.72 ' HB1' ' HB2' ' A' ' 27' ' ' HIS . . . -105.64 117.85 35.09 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 176.695 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.795 ' HA2' HG23 ' A' ' 34' ' ' ILE . . . -73.21 -159.27 5.25 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 115.743 1.057 . . . . 0.0 115.743 -176.258 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.68 -42.93 0.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.783 -0.709 . . . . 0.0 114.15 -177.935 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.67 ' OG1' ' HA ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -73.1 -54.06 9.47 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.039 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.492 ' HB2' ' HB ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -81.25 -43.58 18.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.071 0.462 . . . . 0.0 111.004 -179.621 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 27' ' ' HIS . 0.4 OUTLIER -124.83 83.45 59.41 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.479 179.462 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.95 69.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.638 2.225 . . . . 0.0 112.378 -179.104 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.799 ' CD2' ' CZ ' ' A' ' 35' ' ' PHE . 12.5 t60 -58.23 -18.24 24.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.254 179.31 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.824 HD12 ' CE2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -93.26 -154.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.406 179.409 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.674 ' N ' HG23 ' A' ' 28' ' ' ILE . . . -63.35 -49.5 69.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.57 -179.672 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 167.98 41.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.763 179.995 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.22 155.6 75.98 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 179.897 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.403 ' CB ' HG22 ' A' ' 23' ' ' THR . 73.9 Cg_endo -75.64 55.76 4.39 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.603 2.202 . . . . 0.0 112.345 -179.941 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -117.12 107.12 14.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.365 179.697 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.961 HD11 ' O ' ' A' ' 68' ' ' VAL . 3.1 mt -79.01 130.63 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.994 -179.632 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.824 ' CE2' HD12 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -142.98 152.53 42.07 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.214 0.531 . . . . 0.0 110.389 179.495 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.03 HD12 HD21 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -69.42 155.57 7.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 115.046 -0.979 . . . . 0.0 112.489 -177.096 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -123.09 -28.43 4.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.974 -179.27 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HA ' HG21 ' A' ' 53' ' ' VAL . 0.0 OUTLIER -173.86 130.6 0.41 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.943 -179.625 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.995 HD11 HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -95.33 132.58 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 177.557 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.471 HD11 ' N ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -84.27 114.77 56.74 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.651 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HA ' ' CB ' ' A' ' 46' ' ' ALA . 47.9 Cg_exo -56.36 137.79 81.43 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.733 2.289 . . . . 0.0 112.201 179.913 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 6.91 66.35 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.67 -179.994 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.98 -178.13 22.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.031 179.74 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.882 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -59.48 -33.55 71.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 110.943 -179.955 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.822 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -72.95 -56.92 4.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.781 -179.885 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.478 ' CB ' ' HA ' ' A' ' 41' ' ' PRO . . . -65.45 -31.1 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.855 -179.098 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' HA ' ' A' ' 44' ' ' ALA . 13.7 pt20 -72.15 -32.51 66.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.035 0.445 . . . . 0.0 110.138 179.615 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.536 ' OD2' HD12 ' A' ' 8' ' ' LEU . 11.9 m-20 -80.75 -57.96 3.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.553 179.94 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.54 9.3 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.715 179.564 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' CB ' HG12 ' A' ' 6' ' ' ILE . 17.6 mtt180 -114.96 7.46 15.6 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 179.544 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.03 HD21 HD12 ' A' ' 36' ' ' ILE . 5.9 tp -136.42 154.31 50.83 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.107 0.479 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.567 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -132.35 135.22 46.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.614 179.833 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.621 HG21 ' HA ' ' A' ' 38' ' ' LYS . 60.6 t -49.06 157.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.231 0.538 . . . . 0.0 111.815 -179.878 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' HG12 ' A' ' 53' ' ' VAL . 1.3 t30 78.22 -5.32 2.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.469 179.972 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -64.03 127.93 33.56 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 179.169 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -86.89 105.2 16.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.4 0.619 . . . . 0.0 111.59 -178.846 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.067 HG22 HG21 ' A' ' 65' ' ' VAL . 64.1 mt -48.92 134.87 6.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.522 179.792 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.534 ' C ' HG22 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -120.17 -43.49 2.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.444 179.865 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.7 m-85 -144.55 158.65 43.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.903 -179.893 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.889 HG13 HD21 ' A' ' 86' ' ' LEU . 60.3 t -140.03 98.69 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.256 179.444 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.894 ' OD1' HG23 ' A' ' 84' ' ' VAL . 2.1 t30 67.74 -67.53 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.46 . . . . 0.0 110.22 -178.973 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -155.12 31.69 0.39 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.927 179.361 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 59' ' ' PHE . 47.4 t -120.81 142.39 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.403 -179.312 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 59' ' ' PHE . 7.4 p-10 -103.28 108.84 20.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.473 179.402 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.067 HG21 HG22 ' A' ' 57' ' ' ILE . 29.2 m -97.32 29.46 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.575 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -38.01 80.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.413 . . . . 0.0 110.683 179.762 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -144.23 57.91 1.33 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.786 179.803 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.961 ' O ' HD11 ' A' ' 34' ' ' ILE . 27.6 m -121.19 140.05 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.252 179.341 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.67 ' HA ' ' OG1' ' A' ' 23' ' ' THR . 2.5 p -52.2 150.92 4.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.011 -178.425 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.83 ' O ' HG23 ' A' ' 74' ' ' VAL . 1.9 t-160 -47.07 -33.36 4.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.368 179.552 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 75' ' ' GLU . 0.7 OUTLIER -71.54 -33.76 69.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.183 179.713 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.652 ' O ' ' HG2' ' A' ' 75' ' ' GLU . . . -71.38 -31.7 67.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.125 0.488 . . . . 0.0 109.753 178.827 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.924 ' CB ' HG21 ' A' ' 34' ' ' ILE . . . -71.44 -46.91 58.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.537 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.83 HG23 ' O ' ' A' ' 70' ' ' HIS . 94.6 t -60.87 -50.74 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.457 -1.247 . . . . 0.0 109.728 178.735 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 72' ' ' ALA . 4.8 pt-20 -57.45 -29.56 64.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.66 178.543 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.821 ' CB ' HG21 ' A' ' 60' ' ' VAL . . . -60.59 -51.4 69.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 121.325 0.583 . . . . 0.0 109.795 179.456 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.861 ' CD1' HD12 ' A' ' 19' ' ' ILE . 1.2 mt -58.2 -35.12 71.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.178 179.191 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 74' ' ' VAL . 1.6 mmmt -77.15 -31.75 55.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.859 179.912 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 7.0 pt-20 -96.07 17.22 16.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.527 -178.523 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.916 ' HB1' ' CB ' ' A' ' 84' ' ' VAL . . . -89.54 16.34 7.88 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.323 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 68.01 -103.51 1.01 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.509 179.858 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -127.15 -89.41 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.466 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.838 HG13 HG22 ' A' ' 7' ' ' THR . 7.4 tp -84.68 94.73 3.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.098 0.475 . . . . 0.0 109.878 178.909 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.916 ' CB ' ' HB1' ' A' ' 80' ' ' ALA . 7.6 p -111.06 136.43 47.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -177.444 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 10.4 ptt85 -85.58 102.87 13.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.301 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.889 HD21 HG13 ' A' ' 60' ' ' VAL . 15.9 mt -92.09 139.72 30.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.549 -178.499 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -101.64 135.47 43.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.963 179.39 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.594 HG11 HD11 ' A' ' 51' ' ' LEU . 6.6 m -137.69 168.07 21.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.758 -179.526 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.411 ' N ' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -108.01 141.64 39.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.649 0.261 . . . . 0.0 110.733 -179.989 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.62 106.84 5.23 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.271 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.489 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.03 179.349 . . . . . . . . 2 2 . 1 stop_ save_